data_2lfi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.876 0.369 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 42' ' ' ASP . 40.9 mm -112.64 157.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.842 1.257 . . . . 0.0 109.094 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -124.38 146.96 53.66 Favored Pre-proline 0 N--CA 1.479 1.005 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.64 126.38 12.03 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.071 1.847 . . . . 0.0 111.581 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 41' ' ' ARG . 26.8 pt -127.18 167.39 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.581 0.752 . . . . 0.0 109.802 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 138.78 12.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.554 0.692 . . . . 0.0 111.622 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -87.32 133.83 33.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.9 m -125.29 104.88 8.72 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.2 146.78 24.09 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.131 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.438 HG13 HG13 ' A' ' 34' ' ' ILE . 35.1 m -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' SER . 94.3 t -91.62 102.37 13.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m -101.78 104.27 15.04 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.84 0.856 . . . . 0.0 109.159 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.698 HE21 ' HB2' ' A' ' 98' ' ' GLU . 52.1 tt0 -112.95 125.27 54.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 109.948 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.481 HG23 HG21 ' A' ' 30' ' ' VAL . 85.5 m -99.25 108.09 20.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.479 0.712 . . . . 0.0 109.687 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.495 HG13 ' HB3' ' A' ' 98' ' ' GLU . 1.8 mp -83.57 116.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -95.77 108.81 21.17 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.128 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.601 ' HA ' HG22 ' A' ' 100' ' ' VAL . 97.3 m-85 -79.99 117.98 21.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -137.44 165.57 25.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.979 0.512 . . . . 0.0 109.875 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -94.04 175.53 6.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.312 1.045 . . . . 0.0 109.265 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.26 -21.37 60.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.41 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.05 -19.21 65.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.219 1.007 . . . . 0.0 110.882 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.36 69.12 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.143 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.24 136.8 56.51 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.953 0.901 . . . . 0.0 110.747 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.49 112.9 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.75 72.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.121 0.568 . . . . 0.0 110.203 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -177.11 116.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.401 1.081 . . . . 0.0 109.789 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.46 -38.08 55.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.79 77.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.769 0.428 . . . . 0.0 111.104 -167.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.468 ' HE1' ' HD2' ' A' ' 64' ' ' PRO . 9.4 t-160 -121.45 91.13 3.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.481 HG21 HG23 ' A' ' 14' ' ' THR . 21.6 t -102.14 120.3 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.255 -162.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' A' ' 63' ' ' LEU . 9.0 p -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.879 0.872 . . . . 0.0 109.153 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 67.7 p -136.71 132.01 34.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.79 0.836 . . . . 0.0 109.716 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 60' ' ' PHE . 74.9 mt -110.62 125.67 53.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.438 HG13 HG13 ' A' ' 10' ' ' VAL . 2.4 mp -88.14 112.26 23.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.676 ' HA ' HD22 ' A' ' 56' ' ' LEU . 95.2 m-85 -104.26 124.53 49.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.208 1.003 . . . . 0.0 108.417 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -121.27 107.69 12.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.87 0.468 . . . . 0.0 110.385 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 32.6 tt0 -84.79 95.95 9.13 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 109.089 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -76.12 135.09 39.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.11 -168.12 12.3 Favored Glycine 0 C--O 1.251 1.16 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.43 ' HB2' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -140.02 143.39 36.4 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HB2' HD12 ' A' ' 5' ' ' ILE . 39.6 ttm180 -112.77 122.38 47.48 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.586 0.355 . . . . 0.0 110.261 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.453 ' HA ' HD12 ' A' ' 2' ' ' ILE . 17.3 t70 -71.18 118.2 13.66 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.15 -18.33 55.72 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -75.86 -49.09 18.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.726 0.298 . . . . 0.0 110.24 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 49.7 t-20 -88.68 -31.82 18.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -0.57 58.75 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.854 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 21.2 ptmt -70.33 146.09 50.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.284 1.034 . . . . 0.0 111.591 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.74 112.46 24.16 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.534 0.733 . . . . 0.0 109.855 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.59 93.67 3.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -85.77 140.4 30.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.4 t70 -68.4 110.05 3.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -78.49 -5.46 52.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.736 0.814 . . . . 0.0 111.813 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 7.9 mtmp? -101.65 -4.78 25.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.098 0.559 . . . . 0.0 110.236 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.1 t-105 -62.44 120.31 10.81 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.125 0.57 . . . . 0.0 110.179 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 11.0 p -139.13 111.58 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.168 0.987 . . . . 0.0 108.667 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.676 HD22 ' HA ' ' A' ' 35' ' ' PHE . 64.1 tp -102.21 135.17 44.28 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 11.6 m -98.34 144.95 27.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -148.87 129.32 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 7.0 m -73.67 104.65 4.67 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.754 0.659 . . . . 0.0 110.006 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -65.62 103.53 0.88 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.03 -164.7 0.64 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.254 1.022 . . . . 0.0 108.243 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.1 18.41 10.99 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.525 1.13 . . . . 0.0 111.627 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' A' ' 31' ' ' VAL . 1.2 tm? -107.28 106.09 57.45 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 171.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HD2' ' HE1' ' A' ' 29' ' ' HIS . 73.3 Cg_endo -70.66 -165.13 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.253 2.636 . . . . 0.0 113.728 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 t -164.65 106.52 0.84 Allowed Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 121.4 8.22 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.712 2.274 . . . . 0.0 112.316 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.09 108.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 40.7 mt -101.55 134.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.92 134.46 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.353 0.661 . . . . 0.0 109.891 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.67 20.07 71.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.071 0.857 . . . . 0.0 112.988 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.4 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 65.0 m-85 -139.17 150.75 45.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.651 0.739 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -136.86 118.93 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.15 150.53 48.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.092 0.557 . . . . 0.0 110.336 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.03 -40.6 78.53 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 99.44 16.45 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.126 170.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.16 -2.45 12.34 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.054 2.503 . . . . 0.0 112.117 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.3 ttt -144.31 115.76 8.08 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -80.72 110.16 15.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.496 0.718 . . . . 0.0 111.165 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 59.39 61.43 7.29 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.848 1.342 . . . . 0.0 114.314 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.83 82.43 2.15 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.544 2.163 . . . . 0.0 110.743 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -161.42 137.41 8.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.141 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.0 mt-10 -76.02 89.48 2.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.055 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 t -82.25 126.84 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.553 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 20.0 m -98.46 117.78 33.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.373 0.669 . . . . 0.0 109.909 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.3 t -99.31 116.61 42.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 7.0 p-10 -104.76 172.03 7.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 t -58.53 -30.09 66.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 113.004 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -71.01 -38.19 72.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.127 0.571 . . . . 0.0 111.128 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -107.93 10.83 28.37 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.0 0.52 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.26 -47.19 77.61 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.241 0.616 . . . . 0.0 112.079 -170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.47 -23.67 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.749 0.655 . . . . 0.0 110.814 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.2 143.28 26.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.275 0.63 . . . . 0.0 110.547 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.525 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.53 162.96 22.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 160.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -125.3 -39.22 2.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.82 142.97 45.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -132.68 -52.83 0.93 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.345 1.058 . . . . 0.0 109.447 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.87 148.18 35.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.327 0.584 . . . . 0.0 111.679 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.698 ' HB2' HE21 ' A' ' 13' ' ' GLN . 12.5 tp10 -122.25 155.57 35.62 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.744 1.218 . . . . 0.0 108.627 169.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -139.74 99.78 3.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.7 m -82.22 141.7 14.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.68 110.54 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.967 0.413 . . . . 0.0 110.888 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.61 104.62 10.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 m -98.77 173.93 6.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.23 146.53 15.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 121.137 0.494 . . . . 0.0 111.051 -172.482 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.422 HD11 ' HD3' ' A' ' 40' ' ' LYS . 38.1 mm -112.6 130.45 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.913 0.885 . . . . 0.0 110.655 -172.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.48 143.37 26.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 166.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -77.6 123.44 6.45 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.325 1.35 . . . . 0.0 111.516 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 41' ' ' ARG . 30.6 pt -110.42 172.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.642 0.777 . . . . 0.0 109.807 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -165.92 146.55 6.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.48 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 19.7 mtm180 -113.02 170.15 8.42 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.256 1.022 . . . . 0.0 109.075 168.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.492 HG22 HG23 ' A' ' 34' ' ' ILE . 34.1 m -135.92 106.43 6.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.331 0.652 . . . . 0.0 110.199 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.1 108.27 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.592 0.757 . . . . 0.0 109.024 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.1 m -92.17 145.48 7.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' SER . 92.3 t -119.28 104.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 m -94.84 107.35 19.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.603 0.761 . . . . 0.0 111.654 -166.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.586 HE22 ' HB2' ' A' ' 96' ' ' ARG . 7.2 tp-100 -96.32 104.97 16.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.618 0.767 . . . . 0.0 108.963 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 30' ' ' VAL . 34.5 p -91.75 110.29 21.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -89.5 127.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -107.69 122.56 46.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -92.54 108.06 19.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -117.36 151.17 37.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.94 178.0 8.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.259 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.87 -32.28 73.44 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.33 -18.47 62.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.746 0.818 . . . . 0.0 111.348 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.65 -3.32 56.12 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.932 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.85 142.69 57.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.288 0.635 . . . . 0.0 110.902 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.66 107.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.92 0.488 . . . . 0.0 110.069 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.63 -46.91 74.28 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.243 0.617 . . . . 0.0 109.482 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -161.31 153.87 20.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.646 1.579 . . . . 0.0 108.536 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.72 -153.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.39 0.676 . . . . 0.0 111.548 -173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.89 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.675 1.19 . . . . 0.0 113.356 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -80.98 91.9 6.11 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 165.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 14' ' ' THR . 47.1 t -91.29 123.33 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.232 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 63' ' ' LEU . 7.4 p -115.16 151.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.4 p -143.57 136.1 27.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 70.0 mt -98.32 122.29 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 8' ' ' THR . 2.3 mp -89.01 114.62 27.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.026 0.93 . . . . 0.0 108.901 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.555 ' HA ' HD23 ' A' ' 56' ' ' LEU . 97.9 m-85 -109.93 99.43 8.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.841 0.856 . . . . 0.0 108.726 172.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.7 m -90.17 102.18 14.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.512 ' NE2' ' HB3' ' A' ' 50' ' ' TRP . 38.0 tt0 -78.79 105.68 10.26 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 119.677 -0.201 . . . . 0.0 110.791 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.6 p -74.37 143.53 44.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 124.071 0.857 . . . . 0.0 110.259 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -160.35 10.1 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HD3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -155.79 137.62 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 117.913 0.856 . . . . 0.0 110.876 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.636 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -113.24 128.73 56.56 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.525 0.73 . . . . 0.0 109.156 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 29.0 t70 -79.77 130.15 35.09 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.374 0.67 . . . . 0.0 109.39 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.42 -16.47 45.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 t -94.53 -36.12 11.97 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.401 0.546 . . . . 0.0 110.982 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -89.85 -31.8 17.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.892 0.477 . . . . 0.0 109.962 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.88 27.42 60.59 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HE2' HD12 ' A' ' 49' ' ' ILE . 21.1 ptmt -96.38 140.69 30.66 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.694 0.798 . . . . 0.0 110.946 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.02 115.49 30.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 0.0 110.481 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.414 HD12 ' HE2' ' A' ' 47' ' ' LYS . 3.6 mp -109.77 104.01 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.512 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 74.5 m95 -90.36 145.48 24.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.233 1.013 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 28.1 t70 -67.57 113.85 5.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.16 0.584 . . . . 0.0 110.292 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -62.75 -39.32 93.75 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.913 0.885 . . . . 0.0 112.13 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -82.72 -6.92 59.64 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.671 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HB3' ' HG ' ' A' ' 87' ' ' SER . 60.0 t90 -54.36 124.63 16.54 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 19.9 p -154.34 108.45 2.98 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 35' ' ' PHE . 37.4 tp -101.06 127.0 47.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.9 m -98.83 112.9 24.85 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -119.95 124.77 46.78 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 15.7 m -80.88 135.24 35.88 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.211 0.605 . . . . 0.0 111.619 -174.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -82.61 117.62 22.71 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 158.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -172.45 179.93 2.38 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.001 1.438 . . . . 0.0 109.089 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.53 52.78 4.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.914 0.759 . . . . 0.0 112.273 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 HD22 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -97.33 98.22 4.68 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 168.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.69 92.35 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.782 2.321 . . . . 0.0 111.89 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.1 p -85.82 131.75 46.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.926 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.21 138.57 61.98 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.87 2.38 . . . . 0.0 113.072 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -88.57 111.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 mt -102.56 128.63 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.29 132.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.871 0.468 . . . . 0.0 109.828 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.45 79.87 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.517 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 88.6 m-85 -143.88 157.95 44.02 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.073 0.949 . . . . 0.0 109.107 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.4 m -145.61 116.97 7.96 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.653 0.781 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.32 135.41 57.0 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.673 0.608 . . . . 0.0 109.562 170.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.65 -14.57 61.62 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 0.0 110.773 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.08 84.75 7.23 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.49 1.116 . . . . 0.0 108.575 172.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.16 -5.67 17.01 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.361 2.041 . . . . 0.0 111.661 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 tpt -116.8 109.31 16.95 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.332 1.053 . . . . 0.0 108.312 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 40.6 t -100.96 133.12 45.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 92.53 0.21 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 123.945 0.778 . . . . 0.0 111.59 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -104.44 21.27 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.055 2.504 . . . . 0.0 112.981 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.76 148.02 29.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -165.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 37.1 mt-10 -87.63 129.64 35.05 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.257 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.75 108.84 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.047 0.939 . . . . 0.0 110.016 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 m -92.58 101.13 13.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.4 0.68 . . . . 0.0 110.623 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.25 116.59 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 9.9 t70 -93.46 163.94 13.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.548 ' HG ' ' HB3' ' A' ' 54' ' ' TRP . 49.0 m -57.2 -27.75 62.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.283 1.033 . . . . 0.0 111.93 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -69.69 -30.89 68.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.169 0.988 . . . . 0.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -115.53 8.9 15.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.944 0.498 . . . . 0.0 111.714 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.413 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 82.9 t80 -62.03 -33.89 75.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.876 0.87 . . . . 0.0 112.25 -173.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.74 -18.1 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.323 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -95.63 156.42 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 170.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -141.74 138.71 32.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.691 1.197 . . . . 0.0 108.13 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.36 45.48 0.96 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 0.0 109.694 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.03 121.58 15.02 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.466 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HB2' HE22 ' A' ' 13' ' ' GLN . 53.5 mmm-85 -127.15 177.44 6.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.516 0.726 . . . . 0.0 109.901 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -130.31 122.32 27.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.71 110.59 20.42 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 94.9 m -97.3 122.96 40.92 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.517 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -99.16 137.05 27.77 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.0 mm -100.41 118.76 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 122.782 0.433 . . . . 0.0 110.166 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 91.4 m-85 -88.67 95.63 10.33 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 p -86.65 139.15 31.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.41 114.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.245 1.018 . . . . 0.0 110.649 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 . . . . . 0 C--O 1.241 0.632 0 O-C-N 124.397 1.061 . . . . 0.0 109.758 -177.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.33 154.03 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.801 1.241 . . . . 0.0 109.204 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.07 146.45 53.74 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.59 122.49 5.53 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 121.326 1.351 . . . . 0.0 111.681 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 41' ' ' ARG . 24.5 pt -117.2 169.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 0.0 110.029 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.01 144.21 8.23 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.869 0.468 . . . . 0.0 111.414 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . 84.9 mtt180 -102.06 169.87 8.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.4 1.08 . . . . 0.0 108.946 165.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -144.09 116.85 8.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.099 0.559 . . . . 0.0 110.72 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -114.05 125.03 53.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -104.84 134.64 45.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.21 118.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -109.07 117.64 34.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.206 1.002 . . . . 0.0 110.304 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -90.39 108.64 19.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 p -85.63 104.58 15.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.5 mp -92.68 121.7 43.54 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -125.72 130.91 52.46 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.101 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.652 ' HA ' HG21 ' A' ' 100' ' ' VAL . 71.4 m-85 -92.3 121.99 34.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.956 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -134.99 162.45 32.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.37 0.668 . . . . 0.0 109.32 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -93.33 171.94 8.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.977 0.911 . . . . 0.0 109.444 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.04 -25.13 66.91 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.542 0.737 . . . . 0.0 110.741 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.0 -20.33 66.15 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.89 1.276 . . . . 0.0 111.815 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.52 -19.26 54.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 120.075 -0.291 . . . . 0.0 112.481 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.25 137.51 52.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.024 0.93 . . . . 0.0 110.901 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.98 109.95 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.81 63.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.115 0.566 . . . . 0.0 109.973 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -153.67 166.85 31.52 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.83 1.252 . . . . 0.0 110.487 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.62 82.0 0.59 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -171.76 -3.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.473 ' HB3' HD21 ' A' ' 63' ' ' LEU . 22.1 m170 -99.46 82.22 2.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.67 1.123 . . . . 0.0 111.269 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.91 130.96 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.4 117.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 m -105.83 127.42 53.1 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.445 1.098 . . . . 0.0 108.954 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 58' ' ' GLN . 94.9 mt -108.67 130.86 55.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.461 0.705 . . . . 0.0 110.06 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.3 118.9 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 108.921 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -108.13 104.16 13.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.0 m -94.63 105.75 17.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.425 0.69 . . . . 0.0 109.484 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 35.4 tt0 -79.8 83.79 5.69 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -74.36 133.44 42.51 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.99 -162.08 9.04 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 142.06 32.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.584 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.5 ttm180 -112.2 124.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.295 0.638 . . . . 0.0 109.949 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.53 120.79 20.56 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.4 mt -83.8 -27.31 28.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -73.22 -41.16 64.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.898 0.317 . . . . 0.0 111.026 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -87.98 -29.73 20.55 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.98 36.34 32.32 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -104.37 142.47 34.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.659 0.784 . . . . 0.0 109.69 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.15 114.1 25.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.42 116.44 34.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -114.58 132.72 56.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.78 127.04 32.21 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 t -67.77 -31.05 70.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.975 0.91 . . . . 0.0 111.789 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -86.56 2.75 47.01 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.02 0.528 . . . . 0.0 111.449 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.567 ' CZ2' ' HB2' ' A' ' 56' ' ' LEU . 77.6 t90 -58.79 134.52 56.93 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.32 0.648 . . . . 0.0 110.564 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.1 p -156.04 122.14 5.04 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.909 0.883 . . . . 0.0 109.321 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.567 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 1.5 tm? -104.38 133.86 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -107.12 123.21 47.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.309 0.644 . . . . 0.0 110.31 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.6 mm-40 -129.2 134.01 47.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 0.0 108.902 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.8 m -97.41 118.68 34.42 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.408 0.683 . . . . 0.0 111.377 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -72.94 119.67 17.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -170.09 -163.47 0.36 Allowed 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.534 1.146 . . . . 0.0 108.56 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 64.32 19.69 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.254 1.021 . . . . 0.0 112.544 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 29' ' ' HIS . 35.9 tp -139.74 98.93 7.74 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.287 0.635 . . . . 0.0 109.372 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 77' ' ' MET . 53.6 Cg_endo -88.89 -166.47 0.25 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.366 2.711 . . . . 0.0 111.899 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -116.57 147.11 39.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.129 0.972 . . . . 0.0 110.501 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HG2' ' HH ' ' A' ' 102' ' ' TYR . 18.1 Cg_endo -59.68 125.11 16.9 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.546 2.164 . . . . 0.0 111.555 171.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.87 109.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.26 1.024 . . . . 0.0 109.908 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.02 123.45 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -73.6 135.29 27.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.525 1.53 . . . . 0.0 108.895 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.02 -1.41 86.69 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.599 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 94.5 m-85 -139.5 168.43 19.83 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 117.681 0.74 . . . . 0.0 112.157 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -150.45 121.5 7.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.465 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 147.16 52.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.428 0.691 . . . . 0.0 111.121 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -63.12 -32.42 73.8 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.941 0.896 . . . . 0.0 110.422 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 93.62 7.24 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.1 -1.7 9.95 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.958 2.439 . . . . 0.0 113.266 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 24.8 ttt -148.68 140.06 23.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.28 122.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.02 112.25 3.08 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 124.8 1.312 . . . . 0.0 113.173 -171.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.52 90.49 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.181 2.587 . . . . 0.0 110.677 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -140.17 137.37 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.72 106.22 9.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.592 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.39 112.53 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.508 1.123 . . . . 0.0 109.263 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -100.85 135.51 42.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.97 0.508 . . . . 0.0 110.593 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -103.79 124.67 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.34 164.29 13.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.046 0.939 . . . . 0.0 109.309 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.0 t -58.31 -37.75 75.71 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.764 1.226 . . . . 0.0 112.972 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.16 -41.32 22.6 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.826 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.3 -0.8 51.29 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 117.755 0.252 . . . . 0.0 111.577 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -57.91 -31.32 66.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 0.0 112.388 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.56 -21.79 61.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.32 0.648 . . . . 0.0 111.372 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.19 120.53 40.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.82 0.848 . . . . 0.0 109.45 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.15 105.32 3.93 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.731 0.777 . . . . 0.0 109.05 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -84.65 41.65 0.86 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 111.039 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.95 160.92 19.61 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.247 1.019 . . . . 0.0 111.449 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.63 169.22 19.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.008 0.523 . . . . 0.0 110.215 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.28 126.31 42.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.84 0.856 . . . . 0.0 109.64 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 15' ' ' ILE . 15.7 mm-40 -101.39 123.14 44.98 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.017 0.527 . . . . 0.0 109.744 169.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -109.15 109.8 20.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 17' ' ' TYR . 1.1 m -85.77 141.49 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.209 0.603 . . . . 0.0 109.97 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 94.9 m-85 -76.66 107.8 9.21 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.6 p -109.15 142.03 40.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.07 124.8 10.81 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 124.369 1.043 . . . . 0.0 110.525 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.7 p30 . . . . . 0 CA--C 1.56 1.332 0 C-N-CA 123.956 0.902 . . . . 0.0 110.728 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.7 tpt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.111 0.481 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 42' ' ' ASP . 38.0 mm -102.65 143.46 15.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.908 0.883 . . . . 0.0 109.319 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.78 146.77 51.55 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.97 123.0 4.99 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.478 1.452 . . . . 0.0 111.315 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.582 HD13 ' HB2' ' A' ' 41' ' ' ARG . 38.9 pt -116.76 169.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.329 0.585 . . . . 0.0 110.874 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.428 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -161.31 152.41 18.54 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.007 174.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.412 ' NH2' HD23 ' A' ' 91' ' ' LEU . 27.3 ttp180 -124.2 147.7 47.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.522 HG22 HG23 ' A' ' 34' ' ' ILE . 51.4 m -116.91 106.8 13.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.335 0.654 . . . . 0.0 110.881 -169.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -107.05 102.94 12.25 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.66 127.01 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 32' ' ' SER . 59.7 t -91.4 103.25 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.7 m -96.18 100.56 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.293 -172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 35.1 mm-40 -92.62 100.91 13.34 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -87.01 104.42 16.29 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 68.6 mt -89.89 123.77 42.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 111.545 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 22.9 m170 -101.18 120.56 40.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.574 ' HA ' HG22 ' A' ' 100' ' ' VAL . 17.7 m-85 -90.89 116.51 28.77 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 43.8 mtm105 -134.14 177.08 8.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.267 0.627 . . . . 0.0 109.96 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.501 ' HH ' HD13 ' A' ' 68' ' ' ILE . 92.3 m-85 -104.06 169.59 8.41 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.231 1.012 . . . . 0.0 109.648 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.39 -26.24 68.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.151 0.58 . . . . 0.0 111.28 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.41 -17.26 63.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.271 1.028 . . . . 0.0 110.618 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.57 32.85 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.06 44.65 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.088 0.955 . . . . 0.0 111.862 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 37.7 t -86.73 121.6 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.691 0.396 . . . . 0.0 109.977 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.68 -57.15 3.97 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -168.49 103.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 109.655 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 5.0 p-10 -86.48 -171.41 3.53 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.98 0.512 . . . . 0.0 111.44 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 66.06 16.19 10.36 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.438 1.095 . . . . 0.0 112.56 171.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -89.59 90.54 8.3 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.6 145.42 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 124.534 1.134 . . . . 0.0 112.092 -169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 ' HB ' HD12 ' A' ' 63' ' ' LEU . 5.4 p -125.65 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.4 m -129.01 132.49 47.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.885 0.374 . . . . 0.0 110.723 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.89 123.84 45.69 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 8' ' ' THR . 2.6 mp -82.82 112.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.491 ' HD1' ' HB2' ' A' ' 56' ' ' LEU . 97.3 m-85 -108.83 100.76 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -98.65 108.16 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.501 1.121 . . . . 0.0 110.264 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.52 114.26 20.81 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -87.15 146.81 25.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.355 0.597 . . . . 0.0 110.243 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.48 -157.72 9.74 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.919 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 140.27 25.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.344 0.572 . . . . 0.0 110.007 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.582 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.4 ttm180 -104.64 135.63 45.69 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.332 0.586 . . . . 0.0 109.666 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HA ' HD13 ' A' ' 2' ' ' ILE . 34.6 t70 -82.08 109.59 16.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.831 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 1' ' ' MET . 88.4 mt -81.88 -2.95 52.94 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 t -92.51 -37.53 12.45 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.408 0.549 . . . . 0.0 111.042 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.6 -28.01 13.75 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.143 0.577 . . . . 0.0 109.734 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.88 37.06 9.59 Favored Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -113.65 140.98 47.76 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.568 0.747 . . . . 0.0 109.737 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.1 121.4 38.94 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.391 0.677 . . . . 0.0 110.203 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.36 97.68 5.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.428 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 79.1 m95 -91.95 141.47 28.59 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.7 t70 -69.03 116.39 9.43 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.8 p -66.58 -30.38 70.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.703 0.801 . . . . 0.0 111.627 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.597 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 7.9 mtmp? -80.97 -16.44 53.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.618 0.767 . . . . 0.0 111.151 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.498 ' HB3' ' HG ' ' A' ' 87' ' ' SER . 60.4 t-105 -62.07 132.23 52.19 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.112 0.565 . . . . 0.0 111.883 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.1 p -155.03 144.66 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.896 1.278 . . . . 0.0 108.307 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB2' ' HD1' ' A' ' 35' ' ' PHE . 96.7 mt -120.13 130.1 54.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.232 0.613 . . . . 0.0 109.413 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 m -106.22 119.95 40.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.89 145.3 44.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.774 0.829 . . . . 0.0 108.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 82' ' ' GLU . 16.6 m -99.18 123.61 43.6 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.089 0.556 . . . . 0.0 111.376 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -65.2 128.32 35.34 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 159.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -171.43 168.61 6.46 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.359 0.663 . . . . 0.0 110.837 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.51 14.62 9.65 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.219 1.408 . . . . 0.0 113.339 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 ' HB ' ' A' ' 31' ' ' VAL . 4.6 mm? -62.63 113.21 8.3 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.785 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.54 166.23 28.04 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.157 1.905 . . . . 0.0 110.555 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -156.15 123.08 2.67 Favored Pre-proline 0 N--CA 1.472 0.629 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.44 125.0 15.26 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.307 2.005 . . . . 0.0 111.945 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.9 t -77.18 104.77 5.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.501 HD13 ' HH ' ' A' ' 19' ' ' TYR . 32.5 mt -101.71 113.4 37.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -175.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.1 mm -75.58 134.87 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.303 0.641 . . . . 0.0 109.854 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.01 4.22 82.13 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.969 -169.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -134.43 167.57 20.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.963 0.905 . . . . 0.0 110.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.4 m -156.03 117.55 3.92 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 152.42 38.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.233 0.54 . . . . 0.0 111.702 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.46 -26.88 60.32 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.79 1.236 . . . . 0.0 109.668 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 92.97 4.12 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.767 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.61 3.53 7.63 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.564 2.176 . . . . 0.0 112.659 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 ttt -147.41 78.27 1.46 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.252 0.621 . . . . 0.0 110.151 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.8 t -84.67 152.79 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.74 -81.49 0.34 Allowed Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.112 -1.382 . . . . 0.0 111.724 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -31.75 78.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.762 1 C-N-CA 125.589 4.192 . . . . 0.0 117.073 -162.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -161.32 144.11 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 109.713 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 28.0 mt-10 -91.76 120.54 32.58 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.48 128.6 51.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.196 0.999 . . . . 0.0 109.055 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 29.2 m -110.25 109.67 20.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG21 ' NE2' ' A' ' 94' ' ' GLN . 86.9 t -95.76 110.59 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 163.63 19.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.463 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.498 ' HG ' ' HB3' ' A' ' 54' ' ' TRP . 57.5 m -67.84 -27.15 66.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.812 0.445 . . . . 0.0 111.364 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -76.27 -29.47 57.46 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.327 0.651 . . . . 0.0 112.735 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -116.07 23.82 11.9 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.563 0.345 . . . . 0.0 110.998 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -61.44 -48.51 80.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.785 0.834 . . . . 0.0 111.897 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.412 HD23 ' NH2' ' A' ' 7' ' ' ARG . 3.2 mm? -75.28 -10.48 59.5 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -83.76 120.24 25.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.163 0.585 . . . . 0.0 109.724 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.57 148.86 40.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.068 0.937 . . . . 0.0 111.428 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.437 ' NE2' HG21 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -137.1 14.64 3.05 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.82 168.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -79.79 140.96 36.68 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 46.2 ttp85 -172.28 169.76 5.28 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.9 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.57 135.22 36.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.184 0.994 . . . . 0.0 108.668 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 5.5 mm-40 -126.27 111.38 14.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.34 1.056 . . . . 0.0 110.401 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 m -96.2 130.77 43.19 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.573 -0.704 . . . . 0.0 110.578 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.0 m -96.0 143.07 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 164.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.0 mm -114.69 110.47 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.858 0.463 . . . . 0.0 110.543 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -88.26 102.51 14.9 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 m -87.01 172.93 9.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.76 156.67 8.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -168.151 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 40' ' ' LYS . 32.8 mm -127.31 154.88 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.841 0.857 . . . . 0.0 109.93 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 10.6 pt-20 -121.75 146.06 44.78 Favored Pre-proline 0 N--CA 1.485 1.293 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 165.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.69 125.38 11.06 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.873 1.716 . . . . 0.0 111.265 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 41' ' ' ARG . 32.6 pt -128.15 174.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.664 0.785 . . . . 0.0 109.825 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.55 150.19 7.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 110.951 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -108.99 151.95 25.63 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -134.91 107.93 7.62 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.174 0.59 . . . . 0.0 110.264 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -105.43 124.16 49.08 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.2 m -104.26 139.17 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' SER . 38.8 t -94.76 104.97 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -102.17 102.39 12.83 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.678 ' HG2' ' HB3' ' A' ' 96' ' ' ARG . 25.1 mt-30 -104.46 121.35 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.793 0.837 . . . . 0.0 109.803 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.499 HG21 HG22 ' A' ' 30' ' ' VAL . 32.0 m -92.24 103.4 15.87 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -84.81 128.3 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.241 0.617 . . . . 0.0 109.435 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -106.13 137.69 43.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -108.96 121.25 44.73 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 3.7 tpp180 -145.85 130.15 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 161.58 25.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.289 0.635 . . . . 0.0 110.564 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.22 -25.0 68.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.745 0.818 . . . . 0.0 112.218 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.03 -9.2 58.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 111.62 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.28 68.66 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.94 55.0 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 123.686 0.794 . . . . 0.0 110.232 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 27' ' ' ASP . 47.9 t -90.15 110.08 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.596 0.758 . . . . 0.0 110.521 -172.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.26 -49.46 13.68 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.213 0.205 . . . . 0.0 110.676 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -176.99 90.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.751 1.22 . . . . 0.0 108.463 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.613 ' HB2' HG11 ' A' ' 24' ' ' VAL . 8.8 t70 -98.62 41.08 1.15 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.256 0.623 . . . . 0.0 111.757 -161.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -152.99 16.46 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.63 -0.669 . . . . 0.0 111.883 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.496 ' HE1' ' HG2' ' A' ' 64' ' ' PRO . 9.5 t60 -75.74 93.14 3.08 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 120.725 0.297 . . . . 0.0 110.97 -173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 14' ' ' THR . 39.2 t -95.3 146.03 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 122.784 0.434 . . . . 0.0 110.452 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.16 149.11 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.459 1.103 . . . . 0.0 108.472 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 62.1 p -143.4 127.42 17.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 26.3 mt -104.91 127.16 52.63 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 174.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.7 115.94 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.134 0.973 . . . . 0.0 108.986 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HA ' HD22 ' A' ' 56' ' ' LEU . 69.3 m-85 -108.02 110.43 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 m -111.18 108.24 17.84 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -94.31 110.0 21.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -76.79 142.46 40.34 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.545 0.528 . . . . 0.0 109.8 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.16 -165.54 11.17 Favored Glycine 0 C--O 1.248 1.015 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HB2' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -142.43 139.45 31.63 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HB2' HD12 ' A' ' 5' ' ' ILE . 40.0 ttm180 -107.75 122.93 47.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.638 0.199 . . . . 0.0 110.949 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.1 114.04 6.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.613 1.165 . . . . 0.0 109.403 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.9 -20.21 35.86 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -78.68 -40.22 34.49 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.255 0.48 . . . . 0.0 110.757 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -91.66 -29.81 16.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.662 0.785 . . . . 0.0 110.229 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.6 44.72 7.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HE3' HD13 ' A' ' 49' ' ' ILE . 30.4 ttpt -116.0 142.43 46.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.618 1.567 . . . . 0.0 109.172 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -108.91 121.17 44.54 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.892 0.477 . . . . 0.0 110.451 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.481 HD13 ' HE3' ' A' ' 47' ' ' LYS . 3.7 mp -98.59 107.73 20.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.511 1.124 . . . . 0.0 108.275 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.06 119.32 39.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 37.2 t70 -62.69 115.78 4.61 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.369 0.668 . . . . 0.0 109.883 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 m -64.47 -26.28 68.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.421 1.088 . . . . 0.0 111.936 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -82.47 -13.25 57.04 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.951 0.901 . . . . 0.0 111.414 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.2 t-105 -68.75 137.49 54.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.527 0.731 . . . . 0.0 110.383 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.3 p -152.42 146.92 25.69 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.256 1.022 . . . . 0.0 108.738 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 35' ' ' PHE . 36.9 tp -124.81 125.39 43.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.3 m -97.54 112.32 24.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.49 132.74 53.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.55 HG21 ' HG2' ' A' ' 61' ' ' GLU . 4.8 m -68.43 108.79 3.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.86 0.725 . . . . 0.0 109.986 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.584 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -97.06 96.73 8.67 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.55 ' HG2' HG21 ' A' ' 59' ' ' THR . 11.4 pt-20 -168.41 -159.95 0.29 Allowed 'General case' 0 C--O 1.245 0.846 0 C-N-CA 124.098 0.959 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.81 31.55 16.38 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' HB ' ' A' ' 78' ' ' VAL . 2.2 tm? -84.55 107.94 12.99 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HG2' ' HE1' ' A' ' 29' ' ' HIS . 56.1 Cg_endo -71.29 89.94 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.149 2.566 . . . . 0.0 113.278 -170.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -85.64 125.98 67.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.967 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.7 118.59 5.47 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.443 2.096 . . . . 0.0 110.469 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.92 108.53 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mt -107.37 117.53 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.365 0.602 . . . . 0.0 109.991 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.64 138.95 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.675 1.59 . . . . 0.0 109.344 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.74 8.91 87.19 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.698 0.624 . . . . 0.0 112.253 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.4 m-85 -140.51 167.68 21.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.478 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -148.67 116.98 6.47 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.809 0.843 . . . . 0.0 109.629 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -64.38 154.25 36.08 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.986 0.914 . . . . 0.0 110.757 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.27 -39.65 91.18 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.078 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 92.53 5.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.139 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.22 -0.3 8.42 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.065 2.51 . . . . 0.0 113.04 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.0 ttt -140.9 89.98 2.3 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 21.4 t -76.68 145.01 10.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.72 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.28 127.92 2.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.18 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 8.7 Cg_exo -72.38 29.48 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 124.12 3.213 . . . . 0.0 115.094 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 69.9 -72.47 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.192 1.397 . . . . 0.0 111.609 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.5 130.12 41.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.779 0.831 . . . . 0.0 109.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.1 t -118.1 114.4 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -96.33 110.73 23.01 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.408 0.683 . . . . 0.0 109.422 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.34 114.34 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -92.23 162.02 14.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.5 0.72 . . . . 0.0 109.782 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -30.95 71.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.236 1.014 . . . . 0.0 111.939 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.524 ' HZ1' ' HB3' ' A' ' 88' ' ' LYS . 7.8 mtpm? -66.03 -29.03 69.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.913 0.885 . . . . 0.0 111.741 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -115.11 4.83 14.72 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.084 0.554 . . . . 0.0 111.831 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.61 -23.82 63.57 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.63 161.7 23.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.991 0.917 . . . . 0.0 109.975 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 156.6 32.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.411 ' OE1' HG21 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -119.74 47.04 1.8 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -54.16 122.35 10.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.21 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.678 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 66.0 ttt180 -133.76 172.2 13.1 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.754 0.659 . . . . 0.0 109.641 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.32 119.72 10.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 43.3 mt-10 -123.44 110.37 15.02 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.018 0.527 . . . . 0.0 110.95 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -85.59 122.29 29.49 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.03 134.7 30.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.159 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 170.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 mm -103.17 119.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 86.5 m-85 -84.04 106.94 16.09 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.994 0.918 . . . . 0.0 108.669 170.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.5 p -107.67 134.93 49.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 108.89 0.24 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.511 1.132 . . . . 0.0 110.442 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 p30 . . . . . 0 N--CA 1.477 0.911 0 C-N-CA 123.652 0.781 . . . . 0.0 112.324 -171.365 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.6 tpt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 42' ' ' ASP . 33.1 mm -126.59 152.51 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.203 1.001 . . . . 0.0 109.001 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.453 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 13.9 pt-20 -128.38 155.14 78.99 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.29 127.08 5.77 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.616 1.544 . . . . 0.0 111.6 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -125.72 168.15 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.144 0.578 . . . . 0.0 110.447 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 150.53 23.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.285 0.634 . . . . 0.0 109.932 174.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.441 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 98.7 mtt180 -114.25 159.64 19.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.057 0.543 . . . . 0.0 109.895 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.596 HG21 HG23 ' A' ' 34' ' ' ILE . 28.6 m -113.54 113.38 25.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -110.75 98.05 7.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.4 m -88.38 133.01 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 105.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 27.6 m -103.39 99.48 9.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.132 0.491 . . . . 0.0 110.228 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' A' ' 96' ' ' ARG . 18.6 mt-30 -94.39 131.8 39.68 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.608 0.763 . . . . 0.0 111.433 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 30' ' ' VAL . 50.9 m -103.54 105.53 15.8 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.8 mp -91.03 130.55 40.03 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -129.45 138.71 51.59 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.649 0.738 . . . . 0.0 110.509 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 66.4 m-85 -94.61 119.65 33.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.92 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 53.8 ttt180 -144.86 134.31 23.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 0.0 111.194 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -71.08 163.02 28.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.446 1.099 . . . . 0.0 112.128 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.83 -38.64 79.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.339 . . . . 0.0 112.787 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.37 -17.72 60.14 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.233 1.013 . . . . 0.0 112.026 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.23 28.39 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.691 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 139.52 39.87 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.47 131.25 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 118.129 0.422 . . . . 0.0 110.498 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.87 -58.03 3.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.321 0.648 . . . . 0.0 109.762 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 97.0 m-70 -150.92 171.4 17.32 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.123 1.369 . . . . 0.0 109.128 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -153.75 29.44 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.413 0.625 . . . . 0.0 111.512 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.01 -3.13 17.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.903 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -88.22 75.85 8.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.655 0.741 . . . . 0.0 109.62 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.477 HG22 HG23 ' A' ' 14' ' ' THR . 27.2 t -100.93 112.49 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.959 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.06 146.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.574 1.149 . . . . 0.0 109.307 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -136.29 141.1 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.569 0.748 . . . . 0.0 110.333 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt -112.61 126.79 55.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.441 171.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 8' ' ' THR . 2.0 mp -88.2 104.61 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.261 1.024 . . . . 0.0 108.936 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.59 ' HA ' HD23 ' A' ' 56' ' ' LEU . 67.1 m-85 -97.13 100.72 12.2 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -82.15 101.94 10.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.545 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -87.48 100.97 13.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -94.07 149.76 20.95 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.827 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.77 -151.31 6.17 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.076 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 142.83 27.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.452 0.701 . . . . 0.0 109.655 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HB2' HD13 ' A' ' 5' ' ' ILE . 21.4 ttm-85 -101.15 126.92 47.9 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.247 0.546 . . . . 0.0 110.09 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.0 t70 -74.58 111.77 10.11 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.51 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.2 mt -83.75 -11.29 57.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -173.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.6 t -78.49 -39.75 37.38 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.766 0.712 . . . . 0.0 110.631 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -94.99 -31.64 13.53 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.36 61.13 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.513 ' HE3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -79.08 139.82 38.01 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.704 0.802 . . . . 0.0 110.216 -173.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.9 124.38 35.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.262 0.625 . . . . 0.0 109.736 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.513 HD11 ' HE3' ' A' ' 47' ' ' LYS . 48.8 mm -111.11 137.4 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.441 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 93.6 m95 -126.49 139.67 53.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -173.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.91 109.15 2.41 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.3 t -61.78 -30.57 70.88 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.009 0.818 . . . . 0.0 111.035 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.83 -3.28 50.6 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.88 0.872 . . . . 0.0 112.04 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 14.5 t-105 -78.51 116.84 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 0.0 109.641 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 p -142.0 130.18 22.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.4 tp -123.23 136.17 54.6 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 m -120.06 117.49 28.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.673 0.789 . . . . 0.0 108.964 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -129.93 149.61 51.58 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.402 ' HG1' ' HG3' ' A' ' 82' ' ' GLU . 60.6 m -106.6 122.58 46.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.438 0.695 . . . . 0.0 112.243 -170.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 66.9 m-85 -71.37 96.66 1.49 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 12.5 pt-20 -139.9 178.9 6.92 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.588 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.78 42.13 31.87 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.359 1.037 . . . . 0.0 110.516 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -105.13 97.28 12.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -174.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -91.11 -165.31 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.235 2.623 . . . . 0.0 112.407 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB2' ' OH ' ' A' ' 102' ' ' TYR . 70.6 p -154.21 146.49 17.33 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.484 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.34 120.44 7.76 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.169 1.913 . . . . 0.0 111.329 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.75 106.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.6 mt -94.85 126.48 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.91 131.2 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.975 0.91 . . . . 0.0 110.877 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.81 5.36 89.88 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.106 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.5 159.32 42.14 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.775 0.797 . . . . 0.0 111.601 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.3 m -147.52 129.02 14.97 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.07 156.17 30.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.519 0.327 . . . . 0.0 111.045 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 -42.15 69.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.37 86.42 58.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.369 169.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.59 -6.19 17.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.362 2.041 . . . . 0.0 111.786 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.4 tpt -143.95 114.2 7.43 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.901 1.68 . . . . 0.0 106.546 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 63' ' ' LEU . 83.0 t -68.81 123.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.5 116.21 8.21 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.319 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 91.3 Cg_exo -48.04 131.07 21.05 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.598 2.865 . . . . 0.0 113.956 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.85 132.89 31.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' HG3' ' HG1' ' A' ' 59' ' ' THR . 4.7 mp0 -82.72 118.63 23.5 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.217 1.007 . . . . 0.0 109.638 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.8 t -102.09 132.82 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.106 0.962 . . . . 0.0 108.831 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 m -113.46 113.35 25.03 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 0.0 110.07 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG23 ' NE2' ' A' ' 94' ' ' GLN . 94.0 t -97.7 112.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.78 157.09 16.97 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.589 1.156 . . . . 0.0 108.473 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.8 t -53.43 -33.04 52.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.654 1.181 . . . . 0.0 112.556 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -69.74 -54.92 11.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.429 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.36 19.95 3.04 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -56.82 -37.18 70.86 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.34 1.056 . . . . 0.0 111.718 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.16 -15.32 53.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.71 0.404 . . . . 0.0 111.06 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.02 118.33 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.841 0.856 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.18 152.44 25.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.938 0.495 . . . . 0.0 109.854 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.422 ' NE2' HG23 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -141.71 23.36 2.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.933 0.893 . . . . 0.0 109.705 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' THR . 21.7 p-10 -65.09 114.07 4.37 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.972 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.532 ' H ' ' HG2' ' A' ' 13' ' ' GLN . 54.9 mtm-85 -82.4 165.29 20.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.886 0.851 . . . . 0.0 110.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.95 123.94 33.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 170.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' A' ' 15' ' ' ILE . 36.6 mt-10 -129.12 125.49 37.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.996 0.518 . . . . 0.0 111.158 -172.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -99.93 125.36 45.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.662 0.785 . . . . 0.0 109.01 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -95.37 137.32 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 51.4 mm -105.99 111.4 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.052 0.141 . . . . 0.0 110.7 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.449 ' OH ' ' HB2' ' A' ' 65' ' ' SER . 79.8 m-85 -85.69 104.26 15.24 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.244 0.618 . . . . 0.0 109.63 175.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -89.77 175.33 7.28 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.02 155.78 1.75 Allowed 'General case' 0 C--O 1.246 0.919 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.483 1.22 0 C-N-CA 124.514 1.125 . . . . 0.0 113.554 -168.597 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 42' ' ' ASP . 30.5 mm -109.62 148.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.417 0.687 . . . . 0.0 109.275 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -123.74 137.18 28.29 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.25 126.62 12.51 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.006 1.804 . . . . 0.0 110.723 174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 41' ' ' ARG . 32.4 pt -128.85 135.61 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -142.4 132.74 24.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -113.66 135.22 54.17 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 34' ' ' ILE . 27.5 m -98.5 104.53 16.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.633 0.773 . . . . 0.0 109.03 -166.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.425 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.9 tp-100 -97.62 92.14 5.76 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 34' ' ' ILE . 19.4 m -88.02 118.34 33.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 94' ' ' GLN . 86.3 t -88.62 107.66 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.6 m -94.52 108.2 20.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.364 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.472 ' HB3' HG12 ' A' ' 31' ' ' VAL . 9.0 tt0 -104.89 106.18 16.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.548 HG23 HG22 ' A' ' 30' ' ' VAL . 94.6 m -93.54 107.05 18.96 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -84.77 127.27 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.159 0.504 . . . . 0.0 110.239 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -112.37 109.5 19.16 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.216 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.588 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 39.7 m-85 -78.47 115.27 18.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.91 160.09 40.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.998 0.519 . . . . 0.0 110.539 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -93.87 168.43 10.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.172 0.989 . . . . 0.0 109.861 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.77 -27.4 67.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.22 -17.16 62.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.358 1.063 . . . . 0.0 111.528 -176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.78 -12.65 42.04 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.33 58.51 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.679 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.54 124.61 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.74 -60.36 2.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.228 0.611 . . . . 0.0 110.577 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.588 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 91.2 m-70 -152.61 105.63 3.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.562 1.145 . . . . 0.0 108.622 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.89 -20.31 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.142 0.577 . . . . 0.0 111.853 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.49 96.53 6.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.116 0.966 . . . . 0.0 110.478 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -146.18 74.58 1.37 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG22 HG23 ' A' ' 14' ' ' THR . 39.6 t -92.28 125.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.363 -167.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 13' ' ' GLN . 3.5 p -105.7 115.45 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 168.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 57.5 p -123.65 117.42 24.97 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.1 mt -97.46 129.66 44.64 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.435 HG13 HG12 ' A' ' 10' ' ' VAL . 2.8 mp -86.84 105.04 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.511 0.724 . . . . 0.0 109.341 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -98.53 107.79 20.33 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 m -75.58 103.14 5.56 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' A' ' 87' ' ' SER . 6.2 tp60 -78.69 100.96 7.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.553 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 39.8 t -99.13 143.29 29.57 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.835 -173.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.51 -164.81 16.14 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.239 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.45 150.7 36.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.434 0.694 . . . . 0.0 109.218 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.562 ' HB2' HD11 ' A' ' 5' ' ' ILE . 38.8 ttm180 -119.74 125.11 47.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.676 0.391 . . . . 0.0 110.716 -171.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.444 ' HA ' HD13 ' A' ' 2' ' ' ILE . 26.4 t70 -75.79 115.68 15.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.952 0.901 . . . . 0.0 108.675 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.63 -15.2 58.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -74.85 -43.42 54.61 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.372 0.606 . . . . 0.0 109.993 -173.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -96.48 -29.09 14.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.925 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.48 27.13 33.62 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 19.6 ptmt -93.83 137.67 32.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.922 0.889 . . . . 0.0 109.933 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.48 116.66 29.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.41 87.86 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -80.57 128.63 33.82 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.9 t70 -62.2 126.33 26.97 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 123.52 0.512 . . . . 0.0 110.313 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -64.44 -29.2 70.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.554 1.142 . . . . 0.0 112.039 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.82 -0.34 42.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.286 0.634 . . . . 0.0 111.882 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 51.4 t-105 -66.18 131.09 45.36 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.026 0.441 . . . . 0.0 111.413 -173.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.0 p -150.24 141.01 22.72 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.107 170.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.87 132.11 55.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.7 m -120.04 128.0 53.11 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.023 0.529 . . . . 0.0 110.149 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.76 144.98 35.79 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m -91.87 124.75 36.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.394 1.077 . . . . 0.0 112.195 -169.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -83.36 111.78 19.32 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.64 -162.35 0.38 Allowed 'General case' 0 C--O 1.238 0.493 0 O-C-N 125.049 1.468 . . . . 0.0 108.547 170.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.5 1.34 1.66 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.285 1.434 . . . . 0.0 112.841 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.23 114.03 50.24 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.49 -163.5 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.889 2.392 . . . . 0.0 113.451 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -158.84 124.88 2.4 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' O ' HG13 ' A' ' 68' ' ' ILE . 18.2 Cg_endo -53.61 123.18 12.73 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.879 2.386 . . . . 0.0 111.168 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.12 109.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.61 0.764 . . . . 0.0 109.737 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 66' ' ' PRO . 52.3 mt -112.78 108.31 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.26 124.74 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 110.555 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.94 56.04 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.603 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -134.85 142.89 46.73 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.697 0.799 . . . . 0.0 111.023 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 105' ' ' ASN . 87.3 m -113.04 117.25 31.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 145.44 47.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 109.993 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.64 -31.31 72.48 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.031 0.933 . . . . 0.0 110.196 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.52 109.31 3.6 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 164.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.27 -5.78 17.08 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.674 2.249 . . . . 0.0 111.749 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.8 ttt -140.12 124.28 17.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.31 155.49 4.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.715 0.806 . . . . 0.0 108.992 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.43 85.98 0.84 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -104.83 24.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.036 2.491 . . . . 0.0 113.549 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -156.48 132.21 9.58 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -165.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.4 mt-10 -72.01 126.88 30.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.109 166.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.68 128.17 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.776 0.83 . . . . 0.0 110.748 174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.0 m -109.92 111.49 22.92 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.497 1.119 . . . . 0.0 108.401 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG13 ' HG2' ' A' ' 9' ' ' GLN . 58.5 t -95.68 108.26 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.92 170.35 11.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.023 0.929 . . . . 0.0 109.57 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.533 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 18.2 p -60.93 -30.08 70.0 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.992 0.917 . . . . 0.0 111.57 170.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -67.54 -63.62 1.02 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.032 0.933 . . . . 0.0 111.453 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -90.9 15.9 10.47 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.284 0.634 . . . . 0.0 111.544 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.425 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 36.3 t80 -55.84 -36.1 67.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.671 1.189 . . . . 0.0 112.303 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.38 -13.54 60.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.994 0.518 . . . . 0.0 111.354 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -101.15 145.05 29.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.868 0.867 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.81 145.54 31.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.47 ' HB2' HG12 ' A' ' 11' ' ' VAL . 64.2 mm-40 -104.06 0.06 29.31 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.973 -0.454 . . . . 0.0 111.994 -170.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -149.82 -172.99 4.29 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.805 0.842 . . . . 0.0 110.203 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -158.37 -160.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.661 0.784 . . . . 0.0 110.265 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.51 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 5.2 mp0 -85.91 106.43 17.1 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 30.7 mm-40 -95.48 111.69 23.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.4 m -104.86 117.02 33.0 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.872 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.2 m -82.56 141.34 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.2 116.43 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 122.66 0.384 . . . . 0.0 110.225 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.437 ' HH ' ' HG2' ' A' ' 66' ' ' PRO . 62.9 m-85 -83.75 99.94 10.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 p -89.73 174.71 7.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.09 153.64 14.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.445 0.566 . . . . 0.0 109.967 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.412 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 5.0 t-20 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 121.246 0.546 . . . . 0.0 111.333 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 mm -120.04 158.03 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.773 1.229 . . . . 0.0 109.594 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 9.0 pt-20 -128.75 151.65 77.53 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.93 124.42 7.39 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 121.652 1.568 . . . . 0.0 110.764 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -114.72 163.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.335 1.054 . . . . 0.0 108.546 171.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 142.33 13.52 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 53.6 mtp180 -107.7 156.26 19.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.993 1.317 . . . . 0.0 108.442 168.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.428 HG23 HG22 ' A' ' 34' ' ' ILE . 37.7 m -129.37 108.55 10.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.095 0.558 . . . . 0.0 110.088 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -98.39 120.98 39.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.1 m -108.11 134.83 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.7 t -100.62 104.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -106.05 120.61 42.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.052 0.541 . . . . 0.0 109.927 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.45 127.18 53.1 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.497 HG22 HG22 ' A' ' 30' ' ' VAL . 59.1 m -94.24 103.68 15.7 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.34 125.32 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.395 0.616 . . . . 0.0 110.389 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -113.28 109.03 18.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.455 ' HA ' HG22 ' A' ' 100' ' ' VAL . 65.9 m-85 -81.0 115.01 20.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 16.0 mmt85 -131.3 159.68 37.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.995 0.918 . . . . 0.0 109.419 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -88.58 174.49 8.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.109 0.563 . . . . 0.0 109.56 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.39 -26.52 66.49 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.947 0.499 . . . . 0.0 110.545 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.14 -19.51 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.849 1.26 . . . . 0.0 111.12 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.47 66.0 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.302 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.42 152.58 42.98 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.411 0.685 . . . . 0.0 111.053 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 27' ' ' ASP . 57.4 t -73.21 114.94 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.47 -45.78 13.24 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -173.99 126.51 0.36 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.455 1.102 . . . . 0.0 108.192 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' HG12 ' A' ' 24' ' ' VAL . 9.9 t70 -131.82 88.03 2.52 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.257 -0.902 . . . . 0.0 111.085 -166.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 p30 179.0 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.419 ' CE1' ' HG2' ' A' ' 64' ' ' PRO . 18.8 m170 -83.37 85.32 7.25 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.911 1.232 . . . . 0.0 111.38 -169.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 14' ' ' THR . 40.5 t -94.97 119.8 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.941 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 63' ' ' LEU . 11.7 p -112.69 150.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 0.0 109.073 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 m -141.64 136.65 31.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 35.7 mt -103.88 124.17 48.46 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG22 HG23 ' A' ' 8' ' ' THR . 2.5 mp -88.57 110.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.629 ' HA ' HD23 ' A' ' 56' ' ' LEU . 98.5 m-85 -105.61 101.24 10.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.989 0.916 . . . . 0.0 109.291 173.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.2 m -97.28 103.25 15.16 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.641 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -85.32 100.79 12.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -80.09 135.65 36.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.09 -163.48 11.91 Favored Glycine 0 C--O 1.245 0.84 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HE2' ' HB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.87 137.78 41.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 5' ' ' ILE . 33.5 ttm180 -111.95 124.84 53.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.86 115.07 8.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.244 1.018 . . . . 0.0 108.266 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.8 -24.84 55.97 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -80.51 -43.42 20.79 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.775 0.262 . . . . 0.0 111.238 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.43 -28.52 20.84 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.582 0.353 . . . . 0.0 110.597 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.02 23.55 48.57 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.88 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 49' ' ' ILE . 20.7 ptmt -94.17 142.68 27.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.375 0.67 . . . . 0.0 110.544 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.5 111.73 24.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.946 0.898 . . . . 0.0 110.553 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.485 ' HB ' ' HE2' ' A' ' 40' ' ' LYS . 3.5 mp -108.03 103.4 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.411 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 73.1 m95 -87.96 152.06 22.34 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 110.103 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.31 105.72 7.52 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.3 p -72.57 -19.74 61.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.894 0.877 . . . . 0.0 110.854 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -85.54 -0.86 56.23 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.481 0.712 . . . . 0.0 110.94 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 89.4 t90 -65.88 132.17 48.02 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 110.368 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 28.5 p -154.56 105.43 2.63 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 35' ' ' PHE . 55.6 tp -97.18 126.71 42.54 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.6 m -97.3 110.37 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.05 134.38 55.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.1 m -69.1 118.83 12.49 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.14 0.976 . . . . 0.0 111.445 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -112.5 92.77 4.14 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.854 0.462 . . . . 0.0 109.985 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -159.83 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.264 1.426 . . . . 0.0 108.164 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.425 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . 70.39 15.74 7.26 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.377 1.071 . . . . 0.0 112.555 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.455 HD23 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -65.86 116.27 30.76 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.159 0.584 . . . . 0.0 110.346 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HG2' ' CE1' ' A' ' 29' ' ' HIS . 57.6 Cg_endo -71.33 86.71 0.79 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.049 2.499 . . . . 0.0 111.792 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.458 ' HB2' ' HH ' ' A' ' 102' ' ' TYR . 56.5 p -89.35 130.78 42.6 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.573 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.85 120.62 8.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.87 1.713 . . . . 0.0 110.737 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.49 102.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.0 111.72 33.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.33 129.22 30.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 123.652 0.595 . . . . 0.0 110.413 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.18 -3.32 86.29 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.013 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 22.0 m-85 -118.13 149.03 41.72 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.186 0.994 . . . . 0.0 108.422 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.1 m -140.66 121.91 14.86 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -67.2 152.22 46.14 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.363 0.665 . . . . 0.0 110.402 175.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.63 -30.96 70.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.287 0.565 . . . . 0.0 110.146 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.27 6.3 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.667 1.187 . . . . 0.0 108.178 173.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.12 -4.2 13.68 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.524 2.149 . . . . 0.0 111.403 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 62' ' ' ALA . 38.0 tpp -146.75 129.86 16.47 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.4 0.68 . . . . 0.0 109.216 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.405 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 94.9 t -96.83 124.35 49.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 O-C-N 124.309 1.006 . . . . 0.0 110.576 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.89 152.34 18.82 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.958 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -85.93 36.69 0.52 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.872 3.048 . . . . 0.0 113.475 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 75.88 -55.16 0.61 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.837 1.655 . . . . 0.0 111.751 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -126.14 150.36 48.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.99 0.916 . . . . 0.0 109.925 170.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.44 118.82 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.658 1.183 . . . . 0.0 108.555 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.0 m -101.15 103.58 14.64 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -95.39 118.9 42.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -88.25 171.83 9.9 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.357 1.063 . . . . 0.0 108.921 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.5 t -69.78 -22.36 63.34 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 123.951 0.782 . . . . 0.0 110.533 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.15 -53.4 25.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.709 0.804 . . . . 0.0 110.119 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -96.5 24.24 6.08 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.728 0.811 . . . . 0.0 111.244 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -72.26 -31.13 65.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.011 0.525 . . . . 0.0 111.249 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.34 -11.43 59.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.521 0.329 . . . . 0.0 110.167 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -94.64 136.19 35.23 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -104.16 146.85 28.16 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.67 21.45 16.15 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 118.57 8.68 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.205 1.002 . . . . 0.0 110.255 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -135.8 176.03 9.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.613 0.765 . . . . 0.0 109.345 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.17 117.72 34.94 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -96.32 132.09 42.16 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.043 0.537 . . . . 0.0 109.99 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.3 m -138.46 107.05 5.86 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.9 m -84.61 141.13 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 39.4 mm -116.83 113.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 95.0 m-85 -81.44 108.95 15.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 109.383 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.5 p -96.09 130.97 42.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.03 96.19 1.71 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.592 0.757 . . . . 0.0 109.767 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 . . . . . 0 N--CA 1.474 0.742 0 C-N-CA 124.286 1.034 . . . . 0.0 109.997 177.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' HD11 ' A' ' 43' ' ' LEU . 14.5 tpt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.867 0.365 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.92 157.11 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.076 1.35 . . . . 0.0 107.886 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HB3' HD12 ' A' ' 43' ' ' LEU . 12.4 pt-20 -134.65 146.86 60.77 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.23 124.19 6.47 Favored 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 121.417 1.412 . . . . 0.0 111.517 171.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 41' ' ' ARG . 27.6 pt -119.28 170.77 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 0.0 110.391 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.64 142.11 4.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 110.543 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 81.3 mtp180 -104.63 169.51 8.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.743 0.817 . . . . 0.0 109.774 170.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.578 HG22 HG23 ' A' ' 34' ' ' ILE . 35.5 m -120.33 108.46 14.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.692 0.797 . . . . 0.0 108.958 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.41 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.2 tp60 -105.81 99.65 9.24 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 31.0 m -89.42 127.91 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.41 116.19 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -104.25 105.06 15.07 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 124.195 0.934 . . . . 0.0 111.464 -163.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 96' ' ' ARG . 9.5 mm100 -91.74 99.19 12.12 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.6 0.76 . . . . 0.0 109.578 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.507 ' HG1' ' HA ' ' A' ' 97' ' ' GLU . 74.7 p -79.31 103.92 9.57 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.86 132.88 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 41.0 m-70 -120.35 119.67 33.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.174 0.989 . . . . 0.0 108.522 -174.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -91.32 116.75 29.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.3 mtm105 -142.11 155.22 45.34 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 123.417 0.687 . . . . 0.0 109.414 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -81.27 170.88 15.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.19 -27.87 69.0 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.035 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.78 -18.99 65.57 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 111.784 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.98 -11.52 69.44 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 148.13 48.87 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.849 0.859 . . . . 0.0 110.617 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 55.4 t -91.4 129.8 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.668 0.387 . . . . 0.0 110.471 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.4 -60.45 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -163.77 90.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.346 1.459 . . . . 0.0 108.97 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.5 p-10 -91.48 28.14 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -131.02 21.97 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 111.93 -170.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.16 81.68 5.55 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.014 -1.054 . . . . 0.0 110.404 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.52 127.59 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.222 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.561 ' HB ' HD21 ' A' ' 63' ' ' LEU . 14.8 p -120.44 150.0 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 55.4 m -138.73 141.15 38.89 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.743 0.817 . . . . 0.0 108.971 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 58' ' ' GLN . 77.4 mt -110.94 132.44 54.2 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.578 HG23 HG22 ' A' ' 8' ' ' THR . 3.4 mp -81.96 115.52 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.885 0.874 . . . . 0.0 108.768 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.42 100.47 10.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.1 m -75.58 105.77 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.83 95.37 7.28 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.695 0.798 . . . . 0.0 109.185 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.8 t -87.68 152.56 22.06 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.33 0.586 . . . . 0.0 111.999 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -166.44 -157.5 10.33 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.596 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.12 140.76 30.99 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.445 0.698 . . . . 0.0 110.229 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.7 ttm-85 -102.96 123.61 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -74.93 113.65 12.48 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 1' ' ' MET . 57.5 mt -82.94 -15.52 50.98 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.1 t -87.28 -38.76 16.0 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.772 0.26 . . . . 0.0 110.385 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -86.88 -32.22 20.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.076 0.55 . . . . 0.0 110.245 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.38 38.23 11.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.489 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -112.8 140.77 47.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.879 0.872 . . . . 0.0 109.993 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -98.65 107.77 20.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.975 0.91 . . . . 0.0 109.752 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.92 117.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.47 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 77.0 m95 -103.62 124.74 49.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.26 110.01 1.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m -65.0 -20.86 66.71 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.928 0.891 . . . . 0.0 112.797 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.94 -21.76 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.271 0.629 . . . . 0.0 110.439 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -59.01 139.02 57.26 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.929 0.768 . . . . 0.0 111.634 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 70.1 p -149.89 132.98 16.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.913 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD12 HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -124.22 125.45 44.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -113.09 133.86 54.81 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.574 ' HB3' HD11 ' A' ' 33' ' ' LEU . 76.5 mm-40 -134.41 145.06 48.56 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 m -92.44 116.65 29.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.534 0.734 . . . . 0.0 110.595 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.2 95.51 1.27 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.424 0.63 . . . . 0.0 110.343 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.7 -164.04 1.93 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.801 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.13 28.37 17.08 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.73 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD21 ' HB ' ' A' ' 31' ' ' VAL . 1.3 tm? -119.29 94.92 48.91 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -86.22 152.37 9.43 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.325 2.683 . . . . 0.0 111.883 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.467 ' HB3' ' HH ' ' A' ' 102' ' ' TYR . 45.9 m -105.1 149.05 37.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.961 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.45 127.7 25.65 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.064 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.76 107.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mt -107.55 133.75 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.67 132.07 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.694 0.797 . . . . 0.0 108.941 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.19 -6.31 81.94 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.934 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -133.82 165.44 24.96 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.382 0.673 . . . . 0.0 110.476 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -151.09 130.05 12.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 154.51 33.9 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.993 0.517 . . . . 0.0 110.939 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -64.68 -38.23 90.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.515 0.674 . . . . 0.0 109.183 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 88.85 28.93 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 114.501 -1.227 . . . . 0.0 107.997 171.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.94 -5.13 16.41 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.841 2.361 . . . . 0.0 112.798 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.3 tpt -147.56 114.91 6.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.33 118.82 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.09 135.51 51.75 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.375 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.69 97.32 0.32 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.287 1.991 . . . . 0.0 111.964 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -114.14 113.17 24.34 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.305 0.642 . . . . 0.0 110.853 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.38 118.14 17.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.336 0.654 . . . . 0.0 111.179 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.87 135.78 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.37 1.068 . . . . 0.0 108.58 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -105.14 110.25 22.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.27 0.628 . . . . 0.0 109.751 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG23 HE21 ' A' ' 94' ' ' GLN . 94.0 t -95.66 108.49 21.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' H ' ' ND2' ' A' ' 89' ' ' ASN . 1.1 p30 -110.86 176.54 4.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.738 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.66 -24.04 65.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.24 -51.16 10.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.198 0.599 . . . . 0.0 110.175 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 86' ' ' ASP . 6.4 p30 -92.23 6.68 45.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.41 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 52.7 t80 -54.75 -34.6 62.74 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.625 1.17 . . . . 0.0 112.251 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.1 -23.64 47.83 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.97 116.05 28.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.297 0.639 . . . . 0.0 109.987 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -79.83 106.15 11.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 122.092 0.949 . . . . 0.0 109.029 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.477 HE21 HG23 ' A' ' 85' ' ' VAL . 15.6 pt20 -91.77 38.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.418 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -70.3 154.44 41.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.44 1.096 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HB2' ' NE2' ' A' ' 13' ' ' GLN . 44.7 mmm-85 -129.5 141.4 51.01 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.244 0.545 . . . . 0.0 111.756 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HA ' ' HG1' ' A' ' 14' ' ' THR . 2.0 tm-20 -102.78 110.41 22.33 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 163.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -115.7 136.16 53.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.382 0.673 . . . . 0.0 110.286 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.4 m -113.47 119.14 36.56 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 167.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.03 140.71 15.37 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.69 120.12 53.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 C-N-CA 122.927 0.491 . . . . 0.0 110.683 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.467 ' HH ' ' HB3' ' A' ' 65' ' ' SER . 54.3 m-85 -85.54 104.83 15.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.603 0.761 . . . . 0.0 109.868 172.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.9 t -98.31 155.45 17.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 128.94 19.07 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.69 0.619 . . . . 0.0 109.39 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.4 p30 . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 122.282 0.233 . . . . 0.0 111.052 -175.476 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 42' ' ' ASP . 41.0 mm -117.35 136.17 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.97 146.16 35.55 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -77.16 124.08 7.05 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 121.507 1.471 . . . . 0.0 109.919 167.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -112.52 -176.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.8 0.84 . . . . 0.0 109.849 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -151.63 146.41 25.79 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.665 0.786 . . . . 0.0 109.008 173.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' THR . 24.8 tpt180 -103.69 138.08 40.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -121.32 105.71 10.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.04 107.35 14.84 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 109.708 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 14.5 m -90.45 119.02 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 93' ' ' LYS . 92.2 t -91.13 118.59 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.487 ' H ' ' HD3' ' A' ' 93' ' ' LYS . 70.7 m -106.96 103.3 12.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.329 0.651 . . . . 0.0 110.434 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 94.03 5.85 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 12' ' ' THR . 82.2 p -86.47 114.47 23.25 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 52.7 mt -110.68 126.19 68.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-O 121.936 0.874 . . . . 0.0 111.234 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.32 110.25 22.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.324 -1.762 . . . . 0.0 106.865 -173.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.449 ' HD1' HG22 ' A' ' 100' ' ' VAL . 23.0 m-85 -82.08 109.78 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.6 mtm180 -141.22 164.22 30.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.35 0.66 . . . . 0.0 109.791 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -92.2 175.95 6.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.401 0.68 . . . . 0.0 110.314 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.62 -25.66 68.06 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.387 171.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.14 -17.08 63.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.603 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.05 -13.5 66.81 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.04 57.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.372 1.069 . . . . 0.0 111.046 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 38.7 t -83.28 114.98 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 122.948 0.499 . . . . 0.0 109.974 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.29 -56.54 4.94 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -170.81 94.5 0.2 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 0.0 110.147 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.84 106.62 18.58 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.768 -0.582 . . . . 0.0 110.169 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -179.71 -6.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.507 0.723 . . . . 0.0 112.292 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -82.85 86.19 6.97 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.266 0.555 . . . . 0.0 111.487 -163.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.02 125.39 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 0.0 110.71 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -120.25 145.51 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -138.65 131.49 29.41 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.642 0.777 . . . . 0.0 109.703 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 87.7 mt -110.69 136.1 50.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 0.0 109.767 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.42 114.71 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -100.94 96.33 7.19 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 85.1 m -113.59 104.27 12.08 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.613 ' HB2' HD21 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -130.92 139.61 50.1 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 61.2 p -90.81 141.55 28.69 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -167.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.96 -142.37 5.46 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.62 139.44 18.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.632 0.716 . . . . 0.0 111.205 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 5' ' ' ILE . 17.2 ttm180 -103.88 127.12 51.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.102 0.561 . . . . 0.0 110.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 32.4 t70 -73.62 111.25 8.58 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.065 0.946 . . . . 0.0 108.914 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.02 -11.37 56.86 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.5 t -83.24 -31.93 26.73 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.359 0.527 . . . . 0.0 110.401 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -101.39 -30.84 11.23 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.049 0.54 . . . . 0.0 110.207 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.05 49.16 4.35 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 20.0 ptmt -130.29 143.77 50.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.502 1.121 . . . . 0.0 109.521 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -95.27 127.67 41.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.075 0.55 . . . . 0.0 110.49 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.88 126.13 61.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.451 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 81.7 m95 -125.07 143.42 50.93 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.304 1.042 . . . . 0.0 108.268 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 23.2 t70 -62.93 143.13 57.98 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.95 0.5 . . . . 0.0 110.384 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.8 p -68.6 -38.21 80.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.232 0.213 . . . . 0.0 111.496 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.18 -0.94 57.49 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.841 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.57 ' HE1' ' HB3' ' A' ' 37' ' ' GLN . 19.5 t90 -48.3 120.64 3.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.991 0.916 . . . . 0.0 111.394 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 p -154.91 130.01 9.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 37' ' ' GLN . 23.6 tp -115.08 139.56 49.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 m -110.87 150.37 29.27 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.487 0.715 . . . . 0.0 109.803 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -153.87 127.91 8.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 m -78.27 110.27 13.14 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.31 0.644 . . . . 0.0 111.286 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.53 130.23 38.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.25 174.42 8.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.821 0.848 . . . . 0.0 109.961 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 69.91 56.81 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.586 1.154 . . . . 0.0 111.802 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 3.5 mm? -113.7 91.83 22.51 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.467 0.707 . . . . 0.0 109.976 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.47 99.9 0.77 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 123.655 2.904 . . . . 0.0 113.097 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.558 ' HB3' ' HH ' ' A' ' 102' ' ' TYR . 66.5 m -78.73 124.25 85.16 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.772 173.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.3 122.93 11.58 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 123.521 2.814 . . . . 0.0 112.895 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.0 108.8 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.0 mt -101.89 117.12 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.9 mm -72.88 135.75 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.202 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.49 84.01 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.709 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -130.22 172.17 12.09 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.279 1.032 . . . . 0.0 110.322 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -144.52 123.53 12.8 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -67.88 131.41 45.46 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.95 -38.58 76.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.854 0.862 . . . . 0.0 109.245 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.6 84.9 49.34 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.604 169.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 57.8 Cg_endo -67.0 -4.39 11.38 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.107 2.538 . . . . 0.0 113.227 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 63' ' ' LEU . 17.1 tpt -143.97 136.62 27.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.281 1.032 . . . . 0.0 108.699 172.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -125.54 126.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 71.67 0.91 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 123.914 0.759 . . . . 0.0 112.551 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -96.67 22.52 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.328 2.685 . . . . 0.0 114.355 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -165.81 -169.19 1.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 118.366 0.53 . . . . 0.0 112.216 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 9.2 mp0 -68.04 133.18 48.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.134 1.374 . . . . 0.0 111.601 -171.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.21 110.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.06 0.944 . . . . 0.0 109.178 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.6 m -96.82 117.19 30.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.955 0.502 . . . . 0.0 109.774 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 90' ' ' PHE . 37.8 t -97.98 116.32 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.55 162.55 14.15 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.796 0.838 . . . . 0.0 110.899 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 39.9 p -57.78 -35.23 70.51 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.52 1.128 . . . . 0.0 110.802 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -49.59 -49.73 45.51 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.007 1.442 . . . . 0.0 111.202 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -118.35 16.12 13.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.818 -172.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 85' ' ' VAL . 9.6 t80 -66.08 -27.07 67.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.543 0.61 . . . . 0.0 112.459 -166.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.5 -16.87 57.03 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -102.65 156.11 17.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.045 1.338 . . . . 0.0 110.201 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 12' ' ' THR . 9.2 ptpp? -111.71 126.68 55.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -77.91 -12.62 60.0 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -116.15 127.66 55.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.75 -93.05 0.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.904 0.882 . . . . 0.0 109.523 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -108.32 104.94 14.43 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 3.3 mp0 -110.68 135.63 51.0 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -121.5 122.09 38.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.423 0.689 . . . . 0.0 110.09 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.6 m -83.23 141.86 14.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.4 110.73 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.089 0.556 . . . . 0.0 110.848 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.558 ' HH ' ' HB3' ' A' ' 65' ' ' SER . 78.5 m-85 -85.94 96.23 9.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 p -99.6 140.05 34.36 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.33 142.09 10.73 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.557 0.536 . . . . 0.0 110.801 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.491 1.6 0 C-N-CA 125.089 1.356 . . . . 0.0 113.016 -162.264 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' HD12 ' A' ' 43' ' ' LEU . 28.0 ttt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 42' ' ' ASP . 49.6 mm -123.91 141.19 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.317 0.647 . . . . 0.0 109.828 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -112.63 128.65 25.28 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 166.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.15 126.63 18.28 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.45 2.1 . . . . 0.0 110.851 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 41' ' ' ARG . 34.0 pt -124.03 -179.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.409 0.684 . . . . 0.0 109.75 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 157.71 24.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.735 1.214 . . . . 0.0 108.291 170.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.502 ' HD3' ' HD2' ' A' ' 90' ' ' PHE . 57.3 ttt-85 -126.77 152.7 46.54 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 35' ' ' PHE . 86.6 m -121.07 108.77 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.454 1.101 . . . . 0.0 108.886 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -100.8 121.78 42.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 34.6 m -105.29 118.09 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 83' ' ' VAL . 97.9 t -97.55 110.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -118.12 131.55 56.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.749 . . . . 0.0 110.57 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 42.3 mt-30 -103.33 100.27 10.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.412 ' HG1' ' HG3' ' A' ' 97' ' ' GLU . 3.1 p -76.83 100.5 5.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 172.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' A' ' 78' ' ' VAL . 13.0 tt -101.55 135.52 37.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 122.261 1.029 . . . . 0.0 111.009 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -118.98 148.42 43.0 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.842 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HH ' HD13 ' A' ' 15' ' ' ILE . 45.7 m-85 -127.17 115.76 19.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 37.5 mtm180 -138.13 152.42 48.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -77.97 169.76 17.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.495 0.718 . . . . 0.0 110.627 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.31 -22.72 63.76 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.843 0.457 . . . . 0.0 111.483 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.96 -12.37 60.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.635 0.774 . . . . 0.0 111.312 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 2.45 68.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.77 147.71 48.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.976 0.51 . . . . 0.0 110.264 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.432 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 96.7 t -82.23 135.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.126 0.571 . . . . 0.0 109.94 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 -63.11 1.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -157.2 97.42 1.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.584 1.154 . . . . 0.0 108.788 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -80.38 -9.23 59.75 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.065 0.546 . . . . 0.0 112.422 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.1 71.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.28 1.032 . . . . 0.0 110.877 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -124.7 122.32 37.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 159.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.35 111.75 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.496 ' HB ' HD22 ' A' ' 63' ' ' LEU . 7.5 p -106.81 125.52 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.759 0.824 . . . . 0.0 108.87 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.3 p -123.92 133.9 53.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.328 0.651 . . . . 0.0 109.418 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 76.7 mt -99.4 123.09 43.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -93.22 116.5 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' THR . 13.7 m-85 -106.43 97.69 7.46 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.4 m -114.57 116.46 28.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.8 44.36 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -76.91 178.12 7.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.926 -165.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.34 -166.73 31.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.186 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 137.74 35.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.7 ttm180 -110.17 124.87 52.35 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.044 0.537 . . . . 0.0 109.887 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 2' ' ' ILE . 26.5 t70 -74.55 113.83 12.25 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.832 1.253 . . . . 0.0 109.882 173.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 1' ' ' MET . 88.9 mt -85.08 -1.86 57.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.6 t -87.67 -28.61 21.71 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.863 0.756 . . . . 0.0 110.842 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -107.59 -30.84 8.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.569 0.348 . . . . 0.0 110.225 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.71 11.98 56.19 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.86 -173.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -84.89 145.95 27.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.041 0.937 . . . . 0.0 110.279 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.29 121.4 42.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.249 0.62 . . . . 0.0 110.273 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.98 116.02 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -108.97 158.86 17.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.59 1.156 . . . . 0.0 109.079 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 54' ' ' TRP . 17.7 t70 -82.9 125.34 31.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -73.0 -25.88 61.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.745 0.418 . . . . 0.0 111.978 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -81.23 -13.17 58.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.14 0.576 . . . . 0.0 110.789 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.512 ' HB3' ' O ' ' A' ' 51' ' ' ASP . 8.8 t90 -69.28 134.58 49.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.138 0.975 . . . . 0.0 111.583 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -152.11 121.41 6.77 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.458 1.503 . . . . 0.0 107.441 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.09 124.86 44.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -109.95 129.84 55.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -129.4 145.48 51.4 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 m -112.01 120.32 41.46 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.841 0.456 . . . . 0.0 111.446 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 13' ' ' GLN . 51.0 m-85 -65.24 136.49 56.68 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 164.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -170.59 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.68 0.792 . . . . 0.0 109.754 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.55 86.09 5.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.783 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 15' ' ' ILE . 3.3 tm? -144.13 112.79 5.24 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -93.17 178.71 1.19 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.552 2.834 . . . . 0.0 111.743 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -159.17 151.38 17.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.211 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.75 117.83 5.36 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 121.963 1.775 . . . . 0.0 110.62 172.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.9 107.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.31 116.33 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.82 139.97 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.7 3.58 89.44 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.401 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.83 171.44 14.51 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.188 0.995 . . . . 0.0 110.073 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -158.5 109.22 2.11 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.17 151.12 46.73 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.559 0.743 . . . . 0.0 111.265 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -73.33 -20.04 60.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.179 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.33 101.57 2.96 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 158.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.26 0.28 5.49 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.151 1.9 . . . . 0.0 113.157 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.6 ttt -150.55 136.67 18.53 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.722 0.809 . . . . 0.0 109.584 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.579 HG12 ' HG3' ' A' ' 98' ' ' GLU . 91.8 t -121.52 107.57 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 163.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.82 -95.74 0.11 Allowed Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.058 -1.412 . . . . 0.0 111.369 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -33.8 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.721 1 C-N-CA 125.463 4.109 . . . . 0.0 115.991 -169.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -168.16 126.73 1.19 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.491 1.116 . . . . 0.0 109.22 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.67 121.5 26.93 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 11' ' ' VAL . 84.2 t -103.23 123.12 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.728 0.811 . . . . 0.0 109.41 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.4 m -103.03 131.17 50.21 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.405 HG21 ' NE2' ' A' ' 94' ' ' GLN . 43.0 t -121.13 112.38 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.99 164.69 23.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.836 0.854 . . . . 0.0 109.251 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.6 p -54.56 -36.52 64.43 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.986 0.804 . . . . 0.0 110.384 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.566 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 7.6 mtpm? -47.87 -49.34 29.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.351 1.46 . . . . 0.0 112.406 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -119.43 23.69 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.675 0.79 . . . . 0.0 111.604 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 12.4 t80 -75.13 -19.76 59.74 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 122.006 -0.434 . . . . 0.0 111.161 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.31 -16.46 27.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.688 0.795 . . . . 0.0 109.196 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -89.08 160.97 16.79 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.204 1.001 . . . . 0.0 109.687 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -111.85 159.55 18.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.58 0.752 . . . . 0.0 109.443 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.405 ' NE2' HG21 ' A' ' 85' ' ' VAL . 12.0 pt20 -143.39 33.39 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.174 0.59 . . . . 0.0 110.064 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.63 166.35 15.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 111.786 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.17 166.11 24.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.837 0.855 . . . . 0.0 111.445 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 19.6 tt0 -129.92 108.29 10.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.579 ' HG3' HG12 ' A' ' 78' ' ' VAL . 25.0 mm-40 -94.29 145.55 24.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.847 0.459 . . . . 0.0 110.104 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.5 m -139.99 98.11 3.39 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.44 142.46 13.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.32 116.74 52.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.017 0.927 . . . . 0.0 110.584 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.87 98.73 9.33 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -83.88 159.96 21.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 144.42 6.97 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.583 0.628 . . . . 0.0 109.805 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.488 1.459 0 C-N-CA 124.655 1.182 . . . . 0.0 112.002 -164.125 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.513 HD13 ' HA ' ' A' ' 42' ' ' ASP . 27.3 mm -116.19 134.07 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.61 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.0 134.99 19.42 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 165.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.51 130.4 24.99 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.687 2.258 . . . . 0.0 111.676 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 41' ' ' ARG . 18.8 pt -125.09 163.72 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.92 0.888 . . . . 0.0 109.995 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -156.3 146.58 21.48 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 12.6 mmm180 -117.72 140.33 49.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.988 1.315 . . . . 0.0 108.506 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.456 HG21 HG23 ' A' ' 34' ' ' ILE . 28.9 m -111.52 122.2 47.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.432 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 5.6 tp-100 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.2 m -119.64 132.82 68.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.051 0.453 . . . . 0.0 110.609 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.61 123.29 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -110.09 105.1 14.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 110.485 -162.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 46.2 tt0 -98.55 109.62 22.35 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.608 HG21 HG22 ' A' ' 30' ' ' VAL . 31.4 m -85.99 104.36 15.54 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.574 0.75 . . . . 0.0 110.378 -177.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -93.08 129.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 122.033 -0.417 . . . . 0.0 110.47 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.412 ' HD1' ' HB2' ' A' ' 27' ' ' ASP . 17.6 m-70 -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.201 1.0 . . . . 0.0 108.452 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -97.73 118.28 33.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 23.7 mtm180 -143.48 159.65 42.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.477 0.711 . . . . 0.0 109.65 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' HH ' HD13 ' A' ' 68' ' ' ILE . 81.1 m-85 -86.5 170.92 11.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.213 1.005 . . . . 0.0 109.916 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -69.15 -22.93 63.91 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.566 0.698 . . . . 0.0 110.313 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.62 -20.94 66.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.327 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.64 -20.51 46.05 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.39 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.17 136.91 52.55 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 0.0 111.452 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 58.7 t -85.57 109.57 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.211 0.604 . . . . 0.0 110.629 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 -49.72 45.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.01 0.524 . . . . 0.0 110.139 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -173.33 90.24 0.08 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB2' ' HD1' ' A' ' 16' ' ' HIS . 5.5 p-10 -71.19 -25.73 62.65 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.25 80.69 2.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.702 0.801 . . . . 0.0 110.386 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -134.18 79.51 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.608 HG22 HG21 ' A' ' 14' ' ' THR . 12.9 t -93.81 118.52 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 113.826 -1.533 . . . . 0.0 108.77 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -102.4 157.71 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -143.27 141.75 31.14 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 109.414 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 88.8 mt -99.9 125.89 45.95 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.456 HG23 HG21 ' A' ' 8' ' ' THR . 3.2 mp -86.06 114.53 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.08 120.2 40.05 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.361 1.464 . . . . 0.0 108.851 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.3 m -100.88 101.73 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.538 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 2.2 mp0 -89.55 79.52 6.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 37.2 p -85.45 137.08 33.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.48 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.43 -156.25 9.71 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.25 135.34 26.95 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.561 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.3 ttm180 -107.44 122.13 46.01 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 109.447 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.513 ' HA ' HD13 ' A' ' 2' ' ' ILE . 12.2 t70 -69.63 127.74 34.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -83.16 -23.01 33.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -71.53 -46.92 58.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.13 0.491 . . . . 0.0 110.006 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -88.71 -32.23 18.06 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.091 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.56 0.29 73.03 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 -169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -67.22 136.58 55.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.476 1.11 . . . . 0.0 110.846 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.58 107.86 18.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.48 0.712 . . . . 0.0 110.288 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.12 91.84 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CH2' ' HG2' ' A' ' 7' ' ' ARG . 36.7 m95 -84.02 124.06 30.66 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 31.6 t70 -52.88 124.43 14.08 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.842 0.714 . . . . 0.0 110.05 -176.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 m -57.85 -37.8 74.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.52 0.728 . . . . 0.0 111.621 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -96.93 16.46 19.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.917 0.887 . . . . 0.0 111.206 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 40.5 t-105 -64.87 142.17 58.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.556 0.342 . . . . 0.0 110.594 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 55.8 p -155.36 140.94 17.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.095 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -116.8 130.44 56.72 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -112.26 124.39 52.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.26 0.624 . . . . 0.0 109.541 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -135.69 141.33 44.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -103.58 126.79 50.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.299 0.64 . . . . 0.0 111.624 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 37.1 m-85 -69.13 112.69 5.9 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.81 -169.66 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.56 1.163 . . . . 0.0 109.072 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.96 5.63 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.342 1.057 . . . . 0.0 112.164 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD21 HG21 ' A' ' 78' ' ' VAL . 31.5 tp -116.63 100.28 53.33 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.804 0.842 . . . . 0.0 108.982 -172.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -92.6 -151.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.285 2.657 . . . . 0.0 111.64 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.45 ' HB2' ' HH ' ' A' ' 102' ' ' TYR . 86.3 p -149.59 145.16 18.65 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.204 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.82 127.58 24.91 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.131 2.554 . . . . 0.0 112.003 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -77.23 106.59 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.449 HD13 ' HH ' ' A' ' 19' ' ' TYR . 64.4 mt -97.2 134.21 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.008 0.923 . . . . 0.0 108.933 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.34 120.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.576 1.55 . . . . 0.0 109.479 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.58 81.32 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.514 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.526 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 93.3 m-85 -139.18 160.76 39.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.53 0.732 . . . . 0.0 110.096 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -151.04 126.36 10.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.4 150.32 35.7 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.749 0.82 . . . . 0.0 111.001 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.8 -29.8 70.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.882 0.739 . . . . 0.0 109.446 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' HG2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -133.48 96.7 16.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.755 168.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.48 -7.6 21.64 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.794 2.33 . . . . 0.0 111.928 175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 tpt -139.12 126.87 22.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 63' ' ' LEU . 88.3 t -65.65 120.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.31 116.46 5.75 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 124.818 1.324 . . . . 0.0 112.694 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 59.9 Cg_endo -70.42 128.96 16.14 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 112.623 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -142.24 135.04 28.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.978 0.418 . . . . 0.0 110.776 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.3 103.9 12.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.581 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -84.03 134.35 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 109.207 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.7 m -121.35 113.78 20.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.363 0.665 . . . . 0.0 109.618 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.17 114.33 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -82.51 174.52 10.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.364 0.602 . . . . 0.0 109.856 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.4 p -71.43 -22.12 61.88 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.934 172.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.21 4.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.126 0.97 . . . . 0.0 109.715 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.66 29.82 3.55 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.323 1.049 . . . . 0.0 110.251 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 9' ' ' GLN . 49.2 t80 -50.94 -48.77 60.77 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.496 1.118 . . . . 0.0 110.634 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 91' ' ' LEU . 1.8 mp -82.58 -23.77 34.28 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.653 -161.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.99 115.07 10.78 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -88.91 106.93 18.73 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.64 46.36 1.33 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.882 0.849 . . . . 0.0 110.229 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -62.55 157.76 19.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.748 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 78.0 ttt180 -157.15 147.3 20.93 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 -172.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.14 144.74 26.11 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 10.4 tp10 -136.34 108.44 7.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 172.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 84.3 m -100.65 122.6 43.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.241 0.617 . . . . 0.0 109.62 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 75' ' ' LYS . 2.4 m -90.71 142.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.24 106.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.474 0.31 . . . . 0.0 110.432 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.526 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 87.2 m-85 -72.75 107.48 5.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.749 1.22 . . . . 0.0 109.682 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p -108.21 140.26 41.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 100.58 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.16 0.984 . . . . 0.0 110.77 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.0 p30 . . . . . 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.971 -171.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.7 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.82 0.343 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.429 HD11 ' HD3' ' A' ' 40' ' ' LYS . 35.4 mm -120.2 142.38 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.204 1.002 . . . . 0.0 109.121 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -120.99 149.92 52.09 Favored Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.26 127.78 13.06 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.395 2.064 . . . . 0.0 111.151 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 41' ' ' ARG . 30.9 pt -135.1 137.21 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 2.2 mptm? -137.13 142.11 42.26 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -116.75 137.67 52.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' ILE . 85.1 m -120.71 104.91 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.361 0.664 . . . . 0.0 109.363 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -105.06 119.2 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.086 0.554 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 32' ' ' SER . 35.0 m -97.5 125.86 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' SER . 57.1 t -90.86 104.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -95.9 102.47 14.27 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.852 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.589 HE21 HD12 ' A' ' 15' ' ' ILE . 28.2 tt0 -108.28 113.03 25.8 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.487 HG22 HG22 ' A' ' 30' ' ' VAL . 95.7 m -92.73 107.53 19.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.865 0.866 . . . . 0.0 109.772 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.589 HD12 HE21 ' A' ' 13' ' ' GLN . 1.6 mp -90.13 130.63 39.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.387 0.613 . . . . 0.0 109.932 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 11.5 m-70 -109.26 110.36 21.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.566 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' HG22 ' A' ' 100' ' ' VAL . 85.0 m-85 -87.29 116.3 25.28 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -134.33 -171.32 2.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.52 0.728 . . . . 0.0 110.528 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -121.43 167.4 12.85 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.61 -17.98 63.57 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.803 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.45 -17.26 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.627 1.171 . . . . 0.0 111.192 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.55 54.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.44 137.98 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.57 1.148 . . . . 0.0 111.244 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.3 137.59 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.208 0.603 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.45 -60.49 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.15 115.29 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.309 1.043 . . . . 0.0 108.893 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.628 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.8 p-10 -102.3 26.29 7.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.654 0.781 . . . . 0.0 112.862 -173.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.23 10.79 39.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.677 0.791 . . . . 0.0 111.776 -173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -90.13 73.06 7.26 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.167 0.984 . . . . 0.0 111.038 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.487 HG22 HG22 ' A' ' 14' ' ' THR . 24.3 t -93.63 119.01 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.898 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG11 HD23 ' A' ' 63' ' ' LEU . 6.1 p -105.84 130.99 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.542 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 60.4 p -122.36 118.34 28.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.597 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 39.7 mt -98.97 122.9 42.83 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.57 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -82.83 124.66 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.097 0.959 . . . . 0.0 109.898 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.44 ' HA ' HD23 ' A' ' 56' ' ' LEU . 85.5 m-85 -115.35 101.82 9.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.194 0.998 . . . . 0.0 109.099 172.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 m -95.82 107.7 19.97 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -94.33 123.81 37.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 57.5 p -88.14 138.73 31.19 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.746 0.654 . . . . 0.0 109.663 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.21 -171.57 18.01 Favored Glycine 0 C--O 1.241 0.566 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.126 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HD3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -136.55 143.84 43.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 5' ' ' ILE . 38.7 ttm180 -114.95 118.62 33.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.632 0.373 . . . . 0.0 110.44 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.04 107.11 8.03 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.505 HD12 ' HG3' ' A' ' 1' ' ' MET . 84.4 mt -79.98 -1.31 39.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.927 0.891 . . . . 0.0 112.719 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -73.42 -43.25 60.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.419 0.688 . . . . 0.0 109.927 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.57 -24.12 14.53 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.925 0.89 . . . . 0.0 109.887 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.85 34.11 35.29 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.733 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -104.13 141.98 35.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 110.777 -172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.92 122.86 41.54 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 123.276 0.63 . . . . 0.0 110.728 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.26 105.23 17.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -102.61 137.25 41.09 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -69.12 118.56 12.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 t -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.392 0.677 . . . . 0.0 111.171 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.27 -18.52 60.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.273 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -61.43 128.03 34.34 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 p -153.99 117.44 4.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.941 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 35' ' ' PHE . 57.0 tp -101.22 130.14 47.28 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 39.3 m -95.55 111.07 23.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.597 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 5.6 tp-100 -112.06 124.66 52.89 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.502 HG21 ' HG2' ' A' ' 61' ' ' GLU . 31.5 m -64.57 118.52 8.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.527 1.131 . . . . 0.0 110.642 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.97 115.03 29.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HG2' HG21 ' A' ' 59' ' ' THR . 12.3 pt-20 -179.32 -161.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.03 0.932 . . . . 0.0 109.897 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.92 -98.39 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.862 1.265 . . . . 0.0 110.276 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HG ' HG12 ' A' ' 15' ' ' ILE . 3.6 mm? 47.36 91.57 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.767 0.827 . . . . 0.0 111.179 -170.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.81 97.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.566 2.844 . . . . 0.0 112.588 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -81.99 113.54 43.98 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.487 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.2 121.2 9.57 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.47 2.113 . . . . 0.0 110.432 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.91 103.62 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.5 mt -107.22 112.91 42.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -76.94 137.87 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.351 0.66 . . . . 0.0 109.786 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.94 4.5 84.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.199 -170.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.9 m-85 -142.63 162.76 34.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.575 0.75 . . . . 0.0 111.415 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -151.19 135.02 16.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.638 1.175 . . . . 0.0 107.85 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 159.18 29.87 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.791 0.836 . . . . 0.0 111.061 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.64 -34.55 74.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 105.12 6.64 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.167 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.82 -4.61 15.69 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.102 1.868 . . . . 0.0 111.688 163.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.5 tpp -135.19 107.38 7.2 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG11 ' HG2' ' A' ' 98' ' ' GLU . 95.7 t -83.7 123.41 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.393 0.677 . . . . 0.0 111.701 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.81 53.58 13.42 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 125.022 1.451 . . . . 0.0 115.397 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.14 80.68 2.12 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.251 1.967 . . . . 0.0 111.851 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -158.48 119.42 3.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.12 0.568 . . . . 0.0 109.703 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.01 100.85 0.45 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 123.967 0.792 . . . . 0.0 111.058 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.4 112.17 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.991 0.916 . . . . 0.0 110.548 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 10.4 m -94.97 101.23 12.99 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.324 0.65 . . . . 0.0 109.267 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.91 124.64 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.94 170.38 16.56 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.994 0.809 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 16.7 t -70.46 -27.0 63.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.34 171.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.27 -49.82 62.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.718 1.207 . . . . 0.0 111.34 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -104.38 23.1 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.837 0.455 . . . . 0.0 111.21 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 52.7 t80 -58.94 -53.46 58.18 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.349 1.059 . . . . 0.0 112.696 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.95 -4.37 37.77 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.259 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.93 134.11 44.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.571 0.748 . . . . 0.0 110.019 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -90.19 172.57 8.7 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.181 0.593 . . . . 0.0 109.939 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 15.06 4.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.768 0.827 . . . . 0.0 110.784 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -162.62 -165.86 1.24 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 108.856 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.74 -53.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.381 0.672 . . . . 0.0 109.858 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -145.03 115.53 7.63 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.654 -170.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.503 ' HG2' HG11 ' A' ' 78' ' ' VAL . 16.7 tp10 -107.25 148.29 29.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.825 1.25 . . . . 0.0 109.777 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -136.85 117.84 14.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.26 0.624 . . . . 0.0 109.975 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -86.7 141.75 13.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.23 120.55 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 56.7 m-85 -80.21 117.79 21.32 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.77 0.828 . . . . 0.0 109.501 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.1 p -110.93 158.43 18.76 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 119.16 8.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.143 0.577 . . . . 0.0 110.638 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 123.911 0.884 . . . . 0.0 112.902 -167.151 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 42' ' ' ASP . 37.0 mm -114.09 154.12 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.692 1.197 . . . . 0.0 109.841 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.23 150.73 49.81 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.86 0.864 . . . . 0.0 108.797 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.1 124.22 4.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.897 1.731 . . . . 0.0 111.674 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -121.55 171.67 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.373 0.669 . . . . 0.0 111.292 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.49 146.68 4.17 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.115 0.884 . . . . 0.0 110.738 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -106.97 165.33 11.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.796 0.838 . . . . 0.0 110.21 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.546 HG21 HG23 ' A' ' 34' ' ' ILE . 93.1 m -131.88 106.29 7.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.145 0.978 . . . . 0.0 109.608 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -114.29 103.4 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 34' ' ' ILE . 27.8 m -89.89 132.23 35.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 121.017 0.437 . . . . 0.0 109.85 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 94' ' ' GLN . 75.8 t -99.79 107.75 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -96.03 107.64 19.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.666 0.786 . . . . 0.0 110.89 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -88.79 113.53 24.44 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 m -107.85 106.95 17.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 108.418 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 63' ' ' LEU . 19.0 tt -104.13 137.71 31.83 Favored 'Isoleucine or valine' 0 C--O 1.265 1.87 0 CA-C-O 122.229 1.014 . . . . 0.0 111.88 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -115.78 161.18 19.12 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.94 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.61 109.5 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.037 0.935 . . . . 0.0 108.872 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 32.1 mtm180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.245 0.618 . . . . 0.0 109.768 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 87.7 m-85 -88.52 176.05 7.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.454 0.702 . . . . 0.0 110.291 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.14 -22.28 60.55 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.468 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.46 -19.71 60.88 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.677 0.791 . . . . 0.0 110.607 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 -10.44 53.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.318 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.54 136.15 57.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.671 0.789 . . . . 0.0 111.076 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 56.0 t -80.35 111.9 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.645 0.378 . . . . 0.0 110.307 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.88 5.46 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -165.92 -175.35 3.36 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.704 1.602 . . . . 0.0 109.038 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.59 -161.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.039 0.936 . . . . 0.0 108.64 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 73.69 35.91 0.8 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.214 1.006 . . . . 0.0 109.799 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -111.37 121.32 44.93 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.18 144.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.031 0.532 . . . . 0.0 110.536 -173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG13 ' HE1' ' A' ' 60' ' ' PHE . 8.3 p -136.95 121.25 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -119.37 131.2 55.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.692 0.797 . . . . 0.0 109.245 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 96.5 mt -105.2 129.11 53.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.158 0.583 . . . . 0.0 110.005 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.546 HG23 HG21 ' A' ' 8' ' ' THR . 2.7 mp -87.53 111.9 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 123.972 0.795 . . . . 0.0 108.956 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.492 ' HA ' HD23 ' A' ' 56' ' ' LEU . 41.3 m-85 -94.19 101.03 13.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.74 104.14 16.44 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -81.14 97.14 7.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 110.131 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 p -76.03 139.3 41.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.585 0.553 . . . . 0.0 110.453 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.48 -160.33 9.66 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.639 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 143.47 29.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.61 ' HB2' HD13 ' A' ' 5' ' ' ILE . 36.0 ttm180 -112.39 128.8 56.41 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.329 0.652 . . . . 0.0 110.489 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HA ' HD12 ' A' ' 2' ' ' ILE . 16.3 t0 -72.59 121.99 20.64 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.94 -21.31 34.12 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -77.23 -49.76 14.39 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -171.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.36 -28.4 21.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.567 0.747 . . . . 0.0 109.676 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.91 30.51 20.42 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.354 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -102.74 136.36 42.7 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.323 1.049 . . . . 0.0 110.06 -176.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -91.65 120.18 32.19 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.093 0.557 . . . . 0.0 110.358 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.31 116.65 36.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -114.28 136.9 52.46 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 6.8 m-20 -64.12 125.73 25.43 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 m -62.1 -41.9 98.68 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.758 0.661 . . . . 0.0 111.088 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.91 7.73 26.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.656 0.782 . . . . 0.0 111.984 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 81.0 t90 -61.46 132.62 54.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -155.33 123.02 5.66 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.049 0.939 . . . . 0.0 108.807 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 35' ' ' PHE . 22.9 tp -109.07 135.05 50.85 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -112.14 116.45 30.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.84 0.856 . . . . 0.0 108.871 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -119.93 144.66 47.32 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.815 0.446 . . . . 0.0 110.141 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 61' ' ' GLU . 31.6 m -88.93 113.05 24.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.587 1.155 . . . . 0.0 112.24 -167.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.536 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 2.7 m-85 -99.98 102.38 13.73 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.935 0.894 . . . . 0.0 109.7 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HG2' HG21 ' A' ' 59' ' ' THR . 11.7 pt-20 -163.39 -165.68 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.285 0.634 . . . . 0.0 109.697 173.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.32 17.04 10.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.351 1.06 . . . . 0.0 111.807 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 15' ' ' ILE . 43.0 tp -102.0 99.7 12.97 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.995 0.918 . . . . 0.0 109.078 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -92.68 -165.34 0.14 Allowed 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.529 2.819 . . . . 0.0 113.344 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -150.67 146.41 19.54 Favored Pre-proline 0 CA--C 1.557 1.218 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.755 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.66 139.4 48.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.536 2.824 . . . . 0.0 113.079 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.87 107.8 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.59 130.49 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.47 129.99 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.3 86.99 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.893 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 86.8 m-85 -140.37 146.31 38.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.34 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.0 m -144.03 134.08 24.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.635 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -66.58 156.61 34.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.639 0.775 . . . . 0.0 111.66 -175.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -65.63 -25.01 67.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.811 0.844 . . . . 0.0 110.214 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HG2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.35 85.19 6.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 -7.32 21.1 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.187 1.925 . . . . 0.0 112.982 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.4 ttt -146.61 95.37 2.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.709 1.204 . . . . 0.0 107.946 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.453 HG22 ' HG3' ' A' ' 75' ' ' LYS . 53.9 t -71.81 111.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.679 0.792 . . . . 0.0 109.911 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.59 84.74 0.25 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.797 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 28.2 Cg_exo -65.44 0.04 3.18 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.593 2.862 . . . . 0.0 113.655 166.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 72.35 -88.39 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.881 1.672 . . . . 0.0 110.555 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -141.74 139.09 32.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.892 0.877 . . . . 0.0 110.517 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.3 t -116.03 120.33 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.16 0.984 . . . . 0.0 108.963 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.4 m -99.24 101.87 13.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.414 0.686 . . . . 0.0 109.596 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.33 125.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.16 168.0 16.21 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.139 0.976 . . . . 0.0 110.336 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.6 t -62.49 -27.47 69.15 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.267 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.74 -56.73 17.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.429 1.492 . . . . 0.0 110.773 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -105.19 15.38 27.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.648 0.779 . . . . 0.0 111.599 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -61.53 -24.5 66.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 0.0 111.185 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.28 -24.77 61.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.784 0.834 . . . . 0.0 111.156 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.0 136.11 33.42 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 109.264 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.66 138.89 33.55 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.464 ' O ' HG12 ' A' ' 11' ' ' VAL . 44.1 mt-30 -100.24 57.45 0.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.93 96.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -90.11 142.57 27.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.942 1.297 . . . . 0.0 109.864 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.68 125.09 10.93 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -134.91 141.56 46.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.473 0.709 . . . . 0.0 110.046 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.2 m -107.27 131.65 53.97 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.635 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 6.3 m -83.78 139.43 17.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.01 107.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 122.883 0.473 . . . . 0.0 110.196 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . 93.6 m-85 -74.96 103.33 5.12 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.08 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.0 p -111.72 147.96 34.49 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 126.4 22.14 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.03 0.831 . . . . 0.0 110.356 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 p30 . . . . . 0 N--CA 1.474 0.746 0 O-C-N 123.268 0.355 . . . . 0.0 110.433 179.509 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.0 140.2 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.577 0.751 . . . . 0.0 109.618 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.91 151.77 58.44 Favored Pre-proline 0 N--CA 1.476 0.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.92 121.4 3.61 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.512 1.475 . . . . 0.0 109.955 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 41' ' ' ARG . 17.4 pt -109.8 169.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.845 0.858 . . . . 0.0 109.483 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 141.35 11.24 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.198 0.523 . . . . 0.0 111.036 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -112.36 136.26 52.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.505 HG22 HG23 ' A' ' 34' ' ' ILE . 87.3 m -114.01 107.81 16.17 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.695 0.798 . . . . 0.0 109.752 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -101.4 113.21 26.09 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.273 0.629 . . . . 0.0 109.445 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 21.7 m -96.6 146.36 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 94' ' ' GLN . 68.5 t -105.77 104.29 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.579 ' HB ' HD21 ' A' ' 95' ' ' ASN . 22.8 m -101.33 103.15 14.1 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 110.081 -171.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 12.8 mm100 -94.92 113.2 24.89 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.978 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.53 ' HB ' ' HG2' ' A' ' 97' ' ' GLU . 85.1 m -92.64 104.41 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 2.0 mp -93.01 131.52 39.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.527 0.679 . . . . 0.0 110.25 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 2.3 p80 -133.83 118.62 18.2 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.126 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' HA ' HG12 ' A' ' 100' ' ' VAL . 56.2 m-85 -78.61 130.49 35.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.522 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 41.9 mtm180 -141.45 162.06 36.41 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 123.931 0.892 . . . . 0.0 109.314 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -89.54 175.08 7.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.73 -25.1 68.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.409 0.684 . . . . 0.0 112.097 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.52 -20.14 61.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.127 0.971 . . . . 0.0 111.104 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.03 3.29 60.54 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.373 0.421 . . . . 0.0 112.652 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.6 130.03 39.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.504 0.721 . . . . 0.0 109.532 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 34.9 t -82.55 103.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.274 0.488 . . . . 0.0 109.975 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -61.28 -39.59 91.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.337 0.655 . . . . 0.0 111.087 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -168.81 145.82 3.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.695 0.798 . . . . 0.0 109.005 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -137.52 109.99 7.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.408 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 174.55 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 124.689 1.243 . . . . 0.0 112.494 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.4 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 2.5 t-160 -75.99 78.64 2.86 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.88 0.738 . . . . 0.0 112.398 -155.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 14' ' ' THR . 48.2 t -92.44 128.36 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.96 166.03 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.4 p -156.85 141.62 16.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.551 0.74 . . . . 0.0 109.803 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 10.8 tp -121.86 123.48 41.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 122.585 0.354 . . . . 0.0 111.323 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 8' ' ' THR . 2.4 mp -91.98 120.49 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.729 0.812 . . . . 0.0 109.663 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 89.9 m-85 -115.71 110.13 18.69 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.012 0.925 . . . . 0.0 109.209 173.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 m -103.24 102.04 12.0 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.683 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -85.97 99.33 11.36 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.5 t -89.64 133.4 34.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.422 0.629 . . . . 0.0 110.159 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.53 -156.35 9.29 Favored Glycine 0 C--O 1.242 0.617 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.832 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 144.67 37.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.969 0.508 . . . . 0.0 109.718 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.9 ttm-85 -115.17 129.94 56.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.866 0.466 . . . . 0.0 109.978 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 2.0 m-20 -75.4 113.83 13.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.6 -8.02 56.4 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.402 0.681 . . . . 0.0 111.411 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 t -78.68 -44.05 24.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.499 0.72 . . . . 0.0 110.925 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -101.57 -21.0 14.83 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.353 0.661 . . . . 0.0 112.055 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.75 25.74 71.21 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 21.3 ptmt -95.88 138.56 33.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.333 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -106.57 116.39 31.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.577 0.751 . . . . 0.0 110.266 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 47' ' ' LYS . 3.6 mp -101.05 102.65 13.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -104.26 152.77 21.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.128 0.971 . . . . 0.0 108.936 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.55 120.98 40.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.378 0.671 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -74.98 -15.24 60.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.157 0.583 . . . . 0.0 112.172 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -85.38 -3.6 58.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.103 0.561 . . . . 0.0 111.103 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.472 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 88.3 t90 -60.77 128.03 34.56 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 p -155.31 114.51 3.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.6 tp -133.55 130.24 38.16 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 t -99.86 142.39 31.39 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.007 0.523 . . . . 0.0 109.7 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -123.22 145.02 49.0 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.527 HG21 ' HG3' ' A' ' 61' ' ' GLU . 4.7 m -70.44 118.03 12.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.076 1.351 . . . . 0.0 110.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 115.92 29.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.527 ' HG3' HG21 ' A' ' 59' ' ' THR . 0.0 OUTLIER -168.6 -155.78 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.33 1.052 . . . . 0.0 109.014 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 65.19 11.74 7.45 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.41 1.084 . . . . 0.0 111.819 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 100.28 8.99 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 87.2 Cg_endo -85.09 -173.35 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.547 2.165 . . . . 0.0 111.92 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.0 p -146.47 131.15 8.83 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.65 120.52 7.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.456 2.104 . . . . 0.0 111.039 172.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.65 105.95 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -106.72 114.46 45.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.2 mm -71.7 138.94 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 123.515 0.51 . . . . 0.0 109.785 -174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.17 8.66 85.15 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.961 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 96.8 m-85 -140.31 152.04 45.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.663 0.785 . . . . 0.0 110.074 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 m -134.28 115.67 14.39 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.39 150.94 45.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.927 0.891 . . . . 0.0 111.362 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.01 -39.37 75.88 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.698 0.761 . . . . 0.0 109.008 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -129.62 92.97 36.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.34 -1.3 . . . . 0.0 107.812 169.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.58 -4.92 14.03 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.636 2.224 . . . . 0.0 112.516 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 23.4 ttt -145.8 108.73 4.56 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 168.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG11 ' HG2' ' A' ' 98' ' ' GLU . 76.7 t -70.5 115.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.199 0.312 . . . . 0.0 111.574 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 52.59 63.38 4.98 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.913 1.383 . . . . 0.0 114.862 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.57 77.7 3.35 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.316 2.011 . . . . 0.0 110.136 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -155.82 148.42 23.95 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.72 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -80.25 106.78 12.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.28 128.26 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 m -111.11 123.84 51.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.053 0.541 . . . . 0.0 110.544 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.466 ' HA ' HD22 ' A' ' 89' ' ' ASN . 77.1 t -113.56 122.79 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.175 0.59 . . . . 0.0 109.521 172.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.47 162.12 13.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 29.7 m -58.3 -29.84 66.18 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.686 0.794 . . . . 0.0 112.335 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -65.83 -31.94 73.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.416 1.086 . . . . 0.0 111.563 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 85' ' ' VAL . 2.9 p-10 -115.86 19.24 15.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.367 0.667 . . . . 0.0 111.191 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 84.1 t80 -74.59 -33.01 62.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.26 0.624 . . . . 0.0 112.591 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.74 -22.8 56.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.111 0.564 . . . . 0.0 109.598 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -81.67 136.49 35.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.701 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -100.3 159.08 15.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.625 ' HB2' HG13 ' A' ' 11' ' ' VAL . 55.4 mt-30 -109.4 34.12 3.95 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.579 HD21 ' HB ' ' A' ' 12' ' ' THR . 27.9 t-20 -58.82 101.14 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.898 0.879 . . . . 0.0 110.251 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 28.3 tpt180 -133.34 142.24 48.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.641 0.777 . . . . 0.0 110.404 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.563 ' HB3' ' HE2' ' A' ' 16' ' ' HIS . 40.2 mt-10 -90.56 119.1 30.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 169.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HG2' HG11 ' A' ' 78' ' ' VAL . 10.5 tp10 -105.09 114.51 28.76 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.8 m -91.61 132.46 36.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.607 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -106.85 119.0 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.96 109.99 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 66.4 m-85 -80.49 101.32 9.02 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.543 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 m -91.64 152.36 20.28 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.21 133.49 19.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.379 0.536 . . . . 0.0 110.023 173.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 123.854 0.862 . . . . 0.0 109.989 -177.398 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.906 0.384 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.0 mm -106.61 138.82 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.494 1.118 . . . . 0.0 109.302 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -118.97 141.25 29.88 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 44.3 Cg_endo -68.12 128.11 17.05 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.27 1.98 . . . . 0.0 110.513 171.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 41' ' ' ARG . 13.4 pt -132.15 137.06 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -133.77 140.8 47.18 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.352 -0.217 . . . . 0.0 111.023 -170.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -101.92 151.51 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.234 1.014 . . . . 0.0 109.063 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -123.55 109.19 13.48 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.813 0.845 . . . . 0.0 110.436 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -112.25 125.92 54.67 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 25.5 m -105.08 141.49 20.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 83' ' ' VAL . 43.0 t -100.72 105.56 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -98.84 106.52 18.79 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.108 -170.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -93.19 95.87 9.66 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 90.1 m -85.02 136.14 33.71 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.3 134.94 47.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.411 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 42.0 m170 -103.58 119.28 38.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.839 172.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' OH ' HD11 ' A' ' 63' ' ' LEU . 93.8 m-85 -91.67 121.06 32.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -144.04 158.7 43.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -90.37 172.48 8.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.56 0.744 . . . . 0.0 109.773 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 101' ' ' ILE . 15.0 pt-20 -62.98 -43.31 99.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.921 0.888 . . . . 0.0 111.911 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.03 -16.63 61.49 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.444 1.098 . . . . 0.0 111.451 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 16.69 23.37 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.518 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.48 147.27 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.231 0.515 . . . . 0.0 110.171 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -75.68 121.05 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.114 0.566 . . . . 0.0 110.524 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.42 -57.88 2.63 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 166.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.484 ' HD2' ' HB2' ' A' ' 29' ' ' HIS . 22.1 t60 -172.8 75.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.071 0.948 . . . . 0.0 108.499 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 8.6 p-10 -88.36 57.43 4.24 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -168.37 18.44 0.02 OUTLIER 'General case' 0 C--N 1.356 0.861 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 26' ' ' HIS . 5.4 t60 -104.36 129.71 52.25 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.707 0.685 . . . . 0.0 110.461 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 14' ' ' THR . 43.3 t -129.65 135.36 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.39 1.076 . . . . 0.0 110.514 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.66 154.63 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 51.8 p -148.5 143.41 26.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.644 0.778 . . . . 0.0 110.683 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 58' ' ' GLN . 60.7 mt -106.23 125.41 50.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.652 0.781 . . . . 0.0 108.893 174.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.52 102.61 13.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HD2' ' HB3' ' A' ' 56' ' ' LEU . 96.9 m-85 -93.79 102.03 14.15 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.099 0.96 . . . . 0.0 109.338 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 103.64 14.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.341 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.33 101.89 11.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.581 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 63.5 p -73.33 148.91 43.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.221 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.01 -177.07 24.5 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.992 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 139.59 42.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.613 0.706 . . . . 0.0 110.564 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HB2' HD13 ' A' ' 5' ' ' ILE . 20.9 ttm-85 -116.28 122.62 45.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.954 0.502 . . . . 0.0 110.186 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.83 112.34 13.32 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.59 -10.74 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 t -72.86 -53.49 11.28 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.764 0.826 . . . . 0.0 110.399 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.29 -18.6 19.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.614 0.765 . . . . 0.0 111.267 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.93 62.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.506 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' NZ ' HD11 ' A' ' 49' ' ' ILE . 9.5 ptmm? -94.46 128.51 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.829 0.851 . . . . 0.0 110.318 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.33 111.04 23.17 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.092 0.957 . . . . 0.0 109.963 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 HD11 ' NZ ' ' A' ' 47' ' ' LYS . 1.6 mp -98.29 107.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -101.35 117.27 34.61 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.19 121.27 17.24 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 123.402 0.439 . . . . 0.0 109.997 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -63.3 -36.12 82.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.798 1.239 . . . . 0.0 112.009 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -78.29 -7.66 57.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.719 0.408 . . . . 0.0 110.897 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.95 127.62 33.08 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.243 0.544 . . . . 0.0 109.918 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.8 p -137.49 157.16 47.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.589 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -130.77 124.23 30.94 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 m -115.72 122.29 45.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.348 0.659 . . . . 0.0 109.704 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 33' ' ' LEU . 76.4 mt-30 -122.35 145.3 48.39 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.376 0.67 . . . . 0.0 109.42 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.581 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 30.6 m -69.38 125.75 27.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.313 1.045 . . . . 0.0 110.708 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.42 109.13 15.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.8 -171.83 0.4 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.362 1.465 . . . . 0.0 109.23 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.22 86.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.545 1.138 . . . . 0.0 112.393 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -98.59 115.11 65.89 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.527 0.731 . . . . 0.0 109.29 -178.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.9 80.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.96 3.106 . . . . 0.0 113.262 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' ' HH ' ' A' ' 102' ' ' TYR . 13.7 p -95.13 137.47 22.18 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.819 0.848 . . . . 0.0 110.982 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -44.54 125.77 6.4 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.133 3.222 . . . . 0.0 114.223 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.9 t -85.97 108.94 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 172.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.58 132.45 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.288 0.635 . . . . 0.0 109.315 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.79 124.1 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.31 3.88 88.41 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.302 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -136.06 149.62 48.83 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.815 0.808 . . . . 0.0 109.747 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -137.87 131.05 30.45 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.7 57.05 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.552 0.533 . . . . 0.0 109.924 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.13 -31.79 71.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.69 98.65 7.04 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.559 1.144 . . . . 0.0 108.739 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.34 -6.02 18.13 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.357 2.038 . . . . 0.0 112.383 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.603 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 36.1 ttm -136.99 120.51 17.11 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.054 0.942 . . . . 0.0 108.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.39 143.09 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.673 0.789 . . . . 0.0 109.627 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.38 57.89 17.45 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.294 0.996 . . . . 0.0 112.453 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -85.48 56.91 4.38 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.753 2.302 . . . . 0.0 111.245 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -154.64 120.38 5.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.504 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 1.8 mp0 -48.2 123.42 6.37 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 125.371 1.669 . . . . 0.0 111.027 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.785 HG12 HG22 ' A' ' 11' ' ' VAL . 81.4 t -89.65 121.11 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 123.659 0.6 . . . . 0.0 110.728 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 m -104.81 112.41 25.51 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.76 109.39 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.463 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 13.7 t70 -95.51 166.67 11.74 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.2 m -57.23 -33.77 67.89 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.332 0.653 . . . . 0.0 111.711 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 20.7 ptmt -67.4 -36.3 81.02 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.841 0.857 . . . . 0.0 111.745 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -115.85 27.61 9.18 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.886 0.875 . . . . 0.0 110.035 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -64.61 -37.05 86.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.382 0.673 . . . . 0.0 111.399 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.92 -6.44 56.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.472 0.309 . . . . 0.0 110.666 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.89 135.42 34.15 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.229 0.538 . . . . 0.0 110.984 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -93.04 -25.66 17.84 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 0.0 111.751 -176.061 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 51.91 12.29 0.18 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 127.577 2.351 . . . . 0.0 116.077 171.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HB2' HG13 ' A' ' 11' ' ' VAL . 6.1 m120 -151.01 153.46 35.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.92 . . . . 0.0 109.428 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.52 -159.61 0.98 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.829 -167.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' THR . 1.8 tm-20 -90.9 112.74 24.73 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.301 0.64 . . . . 0.0 109.275 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -112.47 125.11 53.88 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.149 0.98 . . . . 0.0 109.665 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.9 m -91.13 133.41 35.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.51 0.724 . . . . 0.0 109.958 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.54 144.45 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 20' ' ' GLU . 40.8 mm -114.52 111.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.864 0.466 . . . . 0.0 111.582 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.439 ' HH ' ' HB2' ' A' ' 65' ' ' SER . 90.0 m-85 -82.82 105.49 13.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.564 1.146 . . . . 0.0 109.254 172.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 p -110.97 146.02 37.37 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.25 104.35 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.46 1.1 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.5 p30 . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 123.929 0.892 . . . . 0.0 111.732 -175.712 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG3' HD11 ' A' ' 43' ' ' LEU . 13.4 tpt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.7 mm -121.21 155.6 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 124.579 1.152 . . . . 0.0 109.3 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 8.8 pt-20 -128.38 149.94 72.91 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 167.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.34 128.16 11.01 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 122.063 1.842 . . . . 0.0 111.377 168.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' A' ' 41' ' ' ARG . 26.5 pt -126.24 168.44 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.73 143.22 19.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.462 0.705 . . . . 0.0 109.651 174.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.433 ' HG2' ' HE2' ' A' ' 90' ' ' PHE . 22.9 tpp180 -105.41 161.01 14.69 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 34' ' ' ILE . 21.6 m -130.2 108.47 10.06 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.45 0.7 . . . . 0.0 109.285 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.498 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp-100 -112.44 117.73 33.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 33.3 m -102.15 134.59 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 120.81 0.338 . . . . 0.0 110.202 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.6 t -93.43 108.93 21.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -94.55 98.89 11.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.521 0.728 . . . . 0.0 109.747 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.29 97.41 9.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.368 0.604 . . . . 0.0 109.807 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -92.17 138.91 31.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.56 139.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -106.62 146.74 30.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.899 1.28 . . . . 0.0 108.335 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -114.65 111.2 20.95 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -175.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 26.5 mmt85 -126.84 168.19 14.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.641 0.777 . . . . 0.0 109.445 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.556 ' HH ' HD13 ' A' ' 68' ' ' ILE . 90.3 m-85 -105.8 172.22 6.92 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.977 0.911 . . . . 0.0 108.612 172.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.06 -22.49 63.06 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.519 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -69.52 -21.99 63.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.856 0.862 . . . . 0.0 111.503 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.78 -3.41 55.97 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.65 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.79 157.9 37.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.657 0.783 . . . . 0.0 110.871 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 12.3 t -102.18 123.9 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 17' ' ' TYR . . . -76.17 -47.28 24.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -169.96 159.65 7.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.793 0.837 . . . . 0.0 110.125 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -120.73 152.36 38.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.885 0.474 . . . . 0.0 111.815 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 53.53 76.28 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.648 1.579 . . . . 0.0 112.794 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.438 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 51.4 m170 -120.47 112.39 18.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.21 141.2 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.033 0.933 . . . . 0.0 111.461 -162.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.65 116.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 165.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 p -115.29 124.04 50.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.88 0.872 . . . . 0.0 109.642 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 83.6 mt -106.99 134.43 50.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.801 0.441 . . . . 0.0 111.054 -177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 8' ' ' THR . 3.0 mp -87.6 121.93 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.427 1.091 . . . . 0.0 110.336 -174.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 72.2 m-85 -111.31 104.47 12.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.236 1.014 . . . . 0.0 108.637 173.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -93.05 103.82 16.08 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.114 0.565 . . . . 0.0 110.327 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.63 104.36 15.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.8 p -72.1 163.75 27.37 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.138 0.494 . . . . 0.0 111.074 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.23 -158.27 22.91 Favored Glycine 0 C--O 1.238 0.362 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 139.21 17.59 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.03 0.532 . . . . 0.0 110.042 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' HB2' HD11 ' A' ' 5' ' ' ILE . 37.4 ttm-85 -102.34 129.35 48.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.443 ' HA ' HD13 ' A' ' 2' ' ' ILE . 32.5 t70 -77.02 118.38 19.53 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 1' ' ' MET . 83.9 mt -82.55 -9.1 59.55 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -169.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -94.92 -30.41 14.17 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.31 0.504 . . . . 0.0 111.458 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.01 -30.25 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.909 0.484 . . . . 0.0 110.254 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.18 2.58 77.18 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.222 -174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HB2' ' HZ1' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -72.58 137.03 45.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.253 0.621 . . . . 0.0 109.693 -178.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -105.37 118.49 36.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.787 0.835 . . . . 0.0 110.054 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.4 107.6 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -95.76 165.16 12.44 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.899 0.88 . . . . 0.0 109.831 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 29.6 m-20 -75.15 113.45 12.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.2 m -75.61 -23.84 56.46 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.851 0.46 . . . . 0.0 111.393 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -85.96 -3.99 59.06 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.798 0.839 . . . . 0.0 111.369 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 80.5 t90 -60.3 128.98 39.4 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.191 0.52 . . . . 0.0 109.684 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -154.84 113.57 3.58 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.67 140.48 48.19 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 82' ' ' GLU . 5.3 t -108.7 153.94 22.73 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -148.06 144.26 27.75 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.477 HG21 ' HG2' ' A' ' 61' ' ' GLU . 24.1 m -79.16 109.49 13.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.222 1.009 . . . . 0.0 112.927 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -102.61 102.02 12.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.288 0.635 . . . . 0.0 109.505 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' HG2' HG21 ' A' ' 59' ' ' THR . 13.0 pt-20 -173.87 -169.86 0.52 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.727 0.811 . . . . 0.0 109.416 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 70.95 20.68 5.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB2' HG12 ' A' ' 78' ' ' VAL . 2.3 mm? -92.54 110.33 44.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.107 0.563 . . . . 0.0 110.298 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.09 -146.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.74 2.96 . . . . 0.0 111.149 173.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -162.55 163.37 18.18 Favored Pre-proline 0 N--CA 1.495 1.782 0 C-N-CA 124.341 1.056 . . . . 0.0 110.192 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.69 125.41 15.42 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 121.882 1.721 . . . . 0.0 110.428 169.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.42 107.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.556 HD13 ' HH ' ' A' ' 19' ' ' TYR . 46.0 mt -100.84 122.07 52.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -72.8 128.64 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.049 0.94 . . . . 0.0 111.01 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.96 1.5 89.75 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.35 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -126.6 159.78 32.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 0.0 110.689 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -145.35 135.52 23.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.176 1.391 . . . . 0.0 107.493 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 76' ' ' PRO . . . -71.11 139.32 50.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.074 0.55 . . . . 0.0 111.086 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -69.36 -18.44 63.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.48 1.912 . . . . 0.0 110.551 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.777 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.92 82.64 7.09 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 29.9 Cg_endo -90.26 23.03 0.7 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.541 2.827 . . . . 0.0 114.12 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.66 144.63 27.29 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.523 HG21 ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -131.34 136.61 57.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 164.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.32 71.0 0.2 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' A' ' 78' ' ' VAL . 53.0 Cg_exo -58.26 -16.42 28.15 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.35 2.033 . . . . 0.0 110.773 162.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 59' ' ' THR . 29.7 t70 74.23 -71.53 0.13 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 126.682 1.993 . . . . 0.0 109.71 172.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 61.6 mt-10 -140.16 134.47 31.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.953 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.56 124.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.3 m -100.12 123.94 44.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.178 0.591 . . . . 0.0 109.853 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.21 121.39 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.26 161.96 16.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.294 1.038 . . . . 0.0 109.403 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 68.2 m -62.02 -29.08 70.03 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.004 0.431 . . . . 0.0 110.942 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.53 -46.61 89.53 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.037 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -100.07 2.79 43.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.095 0.558 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.433 ' HE2' ' HG2' ' A' ' 7' ' ' ARG . 79.1 t80 -62.09 -33.84 75.19 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.119 0.968 . . . . 0.0 113.345 -168.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.59 -27.21 66.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.109 0.48 . . . . 0.0 110.157 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -93.73 156.88 16.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.189 0.995 . . . . 0.0 109.189 170.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.498 ' HE2' ' OE1' ' A' ' 9' ' ' GLN . 18.4 ptpt -119.39 139.0 52.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.78 40.29 1.14 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.577 0.703 . . . . 0.0 109.656 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 95' ' ' ASN . 0.1 OUTLIER -51.27 149.53 3.92 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.304 168.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -152.59 115.84 4.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.834 0.349 . . . . 0.0 111.281 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -104.51 110.68 23.05 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -121.67 171.39 8.88 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 110.283 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.8 m -130.9 134.49 46.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.374 0.669 . . . . 0.0 111.598 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.777 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 3.7 m -98.26 142.0 15.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 123.319 0.647 . . . . 0.0 110.227 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -114.08 114.82 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 0.0 110.318 -175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.96 103.29 15.9 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -97.96 174.43 6.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.27 156.25 15.95 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.486 1.347 0 C-N-CA 124.392 1.077 . . . . 0.0 112.937 -167.574 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG2' HD12 ' A' ' 43' ' ' LEU . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.461 HD11 ' HD3' ' A' ' 40' ' ' LYS . 41.6 mm -107.87 142.98 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.939 0.896 . . . . 0.0 109.998 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.6 148.59 65.2 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.058 0.543 . . . . 0.0 109.94 166.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.2 125.53 10.36 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 0.0 110.506 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' A' ' 41' ' ' ARG . 45.0 pt -125.68 154.95 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.177 0.513 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -159.68 145.86 16.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.832 173.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -111.15 156.68 21.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.335 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 34' ' ' ILE . 59.2 m -129.49 122.19 28.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.263 0.625 . . . . 0.0 110.284 -172.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp-100 -122.76 107.16 11.59 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG13 HG13 ' A' ' 34' ' ' ILE . 4.2 m -92.62 133.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 94' ' ' GLN . 69.3 t -102.02 124.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 173.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -123.05 115.34 21.69 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -164.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.596 HE21 ' HG3' ' A' ' 80' ' ' PRO . 8.4 mm-40 -89.47 104.71 17.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.413 1.085 . . . . 0.0 111.068 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -95.35 112.5 24.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.154 0.982 . . . . 0.0 109.176 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 98' ' ' GLU . 87.2 mt -111.58 131.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.508 0.671 . . . . 0.0 111.083 -170.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -112.06 116.28 30.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -86.02 107.08 17.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -133.26 156.85 46.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.915 0.886 . . . . 0.0 109.476 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -89.15 176.4 6.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.4 0.68 . . . . 0.0 110.949 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.74 -24.9 67.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.135 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.84 -7.78 58.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.782 0.833 . . . . 0.0 111.225 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.27 82.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.95 150.68 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.092 0.557 . . . . 0.0 109.957 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.7 t -74.41 127.03 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.093 0.557 . . . . 0.0 110.563 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.44 -62.99 1.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -159.52 99.77 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.308 1.043 . . . . 0.0 109.566 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.97 171.44 15.2 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.624 -0.672 . . . . 0.0 110.875 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 57.54 80.33 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.496 1.118 . . . . 0.0 111.679 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -130.94 91.99 3.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.85 127.47 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.699 . . . . 0.0 110.918 -169.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.98 149.97 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.1 p -144.46 144.64 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.923 0.392 . . . . 0.0 110.884 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.68 124.08 51.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.181 0.992 . . . . 0.0 109.109 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.484 HG23 HG23 ' A' ' 8' ' ' THR . 1.8 mp -94.9 109.29 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.351 1.06 . . . . 0.0 108.894 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 57.9 m-85 -97.36 99.08 10.53 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -98.82 103.29 15.23 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.403 0.681 . . . . 0.0 109.749 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.46 108.88 14.46 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 t -92.5 159.16 15.65 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.376 0.67 . . . . 0.0 110.742 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.02 -161.93 26.07 Favored Glycine 0 C--O 1.238 0.375 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.716 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.461 ' HD3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -144.15 142.02 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.216 0.606 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.557 ' HB2' HD12 ' A' ' 5' ' ' ILE . 15.8 ttm180 -104.74 125.11 50.49 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.713 0.405 . . . . 0.0 110.122 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.86 106.59 8.62 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 1' ' ' MET . 96.2 mt -75.78 -2.76 31.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.986 0.914 . . . . 0.0 112.171 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -42.37 60.88 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.527 0.731 . . . . 0.0 109.932 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.04 -24.62 14.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.816 0.846 . . . . 0.0 111.234 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.46 16.09 72.11 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.994 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -87.99 143.51 27.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.432 0.693 . . . . 0.0 111.142 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.46 107.65 19.91 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.529 1.132 . . . . 0.0 110.508 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.62 97.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.438 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 59.8 m95 -90.31 171.89 9.15 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.065 0.946 . . . . 0.0 109.406 171.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.64 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 26.9 m-20 -76.82 115.73 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 164.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -62.17 -31.68 72.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.108 0.563 . . . . 0.0 110.324 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -92.04 15.45 13.31 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.688 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.64 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 90.5 t90 -70.4 127.86 34.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 81.0 p -154.86 115.53 3.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.768 1.227 . . . . 0.0 107.805 170.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.5 tp -103.57 132.97 49.36 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 m -110.23 115.42 29.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.804 0.842 . . . . 0.0 109.516 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -129.34 132.52 47.12 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.543 0.737 . . . . 0.0 109.126 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.4 m -85.34 135.21 33.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.156 0.583 . . . . 0.0 111.266 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.06 104.92 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 160.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.7 -174.09 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.349 1.06 . . . . 0.0 108.589 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.97 21.78 12.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.755 0.822 . . . . 0.0 112.824 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.37 114.13 65.55 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.27 -165.92 0.31 Allowed 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 123.055 2.503 . . . . 0.0 113.31 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.7 p -157.18 146.98 15.44 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 118.47 5.36 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.999 1.799 . . . . 0.0 110.286 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.52 104.63 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.03 119.01 41.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.48 132.27 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.839 0.712 . . . . 0.0 109.812 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.43 12.43 80.44 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.373 -0.681 . . . . 0.0 112.86 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 87.5 m-85 -137.25 148.97 46.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.752 0.821 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -110.31 126.95 54.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.795 1.638 . . . . 0.0 107.729 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.8 143.96 26.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.938 0.79 . . . . 0.0 109.987 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -37.33 78.37 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.261 0.625 . . . . 0.0 110.938 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HG2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -146.91 98.32 4.11 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.28 -8.07 21.87 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.466 2.111 . . . . 0.0 112.511 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ttt -143.78 105.77 4.36 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.24 111.59 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.28 78.74 0.24 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HG3' HE21 ' A' ' 13' ' ' GLN . 61.4 Cg_endo -71.23 -0.63 8.37 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.825 2.35 . . . . 0.0 113.446 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 76.1 -159.68 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.009 1.324 . . . . 0.0 112.456 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.97 128.73 31.53 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.87 109.83 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.134 1.374 . . . . 0.0 107.91 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.8 m -98.31 128.73 44.88 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.73 115.07 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.9 p30 -90.7 173.08 8.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.764 0.826 . . . . 0.0 110.196 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -60.2 -29.93 69.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.417 1.087 . . . . 0.0 113.206 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -38.33 23.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.103 0.561 . . . . 0.0 110.668 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.45 8.95 40.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.99 -24.57 67.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.717 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.71 -21.41 55.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 110.299 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.65 118.43 33.1 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.176 0.991 . . . . 0.0 110.924 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . 21.1 pttp -83.87 127.78 34.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.413 ' H ' HG23 ' A' ' 11' ' ' VAL . 36.8 mt-30 -86.78 42.4 1.01 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -64.03 121.36 13.96 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 110.535 -175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -113.93 145.41 41.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -116.02 110.05 18.38 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.575 ' HB2' HG12 ' A' ' 15' ' ' ILE . 17.4 mm-40 -93.18 155.97 17.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.766 0.793 . . . . 0.0 110.725 175.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.2 m -142.28 107.53 4.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.888 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.404 HG13 ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -79.33 137.82 21.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mm -108.87 122.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 94.0 m-85 -88.77 106.09 18.13 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.725 1.21 . . . . 0.0 109.413 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 p -112.47 130.39 56.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.17 129.14 23.71 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.028 0.931 . . . . 0.0 113.152 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.493 1.717 0 C-N-CA 125.517 1.527 . . . . 0.0 114.037 -176.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 42' ' ' ASP . 37.9 mm -113.95 151.21 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.386 0.675 . . . . 0.0 109.315 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.77 151.3 77.84 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.225 0.61 . . . . 0.0 110.011 170.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.75 133.79 28.43 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.606 2.204 . . . . 0.0 111.986 171.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 41' ' ' ARG . 11.6 pt -142.57 137.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.8 mptm? -133.72 154.26 51.08 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.487 0.715 . . . . 0.0 109.114 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.417 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 23.7 mmm180 -121.82 149.65 43.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 108.307 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 34' ' ' ILE . 27.1 m -122.26 108.05 12.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 6.2 tp-100 -105.37 148.98 26.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 28.6 m -124.98 123.78 66.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 110.197 173.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.56 115.54 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -96.37 152.03 18.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.091 0.957 . . . . 0.0 111.275 -171.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.689 ' HG3' ' HB2' ' A' ' 96' ' ' ARG . 52.9 tt0 -125.77 107.89 10.96 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -82.61 106.54 14.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.313 0.645 . . . . 0.0 110.791 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -99.6 133.11 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 121.533 0.682 . . . . 0.0 109.844 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -111.88 125.68 54.29 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -97.41 123.66 41.33 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 70.8 mtp180 -141.52 -173.86 3.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.757 0.823 . . . . 0.0 110.648 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.582 ' HH ' HD13 ' A' ' 68' ' ' ILE . 89.8 m-85 -118.14 164.69 14.77 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.4 -26.17 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.838 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -19.16 64.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.157 1.383 . . . . 0.0 110.849 175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.97 -14.45 63.9 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.96 153.27 29.82 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 111.364 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.9 t -92.52 133.86 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.196 0.598 . . . . 0.0 110.164 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.26 -54.09 3.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 0.0 110.184 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -157.24 96.21 1.54 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.652 1.181 . . . . 0.0 108.804 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.66 142.39 32.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 68.63 86.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.039 1.336 . . . . 0.0 111.417 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -141.16 92.79 2.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -111.2 133.68 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -166.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.0 p -108.48 137.13 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 37.4 m -113.32 137.72 51.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.93 0.492 . . . . 0.0 110.442 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.2 mt -98.92 123.36 43.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG23 HG22 ' A' ' 8' ' ' THR . 2.1 mp -99.85 105.4 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.019 0.927 . . . . 0.0 108.664 -173.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.28 107.61 20.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.893 0.877 . . . . 0.0 110.096 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 m -83.81 103.09 12.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 32.6 tt0 -85.53 107.79 17.63 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.468 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 17.0 p -91.65 139.64 30.49 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.64 -167.13 16.03 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 136.68 35.42 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.29 0.545 . . . . 0.0 110.75 -175.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB2' HD12 ' A' ' 5' ' ' ILE . 25.7 ttm180 -103.58 122.21 44.51 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.821 0.449 . . . . 0.0 110.176 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' HD12 ' A' ' 2' ' ' ILE . 8.0 t70 -74.67 113.28 11.75 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.598 1.159 . . . . 0.0 108.582 169.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.7 mt -84.66 -4.44 59.01 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 t -87.11 -36.32 18.17 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.644 0.656 . . . . 0.0 110.86 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.04 -31.09 11.61 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.57 63.65 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.916 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.59 ' HZ2' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -71.51 133.53 45.88 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.018 0.927 . . . . 0.0 110.138 -177.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.55 113.93 27.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.353 0.661 . . . . 0.0 110.081 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.98 104.29 15.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.477 ' CZ2' HD13 ' A' ' 5' ' ' ILE . 55.2 m95 -103.75 119.86 39.78 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.88 131.06 43.2 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.78 0.675 . . . . 0.0 110.711 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -64.5 -26.28 68.36 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.297 0.998 . . . . 0.0 110.215 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -64.29 -22.25 66.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.69 0.796 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.448 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 67.8 t-105 -74.32 127.17 32.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.458 0.474 . . . . 0.0 109.896 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 p -153.87 144.53 22.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.514 1.126 . . . . 0.0 109.528 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 tt -134.12 125.18 27.42 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.4 m -107.92 127.64 53.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -130.8 140.19 50.26 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -101.56 132.83 47.0 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 111.117 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 m-85 -72.52 102.46 3.24 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.71 141.96 28.53 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.2 1.0 . . . . 0.0 108.307 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.79 108.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.401 1.08 . . . . 0.0 110.77 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 107.14 21.4 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.55 102.89 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.213 2.609 . . . . 0.0 112.92 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -98.64 134.06 22.02 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.131 0.972 . . . . 0.0 110.62 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 120.66 7.97 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.67 2.247 . . . . 0.0 110.583 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.07 107.25 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' HH ' ' A' ' 19' ' ' TYR . 25.9 mt -102.33 114.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.0 mm -75.62 137.86 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.53 87.42 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.346 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 97.9 m-85 -141.75 162.33 35.74 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.393 0.677 . . . . 0.0 110.26 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -147.24 120.03 8.66 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.95 148.23 52.13 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 123.799 0.687 . . . . 0.0 109.456 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.5 -33.6 73.09 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.787 0.68 . . . . 0.0 109.277 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 97.71 7.07 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.612 168.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.72 -6.23 17.34 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.199 1.932 . . . . 0.0 111.568 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tpt -128.47 125.61 38.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.388 1.075 . . . . 0.0 108.384 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.473 HG12 HE22 ' A' ' 13' ' ' GLN . 29.9 t -86.12 130.26 36.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 109.403 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.75 161.16 49.34 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.365 1.041 . . . . 0.0 113.418 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.5 118.81 5.91 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 123.206 2.604 . . . . 0.0 113.672 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 22.4 m-20 -109.79 94.54 5.08 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.711 0.805 . . . . 0.0 109.715 173.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -72.47 91.67 1.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.17 0.588 . . . . 0.0 110.768 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.404 HG12 HG21 ' A' ' 85' ' ' VAL . 74.8 t -85.52 103.03 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.873 0.869 . . . . 0.0 110.183 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.1 m -90.17 106.54 18.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.401 0.68 . . . . 0.0 109.548 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.433 ' HA ' HD22 ' A' ' 89' ' ' ASN . 85.4 t -106.5 110.7 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 170.98 12.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.411 1.084 . . . . 0.0 108.23 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.3 m -65.7 -23.8 66.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.324 166.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -67.53 -45.28 76.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.978 1.311 . . . . 0.0 110.694 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.433 HD22 ' HA ' ' A' ' 85' ' ' VAL . 3.4 p-10 -113.66 29.64 7.84 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.724 0.81 . . . . 0.0 109.892 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' GLN . 59.9 t80 -62.07 -46.53 88.68 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.616 0.767 . . . . 0.0 111.78 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.5 -1.09 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.48 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.01 149.69 25.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.888 0.875 . . . . 0.0 109.459 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -108.57 144.07 36.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.471 0.708 . . . . 0.0 109.699 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.4 40.11 3.75 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.37 103.67 1.69 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.583 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.689 ' HB2' ' HG3' ' A' ' 13' ' ' GLN . 28.2 mmm180 -76.42 156.41 33.16 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.458 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.87 132.15 18.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.453 0.301 . . . . 0.0 110.454 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 47.1 mt-10 -141.75 138.33 32.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.516 0.726 . . . . 0.0 110.643 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.5 m -109.03 115.28 29.76 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.41 141.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.08 113.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.747 0.419 . . . . 0.0 110.151 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 63.2 m-85 -84.05 110.45 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.995 0.918 . . . . 0.0 108.877 173.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -99.63 143.56 29.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.81 123.92 10.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.572 0.749 . . . . 0.0 109.295 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 126.592 1.957 . . . . 0.0 113.317 -162.072 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.492 HD12 ' HD3' ' A' ' 40' ' ' LYS . 29.4 mm -118.72 119.86 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.409 1.084 . . . . 0.0 110.037 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.457 ' HG2' HD23 ' A' ' 43' ' ' LEU . 10.5 pt-20 -97.88 137.42 20.93 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 167.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.98 122.95 8.53 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.909 1.739 . . . . 0.0 110.355 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 41' ' ' ARG . 42.0 pt -119.34 161.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.401 0.68 . . . . 0.0 110.368 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 136.82 12.82 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -96.83 154.34 17.35 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.585 HG23 HG23 ' A' ' 34' ' ' ILE . 76.6 m -128.54 105.45 8.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -99.48 102.14 13.6 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' HG ' ' A' ' 32' ' ' SER . 23.6 m -91.13 117.5 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.7 t -89.75 107.1 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.3 m -92.49 102.22 14.67 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.488 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 9.5 tt0 -91.73 105.24 17.57 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.561 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.493 ' HG1' ' HA ' ' A' ' 97' ' ' GLU . 70.9 p -92.91 106.21 18.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 98' ' ' GLU . 19.9 mt -97.29 132.5 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.724 0.773 . . . . 0.0 111.681 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -116.75 118.09 31.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.98 -1.464 . . . . 0.0 107.056 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -87.33 115.41 24.73 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.0 ttt-85 -147.37 145.42 29.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.635 0.374 . . . . 0.0 110.518 -171.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.571 ' HH ' HD13 ' A' ' 68' ' ' ILE . 80.4 m-85 -79.48 163.2 24.92 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.477 1.111 . . . . 0.0 111.031 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.99 -28.32 69.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.452 0.701 . . . . 0.0 110.324 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.54 -20.03 65.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.048 1.339 . . . . 0.0 112.042 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.74 -10.25 66.42 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.869 -176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.29 54.14 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.564 0.746 . . . . 0.0 109.494 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 27' ' ' ASP . 39.8 t -86.76 124.89 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.91 51.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.541 0.737 . . . . 0.0 110.857 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -166.25 119.22 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.309 1.043 . . . . 0.0 108.531 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.521 ' HB2' HG12 ' A' ' 24' ' ' VAL . 22.7 t70 -98.19 162.2 13.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.23 0.612 . . . . 0.0 110.037 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 61.97 73.76 0.46 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.822 1.249 . . . . 0.0 112.323 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -127.62 83.7 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 171.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -102.35 127.23 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.599 -171.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 p -117.48 134.91 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.526 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 28.4 t -130.01 127.71 40.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.56 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 50.3 mt -108.81 131.23 55.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.609 0.764 . . . . 0.0 110.655 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.585 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -82.05 113.07 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.148 0.979 . . . . 0.0 109.619 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -103.99 103.75 13.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.508 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 85.5 m -91.95 107.17 19.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.93 0.892 . . . . 0.0 111.23 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.434 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 8.0 tt0 -86.63 107.78 18.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.0 p -78.19 169.58 18.03 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.851 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.95 -158.93 22.94 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.449 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -149.35 144.85 26.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.706 0.802 . . . . 0.0 109.531 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm180 -119.25 119.9 35.44 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.953 0.501 . . . . 0.0 110.566 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.8 113.81 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.206 1.002 . . . . 0.0 108.803 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 3' ' ' GLU . 52.0 mt -82.86 -6.63 59.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -73.55 -48.32 33.94 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.071 0.548 . . . . 0.0 110.533 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -93.07 -26.44 17.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.967 0.507 . . . . 0.0 110.928 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.24 54.36 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.071 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HZ2' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.41 137.59 34.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.708 0.803 . . . . 0.0 110.918 -174.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -98.58 113.79 25.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.862 0.865 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.15 110.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -100.35 139.15 36.43 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.7 t70 -68.01 108.53 3.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 p -77.12 -9.88 59.03 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.189 0.596 . . . . 0.0 112.29 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -97.74 -1.13 44.07 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.339 0.656 . . . . 0.0 111.262 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 62.3 t-105 -66.48 150.52 48.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.435 0.694 . . . . 0.0 110.826 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.4 p -151.73 135.84 16.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HG ' ' H ' ' A' ' 36' ' ' THR . 1.4 tm? -111.51 124.1 51.58 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 m -99.94 127.82 46.09 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.762 0.825 . . . . 0.0 108.845 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 8.5 tp-100 -139.62 132.33 28.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 17.1 m -75.02 105.07 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.33 0.652 . . . . 0.0 112.056 -171.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.44 100.13 3.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 161.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -109.32 157.45 18.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.331 1.052 . . . . 0.0 110.138 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -46.69 114.99 0.93 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.943 1.697 . . . . 0.0 114.376 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HG ' HD12 ' A' ' 15' ' ' ILE . 3.7 mm? -82.36 124.3 78.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.51 100.52 0.23 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.735 2.29 . . . . 0.0 112.349 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 t -86.19 104.53 5.63 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.84 122.32 11.15 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.044 2.496 . . . . 0.0 112.475 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.23 107.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.571 HD13 ' HH ' ' A' ' 19' ' ' TYR . 66.4 mt -97.53 135.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.648 0.779 . . . . 0.0 108.938 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.33 118.89 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.495 -172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.09 68.13 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.154 -173.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.648 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 81.5 m-85 -141.21 136.52 31.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.816 0.846 . . . . 0.0 111.014 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.1 m -118.78 124.76 48.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 108.597 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.54 138.48 53.32 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.347 0.659 . . . . 0.0 110.971 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.91 -27.4 65.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.424 1.09 . . . . 0.0 110.593 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 94.5 7.29 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.058 0.943 . . . . 0.0 108.661 169.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.55 -5.45 16.9 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.432 2.088 . . . . 0.0 112.19 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.612 ' HE3' ' HA ' ' A' ' 80' ' ' PRO . 13.9 tpt -131.62 110.42 10.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.283 1.033 . . . . 0.0 108.487 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.05 129.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 77.13 0.56 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -167.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.612 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 42.0 Cg_endo -97.57 8.13 1.26 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.371 2.047 . . . . 0.0 114.618 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -162.38 172.77 15.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.251 1.024 . . . . 0.0 112.838 -169.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 33.9 mt-10 -85.46 129.77 34.74 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.341 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.51 140.14 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.027 0.931 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.6 m -112.12 120.98 43.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.799 0.84 . . . . 0.0 109.964 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -97.46 118.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.68 157.33 16.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.582 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 68.0 m -58.71 -33.64 70.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.74 0.816 . . . . 0.0 112.461 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.52 -30.29 69.07 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -117.64 24.24 11.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 34.5 t80 -62.65 -34.17 76.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.096 0.558 . . . . 0.0 111.998 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.63 -1.37 50.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.875 0.87 . . . . 0.0 111.704 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -101.16 163.07 12.46 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.93 0.892 . . . . 0.0 110.509 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -84.46 175.35 9.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.936 0.894 . . . . 0.0 111.103 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -121.9 -36.84 2.94 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 165.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -171.86 158.09 4.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.426 1.491 . . . . 0.0 107.87 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 76.7 mtm180 -138.92 -87.99 0.22 Allowed 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HA ' ' HG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -98.09 109.99 22.65 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -166.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.581 ' HB2' HG12 ' A' ' 15' ' ' ILE . 71.0 mm-40 -118.04 114.23 22.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.564 1.145 . . . . 0.0 109.609 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 83.4 m -106.63 122.06 45.58 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.74 132.81 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 30.1 mm -104.18 122.15 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.886 0.475 . . . . 0.0 110.67 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.648 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 97.0 m-85 -91.71 108.91 20.25 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.077 0.951 . . . . 0.0 109.974 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 m -98.29 131.42 44.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.798 0.839 . . . . 0.0 109.786 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.76 7.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.059 0.944 . . . . 0.0 111.015 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.835 1.254 . . . . 0.0 111.628 -176.128 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.876 0.369 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 42' ' ' ASP . 40.9 mm -112.64 157.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.842 1.257 . . . . 0.0 109.094 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -124.38 146.96 53.66 Favored Pre-proline 0 N--CA 1.479 1.005 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.64 126.38 12.03 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.071 1.847 . . . . 0.0 111.581 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 41' ' ' ARG . 26.8 pt -127.18 167.39 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.581 0.752 . . . . 0.0 109.802 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 138.78 12.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.554 0.692 . . . . 0.0 111.622 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -87.32 133.83 33.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.9 m -125.29 104.88 8.72 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.2 146.78 24.09 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.131 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.438 HG13 HG13 ' A' ' 34' ' ' ILE . 35.1 m -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' SER . 94.3 t -91.62 102.37 13.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m -101.78 104.27 15.04 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.84 0.856 . . . . 0.0 109.159 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.698 HE21 ' HB2' ' A' ' 98' ' ' GLU . 52.1 tt0 -112.95 125.27 54.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 109.948 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.481 HG23 HG21 ' A' ' 30' ' ' VAL . 85.5 m -99.25 108.09 20.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.479 0.712 . . . . 0.0 109.687 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.495 HG13 ' HB3' ' A' ' 98' ' ' GLU . 1.8 mp -83.57 116.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -95.77 108.81 21.17 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.128 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.601 ' HA ' HG22 ' A' ' 100' ' ' VAL . 97.3 m-85 -79.99 117.98 21.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -137.44 165.57 25.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.979 0.512 . . . . 0.0 109.875 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -94.04 175.53 6.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.312 1.045 . . . . 0.0 109.265 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.26 -21.37 60.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.41 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.05 -19.21 65.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.219 1.007 . . . . 0.0 110.882 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.36 69.12 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.143 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.24 136.8 56.51 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.953 0.901 . . . . 0.0 110.747 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.49 112.9 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.75 72.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.121 0.568 . . . . 0.0 110.203 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -177.11 116.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.401 1.081 . . . . 0.0 109.789 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.46 -38.08 55.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.79 77.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.769 0.428 . . . . 0.0 111.104 -167.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.468 ' HE1' ' HD2' ' A' ' 64' ' ' PRO . 9.4 t-160 -121.45 91.13 3.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.481 HG21 HG23 ' A' ' 14' ' ' THR . 21.6 t -102.14 120.3 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.255 -162.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' A' ' 63' ' ' LEU . 9.0 p -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.879 0.872 . . . . 0.0 109.153 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 67.7 p -136.71 132.01 34.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.79 0.836 . . . . 0.0 109.716 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 60' ' ' PHE . 74.9 mt -110.62 125.67 53.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 HG13 HG13 ' A' ' 10' ' ' VAL . 2.4 mp -88.14 112.26 23.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.676 ' HA ' HD22 ' A' ' 56' ' ' LEU . 95.2 m-85 -104.26 124.53 49.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.208 1.003 . . . . 0.0 108.417 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -121.27 107.69 12.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.87 0.468 . . . . 0.0 110.385 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 32.6 tt0 -84.79 95.95 9.13 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 109.089 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -76.12 135.09 39.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.11 -168.12 12.3 Favored Glycine 0 C--O 1.251 1.16 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.43 ' HB2' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -140.02 143.39 36.4 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HB2' HD12 ' A' ' 5' ' ' ILE . 39.6 ttm180 -112.77 122.38 47.48 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.586 0.355 . . . . 0.0 110.261 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.453 ' HA ' HD12 ' A' ' 2' ' ' ILE . 17.3 t70 -71.18 118.2 13.66 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.15 -18.33 55.72 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -75.86 -49.09 18.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.726 0.298 . . . . 0.0 110.24 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 49.7 t-20 -88.68 -31.82 18.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -0.57 58.75 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.854 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 21.2 ptmt -70.33 146.09 50.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.284 1.034 . . . . 0.0 111.591 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.74 112.46 24.16 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.534 0.733 . . . . 0.0 109.855 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.59 93.67 3.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -85.77 140.4 30.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.4 t70 -68.4 110.05 3.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -78.49 -5.46 52.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.736 0.814 . . . . 0.0 111.813 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 7.9 mtmp? -101.65 -4.78 25.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.098 0.559 . . . . 0.0 110.236 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.1 t-105 -62.44 120.31 10.81 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.125 0.57 . . . . 0.0 110.179 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 11.0 p -139.13 111.58 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.168 0.987 . . . . 0.0 108.667 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.676 HD22 ' HA ' ' A' ' 35' ' ' PHE . 64.1 tp -102.21 135.17 44.28 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 11.6 m -98.34 144.95 27.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -148.87 129.32 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 7.0 m -73.67 104.65 4.67 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.754 0.659 . . . . 0.0 110.006 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -65.62 103.53 0.88 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.03 -164.7 0.64 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.254 1.022 . . . . 0.0 108.243 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.1 18.41 10.99 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.525 1.13 . . . . 0.0 111.627 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' A' ' 31' ' ' VAL . 1.2 tm? -107.28 106.09 57.45 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 171.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HD2' ' HE1' ' A' ' 29' ' ' HIS . 73.3 Cg_endo -70.66 -165.13 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.253 2.636 . . . . 0.0 113.728 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 t -164.65 106.52 0.84 Allowed Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 121.4 8.22 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.712 2.274 . . . . 0.0 112.316 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.09 108.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 40.7 mt -101.55 134.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.92 134.46 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.353 0.661 . . . . 0.0 109.891 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.67 20.07 71.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.071 0.857 . . . . 0.0 112.988 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.4 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 65.0 m-85 -139.17 150.75 45.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.651 0.739 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -136.86 118.93 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.15 150.53 48.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.092 0.557 . . . . 0.0 110.336 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.03 -40.6 78.53 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 99.44 16.45 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.126 170.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.16 -2.45 12.34 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.054 2.503 . . . . 0.0 112.117 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.3 ttt -144.31 115.76 8.08 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -80.72 110.16 15.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.496 0.718 . . . . 0.0 111.165 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 59.39 61.43 7.29 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.848 1.342 . . . . 0.0 114.314 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.83 82.43 2.15 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.544 2.163 . . . . 0.0 110.743 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -161.42 137.41 8.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.141 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.0 mt-10 -76.02 89.48 2.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.055 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 t -82.25 126.84 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.553 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 20.0 m -98.46 117.78 33.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.373 0.669 . . . . 0.0 109.909 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.3 t -99.31 116.61 42.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 7.0 p-10 -104.76 172.03 7.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 t -58.53 -30.09 66.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 113.004 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -71.01 -38.19 72.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.127 0.571 . . . . 0.0 111.128 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -107.93 10.83 28.37 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.0 0.52 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.26 -47.19 77.61 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.241 0.616 . . . . 0.0 112.079 -170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.47 -23.67 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.749 0.655 . . . . 0.0 110.814 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.2 143.28 26.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.275 0.63 . . . . 0.0 110.547 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.525 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.53 162.96 22.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 160.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -125.3 -39.22 2.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.82 142.97 45.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -132.68 -52.83 0.93 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.345 1.058 . . . . 0.0 109.447 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.87 148.18 35.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.327 0.584 . . . . 0.0 111.679 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.698 ' HB2' HE21 ' A' ' 13' ' ' GLN . 12.5 tp10 -122.25 155.57 35.62 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.744 1.218 . . . . 0.0 108.627 169.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -139.74 99.78 3.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.7 m -82.22 141.7 14.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.68 110.54 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.967 0.413 . . . . 0.0 110.888 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.61 104.62 10.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 m -98.77 173.93 6.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.23 146.53 15.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.03 151.95 38.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.137 0.494 . . . . 0.0 111.051 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -58.37 -11.12 2.5 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 125.253 1.421 . . . . 0.0 112.632 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.57 -53.0 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.882 0.873 . . . . 0.0 110.279 167.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 -2.15 41.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.897 0.479 . . . . 0.0 111.466 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -115.87 141.24 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.173 0.589 . . . . 0.0 111.548 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.46 155.1 36.59 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.552 0.741 . . . . 0.0 109.398 168.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.69 90.92 0.18 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.05 -33.0 67.63 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.229 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -111.11 124.32 51.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.539 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.42 36.34 0.13 Allowed Glycine 0 C--N 1.322 -0.245 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.311 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -91.93 0.62 57.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.707 1.203 . . . . 0.0 110.893 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 66.64 101.71 0.05 OUTLIER 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.52 1.528 . . . . 0.0 109.56 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -53.47 107.03 0.21 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.43 1.092 . . . . 0.0 111.211 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -73.0 113.32 9.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.406 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -121.43 173.84 7.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.01 0.924 . . . . 0.0 110.039 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -77.3 125.04 28.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.799 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -82.64 -40.85 20.19 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.252 1.186 0 O-C-N 125.022 1.451 . . . . 0.0 109.977 -171.109 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.422 HD11 ' HD3' ' A' ' 40' ' ' LYS . 38.1 mm -112.6 130.45 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.913 0.885 . . . . 0.0 110.655 -172.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.48 143.37 26.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 166.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -77.6 123.44 6.45 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.325 1.35 . . . . 0.0 111.516 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 41' ' ' ARG . 30.6 pt -110.42 172.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.642 0.777 . . . . 0.0 109.807 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -165.92 146.55 6.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.48 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 19.7 mtm180 -113.02 170.15 8.42 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.256 1.022 . . . . 0.0 109.075 168.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.492 HG22 HG23 ' A' ' 34' ' ' ILE . 34.1 m -135.92 106.43 6.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.331 0.652 . . . . 0.0 110.199 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.1 108.27 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.592 0.757 . . . . 0.0 109.024 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.1 m -92.17 145.48 7.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' SER . 92.3 t -119.28 104.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 m -94.84 107.35 19.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.603 0.761 . . . . 0.0 111.654 -166.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.586 HE22 ' HB2' ' A' ' 96' ' ' ARG . 7.2 tp-100 -96.32 104.97 16.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.618 0.767 . . . . 0.0 108.963 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 30' ' ' VAL . 34.5 p -91.75 110.29 21.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -89.5 127.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -107.69 122.56 46.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -92.54 108.06 19.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -117.36 151.17 37.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.94 178.0 8.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.259 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.87 -32.28 73.44 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.33 -18.47 62.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.746 0.818 . . . . 0.0 111.348 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.65 -3.32 56.12 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.932 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.85 142.69 57.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.288 0.635 . . . . 0.0 110.902 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.66 107.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.92 0.488 . . . . 0.0 110.069 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.63 -46.91 74.28 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.243 0.617 . . . . 0.0 109.482 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -161.31 153.87 20.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.646 1.579 . . . . 0.0 108.536 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.72 -153.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.39 0.676 . . . . 0.0 111.548 -173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.89 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.675 1.19 . . . . 0.0 113.356 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -80.98 91.9 6.11 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 165.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 14' ' ' THR . 47.1 t -91.29 123.33 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.232 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 63' ' ' LEU . 7.4 p -115.16 151.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.4 p -143.57 136.1 27.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 70.0 mt -98.32 122.29 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 8' ' ' THR . 2.3 mp -89.01 114.62 27.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.026 0.93 . . . . 0.0 108.901 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.555 ' HA ' HD23 ' A' ' 56' ' ' LEU . 97.9 m-85 -109.93 99.43 8.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.841 0.856 . . . . 0.0 108.726 172.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.7 m -90.17 102.18 14.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.512 ' NE2' ' HB3' ' A' ' 50' ' ' TRP . 38.0 tt0 -78.79 105.68 10.26 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 119.677 -0.201 . . . . 0.0 110.791 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.6 p -74.37 143.53 44.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 124.071 0.857 . . . . 0.0 110.259 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -160.35 10.1 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HD3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -155.79 137.62 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 117.913 0.856 . . . . 0.0 110.876 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.636 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -113.24 128.73 56.56 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.525 0.73 . . . . 0.0 109.156 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 29.0 t70 -79.77 130.15 35.09 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.374 0.67 . . . . 0.0 109.39 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.42 -16.47 45.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 t -94.53 -36.12 11.97 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.401 0.546 . . . . 0.0 110.982 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -89.85 -31.8 17.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.892 0.477 . . . . 0.0 109.962 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.88 27.42 60.59 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HE2' HD12 ' A' ' 49' ' ' ILE . 21.1 ptmt -96.38 140.69 30.66 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.694 0.798 . . . . 0.0 110.946 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.02 115.49 30.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 0.0 110.481 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.414 HD12 ' HE2' ' A' ' 47' ' ' LYS . 3.6 mp -109.77 104.01 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.512 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 74.5 m95 -90.36 145.48 24.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.233 1.013 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 28.1 t70 -67.57 113.85 5.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.16 0.584 . . . . 0.0 110.292 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -62.75 -39.32 93.75 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.913 0.885 . . . . 0.0 112.13 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -82.72 -6.92 59.64 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.671 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HB3' ' HG ' ' A' ' 87' ' ' SER . 60.0 t90 -54.36 124.63 16.54 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 19.9 p -154.34 108.45 2.98 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 35' ' ' PHE . 37.4 tp -101.06 127.0 47.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.9 m -98.83 112.9 24.85 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -119.95 124.77 46.78 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 15.7 m -80.88 135.24 35.88 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.211 0.605 . . . . 0.0 111.619 -174.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -82.61 117.62 22.71 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 158.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -172.45 179.93 2.38 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.001 1.438 . . . . 0.0 109.089 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.53 52.78 4.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.914 0.759 . . . . 0.0 112.273 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 HD22 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -97.33 98.22 4.68 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 168.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.69 92.35 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.782 2.321 . . . . 0.0 111.89 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.1 p -85.82 131.75 46.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.926 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.21 138.57 61.98 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.87 2.38 . . . . 0.0 113.072 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -88.57 111.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 mt -102.56 128.63 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.29 132.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.871 0.468 . . . . 0.0 109.828 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.45 79.87 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.517 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 88.6 m-85 -143.88 157.95 44.02 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.073 0.949 . . . . 0.0 109.107 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.4 m -145.61 116.97 7.96 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.653 0.781 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.32 135.41 57.0 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.673 0.608 . . . . 0.0 109.562 170.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.65 -14.57 61.62 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 0.0 110.773 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.08 84.75 7.23 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.49 1.116 . . . . 0.0 108.575 172.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.16 -5.67 17.01 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.361 2.041 . . . . 0.0 111.661 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 tpt -116.8 109.31 16.95 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.332 1.053 . . . . 0.0 108.312 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 40.6 t -100.96 133.12 45.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 92.53 0.21 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 123.945 0.778 . . . . 0.0 111.59 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -104.44 21.27 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.055 2.504 . . . . 0.0 112.981 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.76 148.02 29.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -165.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 37.1 mt-10 -87.63 129.64 35.05 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.257 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.75 108.84 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.047 0.939 . . . . 0.0 110.016 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 m -92.58 101.13 13.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.4 0.68 . . . . 0.0 110.623 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.25 116.59 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 9.9 t70 -93.46 163.94 13.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.548 ' HG ' ' HB3' ' A' ' 54' ' ' TRP . 49.0 m -57.2 -27.75 62.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.283 1.033 . . . . 0.0 111.93 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -69.69 -30.89 68.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.169 0.988 . . . . 0.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -115.53 8.9 15.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.944 0.498 . . . . 0.0 111.714 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.413 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 82.9 t80 -62.03 -33.89 75.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.876 0.87 . . . . 0.0 112.25 -173.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.74 -18.1 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.323 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -95.63 156.42 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 170.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -141.74 138.71 32.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.691 1.197 . . . . 0.0 108.13 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.36 45.48 0.96 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 0.0 109.694 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.03 121.58 15.02 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.466 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HB2' HE22 ' A' ' 13' ' ' GLN . 53.5 mmm-85 -127.15 177.44 6.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.516 0.726 . . . . 0.0 109.901 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -130.31 122.32 27.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.71 110.59 20.42 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 94.9 m -97.3 122.96 40.92 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.517 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -99.16 137.05 27.77 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.0 mm -100.41 118.76 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 122.782 0.433 . . . . 0.0 110.166 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 91.4 m-85 -88.67 95.63 10.33 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 p -86.65 139.15 31.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.41 114.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.245 1.018 . . . . 0.0 110.649 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.439 ' OD1' HG21 ' A' ' 106' ' ' THR . 31.9 t-20 -62.6 149.85 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.397 1.061 . . . . 0.0 109.758 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.439 HG21 ' OD1' ' A' ' 105' ' ' ASN . 6.9 t -47.98 -32.96 7.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.644 1.178 . . . . 0.0 111.481 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.9 mm -54.34 -46.86 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.653 1.181 . . . . 0.0 111.511 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 t -89.15 -24.86 22.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.944 0.498 . . . . 0.0 111.036 -175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -71.7 -49.04 43.2 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.872 0.469 . . . . 0.0 111.154 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 173.12 12.91 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.116 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.82 135.51 16.27 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.756 0.822 . . . . 0.0 109.247 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -55.57 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.394 0.678 . . . . 0.0 110.304 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -178.23 171.42 1.67 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.317 1.447 . . . . 0.0 108.82 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.25 32.23 83.44 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.274 0.359 . . . . 0.0 112.495 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -92.12 -26.5 18.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.712 0.805 . . . . 0.0 110.589 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 65.72 -79.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.282 1.433 . . . . 0.0 110.625 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -169.04 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.987 1.315 . . . . 0.0 108.158 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.5 m170 56.54 85.8 0.07 Allowed 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.754 1.622 . . . . 0.0 111.14 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -125.73 98.04 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -92.98 -179.95 5.26 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.537 0.735 . . . . 0.0 110.161 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -90.54 4.7 50.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.6 0.36 . . . . 0.0 111.101 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 125.199 1.399 . . . . 0.0 109.551 -169.682 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.33 154.03 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.801 1.241 . . . . 0.0 109.204 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.07 146.45 53.74 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.59 122.49 5.53 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 121.326 1.351 . . . . 0.0 111.681 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 41' ' ' ARG . 24.5 pt -117.2 169.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 0.0 110.029 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.01 144.21 8.23 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.869 0.468 . . . . 0.0 111.414 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . 84.9 mtt180 -102.06 169.87 8.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.4 1.08 . . . . 0.0 108.946 165.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -144.09 116.85 8.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.099 0.559 . . . . 0.0 110.72 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -114.05 125.03 53.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -104.84 134.64 45.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.21 118.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -109.07 117.64 34.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.206 1.002 . . . . 0.0 110.304 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -90.39 108.64 19.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 p -85.63 104.58 15.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.5 mp -92.68 121.7 43.54 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -125.72 130.91 52.46 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.101 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.652 ' HA ' HG21 ' A' ' 100' ' ' VAL . 71.4 m-85 -92.3 121.99 34.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.956 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -134.99 162.45 32.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.37 0.668 . . . . 0.0 109.32 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -93.33 171.94 8.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.977 0.911 . . . . 0.0 109.444 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.04 -25.13 66.91 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.542 0.737 . . . . 0.0 110.741 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.0 -20.33 66.15 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.89 1.276 . . . . 0.0 111.815 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.52 -19.26 54.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 120.075 -0.291 . . . . 0.0 112.481 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.25 137.51 52.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.024 0.93 . . . . 0.0 110.901 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.98 109.95 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.81 63.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.115 0.566 . . . . 0.0 109.973 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -153.67 166.85 31.52 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.83 1.252 . . . . 0.0 110.487 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.62 82.0 0.59 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -171.76 -3.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.473 ' HB3' HD21 ' A' ' 63' ' ' LEU . 22.1 m170 -99.46 82.22 2.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.67 1.123 . . . . 0.0 111.269 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.91 130.96 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.4 117.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 m -105.83 127.42 53.1 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.445 1.098 . . . . 0.0 108.954 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 58' ' ' GLN . 94.9 mt -108.67 130.86 55.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.461 0.705 . . . . 0.0 110.06 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.3 118.9 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 108.921 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -108.13 104.16 13.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.0 m -94.63 105.75 17.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.425 0.69 . . . . 0.0 109.484 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 35.4 tt0 -79.8 83.79 5.69 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -74.36 133.44 42.51 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.99 -162.08 9.04 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 142.06 32.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.584 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.5 ttm180 -112.2 124.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.295 0.638 . . . . 0.0 109.949 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.53 120.79 20.56 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.4 mt -83.8 -27.31 28.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -73.22 -41.16 64.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.898 0.317 . . . . 0.0 111.026 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -87.98 -29.73 20.55 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.98 36.34 32.32 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -104.37 142.47 34.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.659 0.784 . . . . 0.0 109.69 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.15 114.1 25.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.42 116.44 34.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -114.58 132.72 56.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.78 127.04 32.21 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 t -67.77 -31.05 70.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.975 0.91 . . . . 0.0 111.789 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -86.56 2.75 47.01 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.02 0.528 . . . . 0.0 111.449 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.567 ' CZ2' ' HB2' ' A' ' 56' ' ' LEU . 77.6 t90 -58.79 134.52 56.93 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.32 0.648 . . . . 0.0 110.564 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.1 p -156.04 122.14 5.04 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.909 0.883 . . . . 0.0 109.321 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.567 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 1.5 tm? -104.38 133.86 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -107.12 123.21 47.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.309 0.644 . . . . 0.0 110.31 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.6 mm-40 -129.2 134.01 47.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 0.0 108.902 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.8 m -97.41 118.68 34.42 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.408 0.683 . . . . 0.0 111.377 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -72.94 119.67 17.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -170.09 -163.47 0.36 Allowed 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.534 1.146 . . . . 0.0 108.56 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 64.32 19.69 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.254 1.021 . . . . 0.0 112.544 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 29' ' ' HIS . 35.9 tp -139.74 98.93 7.74 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.287 0.635 . . . . 0.0 109.372 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 77' ' ' MET . 53.6 Cg_endo -88.89 -166.47 0.25 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.366 2.711 . . . . 0.0 111.899 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -116.57 147.11 39.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.129 0.972 . . . . 0.0 110.501 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HG2' ' HH ' ' A' ' 102' ' ' TYR . 18.1 Cg_endo -59.68 125.11 16.9 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.546 2.164 . . . . 0.0 111.555 171.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.87 109.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.26 1.024 . . . . 0.0 109.908 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.02 123.45 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -73.6 135.29 27.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.525 1.53 . . . . 0.0 108.895 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.02 -1.41 86.69 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.599 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 94.5 m-85 -139.5 168.43 19.83 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 117.681 0.74 . . . . 0.0 112.157 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -150.45 121.5 7.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.465 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 147.16 52.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.428 0.691 . . . . 0.0 111.121 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -63.12 -32.42 73.8 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.941 0.896 . . . . 0.0 110.422 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 93.62 7.24 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.1 -1.7 9.95 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.958 2.439 . . . . 0.0 113.266 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 24.8 ttt -148.68 140.06 23.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.28 122.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.02 112.25 3.08 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 124.8 1.312 . . . . 0.0 113.173 -171.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.52 90.49 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.181 2.587 . . . . 0.0 110.677 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -140.17 137.37 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.72 106.22 9.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.592 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.39 112.53 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.508 1.123 . . . . 0.0 109.263 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -100.85 135.51 42.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.97 0.508 . . . . 0.0 110.593 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -103.79 124.67 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.34 164.29 13.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.046 0.939 . . . . 0.0 109.309 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.0 t -58.31 -37.75 75.71 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.764 1.226 . . . . 0.0 112.972 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.16 -41.32 22.6 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.826 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.3 -0.8 51.29 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 117.755 0.252 . . . . 0.0 111.577 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -57.91 -31.32 66.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 0.0 112.388 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.56 -21.79 61.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.32 0.648 . . . . 0.0 111.372 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.19 120.53 40.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.82 0.848 . . . . 0.0 109.45 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.15 105.32 3.93 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.731 0.777 . . . . 0.0 109.05 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -84.65 41.65 0.86 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 111.039 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.95 160.92 19.61 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.247 1.019 . . . . 0.0 111.449 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.63 169.22 19.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.008 0.523 . . . . 0.0 110.215 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.28 126.31 42.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.84 0.856 . . . . 0.0 109.64 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 15' ' ' ILE . 15.7 mm-40 -101.39 123.14 44.98 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.017 0.527 . . . . 0.0 109.744 169.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -109.15 109.8 20.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 17' ' ' TYR . 1.1 m -85.77 141.49 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.209 0.603 . . . . 0.0 109.97 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 94.9 m-85 -76.66 107.8 9.21 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.6 p -109.15 142.03 40.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.07 124.8 10.81 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 124.369 1.043 . . . . 0.0 110.525 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 51.7 p30 -69.45 -141.31 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.956 0.902 . . . . 0.0 110.728 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.2 t -54.93 -9.9 0.42 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 98.2 mt -45.52 -52.85 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 124.51 1.124 . . . . 0.0 110.725 166.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -101.91 -27.25 13.09 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 111.189 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -93.91 -172.45 2.86 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.847 0.859 . . . . 0.0 111.656 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -96.79 -31.84 12.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.352 1.061 . . . . 0.0 109.596 167.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.5 143.86 30.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.837 0.855 . . . . 0.0 110.102 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 105' ' ' ASN . 43.4 mtpt -80.74 -84.83 0.1 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 166.59 -170.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.137 1.375 . . . . 0.0 109.258 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.2 45.26 40.72 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.052 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.07 -38.91 58.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.469 1.108 . . . . 0.0 110.543 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -155.27 130.38 9.49 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.523 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -66.25 109.84 2.81 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.864 0.866 . . . . 0.0 110.592 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -75.78 104.2 6.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 109.209 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -60.96 100.65 0.12 Allowed 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.718 0.77 . . . . 0.0 111.027 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -137.11 129.46 29.77 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 109.093 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -76.22 85.03 3.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.988 1.315 . . . . 0.0 109.329 -170.267 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.7 tpt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.111 0.481 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 42' ' ' ASP . 38.0 mm -102.65 143.46 15.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.908 0.883 . . . . 0.0 109.319 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.78 146.77 51.55 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.97 123.0 4.99 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.478 1.452 . . . . 0.0 111.315 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.582 HD13 ' HB2' ' A' ' 41' ' ' ARG . 38.9 pt -116.76 169.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.329 0.585 . . . . 0.0 110.874 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.428 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -161.31 152.41 18.54 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.007 174.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.412 ' NH2' HD23 ' A' ' 91' ' ' LEU . 27.3 ttp180 -124.2 147.7 47.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.522 HG22 HG23 ' A' ' 34' ' ' ILE . 51.4 m -116.91 106.8 13.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.335 0.654 . . . . 0.0 110.881 -169.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -107.05 102.94 12.25 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.66 127.01 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 32' ' ' SER . 59.7 t -91.4 103.25 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.7 m -96.18 100.56 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.293 -172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 35.1 mm-40 -92.62 100.91 13.34 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -87.01 104.42 16.29 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 68.6 mt -89.89 123.77 42.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 111.545 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 22.9 m170 -101.18 120.56 40.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.574 ' HA ' HG22 ' A' ' 100' ' ' VAL . 17.7 m-85 -90.89 116.51 28.77 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 43.8 mtm105 -134.14 177.08 8.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.267 0.627 . . . . 0.0 109.96 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.501 ' HH ' HD13 ' A' ' 68' ' ' ILE . 92.3 m-85 -104.06 169.59 8.41 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.231 1.012 . . . . 0.0 109.648 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.39 -26.24 68.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.151 0.58 . . . . 0.0 111.28 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.41 -17.26 63.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.271 1.028 . . . . 0.0 110.618 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.57 32.85 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.06 44.65 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.088 0.955 . . . . 0.0 111.862 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 37.7 t -86.73 121.6 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.691 0.396 . . . . 0.0 109.977 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.68 -57.15 3.97 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -168.49 103.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 109.655 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 5.0 p-10 -86.48 -171.41 3.53 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.98 0.512 . . . . 0.0 111.44 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 66.06 16.19 10.36 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.438 1.095 . . . . 0.0 112.56 171.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -89.59 90.54 8.3 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.6 145.42 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 124.534 1.134 . . . . 0.0 112.092 -169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 ' HB ' HD12 ' A' ' 63' ' ' LEU . 5.4 p -125.65 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.4 m -129.01 132.49 47.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.885 0.374 . . . . 0.0 110.723 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.89 123.84 45.69 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 8' ' ' THR . 2.6 mp -82.82 112.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' HD1' ' HB2' ' A' ' 56' ' ' LEU . 97.3 m-85 -108.83 100.76 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -98.65 108.16 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.501 1.121 . . . . 0.0 110.264 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.52 114.26 20.81 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -87.15 146.81 25.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.355 0.597 . . . . 0.0 110.243 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.48 -157.72 9.74 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.919 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 140.27 25.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.344 0.572 . . . . 0.0 110.007 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.582 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.4 ttm180 -104.64 135.63 45.69 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.332 0.586 . . . . 0.0 109.666 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HA ' HD13 ' A' ' 2' ' ' ILE . 34.6 t70 -82.08 109.59 16.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.831 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 1' ' ' MET . 88.4 mt -81.88 -2.95 52.94 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 t -92.51 -37.53 12.45 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.408 0.549 . . . . 0.0 111.042 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.6 -28.01 13.75 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.143 0.577 . . . . 0.0 109.734 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.88 37.06 9.59 Favored Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -113.65 140.98 47.76 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.568 0.747 . . . . 0.0 109.737 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.1 121.4 38.94 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.391 0.677 . . . . 0.0 110.203 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.36 97.68 5.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.428 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 79.1 m95 -91.95 141.47 28.59 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.7 t70 -69.03 116.39 9.43 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.8 p -66.58 -30.38 70.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.703 0.801 . . . . 0.0 111.627 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.597 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 7.9 mtmp? -80.97 -16.44 53.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.618 0.767 . . . . 0.0 111.151 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.498 ' HB3' ' HG ' ' A' ' 87' ' ' SER . 60.4 t-105 -62.07 132.23 52.19 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.112 0.565 . . . . 0.0 111.883 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.1 p -155.03 144.66 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.896 1.278 . . . . 0.0 108.307 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB2' ' HD1' ' A' ' 35' ' ' PHE . 96.7 mt -120.13 130.1 54.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.232 0.613 . . . . 0.0 109.413 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 m -106.22 119.95 40.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.89 145.3 44.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.774 0.829 . . . . 0.0 108.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 82' ' ' GLU . 16.6 m -99.18 123.61 43.6 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.089 0.556 . . . . 0.0 111.376 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -65.2 128.32 35.34 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 159.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -171.43 168.61 6.46 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.359 0.663 . . . . 0.0 110.837 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.51 14.62 9.65 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.219 1.408 . . . . 0.0 113.339 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 ' HB ' ' A' ' 31' ' ' VAL . 4.6 mm? -62.63 113.21 8.3 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.785 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.54 166.23 28.04 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.157 1.905 . . . . 0.0 110.555 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -156.15 123.08 2.67 Favored Pre-proline 0 N--CA 1.472 0.629 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.44 125.0 15.26 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.307 2.005 . . . . 0.0 111.945 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.9 t -77.18 104.77 5.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.501 HD13 ' HH ' ' A' ' 19' ' ' TYR . 32.5 mt -101.71 113.4 37.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -175.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.1 mm -75.58 134.87 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.303 0.641 . . . . 0.0 109.854 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.01 4.22 82.13 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.969 -169.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -134.43 167.57 20.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.963 0.905 . . . . 0.0 110.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.4 m -156.03 117.55 3.92 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 152.42 38.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.233 0.54 . . . . 0.0 111.702 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.46 -26.88 60.32 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.79 1.236 . . . . 0.0 109.668 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 92.97 4.12 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.767 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.61 3.53 7.63 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.564 2.176 . . . . 0.0 112.659 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 ttt -147.41 78.27 1.46 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.252 0.621 . . . . 0.0 110.151 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.8 t -84.67 152.79 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.74 -81.49 0.34 Allowed Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.112 -1.382 . . . . 0.0 111.724 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -31.75 78.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.762 1 C-N-CA 125.589 4.192 . . . . 0.0 117.073 -162.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -161.32 144.11 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 109.713 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 28.0 mt-10 -91.76 120.54 32.58 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.48 128.6 51.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.196 0.999 . . . . 0.0 109.055 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 29.2 m -110.25 109.67 20.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG21 ' NE2' ' A' ' 94' ' ' GLN . 86.9 t -95.76 110.59 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 163.63 19.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.463 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.498 ' HG ' ' HB3' ' A' ' 54' ' ' TRP . 57.5 m -67.84 -27.15 66.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.812 0.445 . . . . 0.0 111.364 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -76.27 -29.47 57.46 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.327 0.651 . . . . 0.0 112.735 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -116.07 23.82 11.9 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.563 0.345 . . . . 0.0 110.998 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -61.44 -48.51 80.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.785 0.834 . . . . 0.0 111.897 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.412 HD23 ' NH2' ' A' ' 7' ' ' ARG . 3.2 mm? -75.28 -10.48 59.5 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -83.76 120.24 25.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.163 0.585 . . . . 0.0 109.724 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.57 148.86 40.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.068 0.937 . . . . 0.0 111.428 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.437 ' NE2' HG21 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -137.1 14.64 3.05 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.82 168.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -79.79 140.96 36.68 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 46.2 ttp85 -172.28 169.76 5.28 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.9 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.57 135.22 36.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.184 0.994 . . . . 0.0 108.668 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 5.5 mm-40 -126.27 111.38 14.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.34 1.056 . . . . 0.0 110.401 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 m -96.2 130.77 43.19 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.573 -0.704 . . . . 0.0 110.578 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.0 m -96.0 143.07 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 164.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.0 mm -114.69 110.47 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.858 0.463 . . . . 0.0 110.543 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -88.26 102.51 14.9 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 m -87.01 172.93 9.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.76 156.67 8.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -58.59 153.2 16.78 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.7 t -46.75 -26.03 0.86 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.594 1.558 . . . . 0.0 113.317 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.14 -53.16 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.654 0.782 . . . . 0.0 110.772 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -91.53 -4.83 55.02 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -64.12 87.27 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.264 0.554 . . . . 0.0 111.166 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -72.76 135.31 45.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.302 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -118.68 147.33 43.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.17 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.96 -60.99 2.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 t70 57.18 -167.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.809 1.244 . . . . 0.0 110.375 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.09 -54.72 0.46 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.3 mt 64.53 6.26 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.94 1.296 . . . . 0.0 112.375 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.23 -175.58 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.704 1.601 . . . . 0.0 111.461 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -87.17 7.63 27.34 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.583 0.753 . . . . 0.0 110.924 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -62.75 114.12 3.42 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.362 1.065 . . . . 0.0 111.801 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.6 t60 63.33 29.99 15.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.691 1.197 . . . . 0.0 111.846 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -84.78 -27.66 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -149.1 -52.49 0.16 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.781 1.632 . . . . 0.0 106.971 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.954 1.302 . . . . 0.0 107.835 170.095 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 40' ' ' LYS . 32.8 mm -127.31 154.88 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.841 0.857 . . . . 0.0 109.93 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 10.6 pt-20 -121.75 146.06 44.78 Favored Pre-proline 0 N--CA 1.485 1.293 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 165.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.69 125.38 11.06 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.873 1.716 . . . . 0.0 111.265 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 41' ' ' ARG . 32.6 pt -128.15 174.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.664 0.785 . . . . 0.0 109.825 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.55 150.19 7.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 110.951 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -108.99 151.95 25.63 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -134.91 107.93 7.62 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.174 0.59 . . . . 0.0 110.264 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -105.43 124.16 49.08 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.2 m -104.26 139.17 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' SER . 38.8 t -94.76 104.97 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -102.17 102.39 12.83 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.678 ' HG2' ' HB3' ' A' ' 96' ' ' ARG . 25.1 mt-30 -104.46 121.35 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.793 0.837 . . . . 0.0 109.803 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.499 HG21 HG22 ' A' ' 30' ' ' VAL . 32.0 m -92.24 103.4 15.87 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -84.81 128.3 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.241 0.617 . . . . 0.0 109.435 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -106.13 137.69 43.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -108.96 121.25 44.73 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 3.7 tpp180 -145.85 130.15 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 161.58 25.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.289 0.635 . . . . 0.0 110.564 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.22 -25.0 68.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.745 0.818 . . . . 0.0 112.218 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.03 -9.2 58.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 111.62 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.28 68.66 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.94 55.0 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 123.686 0.794 . . . . 0.0 110.232 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 27' ' ' ASP . 47.9 t -90.15 110.08 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.596 0.758 . . . . 0.0 110.521 -172.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.26 -49.46 13.68 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.213 0.205 . . . . 0.0 110.676 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -176.99 90.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.751 1.22 . . . . 0.0 108.463 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.613 ' HB2' HG11 ' A' ' 24' ' ' VAL . 8.8 t70 -98.62 41.08 1.15 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.256 0.623 . . . . 0.0 111.757 -161.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -152.99 16.46 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.63 -0.669 . . . . 0.0 111.883 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.496 ' HE1' ' HG2' ' A' ' 64' ' ' PRO . 9.5 t60 -75.74 93.14 3.08 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 120.725 0.297 . . . . 0.0 110.97 -173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 14' ' ' THR . 39.2 t -95.3 146.03 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 122.784 0.434 . . . . 0.0 110.452 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.16 149.11 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.459 1.103 . . . . 0.0 108.472 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 62.1 p -143.4 127.42 17.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 26.3 mt -104.91 127.16 52.63 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 174.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.7 115.94 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.134 0.973 . . . . 0.0 108.986 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HA ' HD22 ' A' ' 56' ' ' LEU . 69.3 m-85 -108.02 110.43 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 m -111.18 108.24 17.84 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -94.31 110.0 21.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -76.79 142.46 40.34 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.545 0.528 . . . . 0.0 109.8 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.16 -165.54 11.17 Favored Glycine 0 C--O 1.248 1.015 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HB2' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -142.43 139.45 31.63 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HB2' HD12 ' A' ' 5' ' ' ILE . 40.0 ttm180 -107.75 122.93 47.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.638 0.199 . . . . 0.0 110.949 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.1 114.04 6.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.613 1.165 . . . . 0.0 109.403 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.9 -20.21 35.86 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -78.68 -40.22 34.49 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.255 0.48 . . . . 0.0 110.757 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -91.66 -29.81 16.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.662 0.785 . . . . 0.0 110.229 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.6 44.72 7.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HE3' HD13 ' A' ' 49' ' ' ILE . 30.4 ttpt -116.0 142.43 46.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.618 1.567 . . . . 0.0 109.172 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -108.91 121.17 44.54 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.892 0.477 . . . . 0.0 110.451 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.481 HD13 ' HE3' ' A' ' 47' ' ' LYS . 3.7 mp -98.59 107.73 20.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.511 1.124 . . . . 0.0 108.275 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.06 119.32 39.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 37.2 t70 -62.69 115.78 4.61 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.369 0.668 . . . . 0.0 109.883 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 m -64.47 -26.28 68.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.421 1.088 . . . . 0.0 111.936 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -82.47 -13.25 57.04 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.951 0.901 . . . . 0.0 111.414 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.2 t-105 -68.75 137.49 54.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.527 0.731 . . . . 0.0 110.383 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.3 p -152.42 146.92 25.69 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.256 1.022 . . . . 0.0 108.738 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 35' ' ' PHE . 36.9 tp -124.81 125.39 43.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.3 m -97.54 112.32 24.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.49 132.74 53.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.55 HG21 ' HG2' ' A' ' 61' ' ' GLU . 4.8 m -68.43 108.79 3.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.86 0.725 . . . . 0.0 109.986 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.584 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -97.06 96.73 8.67 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.55 ' HG2' HG21 ' A' ' 59' ' ' THR . 11.4 pt-20 -168.41 -159.95 0.29 Allowed 'General case' 0 C--O 1.245 0.846 0 C-N-CA 124.098 0.959 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.81 31.55 16.38 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' HB ' ' A' ' 78' ' ' VAL . 2.2 tm? -84.55 107.94 12.99 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HG2' ' HE1' ' A' ' 29' ' ' HIS . 56.1 Cg_endo -71.29 89.94 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.149 2.566 . . . . 0.0 113.278 -170.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -85.64 125.98 67.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.967 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.7 118.59 5.47 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.443 2.096 . . . . 0.0 110.469 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.92 108.53 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mt -107.37 117.53 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.365 0.602 . . . . 0.0 109.991 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.64 138.95 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.675 1.59 . . . . 0.0 109.344 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.74 8.91 87.19 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.698 0.624 . . . . 0.0 112.253 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.4 m-85 -140.51 167.68 21.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.478 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 116' ' ' GLU . 95.4 m -148.67 116.98 6.47 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.809 0.843 . . . . 0.0 109.629 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -64.38 154.25 36.08 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.986 0.914 . . . . 0.0 110.757 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.27 -39.65 91.18 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.078 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 92.53 5.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.139 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.22 -0.3 8.42 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.065 2.51 . . . . 0.0 113.04 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.0 ttt -140.9 89.98 2.3 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 21.4 t -76.68 145.01 10.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.72 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.28 127.92 2.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.18 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 8.7 Cg_exo -72.38 29.48 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 124.12 3.213 . . . . 0.0 115.094 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 69.9 -72.47 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.192 1.397 . . . . 0.0 111.609 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.5 130.12 41.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.779 0.831 . . . . 0.0 109.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.1 t -118.1 114.4 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -96.33 110.73 23.01 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.408 0.683 . . . . 0.0 109.422 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.34 114.34 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -92.23 162.02 14.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.5 0.72 . . . . 0.0 109.782 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -30.95 71.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.236 1.014 . . . . 0.0 111.939 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' HZ1' ' HB3' ' A' ' 88' ' ' LYS . 7.8 mtpm? -66.03 -29.03 69.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.913 0.885 . . . . 0.0 111.741 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -115.11 4.83 14.72 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.084 0.554 . . . . 0.0 111.831 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.61 -23.82 63.57 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.63 161.7 23.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.991 0.917 . . . . 0.0 109.975 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 156.6 32.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.411 ' OE1' HG21 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -119.74 47.04 1.8 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -54.16 122.35 10.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.21 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.678 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 66.0 ttt180 -133.76 172.2 13.1 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.754 0.659 . . . . 0.0 109.641 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.32 119.72 10.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 43.3 mt-10 -123.44 110.37 15.02 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.018 0.527 . . . . 0.0 110.95 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -85.59 122.29 29.49 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.03 134.7 30.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.159 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 170.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 mm -103.17 119.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 86.5 m-85 -84.04 106.94 16.09 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.994 0.918 . . . . 0.0 108.669 170.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.5 p -107.67 134.93 49.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 108.89 0.24 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.511 1.132 . . . . 0.0 110.442 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -71.42 166.68 21.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.652 0.781 . . . . 0.0 112.324 -171.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.603 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 7.0 t -63.29 -15.6 57.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.161 0.584 . . . . 0.0 112.354 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.91 -54.88 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.841 0.857 . . . . 0.0 109.518 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 t -78.25 -21.47 49.84 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 122.37 0.268 . . . . 0.0 110.495 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.603 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 16.5 mm100 -88.91 -168.75 2.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 109.591 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -107.04 -66.11 1.04 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.226 0.611 . . . . 0.0 109.536 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -138.57 148.25 43.96 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.281 0.632 . . . . 0.0 111.019 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.597 ' HE3' ' HG3' ' A' ' 109' ' ' GLN . 14.7 ptpt -172.03 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.157 1.383 . . . . 0.0 109.971 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 66.78 -174.34 0.19 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.021 1.329 . . . . 0.0 110.95 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.58 -35.18 2.85 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt 73.41 -9.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.598 1.559 . . . . 0.0 114.403 170.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 72' ' ' THR . 36.9 mt-10 68.57 -170.66 0.18 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.419 1.087 . . . . 0.0 109.135 -170.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.84 145.3 23.14 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.793 -0.567 . . . . 0.0 111.012 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -87.87 148.76 24.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.908 0.883 . . . . 0.0 111.233 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -143.28 84.83 1.83 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.523 0.729 . . . . 0.0 110.292 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -135.56 132.41 37.17 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -76.44 95.84 3.93 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.674 0.609 . . . . 0.0 110.495 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.172 0.989 . . . . 0.0 110.281 -178.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.6 tpt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 42' ' ' ASP . 33.1 mm -126.59 152.51 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.203 1.001 . . . . 0.0 109.001 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 13.9 pt-20 -128.38 155.14 78.99 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.29 127.08 5.77 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.616 1.544 . . . . 0.0 111.6 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -125.72 168.15 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.144 0.578 . . . . 0.0 110.447 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 150.53 23.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.285 0.634 . . . . 0.0 109.932 174.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.441 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 98.7 mtt180 -114.25 159.64 19.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.057 0.543 . . . . 0.0 109.895 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.596 HG21 HG23 ' A' ' 34' ' ' ILE . 28.6 m -113.54 113.38 25.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -110.75 98.05 7.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.4 m -88.38 133.01 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 105.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 27.6 m -103.39 99.48 9.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.132 0.491 . . . . 0.0 110.228 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' A' ' 96' ' ' ARG . 18.6 mt-30 -94.39 131.8 39.68 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.608 0.763 . . . . 0.0 111.433 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 30' ' ' VAL . 50.9 m -103.54 105.53 15.8 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.8 mp -91.03 130.55 40.03 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -129.45 138.71 51.59 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.649 0.738 . . . . 0.0 110.509 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.484 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 66.4 m-85 -94.61 119.65 33.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.92 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 53.8 ttt180 -144.86 134.31 23.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 0.0 111.194 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -71.08 163.02 28.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.446 1.099 . . . . 0.0 112.128 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.83 -38.64 79.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.339 . . . . 0.0 112.787 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.37 -17.72 60.14 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.233 1.013 . . . . 0.0 112.026 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.23 28.39 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.691 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 139.52 39.87 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.47 131.25 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 118.129 0.422 . . . . 0.0 110.498 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.87 -58.03 3.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.321 0.648 . . . . 0.0 109.762 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 97.0 m-70 -150.92 171.4 17.32 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.123 1.369 . . . . 0.0 109.128 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -153.75 29.44 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.413 0.625 . . . . 0.0 111.512 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.01 -3.13 17.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.903 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -88.22 75.85 8.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.655 0.741 . . . . 0.0 109.62 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.477 HG22 HG23 ' A' ' 14' ' ' THR . 27.2 t -100.93 112.49 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.959 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.06 146.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.574 1.149 . . . . 0.0 109.307 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -136.29 141.1 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.569 0.748 . . . . 0.0 110.333 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt -112.61 126.79 55.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.441 171.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 8' ' ' THR . 2.0 mp -88.2 104.61 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.261 1.024 . . . . 0.0 108.936 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.59 ' HA ' HD23 ' A' ' 56' ' ' LEU . 67.1 m-85 -97.13 100.72 12.2 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -82.15 101.94 10.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.545 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -87.48 100.97 13.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -94.07 149.76 20.95 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.827 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.77 -151.31 6.17 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.076 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 142.83 27.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.452 0.701 . . . . 0.0 109.655 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HB2' HD13 ' A' ' 5' ' ' ILE . 21.4 ttm-85 -101.15 126.92 47.9 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.247 0.546 . . . . 0.0 110.09 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.0 t70 -74.58 111.77 10.11 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.51 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.2 mt -83.75 -11.29 57.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -173.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.6 t -78.49 -39.75 37.38 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.766 0.712 . . . . 0.0 110.631 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -94.99 -31.64 13.53 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.36 61.13 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.513 ' HE3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -79.08 139.82 38.01 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.704 0.802 . . . . 0.0 110.216 -173.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.9 124.38 35.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.262 0.625 . . . . 0.0 109.736 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.513 HD11 ' HE3' ' A' ' 47' ' ' LYS . 48.8 mm -111.11 137.4 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.441 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 93.6 m95 -126.49 139.67 53.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -173.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.91 109.15 2.41 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.3 t -61.78 -30.57 70.88 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.009 0.818 . . . . 0.0 111.035 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.83 -3.28 50.6 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.88 0.872 . . . . 0.0 112.04 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 14.5 t-105 -78.51 116.84 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 0.0 109.641 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 p -142.0 130.18 22.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.4 tp -123.23 136.17 54.6 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 m -120.06 117.49 28.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.673 0.789 . . . . 0.0 108.964 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -129.93 149.61 51.58 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.402 ' HG1' ' HG3' ' A' ' 82' ' ' GLU . 60.6 m -106.6 122.58 46.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.438 0.695 . . . . 0.0 112.243 -170.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 66.9 m-85 -71.37 96.66 1.49 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 12.5 pt-20 -139.9 178.9 6.92 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.588 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.78 42.13 31.87 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.359 1.037 . . . . 0.0 110.516 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -105.13 97.28 12.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -174.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -91.11 -165.31 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.235 2.623 . . . . 0.0 112.407 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB2' ' OH ' ' A' ' 102' ' ' TYR . 70.6 p -154.21 146.49 17.33 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.484 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.34 120.44 7.76 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.169 1.913 . . . . 0.0 111.329 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.75 106.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.6 mt -94.85 126.48 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.91 131.2 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.975 0.91 . . . . 0.0 110.877 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.81 5.36 89.88 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.106 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.5 159.32 42.14 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.775 0.797 . . . . 0.0 111.601 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.3 m -147.52 129.02 14.97 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.07 156.17 30.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.519 0.327 . . . . 0.0 111.045 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 -42.15 69.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.37 86.42 58.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.369 169.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.59 -6.19 17.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.362 2.041 . . . . 0.0 111.786 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.4 tpt -143.95 114.2 7.43 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.901 1.68 . . . . 0.0 106.546 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 63' ' ' LEU . 83.0 t -68.81 123.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.5 116.21 8.21 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.319 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 91.3 Cg_exo -48.04 131.07 21.05 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.598 2.865 . . . . 0.0 113.956 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.85 132.89 31.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' HG3' ' HG1' ' A' ' 59' ' ' THR . 4.7 mp0 -82.72 118.63 23.5 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.217 1.007 . . . . 0.0 109.638 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.8 t -102.09 132.82 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.106 0.962 . . . . 0.0 108.831 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 m -113.46 113.35 25.03 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 0.0 110.07 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG23 ' NE2' ' A' ' 94' ' ' GLN . 94.0 t -97.7 112.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.78 157.09 16.97 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.589 1.156 . . . . 0.0 108.473 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.8 t -53.43 -33.04 52.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.654 1.181 . . . . 0.0 112.556 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -69.74 -54.92 11.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.429 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.36 19.95 3.04 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -56.82 -37.18 70.86 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.34 1.056 . . . . 0.0 111.718 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.16 -15.32 53.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.71 0.404 . . . . 0.0 111.06 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.02 118.33 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.841 0.856 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.18 152.44 25.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.938 0.495 . . . . 0.0 109.854 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' NE2' HG23 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -141.71 23.36 2.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.933 0.893 . . . . 0.0 109.705 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' THR . 21.7 p-10 -65.09 114.07 4.37 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.972 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.532 ' H ' ' HG2' ' A' ' 13' ' ' GLN . 54.9 mtm-85 -82.4 165.29 20.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.886 0.851 . . . . 0.0 110.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.95 123.94 33.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 170.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' A' ' 15' ' ' ILE . 36.6 mt-10 -129.12 125.49 37.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.996 0.518 . . . . 0.0 111.158 -172.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -99.93 125.36 45.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.662 0.785 . . . . 0.0 109.01 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -95.37 137.32 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 51.4 mm -105.99 111.4 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.052 0.141 . . . . 0.0 110.7 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.449 ' OH ' ' HB2' ' A' ' 65' ' ' SER . 79.8 m-85 -85.69 104.26 15.24 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.244 0.618 . . . . 0.0 109.63 175.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -89.77 175.33 7.28 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.545 ' HB2' HG21 ' A' ' 108' ' ' THR . . . -52.02 155.78 1.75 Allowed 'General case' 0 C--O 1.246 0.919 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 167.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 108' ' ' THR . 10.0 t-20 -50.75 161.28 0.36 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.514 1.125 . . . . 0.0 113.554 -168.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -45.48 -24.04 0.28 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.134 1.373 . . . . 0.0 114.002 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.7 -44.67 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.779 0.832 . . . . 0.0 111.653 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 104' ' ' ALA . 11.4 t -74.7 -28.23 60.72 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.756 0.313 . . . . 0.0 111.286 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.17 129.04 36.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.405 0.682 . . . . 0.0 110.607 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -72.4 171.25 12.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 111' ' ' LYS . 10.4 mptt -85.74 85.93 7.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.914 0.885 . . . . 0.0 109.315 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -106.11 -33.04 7.98 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.445 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.18 72.25 5.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.329 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.49 8.04 12.19 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.458 171.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.2 mt -79.0 -70.35 0.51 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 54.74 107.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 112.679 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -57.55 156.06 8.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.487 0.715 . . . . 0.0 110.633 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -62.83 87.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.521 0.677 . . . . 0.0 110.429 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -83.35 70.69 10.22 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.823 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -70.91 -47.9 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.275 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -158.47 104.96 1.84 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.407 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 22.6 p-80 . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -165.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 42' ' ' ASP . 30.5 mm -109.62 148.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.417 0.687 . . . . 0.0 109.275 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -123.74 137.18 28.29 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.25 126.62 12.51 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.006 1.804 . . . . 0.0 110.723 174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 41' ' ' ARG . 32.4 pt -128.85 135.61 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -142.4 132.74 24.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -113.66 135.22 54.17 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 34' ' ' ILE . 27.5 m -98.5 104.53 16.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.633 0.773 . . . . 0.0 109.03 -166.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.425 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.9 tp-100 -97.62 92.14 5.76 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 34' ' ' ILE . 19.4 m -88.02 118.34 33.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 94' ' ' GLN . 86.3 t -88.62 107.66 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.6 m -94.52 108.2 20.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.364 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.472 ' HB3' HG12 ' A' ' 31' ' ' VAL . 9.0 tt0 -104.89 106.18 16.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.548 HG23 HG22 ' A' ' 30' ' ' VAL . 94.6 m -93.54 107.05 18.96 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -84.77 127.27 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.159 0.504 . . . . 0.0 110.239 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -112.37 109.5 19.16 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.216 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 39.7 m-85 -78.47 115.27 18.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.91 160.09 40.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.998 0.519 . . . . 0.0 110.539 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -93.87 168.43 10.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.172 0.989 . . . . 0.0 109.861 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.77 -27.4 67.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.22 -17.16 62.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.358 1.063 . . . . 0.0 111.528 -176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.78 -12.65 42.04 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.33 58.51 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.679 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.54 124.61 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.74 -60.36 2.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.228 0.611 . . . . 0.0 110.577 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.588 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 91.2 m-70 -152.61 105.63 3.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.562 1.145 . . . . 0.0 108.622 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.89 -20.31 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.142 0.577 . . . . 0.0 111.853 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.49 96.53 6.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.116 0.966 . . . . 0.0 110.478 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -146.18 74.58 1.37 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG22 HG23 ' A' ' 14' ' ' THR . 39.6 t -92.28 125.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.363 -167.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 13' ' ' GLN . 3.5 p -105.7 115.45 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 168.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 57.5 p -123.65 117.42 24.97 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.1 mt -97.46 129.66 44.64 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.435 HG13 HG12 ' A' ' 10' ' ' VAL . 2.8 mp -86.84 105.04 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.511 0.724 . . . . 0.0 109.341 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -98.53 107.79 20.33 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 m -75.58 103.14 5.56 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' A' ' 87' ' ' SER . 6.2 tp60 -78.69 100.96 7.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.553 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 39.8 t -99.13 143.29 29.57 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.835 -173.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.51 -164.81 16.14 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.239 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.45 150.7 36.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.434 0.694 . . . . 0.0 109.218 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.562 ' HB2' HD11 ' A' ' 5' ' ' ILE . 38.8 ttm180 -119.74 125.11 47.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.676 0.391 . . . . 0.0 110.716 -171.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.444 ' HA ' HD13 ' A' ' 2' ' ' ILE . 26.4 t70 -75.79 115.68 15.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.952 0.901 . . . . 0.0 108.675 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.63 -15.2 58.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -74.85 -43.42 54.61 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.372 0.606 . . . . 0.0 109.993 -173.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -96.48 -29.09 14.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.925 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.48 27.13 33.62 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 19.6 ptmt -93.83 137.67 32.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.922 0.889 . . . . 0.0 109.933 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.48 116.66 29.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.41 87.86 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -80.57 128.63 33.82 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.9 t70 -62.2 126.33 26.97 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 123.52 0.512 . . . . 0.0 110.313 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -64.44 -29.2 70.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.554 1.142 . . . . 0.0 112.039 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.82 -0.34 42.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.286 0.634 . . . . 0.0 111.882 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 51.4 t-105 -66.18 131.09 45.36 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.026 0.441 . . . . 0.0 111.413 -173.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.0 p -150.24 141.01 22.72 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.107 170.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.87 132.11 55.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.7 m -120.04 128.0 53.11 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.023 0.529 . . . . 0.0 110.149 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.76 144.98 35.79 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m -91.87 124.75 36.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.394 1.077 . . . . 0.0 112.195 -169.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -83.36 111.78 19.32 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.64 -162.35 0.38 Allowed 'General case' 0 C--O 1.238 0.493 0 O-C-N 125.049 1.468 . . . . 0.0 108.547 170.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.5 1.34 1.66 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.285 1.434 . . . . 0.0 112.841 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.23 114.03 50.24 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.49 -163.5 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.889 2.392 . . . . 0.0 113.451 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -158.84 124.88 2.4 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' O ' HG13 ' A' ' 68' ' ' ILE . 18.2 Cg_endo -53.61 123.18 12.73 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.879 2.386 . . . . 0.0 111.168 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.12 109.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.61 0.764 . . . . 0.0 109.737 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 66' ' ' PRO . 52.3 mt -112.78 108.31 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.26 124.74 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 110.555 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.94 56.04 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.603 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -134.85 142.89 46.73 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.697 0.799 . . . . 0.0 111.023 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 105' ' ' ASN . 87.3 m -113.04 117.25 31.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 145.44 47.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 109.993 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.64 -31.31 72.48 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.031 0.933 . . . . 0.0 110.196 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.52 109.31 3.6 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 164.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.27 -5.78 17.08 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.674 2.249 . . . . 0.0 111.749 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.8 ttt -140.12 124.28 17.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.31 155.49 4.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.715 0.806 . . . . 0.0 108.992 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.43 85.98 0.84 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -104.83 24.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.036 2.491 . . . . 0.0 113.549 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -156.48 132.21 9.58 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -165.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.4 mt-10 -72.01 126.88 30.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.109 166.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.68 128.17 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.776 0.83 . . . . 0.0 110.748 174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.0 m -109.92 111.49 22.92 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.497 1.119 . . . . 0.0 108.401 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG13 ' HG2' ' A' ' 9' ' ' GLN . 58.5 t -95.68 108.26 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.92 170.35 11.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.023 0.929 . . . . 0.0 109.57 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.533 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 18.2 p -60.93 -30.08 70.0 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.992 0.917 . . . . 0.0 111.57 170.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -67.54 -63.62 1.02 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.032 0.933 . . . . 0.0 111.453 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -90.9 15.9 10.47 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.284 0.634 . . . . 0.0 111.544 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.425 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 36.3 t80 -55.84 -36.1 67.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.671 1.189 . . . . 0.0 112.303 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.38 -13.54 60.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.994 0.518 . . . . 0.0 111.354 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -101.15 145.05 29.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.868 0.867 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.81 145.54 31.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.47 ' HB2' HG12 ' A' ' 11' ' ' VAL . 64.2 mm-40 -104.06 0.06 29.31 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.973 -0.454 . . . . 0.0 111.994 -170.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -149.82 -172.99 4.29 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.805 0.842 . . . . 0.0 110.203 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -158.37 -160.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.661 0.784 . . . . 0.0 110.265 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.51 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 5.2 mp0 -85.91 106.43 17.1 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 30.7 mm-40 -95.48 111.69 23.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.4 m -104.86 117.02 33.0 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.872 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.2 m -82.56 141.34 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.2 116.43 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 122.66 0.384 . . . . 0.0 110.225 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.437 ' HH ' ' HG2' ' A' ' 66' ' ' PRO . 62.9 m-85 -83.75 99.94 10.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 p -89.73 174.71 7.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.09 153.64 14.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.445 0.566 . . . . 0.0 109.967 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.412 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 5.0 t-20 -64.99 156.79 30.15 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.246 0.546 . . . . 0.0 111.333 -173.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.615 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 9.0 t -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.546 1.138 . . . . 0.0 112.537 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.8 mt -57.07 -46.14 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 124.018 0.927 . . . . 0.0 110.529 172.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 t -88.84 -19.4 25.97 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.615 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 24.5 mt-30 -94.52 -165.52 1.32 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.244 0.618 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -89.11 164.08 15.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.155 0.582 . . . . 0.0 111.807 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -83.3 112.6 20.04 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.597 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -140.75 -48.08 0.42 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.456 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.52 -92.68 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.24 1.416 . . . . 0.0 109.527 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 55.6 24.01 38.02 Favored Glycine 0 C--N 1.358 1.799 0 O-C-N 123.518 0.511 . . . . 0.0 113.796 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.1 mt -86.66 -26.13 24.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.2 1.0 . . . . 0.0 109.569 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 56.08 89.57 0.04 OUTLIER 'General case' 0 C--N 1.352 0.683 0 C-N-CA 125.705 1.602 . . . . 0.0 110.984 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -63.09 134.49 56.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.037 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -164.68 133.14 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.84 1.256 . . . . 0.0 107.931 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -166.78 115.24 0.86 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -125.39 116.65 22.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.897 0.879 . . . . 0.0 109.077 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -78.2 82.76 4.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.923 0.868 . . . . 0.0 109.235 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 CA--C 1.548 0.892 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.759 178.349 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 mm -120.04 158.03 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.773 1.229 . . . . 0.0 109.594 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 9.0 pt-20 -128.75 151.65 77.53 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.93 124.42 7.39 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 121.652 1.568 . . . . 0.0 110.764 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -114.72 163.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.335 1.054 . . . . 0.0 108.546 171.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 142.33 13.52 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 53.6 mtp180 -107.7 156.26 19.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.993 1.317 . . . . 0.0 108.442 168.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.428 HG23 HG22 ' A' ' 34' ' ' ILE . 37.7 m -129.37 108.55 10.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.095 0.558 . . . . 0.0 110.088 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -98.39 120.98 39.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.1 m -108.11 134.83 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.7 t -100.62 104.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -106.05 120.61 42.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.052 0.541 . . . . 0.0 109.927 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.45 127.18 53.1 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.497 HG22 HG22 ' A' ' 30' ' ' VAL . 59.1 m -94.24 103.68 15.7 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.34 125.32 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.395 0.616 . . . . 0.0 110.389 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -113.28 109.03 18.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.455 ' HA ' HG22 ' A' ' 100' ' ' VAL . 65.9 m-85 -81.0 115.01 20.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 16.0 mmt85 -131.3 159.68 37.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.995 0.918 . . . . 0.0 109.419 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -88.58 174.49 8.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.109 0.563 . . . . 0.0 109.56 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.39 -26.52 66.49 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.947 0.499 . . . . 0.0 110.545 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.14 -19.51 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.849 1.26 . . . . 0.0 111.12 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.47 66.0 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.302 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.42 152.58 42.98 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.411 0.685 . . . . 0.0 111.053 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 27' ' ' ASP . 57.4 t -73.21 114.94 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.47 -45.78 13.24 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -173.99 126.51 0.36 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.455 1.102 . . . . 0.0 108.192 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' HG12 ' A' ' 24' ' ' VAL . 9.9 t70 -131.82 88.03 2.52 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.257 -0.902 . . . . 0.0 111.085 -166.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 p30 179.0 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.419 ' CE1' ' HG2' ' A' ' 64' ' ' PRO . 18.8 m170 -83.37 85.32 7.25 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.911 1.232 . . . . 0.0 111.38 -169.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 14' ' ' THR . 40.5 t -94.97 119.8 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.941 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 63' ' ' LEU . 11.7 p -112.69 150.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 0.0 109.073 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 m -141.64 136.65 31.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 35.7 mt -103.88 124.17 48.46 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG22 HG23 ' A' ' 8' ' ' THR . 2.5 mp -88.57 110.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.629 ' HA ' HD23 ' A' ' 56' ' ' LEU . 98.5 m-85 -105.61 101.24 10.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.989 0.916 . . . . 0.0 109.291 173.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.2 m -97.28 103.25 15.16 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.641 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -85.32 100.79 12.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -80.09 135.65 36.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.09 -163.48 11.91 Favored Glycine 0 C--O 1.245 0.84 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HE2' ' HB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.87 137.78 41.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 5' ' ' ILE . 33.5 ttm180 -111.95 124.84 53.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.86 115.07 8.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.244 1.018 . . . . 0.0 108.266 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.8 -24.84 55.97 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -80.51 -43.42 20.79 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.775 0.262 . . . . 0.0 111.238 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.43 -28.52 20.84 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.582 0.353 . . . . 0.0 110.597 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.02 23.55 48.57 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.88 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 49' ' ' ILE . 20.7 ptmt -94.17 142.68 27.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.375 0.67 . . . . 0.0 110.544 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.5 111.73 24.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.946 0.898 . . . . 0.0 110.553 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.485 ' HB ' ' HE2' ' A' ' 40' ' ' LYS . 3.5 mp -108.03 103.4 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.411 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 73.1 m95 -87.96 152.06 22.34 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 110.103 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.31 105.72 7.52 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.3 p -72.57 -19.74 61.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.894 0.877 . . . . 0.0 110.854 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -85.54 -0.86 56.23 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.481 0.712 . . . . 0.0 110.94 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 89.4 t90 -65.88 132.17 48.02 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 110.368 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 28.5 p -154.56 105.43 2.63 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 35' ' ' PHE . 55.6 tp -97.18 126.71 42.54 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.6 m -97.3 110.37 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.05 134.38 55.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.1 m -69.1 118.83 12.49 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.14 0.976 . . . . 0.0 111.445 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -112.5 92.77 4.14 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.854 0.462 . . . . 0.0 109.985 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -159.83 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.264 1.426 . . . . 0.0 108.164 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.425 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . 70.39 15.74 7.26 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.377 1.071 . . . . 0.0 112.555 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.455 HD23 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -65.86 116.27 30.76 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.159 0.584 . . . . 0.0 110.346 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HG2' ' CE1' ' A' ' 29' ' ' HIS . 57.6 Cg_endo -71.33 86.71 0.79 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.049 2.499 . . . . 0.0 111.792 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.458 ' HB2' ' HH ' ' A' ' 102' ' ' TYR . 56.5 p -89.35 130.78 42.6 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.573 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.85 120.62 8.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.87 1.713 . . . . 0.0 110.737 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.49 102.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.0 111.72 33.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.33 129.22 30.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 123.652 0.595 . . . . 0.0 110.413 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.798 ' HA3' ' HB ' ' A' ' 108' ' ' THR . . . 84.18 -3.32 86.29 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.013 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 22.0 m-85 -118.13 149.03 41.72 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.186 0.994 . . . . 0.0 108.422 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.1 m -140.66 121.91 14.86 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -67.2 152.22 46.14 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.363 0.665 . . . . 0.0 110.402 175.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.63 -30.96 70.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.287 0.565 . . . . 0.0 110.146 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.27 6.3 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.667 1.187 . . . . 0.0 108.178 173.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.12 -4.2 13.68 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.524 2.149 . . . . 0.0 111.403 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 62' ' ' ALA . 38.0 tpp -146.75 129.86 16.47 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.4 0.68 . . . . 0.0 109.216 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.405 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 94.9 t -96.83 124.35 49.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 O-C-N 124.309 1.006 . . . . 0.0 110.576 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.89 152.34 18.82 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.958 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -85.93 36.69 0.52 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.872 3.048 . . . . 0.0 113.475 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 75.88 -55.16 0.61 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.837 1.655 . . . . 0.0 111.751 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -126.14 150.36 48.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.99 0.916 . . . . 0.0 109.925 170.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.44 118.82 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.658 1.183 . . . . 0.0 108.555 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.0 m -101.15 103.58 14.64 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -95.39 118.9 42.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -88.25 171.83 9.9 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.357 1.063 . . . . 0.0 108.921 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.5 t -69.78 -22.36 63.34 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 123.951 0.782 . . . . 0.0 110.533 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.15 -53.4 25.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.709 0.804 . . . . 0.0 110.119 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -96.5 24.24 6.08 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.728 0.811 . . . . 0.0 111.244 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -72.26 -31.13 65.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.011 0.525 . . . . 0.0 111.249 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.34 -11.43 59.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.521 0.329 . . . . 0.0 110.167 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -94.64 136.19 35.23 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -104.16 146.85 28.16 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.67 21.45 16.15 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.03 118.57 8.68 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.205 1.002 . . . . 0.0 110.255 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -135.8 176.03 9.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.613 0.765 . . . . 0.0 109.345 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.17 117.72 34.94 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -96.32 132.09 42.16 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.043 0.537 . . . . 0.0 109.99 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.3 m -138.46 107.05 5.86 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.9 m -84.61 141.13 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 39.4 mm -116.83 113.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 95.0 m-85 -81.44 108.95 15.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 109.383 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.5 p -96.09 130.97 42.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.03 96.19 1.71 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.592 0.757 . . . . 0.0 109.767 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -68.59 167.97 13.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.286 1.034 . . . . 0.0 109.997 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -69.9 -9.65 55.68 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.215 0.606 . . . . 0.0 111.359 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.518 ' HB ' ' HA2' ' A' ' 70' ' ' GLY . 56.2 mt -50.81 -58.52 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.335 1.454 . . . . 0.0 110.282 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.798 ' HB ' ' HA3' ' A' ' 70' ' ' GLY . 15.3 t -72.08 -23.38 61.34 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.373 0.42 . . . . 0.0 111.747 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.37 -35.76 66.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.535 0.683 . . . . 0.0 110.296 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 111' ' ' LYS . 34.2 m-80 -115.87 -166.08 1.1 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.595 1.158 . . . . 0.0 109.93 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -53.77 131.53 39.68 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.705 0.802 . . . . 0.0 109.971 170.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 19.2 pttp -127.85 -58.19 1.24 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 65.05 -76.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.392 1.077 . . . . 0.0 110.39 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 33.74 74.05 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.51 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -96.01 -76.75 0.49 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 43.08 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.302 1.841 . . . . 0.0 112.722 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.44 122.76 17.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.402 1.081 . . . . 0.0 108.365 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -135.17 104.65 5.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.685 0.794 . . . . 0.0 109.001 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -121.15 117.88 28.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.812 0.845 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -79.94 -16.84 54.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 0.0 111.153 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -99.43 126.12 45.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.416 0.686 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 . . . . . 0 C--O 1.25 1.127 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' HD11 ' A' ' 43' ' ' LEU . 14.5 tpt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.867 0.365 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.92 157.11 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.076 1.35 . . . . 0.0 107.886 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HB3' HD12 ' A' ' 43' ' ' LEU . 12.4 pt-20 -134.65 146.86 60.77 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.23 124.19 6.47 Favored 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 121.417 1.412 . . . . 0.0 111.517 171.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 41' ' ' ARG . 27.6 pt -119.28 170.77 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 0.0 110.391 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.64 142.11 4.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 110.543 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 81.3 mtp180 -104.63 169.51 8.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.743 0.817 . . . . 0.0 109.774 170.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.578 HG22 HG23 ' A' ' 34' ' ' ILE . 35.5 m -120.33 108.46 14.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.692 0.797 . . . . 0.0 108.958 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.41 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.2 tp60 -105.81 99.65 9.24 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 31.0 m -89.42 127.91 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.41 116.19 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -104.25 105.06 15.07 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 124.195 0.934 . . . . 0.0 111.464 -163.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 96' ' ' ARG . 9.5 mm100 -91.74 99.19 12.12 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.6 0.76 . . . . 0.0 109.578 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.507 ' HG1' ' HA ' ' A' ' 97' ' ' GLU . 74.7 p -79.31 103.92 9.57 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.86 132.88 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 41.0 m-70 -120.35 119.67 33.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.174 0.989 . . . . 0.0 108.522 -174.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -91.32 116.75 29.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.3 mtm105 -142.11 155.22 45.34 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 123.417 0.687 . . . . 0.0 109.414 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -81.27 170.88 15.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.19 -27.87 69.0 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.035 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.78 -18.99 65.57 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 111.784 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.98 -11.52 69.44 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 148.13 48.87 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.849 0.859 . . . . 0.0 110.617 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 55.4 t -91.4 129.8 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.668 0.387 . . . . 0.0 110.471 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.4 -60.45 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -163.77 90.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.346 1.459 . . . . 0.0 108.97 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.5 p-10 -91.48 28.14 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -131.02 21.97 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 111.93 -170.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.16 81.68 5.55 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.014 -1.054 . . . . 0.0 110.404 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.52 127.59 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.222 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.561 ' HB ' HD21 ' A' ' 63' ' ' LEU . 14.8 p -120.44 150.0 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 55.4 m -138.73 141.15 38.89 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.743 0.817 . . . . 0.0 108.971 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 58' ' ' GLN . 77.4 mt -110.94 132.44 54.2 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.578 HG23 HG22 ' A' ' 8' ' ' THR . 3.4 mp -81.96 115.52 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.885 0.874 . . . . 0.0 108.768 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.42 100.47 10.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.1 m -75.58 105.77 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.83 95.37 7.28 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.695 0.798 . . . . 0.0 109.185 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.8 t -87.68 152.56 22.06 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.33 0.586 . . . . 0.0 111.999 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -166.44 -157.5 10.33 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.596 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.12 140.76 30.99 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.445 0.698 . . . . 0.0 110.229 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.7 ttm-85 -102.96 123.61 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -74.93 113.65 12.48 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 1' ' ' MET . 57.5 mt -82.94 -15.52 50.98 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.1 t -87.28 -38.76 16.0 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.772 0.26 . . . . 0.0 110.385 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -86.88 -32.22 20.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.076 0.55 . . . . 0.0 110.245 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.38 38.23 11.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.489 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -112.8 140.77 47.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.879 0.872 . . . . 0.0 109.993 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -98.65 107.77 20.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.975 0.91 . . . . 0.0 109.752 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.92 117.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.47 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 77.0 m95 -103.62 124.74 49.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.26 110.01 1.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m -65.0 -20.86 66.71 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.928 0.891 . . . . 0.0 112.797 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.94 -21.76 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.271 0.629 . . . . 0.0 110.439 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -59.01 139.02 57.26 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.929 0.768 . . . . 0.0 111.634 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 70.1 p -149.89 132.98 16.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.913 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD12 HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -124.22 125.45 44.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -113.09 133.86 54.81 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.574 ' HB3' HD11 ' A' ' 33' ' ' LEU . 76.5 mm-40 -134.41 145.06 48.56 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 m -92.44 116.65 29.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.534 0.734 . . . . 0.0 110.595 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.2 95.51 1.27 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.424 0.63 . . . . 0.0 110.343 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.7 -164.04 1.93 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.801 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.13 28.37 17.08 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.73 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD21 ' HB ' ' A' ' 31' ' ' VAL . 1.3 tm? -119.29 94.92 48.91 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -86.22 152.37 9.43 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.325 2.683 . . . . 0.0 111.883 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.467 ' HB3' ' HH ' ' A' ' 102' ' ' TYR . 45.9 m -105.1 149.05 37.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.961 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.45 127.7 25.65 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.064 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.76 107.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mt -107.55 133.75 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.67 132.07 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.694 0.797 . . . . 0.0 108.941 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.19 -6.31 81.94 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.934 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -133.82 165.44 24.96 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.382 0.673 . . . . 0.0 110.476 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -151.09 130.05 12.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 154.51 33.9 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.993 0.517 . . . . 0.0 110.939 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -64.68 -38.23 90.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.515 0.674 . . . . 0.0 109.183 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 88.85 28.93 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 114.501 -1.227 . . . . 0.0 107.997 171.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.94 -5.13 16.41 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.841 2.361 . . . . 0.0 112.798 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.3 tpt -147.56 114.91 6.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.33 118.82 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.09 135.51 51.75 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.375 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.69 97.32 0.32 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.287 1.991 . . . . 0.0 111.964 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -114.14 113.17 24.34 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.305 0.642 . . . . 0.0 110.853 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.38 118.14 17.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.336 0.654 . . . . 0.0 111.179 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.87 135.78 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.37 1.068 . . . . 0.0 108.58 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -105.14 110.25 22.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.27 0.628 . . . . 0.0 109.751 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG23 HE21 ' A' ' 94' ' ' GLN . 94.0 t -95.66 108.49 21.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' H ' ' ND2' ' A' ' 89' ' ' ASN . 1.1 p30 -110.86 176.54 4.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.738 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.66 -24.04 65.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.24 -51.16 10.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.198 0.599 . . . . 0.0 110.175 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 86' ' ' ASP . 6.4 p30 -92.23 6.68 45.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.41 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 52.7 t80 -54.75 -34.6 62.74 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.625 1.17 . . . . 0.0 112.251 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.1 -23.64 47.83 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.97 116.05 28.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.297 0.639 . . . . 0.0 109.987 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -79.83 106.15 11.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 122.092 0.949 . . . . 0.0 109.029 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.477 HE21 HG23 ' A' ' 85' ' ' VAL . 15.6 pt20 -91.77 38.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.418 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -70.3 154.44 41.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.44 1.096 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HB2' ' NE2' ' A' ' 13' ' ' GLN . 44.7 mmm-85 -129.5 141.4 51.01 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.244 0.545 . . . . 0.0 111.756 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HA ' ' HG1' ' A' ' 14' ' ' THR . 2.0 tm-20 -102.78 110.41 22.33 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 163.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -115.7 136.16 53.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.382 0.673 . . . . 0.0 110.286 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.4 m -113.47 119.14 36.56 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 167.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.03 140.71 15.37 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.69 120.12 53.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 C-N-CA 122.927 0.491 . . . . 0.0 110.683 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.467 ' HH ' ' HB3' ' A' ' 65' ' ' SER . 54.3 m-85 -85.54 104.83 15.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.603 0.761 . . . . 0.0 109.868 172.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.9 t -98.31 155.45 17.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 128.94 19.07 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.69 0.619 . . . . 0.0 109.39 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.75 158.67 26.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.282 0.233 . . . . 0.0 111.052 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -58.71 -19.26 38.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.452 0.701 . . . . 0.0 112.377 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.08 -48.9 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.423 1.089 . . . . 0.0 110.675 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 t -89.72 -19.33 24.92 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.95 87.37 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -82.04 174.91 10.8 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.361 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -79.69 94.91 5.8 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.16 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -154.62 -43.92 0.09 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.339 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -137.91 177.22 8.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.299 0.64 . . . . 0.0 110.547 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.11 60.82 0.26 Allowed Glycine 0 CA--C 1.502 -0.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.41 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.03 -41.74 75.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.63 0.772 . . . . 0.0 109.84 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -166.56 137.48 3.38 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.2 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -74.17 141.44 45.51 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.552 0.741 . . . . 0.0 110.126 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -84.92 27.82 0.73 Allowed 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.549 1.14 . . . . 0.0 111.715 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -168.78 22.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.132 0.973 . . . . 0.0 110.255 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 m80 65.95 -171.22 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.608 1.163 . . . . 0.0 110.011 -165.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -47.17 136.21 9.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.317 1.047 . . . . 0.0 112.673 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 CA--C 1.552 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 109.875 178.078 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 42' ' ' ASP . 41.0 mm -117.35 136.17 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.97 146.16 35.55 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -77.16 124.08 7.05 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 121.507 1.471 . . . . 0.0 109.919 167.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -112.52 -176.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.8 0.84 . . . . 0.0 109.849 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -151.63 146.41 25.79 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.665 0.786 . . . . 0.0 109.008 173.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' THR . 24.8 tpt180 -103.69 138.08 40.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -121.32 105.71 10.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.04 107.35 14.84 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 109.708 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 14.5 m -90.45 119.02 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 93' ' ' LYS . 92.2 t -91.13 118.59 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.487 ' H ' ' HD3' ' A' ' 93' ' ' LYS . 70.7 m -106.96 103.3 12.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.329 0.651 . . . . 0.0 110.434 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 94.03 5.85 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 12' ' ' THR . 82.2 p -86.47 114.47 23.25 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 52.7 mt -110.68 126.19 68.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-O 121.936 0.874 . . . . 0.0 111.234 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.32 110.25 22.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.324 -1.762 . . . . 0.0 106.865 -173.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' HD1' HG22 ' A' ' 100' ' ' VAL . 23.0 m-85 -82.08 109.78 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.6 mtm180 -141.22 164.22 30.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.35 0.66 . . . . 0.0 109.791 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -92.2 175.95 6.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.401 0.68 . . . . 0.0 110.314 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.62 -25.66 68.06 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.387 171.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.14 -17.08 63.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.603 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.05 -13.5 66.81 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.04 57.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.372 1.069 . . . . 0.0 111.046 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 38.7 t -83.28 114.98 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 122.948 0.499 . . . . 0.0 109.974 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.29 -56.54 4.94 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -170.81 94.5 0.2 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 0.0 110.147 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.84 106.62 18.58 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.768 -0.582 . . . . 0.0 110.169 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -179.71 -6.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.507 0.723 . . . . 0.0 112.292 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -82.85 86.19 6.97 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.266 0.555 . . . . 0.0 111.487 -163.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.02 125.39 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 0.0 110.71 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -120.25 145.51 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -138.65 131.49 29.41 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.642 0.777 . . . . 0.0 109.703 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 87.7 mt -110.69 136.1 50.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 0.0 109.767 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.42 114.71 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -100.94 96.33 7.19 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 85.1 m -113.59 104.27 12.08 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.613 ' HB2' HD21 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -130.92 139.61 50.1 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 61.2 p -90.81 141.55 28.69 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -167.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.96 -142.37 5.46 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.62 139.44 18.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.632 0.716 . . . . 0.0 111.205 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 5' ' ' ILE . 17.2 ttm180 -103.88 127.12 51.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.102 0.561 . . . . 0.0 110.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 32.4 t70 -73.62 111.25 8.58 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.065 0.946 . . . . 0.0 108.914 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.02 -11.37 56.86 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.5 t -83.24 -31.93 26.73 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.359 0.527 . . . . 0.0 110.401 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -101.39 -30.84 11.23 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.049 0.54 . . . . 0.0 110.207 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.05 49.16 4.35 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 20.0 ptmt -130.29 143.77 50.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.502 1.121 . . . . 0.0 109.521 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -95.27 127.67 41.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.075 0.55 . . . . 0.0 110.49 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.88 126.13 61.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.451 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 81.7 m95 -125.07 143.42 50.93 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.304 1.042 . . . . 0.0 108.268 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 23.2 t70 -62.93 143.13 57.98 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.95 0.5 . . . . 0.0 110.384 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.8 p -68.6 -38.21 80.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.232 0.213 . . . . 0.0 111.496 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.18 -0.94 57.49 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.841 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' HE1' ' HB3' ' A' ' 37' ' ' GLN . 19.5 t90 -48.3 120.64 3.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.991 0.916 . . . . 0.0 111.394 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 p -154.91 130.01 9.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 37' ' ' GLN . 23.6 tp -115.08 139.56 49.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 m -110.87 150.37 29.27 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.487 0.715 . . . . 0.0 109.803 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -153.87 127.91 8.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 m -78.27 110.27 13.14 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.31 0.644 . . . . 0.0 111.286 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.53 130.23 38.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.25 174.42 8.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.821 0.848 . . . . 0.0 109.961 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 69.91 56.81 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.586 1.154 . . . . 0.0 111.802 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 3.5 mm? -113.7 91.83 22.51 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.467 0.707 . . . . 0.0 109.976 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.47 99.9 0.77 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 123.655 2.904 . . . . 0.0 113.097 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.558 ' HB3' ' HH ' ' A' ' 102' ' ' TYR . 66.5 m -78.73 124.25 85.16 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.772 173.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.3 122.93 11.58 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 123.521 2.814 . . . . 0.0 112.895 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.0 108.8 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.0 mt -101.89 117.12 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.9 mm -72.88 135.75 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.202 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.49 84.01 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.709 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -130.22 172.17 12.09 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.279 1.032 . . . . 0.0 110.322 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -144.52 123.53 12.8 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -67.88 131.41 45.46 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.95 -38.58 76.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.854 0.862 . . . . 0.0 109.245 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.6 84.9 49.34 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.604 169.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 57.8 Cg_endo -67.0 -4.39 11.38 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.107 2.538 . . . . 0.0 113.227 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 63' ' ' LEU . 17.1 tpt -143.97 136.62 27.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.281 1.032 . . . . 0.0 108.699 172.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -125.54 126.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 71.67 0.91 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 123.914 0.759 . . . . 0.0 112.551 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -96.67 22.52 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.328 2.685 . . . . 0.0 114.355 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -165.81 -169.19 1.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 118.366 0.53 . . . . 0.0 112.216 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 9.2 mp0 -68.04 133.18 48.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.134 1.374 . . . . 0.0 111.601 -171.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.21 110.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.06 0.944 . . . . 0.0 109.178 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.6 m -96.82 117.19 30.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.955 0.502 . . . . 0.0 109.774 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 90' ' ' PHE . 37.8 t -97.98 116.32 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.55 162.55 14.15 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.796 0.838 . . . . 0.0 110.899 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 39.9 p -57.78 -35.23 70.51 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.52 1.128 . . . . 0.0 110.802 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -49.59 -49.73 45.51 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.007 1.442 . . . . 0.0 111.202 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -118.35 16.12 13.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.818 -172.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 85' ' ' VAL . 9.6 t80 -66.08 -27.07 67.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.543 0.61 . . . . 0.0 112.459 -166.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.5 -16.87 57.03 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -102.65 156.11 17.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.045 1.338 . . . . 0.0 110.201 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 12' ' ' THR . 9.2 ptpp? -111.71 126.68 55.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -77.91 -12.62 60.0 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -116.15 127.66 55.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.75 -93.05 0.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.904 0.882 . . . . 0.0 109.523 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -108.32 104.94 14.43 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 3.3 mp0 -110.68 135.63 51.0 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -121.5 122.09 38.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.423 0.689 . . . . 0.0 110.09 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.6 m -83.23 141.86 14.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.4 110.73 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.089 0.556 . . . . 0.0 110.848 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.558 ' HH ' ' HB3' ' A' ' 65' ' ' SER . 78.5 m-85 -85.94 96.23 9.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 p -99.6 140.05 34.36 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.33 142.09 10.73 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.557 0.536 . . . . 0.0 110.801 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.81 -173.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.089 1.356 . . . . 0.0 113.016 -162.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.536 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 10.0 t -51.96 -11.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.95 1.3 . . . . 0.0 113.751 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.1 mt -48.1 -47.3 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.108 1.363 . . . . 0.0 111.336 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -108.3 -25.24 11.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 112.429 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 19.0 mt-30 -76.82 165.77 24.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.979 0.511 . . . . 0.0 110.23 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -67.1 122.3 17.49 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -66.81 135.28 53.69 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 124.176 0.923 . . . . 0.0 111.241 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -163.19 -53.97 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.468 1.107 . . . . 0.0 109.15 -172.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -165.94 138.21 3.98 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.94 0.896 . . . . 0.0 109.532 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.78 5.88 3.44 Favored Glycine 0 C--N 1.318 -0.425 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.18 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.4 mt -73.02 -21.61 60.79 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.111 0.964 . . . . 0.0 110.775 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.79 105.52 0.46 Allowed 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -142.08 17.97 2.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.36 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -75.37 75.57 2.46 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.36 0.6 . . . . 0.0 110.094 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -92.41 162.75 14.12 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -74.1 -69.06 0.47 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -144.74 -52.13 0.29 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 167.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 CA--C 1.556 1.191 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.826 166.477 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' HD12 ' A' ' 43' ' ' LEU . 28.0 ttt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 42' ' ' ASP . 49.6 mm -123.91 141.19 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.317 0.647 . . . . 0.0 109.828 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -112.63 128.65 25.28 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 166.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.15 126.63 18.28 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.45 2.1 . . . . 0.0 110.851 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 41' ' ' ARG . 34.0 pt -124.03 -179.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.409 0.684 . . . . 0.0 109.75 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 157.71 24.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.735 1.214 . . . . 0.0 108.291 170.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.502 ' HD3' ' HD2' ' A' ' 90' ' ' PHE . 57.3 ttt-85 -126.77 152.7 46.54 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 35' ' ' PHE . 86.6 m -121.07 108.77 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.454 1.101 . . . . 0.0 108.886 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -100.8 121.78 42.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 34.6 m -105.29 118.09 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 83' ' ' VAL . 97.9 t -97.55 110.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -118.12 131.55 56.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.749 . . . . 0.0 110.57 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 42.3 mt-30 -103.33 100.27 10.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.412 ' HG1' ' HG3' ' A' ' 97' ' ' GLU . 3.1 p -76.83 100.5 5.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 172.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' A' ' 78' ' ' VAL . 13.0 tt -101.55 135.52 37.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 122.261 1.029 . . . . 0.0 111.009 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -118.98 148.42 43.0 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.842 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HH ' HD13 ' A' ' 15' ' ' ILE . 45.7 m-85 -127.17 115.76 19.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 37.5 mtm180 -138.13 152.42 48.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -77.97 169.76 17.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.495 0.718 . . . . 0.0 110.627 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.31 -22.72 63.76 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.843 0.457 . . . . 0.0 111.483 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.96 -12.37 60.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.635 0.774 . . . . 0.0 111.312 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 2.45 68.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.77 147.71 48.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.976 0.51 . . . . 0.0 110.264 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.432 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 96.7 t -82.23 135.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.126 0.571 . . . . 0.0 109.94 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 -63.11 1.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -157.2 97.42 1.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.584 1.154 . . . . 0.0 108.788 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -80.38 -9.23 59.75 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.065 0.546 . . . . 0.0 112.422 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.1 71.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.28 1.032 . . . . 0.0 110.877 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -124.7 122.32 37.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 159.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.35 111.75 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.496 ' HB ' HD22 ' A' ' 63' ' ' LEU . 7.5 p -106.81 125.52 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.759 0.824 . . . . 0.0 108.87 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.3 p -123.92 133.9 53.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.328 0.651 . . . . 0.0 109.418 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 76.7 mt -99.4 123.09 43.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -93.22 116.5 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' THR . 13.7 m-85 -106.43 97.69 7.46 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.4 m -114.57 116.46 28.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.8 44.36 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -76.91 178.12 7.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.926 -165.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.34 -166.73 31.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.186 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 137.74 35.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.7 ttm180 -110.17 124.87 52.35 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.044 0.537 . . . . 0.0 109.887 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 2' ' ' ILE . 26.5 t70 -74.55 113.83 12.25 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.832 1.253 . . . . 0.0 109.882 173.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 1' ' ' MET . 88.9 mt -85.08 -1.86 57.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.6 t -87.67 -28.61 21.71 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.863 0.756 . . . . 0.0 110.842 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -107.59 -30.84 8.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.569 0.348 . . . . 0.0 110.225 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.71 11.98 56.19 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.86 -173.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -84.89 145.95 27.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.041 0.937 . . . . 0.0 110.279 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.29 121.4 42.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.249 0.62 . . . . 0.0 110.273 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.98 116.02 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -108.97 158.86 17.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.59 1.156 . . . . 0.0 109.079 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 54' ' ' TRP . 17.7 t70 -82.9 125.34 31.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -73.0 -25.88 61.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.745 0.418 . . . . 0.0 111.978 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -81.23 -13.17 58.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.14 0.576 . . . . 0.0 110.789 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.512 ' HB3' ' O ' ' A' ' 51' ' ' ASP . 8.8 t90 -69.28 134.58 49.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.138 0.975 . . . . 0.0 111.583 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -152.11 121.41 6.77 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.458 1.503 . . . . 0.0 107.441 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.09 124.86 44.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -109.95 129.84 55.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -129.4 145.48 51.4 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 m -112.01 120.32 41.46 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.841 0.456 . . . . 0.0 111.446 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 13' ' ' GLN . 51.0 m-85 -65.24 136.49 56.68 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 164.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -170.59 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.68 0.792 . . . . 0.0 109.754 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.55 86.09 5.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.783 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.528 HD12 HD13 ' A' ' 15' ' ' ILE . 3.3 tm? -144.13 112.79 5.24 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -93.17 178.71 1.19 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.552 2.834 . . . . 0.0 111.743 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -159.17 151.38 17.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.211 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.75 117.83 5.36 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 121.963 1.775 . . . . 0.0 110.62 172.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.9 107.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.31 116.33 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.82 139.97 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.7 3.58 89.44 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.401 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.83 171.44 14.51 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.188 0.995 . . . . 0.0 110.073 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -158.5 109.22 2.11 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.17 151.12 46.73 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.559 0.743 . . . . 0.0 111.265 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -73.33 -20.04 60.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.179 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.33 101.57 2.96 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 158.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.26 0.28 5.49 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.151 1.9 . . . . 0.0 113.157 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.6 ttt -150.55 136.67 18.53 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.722 0.809 . . . . 0.0 109.584 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.579 HG12 ' HG3' ' A' ' 98' ' ' GLU . 91.8 t -121.52 107.57 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 163.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.82 -95.74 0.11 Allowed Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.058 -1.412 . . . . 0.0 111.369 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -33.8 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.721 1 C-N-CA 125.463 4.109 . . . . 0.0 115.991 -169.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -168.16 126.73 1.19 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.491 1.116 . . . . 0.0 109.22 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.67 121.5 26.93 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.426 HG12 HG12 ' A' ' 11' ' ' VAL . 84.2 t -103.23 123.12 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.728 0.811 . . . . 0.0 109.41 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.4 m -103.03 131.17 50.21 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.405 HG21 ' NE2' ' A' ' 94' ' ' GLN . 43.0 t -121.13 112.38 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.99 164.69 23.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.836 0.854 . . . . 0.0 109.251 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.6 p -54.56 -36.52 64.43 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.986 0.804 . . . . 0.0 110.384 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.566 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 7.6 mtpm? -47.87 -49.34 29.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.351 1.46 . . . . 0.0 112.406 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -119.43 23.69 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.675 0.79 . . . . 0.0 111.604 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 12.4 t80 -75.13 -19.76 59.74 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 122.006 -0.434 . . . . 0.0 111.161 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.31 -16.46 27.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.688 0.795 . . . . 0.0 109.196 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -89.08 160.97 16.79 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.204 1.001 . . . . 0.0 109.687 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -111.85 159.55 18.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.58 0.752 . . . . 0.0 109.443 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' NE2' HG21 ' A' ' 85' ' ' VAL . 12.0 pt20 -143.39 33.39 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.174 0.59 . . . . 0.0 110.064 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.63 166.35 15.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 111.786 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.17 166.11 24.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.837 0.855 . . . . 0.0 111.445 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 19.6 tt0 -129.92 108.29 10.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.579 ' HG3' HG12 ' A' ' 78' ' ' VAL . 25.0 mm-40 -94.29 145.55 24.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.847 0.459 . . . . 0.0 110.104 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.5 m -139.99 98.11 3.39 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.44 142.46 13.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.32 116.74 52.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.017 0.927 . . . . 0.0 110.584 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.87 98.73 9.33 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -83.88 159.96 21.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 108' ' ' THR . . . -50.09 144.42 6.97 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.583 0.628 . . . . 0.0 109.805 173.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -46.86 153.53 0.4 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.655 1.182 . . . . 0.0 112.002 -164.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.579 HG22 ' HE2' ' A' ' 112' ' ' LYS . 3.4 t -42.49 -21.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.702 1.601 . . . . 0.0 114.56 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.6 mm -48.75 -52.63 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 125.011 1.325 . . . . 0.0 111.89 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 104' ' ' ALA . 15.2 t -75.39 -24.22 57.18 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.717 0.407 . . . . 0.0 111.535 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -81.65 164.3 21.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.239 0.616 . . . . 0.0 109.597 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.9 OUTLIER -83.26 85.46 7.21 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? 60.16 -165.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.653 1.181 . . . . 0.0 110.492 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.579 ' HE2' HG22 ' A' ' 106' ' ' THR . 85.2 mttt -100.76 -60.81 1.46 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.2 t70 68.72 155.92 0.13 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.981 1.712 . . . . 0.0 111.201 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.99 95.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.5 mt 68.75 -65.25 0.29 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.661 1.984 . . . . 0.0 110.973 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.72 119.38 20.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.968 0.907 . . . . 0.0 110.06 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -134.89 108.93 8.18 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 64.05 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.379 1.072 . . . . 0.0 108.905 -169.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -65.67 -36.95 85.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.592 0.757 . . . . 0.0 112.384 -170.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 61.56 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.603 1.161 . . . . 0.0 109.295 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -163.18 -57.35 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.356 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 124.225 1.01 . . . . 0.0 108.802 179.401 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.513 HD13 ' HA ' ' A' ' 42' ' ' ASP . 27.3 mm -116.19 134.07 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.61 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.0 134.99 19.42 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 165.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.51 130.4 24.99 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.687 2.258 . . . . 0.0 111.676 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 41' ' ' ARG . 18.8 pt -125.09 163.72 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.92 0.888 . . . . 0.0 109.995 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -156.3 146.58 21.48 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 12.6 mmm180 -117.72 140.33 49.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.988 1.315 . . . . 0.0 108.506 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.456 HG21 HG23 ' A' ' 34' ' ' ILE . 28.9 m -111.52 122.2 47.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.432 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 5.6 tp-100 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.2 m -119.64 132.82 68.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.051 0.453 . . . . 0.0 110.609 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.61 123.29 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -110.09 105.1 14.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 110.485 -162.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 46.2 tt0 -98.55 109.62 22.35 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.608 HG21 HG22 ' A' ' 30' ' ' VAL . 31.4 m -85.99 104.36 15.54 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.574 0.75 . . . . 0.0 110.378 -177.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -93.08 129.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 122.033 -0.417 . . . . 0.0 110.47 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.412 ' HD1' ' HB2' ' A' ' 27' ' ' ASP . 17.6 m-70 -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.201 1.0 . . . . 0.0 108.452 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -97.73 118.28 33.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 23.7 mtm180 -143.48 159.65 42.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.477 0.711 . . . . 0.0 109.65 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' HH ' HD13 ' A' ' 68' ' ' ILE . 81.1 m-85 -86.5 170.92 11.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.213 1.005 . . . . 0.0 109.916 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -69.15 -22.93 63.91 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.566 0.698 . . . . 0.0 110.313 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.62 -20.94 66.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.327 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.64 -20.51 46.05 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.39 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.17 136.91 52.55 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 0.0 111.452 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 58.7 t -85.57 109.57 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.211 0.604 . . . . 0.0 110.629 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 -49.72 45.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.01 0.524 . . . . 0.0 110.139 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -173.33 90.24 0.08 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB2' ' HD1' ' A' ' 16' ' ' HIS . 5.5 p-10 -71.19 -25.73 62.65 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.25 80.69 2.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.702 0.801 . . . . 0.0 110.386 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -134.18 79.51 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.608 HG22 HG21 ' A' ' 14' ' ' THR . 12.9 t -93.81 118.52 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 113.826 -1.533 . . . . 0.0 108.77 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -102.4 157.71 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -143.27 141.75 31.14 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 109.414 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 88.8 mt -99.9 125.89 45.95 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG23 HG21 ' A' ' 8' ' ' THR . 3.2 mp -86.06 114.53 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.08 120.2 40.05 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.361 1.464 . . . . 0.0 108.851 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.3 m -100.88 101.73 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.538 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 2.2 mp0 -89.55 79.52 6.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 37.2 p -85.45 137.08 33.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.48 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.43 -156.25 9.71 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.25 135.34 26.95 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.561 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.3 ttm180 -107.44 122.13 46.01 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 109.447 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.513 ' HA ' HD13 ' A' ' 2' ' ' ILE . 12.2 t70 -69.63 127.74 34.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -83.16 -23.01 33.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -71.53 -46.92 58.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.13 0.491 . . . . 0.0 110.006 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -88.71 -32.23 18.06 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.091 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.56 0.29 73.03 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 -169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -67.22 136.58 55.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.476 1.11 . . . . 0.0 110.846 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.58 107.86 18.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.48 0.712 . . . . 0.0 110.288 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.12 91.84 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CH2' ' HG2' ' A' ' 7' ' ' ARG . 36.7 m95 -84.02 124.06 30.66 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 31.6 t70 -52.88 124.43 14.08 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.842 0.714 . . . . 0.0 110.05 -176.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 m -57.85 -37.8 74.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.52 0.728 . . . . 0.0 111.621 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -96.93 16.46 19.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.917 0.887 . . . . 0.0 111.206 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 40.5 t-105 -64.87 142.17 58.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.556 0.342 . . . . 0.0 110.594 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 55.8 p -155.36 140.94 17.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.095 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -116.8 130.44 56.72 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -112.26 124.39 52.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.26 0.624 . . . . 0.0 109.541 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -135.69 141.33 44.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -103.58 126.79 50.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.299 0.64 . . . . 0.0 111.624 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 37.1 m-85 -69.13 112.69 5.9 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.81 -169.66 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.56 1.163 . . . . 0.0 109.072 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.96 5.63 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.342 1.057 . . . . 0.0 112.164 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD21 HG21 ' A' ' 78' ' ' VAL . 31.5 tp -116.63 100.28 53.33 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.804 0.842 . . . . 0.0 108.982 -172.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -92.6 -151.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.285 2.657 . . . . 0.0 111.64 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.45 ' HB2' ' HH ' ' A' ' 102' ' ' TYR . 86.3 p -149.59 145.16 18.65 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.204 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.82 127.58 24.91 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.131 2.554 . . . . 0.0 112.003 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -77.23 106.59 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.449 HD13 ' HH ' ' A' ' 19' ' ' TYR . 64.4 mt -97.2 134.21 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.008 0.923 . . . . 0.0 108.933 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.34 120.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.576 1.55 . . . . 0.0 109.479 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.58 81.32 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.514 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.526 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 93.3 m-85 -139.18 160.76 39.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.53 0.732 . . . . 0.0 110.096 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -151.04 126.36 10.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.4 150.32 35.7 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.749 0.82 . . . . 0.0 111.001 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.8 -29.8 70.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.882 0.739 . . . . 0.0 109.446 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' HG2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -133.48 96.7 16.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.755 168.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.48 -7.6 21.64 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.794 2.33 . . . . 0.0 111.928 175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 tpt -139.12 126.87 22.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 63' ' ' LEU . 88.3 t -65.65 120.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.31 116.46 5.75 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 124.818 1.324 . . . . 0.0 112.694 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 59.9 Cg_endo -70.42 128.96 16.14 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 112.623 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -142.24 135.04 28.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.978 0.418 . . . . 0.0 110.776 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.3 103.9 12.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.581 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -84.03 134.35 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 109.207 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.7 m -121.35 113.78 20.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.363 0.665 . . . . 0.0 109.618 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.17 114.33 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -82.51 174.52 10.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.364 0.602 . . . . 0.0 109.856 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.4 p -71.43 -22.12 61.88 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.934 172.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.21 4.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.126 0.97 . . . . 0.0 109.715 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.66 29.82 3.55 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.323 1.049 . . . . 0.0 110.251 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 9' ' ' GLN . 49.2 t80 -50.94 -48.77 60.77 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.496 1.118 . . . . 0.0 110.634 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 91' ' ' LEU . 1.8 mp -82.58 -23.77 34.28 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.653 -161.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.99 115.07 10.78 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -88.91 106.93 18.73 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.64 46.36 1.33 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.882 0.849 . . . . 0.0 110.229 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -62.55 157.76 19.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.748 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 78.0 ttt180 -157.15 147.3 20.93 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 -172.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.14 144.74 26.11 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 10.4 tp10 -136.34 108.44 7.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 172.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 84.3 m -100.65 122.6 43.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.241 0.617 . . . . 0.0 109.62 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 75' ' ' LYS . 2.4 m -90.71 142.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.24 106.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.474 0.31 . . . . 0.0 110.432 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.526 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 87.2 m-85 -72.75 107.48 5.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.749 1.22 . . . . 0.0 109.682 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p -108.21 140.26 41.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 100.58 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.16 0.984 . . . . 0.0 110.77 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -76.99 -174.13 3.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.971 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -69.98 -19.33 63.35 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 112.23 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -68.0 -47.64 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.253 0.621 . . . . 0.0 110.604 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -71.07 -10.57 59.98 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.171 0.51 . . . . 0.0 111.195 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -99.18 177.6 5.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.995 0.918 . . . . 0.0 109.792 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 67.1 4.42 3.61 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.758 1.223 . . . . 0.0 113.83 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 66.14 170.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.821 1.248 . . . . 0.0 111.999 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -98.38 -44.38 6.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.213 0.605 . . . . 0.0 110.278 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -79.49 97.97 6.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.683 0.793 . . . . 0.0 110.251 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.38 5.05 85.42 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 115.256 -0.884 . . . . 0.0 113.465 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.28 -31.03 71.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.0 0.92 . . . . 0.0 110.844 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.62 140.51 37.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.67 0.788 . . . . 0.0 109.56 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.79 160.9 27.32 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.146 0.578 . . . . 0.0 110.602 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.7 m80 66.24 91.17 0.09 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.468 1.107 . . . . 0.0 109.874 -175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -170.32 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.703 0.801 . . . . 0.0 110.719 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.3 m80 62.21 -171.89 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.335 1.054 . . . . 0.0 112.096 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -157.12 -57.08 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.175 0.59 . . . . 0.0 110.102 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 124.549 1.14 . . . . 0.0 110.356 -177.422 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.7 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.82 0.343 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.429 HD11 ' HD3' ' A' ' 40' ' ' LYS . 35.4 mm -120.2 142.38 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.204 1.002 . . . . 0.0 109.121 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -120.99 149.92 52.09 Favored Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.26 127.78 13.06 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.395 2.064 . . . . 0.0 111.151 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 41' ' ' ARG . 30.9 pt -135.1 137.21 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 2.2 mptm? -137.13 142.11 42.26 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -116.75 137.67 52.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' ILE . 85.1 m -120.71 104.91 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.361 0.664 . . . . 0.0 109.363 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -105.06 119.2 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.086 0.554 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 32' ' ' SER . 35.0 m -97.5 125.86 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' SER . 57.1 t -90.86 104.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -95.9 102.47 14.27 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.852 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.589 HE21 HD12 ' A' ' 15' ' ' ILE . 28.2 tt0 -108.28 113.03 25.8 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.487 HG22 HG22 ' A' ' 30' ' ' VAL . 95.7 m -92.73 107.53 19.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.865 0.866 . . . . 0.0 109.772 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.589 HD12 HE21 ' A' ' 13' ' ' GLN . 1.6 mp -90.13 130.63 39.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.387 0.613 . . . . 0.0 109.932 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 11.5 m-70 -109.26 110.36 21.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.566 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' HG22 ' A' ' 100' ' ' VAL . 85.0 m-85 -87.29 116.3 25.28 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -134.33 -171.32 2.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.52 0.728 . . . . 0.0 110.528 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -121.43 167.4 12.85 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.61 -17.98 63.57 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.803 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.45 -17.26 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.627 1.171 . . . . 0.0 111.192 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.55 54.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.44 137.98 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.57 1.148 . . . . 0.0 111.244 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.3 137.59 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.208 0.603 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.45 -60.49 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.15 115.29 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.309 1.043 . . . . 0.0 108.893 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.628 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.8 p-10 -102.3 26.29 7.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.654 0.781 . . . . 0.0 112.862 -173.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.23 10.79 39.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.677 0.791 . . . . 0.0 111.776 -173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -90.13 73.06 7.26 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.167 0.984 . . . . 0.0 111.038 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.487 HG22 HG22 ' A' ' 14' ' ' THR . 24.3 t -93.63 119.01 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.898 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG11 HD23 ' A' ' 63' ' ' LEU . 6.1 p -105.84 130.99 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.542 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 60.4 p -122.36 118.34 28.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.597 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 39.7 mt -98.97 122.9 42.83 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.57 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -82.83 124.66 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.097 0.959 . . . . 0.0 109.898 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.44 ' HA ' HD23 ' A' ' 56' ' ' LEU . 85.5 m-85 -115.35 101.82 9.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.194 0.998 . . . . 0.0 109.099 172.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 m -95.82 107.7 19.97 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -94.33 123.81 37.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 57.5 p -88.14 138.73 31.19 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.746 0.654 . . . . 0.0 109.663 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.21 -171.57 18.01 Favored Glycine 0 C--O 1.241 0.566 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.126 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HD3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -136.55 143.84 43.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 5' ' ' ILE . 38.7 ttm180 -114.95 118.62 33.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.632 0.373 . . . . 0.0 110.44 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.04 107.11 8.03 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.505 HD12 ' HG3' ' A' ' 1' ' ' MET . 84.4 mt -79.98 -1.31 39.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.927 0.891 . . . . 0.0 112.719 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -73.42 -43.25 60.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.419 0.688 . . . . 0.0 109.927 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.57 -24.12 14.53 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.925 0.89 . . . . 0.0 109.887 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.85 34.11 35.29 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.733 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -104.13 141.98 35.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 110.777 -172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.92 122.86 41.54 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 123.276 0.63 . . . . 0.0 110.728 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.26 105.23 17.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -102.61 137.25 41.09 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -69.12 118.56 12.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 t -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.392 0.677 . . . . 0.0 111.171 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.27 -18.52 60.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.273 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -61.43 128.03 34.34 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 p -153.99 117.44 4.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.941 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 35' ' ' PHE . 57.0 tp -101.22 130.14 47.28 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 39.3 m -95.55 111.07 23.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.597 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 5.6 tp-100 -112.06 124.66 52.89 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.502 HG21 ' HG2' ' A' ' 61' ' ' GLU . 31.5 m -64.57 118.52 8.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.527 1.131 . . . . 0.0 110.642 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.97 115.03 29.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HG2' HG21 ' A' ' 59' ' ' THR . 12.3 pt-20 -179.32 -161.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.03 0.932 . . . . 0.0 109.897 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.92 -98.39 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.862 1.265 . . . . 0.0 110.276 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HG ' HG12 ' A' ' 15' ' ' ILE . 3.6 mm? 47.36 91.57 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.767 0.827 . . . . 0.0 111.179 -170.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.81 97.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.566 2.844 . . . . 0.0 112.588 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -81.99 113.54 43.98 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.487 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.2 121.2 9.57 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.47 2.113 . . . . 0.0 110.432 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.91 103.62 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.5 mt -107.22 112.91 42.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -76.94 137.87 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.351 0.66 . . . . 0.0 109.786 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.94 4.5 84.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.199 -170.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.9 m-85 -142.63 162.76 34.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.575 0.75 . . . . 0.0 111.415 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -151.19 135.02 16.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.638 1.175 . . . . 0.0 107.85 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 159.18 29.87 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.791 0.836 . . . . 0.0 111.061 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.64 -34.55 74.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 105.12 6.64 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.167 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.82 -4.61 15.69 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.102 1.868 . . . . 0.0 111.688 163.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.5 tpp -135.19 107.38 7.2 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG11 ' HG2' ' A' ' 98' ' ' GLU . 95.7 t -83.7 123.41 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.393 0.677 . . . . 0.0 111.701 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.81 53.58 13.42 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 125.022 1.451 . . . . 0.0 115.397 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.14 80.68 2.12 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.251 1.967 . . . . 0.0 111.851 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -158.48 119.42 3.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.12 0.568 . . . . 0.0 109.703 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.01 100.85 0.45 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 123.967 0.792 . . . . 0.0 111.058 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.4 112.17 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.991 0.916 . . . . 0.0 110.548 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 10.4 m -94.97 101.23 12.99 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.324 0.65 . . . . 0.0 109.267 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.91 124.64 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.94 170.38 16.56 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.994 0.809 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 16.7 t -70.46 -27.0 63.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.34 171.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.27 -49.82 62.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.718 1.207 . . . . 0.0 111.34 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -104.38 23.1 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.837 0.455 . . . . 0.0 111.21 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 52.7 t80 -58.94 -53.46 58.18 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.349 1.059 . . . . 0.0 112.696 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.95 -4.37 37.77 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.259 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.93 134.11 44.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.571 0.748 . . . . 0.0 110.019 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -90.19 172.57 8.7 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.181 0.593 . . . . 0.0 109.939 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 15.06 4.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.768 0.827 . . . . 0.0 110.784 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -162.62 -165.86 1.24 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 108.856 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.74 -53.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.381 0.672 . . . . 0.0 109.858 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -145.03 115.53 7.63 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.654 -170.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.503 ' HG2' HG11 ' A' ' 78' ' ' VAL . 16.7 tp10 -107.25 148.29 29.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.825 1.25 . . . . 0.0 109.777 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -136.85 117.84 14.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.26 0.624 . . . . 0.0 109.975 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -86.7 141.75 13.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.23 120.55 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 56.7 m-85 -80.21 117.79 21.32 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.77 0.828 . . . . 0.0 109.501 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.1 p -110.93 158.43 18.76 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 119.16 8.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.143 0.577 . . . . 0.0 110.638 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -75.53 -169.02 0.93 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.911 0.884 . . . . 0.0 112.902 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 14.6 t -50.96 -21.75 1.91 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.558 1.543 . . . . 0.0 114.587 -177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.65 -44.53 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.98 0.512 . . . . 0.0 111.566 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -85.78 -26.27 25.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.878 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.549 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 12.1 mm100 -80.01 167.33 20.59 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.604 0.762 . . . . 0.0 110.656 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -97.16 110.38 22.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 68.48 176.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.832 1.253 . . . . 0.0 112.006 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.451 ' HE3' HG23 ' A' ' 106' ' ' THR . 9.5 ptpp? -127.67 -47.03 1.42 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.067 0.547 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -80.2 108.14 13.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.41 0.684 . . . . 0.0 110.682 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.88 14.94 3.57 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 123.161 0.288 . . . . 0.0 112.422 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.3 mt -87.17 -57.31 3.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.551 0.741 . . . . 0.0 109.611 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 60.02 -75.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.867 1.667 . . . . 0.0 112.454 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -88.15 128.09 35.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.919 1.287 . . . . 0.0 109.954 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 41.0 m80 67.96 139.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.874 1.269 . . . . 0.0 112.764 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.77 152.5 17.75 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.355 0.662 . . . . 0.0 110.406 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -68.55 -18.41 64.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.203 1.001 . . . . 0.0 111.964 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 29.7 m80 76.84 107.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.95 1.7 . . . . 0.0 110.102 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 . . . . . 0 C--O 1.25 1.108 0 C-N-CA 124.203 1.001 . . . . 0.0 111.197 -176.755 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 42' ' ' ASP . 37.0 mm -114.09 154.12 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.692 1.197 . . . . 0.0 109.841 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.23 150.73 49.81 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.86 0.864 . . . . 0.0 108.797 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.1 124.22 4.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.897 1.731 . . . . 0.0 111.674 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -121.55 171.67 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.373 0.669 . . . . 0.0 111.292 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.49 146.68 4.17 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.115 0.884 . . . . 0.0 110.738 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -106.97 165.33 11.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.796 0.838 . . . . 0.0 110.21 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.546 HG21 HG23 ' A' ' 34' ' ' ILE . 93.1 m -131.88 106.29 7.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.145 0.978 . . . . 0.0 109.608 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -114.29 103.4 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 34' ' ' ILE . 27.8 m -89.89 132.23 35.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 121.017 0.437 . . . . 0.0 109.85 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 94' ' ' GLN . 75.8 t -99.79 107.75 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -96.03 107.64 19.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.666 0.786 . . . . 0.0 110.89 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -88.79 113.53 24.44 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 m -107.85 106.95 17.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 108.418 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 63' ' ' LEU . 19.0 tt -104.13 137.71 31.83 Favored 'Isoleucine or valine' 0 C--O 1.265 1.87 0 CA-C-O 122.229 1.014 . . . . 0.0 111.88 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -115.78 161.18 19.12 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.94 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.61 109.5 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.037 0.935 . . . . 0.0 108.872 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 32.1 mtm180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.245 0.618 . . . . 0.0 109.768 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 87.7 m-85 -88.52 176.05 7.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.454 0.702 . . . . 0.0 110.291 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.14 -22.28 60.55 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.468 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.46 -19.71 60.88 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.677 0.791 . . . . 0.0 110.607 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 -10.44 53.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.318 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.54 136.15 57.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.671 0.789 . . . . 0.0 111.076 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 56.0 t -80.35 111.9 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.645 0.378 . . . . 0.0 110.307 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.88 5.46 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -165.92 -175.35 3.36 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.704 1.602 . . . . 0.0 109.038 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.59 -161.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.039 0.936 . . . . 0.0 108.64 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 73.69 35.91 0.8 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.214 1.006 . . . . 0.0 109.799 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -111.37 121.32 44.93 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.18 144.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.031 0.532 . . . . 0.0 110.536 -173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG13 ' HE1' ' A' ' 60' ' ' PHE . 8.3 p -136.95 121.25 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -119.37 131.2 55.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.692 0.797 . . . . 0.0 109.245 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 96.5 mt -105.2 129.11 53.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.158 0.583 . . . . 0.0 110.005 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.546 HG23 HG21 ' A' ' 8' ' ' THR . 2.7 mp -87.53 111.9 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 123.972 0.795 . . . . 0.0 108.956 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.492 ' HA ' HD23 ' A' ' 56' ' ' LEU . 41.3 m-85 -94.19 101.03 13.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.74 104.14 16.44 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -81.14 97.14 7.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 110.131 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 p -76.03 139.3 41.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.585 0.553 . . . . 0.0 110.453 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.48 -160.33 9.66 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.639 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 143.47 29.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.61 ' HB2' HD13 ' A' ' 5' ' ' ILE . 36.0 ttm180 -112.39 128.8 56.41 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.329 0.652 . . . . 0.0 110.489 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HA ' HD12 ' A' ' 2' ' ' ILE . 16.3 t0 -72.59 121.99 20.64 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.94 -21.31 34.12 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -77.23 -49.76 14.39 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -171.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.36 -28.4 21.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.567 0.747 . . . . 0.0 109.676 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.91 30.51 20.42 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.354 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -102.74 136.36 42.7 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.323 1.049 . . . . 0.0 110.06 -176.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -91.65 120.18 32.19 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.093 0.557 . . . . 0.0 110.358 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.31 116.65 36.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -114.28 136.9 52.46 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 6.8 m-20 -64.12 125.73 25.43 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 m -62.1 -41.9 98.68 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.758 0.661 . . . . 0.0 111.088 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.91 7.73 26.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.656 0.782 . . . . 0.0 111.984 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 81.0 t90 -61.46 132.62 54.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -155.33 123.02 5.66 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.049 0.939 . . . . 0.0 108.807 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 35' ' ' PHE . 22.9 tp -109.07 135.05 50.85 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -112.14 116.45 30.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.84 0.856 . . . . 0.0 108.871 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -119.93 144.66 47.32 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.815 0.446 . . . . 0.0 110.141 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 61' ' ' GLU . 31.6 m -88.93 113.05 24.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.587 1.155 . . . . 0.0 112.24 -167.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.536 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 2.7 m-85 -99.98 102.38 13.73 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.935 0.894 . . . . 0.0 109.7 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HG2' HG21 ' A' ' 59' ' ' THR . 11.7 pt-20 -163.39 -165.68 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.285 0.634 . . . . 0.0 109.697 173.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.32 17.04 10.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.351 1.06 . . . . 0.0 111.807 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 15' ' ' ILE . 43.0 tp -102.0 99.7 12.97 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.995 0.918 . . . . 0.0 109.078 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -92.68 -165.34 0.14 Allowed 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.529 2.819 . . . . 0.0 113.344 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -150.67 146.41 19.54 Favored Pre-proline 0 CA--C 1.557 1.218 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.755 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.66 139.4 48.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.536 2.824 . . . . 0.0 113.079 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.87 107.8 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.59 130.49 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.47 129.99 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.3 86.99 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.893 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 86.8 m-85 -140.37 146.31 38.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.34 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.0 m -144.03 134.08 24.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.635 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -66.58 156.61 34.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.639 0.775 . . . . 0.0 111.66 -175.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -65.63 -25.01 67.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.811 0.844 . . . . 0.0 110.214 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HG2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.35 85.19 6.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 -7.32 21.1 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.187 1.925 . . . . 0.0 112.982 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.4 ttt -146.61 95.37 2.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.709 1.204 . . . . 0.0 107.946 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.453 HG22 ' HG3' ' A' ' 75' ' ' LYS . 53.9 t -71.81 111.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.679 0.792 . . . . 0.0 109.911 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.59 84.74 0.25 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.797 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 28.2 Cg_exo -65.44 0.04 3.18 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.593 2.862 . . . . 0.0 113.655 166.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 72.35 -88.39 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.881 1.672 . . . . 0.0 110.555 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -141.74 139.09 32.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.892 0.877 . . . . 0.0 110.517 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.3 t -116.03 120.33 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.16 0.984 . . . . 0.0 108.963 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.4 m -99.24 101.87 13.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.414 0.686 . . . . 0.0 109.596 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.33 125.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.16 168.0 16.21 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.139 0.976 . . . . 0.0 110.336 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.6 t -62.49 -27.47 69.15 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.267 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.74 -56.73 17.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.429 1.492 . . . . 0.0 110.773 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -105.19 15.38 27.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.648 0.779 . . . . 0.0 111.599 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -61.53 -24.5 66.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 0.0 111.185 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.28 -24.77 61.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.784 0.834 . . . . 0.0 111.156 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.0 136.11 33.42 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 109.264 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.66 138.89 33.55 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.464 ' O ' HG12 ' A' ' 11' ' ' VAL . 44.1 mt-30 -100.24 57.45 0.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.93 96.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -90.11 142.57 27.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.942 1.297 . . . . 0.0 109.864 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.68 125.09 10.93 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -134.91 141.56 46.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.473 0.709 . . . . 0.0 110.046 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.2 m -107.27 131.65 53.97 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.635 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 6.3 m -83.78 139.43 17.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.01 107.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 122.883 0.473 . . . . 0.0 110.196 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . 93.6 m-85 -74.96 103.33 5.12 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.08 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.0 p -111.72 147.96 34.49 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 108' ' ' THR . . . -53.86 126.4 22.14 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.03 0.831 . . . . 0.0 110.356 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -74.63 165.01 25.93 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.268 0.355 . . . . 0.0 110.433 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.411 HG22 ' HD2' ' A' ' 117' ' ' HIS . 3.8 t -46.1 -35.9 5.35 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.776 1.23 . . . . 0.0 113.093 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.1 mt -61.27 -48.15 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.314 1.046 . . . . 0.0 111.044 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 104' ' ' ALA . 14.8 t -94.74 -14.91 24.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.192 -173.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.23 147.57 52.05 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.736 0.414 . . . . 0.0 111.963 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.92 128.39 36.25 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 166.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 58.79 88.62 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.171 0.919 . . . . 0.0 110.105 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -70.14 -56.08 7.77 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.15 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.51 -77.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.261 1.424 . . . . 0.0 109.451 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.75 21.57 71.23 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.28 -41.88 89.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.147 0.979 . . . . 0.0 109.474 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -112.76 156.52 22.7 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.933 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.411 ' HD2' HG22 ' A' ' 106' ' ' THR . 36.7 m80 -128.19 164.85 21.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.801 0.84 . . . . 0.0 108.775 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 63.71 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.405 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 130.21 42.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.361 0.665 . . . . 0.0 110.615 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -63.35 -57.49 10.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.472 0.709 . . . . 0.0 111.26 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -152.59 3.73 0.35 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.213 0.605 . . . . 0.0 111.125 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.0 140.2 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.577 0.751 . . . . 0.0 109.618 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.91 151.77 58.44 Favored Pre-proline 0 N--CA 1.476 0.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.92 121.4 3.61 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.512 1.475 . . . . 0.0 109.955 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 41' ' ' ARG . 17.4 pt -109.8 169.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.845 0.858 . . . . 0.0 109.483 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 141.35 11.24 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.198 0.523 . . . . 0.0 111.036 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -112.36 136.26 52.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.505 HG22 HG23 ' A' ' 34' ' ' ILE . 87.3 m -114.01 107.81 16.17 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.695 0.798 . . . . 0.0 109.752 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -101.4 113.21 26.09 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.273 0.629 . . . . 0.0 109.445 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 21.7 m -96.6 146.36 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 94' ' ' GLN . 68.5 t -105.77 104.29 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.579 ' HB ' HD21 ' A' ' 95' ' ' ASN . 22.8 m -101.33 103.15 14.1 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 110.081 -171.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 12.8 mm100 -94.92 113.2 24.89 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.978 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.53 ' HB ' ' HG2' ' A' ' 97' ' ' GLU . 85.1 m -92.64 104.41 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 2.0 mp -93.01 131.52 39.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.527 0.679 . . . . 0.0 110.25 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 2.3 p80 -133.83 118.62 18.2 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.126 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' HA ' HG12 ' A' ' 100' ' ' VAL . 56.2 m-85 -78.61 130.49 35.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.522 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 41.9 mtm180 -141.45 162.06 36.41 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 123.931 0.892 . . . . 0.0 109.314 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -89.54 175.08 7.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.73 -25.1 68.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.409 0.684 . . . . 0.0 112.097 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.52 -20.14 61.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.127 0.971 . . . . 0.0 111.104 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.03 3.29 60.54 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.373 0.421 . . . . 0.0 112.652 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.6 130.03 39.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.504 0.721 . . . . 0.0 109.532 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 34.9 t -82.55 103.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.274 0.488 . . . . 0.0 109.975 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -61.28 -39.59 91.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.337 0.655 . . . . 0.0 111.087 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -168.81 145.82 3.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.695 0.798 . . . . 0.0 109.005 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -137.52 109.99 7.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.408 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 174.55 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 124.689 1.243 . . . . 0.0 112.494 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.4 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 2.5 t-160 -75.99 78.64 2.86 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.88 0.738 . . . . 0.0 112.398 -155.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 14' ' ' THR . 48.2 t -92.44 128.36 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.96 166.03 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.4 p -156.85 141.62 16.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.551 0.74 . . . . 0.0 109.803 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 10.8 tp -121.86 123.48 41.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 122.585 0.354 . . . . 0.0 111.323 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 8' ' ' THR . 2.4 mp -91.98 120.49 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.729 0.812 . . . . 0.0 109.663 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 89.9 m-85 -115.71 110.13 18.69 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.012 0.925 . . . . 0.0 109.209 173.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 m -103.24 102.04 12.0 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.683 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -85.97 99.33 11.36 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.5 t -89.64 133.4 34.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.422 0.629 . . . . 0.0 110.159 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.53 -156.35 9.29 Favored Glycine 0 C--O 1.242 0.617 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.832 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 144.67 37.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.969 0.508 . . . . 0.0 109.718 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.9 ttm-85 -115.17 129.94 56.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.866 0.466 . . . . 0.0 109.978 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 2.0 m-20 -75.4 113.83 13.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.6 -8.02 56.4 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.402 0.681 . . . . 0.0 111.411 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 t -78.68 -44.05 24.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.499 0.72 . . . . 0.0 110.925 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -101.57 -21.0 14.83 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.353 0.661 . . . . 0.0 112.055 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.75 25.74 71.21 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 21.3 ptmt -95.88 138.56 33.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.333 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -106.57 116.39 31.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.577 0.751 . . . . 0.0 110.266 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 47' ' ' LYS . 3.6 mp -101.05 102.65 13.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -104.26 152.77 21.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.128 0.971 . . . . 0.0 108.936 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.55 120.98 40.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.378 0.671 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -74.98 -15.24 60.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.157 0.583 . . . . 0.0 112.172 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -85.38 -3.6 58.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.103 0.561 . . . . 0.0 111.103 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.472 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 88.3 t90 -60.77 128.03 34.56 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 p -155.31 114.51 3.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.6 tp -133.55 130.24 38.16 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 t -99.86 142.39 31.39 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.007 0.523 . . . . 0.0 109.7 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -123.22 145.02 49.0 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.527 HG21 ' HG3' ' A' ' 61' ' ' GLU . 4.7 m -70.44 118.03 12.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.076 1.351 . . . . 0.0 110.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 115.92 29.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.527 ' HG3' HG21 ' A' ' 59' ' ' THR . 0.0 OUTLIER -168.6 -155.78 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.33 1.052 . . . . 0.0 109.014 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 65.19 11.74 7.45 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.41 1.084 . . . . 0.0 111.819 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 100.28 8.99 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 87.2 Cg_endo -85.09 -173.35 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.547 2.165 . . . . 0.0 111.92 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.0 p -146.47 131.15 8.83 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.65 120.52 7.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.456 2.104 . . . . 0.0 111.039 172.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.65 105.95 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -106.72 114.46 45.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.2 mm -71.7 138.94 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 123.515 0.51 . . . . 0.0 109.785 -174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.17 8.66 85.15 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.961 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 96.8 m-85 -140.31 152.04 45.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.663 0.785 . . . . 0.0 110.074 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 m -134.28 115.67 14.39 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.39 150.94 45.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.927 0.891 . . . . 0.0 111.362 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.01 -39.37 75.88 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.698 0.761 . . . . 0.0 109.008 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -129.62 92.97 36.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.34 -1.3 . . . . 0.0 107.812 169.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.58 -4.92 14.03 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.636 2.224 . . . . 0.0 112.516 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 23.4 ttt -145.8 108.73 4.56 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 168.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG11 ' HG2' ' A' ' 98' ' ' GLU . 76.7 t -70.5 115.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.199 0.312 . . . . 0.0 111.574 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 52.59 63.38 4.98 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.913 1.383 . . . . 0.0 114.862 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.57 77.7 3.35 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.316 2.011 . . . . 0.0 110.136 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -155.82 148.42 23.95 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.72 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -80.25 106.78 12.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.28 128.26 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 m -111.11 123.84 51.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.053 0.541 . . . . 0.0 110.544 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.466 ' HA ' HD22 ' A' ' 89' ' ' ASN . 77.1 t -113.56 122.79 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.175 0.59 . . . . 0.0 109.521 172.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.47 162.12 13.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 29.7 m -58.3 -29.84 66.18 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.686 0.794 . . . . 0.0 112.335 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -65.83 -31.94 73.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.416 1.086 . . . . 0.0 111.563 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 85' ' ' VAL . 2.9 p-10 -115.86 19.24 15.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.367 0.667 . . . . 0.0 111.191 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 84.1 t80 -74.59 -33.01 62.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.26 0.624 . . . . 0.0 112.591 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.74 -22.8 56.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.111 0.564 . . . . 0.0 109.598 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -81.67 136.49 35.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.701 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -100.3 159.08 15.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.625 ' HB2' HG13 ' A' ' 11' ' ' VAL . 55.4 mt-30 -109.4 34.12 3.95 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.579 HD21 ' HB ' ' A' ' 12' ' ' THR . 27.9 t-20 -58.82 101.14 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.898 0.879 . . . . 0.0 110.251 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 28.3 tpt180 -133.34 142.24 48.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.641 0.777 . . . . 0.0 110.404 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.563 ' HB3' ' HE2' ' A' ' 16' ' ' HIS . 40.2 mt-10 -90.56 119.1 30.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 169.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HG2' HG11 ' A' ' 78' ' ' VAL . 10.5 tp10 -105.09 114.51 28.76 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.8 m -91.61 132.46 36.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.607 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -106.85 119.0 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.96 109.99 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 66.4 m-85 -80.49 101.32 9.02 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.543 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 m -91.64 152.36 20.28 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.589 ' HB3' HG21 ' A' ' 108' ' ' THR . . . -49.21 133.49 19.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.379 0.536 . . . . 0.0 110.023 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.36 155.23 21.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.854 0.862 . . . . 0.0 109.989 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -45.9 -34.11 3.66 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.004 1.321 . . . . 0.0 113.81 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.8 mm -72.47 -46.85 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.954 0.501 . . . . 0.0 110.549 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 104' ' ' ALA . 14.9 t -91.81 3.3 55.45 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.424 0.69 . . . . 0.0 111.717 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -67.4 110.54 3.63 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -125.54 160.44 29.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.402 1.081 . . . . 0.0 108.788 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -90.32 101.38 14.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.415 0.686 . . . . 0.0 109.563 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -138.47 -55.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.335 1.054 . . . . 0.0 108.604 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.28 -169.59 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.997 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.97 18.09 18.71 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.1 -77.81 0.14 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -178.56 123.88 0.1 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 108.451 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -81.37 82.8 7.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.516 1.15 . . . . 0.0 108.667 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -66.88 91.0 0.19 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.465 -2.152 . . . . 0.0 111.795 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -89.02 -10.4 47.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.112 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -74.5 85.21 2.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.703 0.401 . . . . 0.0 110.371 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 50.75 85.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 112.488 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.7 p80 . . . . . 0 CA--C 1.556 1.191 0 C-N-CA 122.95 0.5 . . . . 0.0 110.093 -178.267 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.906 0.384 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.0 mm -106.61 138.82 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.494 1.118 . . . . 0.0 109.302 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -118.97 141.25 29.88 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 44.3 Cg_endo -68.12 128.11 17.05 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.27 1.98 . . . . 0.0 110.513 171.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 41' ' ' ARG . 13.4 pt -132.15 137.06 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -133.77 140.8 47.18 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.352 -0.217 . . . . 0.0 111.023 -170.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -101.92 151.51 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.234 1.014 . . . . 0.0 109.063 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -123.55 109.19 13.48 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.813 0.845 . . . . 0.0 110.436 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -112.25 125.92 54.67 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 25.5 m -105.08 141.49 20.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 83' ' ' VAL . 43.0 t -100.72 105.56 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -98.84 106.52 18.79 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.108 -170.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -93.19 95.87 9.66 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 90.1 m -85.02 136.14 33.71 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.3 134.94 47.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.411 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 42.0 m170 -103.58 119.28 38.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.839 172.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' OH ' HD11 ' A' ' 63' ' ' LEU . 93.8 m-85 -91.67 121.06 32.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -144.04 158.7 43.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -90.37 172.48 8.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.56 0.744 . . . . 0.0 109.773 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 101' ' ' ILE . 15.0 pt-20 -62.98 -43.31 99.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.921 0.888 . . . . 0.0 111.911 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.03 -16.63 61.49 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.444 1.098 . . . . 0.0 111.451 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 16.69 23.37 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.518 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.48 147.27 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.231 0.515 . . . . 0.0 110.171 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -75.68 121.05 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.114 0.566 . . . . 0.0 110.524 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.42 -57.88 2.63 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 166.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.484 ' HD2' ' HB2' ' A' ' 29' ' ' HIS . 22.1 t60 -172.8 75.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.071 0.948 . . . . 0.0 108.499 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 8.6 p-10 -88.36 57.43 4.24 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -168.37 18.44 0.02 OUTLIER 'General case' 0 C--N 1.356 0.861 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.484 ' HB2' ' HD2' ' A' ' 26' ' ' HIS . 5.4 t60 -104.36 129.71 52.25 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.707 0.685 . . . . 0.0 110.461 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 14' ' ' THR . 43.3 t -129.65 135.36 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.39 1.076 . . . . 0.0 110.514 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.66 154.63 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 51.8 p -148.5 143.41 26.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.644 0.778 . . . . 0.0 110.683 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 58' ' ' GLN . 60.7 mt -106.23 125.41 50.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.652 0.781 . . . . 0.0 108.893 174.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.52 102.61 13.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HD2' ' HB3' ' A' ' 56' ' ' LEU . 96.9 m-85 -93.79 102.03 14.15 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.099 0.96 . . . . 0.0 109.338 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 103.64 14.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.341 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.33 101.89 11.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.581 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 63.5 p -73.33 148.91 43.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.221 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.01 -177.07 24.5 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.992 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 139.59 42.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.613 0.706 . . . . 0.0 110.564 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HB2' HD13 ' A' ' 5' ' ' ILE . 20.9 ttm-85 -116.28 122.62 45.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.954 0.502 . . . . 0.0 110.186 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.83 112.34 13.32 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.59 -10.74 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 t -72.86 -53.49 11.28 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.764 0.826 . . . . 0.0 110.399 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.29 -18.6 19.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.614 0.765 . . . . 0.0 111.267 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.93 62.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.506 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' NZ ' HD11 ' A' ' 49' ' ' ILE . 9.5 ptmm? -94.46 128.51 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.829 0.851 . . . . 0.0 110.318 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.33 111.04 23.17 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.092 0.957 . . . . 0.0 109.963 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 HD11 ' NZ ' ' A' ' 47' ' ' LYS . 1.6 mp -98.29 107.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -101.35 117.27 34.61 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.19 121.27 17.24 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 123.402 0.439 . . . . 0.0 109.997 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -63.3 -36.12 82.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.798 1.239 . . . . 0.0 112.009 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -78.29 -7.66 57.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.719 0.408 . . . . 0.0 110.897 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.95 127.62 33.08 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.243 0.544 . . . . 0.0 109.918 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.8 p -137.49 157.16 47.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.589 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -130.77 124.23 30.94 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 m -115.72 122.29 45.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.348 0.659 . . . . 0.0 109.704 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 33' ' ' LEU . 76.4 mt-30 -122.35 145.3 48.39 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.376 0.67 . . . . 0.0 109.42 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.581 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 30.6 m -69.38 125.75 27.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.313 1.045 . . . . 0.0 110.708 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.42 109.13 15.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.8 -171.83 0.4 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.362 1.465 . . . . 0.0 109.23 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.22 86.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.545 1.138 . . . . 0.0 112.393 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -98.59 115.11 65.89 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.527 0.731 . . . . 0.0 109.29 -178.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.9 80.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.96 3.106 . . . . 0.0 113.262 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' ' HH ' ' A' ' 102' ' ' TYR . 13.7 p -95.13 137.47 22.18 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.819 0.848 . . . . 0.0 110.982 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -44.54 125.77 6.4 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.133 3.222 . . . . 0.0 114.223 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.9 t -85.97 108.94 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 172.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.58 132.45 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.288 0.635 . . . . 0.0 109.315 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.79 124.1 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.31 3.88 88.41 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.302 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -136.06 149.62 48.83 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.815 0.808 . . . . 0.0 109.747 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -137.87 131.05 30.45 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.7 57.05 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.552 0.533 . . . . 0.0 109.924 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.13 -31.79 71.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.69 98.65 7.04 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.559 1.144 . . . . 0.0 108.739 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.34 -6.02 18.13 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.357 2.038 . . . . 0.0 112.383 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.603 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 36.1 ttm -136.99 120.51 17.11 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.054 0.942 . . . . 0.0 108.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.39 143.09 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.673 0.789 . . . . 0.0 109.627 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.38 57.89 17.45 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.294 0.996 . . . . 0.0 112.453 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -85.48 56.91 4.38 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.753 2.302 . . . . 0.0 111.245 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -154.64 120.38 5.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.504 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 1.8 mp0 -48.2 123.42 6.37 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 125.371 1.669 . . . . 0.0 111.027 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.785 HG12 HG22 ' A' ' 11' ' ' VAL . 81.4 t -89.65 121.11 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 123.659 0.6 . . . . 0.0 110.728 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 m -104.81 112.41 25.51 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.3 t -99.76 109.39 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.463 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 13.7 t70 -95.51 166.67 11.74 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.2 m -57.23 -33.77 67.89 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.332 0.653 . . . . 0.0 111.711 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 20.7 ptmt -67.4 -36.3 81.02 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.841 0.857 . . . . 0.0 111.745 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -115.85 27.61 9.18 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.886 0.875 . . . . 0.0 110.035 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -64.61 -37.05 86.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.382 0.673 . . . . 0.0 111.399 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.92 -6.44 56.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.472 0.309 . . . . 0.0 110.666 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.89 135.42 34.15 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.229 0.538 . . . . 0.0 110.984 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -93.04 -25.66 17.84 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 0.0 111.751 -176.061 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 51.91 12.29 0.18 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 127.577 2.351 . . . . 0.0 116.077 171.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HB2' HG13 ' A' ' 11' ' ' VAL . 6.1 m120 -151.01 153.46 35.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.92 . . . . 0.0 109.428 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.52 -159.61 0.98 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.829 -167.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' THR . 1.8 tm-20 -90.9 112.74 24.73 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.301 0.64 . . . . 0.0 109.275 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -112.47 125.11 53.88 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.149 0.98 . . . . 0.0 109.665 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.9 m -91.13 133.41 35.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.51 0.724 . . . . 0.0 109.958 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.54 144.45 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 20' ' ' GLU . 40.8 mm -114.52 111.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.864 0.466 . . . . 0.0 111.582 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.439 ' HH ' ' HB2' ' A' ' 65' ' ' SER . 90.0 m-85 -82.82 105.49 13.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.564 1.146 . . . . 0.0 109.254 172.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 p -110.97 146.02 37.37 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.25 104.35 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.46 1.1 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -71.38 177.04 4.16 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.929 0.892 . . . . 0.0 111.732 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -62.05 -26.7 68.42 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.288 0.635 . . . . 0.0 111.983 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.05 -51.93 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.79 0.836 . . . . 0.0 111.251 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -73.17 -26.13 61.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.442 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.23 -17.24 64.73 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.11 0.564 . . . . 0.0 111.993 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.41 160.95 30.41 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.059 0.457 . . . . 0.0 110.269 174.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -76.66 84.88 3.31 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.54 -78.0 0.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.599 1.16 . . . . 0.0 108.072 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -94.62 -177.65 4.29 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.99 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.04 39.74 62.88 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.71 -52.13 61.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 0.0 109.541 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 49.0 53.21 12.97 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.047 1.739 . . . . 0.0 112.381 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -71.89 87.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -89.25 79.87 7.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.024 -164.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -90.38 -30.59 17.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.157 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -66.1 146.94 54.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.051 0.94 . . . . 0.0 108.747 172.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -69.64 -47.1 64.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.932 -171.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.649 0.78 . . . . 0.0 109.378 176.631 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG3' HD11 ' A' ' 43' ' ' LEU . 13.4 tpt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.7 mm -121.21 155.6 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 124.579 1.152 . . . . 0.0 109.3 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 8.8 pt-20 -128.38 149.94 72.91 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 167.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.34 128.16 11.01 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 122.063 1.842 . . . . 0.0 111.377 168.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' A' ' 41' ' ' ARG . 26.5 pt -126.24 168.44 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.73 143.22 19.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.462 0.705 . . . . 0.0 109.651 174.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' HG2' ' HE2' ' A' ' 90' ' ' PHE . 22.9 tpp180 -105.41 161.01 14.69 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 34' ' ' ILE . 21.6 m -130.2 108.47 10.06 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.45 0.7 . . . . 0.0 109.285 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.498 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp-100 -112.44 117.73 33.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 33.3 m -102.15 134.59 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 120.81 0.338 . . . . 0.0 110.202 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.6 t -93.43 108.93 21.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -94.55 98.89 11.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.521 0.728 . . . . 0.0 109.747 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.29 97.41 9.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.368 0.604 . . . . 0.0 109.807 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -92.17 138.91 31.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 118' ' ' HIS . 1.8 mp -122.56 139.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -106.62 146.74 30.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.899 1.28 . . . . 0.0 108.335 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -114.65 111.2 20.95 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -175.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 26.5 mmt85 -126.84 168.19 14.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.641 0.777 . . . . 0.0 109.445 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.556 ' HH ' HD13 ' A' ' 68' ' ' ILE . 90.3 m-85 -105.8 172.22 6.92 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.977 0.911 . . . . 0.0 108.612 172.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.06 -22.49 63.06 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.519 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -69.52 -21.99 63.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.856 0.862 . . . . 0.0 111.503 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.78 -3.41 55.97 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.65 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.79 157.9 37.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.657 0.783 . . . . 0.0 110.871 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 12.3 t -102.18 123.9 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 17' ' ' TYR . . . -76.17 -47.28 24.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -169.96 159.65 7.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.793 0.837 . . . . 0.0 110.125 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -120.73 152.36 38.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.885 0.474 . . . . 0.0 111.815 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 53.53 76.28 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.648 1.579 . . . . 0.0 112.794 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.438 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 51.4 m170 -120.47 112.39 18.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.21 141.2 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.033 0.933 . . . . 0.0 111.461 -162.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.65 116.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 165.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 p -115.29 124.04 50.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.88 0.872 . . . . 0.0 109.642 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 83.6 mt -106.99 134.43 50.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.801 0.441 . . . . 0.0 111.054 -177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 8' ' ' THR . 3.0 mp -87.6 121.93 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.427 1.091 . . . . 0.0 110.336 -174.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 72.2 m-85 -111.31 104.47 12.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.236 1.014 . . . . 0.0 108.637 173.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -93.05 103.82 16.08 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.114 0.565 . . . . 0.0 110.327 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.63 104.36 15.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.8 p -72.1 163.75 27.37 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.138 0.494 . . . . 0.0 111.074 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.23 -158.27 22.91 Favored Glycine 0 C--O 1.238 0.362 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 139.21 17.59 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.03 0.532 . . . . 0.0 110.042 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' HB2' HD11 ' A' ' 5' ' ' ILE . 37.4 ttm-85 -102.34 129.35 48.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.443 ' HA ' HD13 ' A' ' 2' ' ' ILE . 32.5 t70 -77.02 118.38 19.53 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 1' ' ' MET . 83.9 mt -82.55 -9.1 59.55 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -169.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -94.92 -30.41 14.17 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.31 0.504 . . . . 0.0 111.458 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.01 -30.25 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.909 0.484 . . . . 0.0 110.254 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.18 2.58 77.18 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.222 -174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HB2' ' HZ1' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -72.58 137.03 45.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.253 0.621 . . . . 0.0 109.693 -178.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -105.37 118.49 36.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.787 0.835 . . . . 0.0 110.054 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.4 107.6 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -95.76 165.16 12.44 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.899 0.88 . . . . 0.0 109.831 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 29.6 m-20 -75.15 113.45 12.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.2 m -75.61 -23.84 56.46 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.851 0.46 . . . . 0.0 111.393 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -85.96 -3.99 59.06 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.798 0.839 . . . . 0.0 111.369 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 80.5 t90 -60.3 128.98 39.4 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.191 0.52 . . . . 0.0 109.684 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -154.84 113.57 3.58 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.67 140.48 48.19 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 82' ' ' GLU . 5.3 t -108.7 153.94 22.73 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -148.06 144.26 27.75 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.477 HG21 ' HG2' ' A' ' 61' ' ' GLU . 24.1 m -79.16 109.49 13.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.222 1.009 . . . . 0.0 112.927 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -102.61 102.02 12.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.288 0.635 . . . . 0.0 109.505 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' HG2' HG21 ' A' ' 59' ' ' THR . 13.0 pt-20 -173.87 -169.86 0.52 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.727 0.811 . . . . 0.0 109.416 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 70.95 20.68 5.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.739 ' HB3' ' HA ' ' A' ' 118' ' ' HIS . 2.3 mm? -92.54 110.33 44.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.107 0.563 . . . . 0.0 110.298 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.536 ' HG2' ' HB3' ' A' ' 119' ' ' HIS . 90.2 Cg_endo -85.09 -146.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.74 2.96 . . . . 0.0 111.149 173.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 2.1 m -162.55 163.37 18.18 Favored Pre-proline 0 N--CA 1.495 1.782 0 C-N-CA 124.341 1.056 . . . . 0.0 110.192 174.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.69 125.41 15.42 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 121.882 1.721 . . . . 0.0 110.428 169.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.42 107.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.556 HD13 ' HH ' ' A' ' 19' ' ' TYR . 46.0 mt -100.84 122.07 52.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -72.8 128.64 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.049 0.94 . . . . 0.0 111.01 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.96 1.5 89.75 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.35 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -126.6 159.78 32.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 0.0 110.689 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 ' HB ' ' HG3' ' A' ' 109' ' ' GLN . 52.0 m -145.35 135.52 23.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.176 1.391 . . . . 0.0 107.493 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 76' ' ' PRO . . . -71.11 139.32 50.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.074 0.55 . . . . 0.0 111.086 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.46 ' HA ' HE22 ' A' ' 109' ' ' GLN . 11.9 t70 -69.36 -18.44 63.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.48 1.912 . . . . 0.0 110.551 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.777 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.92 82.64 7.09 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 29.9 Cg_endo -90.26 23.03 0.7 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.541 2.827 . . . . 0.0 114.12 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.66 144.63 27.29 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.523 HG21 ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -131.34 136.61 57.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 164.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.32 71.0 0.2 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' A' ' 78' ' ' VAL . 53.0 Cg_exo -58.26 -16.42 28.15 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.35 2.033 . . . . 0.0 110.773 162.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 59' ' ' THR . 29.7 t70 74.23 -71.53 0.13 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 126.682 1.993 . . . . 0.0 109.71 172.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 61.6 mt-10 -140.16 134.47 31.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.953 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.56 124.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.3 m -100.12 123.94 44.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.178 0.591 . . . . 0.0 109.853 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.21 121.39 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.26 161.96 16.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.294 1.038 . . . . 0.0 109.403 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 68.2 m -62.02 -29.08 70.03 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.004 0.431 . . . . 0.0 110.942 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.53 -46.61 89.53 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.037 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -100.07 2.79 43.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.095 0.558 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.433 ' HE2' ' HG2' ' A' ' 7' ' ' ARG . 79.1 t80 -62.09 -33.84 75.19 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.119 0.968 . . . . 0.0 113.345 -168.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.59 -27.21 66.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.109 0.48 . . . . 0.0 110.157 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -93.73 156.88 16.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.189 0.995 . . . . 0.0 109.189 170.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.498 ' HE2' ' OE1' ' A' ' 9' ' ' GLN . 18.4 ptpt -119.39 139.0 52.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.78 40.29 1.14 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.577 0.703 . . . . 0.0 109.656 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 95' ' ' ASN . 0.1 OUTLIER -51.27 149.53 3.92 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.304 168.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -152.59 115.84 4.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.834 0.349 . . . . 0.0 111.281 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -104.51 110.68 23.05 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -121.67 171.39 8.88 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 110.283 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.8 m -130.9 134.49 46.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.374 0.669 . . . . 0.0 111.598 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.777 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 3.7 m -98.26 142.0 15.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 123.319 0.647 . . . . 0.0 110.227 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -114.08 114.82 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 0.0 110.318 -175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.96 103.29 15.9 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -97.96 174.43 6.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.27 156.25 15.95 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.434 ' OD1' HG21 ' A' ' 106' ' ' THR . 6.5 t-20 -51.13 166.9 0.09 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.392 1.077 . . . . 0.0 112.937 -167.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.434 HG21 ' OD1' ' A' ' 105' ' ' ASN . 12.5 t -44.64 -20.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.615 1.566 . . . . 0.0 114.637 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.1 mt -42.02 -62.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.162 1.385 . . . . 0.0 111.54 169.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 t -111.46 -4.04 14.98 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.817 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.468 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -64.11 140.19 58.84 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.919 0.887 . . . . 0.0 111.052 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -129.25 155.93 44.78 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.461 1.104 . . . . 0.0 109.073 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 69.07 151.81 0.09 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.847 1.259 . . . . 0.0 111.669 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -161.48 -54.67 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 43.73 -82.0 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.204 1.802 . . . . 0.0 113.748 170.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.76 63.89 0.37 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 mt -105.8 -46.55 4.1 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.576 ' HG2' ' HG3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -136.46 154.52 50.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.355 0.662 . . . . 0.0 111.182 176.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.591 ' HA ' HG11 ' A' ' 100' ' ' VAL . 3.1 t-160 178.89 153.25 0.38 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.454 1.102 . . . . 0.0 108.663 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.739 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.6 t60 -163.52 145.5 9.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.536 ' HB3' ' HG2' ' A' ' 64' ' ' PRO . 43.9 t60 -165.98 130.4 2.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.727 1.211 . . . . 0.0 107.928 160.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -141.21 130.2 23.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.853 0.861 . . . . 0.0 109.195 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -87.68 130.41 34.81 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.176 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG2' HD12 ' A' ' 43' ' ' LEU . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.461 HD11 ' HD3' ' A' ' 40' ' ' LYS . 41.6 mm -107.87 142.98 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.939 0.896 . . . . 0.0 109.998 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.6 148.59 65.2 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.058 0.543 . . . . 0.0 109.94 166.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.2 125.53 10.36 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 0.0 110.506 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' A' ' 41' ' ' ARG . 45.0 pt -125.68 154.95 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.177 0.513 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -159.68 145.86 16.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.832 173.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -111.15 156.68 21.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.335 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.484 HG23 HG23 ' A' ' 34' ' ' ILE . 59.2 m -129.49 122.19 28.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.263 0.625 . . . . 0.0 110.284 -172.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp-100 -122.76 107.16 11.59 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG13 HG13 ' A' ' 34' ' ' ILE . 4.2 m -92.62 133.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 94' ' ' GLN . 69.3 t -102.02 124.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 173.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -123.05 115.34 21.69 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -164.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.596 HE21 ' HG3' ' A' ' 80' ' ' PRO . 8.4 mm-40 -89.47 104.71 17.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.413 1.085 . . . . 0.0 111.068 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -95.35 112.5 24.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.154 0.982 . . . . 0.0 109.176 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 98' ' ' GLU . 87.2 mt -111.58 131.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.508 0.671 . . . . 0.0 111.083 -170.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -112.06 116.28 30.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -86.02 107.08 17.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -133.26 156.85 46.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.915 0.886 . . . . 0.0 109.476 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -89.15 176.4 6.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.4 0.68 . . . . 0.0 110.949 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.74 -24.9 67.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.135 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.84 -7.78 58.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.782 0.833 . . . . 0.0 111.225 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.27 82.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.95 150.68 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.092 0.557 . . . . 0.0 109.957 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.7 t -74.41 127.03 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.093 0.557 . . . . 0.0 110.563 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.44 -62.99 1.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -159.52 99.77 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.308 1.043 . . . . 0.0 109.566 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.97 171.44 15.2 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.624 -0.672 . . . . 0.0 110.875 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 57.54 80.33 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.496 1.118 . . . . 0.0 111.679 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -130.94 91.99 3.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.85 127.47 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.699 . . . . 0.0 110.918 -169.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.98 149.97 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.1 p -144.46 144.64 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.923 0.392 . . . . 0.0 110.884 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.68 124.08 51.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.181 0.992 . . . . 0.0 109.109 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.484 HG23 HG23 ' A' ' 8' ' ' THR . 1.8 mp -94.9 109.29 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.351 1.06 . . . . 0.0 108.894 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 57.9 m-85 -97.36 99.08 10.53 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -98.82 103.29 15.23 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.403 0.681 . . . . 0.0 109.749 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.46 108.88 14.46 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 t -92.5 159.16 15.65 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.376 0.67 . . . . 0.0 110.742 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.02 -161.93 26.07 Favored Glycine 0 C--O 1.238 0.375 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.716 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.461 ' HD3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -144.15 142.02 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.216 0.606 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.557 ' HB2' HD12 ' A' ' 5' ' ' ILE . 15.8 ttm180 -104.74 125.11 50.49 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.713 0.405 . . . . 0.0 110.122 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.86 106.59 8.62 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 1' ' ' MET . 96.2 mt -75.78 -2.76 31.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.986 0.914 . . . . 0.0 112.171 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -42.37 60.88 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.527 0.731 . . . . 0.0 109.932 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.04 -24.62 14.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.816 0.846 . . . . 0.0 111.234 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.46 16.09 72.11 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.994 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -87.99 143.51 27.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.432 0.693 . . . . 0.0 111.142 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.46 107.65 19.91 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.529 1.132 . . . . 0.0 110.508 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.62 97.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.438 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 59.8 m95 -90.31 171.89 9.15 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.065 0.946 . . . . 0.0 109.406 171.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.64 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 26.9 m-20 -76.82 115.73 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 164.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -62.17 -31.68 72.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.108 0.563 . . . . 0.0 110.324 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -92.04 15.45 13.31 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.688 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.64 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 90.5 t90 -70.4 127.86 34.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 81.0 p -154.86 115.53 3.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.768 1.227 . . . . 0.0 107.805 170.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.5 tp -103.57 132.97 49.36 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 m -110.23 115.42 29.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.804 0.842 . . . . 0.0 109.516 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -129.34 132.52 47.12 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.543 0.737 . . . . 0.0 109.126 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.4 m -85.34 135.21 33.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.156 0.583 . . . . 0.0 111.266 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.06 104.92 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 160.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.7 -174.09 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.349 1.06 . . . . 0.0 108.589 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.97 21.78 12.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.755 0.822 . . . . 0.0 112.824 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.37 114.13 65.55 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.27 -165.92 0.31 Allowed 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 123.055 2.503 . . . . 0.0 113.31 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.7 p -157.18 146.98 15.44 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 118.47 5.36 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.999 1.799 . . . . 0.0 110.286 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.52 104.63 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.03 119.01 41.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.48 132.27 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.839 0.712 . . . . 0.0 109.812 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.43 12.43 80.44 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.373 -0.681 . . . . 0.0 112.86 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 87.5 m-85 -137.25 148.97 46.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.752 0.821 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -110.31 126.95 54.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.795 1.638 . . . . 0.0 107.729 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.8 143.96 26.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.938 0.79 . . . . 0.0 109.987 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -37.33 78.37 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.261 0.625 . . . . 0.0 110.938 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HG2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -146.91 98.32 4.11 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.28 -8.07 21.87 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.466 2.111 . . . . 0.0 112.511 175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ttt -143.78 105.77 4.36 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.24 111.59 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.28 78.74 0.24 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HG3' HE21 ' A' ' 13' ' ' GLN . 61.4 Cg_endo -71.23 -0.63 8.37 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.825 2.35 . . . . 0.0 113.446 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 76.1 -159.68 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.009 1.324 . . . . 0.0 112.456 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.97 128.73 31.53 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.87 109.83 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.134 1.374 . . . . 0.0 107.91 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.8 m -98.31 128.73 44.88 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.73 115.07 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.9 p30 -90.7 173.08 8.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.764 0.826 . . . . 0.0 110.196 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -60.2 -29.93 69.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.417 1.087 . . . . 0.0 113.206 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -38.33 23.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.103 0.561 . . . . 0.0 110.668 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.45 8.95 40.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.99 -24.57 67.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.717 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.71 -21.41 55.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 110.299 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.65 118.43 33.1 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.176 0.991 . . . . 0.0 110.924 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . 21.1 pttp -83.87 127.78 34.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.413 ' H ' HG23 ' A' ' 11' ' ' VAL . 36.8 mt-30 -86.78 42.4 1.01 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -64.03 121.36 13.96 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 110.535 -175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -113.93 145.41 41.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -116.02 110.05 18.38 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.575 ' HB2' HG12 ' A' ' 15' ' ' ILE . 17.4 mm-40 -93.18 155.97 17.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.766 0.793 . . . . 0.0 110.725 175.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.2 m -142.28 107.53 4.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.888 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.404 HG13 ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -79.33 137.82 21.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mm -108.87 122.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 94.0 m-85 -88.77 106.09 18.13 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.725 1.21 . . . . 0.0 109.413 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 p -112.47 130.39 56.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.17 129.14 23.71 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.028 0.931 . . . . 0.0 113.152 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -54.31 -179.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.517 1.527 . . . . 0.0 114.037 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -66.01 -12.74 57.29 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.609 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -56.76 -50.17 75.67 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 123.965 0.906 . . . . 0.0 110.34 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 t -73.54 -18.22 61.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.233 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -93.77 -164.67 1.2 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.554 1.141 . . . . 0.0 109.29 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 41.9 m-80 -95.32 -177.76 4.22 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 164.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -82.73 94.59 7.64 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 86.25 -39.53 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.634 2.374 . . . . 0.0 111.156 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' A' ' 110' ' ' ASN . 1.3 p-10 39.91 -94.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.458 1.903 . . . . 0.0 113.428 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.48 35.13 88.19 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.13 0.395 . . . . 0.0 113.476 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.27 -82.77 0.08 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.037 0.535 . . . . 0.0 110.256 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.48 -30.06 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.582 0.753 . . . . 0.0 111.449 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 35.5 m170 62.42 104.82 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.904 1.282 . . . . 0.0 110.289 -168.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -62.64 150.09 41.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -60.79 132.46 53.94 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.171 0.588 . . . . 0.0 110.01 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -82.08 57.32 3.49 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.192 0.996 . . . . 0.0 111.64 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -143.27 86.7 1.92 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.596 1.159 . . . . 0.0 107.956 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.933 0.893 . . . . 0.0 109.821 -173.137 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 42' ' ' ASP . 37.9 mm -113.95 151.21 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.386 0.675 . . . . 0.0 109.315 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.77 151.3 77.84 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.225 0.61 . . . . 0.0 110.011 170.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.75 133.79 28.43 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.606 2.204 . . . . 0.0 111.986 171.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 41' ' ' ARG . 11.6 pt -142.57 137.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.8 mptm? -133.72 154.26 51.08 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.487 0.715 . . . . 0.0 109.114 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.417 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 23.7 mmm180 -121.82 149.65 43.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 108.307 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 34' ' ' ILE . 27.1 m -122.26 108.05 12.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 6.2 tp-100 -105.37 148.98 26.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 28.6 m -124.98 123.78 66.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 110.197 173.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.56 115.54 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -96.37 152.03 18.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.091 0.957 . . . . 0.0 111.275 -171.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.689 ' HG3' ' HB2' ' A' ' 96' ' ' ARG . 52.9 tt0 -125.77 107.89 10.96 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -82.61 106.54 14.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.313 0.645 . . . . 0.0 110.791 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -99.6 133.11 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 121.533 0.682 . . . . 0.0 109.844 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -111.88 125.68 54.29 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -97.41 123.66 41.33 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 70.8 mtp180 -141.52 -173.86 3.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.757 0.823 . . . . 0.0 110.648 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.582 ' HH ' HD13 ' A' ' 68' ' ' ILE . 89.8 m-85 -118.14 164.69 14.77 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.4 -26.17 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.838 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -19.16 64.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.157 1.383 . . . . 0.0 110.849 175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.97 -14.45 63.9 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.96 153.27 29.82 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 111.364 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.9 t -92.52 133.86 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.196 0.598 . . . . 0.0 110.164 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.26 -54.09 3.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 0.0 110.184 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -157.24 96.21 1.54 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.652 1.181 . . . . 0.0 108.804 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.66 142.39 32.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 68.63 86.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.039 1.336 . . . . 0.0 111.417 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -141.16 92.79 2.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -111.2 133.68 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -166.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.0 p -108.48 137.13 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 37.4 m -113.32 137.72 51.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.93 0.492 . . . . 0.0 110.442 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.2 mt -98.92 123.36 43.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG23 HG22 ' A' ' 8' ' ' THR . 2.1 mp -99.85 105.4 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.019 0.927 . . . . 0.0 108.664 -173.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.28 107.61 20.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.893 0.877 . . . . 0.0 110.096 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 m -83.81 103.09 12.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 32.6 tt0 -85.53 107.79 17.63 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.468 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 17.0 p -91.65 139.64 30.49 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.64 -167.13 16.03 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 136.68 35.42 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.29 0.545 . . . . 0.0 110.75 -175.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB2' HD12 ' A' ' 5' ' ' ILE . 25.7 ttm180 -103.58 122.21 44.51 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.821 0.449 . . . . 0.0 110.176 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' HD12 ' A' ' 2' ' ' ILE . 8.0 t70 -74.67 113.28 11.75 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.598 1.159 . . . . 0.0 108.582 169.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.7 mt -84.66 -4.44 59.01 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 t -87.11 -36.32 18.17 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.644 0.656 . . . . 0.0 110.86 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.04 -31.09 11.61 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.57 63.65 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.916 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.59 ' HZ2' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -71.51 133.53 45.88 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.018 0.927 . . . . 0.0 110.138 -177.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.55 113.93 27.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.353 0.661 . . . . 0.0 110.081 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.98 104.29 15.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.477 ' CZ2' HD13 ' A' ' 5' ' ' ILE . 55.2 m95 -103.75 119.86 39.78 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.88 131.06 43.2 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.78 0.675 . . . . 0.0 110.711 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -64.5 -26.28 68.36 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.297 0.998 . . . . 0.0 110.215 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -64.29 -22.25 66.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.69 0.796 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.448 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 67.8 t-105 -74.32 127.17 32.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.458 0.474 . . . . 0.0 109.896 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 p -153.87 144.53 22.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.514 1.126 . . . . 0.0 109.528 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 tt -134.12 125.18 27.42 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.4 m -107.92 127.64 53.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -130.8 140.19 50.26 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -101.56 132.83 47.0 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 111.117 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 m-85 -72.52 102.46 3.24 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.71 141.96 28.53 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.2 1.0 . . . . 0.0 108.307 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.79 108.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.401 1.08 . . . . 0.0 110.77 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 107.14 21.4 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.55 102.89 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.213 2.609 . . . . 0.0 112.92 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -98.64 134.06 22.02 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.131 0.972 . . . . 0.0 110.62 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 120.66 7.97 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.67 2.247 . . . . 0.0 110.583 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.07 107.25 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' HH ' ' A' ' 19' ' ' TYR . 25.9 mt -102.33 114.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.0 mm -75.62 137.86 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.53 87.42 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.346 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 97.9 m-85 -141.75 162.33 35.74 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.393 0.677 . . . . 0.0 110.26 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -147.24 120.03 8.66 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.95 148.23 52.13 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 123.799 0.687 . . . . 0.0 109.456 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.5 -33.6 73.09 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.787 0.68 . . . . 0.0 109.277 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 97.71 7.07 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.612 168.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.72 -6.23 17.34 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.199 1.932 . . . . 0.0 111.568 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tpt -128.47 125.61 38.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.388 1.075 . . . . 0.0 108.384 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.473 HG12 HE22 ' A' ' 13' ' ' GLN . 29.9 t -86.12 130.26 36.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 109.403 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.75 161.16 49.34 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.365 1.041 . . . . 0.0 113.418 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.5 118.81 5.91 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 123.206 2.604 . . . . 0.0 113.672 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 22.4 m-20 -109.79 94.54 5.08 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.711 0.805 . . . . 0.0 109.715 173.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -72.47 91.67 1.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.17 0.588 . . . . 0.0 110.768 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.404 HG12 HG21 ' A' ' 85' ' ' VAL . 74.8 t -85.52 103.03 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.873 0.869 . . . . 0.0 110.183 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.1 m -90.17 106.54 18.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.401 0.68 . . . . 0.0 109.548 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.433 ' HA ' HD22 ' A' ' 89' ' ' ASN . 85.4 t -106.5 110.7 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 170.98 12.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.411 1.084 . . . . 0.0 108.23 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.3 m -65.7 -23.8 66.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.324 166.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -67.53 -45.28 76.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.978 1.311 . . . . 0.0 110.694 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.433 HD22 ' HA ' ' A' ' 85' ' ' VAL . 3.4 p-10 -113.66 29.64 7.84 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.724 0.81 . . . . 0.0 109.892 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 9' ' ' GLN . 59.9 t80 -62.07 -46.53 88.68 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.616 0.767 . . . . 0.0 111.78 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.5 -1.09 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.48 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.01 149.69 25.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.888 0.875 . . . . 0.0 109.459 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -108.57 144.07 36.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.471 0.708 . . . . 0.0 109.699 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.4 40.11 3.75 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.37 103.67 1.69 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.583 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.689 ' HB2' ' HG3' ' A' ' 13' ' ' GLN . 28.2 mmm180 -76.42 156.41 33.16 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.458 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.87 132.15 18.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.453 0.301 . . . . 0.0 110.454 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 47.1 mt-10 -141.75 138.33 32.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.516 0.726 . . . . 0.0 110.643 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.5 m -109.03 115.28 29.76 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.41 141.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.08 113.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.747 0.419 . . . . 0.0 110.151 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 63.2 m-85 -84.05 110.45 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.995 0.918 . . . . 0.0 108.877 173.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -99.63 143.56 29.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.81 123.92 10.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.572 0.749 . . . . 0.0 109.295 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -45.75 158.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.592 1.957 . . . . 0.0 113.317 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 11.2 t -47.78 -20.48 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.886 1.274 . . . . 0.0 113.294 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.2 mm -50.58 -53.48 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -87.39 -30.74 20.53 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 75.6 mt-30 -64.53 -61.45 2.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.182 0.515 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 64.66 -85.99 0.02 OUTLIER 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.579 1.551 . . . . 0.0 109.861 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.2 mttm 56.78 -169.91 0.09 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.575 1.15 . . . . 0.0 111.785 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -104.23 -36.69 7.56 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.77 -166.18 0.21 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.952 1.301 . . . . 0.0 109.612 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.69 37.06 92.15 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 119.544 1.066 . . . . 0.0 111.296 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.25 -60.83 2.88 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 110.138 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -173.29 157.07 3.27 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -86.15 93.25 8.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 167.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -82.25 85.68 6.79 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.723 0.773 . . . . 0.0 110.986 -169.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.97 -70.14 0.74 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 168.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 52.37 -88.17 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.861 1.664 . . . . 0.0 112.687 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 38.8 m80 73.35 -60.37 0.54 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.893 1.677 . . . . 0.0 112.274 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 N--CA 1.485 1.314 0 C-N-CA 124.827 1.251 . . . . 0.0 110.112 -177.691 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.492 HD12 ' HD3' ' A' ' 40' ' ' LYS . 29.4 mm -118.72 119.86 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.409 1.084 . . . . 0.0 110.037 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' HG2' HD23 ' A' ' 43' ' ' LEU . 10.5 pt-20 -97.88 137.42 20.93 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 167.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.98 122.95 8.53 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.909 1.739 . . . . 0.0 110.355 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 41' ' ' ARG . 42.0 pt -119.34 161.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.401 0.68 . . . . 0.0 110.368 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 136.82 12.82 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -96.83 154.34 17.35 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.585 HG23 HG23 ' A' ' 34' ' ' ILE . 76.6 m -128.54 105.45 8.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -99.48 102.14 13.6 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' HG ' ' A' ' 32' ' ' SER . 23.6 m -91.13 117.5 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.7 t -89.75 107.1 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.3 m -92.49 102.22 14.67 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.488 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 9.5 tt0 -91.73 105.24 17.57 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.561 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.493 ' HG1' ' HA ' ' A' ' 97' ' ' GLU . 70.9 p -92.91 106.21 18.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 98' ' ' GLU . 19.9 mt -97.29 132.5 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.724 0.773 . . . . 0.0 111.681 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -116.75 118.09 31.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.98 -1.464 . . . . 0.0 107.056 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -87.33 115.41 24.73 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.0 ttt-85 -147.37 145.42 29.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.635 0.374 . . . . 0.0 110.518 -171.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.571 ' HH ' HD13 ' A' ' 68' ' ' ILE . 80.4 m-85 -79.48 163.2 24.92 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.477 1.111 . . . . 0.0 111.031 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.99 -28.32 69.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.452 0.701 . . . . 0.0 110.324 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.54 -20.03 65.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.048 1.339 . . . . 0.0 112.042 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.74 -10.25 66.42 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.869 -176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.29 54.14 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.564 0.746 . . . . 0.0 109.494 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 27' ' ' ASP . 39.8 t -86.76 124.89 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.91 51.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.541 0.737 . . . . 0.0 110.857 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -166.25 119.22 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.309 1.043 . . . . 0.0 108.531 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.521 ' HB2' HG12 ' A' ' 24' ' ' VAL . 22.7 t70 -98.19 162.2 13.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.23 0.612 . . . . 0.0 110.037 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 61.97 73.76 0.46 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.822 1.249 . . . . 0.0 112.323 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -127.62 83.7 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 171.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -102.35 127.23 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.599 -171.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 p -117.48 134.91 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.526 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 28.4 t -130.01 127.71 40.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.56 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 50.3 mt -108.81 131.23 55.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.609 0.764 . . . . 0.0 110.655 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.585 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -82.05 113.07 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.148 0.979 . . . . 0.0 109.619 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -103.99 103.75 13.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.508 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 85.5 m -91.95 107.17 19.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.93 0.892 . . . . 0.0 111.23 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.434 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 8.0 tt0 -86.63 107.78 18.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.0 p -78.19 169.58 18.03 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.851 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.95 -158.93 22.94 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.449 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -149.35 144.85 26.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.706 0.802 . . . . 0.0 109.531 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm180 -119.25 119.9 35.44 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.953 0.501 . . . . 0.0 110.566 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.8 113.81 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.206 1.002 . . . . 0.0 108.803 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD23 ' HG2' ' A' ' 3' ' ' GLU . 52.0 mt -82.86 -6.63 59.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -73.55 -48.32 33.94 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.071 0.548 . . . . 0.0 110.533 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -93.07 -26.44 17.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.967 0.507 . . . . 0.0 110.928 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.24 54.36 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.071 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HZ2' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -95.41 137.59 34.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.708 0.803 . . . . 0.0 110.918 -174.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -98.58 113.79 25.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.862 0.865 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.15 110.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -100.35 139.15 36.43 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.7 t70 -68.01 108.53 3.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 p -77.12 -9.88 59.03 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.189 0.596 . . . . 0.0 112.29 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -97.74 -1.13 44.07 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.339 0.656 . . . . 0.0 111.262 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 62.3 t-105 -66.48 150.52 48.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.435 0.694 . . . . 0.0 110.826 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.4 p -151.73 135.84 16.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HG ' ' H ' ' A' ' 36' ' ' THR . 1.4 tm? -111.51 124.1 51.58 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 m -99.94 127.82 46.09 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.762 0.825 . . . . 0.0 108.845 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 8.5 tp-100 -139.62 132.33 28.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 17.1 m -75.02 105.07 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.33 0.652 . . . . 0.0 112.056 -171.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.44 100.13 3.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 161.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -109.32 157.45 18.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.331 1.052 . . . . 0.0 110.138 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -46.69 114.99 0.93 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.943 1.697 . . . . 0.0 114.376 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HG ' HD12 ' A' ' 15' ' ' ILE . 3.7 mm? -82.36 124.3 78.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.51 100.52 0.23 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.735 2.29 . . . . 0.0 112.349 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 t -86.19 104.53 5.63 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.84 122.32 11.15 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.044 2.496 . . . . 0.0 112.475 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.23 107.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.571 HD13 ' HH ' ' A' ' 19' ' ' TYR . 66.4 mt -97.53 135.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.648 0.779 . . . . 0.0 108.938 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.33 118.89 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.495 -172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.09 68.13 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.154 -173.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.648 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 81.5 m-85 -141.21 136.52 31.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.816 0.846 . . . . 0.0 111.014 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.1 m -118.78 124.76 48.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 108.597 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.54 138.48 53.32 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.347 0.659 . . . . 0.0 110.971 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.91 -27.4 65.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.424 1.09 . . . . 0.0 110.593 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 94.5 7.29 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.058 0.943 . . . . 0.0 108.661 169.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.55 -5.45 16.9 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.432 2.088 . . . . 0.0 112.19 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.612 ' HE3' ' HA ' ' A' ' 80' ' ' PRO . 13.9 tpt -131.62 110.42 10.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.283 1.033 . . . . 0.0 108.487 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.05 129.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 77.13 0.56 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -167.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.612 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 42.0 Cg_endo -97.57 8.13 1.26 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.371 2.047 . . . . 0.0 114.618 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -162.38 172.77 15.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.251 1.024 . . . . 0.0 112.838 -169.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 33.9 mt-10 -85.46 129.77 34.74 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.341 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.51 140.14 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.027 0.931 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.6 m -112.12 120.98 43.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.799 0.84 . . . . 0.0 109.964 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -97.46 118.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.68 157.33 16.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.582 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 68.0 m -58.71 -33.64 70.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.74 0.816 . . . . 0.0 112.461 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.52 -30.29 69.07 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -117.64 24.24 11.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 34.5 t80 -62.65 -34.17 76.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.096 0.558 . . . . 0.0 111.998 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.63 -1.37 50.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.875 0.87 . . . . 0.0 111.704 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -101.16 163.07 12.46 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.93 0.892 . . . . 0.0 110.509 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -84.46 175.35 9.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.936 0.894 . . . . 0.0 111.103 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -121.9 -36.84 2.94 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 165.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -171.86 158.09 4.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.426 1.491 . . . . 0.0 107.87 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 76.7 mtm180 -138.92 -87.99 0.22 Allowed 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HA ' ' HG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -98.09 109.99 22.65 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -166.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.581 ' HB2' HG12 ' A' ' 15' ' ' ILE . 71.0 mm-40 -118.04 114.23 22.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.564 1.145 . . . . 0.0 109.609 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 83.4 m -106.63 122.06 45.58 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.74 132.81 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 30.1 mm -104.18 122.15 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.886 0.475 . . . . 0.0 110.67 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.648 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 97.0 m-85 -91.71 108.91 20.25 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.077 0.951 . . . . 0.0 109.974 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 m -98.29 131.42 44.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.798 0.839 . . . . 0.0 109.786 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.76 7.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.059 0.944 . . . . 0.0 111.015 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 1.9 m-20 -58.72 152.77 18.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.835 1.254 . . . . 0.0 111.628 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -58.56 -24.55 61.05 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.584 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.61 -47.92 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.614 1.166 . . . . 0.0 110.591 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -80.25 -16.84 53.8 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.492 0.317 . . . . 0.0 111.125 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 105' ' ' ASN . 84.9 mm-40 -64.66 -48.47 74.64 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 173.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 56.9 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.922 1.389 . . . . 0.0 111.366 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.1 89.21 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -96.06 -44.14 7.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.288 0.635 . . . . 0.0 109.682 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.56 171.38 15.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.733 0.813 . . . . 0.0 109.653 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.28 55.24 19.43 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -169.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.39 -73.89 0.07 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.333 1.053 . . . . 0.0 111.211 -171.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 68.93 -43.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 127.204 2.202 . . . . 0.0 113.228 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -78.9 128.88 33.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.802 0.841 . . . . 0.0 110.574 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -168.94 73.34 0.09 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.961 0.886 . . . . 0.0 110.235 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -73.34 -44.5 58.69 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -163.57 171.78 15.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.801 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -91.91 149.02 21.78 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.291 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.876 0.369 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.9 mm -112.64 157.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.842 1.257 . . . . 0.0 109.094 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -124.38 146.96 53.66 Favored Pre-proline 0 N--CA 1.479 1.005 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.64 126.38 12.03 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.071 1.847 . . . . 0.0 111.581 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.8 pt -127.18 167.39 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.581 0.752 . . . . 0.0 109.802 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 138.78 12.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.554 0.692 . . . . 0.0 111.622 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.582 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -87.32 133.83 33.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.004 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.9 m -125.29 104.88 8.72 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.2 146.78 24.09 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.131 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 34' ' ' ILE . 35.1 m -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' SER . 94.3 t -91.62 102.37 13.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m -101.78 104.27 15.04 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.84 0.856 . . . . 0.0 109.159 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.784 HE21 ' HB2' ' A' ' 98' ' ' GLU . 52.1 tt0 -112.95 125.27 54.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 109.948 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 30' ' ' VAL . 85.5 m -99.25 108.09 20.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.479 0.712 . . . . 0.0 109.687 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 98' ' ' GLU . 1.8 mp -83.57 116.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -95.77 108.81 21.17 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.128 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' HA ' HG22 ' A' ' 100' ' ' VAL . 97.3 m-85 -79.99 117.98 21.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -137.44 165.57 25.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.979 0.512 . . . . 0.0 109.875 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -94.04 175.53 6.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.312 1.045 . . . . 0.0 109.265 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.26 -21.37 60.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.41 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.05 -19.21 65.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.219 1.007 . . . . 0.0 110.882 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.36 69.12 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.143 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.24 136.8 56.51 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.953 0.901 . . . . 0.0 110.747 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.49 112.9 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.75 72.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.121 0.568 . . . . 0.0 110.203 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -177.11 116.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.401 1.081 . . . . 0.0 109.789 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.46 -38.08 55.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.79 77.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.769 0.428 . . . . 0.0 111.104 -167.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HE1' ' HD2' ' A' ' 64' ' ' PRO . 9.4 t-160 -121.45 91.13 3.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 14' ' ' THR . 21.6 t -102.14 120.3 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.255 -162.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.761 ' HB ' HD23 ' A' ' 63' ' ' LEU . 9.0 p -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.879 0.872 . . . . 0.0 109.153 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 67.7 p -136.71 132.01 34.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.79 0.836 . . . . 0.0 109.716 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.542 HD11 ' HA ' ' A' ' 60' ' ' PHE . 74.9 mt -110.62 125.67 53.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG12 ' A' ' 10' ' ' VAL . 2.4 mp -88.14 112.26 23.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 56' ' ' LEU . 95.2 m-85 -104.26 124.53 49.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.208 1.003 . . . . 0.0 108.417 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -121.27 107.69 12.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.87 0.468 . . . . 0.0 110.385 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 28.0 tt0 -84.79 95.95 9.13 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 109.089 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -76.12 135.09 39.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.11 -168.12 12.3 Favored Glycine 0 C--O 1.251 1.16 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -140.02 143.39 36.4 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.6 ttm180 -112.77 122.38 47.48 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.586 0.355 . . . . 0.0 110.261 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.3 t70 -71.18 118.2 13.66 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.15 -18.33 55.72 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -75.86 -49.09 18.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.726 0.298 . . . . 0.0 110.24 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 49.7 t-20 -88.68 -31.82 18.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -0.57 58.75 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.854 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 21.2 ptmt -70.33 146.09 50.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.284 1.034 . . . . 0.0 111.591 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.74 112.46 24.16 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.534 0.733 . . . . 0.0 109.855 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.59 93.67 3.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -85.77 140.4 30.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.4 t70 -68.4 110.05 3.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -78.49 -5.46 52.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.736 0.814 . . . . 0.0 111.813 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 53' ' ' LYS . 7.9 mtmp? -101.65 -4.78 25.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.098 0.559 . . . . 0.0 110.236 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.1 t-105 -62.44 120.31 10.81 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.125 0.57 . . . . 0.0 110.179 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 11.0 p -139.13 111.58 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.168 0.987 . . . . 0.0 108.667 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 35' ' ' PHE . 64.1 tp -102.21 135.17 44.28 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 11.6 m -98.34 144.95 27.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -148.87 129.32 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 7.0 m -73.67 104.65 4.67 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.754 0.659 . . . . 0.0 110.006 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -65.62 103.53 0.88 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.03 -164.7 0.64 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.254 1.022 . . . . 0.0 108.243 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.1 18.41 10.99 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.525 1.13 . . . . 0.0 111.627 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.2 tm? -107.28 106.09 57.45 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 171.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD2' ' HE1' ' A' ' 29' ' ' HIS . 73.3 Cg_endo -70.66 -165.13 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.253 2.636 . . . . 0.0 113.728 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 t -164.65 106.52 0.84 Allowed Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 121.4 8.22 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.712 2.274 . . . . 0.0 112.316 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.09 108.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 40.7 mt -101.55 134.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.92 134.46 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.353 0.661 . . . . 0.0 109.891 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.67 20.07 71.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.071 0.857 . . . . 0.0 112.988 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 65.0 m-85 -139.17 150.75 45.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.651 0.739 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -136.86 118.93 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.15 150.53 48.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.092 0.557 . . . . 0.0 110.336 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.03 -40.6 78.53 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.04 99.44 16.45 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.126 170.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.16 -2.45 12.34 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.054 2.503 . . . . 0.0 112.117 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.3 ttt -144.31 115.76 8.08 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -80.72 110.16 15.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.496 0.718 . . . . 0.0 111.165 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . 59.39 61.43 7.29 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.848 1.342 . . . . 0.0 114.314 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.83 82.43 2.15 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.544 2.163 . . . . 0.0 110.743 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -161.42 137.41 8.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.141 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.0 mt-10 -76.02 89.48 2.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.055 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 t -82.25 126.84 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.553 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 20.0 m -98.46 117.78 33.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.373 0.669 . . . . 0.0 109.909 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.3 t -99.31 116.61 42.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 7.0 p-10 -104.76 172.03 7.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 t -58.53 -30.09 66.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 113.004 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -71.01 -38.19 72.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.127 0.571 . . . . 0.0 111.128 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -107.93 10.83 28.37 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.0 0.52 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.26 -47.19 77.61 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.241 0.616 . . . . 0.0 112.079 -170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.47 -23.67 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.749 0.655 . . . . 0.0 110.814 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.2 143.28 26.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.275 0.63 . . . . 0.0 110.547 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.571 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.53 162.96 22.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 160.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -125.3 -39.22 2.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.82 142.97 45.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -132.68 -52.83 0.93 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.345 1.058 . . . . 0.0 109.447 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.87 148.18 35.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.327 0.584 . . . . 0.0 111.679 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.784 ' HB2' HE21 ' A' ' 13' ' ' GLN . 12.5 tp10 -122.25 155.57 35.62 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.744 1.218 . . . . 0.0 108.627 169.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -139.74 99.78 3.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.7 m -82.22 141.7 14.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.68 110.54 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.967 0.413 . . . . 0.0 110.888 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.61 104.62 10.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 m -98.77 173.93 6.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.23 146.53 15.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 121.137 0.494 . . . . 0.0 111.051 -172.482 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.442 HD12 ' HD3' ' A' ' 40' ' ' LYS . 38.1 mm -112.6 130.45 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.913 0.885 . . . . 0.0 110.655 -172.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.48 143.37 26.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 166.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -77.6 123.44 6.45 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.325 1.35 . . . . 0.0 111.516 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.6 pt -110.42 172.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.642 0.777 . . . . 0.0 109.807 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.92 146.55 6.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 19.7 mtm180 -113.02 170.15 8.42 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.256 1.022 . . . . 0.0 109.075 168.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 34' ' ' ILE . 34.1 m -135.92 106.43 6.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.331 0.652 . . . . 0.0 110.199 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.1 108.27 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.592 0.757 . . . . 0.0 109.024 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.1 m -92.17 145.48 7.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' SER . 92.3 t -119.28 104.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 m -94.84 107.35 19.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.603 0.761 . . . . 0.0 111.654 -166.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.592 HE22 ' HB2' ' A' ' 96' ' ' ARG . 7.2 tp-100 -96.32 104.97 16.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.618 0.767 . . . . 0.0 108.963 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.491 HG22 HG22 ' A' ' 30' ' ' VAL . 34.5 p -91.75 110.29 21.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -89.5 127.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -107.69 122.56 46.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -92.54 108.06 19.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -117.36 151.17 37.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.94 178.0 8.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.259 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.87 -32.28 73.44 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.33 -18.47 62.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.746 0.818 . . . . 0.0 111.348 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.65 -3.32 56.12 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.932 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.85 142.69 57.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.288 0.635 . . . . 0.0 110.902 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.66 107.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.92 0.488 . . . . 0.0 110.069 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.63 -46.91 74.28 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.243 0.617 . . . . 0.0 109.482 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -161.31 153.87 20.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.646 1.579 . . . . 0.0 108.536 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.72 -153.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.39 0.676 . . . . 0.0 111.548 -173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.89 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.675 1.19 . . . . 0.0 113.356 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -80.98 91.9 6.11 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 165.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 14' ' ' THR . 47.1 t -91.29 123.33 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.232 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 63' ' ' LEU . 7.4 p -115.16 151.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.4 p -143.57 136.1 27.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 70.0 mt -98.32 122.29 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 8' ' ' THR . 2.3 mp -89.01 114.62 27.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.026 0.93 . . . . 0.0 108.901 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 56' ' ' LEU . 97.9 m-85 -109.93 99.43 8.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.841 0.856 . . . . 0.0 108.726 172.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.7 m -90.17 102.18 14.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 50' ' ' TRP . 38.0 tt0 -78.79 105.68 10.26 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 119.677 -0.201 . . . . 0.0 110.791 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.6 p -74.37 143.53 44.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 124.071 0.857 . . . . 0.0 110.259 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -160.35 10.1 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -155.79 137.62 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 117.913 0.856 . . . . 0.0 110.876 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.657 ' HB2' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -113.24 128.73 56.56 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.525 0.73 . . . . 0.0 109.156 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 29.0 t70 -79.77 130.15 35.09 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.374 0.67 . . . . 0.0 109.39 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.42 -16.47 45.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 t -94.53 -36.12 11.97 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.401 0.546 . . . . 0.0 110.982 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -31.8 17.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.892 0.477 . . . . 0.0 109.962 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.88 27.42 60.59 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HE2' HD11 ' A' ' 49' ' ' ILE . 21.1 ptmt -96.38 140.69 30.66 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.694 0.798 . . . . 0.0 110.946 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.02 115.49 30.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 0.0 110.481 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.433 HD11 ' HE2' ' A' ' 47' ' ' LYS . 3.6 mp -109.77 104.01 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.525 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 74.5 m95 -90.36 145.48 24.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.233 1.013 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 28.1 t70 -67.57 113.85 5.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.16 0.584 . . . . 0.0 110.292 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -62.75 -39.32 93.75 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.913 0.885 . . . . 0.0 112.13 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -82.72 -6.92 59.64 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.671 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 60.0 t90 -54.36 124.63 16.54 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 19.9 p -154.34 108.45 2.98 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 35' ' ' PHE . 37.4 tp -101.06 127.0 47.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.9 m -98.83 112.9 24.85 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -119.95 124.77 46.78 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 15.7 m -80.88 135.24 35.88 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.211 0.605 . . . . 0.0 111.619 -174.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -82.61 117.62 22.71 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 158.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -172.45 179.93 2.38 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.001 1.438 . . . . 0.0 109.089 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.53 52.78 4.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.914 0.759 . . . . 0.0 112.273 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.55 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -97.33 98.22 4.68 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 168.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.69 92.35 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.782 2.321 . . . . 0.0 111.89 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.1 p -85.82 131.75 46.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.926 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.21 138.57 61.98 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.87 2.38 . . . . 0.0 113.072 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -88.57 111.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 mt -102.56 128.63 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.29 132.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.871 0.468 . . . . 0.0 109.828 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.45 79.87 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.517 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 88.6 m-85 -143.88 157.95 44.02 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.073 0.949 . . . . 0.0 109.107 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.4 m -145.61 116.97 7.96 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.653 0.781 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.32 135.41 57.0 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.673 0.608 . . . . 0.0 109.562 170.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.65 -14.57 61.62 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 0.0 110.773 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.08 84.75 7.23 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.49 1.116 . . . . 0.0 108.575 172.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.16 -5.67 17.01 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.361 2.041 . . . . 0.0 111.661 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 tpt -116.8 109.31 16.95 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.332 1.053 . . . . 0.0 108.312 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 40.6 t -100.96 133.12 45.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 92.53 0.21 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 123.945 0.778 . . . . 0.0 111.59 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -104.44 21.27 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.055 2.504 . . . . 0.0 112.981 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.76 148.02 29.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -165.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 37.1 mt-10 -87.63 129.64 35.05 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.257 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.75 108.84 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.047 0.939 . . . . 0.0 110.016 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 m -92.58 101.13 13.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.4 0.68 . . . . 0.0 110.623 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.25 116.59 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 9.9 t70 -93.46 163.94 13.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 49.0 m -57.2 -27.75 62.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.283 1.033 . . . . 0.0 111.93 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -69.69 -30.89 68.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.169 0.988 . . . . 0.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -115.53 8.9 15.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.944 0.498 . . . . 0.0 111.714 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 82.9 t80 -62.03 -33.89 75.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.876 0.87 . . . . 0.0 112.25 -173.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.74 -18.1 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.323 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -95.63 156.42 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 170.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -141.74 138.71 32.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.691 1.197 . . . . 0.0 108.13 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.36 45.48 0.96 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 0.0 109.694 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.03 121.58 15.02 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.466 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HB2' HE22 ' A' ' 13' ' ' GLN . 53.5 mmm-85 -127.15 177.44 6.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.516 0.726 . . . . 0.0 109.901 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -130.31 122.32 27.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.71 110.59 20.42 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 94.9 m -97.3 122.96 40.92 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.537 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -99.16 137.05 27.77 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.0 mm -100.41 118.76 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 122.782 0.433 . . . . 0.0 110.166 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 91.4 m-85 -88.67 95.63 10.33 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 p -86.65 139.15 31.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.41 114.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.245 1.018 . . . . 0.0 110.649 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 . . . . . 0 C--O 1.241 0.632 0 O-C-N 124.397 1.061 . . . . 0.0 109.758 -177.771 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 42' ' ' ASP . 31.5 mm -121.33 154.03 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.801 1.241 . . . . 0.0 109.204 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.07 146.45 53.74 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.59 122.49 5.53 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 121.326 1.351 . . . . 0.0 111.681 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 41' ' ' ARG . 24.5 pt -117.2 169.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 0.0 110.029 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.01 144.21 8.23 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.869 0.468 . . . . 0.0 111.414 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . 84.9 mtt180 -102.06 169.87 8.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.4 1.08 . . . . 0.0 108.946 165.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -144.09 116.85 8.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.099 0.559 . . . . 0.0 110.72 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -114.05 125.03 53.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -104.84 134.64 45.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.21 118.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -109.07 117.64 34.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.206 1.002 . . . . 0.0 110.304 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -90.39 108.64 19.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 p -85.63 104.58 15.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.5 mp -92.68 121.7 43.54 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -125.72 130.91 52.46 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.101 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -92.3 121.99 34.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.956 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -134.99 162.45 32.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.37 0.668 . . . . 0.0 109.32 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -93.33 171.94 8.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.977 0.911 . . . . 0.0 109.444 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.04 -25.13 66.91 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.542 0.737 . . . . 0.0 110.741 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.0 -20.33 66.15 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.89 1.276 . . . . 0.0 111.815 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.52 -19.26 54.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 120.075 -0.291 . . . . 0.0 112.481 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.25 137.51 52.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.024 0.93 . . . . 0.0 110.901 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.98 109.95 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.81 63.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.115 0.566 . . . . 0.0 109.973 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -153.67 166.85 31.52 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.83 1.252 . . . . 0.0 110.487 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.62 82.0 0.59 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -171.76 -3.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' HB3' HD21 ' A' ' 63' ' ' LEU . 22.1 m170 -99.46 82.22 2.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.67 1.123 . . . . 0.0 111.269 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.91 130.96 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.4 117.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 m -105.83 127.42 53.1 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.445 1.098 . . . . 0.0 108.954 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 58' ' ' GLN . 94.9 mt -108.67 130.86 55.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.461 0.705 . . . . 0.0 110.06 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.3 118.9 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 108.921 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -108.13 104.16 13.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.0 m -94.63 105.75 17.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.425 0.69 . . . . 0.0 109.484 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 35.4 tt0 -79.8 83.79 5.69 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -74.36 133.44 42.51 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.99 -162.08 9.04 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 142.06 32.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.595 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.5 ttm180 -112.2 124.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.295 0.638 . . . . 0.0 109.949 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' HA ' HD13 ' A' ' 2' ' ' ILE . 27.3 t70 -74.53 120.79 20.56 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.4 mt -83.8 -27.31 28.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -73.22 -41.16 64.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.898 0.317 . . . . 0.0 111.026 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.98 -29.73 20.55 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.98 36.34 32.32 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -104.37 142.47 34.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.659 0.784 . . . . 0.0 109.69 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 51.1 mt-10 -97.15 114.1 25.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.42 116.44 34.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -114.58 132.72 56.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.78 127.04 32.21 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 t -67.77 -31.05 70.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.975 0.91 . . . . 0.0 111.789 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -86.56 2.75 47.01 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.02 0.528 . . . . 0.0 111.449 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 56' ' ' LEU . 77.6 t90 -58.79 134.52 56.93 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.32 0.648 . . . . 0.0 110.564 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.1 p -156.04 122.14 5.04 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.909 0.883 . . . . 0.0 109.321 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 1.5 tm? -104.38 133.86 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -107.12 123.21 47.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.309 0.644 . . . . 0.0 110.31 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.6 mm-40 -129.2 134.01 47.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 0.0 108.902 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.8 m -97.41 118.68 34.42 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.408 0.683 . . . . 0.0 111.377 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -72.94 119.67 17.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -170.09 -163.47 0.36 Allowed 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.534 1.146 . . . . 0.0 108.56 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 64.32 19.69 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.254 1.021 . . . . 0.0 112.544 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 29' ' ' HIS . 35.9 tp -139.74 98.93 7.74 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.287 0.635 . . . . 0.0 109.372 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 77' ' ' MET . 53.6 Cg_endo -88.89 -166.47 0.25 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.366 2.711 . . . . 0.0 111.899 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -116.57 147.11 39.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.129 0.972 . . . . 0.0 110.501 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.68 125.11 16.9 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.546 2.164 . . . . 0.0 111.555 171.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.87 109.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.26 1.024 . . . . 0.0 109.908 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.02 123.45 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -73.6 135.29 27.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.525 1.53 . . . . 0.0 108.895 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.02 -1.41 86.69 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.599 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 94.5 m-85 -139.5 168.43 19.83 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 117.681 0.74 . . . . 0.0 112.157 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -150.45 121.5 7.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.465 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 147.16 52.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.428 0.691 . . . . 0.0 111.121 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -63.12 -32.42 73.8 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.941 0.896 . . . . 0.0 110.422 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -142.16 93.62 7.24 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.1 -1.7 9.95 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.958 2.439 . . . . 0.0 113.266 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 24.8 ttt -148.68 140.06 23.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.28 122.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.02 112.25 3.08 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 124.8 1.312 . . . . 0.0 113.173 -171.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.52 90.49 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.181 2.587 . . . . 0.0 110.677 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -140.17 137.37 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.72 106.22 9.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.592 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.39 112.53 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.508 1.123 . . . . 0.0 109.263 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -100.85 135.51 42.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.97 0.508 . . . . 0.0 110.593 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -103.79 124.67 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.34 164.29 13.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.046 0.939 . . . . 0.0 109.309 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.0 t -58.31 -37.75 75.71 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.764 1.226 . . . . 0.0 112.972 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.16 -41.32 22.6 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.826 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.3 -0.8 51.29 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 117.755 0.252 . . . . 0.0 111.577 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -57.91 -31.32 66.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 0.0 112.388 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.56 -21.79 61.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.32 0.648 . . . . 0.0 111.372 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.19 120.53 40.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.82 0.848 . . . . 0.0 109.45 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.15 105.32 3.93 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.731 0.777 . . . . 0.0 109.05 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -84.65 41.65 0.86 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 111.039 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.95 160.92 19.61 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.247 1.019 . . . . 0.0 111.449 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.63 169.22 19.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.008 0.523 . . . . 0.0 110.215 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.28 126.31 42.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.84 0.856 . . . . 0.0 109.64 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 15' ' ' ILE . 15.7 mm-40 -101.39 123.14 44.98 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.017 0.527 . . . . 0.0 109.744 169.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -109.15 109.8 20.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.1 m -85.77 141.49 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.209 0.603 . . . . 0.0 109.97 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.9 m-85 -76.66 107.8 9.21 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.6 p -109.15 142.03 40.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.07 124.8 10.81 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 124.369 1.043 . . . . 0.0 110.525 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.7 p30 . . . . . 0 CA--C 1.56 1.332 0 C-N-CA 123.956 0.902 . . . . 0.0 110.728 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' HD12 ' A' ' 43' ' ' LEU . 16.7 tpt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.111 0.481 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -102.65 143.46 15.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.908 0.883 . . . . 0.0 109.319 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.78 146.77 51.55 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.97 123.0 4.99 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.478 1.452 . . . . 0.0 111.315 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 38.9 pt -116.76 169.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.329 0.585 . . . . 0.0 110.874 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -161.31 152.41 18.54 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.007 174.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' NH2' HD21 ' A' ' 91' ' ' LEU . 27.3 ttp180 -124.2 147.7 47.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.525 HG23 HG23 ' A' ' 34' ' ' ILE . 51.4 m -116.91 106.8 13.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.335 0.654 . . . . 0.0 110.881 -169.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -107.05 102.94 12.25 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.66 127.01 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' SER . 59.7 t -91.4 103.25 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' ' 95' ' ' ASN . 29.7 m -96.18 100.56 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.293 -172.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -92.62 100.91 13.34 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 60.7 m -87.01 104.42 16.29 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 68.6 mt -89.89 123.77 42.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 111.545 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 22.9 m170 -101.18 120.56 40.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' VAL . 17.7 m-85 -90.89 116.51 28.77 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 43.8 mtm105 -134.14 177.08 8.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.267 0.627 . . . . 0.0 109.96 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -104.06 169.59 8.41 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.231 1.012 . . . . 0.0 109.648 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.39 -26.24 68.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.151 0.58 . . . . 0.0 111.28 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.41 -17.26 63.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.271 1.028 . . . . 0.0 110.618 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.57 32.85 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.06 44.65 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.088 0.955 . . . . 0.0 111.862 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 37.7 t -86.73 121.6 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.691 0.396 . . . . 0.0 109.977 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -77.68 -57.15 3.97 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -168.49 103.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 109.655 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 5.0 p-10 -86.48 -171.41 3.53 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.98 0.512 . . . . 0.0 111.44 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 66.06 16.19 10.36 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.438 1.095 . . . . 0.0 112.56 171.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -89.59 90.54 8.3 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -94.6 145.42 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 124.534 1.134 . . . . 0.0 112.092 -169.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 63' ' ' LEU . 5.4 p -125.65 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.4 m -129.01 132.49 47.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.885 0.374 . . . . 0.0 110.723 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.89 123.84 45.69 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 HG23 ' A' ' 8' ' ' THR . 2.6 mp -82.82 112.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 56' ' ' LEU . 97.3 m-85 -108.83 100.76 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -98.65 108.16 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.501 1.121 . . . . 0.0 110.264 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.52 114.26 20.81 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -87.15 146.81 25.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.355 0.597 . . . . 0.0 110.243 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.48 -157.72 9.74 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.919 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 140.27 25.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.344 0.572 . . . . 0.0 110.007 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.4 ttm180 -104.64 135.63 45.69 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.332 0.586 . . . . 0.0 109.666 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.08 109.59 16.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.831 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.4 mt -81.88 -2.95 52.94 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 t -92.51 -37.53 12.45 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.408 0.549 . . . . 0.0 111.042 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.6 -28.01 13.75 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.143 0.577 . . . . 0.0 109.734 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.88 37.06 9.59 Favored Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -113.65 140.98 47.76 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.568 0.747 . . . . 0.0 109.737 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.1 121.4 38.94 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.391 0.677 . . . . 0.0 110.203 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.36 97.68 5.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.401 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 79.1 m95 -91.95 141.47 28.59 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.7 t70 -69.03 116.39 9.43 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.8 p -66.58 -30.38 70.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.703 0.801 . . . . 0.0 111.627 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -80.97 -16.44 53.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.618 0.767 . . . . 0.0 111.151 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 60.4 t-105 -62.07 132.23 52.19 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.112 0.565 . . . . 0.0 111.883 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.1 p -155.03 144.66 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.896 1.278 . . . . 0.0 108.307 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.506 ' HB2' ' HD1' ' A' ' 35' ' ' PHE . 96.7 mt -120.13 130.1 54.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.232 0.613 . . . . 0.0 109.413 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 m -106.22 119.95 40.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.89 145.3 44.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.774 0.829 . . . . 0.0 108.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' HG2' ' A' ' 82' ' ' GLU . 16.6 m -99.18 123.61 43.6 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.089 0.556 . . . . 0.0 111.376 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -65.2 128.32 35.34 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 159.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -171.43 168.61 6.46 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.359 0.663 . . . . 0.0 110.837 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.51 14.62 9.65 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.219 1.408 . . . . 0.0 113.339 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 31' ' ' VAL . 4.6 mm? -62.63 113.21 8.3 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.785 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.54 166.23 28.04 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.157 1.905 . . . . 0.0 110.555 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -156.15 123.08 2.67 Favored Pre-proline 0 N--CA 1.472 0.629 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.44 125.0 15.26 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.307 2.005 . . . . 0.0 111.945 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.9 t -77.18 104.77 5.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mt -101.71 113.4 37.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.1 mm -75.58 134.87 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.303 0.641 . . . . 0.0 109.854 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.01 4.22 82.13 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.969 -169.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -134.43 167.57 20.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.963 0.905 . . . . 0.0 110.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.4 m -156.03 117.55 3.92 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -75.15 152.42 38.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.233 0.54 . . . . 0.0 111.702 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.46 -26.88 60.32 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.79 1.236 . . . . 0.0 109.668 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 92.97 4.12 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.767 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.61 3.53 7.63 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.564 2.176 . . . . 0.0 112.659 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 ttt -147.41 78.27 1.46 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.252 0.621 . . . . 0.0 110.151 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.8 t -84.67 152.79 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.74 -81.49 0.34 Allowed Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.112 -1.382 . . . . 0.0 111.724 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -31.75 78.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.762 1 C-N-CA 125.589 4.192 . . . . 0.0 117.073 -162.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -161.32 144.11 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 109.713 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 28.0 mt-10 -91.76 120.54 32.58 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.48 128.6 51.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.196 0.999 . . . . 0.0 109.055 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 29.2 m -110.25 109.67 20.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.436 HG22 ' NE2' ' A' ' 94' ' ' GLN . 86.9 t -95.76 110.59 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 163.63 19.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.463 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -67.84 -27.15 66.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.812 0.445 . . . . 0.0 111.364 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -76.27 -29.47 57.46 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.327 0.651 . . . . 0.0 112.735 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -116.07 23.82 11.9 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.563 0.345 . . . . 0.0 110.998 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -61.44 -48.51 80.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.785 0.834 . . . . 0.0 111.897 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.442 HD21 ' NH2' ' A' ' 7' ' ' ARG . 3.2 mm? -75.28 -10.48 59.5 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -83.76 120.24 25.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.163 0.585 . . . . 0.0 109.724 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.57 148.86 40.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.068 0.937 . . . . 0.0 111.428 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -137.1 14.64 3.05 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.82 168.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' A' ' 12' ' ' THR . 2.9 p-10 -79.79 140.96 36.68 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -172.28 169.76 5.28 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.9 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.57 135.22 36.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.184 0.994 . . . . 0.0 108.668 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 5.5 mm-40 -126.27 111.38 14.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.34 1.056 . . . . 0.0 110.401 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 m -96.2 130.77 43.19 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.573 -0.704 . . . . 0.0 110.578 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.0 m -96.0 143.07 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 164.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.0 mm -114.69 110.47 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.858 0.463 . . . . 0.0 110.543 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 85.1 m-85 -88.26 102.51 14.9 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 m -87.01 172.93 9.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.76 156.67 8.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -168.151 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 40' ' ' LYS . 32.8 mm -127.31 154.88 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.841 0.857 . . . . 0.0 109.93 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 10.6 pt-20 -121.75 146.06 44.78 Favored Pre-proline 0 N--CA 1.485 1.293 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 165.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.69 125.38 11.06 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.873 1.716 . . . . 0.0 111.265 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.6 pt -128.15 174.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.664 0.785 . . . . 0.0 109.825 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.55 150.19 7.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 110.951 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -108.99 151.95 25.63 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -134.91 107.93 7.62 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.174 0.59 . . . . 0.0 110.264 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -105.43 124.16 49.08 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.2 m -104.26 139.17 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' SER . 38.8 t -94.76 104.97 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -102.17 102.39 12.83 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.677 ' HG2' ' HB3' ' A' ' 96' ' ' ARG . 76.1 mt-30 -104.46 121.35 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.793 0.837 . . . . 0.0 109.803 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 30' ' ' VAL . 32.0 m -92.24 103.4 15.87 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -84.81 128.3 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.241 0.617 . . . . 0.0 109.435 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -106.13 137.69 43.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -108.96 121.25 44.73 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 3.7 tpp180 -145.85 130.15 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 161.58 25.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.289 0.635 . . . . 0.0 110.564 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.22 -25.0 68.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.745 0.818 . . . . 0.0 112.218 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.03 -9.2 58.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 111.62 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.28 68.66 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.94 55.0 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 123.686 0.794 . . . . 0.0 110.232 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 27' ' ' ASP . 47.9 t -90.15 110.08 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.596 0.758 . . . . 0.0 110.521 -172.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.26 -49.46 13.68 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.213 0.205 . . . . 0.0 110.676 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -176.99 90.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.751 1.22 . . . . 0.0 108.463 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.644 ' HB2' HG13 ' A' ' 24' ' ' VAL . 8.8 t70 -98.62 41.08 1.15 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.256 0.623 . . . . 0.0 111.757 -161.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -152.99 16.46 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.63 -0.669 . . . . 0.0 111.883 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.483 ' HE1' ' HG2' ' A' ' 64' ' ' PRO . 9.5 t60 -75.74 93.14 3.08 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 120.725 0.297 . . . . 0.0 110.97 -173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 14' ' ' THR . 39.2 t -95.3 146.03 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 122.784 0.434 . . . . 0.0 110.452 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.16 149.11 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.459 1.103 . . . . 0.0 108.472 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 62.1 p -143.4 127.42 17.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 26.3 mt -104.91 127.16 52.63 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 174.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.7 115.94 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.134 0.973 . . . . 0.0 108.986 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' HA ' HD23 ' A' ' 56' ' ' LEU . 69.3 m-85 -108.02 110.43 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 m -111.18 108.24 17.84 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -94.31 110.0 21.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -76.79 142.46 40.34 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.545 0.528 . . . . 0.0 109.8 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.16 -165.54 11.17 Favored Glycine 0 C--O 1.248 1.015 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -142.43 139.45 31.63 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 40.0 ttm180 -107.75 122.93 47.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.638 0.199 . . . . 0.0 110.949 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.1 114.04 6.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.613 1.165 . . . . 0.0 109.403 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.9 -20.21 35.86 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -78.68 -40.22 34.49 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.255 0.48 . . . . 0.0 110.757 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -91.66 -29.81 16.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.662 0.785 . . . . 0.0 110.229 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.6 44.72 7.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HE3' HD11 ' A' ' 49' ' ' ILE . 30.4 ttpt -116.0 142.43 46.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.618 1.567 . . . . 0.0 109.172 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -108.91 121.17 44.54 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.892 0.477 . . . . 0.0 110.451 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' HE3' ' A' ' 47' ' ' LYS . 3.7 mp -98.59 107.73 20.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.511 1.124 . . . . 0.0 108.275 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.06 119.32 39.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 37.2 t70 -62.69 115.78 4.61 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.369 0.668 . . . . 0.0 109.883 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 m -64.47 -26.28 68.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.421 1.088 . . . . 0.0 111.936 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -82.47 -13.25 57.04 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.951 0.901 . . . . 0.0 111.414 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.2 t-105 -68.75 137.49 54.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.527 0.731 . . . . 0.0 110.383 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.3 p -152.42 146.92 25.69 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.256 1.022 . . . . 0.0 108.738 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.9 tp -124.81 125.39 43.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.3 m -97.54 112.32 24.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.49 132.74 53.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 61' ' ' GLU . 4.8 m -68.43 108.79 3.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.86 0.725 . . . . 0.0 109.986 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -97.06 96.73 8.67 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.568 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.4 pt-20 -168.41 -159.95 0.29 Allowed 'General case' 0 C--O 1.245 0.846 0 C-N-CA 124.098 0.959 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.81 31.55 16.38 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 78' ' ' VAL . 2.2 tm? -84.55 107.94 12.99 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HG2' ' HE1' ' A' ' 29' ' ' HIS . 56.1 Cg_endo -71.29 89.94 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.149 2.566 . . . . 0.0 113.278 -170.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -85.64 125.98 67.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.967 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.7 118.59 5.47 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.443 2.096 . . . . 0.0 110.469 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.92 108.53 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mt -107.37 117.53 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.365 0.602 . . . . 0.0 109.991 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 69' ' ' ILE . 1.3 mp -74.64 138.95 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.675 1.59 . . . . 0.0 109.344 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.74 8.91 87.19 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.698 0.624 . . . . 0.0 112.253 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.4 m-85 -140.51 167.68 21.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.478 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -148.67 116.98 6.47 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.809 0.843 . . . . 0.0 109.629 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -64.38 154.25 36.08 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.986 0.914 . . . . 0.0 110.757 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.27 -39.65 91.18 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.078 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 92.53 5.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.139 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.22 -0.3 8.42 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.065 2.51 . . . . 0.0 113.04 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.0 ttt -140.9 89.98 2.3 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 21.4 t -76.68 145.01 10.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.72 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.28 127.92 2.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.18 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 8.7 Cg_exo -72.38 29.48 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 124.12 3.213 . . . . 0.0 115.094 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 69.9 -72.47 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.192 1.397 . . . . 0.0 111.609 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.5 130.12 41.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.779 0.831 . . . . 0.0 109.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.1 t -118.1 114.4 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -96.33 110.73 23.01 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.408 0.683 . . . . 0.0 109.422 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.34 114.34 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -92.23 162.02 14.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.5 0.72 . . . . 0.0 109.782 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -30.95 71.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.236 1.014 . . . . 0.0 111.939 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.03 -29.03 69.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.913 0.885 . . . . 0.0 111.741 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -115.11 4.83 14.72 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.084 0.554 . . . . 0.0 111.831 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.61 -23.82 63.57 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.63 161.7 23.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.991 0.917 . . . . 0.0 109.975 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 156.6 32.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.409 ' OE1' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -119.74 47.04 1.8 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -54.16 122.35 10.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.21 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.677 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 66.0 ttt180 -133.76 172.2 13.1 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.754 0.659 . . . . 0.0 109.641 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.32 119.72 10.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 43.3 mt-10 -123.44 110.37 15.02 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.018 0.527 . . . . 0.0 110.95 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -85.59 122.29 29.49 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.03 134.7 30.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.159 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 170.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 mm -103.17 119.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 86.5 m-85 -84.04 106.94 16.09 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.994 0.918 . . . . 0.0 108.669 170.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.5 p -107.67 134.93 49.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 108.89 0.24 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.511 1.132 . . . . 0.0 110.442 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 p30 . . . . . 0 N--CA 1.477 0.911 0 C-N-CA 123.652 0.781 . . . . 0.0 112.324 -171.365 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.6 tpt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 42' ' ' ASP . 33.1 mm -126.59 152.51 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.203 1.001 . . . . 0.0 109.001 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 13.9 pt-20 -128.38 155.14 78.99 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.29 127.08 5.77 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.616 1.544 . . . . 0.0 111.6 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -125.72 168.15 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.144 0.578 . . . . 0.0 110.447 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 150.53 23.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.285 0.634 . . . . 0.0 109.932 174.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.448 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 98.7 mtt180 -114.25 159.64 19.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.057 0.543 . . . . 0.0 109.895 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.618 HG23 HG23 ' A' ' 34' ' ' ILE . 28.6 m -113.54 113.38 25.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -110.75 98.05 7.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.4 m -88.38 133.01 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 105.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 27.6 m -103.39 99.48 9.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.132 0.491 . . . . 0.0 110.228 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.581 ' HG2' ' H ' ' A' ' 96' ' ' ARG . 65.7 mt-30 -94.39 131.8 39.68 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.608 0.763 . . . . 0.0 111.433 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.499 HG23 HG22 ' A' ' 30' ' ' VAL . 50.9 m -103.54 105.53 15.8 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.8 mp -91.03 130.55 40.03 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -129.45 138.71 51.59 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.649 0.738 . . . . 0.0 110.509 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 66.4 m-85 -94.61 119.65 33.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.92 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 53.8 ttt180 -144.86 134.31 23.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 0.0 111.194 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -71.08 163.02 28.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.446 1.099 . . . . 0.0 112.128 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.83 -38.64 79.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.339 . . . . 0.0 112.787 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.37 -17.72 60.14 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.233 1.013 . . . . 0.0 112.026 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.23 28.39 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.691 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 139.52 39.87 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.47 131.25 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 118.129 0.422 . . . . 0.0 110.498 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.87 -58.03 3.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.321 0.648 . . . . 0.0 109.762 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 97.0 m-70 -150.92 171.4 17.32 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.123 1.369 . . . . 0.0 109.128 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -153.75 29.44 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.413 0.625 . . . . 0.0 111.512 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.01 -3.13 17.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.903 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -88.22 75.85 8.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.655 0.741 . . . . 0.0 109.62 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 14' ' ' THR . 27.2 t -100.93 112.49 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.959 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.06 146.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.574 1.149 . . . . 0.0 109.307 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -136.29 141.1 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.569 0.748 . . . . 0.0 110.333 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt -112.61 126.79 55.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.441 171.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 8' ' ' THR . 2.0 mp -88.2 104.61 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.261 1.024 . . . . 0.0 108.936 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.604 ' HA ' HD23 ' A' ' 56' ' ' LEU . 67.1 m-85 -97.13 100.72 12.2 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -82.15 101.94 10.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.545 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -87.48 100.97 13.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -94.07 149.76 20.95 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.827 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.77 -151.31 6.17 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.076 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 142.83 27.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.452 0.701 . . . . 0.0 109.655 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.617 ' HB2' HD13 ' A' ' 5' ' ' ILE . 21.4 ttm-85 -101.15 126.92 47.9 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.247 0.546 . . . . 0.0 110.09 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.0 t70 -74.58 111.77 10.11 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.51 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.2 mt -83.75 -11.29 57.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -173.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.6 t -78.49 -39.75 37.38 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.766 0.712 . . . . 0.0 110.631 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -94.99 -31.64 13.53 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.36 61.13 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HE3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -79.08 139.82 38.01 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.704 0.802 . . . . 0.0 110.216 -173.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.9 124.38 35.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.262 0.625 . . . . 0.0 109.736 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HE3' ' A' ' 47' ' ' LYS . 48.8 mm -111.11 137.4 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 93.6 m95 -126.49 139.67 53.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -173.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 27.5 t0 -65.91 109.15 2.41 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.3 t -61.78 -30.57 70.88 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.009 0.818 . . . . 0.0 111.035 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.83 -3.28 50.6 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.88 0.872 . . . . 0.0 112.04 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.5 t-105 -78.51 116.84 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 0.0 109.641 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 p -142.0 130.18 22.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.4 tp -123.23 136.17 54.6 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 m -120.06 117.49 28.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.673 0.789 . . . . 0.0 108.964 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -129.93 149.61 51.58 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.6 m -106.6 122.58 46.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.438 0.695 . . . . 0.0 112.243 -170.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 66.9 m-85 -71.37 96.66 1.49 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 12.5 pt-20 -139.9 178.9 6.92 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.588 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.78 42.13 31.87 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.359 1.037 . . . . 0.0 110.516 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -105.13 97.28 12.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -174.193 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -91.11 -165.31 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.235 2.623 . . . . 0.0 112.407 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' A' ' 102' ' ' TYR . 70.6 p -154.21 146.49 17.33 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.484 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.34 120.44 7.76 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.169 1.913 . . . . 0.0 111.329 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.75 106.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.6 mt -94.85 126.48 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.91 131.2 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.975 0.91 . . . . 0.0 110.877 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.81 5.36 89.88 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.106 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.5 159.32 42.14 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.775 0.797 . . . . 0.0 111.601 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.3 m -147.52 129.02 14.97 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.07 156.17 30.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.519 0.327 . . . . 0.0 111.045 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 -42.15 69.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.37 86.42 58.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.369 169.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.59 -6.19 17.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.362 2.041 . . . . 0.0 111.786 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.4 tpt -143.95 114.2 7.43 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.901 1.68 . . . . 0.0 106.546 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 63' ' ' LEU . 83.0 t -68.81 123.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.5 116.21 8.21 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.319 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 91.3 Cg_exo -48.04 131.07 21.05 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.598 2.865 . . . . 0.0 113.956 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.85 132.89 31.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -82.72 118.63 23.5 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.217 1.007 . . . . 0.0 109.638 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.8 t -102.09 132.82 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.106 0.962 . . . . 0.0 108.831 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 m -113.46 113.35 25.03 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 0.0 110.07 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.429 HG22 ' NE2' ' A' ' 94' ' ' GLN . 94.0 t -97.7 112.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.78 157.09 16.97 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.589 1.156 . . . . 0.0 108.473 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.8 t -53.43 -33.04 52.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.654 1.181 . . . . 0.0 112.556 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -69.74 -54.92 11.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.429 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.36 19.95 3.04 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -56.82 -37.18 70.86 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.34 1.056 . . . . 0.0 111.718 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.16 -15.32 53.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.71 0.404 . . . . 0.0 111.06 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.02 118.33 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.841 0.856 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.18 152.44 25.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.938 0.495 . . . . 0.0 109.854 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -141.71 23.36 2.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.933 0.893 . . . . 0.0 109.705 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 12' ' ' THR . 21.7 p-10 -65.09 114.07 4.37 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.972 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' H ' ' HG2' ' A' ' 13' ' ' GLN . 54.9 mtm-85 -82.4 165.29 20.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.886 0.851 . . . . 0.0 110.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.95 123.94 33.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 170.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' A' ' 15' ' ' ILE . 36.6 mt-10 -129.12 125.49 37.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.996 0.518 . . . . 0.0 111.158 -172.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -99.93 125.36 45.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.662 0.785 . . . . 0.0 109.01 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -95.37 137.32 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 51.4 mm -105.99 111.4 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.052 0.141 . . . . 0.0 110.7 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' A' ' 65' ' ' SER . 79.8 m-85 -85.69 104.26 15.24 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.244 0.618 . . . . 0.0 109.63 175.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -89.77 175.33 7.28 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.02 155.78 1.75 Allowed 'General case' 0 C--O 1.246 0.919 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.483 1.22 0 C-N-CA 124.514 1.125 . . . . 0.0 113.554 -168.597 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 42' ' ' ASP . 30.5 mm -109.62 148.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.417 0.687 . . . . 0.0 109.275 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -123.74 137.18 28.29 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.25 126.62 12.51 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.006 1.804 . . . . 0.0 110.723 174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.4 pt -128.85 135.61 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -142.4 132.74 24.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -113.66 135.22 54.17 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 34' ' ' ILE . 27.5 m -98.5 104.53 16.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.633 0.773 . . . . 0.0 109.03 -166.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.9 tp-100 -97.62 92.14 5.76 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 34' ' ' ILE . 19.4 m -88.02 118.34 33.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 94' ' ' GLN . 86.3 t -88.62 107.66 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.6 m -94.52 108.2 20.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.364 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' HB3' HG13 ' A' ' 31' ' ' VAL . 9.0 tt0 -104.89 106.18 16.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 30' ' ' VAL . 94.6 m -93.54 107.05 18.96 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -84.77 127.27 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.159 0.504 . . . . 0.0 110.239 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -112.37 109.5 19.16 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.216 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 39.7 m-85 -78.47 115.27 18.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.91 160.09 40.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.998 0.519 . . . . 0.0 110.539 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -93.87 168.43 10.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.172 0.989 . . . . 0.0 109.861 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.77 -27.4 67.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.22 -17.16 62.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.358 1.063 . . . . 0.0 111.528 -176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.78 -12.65 42.04 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.33 58.51 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.679 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.54 124.61 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.74 -60.36 2.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.228 0.611 . . . . 0.0 110.577 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.602 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 91.2 m-70 -152.61 105.63 3.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.562 1.145 . . . . 0.0 108.622 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.89 -20.31 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.142 0.577 . . . . 0.0 111.853 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.49 96.53 6.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.116 0.966 . . . . 0.0 110.478 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -146.18 74.58 1.37 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 14' ' ' THR . 39.6 t -92.28 125.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.363 -167.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 13' ' ' GLN . 3.5 p -105.7 115.45 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 168.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 57.5 p -123.65 117.42 24.97 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.1 mt -97.46 129.66 44.64 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 HG12 ' A' ' 10' ' ' VAL . 2.8 mp -86.84 105.04 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.511 0.724 . . . . 0.0 109.341 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -98.53 107.79 20.33 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 m -75.58 103.14 5.56 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 87' ' ' SER . 6.2 tp60 -78.69 100.96 7.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.547 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 39.8 t -99.13 143.29 29.57 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.835 -173.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.51 -164.81 16.14 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.239 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.45 150.7 36.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.434 0.694 . . . . 0.0 109.218 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.588 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.8 ttm180 -119.74 125.11 47.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.676 0.391 . . . . 0.0 110.716 -171.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 26.4 t70 -75.79 115.68 15.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.952 0.901 . . . . 0.0 108.675 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.63 -15.2 58.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -74.85 -43.42 54.61 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.372 0.606 . . . . 0.0 109.993 -173.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -96.48 -29.09 14.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.925 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.48 27.13 33.62 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 19.6 ptmt -93.83 137.67 32.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.922 0.889 . . . . 0.0 109.933 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.48 116.66 29.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.41 87.86 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -80.57 128.63 33.82 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.9 t70 -62.2 126.33 26.97 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 123.52 0.512 . . . . 0.0 110.313 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -64.44 -29.2 70.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.554 1.142 . . . . 0.0 112.039 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.82 -0.34 42.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.286 0.634 . . . . 0.0 111.882 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 51.4 t-105 -66.18 131.09 45.36 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.026 0.441 . . . . 0.0 111.413 -173.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.0 p -150.24 141.01 22.72 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.107 170.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.87 132.11 55.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.7 m -120.04 128.0 53.11 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.023 0.529 . . . . 0.0 110.149 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.76 144.98 35.79 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m -91.87 124.75 36.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.394 1.077 . . . . 0.0 112.195 -169.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -83.36 111.78 19.32 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.64 -162.35 0.38 Allowed 'General case' 0 C--O 1.238 0.493 0 O-C-N 125.049 1.468 . . . . 0.0 108.547 170.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.5 1.34 1.66 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.285 1.434 . . . . 0.0 112.841 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.23 114.03 50.24 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.49 -163.5 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.889 2.392 . . . . 0.0 113.451 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -158.84 124.88 2.4 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' O ' HG13 ' A' ' 68' ' ' ILE . 18.2 Cg_endo -53.61 123.18 12.73 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.879 2.386 . . . . 0.0 111.168 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.12 109.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.61 0.764 . . . . 0.0 109.737 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 66' ' ' PRO . 52.3 mt -112.78 108.31 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.26 124.74 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 110.555 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.94 56.04 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.603 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -134.85 142.89 46.73 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.697 0.799 . . . . 0.0 111.023 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 105' ' ' ASN . 87.3 m -113.04 117.25 31.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 145.44 47.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 109.993 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.64 -31.31 72.48 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.031 0.933 . . . . 0.0 110.196 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.52 109.31 3.6 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 164.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.27 -5.78 17.08 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.674 2.249 . . . . 0.0 111.749 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.8 ttt -140.12 124.28 17.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG11 HG13 ' A' ' 15' ' ' ILE . 2.5 t -102.31 155.49 4.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.715 0.806 . . . . 0.0 108.992 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.43 85.98 0.84 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -104.83 24.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.036 2.491 . . . . 0.0 113.549 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -156.48 132.21 9.58 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -165.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.4 mt-10 -72.01 126.88 30.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.109 166.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.68 128.17 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.776 0.83 . . . . 0.0 110.748 174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.0 m -109.92 111.49 22.92 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.497 1.119 . . . . 0.0 108.401 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 ' HG2' ' A' ' 9' ' ' GLN . 58.5 t -95.68 108.26 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.92 170.35 11.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.023 0.929 . . . . 0.0 109.57 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 18.2 p -60.93 -30.08 70.0 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.992 0.917 . . . . 0.0 111.57 170.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -67.54 -63.62 1.02 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.032 0.933 . . . . 0.0 111.453 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -90.9 15.9 10.47 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.284 0.634 . . . . 0.0 111.544 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.45 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 36.3 t80 -55.84 -36.1 67.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.671 1.189 . . . . 0.0 112.303 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.38 -13.54 60.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.994 0.518 . . . . 0.0 111.354 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -101.15 145.05 29.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.868 0.867 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.81 145.54 31.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.488 ' HB2' HG11 ' A' ' 11' ' ' VAL . 64.2 mm-40 -104.06 0.06 29.31 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.973 -0.454 . . . . 0.0 111.994 -170.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -149.82 -172.99 4.29 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.805 0.842 . . . . 0.0 110.203 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -158.37 -160.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.661 0.784 . . . . 0.0 110.265 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 5.2 mp0 -85.91 106.43 17.1 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 30.7 mm-40 -95.48 111.69 23.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.4 m -104.86 117.02 33.0 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.872 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.2 m -82.56 141.34 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.2 116.43 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 122.66 0.384 . . . . 0.0 110.225 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -83.75 99.94 10.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 p -89.73 174.71 7.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.09 153.64 14.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.445 0.566 . . . . 0.0 109.967 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 5.0 t-20 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 121.246 0.546 . . . . 0.0 111.333 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 mm -120.04 158.03 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.773 1.229 . . . . 0.0 109.594 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 9.0 pt-20 -128.75 151.65 77.53 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.93 124.42 7.39 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 121.652 1.568 . . . . 0.0 110.764 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -114.72 163.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.335 1.054 . . . . 0.0 108.546 171.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 142.33 13.52 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 53.6 mtp180 -107.7 156.26 19.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.993 1.317 . . . . 0.0 108.442 168.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 34' ' ' ILE . 37.7 m -129.37 108.55 10.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.095 0.558 . . . . 0.0 110.088 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -98.39 120.98 39.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.1 m -108.11 134.83 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.7 t -100.62 104.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 95' ' ' ASN . 31.4 m -106.05 120.61 42.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.052 0.541 . . . . 0.0 109.927 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.45 127.18 53.1 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.529 HG23 HG22 ' A' ' 30' ' ' VAL . 59.1 m -94.24 103.68 15.7 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.34 125.32 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.395 0.616 . . . . 0.0 110.389 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.408 ' HB2' HG23 ' A' ' 99' ' ' THR . 24.0 m-70 -113.28 109.03 18.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HA ' HG22 ' A' ' 100' ' ' VAL . 65.9 m-85 -81.0 115.01 20.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 16.0 mmt85 -131.3 159.68 37.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.995 0.918 . . . . 0.0 109.419 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -88.58 174.49 8.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.109 0.563 . . . . 0.0 109.56 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.39 -26.52 66.49 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.947 0.499 . . . . 0.0 110.545 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.14 -19.51 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.849 1.26 . . . . 0.0 111.12 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.47 66.0 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.302 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.42 152.58 42.98 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.411 0.685 . . . . 0.0 111.053 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 27' ' ' ASP . 57.4 t -73.21 114.94 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.47 -45.78 13.24 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -173.99 126.51 0.36 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.455 1.102 . . . . 0.0 108.192 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 24' ' ' VAL . 9.9 t70 -131.82 88.03 2.52 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.257 -0.902 . . . . 0.0 111.085 -166.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 p30 179.0 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 64' ' ' PRO . 18.8 m170 -83.37 85.32 7.25 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.911 1.232 . . . . 0.0 111.38 -169.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 14' ' ' THR . 40.5 t -94.97 119.8 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.941 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 63' ' ' LEU . 11.7 p -112.69 150.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 0.0 109.073 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 m -141.64 136.65 31.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 35.7 mt -103.88 124.17 48.46 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -88.57 110.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.645 ' HA ' HD23 ' A' ' 56' ' ' LEU . 98.5 m-85 -105.61 101.24 10.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.989 0.916 . . . . 0.0 109.291 173.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.2 m -97.28 103.25 15.16 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.641 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -85.32 100.79 12.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -80.09 135.65 36.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.09 -163.48 11.91 Favored Glycine 0 C--O 1.245 0.84 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.494 ' HE2' ' HB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.87 137.78 41.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 5' ' ' ILE . 33.5 ttm180 -111.95 124.84 53.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.86 115.07 8.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.244 1.018 . . . . 0.0 108.266 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.8 -24.84 55.97 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -80.51 -43.42 20.79 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.775 0.262 . . . . 0.0 111.238 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.43 -28.52 20.84 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.582 0.353 . . . . 0.0 110.597 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.02 23.55 48.57 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.88 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.7 ptmt -94.17 142.68 27.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.375 0.67 . . . . 0.0 110.544 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.5 111.73 24.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.946 0.898 . . . . 0.0 110.553 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' HB ' ' HE2' ' A' ' 40' ' ' LYS . 3.5 mp -108.03 103.4 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 73.1 m95 -87.96 152.06 22.34 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 110.103 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.31 105.72 7.52 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.3 p -72.57 -19.74 61.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.894 0.877 . . . . 0.0 110.854 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -85.54 -0.86 56.23 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.481 0.712 . . . . 0.0 110.94 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.55 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 89.4 t90 -65.88 132.17 48.02 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 110.368 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 28.5 p -154.56 105.43 2.63 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 35' ' ' PHE . 55.6 tp -97.18 126.71 42.54 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.6 m -97.3 110.37 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.05 134.38 55.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.1 m -69.1 118.83 12.49 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.14 0.976 . . . . 0.0 111.445 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -112.5 92.77 4.14 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.854 0.462 . . . . 0.0 109.985 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -159.83 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.264 1.426 . . . . 0.0 108.164 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.425 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . 70.39 15.74 7.26 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.377 1.071 . . . . 0.0 112.555 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -65.86 116.27 30.76 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.159 0.584 . . . . 0.0 110.346 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 29' ' ' HIS . 57.6 Cg_endo -71.33 86.71 0.79 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.049 2.499 . . . . 0.0 111.792 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -89.35 130.78 42.6 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.573 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.85 120.62 8.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.87 1.713 . . . . 0.0 110.737 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.49 102.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.0 111.72 33.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.33 129.22 30.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 123.652 0.595 . . . . 0.0 110.413 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.18 -3.32 86.29 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.013 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 22.0 m-85 -118.13 149.03 41.72 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.186 0.994 . . . . 0.0 108.422 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.1 m -140.66 121.91 14.86 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -67.2 152.22 46.14 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.363 0.665 . . . . 0.0 110.402 175.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.63 -30.96 70.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.287 0.565 . . . . 0.0 110.146 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.27 6.3 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.667 1.187 . . . . 0.0 108.178 173.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.12 -4.2 13.68 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.524 2.149 . . . . 0.0 111.403 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 62' ' ' ALA . 38.0 tpp -146.75 129.86 16.47 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.4 0.68 . . . . 0.0 109.216 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.423 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 94.9 t -96.83 124.35 49.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 O-C-N 124.309 1.006 . . . . 0.0 110.576 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.89 152.34 18.82 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.958 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -85.93 36.69 0.52 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.872 3.048 . . . . 0.0 113.475 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 75.88 -55.16 0.61 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.837 1.655 . . . . 0.0 111.751 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -126.14 150.36 48.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.99 0.916 . . . . 0.0 109.925 170.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.44 118.82 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.658 1.183 . . . . 0.0 108.555 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.0 m -101.15 103.58 14.64 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -95.39 118.9 42.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -88.25 171.83 9.9 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.357 1.063 . . . . 0.0 108.921 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.5 t -69.78 -22.36 63.34 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 123.951 0.782 . . . . 0.0 110.533 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.15 -53.4 25.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.709 0.804 . . . . 0.0 110.119 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -96.5 24.24 6.08 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.728 0.811 . . . . 0.0 111.244 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -72.26 -31.13 65.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.011 0.525 . . . . 0.0 111.249 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.34 -11.43 59.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.521 0.329 . . . . 0.0 110.167 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -94.64 136.19 35.23 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -104.16 146.85 28.16 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.67 21.45 16.15 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 6.7 t30 -64.03 118.57 8.68 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.205 1.002 . . . . 0.0 110.255 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -135.8 176.03 9.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.613 0.765 . . . . 0.0 109.345 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.17 117.72 34.94 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -96.32 132.09 42.16 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.043 0.537 . . . . 0.0 109.99 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.408 HG23 ' HB2' ' A' ' 16' ' ' HIS . 75.3 m -138.46 107.05 5.86 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.9 m -84.61 141.13 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 39.4 mm -116.83 113.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 95.0 m-85 -81.44 108.95 15.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 109.383 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.5 p -96.09 130.97 42.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.03 96.19 1.71 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.592 0.757 . . . . 0.0 109.767 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 . . . . . 0 N--CA 1.474 0.742 0 C-N-CA 124.286 1.034 . . . . 0.0 109.997 177.78 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.535 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.5 tpt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.867 0.365 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.92 157.11 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.076 1.35 . . . . 0.0 107.886 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 12.4 pt-20 -134.65 146.86 60.77 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.23 124.19 6.47 Favored 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 121.417 1.412 . . . . 0.0 111.517 171.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 41' ' ' ARG . 27.6 pt -119.28 170.77 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 0.0 110.391 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.64 142.11 4.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 110.543 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.478 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 81.3 mtp180 -104.63 169.51 8.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.743 0.817 . . . . 0.0 109.774 170.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.609 HG23 HG23 ' A' ' 34' ' ' ILE . 35.5 m -120.33 108.46 14.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.692 0.797 . . . . 0.0 108.958 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.2 tp60 -105.81 99.65 9.24 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 31.0 m -89.42 127.91 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.41 116.19 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -104.25 105.06 15.07 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 124.195 0.934 . . . . 0.0 111.464 -163.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 96' ' ' ARG . 9.5 mm100 -91.74 99.19 12.12 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.6 0.76 . . . . 0.0 109.578 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 p -79.31 103.92 9.57 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.86 132.88 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 41.0 m-70 -120.35 119.67 33.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.174 0.989 . . . . 0.0 108.522 -174.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -91.32 116.75 29.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.3 mtm105 -142.11 155.22 45.34 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 123.417 0.687 . . . . 0.0 109.414 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -81.27 170.88 15.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.19 -27.87 69.0 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.035 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.78 -18.99 65.57 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 111.784 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.98 -11.52 69.44 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 148.13 48.87 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.849 0.859 . . . . 0.0 110.617 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 55.4 t -91.4 129.8 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.668 0.387 . . . . 0.0 110.471 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.4 -60.45 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -163.77 90.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.346 1.459 . . . . 0.0 108.97 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.5 p-10 -91.48 28.14 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -131.02 21.97 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 111.93 -170.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.16 81.68 5.55 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.014 -1.054 . . . . 0.0 110.404 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.52 127.59 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.222 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HB ' HD23 ' A' ' 63' ' ' LEU . 14.8 p -120.44 150.0 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.467 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 55.4 m -138.73 141.15 38.89 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.743 0.817 . . . . 0.0 108.971 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 58' ' ' GLN . 77.4 mt -110.94 132.44 54.2 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.609 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -81.96 115.52 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.885 0.874 . . . . 0.0 108.768 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.42 100.47 10.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.1 m -75.58 105.77 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.431 ' HA ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -81.83 95.37 7.28 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.695 0.798 . . . . 0.0 109.185 176.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.8 t -87.68 152.56 22.06 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.33 0.586 . . . . 0.0 111.999 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -166.44 -157.5 10.33 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.596 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.12 140.76 30.99 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.445 0.698 . . . . 0.0 110.229 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.7 ttm-85 -102.96 123.61 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -74.93 113.65 12.48 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.535 HD12 ' HG3' ' A' ' 1' ' ' MET . 57.5 mt -82.94 -15.52 50.98 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.1 t -87.28 -38.76 16.0 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.772 0.26 . . . . 0.0 110.385 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.88 -32.22 20.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.076 0.55 . . . . 0.0 110.245 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.38 38.23 11.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.489 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.3 ptmt -112.8 140.77 47.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.879 0.872 . . . . 0.0 109.993 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -98.65 107.77 20.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.975 0.91 . . . . 0.0 109.752 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.7 mp -95.92 117.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 77.0 m95 -103.62 124.74 49.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.26 110.01 1.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m -65.0 -20.86 66.71 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.928 0.891 . . . . 0.0 112.797 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.94 -21.76 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.271 0.629 . . . . 0.0 110.439 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -59.01 139.02 57.26 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.929 0.768 . . . . 0.0 111.634 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 70.1 p -149.89 132.98 16.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.913 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.22 125.45 44.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -113.09 133.86 54.81 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HB3' HD13 ' A' ' 33' ' ' LEU . 8.1 mm100 -134.41 145.06 48.56 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 m -92.44 116.65 29.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.534 0.734 . . . . 0.0 110.595 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.2 95.51 1.27 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.424 0.63 . . . . 0.0 110.343 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.7 -164.04 1.93 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.801 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.13 28.37 17.08 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.73 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.568 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.3 tm? -119.29 94.92 48.91 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -86.22 152.37 9.43 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.325 2.683 . . . . 0.0 111.883 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' OH ' ' A' ' 102' ' ' TYR . 45.9 m -105.1 149.05 37.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.961 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.45 127.7 25.65 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.064 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.76 107.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mt -107.55 133.75 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.67 132.07 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.694 0.797 . . . . 0.0 108.941 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.19 -6.31 81.94 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.934 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -133.82 165.44 24.96 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.382 0.673 . . . . 0.0 110.476 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -151.09 130.05 12.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 154.51 33.9 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.993 0.517 . . . . 0.0 110.939 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -64.68 -38.23 90.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.515 0.674 . . . . 0.0 109.183 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 88.85 28.93 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 114.501 -1.227 . . . . 0.0 107.997 171.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.94 -5.13 16.41 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.841 2.361 . . . . 0.0 112.798 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.3 tpt -147.56 114.91 6.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.33 118.82 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.09 135.51 51.75 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.375 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.69 97.32 0.32 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.287 1.991 . . . . 0.0 111.964 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -114.14 113.17 24.34 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.305 0.642 . . . . 0.0 110.853 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.38 118.14 17.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.336 0.654 . . . . 0.0 111.179 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.87 135.78 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.37 1.068 . . . . 0.0 108.58 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -105.14 110.25 22.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.27 0.628 . . . . 0.0 109.751 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 89' ' ' ASN . 94.0 t -95.66 108.49 21.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.1 p30 -110.86 176.54 4.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.738 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.66 -24.04 65.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.24 -51.16 10.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.198 0.599 . . . . 0.0 110.175 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.488 HD22 ' HA ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -92.23 6.68 45.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 52.7 t80 -54.75 -34.6 62.74 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.625 1.17 . . . . 0.0 112.251 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.1 -23.64 47.83 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.97 116.05 28.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.297 0.639 . . . . 0.0 109.987 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -79.83 106.15 11.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 122.092 0.949 . . . . 0.0 109.029 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -91.77 38.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.418 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -70.3 154.44 41.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.44 1.096 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HB2' ' NE2' ' A' ' 13' ' ' GLN . 44.7 mmm-85 -129.5 141.4 51.01 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.244 0.545 . . . . 0.0 111.756 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -102.78 110.41 22.33 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 163.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -115.7 136.16 53.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.382 0.673 . . . . 0.0 110.286 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.4 m -113.47 119.14 36.56 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 167.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.03 140.71 15.37 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.69 120.12 53.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 C-N-CA 122.927 0.491 . . . . 0.0 110.683 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.401 ' OH ' ' HB3' ' A' ' 65' ' ' SER . 54.3 m-85 -85.54 104.83 15.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.603 0.761 . . . . 0.0 109.868 172.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.9 t -98.31 155.45 17.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 128.94 19.07 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.69 0.619 . . . . 0.0 109.39 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.4 p30 . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 122.282 0.233 . . . . 0.0 111.052 -175.476 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 42' ' ' ASP . 41.0 mm -117.35 136.17 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.97 146.16 35.55 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -77.16 124.08 7.05 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 121.507 1.471 . . . . 0.0 109.919 167.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -112.52 -176.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.8 0.84 . . . . 0.0 109.849 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -151.63 146.41 25.79 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.665 0.786 . . . . 0.0 109.008 173.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 36' ' ' THR . 24.8 tpt180 -103.69 138.08 40.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -121.32 105.71 10.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.04 107.35 14.84 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 109.708 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 14.5 m -90.45 119.02 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 93' ' ' LYS . 92.2 t -91.13 118.59 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.524 ' H ' ' HD3' ' A' ' 93' ' ' LYS . 70.7 m -106.96 103.3 12.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.329 0.651 . . . . 0.0 110.434 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -80.01 94.03 5.85 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.444 HG23 HG22 ' A' ' 12' ' ' THR . 82.2 p -86.47 114.47 23.25 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 52.7 mt -110.68 126.19 68.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-O 121.936 0.874 . . . . 0.0 111.234 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.32 110.25 22.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.324 -1.762 . . . . 0.0 106.865 -173.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HD1' HG22 ' A' ' 100' ' ' VAL . 23.0 m-85 -82.08 109.78 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.6 mtm180 -141.22 164.22 30.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.35 0.66 . . . . 0.0 109.791 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -92.2 175.95 6.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.401 0.68 . . . . 0.0 110.314 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.62 -25.66 68.06 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.387 171.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.14 -17.08 63.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.603 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.05 -13.5 66.81 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.04 57.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.372 1.069 . . . . 0.0 111.046 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 38.7 t -83.28 114.98 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 122.948 0.499 . . . . 0.0 109.974 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.29 -56.54 4.94 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -170.81 94.5 0.2 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 0.0 110.147 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.84 106.62 18.58 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.768 -0.582 . . . . 0.0 110.169 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -179.71 -6.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.507 0.723 . . . . 0.0 112.292 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -82.85 86.19 6.97 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.266 0.555 . . . . 0.0 111.487 -163.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.02 125.39 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 0.0 110.71 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -120.25 145.51 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -138.65 131.49 29.41 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.642 0.777 . . . . 0.0 109.703 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 87.7 mt -110.69 136.1 50.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 0.0 109.767 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.42 114.71 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -100.94 96.33 7.19 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 85.1 m -113.59 104.27 12.08 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.626 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -130.92 139.61 50.1 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 61.2 p -90.81 141.55 28.69 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -167.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.96 -142.37 5.46 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.62 139.44 18.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.632 0.716 . . . . 0.0 111.205 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB2' HD13 ' A' ' 5' ' ' ILE . 17.2 ttm180 -103.88 127.12 51.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.102 0.561 . . . . 0.0 110.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 32.4 t70 -73.62 111.25 8.58 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.065 0.946 . . . . 0.0 108.914 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.02 -11.37 56.86 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.5 t -83.24 -31.93 26.73 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.359 0.527 . . . . 0.0 110.401 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -101.39 -30.84 11.23 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.049 0.54 . . . . 0.0 110.207 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.05 49.16 4.35 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 20.0 ptmt -130.29 143.77 50.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.502 1.121 . . . . 0.0 109.521 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -95.27 127.67 41.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.075 0.55 . . . . 0.0 110.49 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.88 126.13 61.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.453 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 81.7 m95 -125.07 143.42 50.93 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.304 1.042 . . . . 0.0 108.268 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 23.2 t70 -62.93 143.13 57.98 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.95 0.5 . . . . 0.0 110.384 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.8 p -68.6 -38.21 80.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.232 0.213 . . . . 0.0 111.496 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.18 -0.94 57.49 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.841 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 37' ' ' GLN . 19.5 t90 -48.3 120.64 3.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.991 0.916 . . . . 0.0 111.394 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 p -154.91 130.01 9.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 37' ' ' GLN . 23.6 tp -115.08 139.56 49.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 m -110.87 150.37 29.27 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.487 0.715 . . . . 0.0 109.803 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 30.8 tp60 -153.87 127.91 8.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 m -78.27 110.27 13.14 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.31 0.644 . . . . 0.0 111.286 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.434 ' HD2' HG21 ' A' ' 83' ' ' VAL . 15.0 m-85 -75.53 130.23 38.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.25 174.42 8.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.821 0.848 . . . . 0.0 109.961 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 69.91 56.81 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.586 1.154 . . . . 0.0 111.802 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 3.5 mm? -113.7 91.83 22.51 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.467 0.707 . . . . 0.0 109.976 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.47 99.9 0.77 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 123.655 2.904 . . . . 0.0 113.097 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 m -78.73 124.25 85.16 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.772 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.3 122.93 11.58 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 123.521 2.814 . . . . 0.0 112.895 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.0 108.8 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.0 mt -101.89 117.12 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.9 mm -72.88 135.75 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.202 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.49 84.01 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.709 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -130.22 172.17 12.09 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.279 1.032 . . . . 0.0 110.322 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -144.52 123.53 12.8 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.88 131.41 45.46 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.95 -38.58 76.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.854 0.862 . . . . 0.0 109.245 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.6 84.9 49.34 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.604 169.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.0 -4.39 11.38 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.107 2.538 . . . . 0.0 113.227 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 63' ' ' LEU . 17.1 tpt -143.97 136.62 27.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.281 1.032 . . . . 0.0 108.699 172.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -125.54 126.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 71.67 0.91 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 123.914 0.759 . . . . 0.0 112.551 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -96.67 22.52 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.328 2.685 . . . . 0.0 114.355 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -165.81 -169.19 1.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 118.366 0.53 . . . . 0.0 112.216 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 9.2 mp0 -68.04 133.18 48.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.134 1.374 . . . . 0.0 111.601 -171.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.434 HG21 ' HD2' ' A' ' 60' ' ' PHE . 60.0 t -122.21 110.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.06 0.944 . . . . 0.0 109.178 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.6 m -96.82 117.19 30.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.955 0.502 . . . . 0.0 109.774 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 90' ' ' PHE . 37.8 t -97.98 116.32 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.55 162.55 14.15 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.796 0.838 . . . . 0.0 110.899 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 39.9 p -57.78 -35.23 70.51 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.52 1.128 . . . . 0.0 110.802 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -49.59 -49.73 45.51 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.007 1.442 . . . . 0.0 111.202 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -118.35 16.12 13.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.818 -172.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' HA ' HG12 ' A' ' 85' ' ' VAL . 9.6 t80 -66.08 -27.07 67.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.543 0.61 . . . . 0.0 112.459 -166.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.5 -16.87 57.03 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -102.65 156.11 17.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.045 1.338 . . . . 0.0 110.201 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 12' ' ' THR . 9.2 ptpp? -111.71 126.68 55.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -77.91 -12.62 60.0 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -116.15 127.66 55.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.75 -93.05 0.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.904 0.882 . . . . 0.0 109.523 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -108.32 104.94 14.43 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 3.3 mp0 -110.68 135.63 51.0 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -121.5 122.09 38.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.423 0.689 . . . . 0.0 110.09 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' A' ' 17' ' ' TYR . 1.6 m -83.23 141.86 14.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.4 110.73 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.089 0.556 . . . . 0.0 110.848 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -85.94 96.23 9.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 p -99.6 140.05 34.36 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.33 142.09 10.73 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.557 0.536 . . . . 0.0 110.801 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.491 1.6 0 C-N-CA 125.089 1.356 . . . . 0.0 113.016 -162.264 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' HD12 ' A' ' 43' ' ' LEU . 28.0 ttt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 42' ' ' ASP . 49.6 mm -123.91 141.19 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.317 0.647 . . . . 0.0 109.828 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -112.63 128.65 25.28 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 166.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.15 126.63 18.28 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.45 2.1 . . . . 0.0 110.851 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 41' ' ' ARG . 34.0 pt -124.03 -179.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.409 0.684 . . . . 0.0 109.75 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 157.71 24.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.735 1.214 . . . . 0.0 108.291 170.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.509 ' HD3' ' HD2' ' A' ' 90' ' ' PHE . 57.3 ttt-85 -126.77 152.7 46.54 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 34' ' ' ILE . 86.6 m -121.07 108.77 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.454 1.101 . . . . 0.0 108.886 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -100.8 121.78 42.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 34.6 m -105.29 118.09 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 83' ' ' VAL . 97.9 t -97.55 110.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -118.12 131.55 56.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.749 . . . . 0.0 110.57 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 42.3 mt-30 -103.33 100.27 10.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -76.83 100.5 5.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.569 HD12 ' HB ' ' A' ' 78' ' ' VAL . 13.0 tt -101.55 135.52 37.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 122.261 1.029 . . . . 0.0 111.009 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -118.98 148.42 43.0 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.842 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.17 115.76 19.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 37.5 mtm180 -138.13 152.42 48.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HE2' HG21 ' A' ' 68' ' ' ILE . 63.5 m-85 -77.97 169.76 17.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.495 0.718 . . . . 0.0 110.627 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.31 -22.72 63.76 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.843 0.457 . . . . 0.0 111.483 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.96 -12.37 60.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.635 0.774 . . . . 0.0 111.312 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 2.45 68.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.77 147.71 48.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.976 0.51 . . . . 0.0 110.264 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 96.7 t -82.23 135.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.126 0.571 . . . . 0.0 109.94 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 -63.11 1.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -157.2 97.42 1.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.584 1.154 . . . . 0.0 108.788 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -80.38 -9.23 59.75 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.065 0.546 . . . . 0.0 112.422 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.1 71.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.28 1.032 . . . . 0.0 110.877 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -124.7 122.32 37.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 159.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.35 111.75 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.5 p -106.81 125.52 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.759 0.824 . . . . 0.0 108.87 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.3 p -123.92 133.9 53.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.328 0.651 . . . . 0.0 109.418 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 76.7 mt -99.4 123.09 43.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -93.22 116.5 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 8' ' ' THR . 13.7 m-85 -106.43 97.69 7.46 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.4 m -114.57 116.46 28.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.8 44.36 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -76.91 178.12 7.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.926 -165.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.34 -166.73 31.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.186 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 137.74 35.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.7 ttm180 -110.17 124.87 52.35 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.044 0.537 . . . . 0.0 109.887 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 26.5 t70 -74.55 113.83 12.25 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.832 1.253 . . . . 0.0 109.882 173.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 1' ' ' MET . 88.9 mt -85.08 -1.86 57.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.6 t -87.67 -28.61 21.71 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.863 0.756 . . . . 0.0 110.842 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -107.59 -30.84 8.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.569 0.348 . . . . 0.0 110.225 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.71 11.98 56.19 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.86 -173.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -84.89 145.95 27.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.041 0.937 . . . . 0.0 110.279 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.29 121.4 42.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.249 0.62 . . . . 0.0 110.273 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.98 116.02 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -108.97 158.86 17.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.59 1.156 . . . . 0.0 109.079 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 54' ' ' TRP . 17.7 t70 -82.9 125.34 31.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -73.0 -25.88 61.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.745 0.418 . . . . 0.0 111.978 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -81.23 -13.17 58.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.14 0.576 . . . . 0.0 110.789 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' ASP . 8.8 t90 -69.28 134.58 49.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.138 0.975 . . . . 0.0 111.583 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -152.11 121.41 6.77 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.458 1.503 . . . . 0.0 107.441 172.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.09 124.86 44.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -109.95 129.84 55.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -129.4 145.48 51.4 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 m -112.01 120.32 41.46 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.841 0.456 . . . . 0.0 111.446 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 13' ' ' GLN . 51.0 m-85 -65.24 136.49 56.68 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 164.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -170.59 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.68 0.792 . . . . 0.0 109.754 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.55 86.09 5.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.783 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 15' ' ' ILE . 3.3 tm? -144.13 112.79 5.24 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -93.17 178.71 1.19 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.552 2.834 . . . . 0.0 111.743 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -159.17 151.38 17.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.211 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.75 117.83 5.36 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 121.963 1.775 . . . . 0.0 110.62 172.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.9 107.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 19' ' ' TYR . 40.9 mt -102.31 116.33 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.82 139.97 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.7 3.58 89.44 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.401 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.83 171.44 14.51 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.188 0.995 . . . . 0.0 110.073 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -158.5 109.22 2.11 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.17 151.12 46.73 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.559 0.743 . . . . 0.0 111.265 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -73.33 -20.04 60.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.179 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.33 101.57 2.96 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 158.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.26 0.28 5.49 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.151 1.9 . . . . 0.0 113.157 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.6 ttt -150.55 136.67 18.53 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.722 0.809 . . . . 0.0 109.584 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.599 HG11 ' HG3' ' A' ' 98' ' ' GLU . 91.8 t -121.52 107.57 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 163.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.82 -95.74 0.11 Allowed Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.058 -1.412 . . . . 0.0 111.369 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -33.8 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.721 1 C-N-CA 125.463 4.109 . . . . 0.0 115.991 -169.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -168.16 126.73 1.19 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.491 1.116 . . . . 0.0 109.22 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.67 121.5 26.93 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 11' ' ' VAL . 84.2 t -103.23 123.12 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.728 0.811 . . . . 0.0 109.41 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.4 m -103.03 131.17 50.21 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.13 112.38 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 4.1 m-20 -79.99 164.69 23.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.836 0.854 . . . . 0.0 109.251 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.6 p -54.56 -36.52 64.43 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.986 0.804 . . . . 0.0 110.384 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -47.87 -49.34 29.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.351 1.46 . . . . 0.0 112.406 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -119.43 23.69 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.675 0.79 . . . . 0.0 111.604 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.509 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 12.4 t80 -75.13 -19.76 59.74 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 122.006 -0.434 . . . . 0.0 111.161 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.31 -16.46 27.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.688 0.795 . . . . 0.0 109.196 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -89.08 160.97 16.79 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.204 1.001 . . . . 0.0 109.687 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -111.85 159.55 18.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.58 0.752 . . . . 0.0 109.443 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -143.39 33.39 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.174 0.59 . . . . 0.0 110.064 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.63 166.35 15.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 111.786 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.17 166.11 24.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.837 0.855 . . . . 0.0 111.445 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -129.92 108.29 10.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' HG3' HG11 ' A' ' 78' ' ' VAL . 25.0 mm-40 -94.29 145.55 24.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.847 0.459 . . . . 0.0 110.104 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.5 m -139.99 98.11 3.39 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.44 142.46 13.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.32 116.74 52.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.017 0.927 . . . . 0.0 110.584 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.87 98.73 9.33 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -83.88 159.96 21.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 144.42 6.97 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.583 0.628 . . . . 0.0 109.805 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.488 1.459 0 C-N-CA 124.655 1.182 . . . . 0.0 112.002 -164.125 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 42' ' ' ASP . 27.3 mm -116.19 134.07 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.61 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.0 134.99 19.42 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 165.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.51 130.4 24.99 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.687 2.258 . . . . 0.0 111.676 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 41' ' ' ARG . 18.8 pt -125.09 163.72 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.92 0.888 . . . . 0.0 109.995 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -156.3 146.58 21.48 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 12.6 mmm180 -117.72 140.33 49.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.988 1.315 . . . . 0.0 108.506 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.448 HG23 HG23 ' A' ' 34' ' ' ILE . 28.9 m -111.52 122.2 47.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.432 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 5.6 tp-100 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.2 m -119.64 132.82 68.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.051 0.453 . . . . 0.0 110.609 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.61 123.29 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -110.09 105.1 14.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 110.485 -162.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 46.2 tt0 -98.55 109.62 22.35 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.664 HG23 HG22 ' A' ' 30' ' ' VAL . 31.4 m -85.99 104.36 15.54 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.574 0.75 . . . . 0.0 110.378 -177.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -93.08 129.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 122.033 -0.417 . . . . 0.0 110.47 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.201 1.0 . . . . 0.0 108.452 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.433 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -97.73 118.28 33.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 23.7 mtm180 -143.48 159.65 42.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.477 0.711 . . . . 0.0 109.65 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 81.1 m-85 -86.5 170.92 11.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.213 1.005 . . . . 0.0 109.916 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -69.15 -22.93 63.91 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.566 0.698 . . . . 0.0 110.313 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.62 -20.94 66.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.327 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.64 -20.51 46.05 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.39 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.17 136.91 52.55 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 0.0 111.452 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 58.7 t -85.57 109.57 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.211 0.604 . . . . 0.0 110.629 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 -49.72 45.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.01 0.524 . . . . 0.0 110.139 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -173.33 90.24 0.08 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.19 -25.73 62.65 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.25 80.69 2.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.702 0.801 . . . . 0.0 110.386 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -134.18 79.51 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 14' ' ' THR . 12.9 t -93.81 118.52 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 113.826 -1.533 . . . . 0.0 108.77 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -102.4 157.71 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -143.27 141.75 31.14 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 109.414 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 88.8 mt -99.9 125.89 45.95 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 8' ' ' THR . 3.2 mp -86.06 114.53 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.08 120.2 40.05 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.361 1.464 . . . . 0.0 108.851 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.3 m -100.88 101.73 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.545 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 2.2 mp0 -89.55 79.52 6.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 37.2 p -85.45 137.08 33.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.48 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.43 -156.25 9.71 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -143.25 135.34 26.95 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.3 ttm180 -107.44 122.13 46.01 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 109.447 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.526 ' HA ' HD13 ' A' ' 2' ' ' ILE . 12.2 t70 -69.63 127.74 34.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -83.16 -23.01 33.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -71.53 -46.92 58.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.13 0.491 . . . . 0.0 110.006 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -88.71 -32.23 18.06 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.091 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.56 0.29 73.03 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 -169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -67.22 136.58 55.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.476 1.11 . . . . 0.0 110.846 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.58 107.86 18.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.48 0.712 . . . . 0.0 110.288 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 49' ' ' ILE . 2.9 mp -94.12 91.84 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CH2' ' HG2' ' A' ' 7' ' ' ARG . 36.7 m95 -84.02 124.06 30.66 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 31.6 t70 -52.88 124.43 14.08 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.842 0.714 . . . . 0.0 110.05 -176.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 m -57.85 -37.8 74.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.52 0.728 . . . . 0.0 111.621 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -96.93 16.46 19.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.917 0.887 . . . . 0.0 111.206 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.545 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 40.5 t-105 -64.87 142.17 58.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.556 0.342 . . . . 0.0 110.594 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 55.8 p -155.36 140.94 17.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.095 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -116.8 130.44 56.72 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -112.26 124.39 52.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.26 0.624 . . . . 0.0 109.541 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -135.69 141.33 44.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -103.58 126.79 50.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.299 0.64 . . . . 0.0 111.624 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 37.1 m-85 -69.13 112.69 5.9 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.81 -169.66 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.56 1.163 . . . . 0.0 109.072 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.96 5.63 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.342 1.057 . . . . 0.0 112.164 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.423 HD23 HG21 ' A' ' 78' ' ' VAL . 31.5 tp -116.63 100.28 53.33 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.804 0.842 . . . . 0.0 108.982 -172.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -92.6 -151.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.285 2.657 . . . . 0.0 111.64 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -149.59 145.16 18.65 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.204 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.82 127.58 24.91 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.131 2.554 . . . . 0.0 112.003 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -77.23 106.59 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.2 134.21 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.008 0.923 . . . . 0.0 108.933 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.34 120.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.576 1.55 . . . . 0.0 109.479 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.58 81.32 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.514 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 93.3 m-85 -139.18 160.76 39.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.53 0.732 . . . . 0.0 110.096 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -151.04 126.36 10.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.4 150.32 35.7 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.749 0.82 . . . . 0.0 111.001 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.8 -29.8 70.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.882 0.739 . . . . 0.0 109.446 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -133.48 96.7 16.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.755 168.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.48 -7.6 21.64 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.794 2.33 . . . . 0.0 111.928 175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 tpt -139.12 126.87 22.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 63' ' ' LEU . 88.3 t -65.65 120.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.31 116.46 5.75 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 124.818 1.324 . . . . 0.0 112.694 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 59.9 Cg_endo -70.42 128.96 16.14 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 112.623 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -142.24 135.04 28.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.978 0.418 . . . . 0.0 110.776 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.3 103.9 12.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.581 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -84.03 134.35 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 109.207 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.7 m -121.35 113.78 20.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.363 0.665 . . . . 0.0 109.618 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.17 114.33 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -82.51 174.52 10.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.364 0.602 . . . . 0.0 109.856 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.4 p -71.43 -22.12 61.88 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.934 172.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.21 4.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.126 0.97 . . . . 0.0 109.715 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.66 29.82 3.55 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.323 1.049 . . . . 0.0 110.251 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 9' ' ' GLN . 49.2 t80 -50.94 -48.77 60.77 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.496 1.118 . . . . 0.0 110.634 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 91' ' ' LEU . 1.8 mp -82.58 -23.77 34.28 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.653 -161.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.99 115.07 10.78 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -88.91 106.93 18.73 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.64 46.36 1.33 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.882 0.849 . . . . 0.0 110.229 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -62.55 157.76 19.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.748 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 78.0 ttt180 -157.15 147.3 20.93 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 -172.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.14 144.74 26.11 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 10.4 tp10 -136.34 108.44 7.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 172.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 84.3 m -100.65 122.6 43.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.241 0.617 . . . . 0.0 109.62 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.463 HG12 ' HG2' ' A' ' 75' ' ' LYS . 2.4 m -90.71 142.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.24 106.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.474 0.31 . . . . 0.0 110.432 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 87.2 m-85 -72.75 107.48 5.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.749 1.22 . . . . 0.0 109.682 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p -108.21 140.26 41.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 100.58 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.16 0.984 . . . . 0.0 110.77 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.0 p30 . . . . . 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.971 -171.836 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.7 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.82 0.343 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.481 HD12 ' HD3' ' A' ' 40' ' ' LYS . 35.4 mm -120.2 142.38 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.204 1.002 . . . . 0.0 109.121 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -120.99 149.92 52.09 Favored Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.26 127.78 13.06 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.395 2.064 . . . . 0.0 111.151 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.9 pt -135.1 137.21 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 2.2 mptm? -137.13 142.11 42.26 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -116.75 137.67 52.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 34' ' ' ILE . 85.1 m -120.71 104.91 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.361 0.664 . . . . 0.0 109.363 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -105.06 119.2 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.086 0.554 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 32' ' ' SER . 35.0 m -97.5 125.86 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 104.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -95.9 102.47 14.27 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.852 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -108.28 113.03 25.8 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 30' ' ' VAL . 95.7 m -92.73 107.53 19.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.865 0.866 . . . . 0.0 109.772 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' HG ' ' A' ' 63' ' ' LEU . 1.6 mp -90.13 130.63 39.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.387 0.613 . . . . 0.0 109.932 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 11.5 m-70 -109.26 110.36 21.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.566 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 100' ' ' VAL . 85.0 m-85 -87.29 116.3 25.28 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.403 HH21 HD11 ' A' ' 101' ' ' ILE . 61.7 mtm180 -134.33 -171.32 2.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.52 0.728 . . . . 0.0 110.528 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -121.43 167.4 12.85 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.61 -17.98 63.57 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.803 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.45 -17.26 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.627 1.171 . . . . 0.0 111.192 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.55 54.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.44 137.98 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.57 1.148 . . . . 0.0 111.244 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.3 137.59 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.208 0.603 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.45 -60.49 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.15 115.29 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.309 1.043 . . . . 0.0 108.893 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.628 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.8 p-10 -102.3 26.29 7.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.654 0.781 . . . . 0.0 112.862 -173.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.23 10.79 39.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.677 0.791 . . . . 0.0 111.776 -173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -90.13 73.06 7.26 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.167 0.984 . . . . 0.0 111.038 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 14' ' ' THR . 24.3 t -93.63 119.01 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.898 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 63' ' ' LEU . 6.1 p -105.84 130.99 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 60.4 p -122.36 118.34 28.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.619 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 39.7 mt -98.97 122.9 42.83 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -82.83 124.66 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.097 0.959 . . . . 0.0 109.898 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HA ' HD23 ' A' ' 56' ' ' LEU . 85.5 m-85 -115.35 101.82 9.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.194 0.998 . . . . 0.0 109.099 172.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 m -95.82 107.7 19.97 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -94.33 123.81 37.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 57.5 p -88.14 138.73 31.19 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.746 0.654 . . . . 0.0 109.663 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.21 -171.57 18.01 Favored Glycine 0 C--O 1.241 0.566 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.126 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -136.55 143.84 43.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.7 ttm180 -114.95 118.62 33.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.632 0.373 . . . . 0.0 110.44 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.04 107.11 8.03 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.534 HD12 ' HG3' ' A' ' 1' ' ' MET . 84.4 mt -79.98 -1.31 39.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.927 0.891 . . . . 0.0 112.719 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -73.42 -43.25 60.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.419 0.688 . . . . 0.0 109.927 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -100.57 -24.12 14.53 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.925 0.89 . . . . 0.0 109.887 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.85 34.11 35.29 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.733 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -104.13 141.98 35.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 110.777 -172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 42.0 mt-10 -97.92 122.86 41.54 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 123.276 0.63 . . . . 0.0 110.728 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 49' ' ' ILE . 2.6 mp -103.26 105.23 17.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -102.61 137.25 41.09 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -69.12 118.56 12.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 t -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.392 0.677 . . . . 0.0 111.171 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.27 -18.52 60.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.273 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -61.43 128.03 34.34 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 p -153.99 117.44 4.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.941 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 35' ' ' PHE . 57.0 tp -101.22 130.14 47.28 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -95.55 111.07 23.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 33.9 tp60 -112.06 124.66 52.89 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.5 m -64.57 118.52 8.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.527 1.131 . . . . 0.0 110.642 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -106.97 115.03 29.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 59' ' ' THR . 12.3 pt-20 -179.32 -161.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.03 0.932 . . . . 0.0 109.897 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.92 -98.39 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.862 1.265 . . . . 0.0 110.276 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HG ' HG12 ' A' ' 15' ' ' ILE . 3.6 mm? 47.36 91.57 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.767 0.827 . . . . 0.0 111.179 -170.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.81 97.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.566 2.844 . . . . 0.0 112.588 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -81.99 113.54 43.98 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.487 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' ILE . 17.9 Cg_endo -56.2 121.2 9.57 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.47 2.113 . . . . 0.0 110.432 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.91 103.62 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 66' ' ' PRO . 48.5 mt -107.22 112.91 42.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -76.94 137.87 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.351 0.66 . . . . 0.0 109.786 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.94 4.5 84.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.199 -170.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.9 m-85 -142.63 162.76 34.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.575 0.75 . . . . 0.0 111.415 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -151.19 135.02 16.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.638 1.175 . . . . 0.0 107.85 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 159.18 29.87 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.791 0.836 . . . . 0.0 111.061 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.64 -34.55 74.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 105.12 6.64 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.167 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.82 -4.61 15.69 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.102 1.868 . . . . 0.0 111.688 163.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.5 tpp -135.19 107.38 7.2 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 98' ' ' GLU . 95.7 t -83.7 123.41 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.393 0.677 . . . . 0.0 111.701 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.81 53.58 13.42 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 125.022 1.451 . . . . 0.0 115.397 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 72.9 Cg_endo -74.14 80.68 2.12 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.251 1.967 . . . . 0.0 111.851 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -158.48 119.42 3.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.12 0.568 . . . . 0.0 109.703 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.01 100.85 0.45 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 123.967 0.792 . . . . 0.0 111.058 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.4 112.17 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.991 0.916 . . . . 0.0 110.548 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.4 m -94.97 101.23 12.99 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.324 0.65 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.91 124.64 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.94 170.38 16.56 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.994 0.809 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 16.7 t -70.46 -27.0 63.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.34 171.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.27 -49.82 62.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.718 1.207 . . . . 0.0 111.34 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -104.38 23.1 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.837 0.455 . . . . 0.0 111.21 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 52.7 t80 -58.94 -53.46 58.18 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.349 1.059 . . . . 0.0 112.696 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.95 -4.37 37.77 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.259 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.93 134.11 44.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.571 0.748 . . . . 0.0 110.019 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -90.19 172.57 8.7 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.181 0.593 . . . . 0.0 109.939 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 15.06 4.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.768 0.827 . . . . 0.0 110.784 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -162.62 -165.86 1.24 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 108.856 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.74 -53.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.381 0.672 . . . . 0.0 109.858 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -145.03 115.53 7.63 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.654 -170.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HG2' HG13 ' A' ' 78' ' ' VAL . 16.7 tp10 -107.25 148.29 29.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.825 1.25 . . . . 0.0 109.777 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -136.85 117.84 14.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.26 0.624 . . . . 0.0 109.975 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -86.7 141.75 13.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.403 HD11 HH21 ' A' ' 18' ' ' ARG . 30.9 mm -112.23 120.55 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 56.7 m-85 -80.21 117.79 21.32 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.77 0.828 . . . . 0.0 109.501 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.1 p -110.93 158.43 18.76 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 119.16 8.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.143 0.577 . . . . 0.0 110.638 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 123.911 0.884 . . . . 0.0 112.902 -167.151 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.0 mm -114.09 154.12 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.692 1.197 . . . . 0.0 109.841 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.23 150.73 49.81 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.86 0.864 . . . . 0.0 108.797 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.1 124.22 4.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.897 1.731 . . . . 0.0 111.674 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.626 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -121.55 171.67 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.373 0.669 . . . . 0.0 111.292 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.49 146.68 4.17 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.115 0.884 . . . . 0.0 110.738 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -106.97 165.33 11.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.796 0.838 . . . . 0.0 110.21 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' ILE . 93.1 m -131.88 106.29 7.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.145 0.978 . . . . 0.0 109.608 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -114.29 103.4 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 27.8 m -89.89 132.23 35.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 121.017 0.437 . . . . 0.0 109.85 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 94' ' ' GLN . 75.8 t -99.79 107.75 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -96.03 107.64 19.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.666 0.786 . . . . 0.0 110.89 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.453 HE21 HG11 ' A' ' 78' ' ' VAL . 3.2 tp60 -88.79 113.53 24.44 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 m -107.85 106.95 17.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 108.418 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 63' ' ' LEU . 19.0 tt -104.13 137.71 31.83 Favored 'Isoleucine or valine' 0 C--O 1.265 1.87 0 CA-C-O 122.229 1.014 . . . . 0.0 111.88 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -115.78 161.18 19.12 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.94 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.61 109.5 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.037 0.935 . . . . 0.0 108.872 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 32.1 mtm180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.245 0.618 . . . . 0.0 109.768 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 87.7 m-85 -88.52 176.05 7.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.454 0.702 . . . . 0.0 110.291 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.14 -22.28 60.55 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.468 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.46 -19.71 60.88 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.677 0.791 . . . . 0.0 110.607 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 -10.44 53.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.318 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.54 136.15 57.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.671 0.789 . . . . 0.0 111.076 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 56.0 t -80.35 111.9 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.645 0.378 . . . . 0.0 110.307 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.88 5.46 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -165.92 -175.35 3.36 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.704 1.602 . . . . 0.0 109.038 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.59 -161.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.039 0.936 . . . . 0.0 108.64 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 73.69 35.91 0.8 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.214 1.006 . . . . 0.0 109.799 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -111.37 121.32 44.93 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.18 144.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.031 0.532 . . . . 0.0 110.536 -173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -136.95 121.25 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -119.37 131.2 55.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.692 0.797 . . . . 0.0 109.245 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 96.5 mt -105.2 129.11 53.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.158 0.583 . . . . 0.0 110.005 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.57 HG23 HG23 ' A' ' 8' ' ' THR . 2.7 mp -87.53 111.9 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 123.972 0.795 . . . . 0.0 108.956 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HA ' HD23 ' A' ' 56' ' ' LEU . 41.3 m-85 -94.19 101.03 13.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.74 104.14 16.44 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -81.14 97.14 7.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 110.131 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 p -76.03 139.3 41.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.585 0.553 . . . . 0.0 110.453 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.48 -160.33 9.66 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.639 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 143.47 29.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HB2' HD13 ' A' ' 5' ' ' ILE . 36.0 ttm180 -112.39 128.8 56.41 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.329 0.652 . . . . 0.0 110.489 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 2' ' ' ILE . 16.3 t0 -72.59 121.99 20.64 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.94 -21.31 34.12 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -77.23 -49.76 14.39 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -171.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.36 -28.4 21.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.567 0.747 . . . . 0.0 109.676 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.91 30.51 20.42 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.354 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.74 136.36 42.7 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.323 1.049 . . . . 0.0 110.06 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -91.65 120.18 32.19 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.093 0.557 . . . . 0.0 110.358 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.31 116.65 36.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -114.28 136.9 52.46 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 6.8 m-20 -64.12 125.73 25.43 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 m -62.1 -41.9 98.68 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.758 0.661 . . . . 0.0 111.088 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.91 7.73 26.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.656 0.782 . . . . 0.0 111.984 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 81.0 t90 -61.46 132.62 54.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -155.33 123.02 5.66 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.049 0.939 . . . . 0.0 108.807 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 35' ' ' PHE . 22.9 tp -109.07 135.05 50.85 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -112.14 116.45 30.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.84 0.856 . . . . 0.0 108.871 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -119.93 144.66 47.32 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.815 0.446 . . . . 0.0 110.141 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.505 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.6 m -88.93 113.05 24.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.587 1.155 . . . . 0.0 112.24 -167.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.543 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 2.7 m-85 -99.98 102.38 13.73 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.935 0.894 . . . . 0.0 109.7 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.7 pt-20 -163.39 -165.68 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.285 0.634 . . . . 0.0 109.697 173.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.32 17.04 10.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.351 1.06 . . . . 0.0 111.807 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.449 HD11 HG21 ' A' ' 15' ' ' ILE . 43.0 tp -102.0 99.7 12.97 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.995 0.918 . . . . 0.0 109.078 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -92.68 -165.34 0.14 Allowed 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.529 2.819 . . . . 0.0 113.344 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -150.67 146.41 19.54 Favored Pre-proline 0 CA--C 1.557 1.218 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.755 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.66 139.4 48.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.536 2.824 . . . . 0.0 113.079 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.87 107.8 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.59 130.49 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.47 129.99 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.3 86.99 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.893 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 86.8 m-85 -140.37 146.31 38.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.34 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.0 m -144.03 134.08 24.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.655 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -66.58 156.61 34.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.639 0.775 . . . . 0.0 111.66 -175.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -65.63 -25.01 67.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.811 0.844 . . . . 0.0 110.214 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.35 85.19 6.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 -7.32 21.1 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.187 1.925 . . . . 0.0 112.982 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.4 ttt -146.61 95.37 2.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.709 1.204 . . . . 0.0 107.946 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 75' ' ' LYS . 53.9 t -71.81 111.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.679 0.792 . . . . 0.0 109.911 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.59 84.74 0.25 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.797 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 28.2 Cg_exo -65.44 0.04 3.18 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.593 2.862 . . . . 0.0 113.655 166.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 72.35 -88.39 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.881 1.672 . . . . 0.0 110.555 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -141.74 139.09 32.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.892 0.877 . . . . 0.0 110.517 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.3 t -116.03 120.33 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.16 0.984 . . . . 0.0 108.963 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.4 m -99.24 101.87 13.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.414 0.686 . . . . 0.0 109.596 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.33 125.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.16 168.0 16.21 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.139 0.976 . . . . 0.0 110.336 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.6 t -62.49 -27.47 69.15 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.267 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.74 -56.73 17.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.429 1.492 . . . . 0.0 110.773 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -105.19 15.38 27.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.648 0.779 . . . . 0.0 111.599 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -61.53 -24.5 66.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 0.0 111.185 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.28 -24.77 61.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.784 0.834 . . . . 0.0 111.156 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.0 136.11 33.42 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 109.264 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.66 138.89 33.55 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 11' ' ' VAL . 44.1 mt-30 -100.24 57.45 0.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.93 96.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -90.11 142.57 27.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.942 1.297 . . . . 0.0 109.864 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.68 125.09 10.93 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -134.91 141.56 46.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.473 0.709 . . . . 0.0 110.046 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.2 m -107.27 131.65 53.97 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.655 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 6.3 m -83.78 139.43 17.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.01 107.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 122.883 0.473 . . . . 0.0 110.196 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . 93.6 m-85 -74.96 103.33 5.12 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.08 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.0 p -111.72 147.96 34.49 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 126.4 22.14 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.03 0.831 . . . . 0.0 110.356 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 p30 . . . . . 0 N--CA 1.474 0.746 0 O-C-N 123.268 0.355 . . . . 0.0 110.433 179.509 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.0 140.2 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.577 0.751 . . . . 0.0 109.618 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.91 151.77 58.44 Favored Pre-proline 0 N--CA 1.476 0.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.92 121.4 3.61 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.512 1.475 . . . . 0.0 109.955 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 41' ' ' ARG . 17.4 pt -109.8 169.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.845 0.858 . . . . 0.0 109.483 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 141.35 11.24 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.198 0.523 . . . . 0.0 111.036 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -112.36 136.26 52.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 34' ' ' ILE . 87.3 m -114.01 107.81 16.17 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.695 0.798 . . . . 0.0 109.752 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -101.4 113.21 26.09 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.273 0.629 . . . . 0.0 109.445 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 21.7 m -96.6 146.36 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 94' ' ' GLN . 68.5 t -105.77 104.29 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -101.33 103.15 14.1 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 110.081 -171.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 12.8 mm100 -94.92 113.2 24.89 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.978 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.545 ' HB ' ' HG2' ' A' ' 97' ' ' GLU . 85.1 m -92.64 104.41 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 29' ' ' HIS . 2.0 mp -93.01 131.52 39.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.527 0.679 . . . . 0.0 110.25 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -133.83 118.62 18.2 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.126 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' HA ' HG13 ' A' ' 100' ' ' VAL . 56.2 m-85 -78.61 130.49 35.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.522 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 41.9 mtm180 -141.45 162.06 36.41 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 123.931 0.892 . . . . 0.0 109.314 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -89.54 175.08 7.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.73 -25.1 68.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.409 0.684 . . . . 0.0 112.097 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.52 -20.14 61.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.127 0.971 . . . . 0.0 111.104 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.03 3.29 60.54 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.373 0.421 . . . . 0.0 112.652 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.6 130.03 39.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.504 0.721 . . . . 0.0 109.532 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 34.9 t -82.55 103.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.274 0.488 . . . . 0.0 109.975 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -61.28 -39.59 91.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.337 0.655 . . . . 0.0 111.087 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -168.81 145.82 3.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.695 0.798 . . . . 0.0 109.005 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -137.52 109.99 7.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.408 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 174.55 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 124.689 1.243 . . . . 0.0 112.494 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 2.5 t-160 -75.99 78.64 2.86 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.88 0.738 . . . . 0.0 112.398 -155.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -92.44 128.36 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.96 166.03 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.4 p -156.85 141.62 16.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.551 0.74 . . . . 0.0 109.803 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 10.8 tp -121.86 123.48 41.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 122.585 0.354 . . . . 0.0 111.323 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -91.98 120.49 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.729 0.812 . . . . 0.0 109.663 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 89.9 m-85 -115.71 110.13 18.69 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.012 0.925 . . . . 0.0 109.209 173.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 m -103.24 102.04 12.0 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.683 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.97 99.33 11.36 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.5 t -89.64 133.4 34.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.422 0.629 . . . . 0.0 110.159 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.53 -156.35 9.29 Favored Glycine 0 C--O 1.242 0.617 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.832 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 144.67 37.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.969 0.508 . . . . 0.0 109.718 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.9 ttm-85 -115.17 129.94 56.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.866 0.466 . . . . 0.0 109.978 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 2.0 m-20 -75.4 113.83 13.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.6 -8.02 56.4 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.402 0.681 . . . . 0.0 111.411 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 t -78.68 -44.05 24.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.499 0.72 . . . . 0.0 110.925 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -101.57 -21.0 14.83 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.353 0.661 . . . . 0.0 112.055 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.75 25.74 71.21 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 21.3 ptmt -95.88 138.56 33.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.333 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -106.57 116.39 31.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.577 0.751 . . . . 0.0 110.266 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.6 mp -101.05 102.65 13.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -104.26 152.77 21.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.128 0.971 . . . . 0.0 108.936 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.55 120.98 40.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.378 0.671 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -74.98 -15.24 60.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.157 0.583 . . . . 0.0 112.172 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -85.38 -3.6 58.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.103 0.561 . . . . 0.0 111.103 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.48 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 88.3 t90 -60.77 128.03 34.56 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 p -155.31 114.51 3.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.6 tp -133.55 130.24 38.16 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 t -99.86 142.39 31.39 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.007 0.523 . . . . 0.0 109.7 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -123.22 145.02 49.0 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HG3' ' A' ' 61' ' ' GLU . 4.7 m -70.44 118.03 12.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.076 1.351 . . . . 0.0 110.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 115.92 29.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.0 OUTLIER -168.6 -155.78 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.33 1.052 . . . . 0.0 109.014 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 65.19 11.74 7.45 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.41 1.084 . . . . 0.0 111.819 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 100.28 8.99 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 87.2 Cg_endo -85.09 -173.35 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.547 2.165 . . . . 0.0 111.92 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.0 p -146.47 131.15 8.83 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.65 120.52 7.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.456 2.104 . . . . 0.0 111.039 172.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.65 105.95 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -106.72 114.46 45.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.2 mm -71.7 138.94 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 123.515 0.51 . . . . 0.0 109.785 -174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.17 8.66 85.15 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.961 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 96.8 m-85 -140.31 152.04 45.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.663 0.785 . . . . 0.0 110.074 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 m -134.28 115.67 14.39 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.39 150.94 45.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.927 0.891 . . . . 0.0 111.362 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.01 -39.37 75.88 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.698 0.761 . . . . 0.0 109.008 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -129.62 92.97 36.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.34 -1.3 . . . . 0.0 107.812 169.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.58 -4.92 14.03 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.636 2.224 . . . . 0.0 112.516 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 23.4 ttt -145.8 108.73 4.56 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 168.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 98' ' ' GLU . 76.7 t -70.5 115.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.199 0.312 . . . . 0.0 111.574 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 52.59 63.38 4.98 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.913 1.383 . . . . 0.0 114.862 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.57 77.7 3.35 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.316 2.011 . . . . 0.0 110.136 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -155.82 148.42 23.95 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.72 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -80.25 106.78 12.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.28 128.26 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 m -111.11 123.84 51.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.053 0.541 . . . . 0.0 110.544 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HA ' HD21 ' A' ' 89' ' ' ASN . 77.1 t -113.56 122.79 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.175 0.59 . . . . 0.0 109.521 172.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.47 162.12 13.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 29.7 m -58.3 -29.84 66.18 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.686 0.794 . . . . 0.0 112.335 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -65.83 -31.94 73.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.416 1.086 . . . . 0.0 111.563 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.528 HD21 ' HA ' ' A' ' 85' ' ' VAL . 2.9 p-10 -115.86 19.24 15.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.367 0.667 . . . . 0.0 111.191 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 84.1 t80 -74.59 -33.01 62.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.26 0.624 . . . . 0.0 112.591 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.74 -22.8 56.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.111 0.564 . . . . 0.0 109.598 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -81.67 136.49 35.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.701 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -100.3 159.08 15.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.672 ' HB2' HG13 ' A' ' 11' ' ' VAL . 55.4 mt-30 -109.4 34.12 3.95 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.82 101.14 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.898 0.879 . . . . 0.0 110.251 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 28.3 tpt180 -133.34 142.24 48.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.641 0.777 . . . . 0.0 110.404 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 14' ' ' THR . 40.2 mt-10 -90.56 119.1 30.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 169.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.594 ' HG2' HG13 ' A' ' 78' ' ' VAL . 10.5 tp10 -105.09 114.51 28.76 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.8 m -91.61 132.46 36.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.626 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -106.85 119.0 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.96 109.99 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 66.4 m-85 -80.49 101.32 9.02 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.543 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 m -91.64 152.36 20.28 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.21 133.49 19.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.379 0.536 . . . . 0.0 110.023 173.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 123.854 0.862 . . . . 0.0 109.989 -177.398 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.906 0.384 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.0 mm -106.61 138.82 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.494 1.118 . . . . 0.0 109.302 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -118.97 141.25 29.88 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 44.3 Cg_endo -68.12 128.11 17.05 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.27 1.98 . . . . 0.0 110.513 171.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 41' ' ' ARG . 13.4 pt -132.15 137.06 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -133.77 140.8 47.18 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.352 -0.217 . . . . 0.0 111.023 -170.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -101.92 151.51 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.234 1.014 . . . . 0.0 109.063 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.403 HG23 HG23 ' A' ' 34' ' ' ILE . 92.4 m -123.55 109.19 13.48 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.813 0.845 . . . . 0.0 110.436 -177.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -112.25 125.92 54.67 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 25.5 m -105.08 141.49 20.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.801 HG21 HG11 ' A' ' 83' ' ' VAL . 43.0 t -100.72 105.56 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -98.84 106.52 18.79 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.108 -170.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -93.19 95.87 9.66 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 90.1 m -85.02 136.14 33.71 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.3 134.94 47.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.411 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 42.0 m170 -103.58 119.28 38.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.839 172.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' OH ' HD12 ' A' ' 63' ' ' LEU . 93.8 m-85 -91.67 121.06 32.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 24' ' ' VAL . 3.5 tpt180 -144.04 158.7 43.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -90.37 172.48 8.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.56 0.744 . . . . 0.0 109.773 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 101' ' ' ILE . 15.0 pt-20 -62.98 -43.31 99.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.921 0.888 . . . . 0.0 111.911 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.03 -16.63 61.49 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.444 1.098 . . . . 0.0 111.451 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 16.69 23.37 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.518 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.48 147.27 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.231 0.515 . . . . 0.0 110.171 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 81.4 t -75.68 121.05 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.114 0.566 . . . . 0.0 110.524 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.42 -57.88 2.63 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 166.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -172.8 75.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.071 0.948 . . . . 0.0 108.499 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 8.6 p-10 -88.36 57.43 4.24 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -168.37 18.44 0.02 OUTLIER 'General case' 0 C--N 1.356 0.861 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -104.36 129.71 52.25 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.707 0.685 . . . . 0.0 110.461 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 14' ' ' THR . 43.3 t -129.65 135.36 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.39 1.076 . . . . 0.0 110.514 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.66 154.63 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 51.8 p -148.5 143.41 26.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.644 0.778 . . . . 0.0 110.683 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 58' ' ' GLN . 60.7 mt -106.23 125.41 50.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.652 0.781 . . . . 0.0 108.893 174.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.403 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -95.52 102.61 13.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HD2' ' HB3' ' A' ' 56' ' ' LEU . 96.9 m-85 -93.79 102.03 14.15 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.099 0.96 . . . . 0.0 109.338 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 103.64 14.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.341 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.33 101.89 11.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.577 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 63.5 p -73.33 148.91 43.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.221 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.01 -177.07 24.5 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.992 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 139.59 42.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.613 0.706 . . . . 0.0 110.564 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 5' ' ' ILE . 20.9 ttm-85 -116.28 122.62 45.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.954 0.502 . . . . 0.0 110.186 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.83 112.34 13.32 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.59 -10.74 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 t -72.86 -53.49 11.28 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.764 0.826 . . . . 0.0 110.399 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -96.29 -18.6 19.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.614 0.765 . . . . 0.0 111.267 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.93 62.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.506 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -94.46 128.51 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.829 0.851 . . . . 0.0 110.318 -176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.33 111.04 23.17 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.092 0.957 . . . . 0.0 109.963 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.29 107.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -101.35 117.27 34.61 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.19 121.27 17.24 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 123.402 0.439 . . . . 0.0 109.997 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -63.3 -36.12 82.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.798 1.239 . . . . 0.0 112.009 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -78.29 -7.66 57.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.719 0.408 . . . . 0.0 110.897 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.95 127.62 33.08 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.243 0.544 . . . . 0.0 109.918 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.8 p -137.49 157.16 47.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.589 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.504 HD12 HE21 ' A' ' 58' ' ' GLN . 0.4 OUTLIER -130.77 124.23 30.94 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 m -115.72 122.29 45.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.348 0.659 . . . . 0.0 109.704 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.598 ' HB2' HD13 ' A' ' 33' ' ' LEU . 76.4 mt-30 -122.35 145.3 48.39 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.376 0.67 . . . . 0.0 109.42 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.581 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 30.6 m -69.38 125.75 27.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.313 1.045 . . . . 0.0 110.708 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.42 109.13 15.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.8 -171.83 0.4 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.362 1.465 . . . . 0.0 109.23 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.22 86.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.545 1.138 . . . . 0.0 112.393 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -98.59 115.11 65.89 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.527 0.731 . . . . 0.0 109.29 -178.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.9 80.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.96 3.106 . . . . 0.0 113.262 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 p -95.13 137.47 22.18 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.819 0.848 . . . . 0.0 110.982 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -44.54 125.77 6.4 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.133 3.222 . . . . 0.0 114.223 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.9 t -85.97 108.94 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 172.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.58 132.45 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.288 0.635 . . . . 0.0 109.315 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.79 124.1 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.31 3.88 88.41 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.302 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -136.06 149.62 48.83 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.815 0.808 . . . . 0.0 109.747 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -137.87 131.05 30.45 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.7 57.05 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.552 0.533 . . . . 0.0 109.924 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.13 -31.79 71.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.69 98.65 7.04 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.559 1.144 . . . . 0.0 108.739 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.34 -6.02 18.13 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.357 2.038 . . . . 0.0 112.383 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.609 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 36.1 ttm -136.99 120.51 17.11 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.054 0.942 . . . . 0.0 108.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.39 143.09 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.673 0.789 . . . . 0.0 109.627 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.38 57.89 17.45 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.294 0.996 . . . . 0.0 112.453 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -85.48 56.91 4.38 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.753 2.302 . . . . 0.0 111.245 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -154.64 120.38 5.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.504 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 1.8 mp0 -48.2 123.42 6.37 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 125.371 1.669 . . . . 0.0 111.027 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.801 HG11 HG21 ' A' ' 11' ' ' VAL . 81.4 t -89.65 121.11 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 123.659 0.6 . . . . 0.0 110.728 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 m -104.81 112.41 25.51 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 89' ' ' ASN . 95.3 t -99.76 109.39 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 13.7 t70 -95.51 166.67 11.74 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.2 m -57.23 -33.77 67.89 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.332 0.653 . . . . 0.0 111.711 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 20.7 ptmt -67.4 -36.3 81.02 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.841 0.857 . . . . 0.0 111.745 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' A' ' 85' ' ' VAL . 4.6 p-10 -115.85 27.61 9.18 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.886 0.875 . . . . 0.0 110.035 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -64.61 -37.05 86.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.382 0.673 . . . . 0.0 111.399 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.92 -6.44 56.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.472 0.309 . . . . 0.0 110.666 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.89 135.42 34.15 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.229 0.538 . . . . 0.0 110.984 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.04 -25.66 17.84 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 0.0 111.751 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 51.91 12.29 0.18 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 127.577 2.351 . . . . 0.0 116.077 171.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -151.01 153.46 35.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.92 . . . . 0.0 109.428 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.52 -159.61 0.98 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.829 -167.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' THR . 1.8 tm-20 -90.9 112.74 24.73 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.301 0.64 . . . . 0.0 109.275 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -112.47 125.11 53.88 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.149 0.98 . . . . 0.0 109.665 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.9 m -91.13 133.41 35.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.51 0.724 . . . . 0.0 109.958 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.54 144.45 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 20' ' ' GLU . 40.8 mm -114.52 111.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.864 0.466 . . . . 0.0 111.582 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -82.82 105.49 13.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.564 1.146 . . . . 0.0 109.254 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 p -110.97 146.02 37.37 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.25 104.35 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.46 1.1 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.5 p30 . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 123.929 0.892 . . . . 0.0 111.732 -175.712 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.4 tpt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.7 mm -121.21 155.6 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 124.579 1.152 . . . . 0.0 109.3 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 8.8 pt-20 -128.38 149.94 72.91 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 167.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.34 128.16 11.01 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 122.063 1.842 . . . . 0.0 111.377 168.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.5 pt -126.24 168.44 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.73 143.22 19.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.462 0.705 . . . . 0.0 109.651 174.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.447 ' HG2' ' HE2' ' A' ' 90' ' ' PHE . 22.9 tpp180 -105.41 161.01 14.69 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 34' ' ' ILE . 21.6 m -130.2 108.47 10.06 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.45 0.7 . . . . 0.0 109.285 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.517 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp-100 -112.44 117.73 33.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 33.3 m -102.15 134.59 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 120.81 0.338 . . . . 0.0 110.202 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.6 t -93.43 108.93 21.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -94.55 98.89 11.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.521 0.728 . . . . 0.0 109.747 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -96.29 97.41 9.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.368 0.604 . . . . 0.0 109.807 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 HG22 ' A' ' 30' ' ' VAL . 29.8 m -92.17 138.91 31.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.489 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.56 139.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -106.62 146.74 30.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.899 1.28 . . . . 0.0 108.335 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -114.65 111.2 20.95 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -175.31 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 26.5 mmt85 -126.84 168.19 14.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.641 0.777 . . . . 0.0 109.445 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -105.8 172.22 6.92 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.977 0.911 . . . . 0.0 108.612 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.06 -22.49 63.06 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.519 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -69.52 -21.99 63.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.856 0.862 . . . . 0.0 111.503 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.78 -3.41 55.97 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.65 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.79 157.9 37.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.657 0.783 . . . . 0.0 110.871 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 12.3 t -102.18 123.9 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . . . -76.17 -47.28 24.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.447 ' H ' ' HB2' ' A' ' 17' ' ' TYR . 38.1 t-80 -169.96 159.65 7.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.793 0.837 . . . . 0.0 110.125 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -120.73 152.36 38.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.885 0.474 . . . . 0.0 111.815 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 53.53 76.28 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.648 1.579 . . . . 0.0 112.794 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.461 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 51.4 m170 -120.47 112.39 18.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 14' ' ' THR . 47.9 t -119.21 141.2 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.033 0.933 . . . . 0.0 111.461 -162.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.65 116.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 165.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 p -115.29 124.04 50.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.88 0.872 . . . . 0.0 109.642 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 83.6 mt -106.99 134.43 50.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.801 0.441 . . . . 0.0 111.054 -177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -87.6 121.93 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.427 1.091 . . . . 0.0 110.336 -174.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 72.2 m-85 -111.31 104.47 12.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.236 1.014 . . . . 0.0 108.637 173.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -93.05 103.82 16.08 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.114 0.565 . . . . 0.0 110.327 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.63 104.36 15.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.8 p -72.1 163.75 27.37 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.138 0.494 . . . . 0.0 111.074 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.23 -158.27 22.91 Favored Glycine 0 C--O 1.238 0.362 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 139.21 17.59 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.03 0.532 . . . . 0.0 110.042 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm-85 -102.34 129.35 48.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.47 ' HA ' HD13 ' A' ' 2' ' ' ILE . 32.5 t70 -77.02 118.38 19.53 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 1' ' ' MET . 83.9 mt -82.55 -9.1 59.55 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -169.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -94.92 -30.41 14.17 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.31 0.504 . . . . 0.0 111.458 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.01 -30.25 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.909 0.484 . . . . 0.0 110.254 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.18 2.58 77.18 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.222 -174.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.03 45.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.253 0.621 . . . . 0.0 109.693 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -105.37 118.49 36.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.787 0.835 . . . . 0.0 110.054 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.4 107.6 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -95.76 165.16 12.44 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.899 0.88 . . . . 0.0 109.831 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 29.6 m-20 -75.15 113.45 12.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.2 m -75.61 -23.84 56.46 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.851 0.46 . . . . 0.0 111.393 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -85.96 -3.99 59.06 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.798 0.839 . . . . 0.0 111.369 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 80.5 t90 -60.3 128.98 39.4 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.191 0.52 . . . . 0.0 109.684 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -154.84 113.57 3.58 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.67 140.48 48.19 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 82' ' ' GLU . 5.3 t -108.7 153.94 22.73 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -148.06 144.26 27.75 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.477 HG22 ' HG2' ' A' ' 61' ' ' GLU . 24.1 m -79.16 109.49 13.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.222 1.009 . . . . 0.0 112.927 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -102.61 102.02 12.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.288 0.635 . . . . 0.0 109.505 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' HG2' HG22 ' A' ' 59' ' ' THR . 13.0 pt-20 -173.87 -169.86 0.52 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.727 0.811 . . . . 0.0 109.416 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 70.95 20.68 5.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HB2' HG12 ' A' ' 78' ' ' VAL . 2.3 mm? -92.54 110.33 44.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.107 0.563 . . . . 0.0 110.298 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.09 -146.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.74 2.96 . . . . 0.0 111.149 173.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -162.55 163.37 18.18 Favored Pre-proline 0 N--CA 1.495 1.782 0 C-N-CA 124.341 1.056 . . . . 0.0 110.192 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.69 125.41 15.42 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 121.882 1.721 . . . . 0.0 110.428 169.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.42 107.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.0 mt -100.84 122.07 52.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -72.8 128.64 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.049 0.94 . . . . 0.0 111.01 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.96 1.5 89.75 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.35 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -126.6 159.78 32.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 0.0 110.689 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -145.35 135.52 23.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.176 1.391 . . . . 0.0 107.493 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -71.11 139.32 50.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.074 0.55 . . . . 0.0 111.086 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -69.36 -18.44 63.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.48 1.912 . . . . 0.0 110.551 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.786 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.92 82.64 7.09 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 29.9 Cg_endo -90.26 23.03 0.7 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.541 2.827 . . . . 0.0 114.12 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.66 144.63 27.29 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -131.34 136.61 57.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 164.293 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.32 71.0 0.2 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 78' ' ' VAL . 53.0 Cg_exo -58.26 -16.42 28.15 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.35 2.033 . . . . 0.0 110.773 162.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 59' ' ' THR . 29.7 t70 74.23 -71.53 0.13 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 126.682 1.993 . . . . 0.0 109.71 172.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 61.6 mt-10 -140.16 134.47 31.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.953 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.56 124.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.3 m -100.12 123.94 44.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.178 0.591 . . . . 0.0 109.853 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.21 121.39 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.26 161.96 16.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.294 1.038 . . . . 0.0 109.403 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 68.2 m -62.02 -29.08 70.03 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.004 0.431 . . . . 0.0 110.942 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.53 -46.61 89.53 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.037 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -100.07 2.79 43.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.095 0.558 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HE2' ' HG2' ' A' ' 7' ' ' ARG . 79.1 t80 -62.09 -33.84 75.19 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.119 0.968 . . . . 0.0 113.345 -168.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.59 -27.21 66.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.109 0.48 . . . . 0.0 110.157 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -93.73 156.88 16.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.189 0.995 . . . . 0.0 109.189 170.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.517 ' HE2' ' OE1' ' A' ' 9' ' ' GLN . 18.4 ptpt -119.39 139.0 52.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.78 40.29 1.14 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.577 0.703 . . . . 0.0 109.656 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -51.27 149.53 3.92 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.304 168.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -152.59 115.84 4.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.834 0.349 . . . . 0.0 111.281 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -104.51 110.68 23.05 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -121.67 171.39 8.88 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 110.283 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.8 m -130.9 134.49 46.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.374 0.669 . . . . 0.0 111.598 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.786 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 3.7 m -98.26 142.0 15.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 123.319 0.647 . . . . 0.0 110.227 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -114.08 114.82 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 0.0 110.318 -175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.96 103.29 15.9 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -97.96 174.43 6.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.27 156.25 15.95 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.486 1.347 0 C-N-CA 124.392 1.077 . . . . 0.0 112.937 -167.574 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG2' HD12 ' A' ' 43' ' ' LEU . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.499 HD12 ' HD3' ' A' ' 40' ' ' LYS . 41.6 mm -107.87 142.98 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.939 0.896 . . . . 0.0 109.998 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.6 148.59 65.2 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.058 0.543 . . . . 0.0 109.94 166.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.2 125.53 10.36 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 0.0 110.506 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 41' ' ' ARG . 45.0 pt -125.68 154.95 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.177 0.513 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -159.68 145.86 16.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.832 173.144 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -111.15 156.68 21.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.335 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 34' ' ' ILE . 59.2 m -129.49 122.19 28.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.263 0.625 . . . . 0.0 110.284 -172.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp-100 -122.76 107.16 11.59 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 4.2 m -92.62 133.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 94' ' ' GLN . 69.3 t -102.02 124.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 173.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -123.05 115.34 21.69 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -164.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.667 HE21 ' HG3' ' A' ' 80' ' ' PRO . 8.4 mm-40 -89.47 104.71 17.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.413 1.085 . . . . 0.0 111.068 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -95.35 112.5 24.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.154 0.982 . . . . 0.0 109.176 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 98' ' ' GLU . 87.2 mt -111.58 131.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.508 0.671 . . . . 0.0 111.083 -170.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -112.06 116.28 30.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.403 ' HB3' ' HE2' ' A' ' 102' ' ' TYR . 34.2 m-85 -86.02 107.08 17.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -133.26 156.85 46.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.915 0.886 . . . . 0.0 109.476 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -89.15 176.4 6.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.4 0.68 . . . . 0.0 110.949 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.74 -24.9 67.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.135 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.84 -7.78 58.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.782 0.833 . . . . 0.0 111.225 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.27 82.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.95 150.68 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.092 0.557 . . . . 0.0 109.957 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.7 t -74.41 127.03 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.093 0.557 . . . . 0.0 110.563 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.44 -62.99 1.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -159.52 99.77 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.308 1.043 . . . . 0.0 109.566 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.97 171.44 15.2 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.624 -0.672 . . . . 0.0 110.875 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 57.54 80.33 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.496 1.118 . . . . 0.0 111.679 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -130.94 91.99 3.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.85 127.47 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.699 . . . . 0.0 110.918 -169.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.98 149.97 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.1 p -144.46 144.64 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.923 0.392 . . . . 0.0 110.884 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.68 124.08 51.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.181 0.992 . . . . 0.0 109.109 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 10' ' ' VAL . 1.8 mp -94.9 109.29 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.351 1.06 . . . . 0.0 108.894 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 57.9 m-85 -97.36 99.08 10.53 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -98.82 103.29 15.23 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.403 0.681 . . . . 0.0 109.749 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.46 108.88 14.46 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 t -92.5 159.16 15.65 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.376 0.67 . . . . 0.0 110.742 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.02 -161.93 26.07 Favored Glycine 0 C--O 1.238 0.375 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.716 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.499 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -144.15 142.02 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.216 0.606 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 5' ' ' ILE . 15.8 ttm180 -104.74 125.11 50.49 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.713 0.405 . . . . 0.0 110.122 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.86 106.59 8.62 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 1' ' ' MET . 96.2 mt -75.78 -2.76 31.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.986 0.914 . . . . 0.0 112.171 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -42.37 60.88 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.527 0.731 . . . . 0.0 109.932 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.04 -24.62 14.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.816 0.846 . . . . 0.0 111.234 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.46 16.09 72.11 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.994 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -87.99 143.51 27.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.432 0.693 . . . . 0.0 111.142 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.46 107.65 19.91 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.529 1.132 . . . . 0.0 110.508 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.62 97.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 59.8 m95 -90.31 171.89 9.15 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.065 0.946 . . . . 0.0 109.406 171.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 26.9 m-20 -76.82 115.73 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 164.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -62.17 -31.68 72.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.108 0.563 . . . . 0.0 110.324 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -92.04 15.45 13.31 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.688 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 90.5 t90 -70.4 127.86 34.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 81.0 p -154.86 115.53 3.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.768 1.227 . . . . 0.0 107.805 170.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 35' ' ' PHE . 62.5 tp -103.57 132.97 49.36 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 m -110.23 115.42 29.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.804 0.842 . . . . 0.0 109.516 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -129.34 132.52 47.12 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.543 0.737 . . . . 0.0 109.126 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.4 m -85.34 135.21 33.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.156 0.583 . . . . 0.0 111.266 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.06 104.92 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 160.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.7 -174.09 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.349 1.06 . . . . 0.0 108.589 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.97 21.78 12.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.755 0.822 . . . . 0.0 112.824 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.37 114.13 65.55 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.27 -165.92 0.31 Allowed 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 123.055 2.503 . . . . 0.0 113.31 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 76' ' ' PRO . 59.7 p -157.18 146.98 15.44 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 118.47 5.36 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.999 1.799 . . . . 0.0 110.286 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.52 104.63 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.03 119.01 41.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.48 132.27 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.839 0.712 . . . . 0.0 109.812 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.43 12.43 80.44 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.373 -0.681 . . . . 0.0 112.86 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 87.5 m-85 -137.25 148.97 46.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.752 0.821 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -110.31 126.95 54.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.795 1.638 . . . . 0.0 107.729 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.8 143.96 26.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.938 0.79 . . . . 0.0 109.987 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -37.33 78.37 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.261 0.625 . . . . 0.0 110.938 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -146.91 98.32 4.11 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.136 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 63.3 Cg_endo -68.28 -8.07 21.87 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.466 2.111 . . . . 0.0 112.511 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ttt -143.78 105.77 4.36 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.24 111.59 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.28 78.74 0.24 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.667 ' HG3' HE21 ' A' ' 13' ' ' GLN . 61.4 Cg_endo -71.23 -0.63 8.37 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.825 2.35 . . . . 0.0 113.446 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 76.1 -159.68 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.009 1.324 . . . . 0.0 112.456 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.97 128.73 31.53 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.87 109.83 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.134 1.374 . . . . 0.0 107.91 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.8 m -98.31 128.73 44.88 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.73 115.07 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.9 p30 -90.7 173.08 8.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.764 0.826 . . . . 0.0 110.196 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -60.2 -29.93 69.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.417 1.087 . . . . 0.0 113.206 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -82.68 -38.33 23.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.103 0.561 . . . . 0.0 110.668 -175.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.45 8.95 40.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.99 -24.57 67.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.717 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.71 -21.41 55.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 110.299 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.65 118.43 33.1 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.176 0.991 . . . . 0.0 110.924 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . 21.1 pttp -83.87 127.78 34.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 11' ' ' VAL . 36.8 mt-30 -86.78 42.4 1.01 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -64.03 121.36 13.96 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 110.535 -175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -113.93 145.41 41.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -116.02 110.05 18.38 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 15' ' ' ILE . 17.4 mm-40 -93.18 155.97 17.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.766 0.793 . . . . 0.0 110.725 175.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.2 m -142.28 107.53 4.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.888 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -79.33 137.82 21.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mm -108.87 122.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.403 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.0 m-85 -88.77 106.09 18.13 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.725 1.21 . . . . 0.0 109.413 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 p -112.47 130.39 56.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.17 129.14 23.71 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.028 0.931 . . . . 0.0 113.152 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.493 1.717 0 C-N-CA 125.517 1.527 . . . . 0.0 114.037 -176.917 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.9 mm -113.95 151.21 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.386 0.675 . . . . 0.0 109.315 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.77 151.3 77.84 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.225 0.61 . . . . 0.0 110.011 170.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.75 133.79 28.43 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.606 2.204 . . . . 0.0 111.986 171.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 41' ' ' ARG . 11.6 pt -142.57 137.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.8 mptm? -133.72 154.26 51.08 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.487 0.715 . . . . 0.0 109.114 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 23.7 mmm180 -121.82 149.65 43.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 108.307 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 34' ' ' ILE . 27.1 m -122.26 108.05 12.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 6.2 tp-100 -105.37 148.98 26.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 28.6 m -124.98 123.78 66.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 110.197 173.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.56 115.54 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -96.37 152.03 18.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.091 0.957 . . . . 0.0 111.275 -171.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.701 ' HG3' ' HB2' ' A' ' 96' ' ' ARG . 8.4 tt0 -125.77 107.89 10.96 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -82.61 106.54 14.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.313 0.645 . . . . 0.0 110.791 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -99.6 133.11 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 121.533 0.682 . . . . 0.0 109.844 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -111.88 125.68 54.29 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -97.41 123.66 41.33 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 70.8 mtp180 -141.52 -173.86 3.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.757 0.823 . . . . 0.0 110.648 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.14 164.69 14.77 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.4 -26.17 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.838 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -19.16 64.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.157 1.383 . . . . 0.0 110.849 175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.97 -14.45 63.9 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.96 153.27 29.82 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 111.364 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.9 t -92.52 133.86 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.196 0.598 . . . . 0.0 110.164 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.26 -54.09 3.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 0.0 110.184 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -157.24 96.21 1.54 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.652 1.181 . . . . 0.0 108.804 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.66 142.39 32.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 68.63 86.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.039 1.336 . . . . 0.0 111.417 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -141.16 92.79 2.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -111.2 133.68 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -166.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.0 p -108.48 137.13 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.4 m -113.32 137.72 51.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.93 0.492 . . . . 0.0 110.442 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.2 mt -98.92 123.36 43.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.424 HG23 HG23 ' A' ' 8' ' ' THR . 2.1 mp -99.85 105.4 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.019 0.927 . . . . 0.0 108.664 -173.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.28 107.61 20.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.893 0.877 . . . . 0.0 110.096 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 m -83.81 103.09 12.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.447 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 20.4 tt0 -85.53 107.79 17.63 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 17.0 p -91.65 139.64 30.49 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.64 -167.13 16.03 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 136.68 35.42 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.29 0.545 . . . . 0.0 110.75 -175.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HB2' HD13 ' A' ' 5' ' ' ILE . 25.7 ttm180 -103.58 122.21 44.51 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.821 0.449 . . . . 0.0 110.176 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 2' ' ' ILE . 8.0 t70 -74.67 113.28 11.75 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.598 1.159 . . . . 0.0 108.582 169.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.7 mt -84.66 -4.44 59.01 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 t -87.11 -36.32 18.17 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.644 0.656 . . . . 0.0 110.86 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.04 -31.09 11.61 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.57 63.65 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.916 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 133.53 45.88 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.018 0.927 . . . . 0.0 110.138 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.55 113.93 27.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.353 0.661 . . . . 0.0 110.081 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.98 104.29 15.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.495 ' CZ2' HD12 ' A' ' 5' ' ' ILE . 55.2 m95 -103.75 119.86 39.78 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.88 131.06 43.2 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.78 0.675 . . . . 0.0 110.711 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -64.5 -26.28 68.36 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.297 0.998 . . . . 0.0 110.215 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -64.29 -22.25 66.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.69 0.796 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.447 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 67.8 t-105 -74.32 127.17 32.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.458 0.474 . . . . 0.0 109.896 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 p -153.87 144.53 22.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.514 1.126 . . . . 0.0 109.528 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 tt -134.12 125.18 27.42 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.4 m -107.92 127.64 53.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -130.8 140.19 50.26 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 91.8 m -101.56 132.83 47.0 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 111.117 -175.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 m-85 -72.52 102.46 3.24 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.71 141.96 28.53 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.2 1.0 . . . . 0.0 108.307 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.79 108.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.401 1.08 . . . . 0.0 110.77 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 107.14 21.4 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.55 102.89 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.213 2.609 . . . . 0.0 112.92 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -98.64 134.06 22.02 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.131 0.972 . . . . 0.0 110.62 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 120.66 7.97 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.67 2.247 . . . . 0.0 110.583 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.07 107.25 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mt -102.33 114.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.0 mm -75.62 137.86 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.53 87.42 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.346 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 97.9 m-85 -141.75 162.33 35.74 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.393 0.677 . . . . 0.0 110.26 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -147.24 120.03 8.66 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.95 148.23 52.13 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 123.799 0.687 . . . . 0.0 109.456 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.5 -33.6 73.09 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.787 0.68 . . . . 0.0 109.277 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 97.71 7.07 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.612 168.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.72 -6.23 17.34 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.199 1.932 . . . . 0.0 111.568 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tpt -128.47 125.61 38.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.388 1.075 . . . . 0.0 108.384 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.12 130.26 36.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 109.403 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.75 161.16 49.34 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.365 1.041 . . . . 0.0 113.418 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.5 118.81 5.91 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 123.206 2.604 . . . . 0.0 113.672 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 22.4 m-20 -109.79 94.54 5.08 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.711 0.805 . . . . 0.0 109.715 173.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -72.47 91.67 1.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.17 0.588 . . . . 0.0 110.768 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 85' ' ' VAL . 74.8 t -85.52 103.03 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.873 0.869 . . . . 0.0 110.183 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.1 m -90.17 106.54 18.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.401 0.68 . . . . 0.0 109.548 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HA ' HD21 ' A' ' 89' ' ' ASN . 85.4 t -106.5 110.7 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 170.98 12.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.411 1.084 . . . . 0.0 108.23 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.3 m -65.7 -23.8 66.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.324 166.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -67.53 -45.28 76.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.978 1.311 . . . . 0.0 110.694 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 85' ' ' VAL . 3.4 p-10 -113.66 29.64 7.84 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.724 0.81 . . . . 0.0 109.892 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 9' ' ' GLN . 59.9 t80 -62.07 -46.53 88.68 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.616 0.767 . . . . 0.0 111.78 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.5 -1.09 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.48 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.01 149.69 25.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.888 0.875 . . . . 0.0 109.459 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -108.57 144.07 36.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.471 0.708 . . . . 0.0 109.699 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.4 40.11 3.75 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.37 103.67 1.69 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.583 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.701 ' HB2' ' HG3' ' A' ' 13' ' ' GLN . 28.2 mmm180 -76.42 156.41 33.16 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.458 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.87 132.15 18.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.453 0.301 . . . . 0.0 110.454 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 47.1 mt-10 -141.75 138.33 32.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.516 0.726 . . . . 0.0 110.643 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.5 m -109.03 115.28 29.76 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.41 141.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.08 113.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.747 0.419 . . . . 0.0 110.151 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 63.2 m-85 -84.05 110.45 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.995 0.918 . . . . 0.0 108.877 173.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -99.63 143.56 29.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.81 123.92 10.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.572 0.749 . . . . 0.0 109.295 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 126.592 1.957 . . . . 0.0 113.317 -162.072 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' HD3' ' A' ' 40' ' ' LYS . 29.4 mm -118.72 119.86 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.409 1.084 . . . . 0.0 110.037 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 43' ' ' LEU . 10.5 pt-20 -97.88 137.42 20.93 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 167.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.98 122.95 8.53 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.909 1.739 . . . . 0.0 110.355 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 42.0 pt -119.34 161.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.401 0.68 . . . . 0.0 110.368 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 136.82 12.82 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -96.83 154.34 17.35 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 34' ' ' ILE . 76.6 m -128.54 105.45 8.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -99.48 102.14 13.6 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.6 m -91.13 117.5 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.7 t -89.75 107.1 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.3 m -92.49 102.22 14.67 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.488 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 9.5 tt0 -91.73 105.24 17.57 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.561 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.9 p -92.91 106.21 18.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 98' ' ' GLU . 19.9 mt -97.29 132.5 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.724 0.773 . . . . 0.0 111.681 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -116.75 118.09 31.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.98 -1.464 . . . . 0.0 107.056 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -87.33 115.41 24.73 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.0 ttt-85 -147.37 145.42 29.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.635 0.374 . . . . 0.0 110.518 -171.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -79.48 163.2 24.92 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.477 1.111 . . . . 0.0 111.031 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.99 -28.32 69.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.452 0.701 . . . . 0.0 110.324 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.54 -20.03 65.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.048 1.339 . . . . 0.0 112.042 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.74 -10.25 66.42 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.869 -176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.29 54.14 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.564 0.746 . . . . 0.0 109.494 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 27' ' ' ASP . 39.8 t -86.76 124.89 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.91 51.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.541 0.737 . . . . 0.0 110.857 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -166.25 119.22 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.309 1.043 . . . . 0.0 108.531 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB2' HG11 ' A' ' 24' ' ' VAL . 22.7 t70 -98.19 162.2 13.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.23 0.612 . . . . 0.0 110.037 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 61.97 73.76 0.46 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.822 1.249 . . . . 0.0 112.323 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -127.62 83.7 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 171.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -102.35 127.23 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.599 -171.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 p -117.48 134.91 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -130.01 127.71 40.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 50.3 mt -108.81 131.23 55.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.609 0.764 . . . . 0.0 110.655 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.617 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -82.05 113.07 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.148 0.979 . . . . 0.0 109.619 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -103.99 103.75 13.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.514 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 85.5 m -91.95 107.17 19.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.93 0.892 . . . . 0.0 111.23 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 8.0 tt0 -86.63 107.78 18.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.0 p -78.19 169.58 18.03 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.851 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.95 -158.93 22.94 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.449 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -149.35 144.85 26.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.706 0.802 . . . . 0.0 109.531 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm180 -119.25 119.9 35.44 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.953 0.501 . . . . 0.0 110.566 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.8 113.81 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.206 1.002 . . . . 0.0 108.803 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 3' ' ' GLU . 52.0 mt -82.86 -6.63 59.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -73.55 -48.32 33.94 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.071 0.548 . . . . 0.0 110.533 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -93.07 -26.44 17.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.967 0.507 . . . . 0.0 110.928 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.24 54.36 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.071 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HG3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -95.41 137.59 34.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.708 0.803 . . . . 0.0 110.918 -174.069 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -98.58 113.79 25.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.862 0.865 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.2 mp -100.15 110.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -100.35 139.15 36.43 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.7 t70 -68.01 108.53 3.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 p -77.12 -9.88 59.03 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.189 0.596 . . . . 0.0 112.29 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -97.74 -1.13 44.07 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.339 0.656 . . . . 0.0 111.262 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 62.3 t-105 -66.48 150.52 48.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.435 0.694 . . . . 0.0 110.826 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.4 p -151.73 135.84 16.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 36' ' ' THR . 1.4 tm? -111.51 124.1 51.58 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 m -99.94 127.82 46.09 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.762 0.825 . . . . 0.0 108.845 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 60.6 tp60 -139.62 132.33 28.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 17.1 m -75.02 105.07 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.33 0.652 . . . . 0.0 112.056 -171.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.44 100.13 3.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 161.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -109.32 157.45 18.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.331 1.052 . . . . 0.0 110.138 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -46.69 114.99 0.93 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.943 1.697 . . . . 0.0 114.376 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' A' ' 15' ' ' ILE . 3.7 mm? -82.36 124.3 78.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.51 100.52 0.23 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.735 2.29 . . . . 0.0 112.349 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 t -86.19 104.53 5.63 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.84 122.32 11.15 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.044 2.496 . . . . 0.0 112.475 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.23 107.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.53 135.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.648 0.779 . . . . 0.0 108.938 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.33 118.89 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.495 -172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.09 68.13 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.154 -173.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 81.5 m-85 -141.21 136.52 31.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.816 0.846 . . . . 0.0 111.014 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.1 m -118.78 124.76 48.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 108.597 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.54 138.48 53.32 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.347 0.659 . . . . 0.0 110.971 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.91 -27.4 65.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.424 1.09 . . . . 0.0 110.593 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 94.5 7.29 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.058 0.943 . . . . 0.0 108.661 169.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.55 -5.45 16.9 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.432 2.088 . . . . 0.0 112.19 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.9 tpt -131.62 110.42 10.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.283 1.033 . . . . 0.0 108.487 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.05 129.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 77.13 0.56 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -167.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -97.57 8.13 1.26 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.371 2.047 . . . . 0.0 114.618 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -162.38 172.77 15.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.251 1.024 . . . . 0.0 112.838 -169.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 33.9 mt-10 -85.46 129.77 34.74 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.341 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.51 140.14 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.027 0.931 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.6 m -112.12 120.98 43.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.799 0.84 . . . . 0.0 109.964 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -97.46 118.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.68 157.33 16.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.615 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 68.0 m -58.71 -33.64 70.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.74 0.816 . . . . 0.0 112.461 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.52 -30.29 69.07 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -117.64 24.24 11.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 34.5 t80 -62.65 -34.17 76.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.096 0.558 . . . . 0.0 111.998 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.63 -1.37 50.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.875 0.87 . . . . 0.0 111.704 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -101.16 163.07 12.46 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.93 0.892 . . . . 0.0 110.509 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -84.46 175.35 9.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.936 0.894 . . . . 0.0 111.103 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -121.9 -36.84 2.94 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 165.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -171.86 158.09 4.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.426 1.491 . . . . 0.0 107.87 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 76.7 mtm180 -138.92 -87.99 0.22 Allowed 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.09 109.99 22.65 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -166.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' HB2' HG12 ' A' ' 15' ' ' ILE . 71.0 mm-40 -118.04 114.23 22.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.564 1.145 . . . . 0.0 109.609 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 83.4 m -106.63 122.06 45.58 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.74 132.81 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 30.1 mm -104.18 122.15 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.886 0.475 . . . . 0.0 110.67 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 97.0 m-85 -91.71 108.91 20.25 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.077 0.951 . . . . 0.0 109.974 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 m -98.29 131.42 44.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.798 0.839 . . . . 0.0 109.786 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.76 7.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.059 0.944 . . . . 0.0 111.015 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.835 1.254 . . . . 0.0 111.628 -176.128 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.876 0.369 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.9 mm -112.64 157.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.842 1.257 . . . . 0.0 109.094 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -124.38 146.96 53.66 Favored Pre-proline 0 N--CA 1.479 1.005 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.64 126.38 12.03 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.071 1.847 . . . . 0.0 111.581 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.8 pt -127.18 167.39 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.581 0.752 . . . . 0.0 109.802 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 138.78 12.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.554 0.692 . . . . 0.0 111.622 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.582 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -87.32 133.83 33.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.004 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.9 m -125.29 104.88 8.72 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.2 146.78 24.09 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.131 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 34' ' ' ILE . 35.1 m -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' SER . 94.3 t -91.62 102.37 13.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m -101.78 104.27 15.04 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.84 0.856 . . . . 0.0 109.159 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.784 HE21 ' HB2' ' A' ' 98' ' ' GLU . 52.1 tt0 -112.95 125.27 54.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 109.948 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 30' ' ' VAL . 85.5 m -99.25 108.09 20.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.479 0.712 . . . . 0.0 109.687 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 98' ' ' GLU . 1.8 mp -83.57 116.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -95.77 108.81 21.17 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.128 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' HA ' HG22 ' A' ' 100' ' ' VAL . 97.3 m-85 -79.99 117.98 21.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -137.44 165.57 25.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.979 0.512 . . . . 0.0 109.875 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -94.04 175.53 6.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.312 1.045 . . . . 0.0 109.265 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.26 -21.37 60.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.41 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.05 -19.21 65.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.219 1.007 . . . . 0.0 110.882 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.36 69.12 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.143 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.24 136.8 56.51 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.953 0.901 . . . . 0.0 110.747 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.49 112.9 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.75 72.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.121 0.568 . . . . 0.0 110.203 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -177.11 116.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.401 1.081 . . . . 0.0 109.789 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.46 -38.08 55.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.79 77.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.769 0.428 . . . . 0.0 111.104 -167.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HE1' ' HD2' ' A' ' 64' ' ' PRO . 9.4 t-160 -121.45 91.13 3.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 14' ' ' THR . 21.6 t -102.14 120.3 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.255 -162.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.761 ' HB ' HD23 ' A' ' 63' ' ' LEU . 9.0 p -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.879 0.872 . . . . 0.0 109.153 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 67.7 p -136.71 132.01 34.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.79 0.836 . . . . 0.0 109.716 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.542 HD11 ' HA ' ' A' ' 60' ' ' PHE . 74.9 mt -110.62 125.67 53.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG12 ' A' ' 10' ' ' VAL . 2.4 mp -88.14 112.26 23.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 56' ' ' LEU . 95.2 m-85 -104.26 124.53 49.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.208 1.003 . . . . 0.0 108.417 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -121.27 107.69 12.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.87 0.468 . . . . 0.0 110.385 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 28.0 tt0 -84.79 95.95 9.13 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 109.089 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -76.12 135.09 39.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.11 -168.12 12.3 Favored Glycine 0 C--O 1.251 1.16 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -140.02 143.39 36.4 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.6 ttm180 -112.77 122.38 47.48 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.586 0.355 . . . . 0.0 110.261 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.3 t70 -71.18 118.2 13.66 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.15 -18.33 55.72 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -75.86 -49.09 18.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.726 0.298 . . . . 0.0 110.24 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 49.7 t-20 -88.68 -31.82 18.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -0.57 58.75 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.854 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 21.2 ptmt -70.33 146.09 50.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.284 1.034 . . . . 0.0 111.591 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.74 112.46 24.16 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.534 0.733 . . . . 0.0 109.855 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.59 93.67 3.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -85.77 140.4 30.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.4 t70 -68.4 110.05 3.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -78.49 -5.46 52.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.736 0.814 . . . . 0.0 111.813 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 53' ' ' LYS . 7.9 mtmp? -101.65 -4.78 25.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.098 0.559 . . . . 0.0 110.236 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.1 t-105 -62.44 120.31 10.81 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.125 0.57 . . . . 0.0 110.179 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 11.0 p -139.13 111.58 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.168 0.987 . . . . 0.0 108.667 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 35' ' ' PHE . 64.1 tp -102.21 135.17 44.28 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 11.6 m -98.34 144.95 27.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -148.87 129.32 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 7.0 m -73.67 104.65 4.67 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.754 0.659 . . . . 0.0 110.006 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -65.62 103.53 0.88 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.03 -164.7 0.64 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.254 1.022 . . . . 0.0 108.243 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.1 18.41 10.99 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.525 1.13 . . . . 0.0 111.627 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.2 tm? -107.28 106.09 57.45 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 171.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD2' ' HE1' ' A' ' 29' ' ' HIS . 73.3 Cg_endo -70.66 -165.13 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.253 2.636 . . . . 0.0 113.728 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 t -164.65 106.52 0.84 Allowed Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 121.4 8.22 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.712 2.274 . . . . 0.0 112.316 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.09 108.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 40.7 mt -101.55 134.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.92 134.46 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.353 0.661 . . . . 0.0 109.891 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.67 20.07 71.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.071 0.857 . . . . 0.0 112.988 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 65.0 m-85 -139.17 150.75 45.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.651 0.739 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -136.86 118.93 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.15 150.53 48.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.092 0.557 . . . . 0.0 110.336 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.03 -40.6 78.53 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.04 99.44 16.45 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.126 170.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.16 -2.45 12.34 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.054 2.503 . . . . 0.0 112.117 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.3 ttt -144.31 115.76 8.08 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -80.72 110.16 15.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.496 0.718 . . . . 0.0 111.165 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . 59.39 61.43 7.29 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.848 1.342 . . . . 0.0 114.314 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.83 82.43 2.15 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.544 2.163 . . . . 0.0 110.743 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -161.42 137.41 8.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.141 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.0 mt-10 -76.02 89.48 2.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.055 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 t -82.25 126.84 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.553 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 20.0 m -98.46 117.78 33.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.373 0.669 . . . . 0.0 109.909 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.3 t -99.31 116.61 42.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 7.0 p-10 -104.76 172.03 7.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 t -58.53 -30.09 66.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 113.004 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -71.01 -38.19 72.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.127 0.571 . . . . 0.0 111.128 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -107.93 10.83 28.37 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.0 0.52 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.26 -47.19 77.61 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.241 0.616 . . . . 0.0 112.079 -170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.47 -23.67 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.749 0.655 . . . . 0.0 110.814 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.2 143.28 26.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.275 0.63 . . . . 0.0 110.547 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.571 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.53 162.96 22.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 160.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -125.3 -39.22 2.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.82 142.97 45.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -132.68 -52.83 0.93 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.345 1.058 . . . . 0.0 109.447 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.87 148.18 35.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.327 0.584 . . . . 0.0 111.679 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.784 ' HB2' HE21 ' A' ' 13' ' ' GLN . 12.5 tp10 -122.25 155.57 35.62 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.744 1.218 . . . . 0.0 108.627 169.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -139.74 99.78 3.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.7 m -82.22 141.7 14.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.68 110.54 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.967 0.413 . . . . 0.0 110.888 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.61 104.62 10.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 m -98.77 173.93 6.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.23 146.53 15.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.03 151.95 38.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.137 0.494 . . . . 0.0 111.051 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -58.37 -11.12 2.5 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 125.253 1.421 . . . . 0.0 112.632 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.57 -53.0 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.882 0.873 . . . . 0.0 110.279 167.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 -2.15 41.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.897 0.479 . . . . 0.0 111.466 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -115.87 141.24 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.173 0.589 . . . . 0.0 111.548 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.46 155.1 36.59 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.552 0.741 . . . . 0.0 109.398 168.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.69 90.92 0.18 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.05 -33.0 67.63 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.229 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -111.11 124.32 51.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.539 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.42 36.34 0.13 Allowed Glycine 0 C--N 1.322 -0.245 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.311 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -91.93 0.62 57.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.707 1.203 . . . . 0.0 110.893 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 66.64 101.71 0.05 OUTLIER 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.52 1.528 . . . . 0.0 109.56 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -53.47 107.03 0.21 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.43 1.092 . . . . 0.0 111.211 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -73.0 113.32 9.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.406 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -121.43 173.84 7.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.01 0.924 . . . . 0.0 110.039 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -77.3 125.04 28.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.799 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -82.64 -40.85 20.19 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.252 1.186 0 O-C-N 125.022 1.451 . . . . 0.0 109.977 -171.109 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.442 HD12 ' HD3' ' A' ' 40' ' ' LYS . 38.1 mm -112.6 130.45 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.913 0.885 . . . . 0.0 110.655 -172.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.48 143.37 26.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 166.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -77.6 123.44 6.45 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.325 1.35 . . . . 0.0 111.516 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.6 pt -110.42 172.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.642 0.777 . . . . 0.0 109.807 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.92 146.55 6.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 19.7 mtm180 -113.02 170.15 8.42 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.256 1.022 . . . . 0.0 109.075 168.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 34' ' ' ILE . 34.1 m -135.92 106.43 6.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.331 0.652 . . . . 0.0 110.199 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.1 108.27 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.592 0.757 . . . . 0.0 109.024 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.1 m -92.17 145.48 7.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' SER . 92.3 t -119.28 104.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 m -94.84 107.35 19.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.603 0.761 . . . . 0.0 111.654 -166.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.592 HE22 ' HB2' ' A' ' 96' ' ' ARG . 7.2 tp-100 -96.32 104.97 16.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.618 0.767 . . . . 0.0 108.963 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.491 HG22 HG22 ' A' ' 30' ' ' VAL . 34.5 p -91.75 110.29 21.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -89.5 127.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -107.69 122.56 46.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -92.54 108.06 19.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -117.36 151.17 37.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.94 178.0 8.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.259 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.87 -32.28 73.44 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.33 -18.47 62.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.746 0.818 . . . . 0.0 111.348 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.65 -3.32 56.12 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.932 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.85 142.69 57.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.288 0.635 . . . . 0.0 110.902 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.66 107.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.92 0.488 . . . . 0.0 110.069 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.63 -46.91 74.28 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.243 0.617 . . . . 0.0 109.482 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -161.31 153.87 20.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.646 1.579 . . . . 0.0 108.536 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.72 -153.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.39 0.676 . . . . 0.0 111.548 -173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.89 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.675 1.19 . . . . 0.0 113.356 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -80.98 91.9 6.11 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 165.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 14' ' ' THR . 47.1 t -91.29 123.33 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.232 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 63' ' ' LEU . 7.4 p -115.16 151.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.4 p -143.57 136.1 27.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 70.0 mt -98.32 122.29 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 8' ' ' THR . 2.3 mp -89.01 114.62 27.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.026 0.93 . . . . 0.0 108.901 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 56' ' ' LEU . 97.9 m-85 -109.93 99.43 8.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.841 0.856 . . . . 0.0 108.726 172.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.7 m -90.17 102.18 14.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 50' ' ' TRP . 38.0 tt0 -78.79 105.68 10.26 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 119.677 -0.201 . . . . 0.0 110.791 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.6 p -74.37 143.53 44.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 124.071 0.857 . . . . 0.0 110.259 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -160.35 10.1 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -155.79 137.62 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 117.913 0.856 . . . . 0.0 110.876 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.657 ' HB2' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -113.24 128.73 56.56 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.525 0.73 . . . . 0.0 109.156 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 29.0 t70 -79.77 130.15 35.09 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.374 0.67 . . . . 0.0 109.39 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.42 -16.47 45.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 t -94.53 -36.12 11.97 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.401 0.546 . . . . 0.0 110.982 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -31.8 17.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.892 0.477 . . . . 0.0 109.962 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.88 27.42 60.59 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HE2' HD11 ' A' ' 49' ' ' ILE . 21.1 ptmt -96.38 140.69 30.66 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.694 0.798 . . . . 0.0 110.946 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.02 115.49 30.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 0.0 110.481 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.433 HD11 ' HE2' ' A' ' 47' ' ' LYS . 3.6 mp -109.77 104.01 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.525 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 74.5 m95 -90.36 145.48 24.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.233 1.013 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 28.1 t70 -67.57 113.85 5.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.16 0.584 . . . . 0.0 110.292 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -62.75 -39.32 93.75 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.913 0.885 . . . . 0.0 112.13 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -82.72 -6.92 59.64 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.671 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 60.0 t90 -54.36 124.63 16.54 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 19.9 p -154.34 108.45 2.98 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 35' ' ' PHE . 37.4 tp -101.06 127.0 47.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.9 m -98.83 112.9 24.85 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -119.95 124.77 46.78 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 15.7 m -80.88 135.24 35.88 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.211 0.605 . . . . 0.0 111.619 -174.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -82.61 117.62 22.71 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 158.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -172.45 179.93 2.38 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.001 1.438 . . . . 0.0 109.089 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.53 52.78 4.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.914 0.759 . . . . 0.0 112.273 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.55 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -97.33 98.22 4.68 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 168.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.69 92.35 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.782 2.321 . . . . 0.0 111.89 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.1 p -85.82 131.75 46.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.926 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.21 138.57 61.98 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.87 2.38 . . . . 0.0 113.072 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -88.57 111.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 mt -102.56 128.63 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.29 132.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.871 0.468 . . . . 0.0 109.828 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.45 79.87 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.517 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 88.6 m-85 -143.88 157.95 44.02 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.073 0.949 . . . . 0.0 109.107 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.4 m -145.61 116.97 7.96 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.653 0.781 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.32 135.41 57.0 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.673 0.608 . . . . 0.0 109.562 170.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.65 -14.57 61.62 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 0.0 110.773 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.08 84.75 7.23 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.49 1.116 . . . . 0.0 108.575 172.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.16 -5.67 17.01 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.361 2.041 . . . . 0.0 111.661 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 tpt -116.8 109.31 16.95 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.332 1.053 . . . . 0.0 108.312 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 40.6 t -100.96 133.12 45.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 92.53 0.21 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 123.945 0.778 . . . . 0.0 111.59 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -104.44 21.27 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.055 2.504 . . . . 0.0 112.981 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.76 148.02 29.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -165.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 37.1 mt-10 -87.63 129.64 35.05 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.257 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.75 108.84 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.047 0.939 . . . . 0.0 110.016 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 m -92.58 101.13 13.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.4 0.68 . . . . 0.0 110.623 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.25 116.59 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 9.9 t70 -93.46 163.94 13.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 49.0 m -57.2 -27.75 62.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.283 1.033 . . . . 0.0 111.93 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -69.69 -30.89 68.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.169 0.988 . . . . 0.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -115.53 8.9 15.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.944 0.498 . . . . 0.0 111.714 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 82.9 t80 -62.03 -33.89 75.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.876 0.87 . . . . 0.0 112.25 -173.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.74 -18.1 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.323 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -95.63 156.42 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 170.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -141.74 138.71 32.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.691 1.197 . . . . 0.0 108.13 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.36 45.48 0.96 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 0.0 109.694 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.03 121.58 15.02 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.466 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HB2' HE22 ' A' ' 13' ' ' GLN . 53.5 mmm-85 -127.15 177.44 6.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.516 0.726 . . . . 0.0 109.901 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -130.31 122.32 27.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.71 110.59 20.42 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 94.9 m -97.3 122.96 40.92 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.537 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -99.16 137.05 27.77 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.0 mm -100.41 118.76 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 122.782 0.433 . . . . 0.0 110.166 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 91.4 m-85 -88.67 95.63 10.33 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 p -86.65 139.15 31.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.41 114.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.245 1.018 . . . . 0.0 110.649 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -62.6 149.85 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.397 1.061 . . . . 0.0 109.758 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 t -47.98 -32.96 7.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.644 1.178 . . . . 0.0 111.481 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.9 mm -54.34 -46.86 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.653 1.181 . . . . 0.0 111.511 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 t -89.15 -24.86 22.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.944 0.498 . . . . 0.0 111.036 -175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -71.7 -49.04 43.2 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.872 0.469 . . . . 0.0 111.154 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -79.6 173.12 12.91 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.116 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.82 135.51 16.27 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.756 0.822 . . . . 0.0 109.247 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -55.57 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.394 0.678 . . . . 0.0 110.304 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -178.23 171.42 1.67 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.317 1.447 . . . . 0.0 108.82 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.25 32.23 83.44 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.274 0.359 . . . . 0.0 112.495 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -92.12 -26.5 18.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.712 0.805 . . . . 0.0 110.589 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 65.72 -79.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.282 1.433 . . . . 0.0 110.625 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -169.04 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.987 1.315 . . . . 0.0 108.158 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.5 m170 56.54 85.8 0.07 Allowed 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.754 1.622 . . . . 0.0 111.14 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -125.73 98.04 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -92.98 -179.95 5.26 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.537 0.735 . . . . 0.0 110.161 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -90.54 4.7 50.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.6 0.36 . . . . 0.0 111.101 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 125.199 1.399 . . . . 0.0 109.551 -169.682 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 42' ' ' ASP . 31.5 mm -121.33 154.03 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.801 1.241 . . . . 0.0 109.204 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.07 146.45 53.74 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.59 122.49 5.53 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 121.326 1.351 . . . . 0.0 111.681 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 41' ' ' ARG . 24.5 pt -117.2 169.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 0.0 110.029 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.01 144.21 8.23 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.869 0.468 . . . . 0.0 111.414 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . 84.9 mtt180 -102.06 169.87 8.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.4 1.08 . . . . 0.0 108.946 165.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -144.09 116.85 8.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.099 0.559 . . . . 0.0 110.72 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -114.05 125.03 53.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -104.84 134.64 45.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.21 118.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -109.07 117.64 34.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.206 1.002 . . . . 0.0 110.304 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -90.39 108.64 19.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 p -85.63 104.58 15.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.5 mp -92.68 121.7 43.54 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -125.72 130.91 52.46 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.101 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -92.3 121.99 34.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.956 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -134.99 162.45 32.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.37 0.668 . . . . 0.0 109.32 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -93.33 171.94 8.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.977 0.911 . . . . 0.0 109.444 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.04 -25.13 66.91 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.542 0.737 . . . . 0.0 110.741 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.0 -20.33 66.15 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.89 1.276 . . . . 0.0 111.815 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.52 -19.26 54.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 120.075 -0.291 . . . . 0.0 112.481 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.25 137.51 52.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.024 0.93 . . . . 0.0 110.901 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.98 109.95 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.81 63.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.115 0.566 . . . . 0.0 109.973 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -153.67 166.85 31.52 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.83 1.252 . . . . 0.0 110.487 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.62 82.0 0.59 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -171.76 -3.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' HB3' HD21 ' A' ' 63' ' ' LEU . 22.1 m170 -99.46 82.22 2.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.67 1.123 . . . . 0.0 111.269 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.91 130.96 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.4 117.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 m -105.83 127.42 53.1 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.445 1.098 . . . . 0.0 108.954 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 58' ' ' GLN . 94.9 mt -108.67 130.86 55.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.461 0.705 . . . . 0.0 110.06 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.3 118.9 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 108.921 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -108.13 104.16 13.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.0 m -94.63 105.75 17.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.425 0.69 . . . . 0.0 109.484 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 35.4 tt0 -79.8 83.79 5.69 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -74.36 133.44 42.51 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.99 -162.08 9.04 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 142.06 32.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.595 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.5 ttm180 -112.2 124.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.295 0.638 . . . . 0.0 109.949 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' HA ' HD13 ' A' ' 2' ' ' ILE . 27.3 t70 -74.53 120.79 20.56 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.4 mt -83.8 -27.31 28.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -73.22 -41.16 64.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.898 0.317 . . . . 0.0 111.026 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.98 -29.73 20.55 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.98 36.34 32.32 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -104.37 142.47 34.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.659 0.784 . . . . 0.0 109.69 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 51.1 mt-10 -97.15 114.1 25.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.42 116.44 34.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -114.58 132.72 56.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.78 127.04 32.21 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 t -67.77 -31.05 70.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.975 0.91 . . . . 0.0 111.789 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -86.56 2.75 47.01 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.02 0.528 . . . . 0.0 111.449 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 56' ' ' LEU . 77.6 t90 -58.79 134.52 56.93 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.32 0.648 . . . . 0.0 110.564 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.1 p -156.04 122.14 5.04 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.909 0.883 . . . . 0.0 109.321 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 1.5 tm? -104.38 133.86 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -107.12 123.21 47.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.309 0.644 . . . . 0.0 110.31 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.6 mm-40 -129.2 134.01 47.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 0.0 108.902 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.8 m -97.41 118.68 34.42 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.408 0.683 . . . . 0.0 111.377 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -72.94 119.67 17.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -170.09 -163.47 0.36 Allowed 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.534 1.146 . . . . 0.0 108.56 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 64.32 19.69 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.254 1.021 . . . . 0.0 112.544 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 29' ' ' HIS . 35.9 tp -139.74 98.93 7.74 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.287 0.635 . . . . 0.0 109.372 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 77' ' ' MET . 53.6 Cg_endo -88.89 -166.47 0.25 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.366 2.711 . . . . 0.0 111.899 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -116.57 147.11 39.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.129 0.972 . . . . 0.0 110.501 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.68 125.11 16.9 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.546 2.164 . . . . 0.0 111.555 171.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.87 109.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.26 1.024 . . . . 0.0 109.908 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.02 123.45 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -73.6 135.29 27.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.525 1.53 . . . . 0.0 108.895 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.02 -1.41 86.69 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.599 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 94.5 m-85 -139.5 168.43 19.83 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 117.681 0.74 . . . . 0.0 112.157 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -150.45 121.5 7.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.465 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 147.16 52.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.428 0.691 . . . . 0.0 111.121 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -63.12 -32.42 73.8 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.941 0.896 . . . . 0.0 110.422 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -142.16 93.62 7.24 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.1 -1.7 9.95 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.958 2.439 . . . . 0.0 113.266 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 24.8 ttt -148.68 140.06 23.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.28 122.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.02 112.25 3.08 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 124.8 1.312 . . . . 0.0 113.173 -171.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.52 90.49 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.181 2.587 . . . . 0.0 110.677 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -140.17 137.37 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.72 106.22 9.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.592 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.39 112.53 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.508 1.123 . . . . 0.0 109.263 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -100.85 135.51 42.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.97 0.508 . . . . 0.0 110.593 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -103.79 124.67 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.34 164.29 13.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.046 0.939 . . . . 0.0 109.309 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.0 t -58.31 -37.75 75.71 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.764 1.226 . . . . 0.0 112.972 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.16 -41.32 22.6 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.826 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.3 -0.8 51.29 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 117.755 0.252 . . . . 0.0 111.577 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -57.91 -31.32 66.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 0.0 112.388 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.56 -21.79 61.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.32 0.648 . . . . 0.0 111.372 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.19 120.53 40.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.82 0.848 . . . . 0.0 109.45 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.15 105.32 3.93 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.731 0.777 . . . . 0.0 109.05 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -84.65 41.65 0.86 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 111.039 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.95 160.92 19.61 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.247 1.019 . . . . 0.0 111.449 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.63 169.22 19.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.008 0.523 . . . . 0.0 110.215 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.28 126.31 42.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.84 0.856 . . . . 0.0 109.64 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 15' ' ' ILE . 15.7 mm-40 -101.39 123.14 44.98 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.017 0.527 . . . . 0.0 109.744 169.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -109.15 109.8 20.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.1 m -85.77 141.49 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.209 0.603 . . . . 0.0 109.97 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.9 m-85 -76.66 107.8 9.21 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.6 p -109.15 142.03 40.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.07 124.8 10.81 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 124.369 1.043 . . . . 0.0 110.525 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 51.7 p30 -69.45 -141.31 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.956 0.902 . . . . 0.0 110.728 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.2 t -54.93 -9.9 0.42 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 98.2 mt -45.52 -52.85 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 124.51 1.124 . . . . 0.0 110.725 166.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -101.91 -27.25 13.09 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 111.189 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -93.91 -172.45 2.86 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.847 0.859 . . . . 0.0 111.656 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -96.79 -31.84 12.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.352 1.061 . . . . 0.0 109.596 167.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.5 143.86 30.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.837 0.855 . . . . 0.0 110.102 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 105' ' ' ASN . 43.4 mtpt -80.74 -84.83 0.1 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 166.59 -170.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.137 1.375 . . . . 0.0 109.258 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.2 45.26 40.72 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.052 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.07 -38.91 58.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.469 1.108 . . . . 0.0 110.543 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -155.27 130.38 9.49 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.523 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -66.25 109.84 2.81 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.864 0.866 . . . . 0.0 110.592 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -75.78 104.2 6.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 109.209 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -60.96 100.65 0.12 Allowed 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.718 0.77 . . . . 0.0 111.027 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -137.11 129.46 29.77 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 109.093 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -76.22 85.03 3.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.988 1.315 . . . . 0.0 109.329 -170.267 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' HD12 ' A' ' 43' ' ' LEU . 16.7 tpt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.111 0.481 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -102.65 143.46 15.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.908 0.883 . . . . 0.0 109.319 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.78 146.77 51.55 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.97 123.0 4.99 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.478 1.452 . . . . 0.0 111.315 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 38.9 pt -116.76 169.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.329 0.585 . . . . 0.0 110.874 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -161.31 152.41 18.54 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.007 174.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' NH2' HD21 ' A' ' 91' ' ' LEU . 27.3 ttp180 -124.2 147.7 47.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.525 HG23 HG23 ' A' ' 34' ' ' ILE . 51.4 m -116.91 106.8 13.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.335 0.654 . . . . 0.0 110.881 -169.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -107.05 102.94 12.25 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.66 127.01 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' SER . 59.7 t -91.4 103.25 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' ' 95' ' ' ASN . 29.7 m -96.18 100.56 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.293 -172.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -92.62 100.91 13.34 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 60.7 m -87.01 104.42 16.29 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 68.6 mt -89.89 123.77 42.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 111.545 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 22.9 m170 -101.18 120.56 40.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' VAL . 17.7 m-85 -90.89 116.51 28.77 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 43.8 mtm105 -134.14 177.08 8.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.267 0.627 . . . . 0.0 109.96 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -104.06 169.59 8.41 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.231 1.012 . . . . 0.0 109.648 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.39 -26.24 68.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.151 0.58 . . . . 0.0 111.28 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.41 -17.26 63.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.271 1.028 . . . . 0.0 110.618 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.57 32.85 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.06 44.65 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.088 0.955 . . . . 0.0 111.862 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 37.7 t -86.73 121.6 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.691 0.396 . . . . 0.0 109.977 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -77.68 -57.15 3.97 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -168.49 103.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 109.655 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 5.0 p-10 -86.48 -171.41 3.53 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.98 0.512 . . . . 0.0 111.44 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 66.06 16.19 10.36 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.438 1.095 . . . . 0.0 112.56 171.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -89.59 90.54 8.3 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -94.6 145.42 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 124.534 1.134 . . . . 0.0 112.092 -169.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 63' ' ' LEU . 5.4 p -125.65 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.4 m -129.01 132.49 47.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.885 0.374 . . . . 0.0 110.723 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.89 123.84 45.69 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 HG23 ' A' ' 8' ' ' THR . 2.6 mp -82.82 112.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 56' ' ' LEU . 97.3 m-85 -108.83 100.76 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -98.65 108.16 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.501 1.121 . . . . 0.0 110.264 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.52 114.26 20.81 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -87.15 146.81 25.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.355 0.597 . . . . 0.0 110.243 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.48 -157.72 9.74 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.919 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 140.27 25.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.344 0.572 . . . . 0.0 110.007 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.4 ttm180 -104.64 135.63 45.69 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.332 0.586 . . . . 0.0 109.666 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.08 109.59 16.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.831 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.4 mt -81.88 -2.95 52.94 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 t -92.51 -37.53 12.45 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.408 0.549 . . . . 0.0 111.042 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.6 -28.01 13.75 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.143 0.577 . . . . 0.0 109.734 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.88 37.06 9.59 Favored Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -113.65 140.98 47.76 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.568 0.747 . . . . 0.0 109.737 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.1 121.4 38.94 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.391 0.677 . . . . 0.0 110.203 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.36 97.68 5.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.401 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 79.1 m95 -91.95 141.47 28.59 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.7 t70 -69.03 116.39 9.43 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.8 p -66.58 -30.38 70.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.703 0.801 . . . . 0.0 111.627 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -80.97 -16.44 53.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.618 0.767 . . . . 0.0 111.151 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 60.4 t-105 -62.07 132.23 52.19 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.112 0.565 . . . . 0.0 111.883 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.1 p -155.03 144.66 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.896 1.278 . . . . 0.0 108.307 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.506 ' HB2' ' HD1' ' A' ' 35' ' ' PHE . 96.7 mt -120.13 130.1 54.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.232 0.613 . . . . 0.0 109.413 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 m -106.22 119.95 40.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.89 145.3 44.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.774 0.829 . . . . 0.0 108.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' HG2' ' A' ' 82' ' ' GLU . 16.6 m -99.18 123.61 43.6 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.089 0.556 . . . . 0.0 111.376 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -65.2 128.32 35.34 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 159.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -171.43 168.61 6.46 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.359 0.663 . . . . 0.0 110.837 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.51 14.62 9.65 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.219 1.408 . . . . 0.0 113.339 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 31' ' ' VAL . 4.6 mm? -62.63 113.21 8.3 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.785 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.54 166.23 28.04 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.157 1.905 . . . . 0.0 110.555 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -156.15 123.08 2.67 Favored Pre-proline 0 N--CA 1.472 0.629 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.44 125.0 15.26 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.307 2.005 . . . . 0.0 111.945 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.9 t -77.18 104.77 5.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mt -101.71 113.4 37.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.1 mm -75.58 134.87 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.303 0.641 . . . . 0.0 109.854 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.01 4.22 82.13 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.969 -169.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -134.43 167.57 20.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.963 0.905 . . . . 0.0 110.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.4 m -156.03 117.55 3.92 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -75.15 152.42 38.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.233 0.54 . . . . 0.0 111.702 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.46 -26.88 60.32 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.79 1.236 . . . . 0.0 109.668 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 92.97 4.12 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.767 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.61 3.53 7.63 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.564 2.176 . . . . 0.0 112.659 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 ttt -147.41 78.27 1.46 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.252 0.621 . . . . 0.0 110.151 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.8 t -84.67 152.79 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.74 -81.49 0.34 Allowed Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.112 -1.382 . . . . 0.0 111.724 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -31.75 78.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.762 1 C-N-CA 125.589 4.192 . . . . 0.0 117.073 -162.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -161.32 144.11 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 109.713 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 28.0 mt-10 -91.76 120.54 32.58 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.48 128.6 51.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.196 0.999 . . . . 0.0 109.055 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 29.2 m -110.25 109.67 20.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.436 HG22 ' NE2' ' A' ' 94' ' ' GLN . 86.9 t -95.76 110.59 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 163.63 19.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.463 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -67.84 -27.15 66.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.812 0.445 . . . . 0.0 111.364 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -76.27 -29.47 57.46 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.327 0.651 . . . . 0.0 112.735 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -116.07 23.82 11.9 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.563 0.345 . . . . 0.0 110.998 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -61.44 -48.51 80.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.785 0.834 . . . . 0.0 111.897 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.442 HD21 ' NH2' ' A' ' 7' ' ' ARG . 3.2 mm? -75.28 -10.48 59.5 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -83.76 120.24 25.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.163 0.585 . . . . 0.0 109.724 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.57 148.86 40.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.068 0.937 . . . . 0.0 111.428 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -137.1 14.64 3.05 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.82 168.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' A' ' 12' ' ' THR . 2.9 p-10 -79.79 140.96 36.68 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -172.28 169.76 5.28 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.9 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.57 135.22 36.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.184 0.994 . . . . 0.0 108.668 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 5.5 mm-40 -126.27 111.38 14.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.34 1.056 . . . . 0.0 110.401 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 m -96.2 130.77 43.19 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.573 -0.704 . . . . 0.0 110.578 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.0 m -96.0 143.07 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 164.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.0 mm -114.69 110.47 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.858 0.463 . . . . 0.0 110.543 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 85.1 m-85 -88.26 102.51 14.9 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 m -87.01 172.93 9.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.76 156.67 8.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -58.59 153.2 16.78 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.7 t -46.75 -26.03 0.86 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.594 1.558 . . . . 0.0 113.317 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.14 -53.16 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.654 0.782 . . . . 0.0 110.772 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -91.53 -4.83 55.02 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -64.12 87.27 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.264 0.554 . . . . 0.0 111.166 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -72.76 135.31 45.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.302 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -118.68 147.33 43.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.17 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.96 -60.99 2.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 t70 57.18 -167.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.809 1.244 . . . . 0.0 110.375 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.09 -54.72 0.46 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.3 mt 64.53 6.26 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.94 1.296 . . . . 0.0 112.375 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.23 -175.58 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.704 1.601 . . . . 0.0 111.461 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -87.17 7.63 27.34 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.583 0.753 . . . . 0.0 110.924 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -62.75 114.12 3.42 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.362 1.065 . . . . 0.0 111.801 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.6 t60 63.33 29.99 15.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.691 1.197 . . . . 0.0 111.846 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -84.78 -27.66 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -149.1 -52.49 0.16 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.781 1.632 . . . . 0.0 106.971 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.954 1.302 . . . . 0.0 107.835 170.095 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 40' ' ' LYS . 32.8 mm -127.31 154.88 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.841 0.857 . . . . 0.0 109.93 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 10.6 pt-20 -121.75 146.06 44.78 Favored Pre-proline 0 N--CA 1.485 1.293 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 165.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.69 125.38 11.06 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.873 1.716 . . . . 0.0 111.265 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.6 pt -128.15 174.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.664 0.785 . . . . 0.0 109.825 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.55 150.19 7.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 110.951 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -108.99 151.95 25.63 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -134.91 107.93 7.62 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.174 0.59 . . . . 0.0 110.264 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -105.43 124.16 49.08 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.2 m -104.26 139.17 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' SER . 38.8 t -94.76 104.97 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -102.17 102.39 12.83 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.677 ' HG2' ' HB3' ' A' ' 96' ' ' ARG . 76.1 mt-30 -104.46 121.35 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.793 0.837 . . . . 0.0 109.803 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 30' ' ' VAL . 32.0 m -92.24 103.4 15.87 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -84.81 128.3 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.241 0.617 . . . . 0.0 109.435 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -106.13 137.69 43.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -108.96 121.25 44.73 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 3.7 tpp180 -145.85 130.15 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 161.58 25.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.289 0.635 . . . . 0.0 110.564 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.22 -25.0 68.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.745 0.818 . . . . 0.0 112.218 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.03 -9.2 58.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 111.62 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.28 68.66 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.94 55.0 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 123.686 0.794 . . . . 0.0 110.232 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 27' ' ' ASP . 47.9 t -90.15 110.08 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.596 0.758 . . . . 0.0 110.521 -172.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.26 -49.46 13.68 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.213 0.205 . . . . 0.0 110.676 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -176.99 90.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.751 1.22 . . . . 0.0 108.463 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.644 ' HB2' HG13 ' A' ' 24' ' ' VAL . 8.8 t70 -98.62 41.08 1.15 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.256 0.623 . . . . 0.0 111.757 -161.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -152.99 16.46 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.63 -0.669 . . . . 0.0 111.883 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.483 ' HE1' ' HG2' ' A' ' 64' ' ' PRO . 9.5 t60 -75.74 93.14 3.08 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 120.725 0.297 . . . . 0.0 110.97 -173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 14' ' ' THR . 39.2 t -95.3 146.03 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 122.784 0.434 . . . . 0.0 110.452 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.16 149.11 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.459 1.103 . . . . 0.0 108.472 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 62.1 p -143.4 127.42 17.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 26.3 mt -104.91 127.16 52.63 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 174.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.7 115.94 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.134 0.973 . . . . 0.0 108.986 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' HA ' HD23 ' A' ' 56' ' ' LEU . 69.3 m-85 -108.02 110.43 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 m -111.18 108.24 17.84 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -94.31 110.0 21.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -76.79 142.46 40.34 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.545 0.528 . . . . 0.0 109.8 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.16 -165.54 11.17 Favored Glycine 0 C--O 1.248 1.015 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -142.43 139.45 31.63 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 40.0 ttm180 -107.75 122.93 47.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.638 0.199 . . . . 0.0 110.949 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.1 114.04 6.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.613 1.165 . . . . 0.0 109.403 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.9 -20.21 35.86 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -78.68 -40.22 34.49 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.255 0.48 . . . . 0.0 110.757 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -91.66 -29.81 16.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.662 0.785 . . . . 0.0 110.229 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.6 44.72 7.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HE3' HD11 ' A' ' 49' ' ' ILE . 30.4 ttpt -116.0 142.43 46.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.618 1.567 . . . . 0.0 109.172 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -108.91 121.17 44.54 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.892 0.477 . . . . 0.0 110.451 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' HE3' ' A' ' 47' ' ' LYS . 3.7 mp -98.59 107.73 20.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.511 1.124 . . . . 0.0 108.275 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.06 119.32 39.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 37.2 t70 -62.69 115.78 4.61 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.369 0.668 . . . . 0.0 109.883 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 m -64.47 -26.28 68.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.421 1.088 . . . . 0.0 111.936 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -82.47 -13.25 57.04 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.951 0.901 . . . . 0.0 111.414 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.2 t-105 -68.75 137.49 54.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.527 0.731 . . . . 0.0 110.383 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.3 p -152.42 146.92 25.69 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.256 1.022 . . . . 0.0 108.738 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.9 tp -124.81 125.39 43.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.3 m -97.54 112.32 24.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.49 132.74 53.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 61' ' ' GLU . 4.8 m -68.43 108.79 3.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.86 0.725 . . . . 0.0 109.986 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -97.06 96.73 8.67 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.568 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.4 pt-20 -168.41 -159.95 0.29 Allowed 'General case' 0 C--O 1.245 0.846 0 C-N-CA 124.098 0.959 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.81 31.55 16.38 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 78' ' ' VAL . 2.2 tm? -84.55 107.94 12.99 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HG2' ' HE1' ' A' ' 29' ' ' HIS . 56.1 Cg_endo -71.29 89.94 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.149 2.566 . . . . 0.0 113.278 -170.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -85.64 125.98 67.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.967 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.7 118.59 5.47 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.443 2.096 . . . . 0.0 110.469 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.92 108.53 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mt -107.37 117.53 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.365 0.602 . . . . 0.0 109.991 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 69' ' ' ILE . 1.3 mp -74.64 138.95 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.675 1.59 . . . . 0.0 109.344 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.74 8.91 87.19 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.698 0.624 . . . . 0.0 112.253 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.4 m-85 -140.51 167.68 21.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.478 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.421 HG21 ' HG2' ' A' ' 116' ' ' GLU . 95.4 m -148.67 116.98 6.47 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.809 0.843 . . . . 0.0 109.629 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -64.38 154.25 36.08 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.986 0.914 . . . . 0.0 110.757 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.27 -39.65 91.18 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.078 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 92.53 5.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.139 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.22 -0.3 8.42 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.065 2.51 . . . . 0.0 113.04 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.0 ttt -140.9 89.98 2.3 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 21.4 t -76.68 145.01 10.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.72 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.28 127.92 2.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.18 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 8.7 Cg_exo -72.38 29.48 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 124.12 3.213 . . . . 0.0 115.094 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 69.9 -72.47 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.192 1.397 . . . . 0.0 111.609 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.5 130.12 41.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.779 0.831 . . . . 0.0 109.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.1 t -118.1 114.4 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -96.33 110.73 23.01 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.408 0.683 . . . . 0.0 109.422 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.34 114.34 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -92.23 162.02 14.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.5 0.72 . . . . 0.0 109.782 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -30.95 71.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.236 1.014 . . . . 0.0 111.939 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.03 -29.03 69.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.913 0.885 . . . . 0.0 111.741 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -115.11 4.83 14.72 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.084 0.554 . . . . 0.0 111.831 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.61 -23.82 63.57 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.63 161.7 23.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.991 0.917 . . . . 0.0 109.975 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 156.6 32.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' OE1' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -119.74 47.04 1.8 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -54.16 122.35 10.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.21 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.677 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 66.0 ttt180 -133.76 172.2 13.1 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.754 0.659 . . . . 0.0 109.641 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.32 119.72 10.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 43.3 mt-10 -123.44 110.37 15.02 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.018 0.527 . . . . 0.0 110.95 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -85.59 122.29 29.49 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.03 134.7 30.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.159 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 170.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 mm -103.17 119.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 86.5 m-85 -84.04 106.94 16.09 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.994 0.918 . . . . 0.0 108.669 170.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.5 p -107.67 134.93 49.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 108.89 0.24 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.511 1.132 . . . . 0.0 110.442 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -71.42 166.68 21.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.652 0.781 . . . . 0.0 112.324 -171.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 7.0 t -63.29 -15.6 57.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.161 0.584 . . . . 0.0 112.354 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.91 -54.88 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.841 0.857 . . . . 0.0 109.518 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 t -78.25 -21.47 49.84 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 122.37 0.268 . . . . 0.0 110.495 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.607 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 16.5 mm100 -88.91 -168.75 2.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 109.591 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -107.04 -66.11 1.04 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.226 0.611 . . . . 0.0 109.536 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -138.57 148.25 43.96 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.281 0.632 . . . . 0.0 111.019 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.597 ' HE3' ' HG3' ' A' ' 109' ' ' GLN . 14.7 ptpt -172.03 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.157 1.383 . . . . 0.0 109.971 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 66.78 -174.34 0.19 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.021 1.329 . . . . 0.0 110.95 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.58 -35.18 2.85 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt 73.41 -9.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.598 1.559 . . . . 0.0 114.403 170.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 72' ' ' THR . 36.9 mt-10 68.57 -170.66 0.18 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.419 1.087 . . . . 0.0 109.135 -170.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.84 145.3 23.14 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.793 -0.567 . . . . 0.0 111.012 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -87.87 148.76 24.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.908 0.883 . . . . 0.0 111.233 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -143.28 84.83 1.83 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.523 0.729 . . . . 0.0 110.292 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -135.56 132.41 37.17 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -76.44 95.84 3.93 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.674 0.609 . . . . 0.0 110.495 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.172 0.989 . . . . 0.0 110.281 -178.826 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.6 tpt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 42' ' ' ASP . 33.1 mm -126.59 152.51 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.203 1.001 . . . . 0.0 109.001 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 13.9 pt-20 -128.38 155.14 78.99 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.29 127.08 5.77 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.616 1.544 . . . . 0.0 111.6 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -125.72 168.15 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.144 0.578 . . . . 0.0 110.447 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 150.53 23.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.285 0.634 . . . . 0.0 109.932 174.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.448 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 98.7 mtt180 -114.25 159.64 19.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.057 0.543 . . . . 0.0 109.895 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.618 HG23 HG23 ' A' ' 34' ' ' ILE . 28.6 m -113.54 113.38 25.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -110.75 98.05 7.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.4 m -88.38 133.01 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 105.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 27.6 m -103.39 99.48 9.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.132 0.491 . . . . 0.0 110.228 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.581 ' HG2' ' H ' ' A' ' 96' ' ' ARG . 65.7 mt-30 -94.39 131.8 39.68 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.608 0.763 . . . . 0.0 111.433 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.499 HG23 HG22 ' A' ' 30' ' ' VAL . 50.9 m -103.54 105.53 15.8 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.8 mp -91.03 130.55 40.03 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -129.45 138.71 51.59 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.649 0.738 . . . . 0.0 110.509 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 66.4 m-85 -94.61 119.65 33.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.92 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 53.8 ttt180 -144.86 134.31 23.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 0.0 111.194 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -71.08 163.02 28.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.446 1.099 . . . . 0.0 112.128 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.83 -38.64 79.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.339 . . . . 0.0 112.787 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.37 -17.72 60.14 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.233 1.013 . . . . 0.0 112.026 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.23 28.39 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.691 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 139.52 39.87 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.47 131.25 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 118.129 0.422 . . . . 0.0 110.498 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.87 -58.03 3.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.321 0.648 . . . . 0.0 109.762 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 97.0 m-70 -150.92 171.4 17.32 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.123 1.369 . . . . 0.0 109.128 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -153.75 29.44 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.413 0.625 . . . . 0.0 111.512 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.01 -3.13 17.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.903 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -88.22 75.85 8.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.655 0.741 . . . . 0.0 109.62 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 14' ' ' THR . 27.2 t -100.93 112.49 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.959 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.06 146.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.574 1.149 . . . . 0.0 109.307 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -136.29 141.1 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.569 0.748 . . . . 0.0 110.333 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt -112.61 126.79 55.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.441 171.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 8' ' ' THR . 2.0 mp -88.2 104.61 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.261 1.024 . . . . 0.0 108.936 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.604 ' HA ' HD23 ' A' ' 56' ' ' LEU . 67.1 m-85 -97.13 100.72 12.2 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -82.15 101.94 10.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.545 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -87.48 100.97 13.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -94.07 149.76 20.95 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.827 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.77 -151.31 6.17 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.076 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 142.83 27.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.452 0.701 . . . . 0.0 109.655 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.617 ' HB2' HD13 ' A' ' 5' ' ' ILE . 21.4 ttm-85 -101.15 126.92 47.9 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.247 0.546 . . . . 0.0 110.09 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.0 t70 -74.58 111.77 10.11 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.51 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.2 mt -83.75 -11.29 57.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -173.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.6 t -78.49 -39.75 37.38 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.766 0.712 . . . . 0.0 110.631 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -94.99 -31.64 13.53 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.36 61.13 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HE3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -79.08 139.82 38.01 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.704 0.802 . . . . 0.0 110.216 -173.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.9 124.38 35.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.262 0.625 . . . . 0.0 109.736 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HE3' ' A' ' 47' ' ' LYS . 48.8 mm -111.11 137.4 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 93.6 m95 -126.49 139.67 53.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -173.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 27.5 t0 -65.91 109.15 2.41 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.3 t -61.78 -30.57 70.88 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.009 0.818 . . . . 0.0 111.035 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.83 -3.28 50.6 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.88 0.872 . . . . 0.0 112.04 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.5 t-105 -78.51 116.84 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 0.0 109.641 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 p -142.0 130.18 22.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.4 tp -123.23 136.17 54.6 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 m -120.06 117.49 28.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.673 0.789 . . . . 0.0 108.964 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -129.93 149.61 51.58 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.6 m -106.6 122.58 46.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.438 0.695 . . . . 0.0 112.243 -170.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 66.9 m-85 -71.37 96.66 1.49 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 12.5 pt-20 -139.9 178.9 6.92 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.588 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.78 42.13 31.87 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.359 1.037 . . . . 0.0 110.516 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -105.13 97.28 12.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -174.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -91.11 -165.31 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.235 2.623 . . . . 0.0 112.407 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' A' ' 102' ' ' TYR . 70.6 p -154.21 146.49 17.33 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.484 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.34 120.44 7.76 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.169 1.913 . . . . 0.0 111.329 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.75 106.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.6 mt -94.85 126.48 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.91 131.2 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.975 0.91 . . . . 0.0 110.877 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.81 5.36 89.88 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.106 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.5 159.32 42.14 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.775 0.797 . . . . 0.0 111.601 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.3 m -147.52 129.02 14.97 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.07 156.17 30.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.519 0.327 . . . . 0.0 111.045 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 -42.15 69.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.37 86.42 58.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.369 169.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.59 -6.19 17.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.362 2.041 . . . . 0.0 111.786 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.4 tpt -143.95 114.2 7.43 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.901 1.68 . . . . 0.0 106.546 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 63' ' ' LEU . 83.0 t -68.81 123.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.5 116.21 8.21 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.319 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 91.3 Cg_exo -48.04 131.07 21.05 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.598 2.865 . . . . 0.0 113.956 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.85 132.89 31.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -82.72 118.63 23.5 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.217 1.007 . . . . 0.0 109.638 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.8 t -102.09 132.82 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.106 0.962 . . . . 0.0 108.831 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 m -113.46 113.35 25.03 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 0.0 110.07 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.429 HG22 ' NE2' ' A' ' 94' ' ' GLN . 94.0 t -97.7 112.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.78 157.09 16.97 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.589 1.156 . . . . 0.0 108.473 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.8 t -53.43 -33.04 52.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.654 1.181 . . . . 0.0 112.556 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -69.74 -54.92 11.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.429 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.36 19.95 3.04 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -56.82 -37.18 70.86 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.34 1.056 . . . . 0.0 111.718 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.16 -15.32 53.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.71 0.404 . . . . 0.0 111.06 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.02 118.33 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.841 0.856 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.18 152.44 25.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.938 0.495 . . . . 0.0 109.854 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -141.71 23.36 2.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.933 0.893 . . . . 0.0 109.705 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 12' ' ' THR . 21.7 p-10 -65.09 114.07 4.37 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.972 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' H ' ' HG2' ' A' ' 13' ' ' GLN . 54.9 mtm-85 -82.4 165.29 20.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.886 0.851 . . . . 0.0 110.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.95 123.94 33.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 170.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' A' ' 15' ' ' ILE . 36.6 mt-10 -129.12 125.49 37.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.996 0.518 . . . . 0.0 111.158 -172.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -99.93 125.36 45.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.662 0.785 . . . . 0.0 109.01 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -95.37 137.32 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 51.4 mm -105.99 111.4 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.052 0.141 . . . . 0.0 110.7 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' A' ' 65' ' ' SER . 79.8 m-85 -85.69 104.26 15.24 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.244 0.618 . . . . 0.0 109.63 175.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -89.77 175.33 7.28 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HB3' HG21 ' A' ' 108' ' ' THR . . . -52.02 155.78 1.75 Allowed 'General case' 0 C--O 1.246 0.919 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 167.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 108' ' ' THR . 10.0 t-20 -50.75 161.28 0.36 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.514 1.125 . . . . 0.0 113.554 -168.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -45.48 -24.04 0.28 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.134 1.373 . . . . 0.0 114.002 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.7 -44.67 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.779 0.832 . . . . 0.0 111.653 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.524 HG21 ' HB3' ' A' ' 104' ' ' ALA . 11.4 t -74.7 -28.23 60.72 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.756 0.313 . . . . 0.0 111.286 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.17 129.04 36.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.405 0.682 . . . . 0.0 110.607 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -72.4 171.25 12.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 111' ' ' LYS . 10.4 mptt -85.74 85.93 7.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.914 0.885 . . . . 0.0 109.315 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -106.11 -33.04 7.98 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.445 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.18 72.25 5.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.329 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.49 8.04 12.19 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.458 171.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.2 mt -79.0 -70.35 0.51 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 54.74 107.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 112.679 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -57.55 156.06 8.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.487 0.715 . . . . 0.0 110.633 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -62.83 87.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.521 0.677 . . . . 0.0 110.429 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -83.35 70.69 10.22 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.823 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -70.91 -47.9 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.275 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -158.47 104.96 1.84 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 22.6 p-80 . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -165.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 42' ' ' ASP . 30.5 mm -109.62 148.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.417 0.687 . . . . 0.0 109.275 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -123.74 137.18 28.29 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.25 126.62 12.51 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.006 1.804 . . . . 0.0 110.723 174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.4 pt -128.85 135.61 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -142.4 132.74 24.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -113.66 135.22 54.17 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 34' ' ' ILE . 27.5 m -98.5 104.53 16.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.633 0.773 . . . . 0.0 109.03 -166.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.9 tp-100 -97.62 92.14 5.76 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 34' ' ' ILE . 19.4 m -88.02 118.34 33.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 94' ' ' GLN . 86.3 t -88.62 107.66 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.6 m -94.52 108.2 20.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.364 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' HB3' HG13 ' A' ' 31' ' ' VAL . 9.0 tt0 -104.89 106.18 16.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 30' ' ' VAL . 94.6 m -93.54 107.05 18.96 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -84.77 127.27 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.159 0.504 . . . . 0.0 110.239 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -112.37 109.5 19.16 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.216 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 39.7 m-85 -78.47 115.27 18.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.91 160.09 40.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.998 0.519 . . . . 0.0 110.539 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -93.87 168.43 10.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.172 0.989 . . . . 0.0 109.861 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.77 -27.4 67.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.22 -17.16 62.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.358 1.063 . . . . 0.0 111.528 -176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.78 -12.65 42.04 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.33 58.51 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.679 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.54 124.61 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.74 -60.36 2.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.228 0.611 . . . . 0.0 110.577 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.602 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 91.2 m-70 -152.61 105.63 3.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.562 1.145 . . . . 0.0 108.622 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.89 -20.31 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.142 0.577 . . . . 0.0 111.853 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.49 96.53 6.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.116 0.966 . . . . 0.0 110.478 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -146.18 74.58 1.37 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 14' ' ' THR . 39.6 t -92.28 125.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.363 -167.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 13' ' ' GLN . 3.5 p -105.7 115.45 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 168.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 57.5 p -123.65 117.42 24.97 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.1 mt -97.46 129.66 44.64 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 HG12 ' A' ' 10' ' ' VAL . 2.8 mp -86.84 105.04 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.511 0.724 . . . . 0.0 109.341 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -98.53 107.79 20.33 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 m -75.58 103.14 5.56 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 87' ' ' SER . 6.2 tp60 -78.69 100.96 7.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.547 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 39.8 t -99.13 143.29 29.57 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.835 -173.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.51 -164.81 16.14 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.239 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.45 150.7 36.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.434 0.694 . . . . 0.0 109.218 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.588 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.8 ttm180 -119.74 125.11 47.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.676 0.391 . . . . 0.0 110.716 -171.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 26.4 t70 -75.79 115.68 15.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.952 0.901 . . . . 0.0 108.675 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.63 -15.2 58.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -74.85 -43.42 54.61 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.372 0.606 . . . . 0.0 109.993 -173.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -96.48 -29.09 14.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.925 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.48 27.13 33.62 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 19.6 ptmt -93.83 137.67 32.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.922 0.889 . . . . 0.0 109.933 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.48 116.66 29.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.41 87.86 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -80.57 128.63 33.82 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.9 t70 -62.2 126.33 26.97 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 123.52 0.512 . . . . 0.0 110.313 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -64.44 -29.2 70.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.554 1.142 . . . . 0.0 112.039 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.82 -0.34 42.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.286 0.634 . . . . 0.0 111.882 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 51.4 t-105 -66.18 131.09 45.36 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.026 0.441 . . . . 0.0 111.413 -173.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.0 p -150.24 141.01 22.72 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.107 170.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.87 132.11 55.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.7 m -120.04 128.0 53.11 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.023 0.529 . . . . 0.0 110.149 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.76 144.98 35.79 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m -91.87 124.75 36.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.394 1.077 . . . . 0.0 112.195 -169.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -83.36 111.78 19.32 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.64 -162.35 0.38 Allowed 'General case' 0 C--O 1.238 0.493 0 O-C-N 125.049 1.468 . . . . 0.0 108.547 170.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.5 1.34 1.66 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.285 1.434 . . . . 0.0 112.841 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.23 114.03 50.24 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.49 -163.5 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.889 2.392 . . . . 0.0 113.451 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -158.84 124.88 2.4 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' O ' HG13 ' A' ' 68' ' ' ILE . 18.2 Cg_endo -53.61 123.18 12.73 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.879 2.386 . . . . 0.0 111.168 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.12 109.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.61 0.764 . . . . 0.0 109.737 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 66' ' ' PRO . 52.3 mt -112.78 108.31 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.26 124.74 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 110.555 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.94 56.04 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.603 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -134.85 142.89 46.73 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.697 0.799 . . . . 0.0 111.023 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 105' ' ' ASN . 87.3 m -113.04 117.25 31.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 145.44 47.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 109.993 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.64 -31.31 72.48 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.031 0.933 . . . . 0.0 110.196 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.52 109.31 3.6 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 164.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.27 -5.78 17.08 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.674 2.249 . . . . 0.0 111.749 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.8 ttt -140.12 124.28 17.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG11 HG13 ' A' ' 15' ' ' ILE . 2.5 t -102.31 155.49 4.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.715 0.806 . . . . 0.0 108.992 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.43 85.98 0.84 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -104.83 24.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.036 2.491 . . . . 0.0 113.549 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -156.48 132.21 9.58 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -165.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.4 mt-10 -72.01 126.88 30.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.109 166.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.68 128.17 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.776 0.83 . . . . 0.0 110.748 174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.0 m -109.92 111.49 22.92 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.497 1.119 . . . . 0.0 108.401 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 ' HG2' ' A' ' 9' ' ' GLN . 58.5 t -95.68 108.26 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.92 170.35 11.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.023 0.929 . . . . 0.0 109.57 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 18.2 p -60.93 -30.08 70.0 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.992 0.917 . . . . 0.0 111.57 170.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -67.54 -63.62 1.02 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.032 0.933 . . . . 0.0 111.453 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -90.9 15.9 10.47 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.284 0.634 . . . . 0.0 111.544 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.45 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 36.3 t80 -55.84 -36.1 67.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.671 1.189 . . . . 0.0 112.303 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.38 -13.54 60.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.994 0.518 . . . . 0.0 111.354 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -101.15 145.05 29.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.868 0.867 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.81 145.54 31.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.488 ' HB2' HG11 ' A' ' 11' ' ' VAL . 64.2 mm-40 -104.06 0.06 29.31 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.973 -0.454 . . . . 0.0 111.994 -170.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -149.82 -172.99 4.29 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.805 0.842 . . . . 0.0 110.203 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -158.37 -160.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.661 0.784 . . . . 0.0 110.265 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 5.2 mp0 -85.91 106.43 17.1 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 30.7 mm-40 -95.48 111.69 23.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.4 m -104.86 117.02 33.0 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.872 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.2 m -82.56 141.34 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.2 116.43 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 122.66 0.384 . . . . 0.0 110.225 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -83.75 99.94 10.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 p -89.73 174.71 7.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.09 153.64 14.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.445 0.566 . . . . 0.0 109.967 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 5.0 t-20 -64.99 156.79 30.15 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.246 0.546 . . . . 0.0 111.333 -173.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.636 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 9.0 t -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.546 1.138 . . . . 0.0 112.537 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.8 mt -57.07 -46.14 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 124.018 0.927 . . . . 0.0 110.529 172.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 t -88.84 -19.4 25.97 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.636 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 24.5 mt-30 -94.52 -165.52 1.32 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.244 0.618 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -89.11 164.08 15.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.155 0.582 . . . . 0.0 111.807 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -83.3 112.6 20.04 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.597 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -140.75 -48.08 0.42 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.456 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.52 -92.68 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.24 1.416 . . . . 0.0 109.527 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 55.6 24.01 38.02 Favored Glycine 0 C--N 1.358 1.799 0 O-C-N 123.518 0.511 . . . . 0.0 113.796 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.1 mt -86.66 -26.13 24.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.2 1.0 . . . . 0.0 109.569 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 56.08 89.57 0.04 OUTLIER 'General case' 0 C--N 1.352 0.683 0 C-N-CA 125.705 1.602 . . . . 0.0 110.984 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -63.09 134.49 56.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.037 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -164.68 133.14 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.84 1.256 . . . . 0.0 107.931 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -166.78 115.24 0.86 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -125.39 116.65 22.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.897 0.879 . . . . 0.0 109.077 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -78.2 82.76 4.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.923 0.868 . . . . 0.0 109.235 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 CA--C 1.548 0.892 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.759 178.349 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 mm -120.04 158.03 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.773 1.229 . . . . 0.0 109.594 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 9.0 pt-20 -128.75 151.65 77.53 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.93 124.42 7.39 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 121.652 1.568 . . . . 0.0 110.764 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -114.72 163.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.335 1.054 . . . . 0.0 108.546 171.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 142.33 13.52 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 53.6 mtp180 -107.7 156.26 19.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.993 1.317 . . . . 0.0 108.442 168.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 34' ' ' ILE . 37.7 m -129.37 108.55 10.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.095 0.558 . . . . 0.0 110.088 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -98.39 120.98 39.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.1 m -108.11 134.83 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.7 t -100.62 104.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 95' ' ' ASN . 31.4 m -106.05 120.61 42.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.052 0.541 . . . . 0.0 109.927 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.45 127.18 53.1 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.529 HG23 HG22 ' A' ' 30' ' ' VAL . 59.1 m -94.24 103.68 15.7 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.34 125.32 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.395 0.616 . . . . 0.0 110.389 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.408 ' HB2' HG23 ' A' ' 99' ' ' THR . 24.0 m-70 -113.28 109.03 18.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HA ' HG22 ' A' ' 100' ' ' VAL . 65.9 m-85 -81.0 115.01 20.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 16.0 mmt85 -131.3 159.68 37.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.995 0.918 . . . . 0.0 109.419 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -88.58 174.49 8.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.109 0.563 . . . . 0.0 109.56 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.39 -26.52 66.49 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.947 0.499 . . . . 0.0 110.545 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.14 -19.51 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.849 1.26 . . . . 0.0 111.12 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.47 66.0 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.302 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.42 152.58 42.98 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.411 0.685 . . . . 0.0 111.053 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 27' ' ' ASP . 57.4 t -73.21 114.94 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.47 -45.78 13.24 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -173.99 126.51 0.36 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.455 1.102 . . . . 0.0 108.192 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 24' ' ' VAL . 9.9 t70 -131.82 88.03 2.52 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.257 -0.902 . . . . 0.0 111.085 -166.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 p30 179.0 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 64' ' ' PRO . 18.8 m170 -83.37 85.32 7.25 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.911 1.232 . . . . 0.0 111.38 -169.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 14' ' ' THR . 40.5 t -94.97 119.8 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.941 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 63' ' ' LEU . 11.7 p -112.69 150.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 0.0 109.073 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 m -141.64 136.65 31.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 35.7 mt -103.88 124.17 48.46 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -88.57 110.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.645 ' HA ' HD23 ' A' ' 56' ' ' LEU . 98.5 m-85 -105.61 101.24 10.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.989 0.916 . . . . 0.0 109.291 173.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.2 m -97.28 103.25 15.16 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.641 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -85.32 100.79 12.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -80.09 135.65 36.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.09 -163.48 11.91 Favored Glycine 0 C--O 1.245 0.84 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.494 ' HE2' ' HB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.87 137.78 41.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 5' ' ' ILE . 33.5 ttm180 -111.95 124.84 53.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.86 115.07 8.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.244 1.018 . . . . 0.0 108.266 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.8 -24.84 55.97 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -80.51 -43.42 20.79 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.775 0.262 . . . . 0.0 111.238 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.43 -28.52 20.84 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.582 0.353 . . . . 0.0 110.597 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.02 23.55 48.57 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.88 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.7 ptmt -94.17 142.68 27.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.375 0.67 . . . . 0.0 110.544 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.5 111.73 24.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.946 0.898 . . . . 0.0 110.553 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' HB ' ' HE2' ' A' ' 40' ' ' LYS . 3.5 mp -108.03 103.4 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 73.1 m95 -87.96 152.06 22.34 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 110.103 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.31 105.72 7.52 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.3 p -72.57 -19.74 61.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.894 0.877 . . . . 0.0 110.854 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -85.54 -0.86 56.23 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.481 0.712 . . . . 0.0 110.94 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.55 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 89.4 t90 -65.88 132.17 48.02 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 110.368 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 28.5 p -154.56 105.43 2.63 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 35' ' ' PHE . 55.6 tp -97.18 126.71 42.54 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.6 m -97.3 110.37 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.05 134.38 55.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.1 m -69.1 118.83 12.49 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.14 0.976 . . . . 0.0 111.445 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -112.5 92.77 4.14 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.854 0.462 . . . . 0.0 109.985 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -159.83 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.264 1.426 . . . . 0.0 108.164 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.425 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . 70.39 15.74 7.26 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.377 1.071 . . . . 0.0 112.555 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -65.86 116.27 30.76 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.159 0.584 . . . . 0.0 110.346 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 29' ' ' HIS . 57.6 Cg_endo -71.33 86.71 0.79 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.049 2.499 . . . . 0.0 111.792 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -89.35 130.78 42.6 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.573 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.85 120.62 8.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.87 1.713 . . . . 0.0 110.737 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.49 102.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.0 111.72 33.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.33 129.22 30.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 123.652 0.595 . . . . 0.0 110.413 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.81 ' HA3' ' HB ' ' A' ' 108' ' ' THR . . . 84.18 -3.32 86.29 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.013 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 22.0 m-85 -118.13 149.03 41.72 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.186 0.994 . . . . 0.0 108.422 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.1 m -140.66 121.91 14.86 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -67.2 152.22 46.14 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.363 0.665 . . . . 0.0 110.402 175.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.63 -30.96 70.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.287 0.565 . . . . 0.0 110.146 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.27 6.3 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.667 1.187 . . . . 0.0 108.178 173.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.12 -4.2 13.68 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.524 2.149 . . . . 0.0 111.403 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 62' ' ' ALA . 38.0 tpp -146.75 129.86 16.47 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.4 0.68 . . . . 0.0 109.216 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.423 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 94.9 t -96.83 124.35 49.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 O-C-N 124.309 1.006 . . . . 0.0 110.576 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.89 152.34 18.82 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.958 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -85.93 36.69 0.52 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.872 3.048 . . . . 0.0 113.475 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 75.88 -55.16 0.61 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.837 1.655 . . . . 0.0 111.751 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -126.14 150.36 48.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.99 0.916 . . . . 0.0 109.925 170.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.44 118.82 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.658 1.183 . . . . 0.0 108.555 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.0 m -101.15 103.58 14.64 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -95.39 118.9 42.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -88.25 171.83 9.9 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.357 1.063 . . . . 0.0 108.921 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.5 t -69.78 -22.36 63.34 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 123.951 0.782 . . . . 0.0 110.533 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.15 -53.4 25.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.709 0.804 . . . . 0.0 110.119 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -96.5 24.24 6.08 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.728 0.811 . . . . 0.0 111.244 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -72.26 -31.13 65.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.011 0.525 . . . . 0.0 111.249 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.34 -11.43 59.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.521 0.329 . . . . 0.0 110.167 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -94.64 136.19 35.23 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -104.16 146.85 28.16 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -103.67 21.45 16.15 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 6.7 t30 -64.03 118.57 8.68 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.205 1.002 . . . . 0.0 110.255 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -135.8 176.03 9.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.613 0.765 . . . . 0.0 109.345 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.17 117.72 34.94 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -96.32 132.09 42.16 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.043 0.537 . . . . 0.0 109.99 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.408 HG23 ' HB2' ' A' ' 16' ' ' HIS . 75.3 m -138.46 107.05 5.86 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.9 m -84.61 141.13 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 39.4 mm -116.83 113.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 95.0 m-85 -81.44 108.95 15.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 109.383 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.5 p -96.09 130.97 42.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.03 96.19 1.71 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.592 0.757 . . . . 0.0 109.767 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -68.59 167.97 13.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.286 1.034 . . . . 0.0 109.997 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -69.9 -9.65 55.68 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.215 0.606 . . . . 0.0 111.359 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HB ' ' HA2' ' A' ' 70' ' ' GLY . 56.2 mt -50.81 -58.52 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.335 1.454 . . . . 0.0 110.282 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.81 ' HB ' ' HA3' ' A' ' 70' ' ' GLY . 15.3 t -72.08 -23.38 61.34 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.373 0.42 . . . . 0.0 111.747 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.37 -35.76 66.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.535 0.683 . . . . 0.0 110.296 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.418 ' HB3' ' HD3' ' A' ' 111' ' ' LYS . 34.2 m-80 -115.87 -166.08 1.1 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.595 1.158 . . . . 0.0 109.93 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -53.77 131.53 39.68 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.705 0.802 . . . . 0.0 109.971 170.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 19.2 pttp -127.85 -58.19 1.24 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 65.05 -76.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.392 1.077 . . . . 0.0 110.39 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 33.74 74.05 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.51 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -96.01 -76.75 0.49 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 43.08 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.302 1.841 . . . . 0.0 112.722 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.44 122.76 17.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.402 1.081 . . . . 0.0 108.365 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -135.17 104.65 5.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.685 0.794 . . . . 0.0 109.001 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -121.15 117.88 28.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.812 0.845 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -79.94 -16.84 54.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 0.0 111.153 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -99.43 126.12 45.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.416 0.686 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 . . . . . 0 C--O 1.25 1.127 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.825 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.5 tpt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.867 0.365 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.92 157.11 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.076 1.35 . . . . 0.0 107.886 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 12.4 pt-20 -134.65 146.86 60.77 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.23 124.19 6.47 Favored 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 121.417 1.412 . . . . 0.0 111.517 171.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 41' ' ' ARG . 27.6 pt -119.28 170.77 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 0.0 110.391 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.64 142.11 4.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 110.543 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.478 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 81.3 mtp180 -104.63 169.51 8.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.743 0.817 . . . . 0.0 109.774 170.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.609 HG23 HG23 ' A' ' 34' ' ' ILE . 35.5 m -120.33 108.46 14.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.692 0.797 . . . . 0.0 108.958 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.2 tp60 -105.81 99.65 9.24 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 31.0 m -89.42 127.91 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.41 116.19 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -104.25 105.06 15.07 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 124.195 0.934 . . . . 0.0 111.464 -163.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 96' ' ' ARG . 9.5 mm100 -91.74 99.19 12.12 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.6 0.76 . . . . 0.0 109.578 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 p -79.31 103.92 9.57 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.86 132.88 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 41.0 m-70 -120.35 119.67 33.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.174 0.989 . . . . 0.0 108.522 -174.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -91.32 116.75 29.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.3 mtm105 -142.11 155.22 45.34 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 123.417 0.687 . . . . 0.0 109.414 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -81.27 170.88 15.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.19 -27.87 69.0 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.035 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.78 -18.99 65.57 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 111.784 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.98 -11.52 69.44 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 148.13 48.87 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.849 0.859 . . . . 0.0 110.617 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 55.4 t -91.4 129.8 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.668 0.387 . . . . 0.0 110.471 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.4 -60.45 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -163.77 90.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.346 1.459 . . . . 0.0 108.97 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.5 p-10 -91.48 28.14 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -131.02 21.97 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 111.93 -170.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.16 81.68 5.55 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.014 -1.054 . . . . 0.0 110.404 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.52 127.59 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.222 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HB ' HD23 ' A' ' 63' ' ' LEU . 14.8 p -120.44 150.0 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.467 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 55.4 m -138.73 141.15 38.89 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.743 0.817 . . . . 0.0 108.971 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 58' ' ' GLN . 77.4 mt -110.94 132.44 54.2 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.609 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -81.96 115.52 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.885 0.874 . . . . 0.0 108.768 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.42 100.47 10.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.1 m -75.58 105.77 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.431 ' HA ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -81.83 95.37 7.28 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.695 0.798 . . . . 0.0 109.185 176.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.8 t -87.68 152.56 22.06 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.33 0.586 . . . . 0.0 111.999 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -166.44 -157.5 10.33 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.596 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.12 140.76 30.99 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.445 0.698 . . . . 0.0 110.229 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.7 ttm-85 -102.96 123.61 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -74.93 113.65 12.48 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.535 HD12 ' HG3' ' A' ' 1' ' ' MET . 57.5 mt -82.94 -15.52 50.98 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.1 t -87.28 -38.76 16.0 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.772 0.26 . . . . 0.0 110.385 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.88 -32.22 20.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.076 0.55 . . . . 0.0 110.245 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.38 38.23 11.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.489 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.3 ptmt -112.8 140.77 47.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.879 0.872 . . . . 0.0 109.993 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -98.65 107.77 20.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.975 0.91 . . . . 0.0 109.752 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.7 mp -95.92 117.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 77.0 m95 -103.62 124.74 49.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.26 110.01 1.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m -65.0 -20.86 66.71 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.928 0.891 . . . . 0.0 112.797 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.94 -21.76 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.271 0.629 . . . . 0.0 110.439 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -59.01 139.02 57.26 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.929 0.768 . . . . 0.0 111.634 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 70.1 p -149.89 132.98 16.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.913 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.22 125.45 44.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -113.09 133.86 54.81 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HB3' HD13 ' A' ' 33' ' ' LEU . 8.1 mm100 -134.41 145.06 48.56 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 m -92.44 116.65 29.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.534 0.734 . . . . 0.0 110.595 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.2 95.51 1.27 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.424 0.63 . . . . 0.0 110.343 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.7 -164.04 1.93 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.801 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.13 28.37 17.08 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.73 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.568 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.3 tm? -119.29 94.92 48.91 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -86.22 152.37 9.43 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.325 2.683 . . . . 0.0 111.883 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' OH ' ' A' ' 102' ' ' TYR . 45.9 m -105.1 149.05 37.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.961 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.45 127.7 25.65 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.064 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.76 107.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mt -107.55 133.75 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.67 132.07 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.694 0.797 . . . . 0.0 108.941 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.19 -6.31 81.94 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.934 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -133.82 165.44 24.96 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.382 0.673 . . . . 0.0 110.476 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -151.09 130.05 12.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 154.51 33.9 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.993 0.517 . . . . 0.0 110.939 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -64.68 -38.23 90.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.515 0.674 . . . . 0.0 109.183 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 88.85 28.93 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 114.501 -1.227 . . . . 0.0 107.997 171.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.94 -5.13 16.41 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.841 2.361 . . . . 0.0 112.798 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.3 tpt -147.56 114.91 6.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.33 118.82 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.09 135.51 51.75 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.375 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.69 97.32 0.32 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.287 1.991 . . . . 0.0 111.964 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -114.14 113.17 24.34 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.305 0.642 . . . . 0.0 110.853 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.38 118.14 17.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.336 0.654 . . . . 0.0 111.179 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.87 135.78 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.37 1.068 . . . . 0.0 108.58 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -105.14 110.25 22.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.27 0.628 . . . . 0.0 109.751 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 89' ' ' ASN . 94.0 t -95.66 108.49 21.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.1 p30 -110.86 176.54 4.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.738 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.66 -24.04 65.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.24 -51.16 10.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.198 0.599 . . . . 0.0 110.175 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.488 HD22 ' HA ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -92.23 6.68 45.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 52.7 t80 -54.75 -34.6 62.74 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.625 1.17 . . . . 0.0 112.251 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.1 -23.64 47.83 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.97 116.05 28.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.297 0.639 . . . . 0.0 109.987 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -79.83 106.15 11.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 122.092 0.949 . . . . 0.0 109.029 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -91.77 38.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.418 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -70.3 154.44 41.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.44 1.096 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HB2' ' NE2' ' A' ' 13' ' ' GLN . 44.7 mmm-85 -129.5 141.4 51.01 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.244 0.545 . . . . 0.0 111.756 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -102.78 110.41 22.33 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 163.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -115.7 136.16 53.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.382 0.673 . . . . 0.0 110.286 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.4 m -113.47 119.14 36.56 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 167.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.03 140.71 15.37 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.69 120.12 53.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 C-N-CA 122.927 0.491 . . . . 0.0 110.683 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.401 ' OH ' ' HB3' ' A' ' 65' ' ' SER . 54.3 m-85 -85.54 104.83 15.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.603 0.761 . . . . 0.0 109.868 172.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.9 t -98.31 155.45 17.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 128.94 19.07 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.69 0.619 . . . . 0.0 109.39 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.75 158.67 26.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.282 0.233 . . . . 0.0 111.052 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -58.71 -19.26 38.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.452 0.701 . . . . 0.0 112.377 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.08 -48.9 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.423 1.089 . . . . 0.0 110.675 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 t -89.72 -19.33 24.92 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.95 87.37 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -82.04 174.91 10.8 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.361 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -79.69 94.91 5.8 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.16 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -154.62 -43.92 0.09 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.339 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -137.91 177.22 8.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.299 0.64 . . . . 0.0 110.547 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.11 60.82 0.26 Allowed Glycine 0 CA--C 1.502 -0.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.41 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.03 -41.74 75.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.63 0.772 . . . . 0.0 109.84 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -166.56 137.48 3.38 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.2 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -74.17 141.44 45.51 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.552 0.741 . . . . 0.0 110.126 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -84.92 27.82 0.73 Allowed 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.549 1.14 . . . . 0.0 111.715 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -168.78 22.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.132 0.973 . . . . 0.0 110.255 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 m80 65.95 -171.22 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.608 1.163 . . . . 0.0 110.011 -165.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -47.17 136.21 9.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.317 1.047 . . . . 0.0 112.673 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 CA--C 1.552 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 109.875 178.078 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 42' ' ' ASP . 41.0 mm -117.35 136.17 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.97 146.16 35.55 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -77.16 124.08 7.05 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 121.507 1.471 . . . . 0.0 109.919 167.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -112.52 -176.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.8 0.84 . . . . 0.0 109.849 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -151.63 146.41 25.79 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.665 0.786 . . . . 0.0 109.008 173.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 36' ' ' THR . 24.8 tpt180 -103.69 138.08 40.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -121.32 105.71 10.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.04 107.35 14.84 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 109.708 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 14.5 m -90.45 119.02 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 93' ' ' LYS . 92.2 t -91.13 118.59 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.524 ' H ' ' HD3' ' A' ' 93' ' ' LYS . 70.7 m -106.96 103.3 12.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.329 0.651 . . . . 0.0 110.434 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -80.01 94.03 5.85 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.444 HG23 HG22 ' A' ' 12' ' ' THR . 82.2 p -86.47 114.47 23.25 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 52.7 mt -110.68 126.19 68.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-O 121.936 0.874 . . . . 0.0 111.234 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.32 110.25 22.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.324 -1.762 . . . . 0.0 106.865 -173.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HD1' HG22 ' A' ' 100' ' ' VAL . 23.0 m-85 -82.08 109.78 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.6 mtm180 -141.22 164.22 30.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.35 0.66 . . . . 0.0 109.791 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -92.2 175.95 6.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.401 0.68 . . . . 0.0 110.314 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.62 -25.66 68.06 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.387 171.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.14 -17.08 63.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.603 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.05 -13.5 66.81 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.04 57.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.372 1.069 . . . . 0.0 111.046 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 38.7 t -83.28 114.98 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 122.948 0.499 . . . . 0.0 109.974 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.29 -56.54 4.94 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -170.81 94.5 0.2 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 0.0 110.147 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.84 106.62 18.58 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.768 -0.582 . . . . 0.0 110.169 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -179.71 -6.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.507 0.723 . . . . 0.0 112.292 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -82.85 86.19 6.97 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.266 0.555 . . . . 0.0 111.487 -163.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.02 125.39 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 0.0 110.71 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -120.25 145.51 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -138.65 131.49 29.41 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.642 0.777 . . . . 0.0 109.703 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 87.7 mt -110.69 136.1 50.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 0.0 109.767 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.42 114.71 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -100.94 96.33 7.19 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 85.1 m -113.59 104.27 12.08 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.626 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -130.92 139.61 50.1 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 61.2 p -90.81 141.55 28.69 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -167.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.96 -142.37 5.46 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.62 139.44 18.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.632 0.716 . . . . 0.0 111.205 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB2' HD13 ' A' ' 5' ' ' ILE . 17.2 ttm180 -103.88 127.12 51.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.102 0.561 . . . . 0.0 110.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 32.4 t70 -73.62 111.25 8.58 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.065 0.946 . . . . 0.0 108.914 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.02 -11.37 56.86 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.5 t -83.24 -31.93 26.73 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.359 0.527 . . . . 0.0 110.401 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -101.39 -30.84 11.23 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.049 0.54 . . . . 0.0 110.207 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.05 49.16 4.35 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 20.0 ptmt -130.29 143.77 50.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.502 1.121 . . . . 0.0 109.521 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -95.27 127.67 41.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.075 0.55 . . . . 0.0 110.49 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.88 126.13 61.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.453 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 81.7 m95 -125.07 143.42 50.93 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.304 1.042 . . . . 0.0 108.268 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 23.2 t70 -62.93 143.13 57.98 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.95 0.5 . . . . 0.0 110.384 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.8 p -68.6 -38.21 80.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.232 0.213 . . . . 0.0 111.496 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.18 -0.94 57.49 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.841 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 37' ' ' GLN . 19.5 t90 -48.3 120.64 3.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.991 0.916 . . . . 0.0 111.394 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 p -154.91 130.01 9.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 37' ' ' GLN . 23.6 tp -115.08 139.56 49.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 m -110.87 150.37 29.27 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.487 0.715 . . . . 0.0 109.803 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 30.8 tp60 -153.87 127.91 8.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 m -78.27 110.27 13.14 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.31 0.644 . . . . 0.0 111.286 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.434 ' HD2' HG21 ' A' ' 83' ' ' VAL . 15.0 m-85 -75.53 130.23 38.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.25 174.42 8.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.821 0.848 . . . . 0.0 109.961 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 69.91 56.81 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.586 1.154 . . . . 0.0 111.802 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 3.5 mm? -113.7 91.83 22.51 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.467 0.707 . . . . 0.0 109.976 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.47 99.9 0.77 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 123.655 2.904 . . . . 0.0 113.097 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 m -78.73 124.25 85.16 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.772 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.3 122.93 11.58 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 123.521 2.814 . . . . 0.0 112.895 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.0 108.8 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.0 mt -101.89 117.12 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.9 mm -72.88 135.75 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.202 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.49 84.01 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.709 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -130.22 172.17 12.09 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.279 1.032 . . . . 0.0 110.322 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -144.52 123.53 12.8 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.88 131.41 45.46 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.95 -38.58 76.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.854 0.862 . . . . 0.0 109.245 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.6 84.9 49.34 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.604 169.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.0 -4.39 11.38 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.107 2.538 . . . . 0.0 113.227 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 63' ' ' LEU . 17.1 tpt -143.97 136.62 27.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.281 1.032 . . . . 0.0 108.699 172.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -125.54 126.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 71.67 0.91 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 123.914 0.759 . . . . 0.0 112.551 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -96.67 22.52 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.328 2.685 . . . . 0.0 114.355 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -165.81 -169.19 1.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 118.366 0.53 . . . . 0.0 112.216 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 9.2 mp0 -68.04 133.18 48.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.134 1.374 . . . . 0.0 111.601 -171.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.434 HG21 ' HD2' ' A' ' 60' ' ' PHE . 60.0 t -122.21 110.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.06 0.944 . . . . 0.0 109.178 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.6 m -96.82 117.19 30.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.955 0.502 . . . . 0.0 109.774 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 90' ' ' PHE . 37.8 t -97.98 116.32 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.55 162.55 14.15 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.796 0.838 . . . . 0.0 110.899 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 39.9 p -57.78 -35.23 70.51 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.52 1.128 . . . . 0.0 110.802 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -49.59 -49.73 45.51 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.007 1.442 . . . . 0.0 111.202 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -118.35 16.12 13.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.818 -172.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' HA ' HG12 ' A' ' 85' ' ' VAL . 9.6 t80 -66.08 -27.07 67.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.543 0.61 . . . . 0.0 112.459 -166.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.5 -16.87 57.03 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -102.65 156.11 17.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.045 1.338 . . . . 0.0 110.201 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 12' ' ' THR . 9.2 ptpp? -111.71 126.68 55.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -77.91 -12.62 60.0 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -116.15 127.66 55.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.75 -93.05 0.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.904 0.882 . . . . 0.0 109.523 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -108.32 104.94 14.43 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 3.3 mp0 -110.68 135.63 51.0 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -121.5 122.09 38.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.423 0.689 . . . . 0.0 110.09 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' A' ' 17' ' ' TYR . 1.6 m -83.23 141.86 14.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.4 110.73 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.089 0.556 . . . . 0.0 110.848 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -85.94 96.23 9.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 p -99.6 140.05 34.36 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.33 142.09 10.73 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.557 0.536 . . . . 0.0 110.801 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.81 -173.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.089 1.356 . . . . 0.0 113.016 -162.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.54 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 10.0 t -51.96 -11.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.95 1.3 . . . . 0.0 113.751 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.1 mt -48.1 -47.3 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.108 1.363 . . . . 0.0 111.336 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -108.3 -25.24 11.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 112.429 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.54 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 19.0 mt-30 -76.82 165.77 24.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.979 0.511 . . . . 0.0 110.23 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -67.1 122.3 17.49 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -66.81 135.28 53.69 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 124.176 0.923 . . . . 0.0 111.241 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -163.19 -53.97 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.468 1.107 . . . . 0.0 109.15 -172.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -165.94 138.21 3.98 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.94 0.896 . . . . 0.0 109.532 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.78 5.88 3.44 Favored Glycine 0 C--N 1.318 -0.425 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.18 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.4 mt -73.02 -21.61 60.79 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.111 0.964 . . . . 0.0 110.775 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.79 105.52 0.46 Allowed 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -142.08 17.97 2.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.36 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -75.37 75.57 2.46 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.36 0.6 . . . . 0.0 110.094 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -92.41 162.75 14.12 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -74.1 -69.06 0.47 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -144.74 -52.13 0.29 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 167.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 CA--C 1.556 1.191 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.826 166.477 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' HD12 ' A' ' 43' ' ' LEU . 28.0 ttt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 42' ' ' ASP . 49.6 mm -123.91 141.19 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.317 0.647 . . . . 0.0 109.828 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -112.63 128.65 25.28 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 166.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.15 126.63 18.28 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.45 2.1 . . . . 0.0 110.851 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 41' ' ' ARG . 34.0 pt -124.03 -179.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.409 0.684 . . . . 0.0 109.75 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 157.71 24.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.735 1.214 . . . . 0.0 108.291 170.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.509 ' HD3' ' HD2' ' A' ' 90' ' ' PHE . 57.3 ttt-85 -126.77 152.7 46.54 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 34' ' ' ILE . 86.6 m -121.07 108.77 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.454 1.101 . . . . 0.0 108.886 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -100.8 121.78 42.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 34.6 m -105.29 118.09 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 83' ' ' VAL . 97.9 t -97.55 110.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -118.12 131.55 56.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.749 . . . . 0.0 110.57 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 42.3 mt-30 -103.33 100.27 10.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -76.83 100.5 5.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.569 HD12 ' HB ' ' A' ' 78' ' ' VAL . 13.0 tt -101.55 135.52 37.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 122.261 1.029 . . . . 0.0 111.009 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -118.98 148.42 43.0 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.842 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.17 115.76 19.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 37.5 mtm180 -138.13 152.42 48.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HE2' HG21 ' A' ' 68' ' ' ILE . 63.5 m-85 -77.97 169.76 17.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.495 0.718 . . . . 0.0 110.627 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.31 -22.72 63.76 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.843 0.457 . . . . 0.0 111.483 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.96 -12.37 60.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.635 0.774 . . . . 0.0 111.312 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 2.45 68.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.77 147.71 48.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.976 0.51 . . . . 0.0 110.264 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 96.7 t -82.23 135.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.126 0.571 . . . . 0.0 109.94 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 -63.11 1.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -157.2 97.42 1.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.584 1.154 . . . . 0.0 108.788 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -80.38 -9.23 59.75 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.065 0.546 . . . . 0.0 112.422 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.1 71.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.28 1.032 . . . . 0.0 110.877 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -124.7 122.32 37.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 159.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.35 111.75 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.5 p -106.81 125.52 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.759 0.824 . . . . 0.0 108.87 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.3 p -123.92 133.9 53.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.328 0.651 . . . . 0.0 109.418 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 76.7 mt -99.4 123.09 43.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -93.22 116.5 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 8' ' ' THR . 13.7 m-85 -106.43 97.69 7.46 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.4 m -114.57 116.46 28.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.8 44.36 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -76.91 178.12 7.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.926 -165.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.34 -166.73 31.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.186 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 137.74 35.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.7 ttm180 -110.17 124.87 52.35 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.044 0.537 . . . . 0.0 109.887 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 26.5 t70 -74.55 113.83 12.25 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.832 1.253 . . . . 0.0 109.882 173.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 1' ' ' MET . 88.9 mt -85.08 -1.86 57.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.6 t -87.67 -28.61 21.71 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.863 0.756 . . . . 0.0 110.842 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -107.59 -30.84 8.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.569 0.348 . . . . 0.0 110.225 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.71 11.98 56.19 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.86 -173.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -84.89 145.95 27.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.041 0.937 . . . . 0.0 110.279 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.29 121.4 42.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.249 0.62 . . . . 0.0 110.273 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.98 116.02 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -108.97 158.86 17.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.59 1.156 . . . . 0.0 109.079 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 54' ' ' TRP . 17.7 t70 -82.9 125.34 31.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -73.0 -25.88 61.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.745 0.418 . . . . 0.0 111.978 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -81.23 -13.17 58.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.14 0.576 . . . . 0.0 110.789 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' ASP . 8.8 t90 -69.28 134.58 49.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.138 0.975 . . . . 0.0 111.583 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -152.11 121.41 6.77 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.458 1.503 . . . . 0.0 107.441 172.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.09 124.86 44.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -109.95 129.84 55.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -129.4 145.48 51.4 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 m -112.01 120.32 41.46 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.841 0.456 . . . . 0.0 111.446 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 13' ' ' GLN . 51.0 m-85 -65.24 136.49 56.68 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 164.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -170.59 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.68 0.792 . . . . 0.0 109.754 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.55 86.09 5.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.783 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 15' ' ' ILE . 3.3 tm? -144.13 112.79 5.24 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -93.17 178.71 1.19 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.552 2.834 . . . . 0.0 111.743 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -159.17 151.38 17.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.211 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.75 117.83 5.36 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 121.963 1.775 . . . . 0.0 110.62 172.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.9 107.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 19' ' ' TYR . 40.9 mt -102.31 116.33 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.82 139.97 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.7 3.58 89.44 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.401 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.83 171.44 14.51 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.188 0.995 . . . . 0.0 110.073 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -158.5 109.22 2.11 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.17 151.12 46.73 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.559 0.743 . . . . 0.0 111.265 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -73.33 -20.04 60.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.179 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.33 101.57 2.96 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 158.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.26 0.28 5.49 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.151 1.9 . . . . 0.0 113.157 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.6 ttt -150.55 136.67 18.53 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.722 0.809 . . . . 0.0 109.584 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.599 HG11 ' HG3' ' A' ' 98' ' ' GLU . 91.8 t -121.52 107.57 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 163.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.82 -95.74 0.11 Allowed Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.058 -1.412 . . . . 0.0 111.369 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -33.8 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.721 1 C-N-CA 125.463 4.109 . . . . 0.0 115.991 -169.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -168.16 126.73 1.19 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.491 1.116 . . . . 0.0 109.22 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.67 121.5 26.93 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 11' ' ' VAL . 84.2 t -103.23 123.12 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.728 0.811 . . . . 0.0 109.41 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.4 m -103.03 131.17 50.21 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.13 112.38 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 4.1 m-20 -79.99 164.69 23.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.836 0.854 . . . . 0.0 109.251 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.6 p -54.56 -36.52 64.43 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.986 0.804 . . . . 0.0 110.384 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -47.87 -49.34 29.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.351 1.46 . . . . 0.0 112.406 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -119.43 23.69 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.675 0.79 . . . . 0.0 111.604 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.509 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 12.4 t80 -75.13 -19.76 59.74 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 122.006 -0.434 . . . . 0.0 111.161 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.31 -16.46 27.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.688 0.795 . . . . 0.0 109.196 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -89.08 160.97 16.79 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.204 1.001 . . . . 0.0 109.687 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -111.85 159.55 18.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.58 0.752 . . . . 0.0 109.443 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -143.39 33.39 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.174 0.59 . . . . 0.0 110.064 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.63 166.35 15.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 111.786 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.17 166.11 24.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.837 0.855 . . . . 0.0 111.445 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -129.92 108.29 10.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' HG3' HG11 ' A' ' 78' ' ' VAL . 25.0 mm-40 -94.29 145.55 24.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.847 0.459 . . . . 0.0 110.104 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.5 m -139.99 98.11 3.39 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.44 142.46 13.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.32 116.74 52.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.017 0.927 . . . . 0.0 110.584 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.87 98.73 9.33 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -83.88 159.96 21.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.515 ' HB3' HG21 ' A' ' 108' ' ' THR . . . -50.09 144.42 6.97 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.583 0.628 . . . . 0.0 109.805 173.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -46.86 153.53 0.4 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.655 1.182 . . . . 0.0 112.002 -164.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.626 HG21 ' HE2' ' A' ' 112' ' ' LYS . 3.4 t -42.49 -21.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.702 1.601 . . . . 0.0 114.56 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.6 mm -48.75 -52.63 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 125.011 1.325 . . . . 0.0 111.89 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 104' ' ' ALA . 15.2 t -75.39 -24.22 57.18 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.717 0.407 . . . . 0.0 111.535 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -81.65 164.3 21.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.239 0.616 . . . . 0.0 109.597 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -83.26 85.46 7.21 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? 60.16 -165.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.653 1.181 . . . . 0.0 110.492 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.626 ' HE2' HG21 ' A' ' 106' ' ' THR . 85.2 mttt -100.76 -60.81 1.46 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.2 t70 68.72 155.92 0.13 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.981 1.712 . . . . 0.0 111.201 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.99 95.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.5 mt 68.75 -65.25 0.29 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.661 1.984 . . . . 0.0 110.973 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.72 119.38 20.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.968 0.907 . . . . 0.0 110.06 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -134.89 108.93 8.18 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 64.05 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.379 1.072 . . . . 0.0 108.905 -169.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -65.67 -36.95 85.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.592 0.757 . . . . 0.0 112.384 -170.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 61.56 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.603 1.161 . . . . 0.0 109.295 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -163.18 -57.35 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.356 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 124.225 1.01 . . . . 0.0 108.802 179.401 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 42' ' ' ASP . 27.3 mm -116.19 134.07 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.61 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.0 134.99 19.42 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 165.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.51 130.4 24.99 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.687 2.258 . . . . 0.0 111.676 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 41' ' ' ARG . 18.8 pt -125.09 163.72 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.92 0.888 . . . . 0.0 109.995 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -156.3 146.58 21.48 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 12.6 mmm180 -117.72 140.33 49.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.988 1.315 . . . . 0.0 108.506 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.448 HG23 HG23 ' A' ' 34' ' ' ILE . 28.9 m -111.52 122.2 47.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.432 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 5.6 tp-100 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.2 m -119.64 132.82 68.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.051 0.453 . . . . 0.0 110.609 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.61 123.29 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -110.09 105.1 14.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 110.485 -162.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 46.2 tt0 -98.55 109.62 22.35 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.664 HG23 HG22 ' A' ' 30' ' ' VAL . 31.4 m -85.99 104.36 15.54 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.574 0.75 . . . . 0.0 110.378 -177.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -93.08 129.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 122.033 -0.417 . . . . 0.0 110.47 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.201 1.0 . . . . 0.0 108.452 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.433 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -97.73 118.28 33.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 23.7 mtm180 -143.48 159.65 42.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.477 0.711 . . . . 0.0 109.65 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 81.1 m-85 -86.5 170.92 11.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.213 1.005 . . . . 0.0 109.916 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -69.15 -22.93 63.91 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.566 0.698 . . . . 0.0 110.313 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.62 -20.94 66.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.327 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.64 -20.51 46.05 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.39 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.17 136.91 52.55 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 0.0 111.452 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 58.7 t -85.57 109.57 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.211 0.604 . . . . 0.0 110.629 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 -49.72 45.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.01 0.524 . . . . 0.0 110.139 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -173.33 90.24 0.08 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.19 -25.73 62.65 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.25 80.69 2.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.702 0.801 . . . . 0.0 110.386 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -134.18 79.51 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 14' ' ' THR . 12.9 t -93.81 118.52 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 113.826 -1.533 . . . . 0.0 108.77 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -102.4 157.71 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -143.27 141.75 31.14 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 109.414 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 88.8 mt -99.9 125.89 45.95 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 8' ' ' THR . 3.2 mp -86.06 114.53 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.08 120.2 40.05 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.361 1.464 . . . . 0.0 108.851 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.3 m -100.88 101.73 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.545 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 2.2 mp0 -89.55 79.52 6.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 37.2 p -85.45 137.08 33.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.48 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.43 -156.25 9.71 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -143.25 135.34 26.95 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.3 ttm180 -107.44 122.13 46.01 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 109.447 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.526 ' HA ' HD13 ' A' ' 2' ' ' ILE . 12.2 t70 -69.63 127.74 34.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -83.16 -23.01 33.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -71.53 -46.92 58.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.13 0.491 . . . . 0.0 110.006 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -88.71 -32.23 18.06 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.091 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.56 0.29 73.03 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 -169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -67.22 136.58 55.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.476 1.11 . . . . 0.0 110.846 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.58 107.86 18.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.48 0.712 . . . . 0.0 110.288 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 49' ' ' ILE . 2.9 mp -94.12 91.84 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CH2' ' HG2' ' A' ' 7' ' ' ARG . 36.7 m95 -84.02 124.06 30.66 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 31.6 t70 -52.88 124.43 14.08 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.842 0.714 . . . . 0.0 110.05 -176.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 m -57.85 -37.8 74.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.52 0.728 . . . . 0.0 111.621 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -96.93 16.46 19.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.917 0.887 . . . . 0.0 111.206 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.545 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 40.5 t-105 -64.87 142.17 58.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.556 0.342 . . . . 0.0 110.594 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 55.8 p -155.36 140.94 17.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.095 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -116.8 130.44 56.72 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -112.26 124.39 52.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.26 0.624 . . . . 0.0 109.541 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -135.69 141.33 44.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -103.58 126.79 50.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.299 0.64 . . . . 0.0 111.624 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 37.1 m-85 -69.13 112.69 5.9 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.81 -169.66 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.56 1.163 . . . . 0.0 109.072 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.96 5.63 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.342 1.057 . . . . 0.0 112.164 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.423 HD23 HG21 ' A' ' 78' ' ' VAL . 31.5 tp -116.63 100.28 53.33 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.804 0.842 . . . . 0.0 108.982 -172.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -92.6 -151.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.285 2.657 . . . . 0.0 111.64 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -149.59 145.16 18.65 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.204 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.82 127.58 24.91 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.131 2.554 . . . . 0.0 112.003 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -77.23 106.59 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.2 134.21 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.008 0.923 . . . . 0.0 108.933 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.34 120.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.576 1.55 . . . . 0.0 109.479 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.58 81.32 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.514 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 93.3 m-85 -139.18 160.76 39.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.53 0.732 . . . . 0.0 110.096 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -151.04 126.36 10.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.4 150.32 35.7 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.749 0.82 . . . . 0.0 111.001 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.8 -29.8 70.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.882 0.739 . . . . 0.0 109.446 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -133.48 96.7 16.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.755 168.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.48 -7.6 21.64 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.794 2.33 . . . . 0.0 111.928 175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 tpt -139.12 126.87 22.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 63' ' ' LEU . 88.3 t -65.65 120.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.31 116.46 5.75 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 124.818 1.324 . . . . 0.0 112.694 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 59.9 Cg_endo -70.42 128.96 16.14 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 112.623 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -142.24 135.04 28.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.978 0.418 . . . . 0.0 110.776 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.3 103.9 12.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.581 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -84.03 134.35 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 109.207 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.7 m -121.35 113.78 20.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.363 0.665 . . . . 0.0 109.618 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.17 114.33 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -82.51 174.52 10.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.364 0.602 . . . . 0.0 109.856 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.4 p -71.43 -22.12 61.88 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.934 172.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.21 4.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.126 0.97 . . . . 0.0 109.715 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.66 29.82 3.55 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.323 1.049 . . . . 0.0 110.251 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 9' ' ' GLN . 49.2 t80 -50.94 -48.77 60.77 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.496 1.118 . . . . 0.0 110.634 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 91' ' ' LEU . 1.8 mp -82.58 -23.77 34.28 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.653 -161.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.99 115.07 10.78 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -88.91 106.93 18.73 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.64 46.36 1.33 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.882 0.849 . . . . 0.0 110.229 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -62.55 157.76 19.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.748 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 78.0 ttt180 -157.15 147.3 20.93 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 -172.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.14 144.74 26.11 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 10.4 tp10 -136.34 108.44 7.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 172.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 84.3 m -100.65 122.6 43.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.241 0.617 . . . . 0.0 109.62 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.463 HG12 ' HG2' ' A' ' 75' ' ' LYS . 2.4 m -90.71 142.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.24 106.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.474 0.31 . . . . 0.0 110.432 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 87.2 m-85 -72.75 107.48 5.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.749 1.22 . . . . 0.0 109.682 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p -108.21 140.26 41.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 100.58 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.16 0.984 . . . . 0.0 110.77 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -76.99 -174.13 3.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.971 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -69.98 -19.33 63.35 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 112.23 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -68.0 -47.64 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.253 0.621 . . . . 0.0 110.604 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -71.07 -10.57 59.98 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.171 0.51 . . . . 0.0 111.195 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -99.18 177.6 5.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.995 0.918 . . . . 0.0 109.792 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 67.1 4.42 3.61 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.758 1.223 . . . . 0.0 113.83 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 66.14 170.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.821 1.248 . . . . 0.0 111.999 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -98.38 -44.38 6.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.213 0.605 . . . . 0.0 110.278 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -79.49 97.97 6.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.683 0.793 . . . . 0.0 110.251 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.38 5.05 85.42 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 115.256 -0.884 . . . . 0.0 113.465 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.28 -31.03 71.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.0 0.92 . . . . 0.0 110.844 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.62 140.51 37.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.67 0.788 . . . . 0.0 109.56 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.79 160.9 27.32 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.146 0.578 . . . . 0.0 110.602 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.7 m80 66.24 91.17 0.09 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.468 1.107 . . . . 0.0 109.874 -175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -170.32 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.703 0.801 . . . . 0.0 110.719 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.3 m80 62.21 -171.89 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.335 1.054 . . . . 0.0 112.096 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -157.12 -57.08 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.175 0.59 . . . . 0.0 110.102 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 124.549 1.14 . . . . 0.0 110.356 -177.422 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.7 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.82 0.343 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.481 HD12 ' HD3' ' A' ' 40' ' ' LYS . 35.4 mm -120.2 142.38 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.204 1.002 . . . . 0.0 109.121 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -120.99 149.92 52.09 Favored Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.26 127.78 13.06 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.395 2.064 . . . . 0.0 111.151 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.9 pt -135.1 137.21 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 2.2 mptm? -137.13 142.11 42.26 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -116.75 137.67 52.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 34' ' ' ILE . 85.1 m -120.71 104.91 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.361 0.664 . . . . 0.0 109.363 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -105.06 119.2 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.086 0.554 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 32' ' ' SER . 35.0 m -97.5 125.86 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 104.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -95.9 102.47 14.27 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.852 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -108.28 113.03 25.8 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 30' ' ' VAL . 95.7 m -92.73 107.53 19.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.865 0.866 . . . . 0.0 109.772 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' HG ' ' A' ' 63' ' ' LEU . 1.6 mp -90.13 130.63 39.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.387 0.613 . . . . 0.0 109.932 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 11.5 m-70 -109.26 110.36 21.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.566 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 100' ' ' VAL . 85.0 m-85 -87.29 116.3 25.28 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.403 HH21 HD11 ' A' ' 101' ' ' ILE . 61.7 mtm180 -134.33 -171.32 2.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.52 0.728 . . . . 0.0 110.528 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -121.43 167.4 12.85 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.61 -17.98 63.57 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.803 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.45 -17.26 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.627 1.171 . . . . 0.0 111.192 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.55 54.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.44 137.98 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.57 1.148 . . . . 0.0 111.244 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.3 137.59 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.208 0.603 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.45 -60.49 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.15 115.29 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.309 1.043 . . . . 0.0 108.893 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.628 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.8 p-10 -102.3 26.29 7.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.654 0.781 . . . . 0.0 112.862 -173.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.23 10.79 39.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.677 0.791 . . . . 0.0 111.776 -173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -90.13 73.06 7.26 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.167 0.984 . . . . 0.0 111.038 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 14' ' ' THR . 24.3 t -93.63 119.01 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.898 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 63' ' ' LEU . 6.1 p -105.84 130.99 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 60.4 p -122.36 118.34 28.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.619 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 39.7 mt -98.97 122.9 42.83 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -82.83 124.66 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.097 0.959 . . . . 0.0 109.898 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HA ' HD23 ' A' ' 56' ' ' LEU . 85.5 m-85 -115.35 101.82 9.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.194 0.998 . . . . 0.0 109.099 172.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 m -95.82 107.7 19.97 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -94.33 123.81 37.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 57.5 p -88.14 138.73 31.19 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.746 0.654 . . . . 0.0 109.663 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.21 -171.57 18.01 Favored Glycine 0 C--O 1.241 0.566 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.126 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -136.55 143.84 43.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.7 ttm180 -114.95 118.62 33.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.632 0.373 . . . . 0.0 110.44 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.04 107.11 8.03 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.534 HD12 ' HG3' ' A' ' 1' ' ' MET . 84.4 mt -79.98 -1.31 39.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.927 0.891 . . . . 0.0 112.719 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -73.42 -43.25 60.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.419 0.688 . . . . 0.0 109.927 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -100.57 -24.12 14.53 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.925 0.89 . . . . 0.0 109.887 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.85 34.11 35.29 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.733 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -104.13 141.98 35.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 110.777 -172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 42.0 mt-10 -97.92 122.86 41.54 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 123.276 0.63 . . . . 0.0 110.728 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 49' ' ' ILE . 2.6 mp -103.26 105.23 17.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -102.61 137.25 41.09 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -69.12 118.56 12.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 t -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.392 0.677 . . . . 0.0 111.171 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.27 -18.52 60.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.273 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -61.43 128.03 34.34 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 p -153.99 117.44 4.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.941 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 35' ' ' PHE . 57.0 tp -101.22 130.14 47.28 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -95.55 111.07 23.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 33.9 tp60 -112.06 124.66 52.89 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.5 m -64.57 118.52 8.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.527 1.131 . . . . 0.0 110.642 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -106.97 115.03 29.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 59' ' ' THR . 12.3 pt-20 -179.32 -161.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.03 0.932 . . . . 0.0 109.897 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.92 -98.39 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.862 1.265 . . . . 0.0 110.276 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HG ' HG12 ' A' ' 15' ' ' ILE . 3.6 mm? 47.36 91.57 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.767 0.827 . . . . 0.0 111.179 -170.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.81 97.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.566 2.844 . . . . 0.0 112.588 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -81.99 113.54 43.98 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.487 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' ILE . 17.9 Cg_endo -56.2 121.2 9.57 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.47 2.113 . . . . 0.0 110.432 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.91 103.62 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 66' ' ' PRO . 48.5 mt -107.22 112.91 42.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -76.94 137.87 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.351 0.66 . . . . 0.0 109.786 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.94 4.5 84.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.199 -170.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.9 m-85 -142.63 162.76 34.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.575 0.75 . . . . 0.0 111.415 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -151.19 135.02 16.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.638 1.175 . . . . 0.0 107.85 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 159.18 29.87 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.791 0.836 . . . . 0.0 111.061 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.64 -34.55 74.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 105.12 6.64 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.167 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.82 -4.61 15.69 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.102 1.868 . . . . 0.0 111.688 163.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.5 tpp -135.19 107.38 7.2 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 98' ' ' GLU . 95.7 t -83.7 123.41 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.393 0.677 . . . . 0.0 111.701 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.81 53.58 13.42 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 125.022 1.451 . . . . 0.0 115.397 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 72.9 Cg_endo -74.14 80.68 2.12 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.251 1.967 . . . . 0.0 111.851 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -158.48 119.42 3.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.12 0.568 . . . . 0.0 109.703 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.01 100.85 0.45 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 123.967 0.792 . . . . 0.0 111.058 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.4 112.17 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.991 0.916 . . . . 0.0 110.548 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.4 m -94.97 101.23 12.99 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.324 0.65 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.91 124.64 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.94 170.38 16.56 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.994 0.809 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 16.7 t -70.46 -27.0 63.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.34 171.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.27 -49.82 62.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.718 1.207 . . . . 0.0 111.34 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -104.38 23.1 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.837 0.455 . . . . 0.0 111.21 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 52.7 t80 -58.94 -53.46 58.18 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.349 1.059 . . . . 0.0 112.696 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.95 -4.37 37.77 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.259 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.93 134.11 44.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.571 0.748 . . . . 0.0 110.019 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -90.19 172.57 8.7 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.181 0.593 . . . . 0.0 109.939 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 15.06 4.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.768 0.827 . . . . 0.0 110.784 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -162.62 -165.86 1.24 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 108.856 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.74 -53.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.381 0.672 . . . . 0.0 109.858 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -145.03 115.53 7.63 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.654 -170.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HG2' HG13 ' A' ' 78' ' ' VAL . 16.7 tp10 -107.25 148.29 29.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.825 1.25 . . . . 0.0 109.777 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -136.85 117.84 14.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.26 0.624 . . . . 0.0 109.975 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -86.7 141.75 13.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.403 HD11 HH21 ' A' ' 18' ' ' ARG . 30.9 mm -112.23 120.55 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 56.7 m-85 -80.21 117.79 21.32 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.77 0.828 . . . . 0.0 109.501 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.1 p -110.93 158.43 18.76 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 119.16 8.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.143 0.577 . . . . 0.0 110.638 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -75.53 -169.02 0.93 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.911 0.884 . . . . 0.0 112.902 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 14.6 t -50.96 -21.75 1.91 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.558 1.543 . . . . 0.0 114.587 -177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.65 -44.53 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.98 0.512 . . . . 0.0 111.566 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -85.78 -26.27 25.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.878 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 12.1 mm100 -80.01 167.33 20.59 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.604 0.762 . . . . 0.0 110.656 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -97.16 110.38 22.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 68.48 176.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.832 1.253 . . . . 0.0 112.006 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' HE3' HG21 ' A' ' 106' ' ' THR . 9.5 ptpp? -127.67 -47.03 1.42 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.067 0.547 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -80.2 108.14 13.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.41 0.684 . . . . 0.0 110.682 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.88 14.94 3.57 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 123.161 0.288 . . . . 0.0 112.422 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.3 mt -87.17 -57.31 3.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.551 0.741 . . . . 0.0 109.611 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 60.02 -75.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.867 1.667 . . . . 0.0 112.454 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -88.15 128.09 35.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.919 1.287 . . . . 0.0 109.954 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 41.0 m80 67.96 139.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.874 1.269 . . . . 0.0 112.764 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.77 152.5 17.75 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.355 0.662 . . . . 0.0 110.406 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -68.55 -18.41 64.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.203 1.001 . . . . 0.0 111.964 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 29.7 m80 76.84 107.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.95 1.7 . . . . 0.0 110.102 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 . . . . . 0 C--O 1.25 1.108 0 C-N-CA 124.203 1.001 . . . . 0.0 111.197 -176.755 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.0 mm -114.09 154.12 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.692 1.197 . . . . 0.0 109.841 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.23 150.73 49.81 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.86 0.864 . . . . 0.0 108.797 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.1 124.22 4.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.897 1.731 . . . . 0.0 111.674 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.626 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -121.55 171.67 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.373 0.669 . . . . 0.0 111.292 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.49 146.68 4.17 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.115 0.884 . . . . 0.0 110.738 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -106.97 165.33 11.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.796 0.838 . . . . 0.0 110.21 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' ILE . 93.1 m -131.88 106.29 7.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.145 0.978 . . . . 0.0 109.608 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -114.29 103.4 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 27.8 m -89.89 132.23 35.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 121.017 0.437 . . . . 0.0 109.85 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 94' ' ' GLN . 75.8 t -99.79 107.75 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -96.03 107.64 19.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.666 0.786 . . . . 0.0 110.89 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.453 HE21 HG11 ' A' ' 78' ' ' VAL . 3.2 tp60 -88.79 113.53 24.44 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 m -107.85 106.95 17.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 108.418 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 63' ' ' LEU . 19.0 tt -104.13 137.71 31.83 Favored 'Isoleucine or valine' 0 C--O 1.265 1.87 0 CA-C-O 122.229 1.014 . . . . 0.0 111.88 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -115.78 161.18 19.12 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.94 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.61 109.5 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.037 0.935 . . . . 0.0 108.872 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 32.1 mtm180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.245 0.618 . . . . 0.0 109.768 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 87.7 m-85 -88.52 176.05 7.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.454 0.702 . . . . 0.0 110.291 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.14 -22.28 60.55 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.468 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.46 -19.71 60.88 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.677 0.791 . . . . 0.0 110.607 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 -10.44 53.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.318 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.54 136.15 57.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.671 0.789 . . . . 0.0 111.076 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 56.0 t -80.35 111.9 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.645 0.378 . . . . 0.0 110.307 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.88 5.46 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -165.92 -175.35 3.36 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.704 1.602 . . . . 0.0 109.038 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.59 -161.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.039 0.936 . . . . 0.0 108.64 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 73.69 35.91 0.8 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.214 1.006 . . . . 0.0 109.799 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -111.37 121.32 44.93 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.18 144.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.031 0.532 . . . . 0.0 110.536 -173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -136.95 121.25 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -119.37 131.2 55.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.692 0.797 . . . . 0.0 109.245 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 96.5 mt -105.2 129.11 53.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.158 0.583 . . . . 0.0 110.005 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.57 HG23 HG23 ' A' ' 8' ' ' THR . 2.7 mp -87.53 111.9 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 123.972 0.795 . . . . 0.0 108.956 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HA ' HD23 ' A' ' 56' ' ' LEU . 41.3 m-85 -94.19 101.03 13.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.74 104.14 16.44 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -81.14 97.14 7.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 110.131 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 p -76.03 139.3 41.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.585 0.553 . . . . 0.0 110.453 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.48 -160.33 9.66 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.639 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 143.47 29.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HB2' HD13 ' A' ' 5' ' ' ILE . 36.0 ttm180 -112.39 128.8 56.41 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.329 0.652 . . . . 0.0 110.489 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 2' ' ' ILE . 16.3 t0 -72.59 121.99 20.64 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.94 -21.31 34.12 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -77.23 -49.76 14.39 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -171.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.36 -28.4 21.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.567 0.747 . . . . 0.0 109.676 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.91 30.51 20.42 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.354 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.74 136.36 42.7 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.323 1.049 . . . . 0.0 110.06 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -91.65 120.18 32.19 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.093 0.557 . . . . 0.0 110.358 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.31 116.65 36.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -114.28 136.9 52.46 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 6.8 m-20 -64.12 125.73 25.43 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 m -62.1 -41.9 98.68 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.758 0.661 . . . . 0.0 111.088 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.91 7.73 26.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.656 0.782 . . . . 0.0 111.984 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 81.0 t90 -61.46 132.62 54.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -155.33 123.02 5.66 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.049 0.939 . . . . 0.0 108.807 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 35' ' ' PHE . 22.9 tp -109.07 135.05 50.85 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -112.14 116.45 30.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.84 0.856 . . . . 0.0 108.871 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -119.93 144.66 47.32 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.815 0.446 . . . . 0.0 110.141 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.505 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.6 m -88.93 113.05 24.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.587 1.155 . . . . 0.0 112.24 -167.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.543 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 2.7 m-85 -99.98 102.38 13.73 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.935 0.894 . . . . 0.0 109.7 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.7 pt-20 -163.39 -165.68 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.285 0.634 . . . . 0.0 109.697 173.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.32 17.04 10.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.351 1.06 . . . . 0.0 111.807 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.449 HD11 HG21 ' A' ' 15' ' ' ILE . 43.0 tp -102.0 99.7 12.97 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.995 0.918 . . . . 0.0 109.078 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -92.68 -165.34 0.14 Allowed 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.529 2.819 . . . . 0.0 113.344 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -150.67 146.41 19.54 Favored Pre-proline 0 CA--C 1.557 1.218 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.755 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.66 139.4 48.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.536 2.824 . . . . 0.0 113.079 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.87 107.8 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.59 130.49 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.47 129.99 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.3 86.99 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.893 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 86.8 m-85 -140.37 146.31 38.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.34 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.0 m -144.03 134.08 24.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.655 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -66.58 156.61 34.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.639 0.775 . . . . 0.0 111.66 -175.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -65.63 -25.01 67.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.811 0.844 . . . . 0.0 110.214 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.35 85.19 6.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 -7.32 21.1 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.187 1.925 . . . . 0.0 112.982 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.4 ttt -146.61 95.37 2.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.709 1.204 . . . . 0.0 107.946 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 75' ' ' LYS . 53.9 t -71.81 111.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.679 0.792 . . . . 0.0 109.911 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.59 84.74 0.25 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.797 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 28.2 Cg_exo -65.44 0.04 3.18 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.593 2.862 . . . . 0.0 113.655 166.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 72.35 -88.39 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.881 1.672 . . . . 0.0 110.555 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -141.74 139.09 32.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.892 0.877 . . . . 0.0 110.517 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.3 t -116.03 120.33 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.16 0.984 . . . . 0.0 108.963 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.4 m -99.24 101.87 13.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.414 0.686 . . . . 0.0 109.596 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.33 125.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.16 168.0 16.21 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.139 0.976 . . . . 0.0 110.336 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.6 t -62.49 -27.47 69.15 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.267 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.74 -56.73 17.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.429 1.492 . . . . 0.0 110.773 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -105.19 15.38 27.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.648 0.779 . . . . 0.0 111.599 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -61.53 -24.5 66.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 0.0 111.185 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.28 -24.77 61.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.784 0.834 . . . . 0.0 111.156 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.0 136.11 33.42 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 109.264 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.66 138.89 33.55 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 11' ' ' VAL . 44.1 mt-30 -100.24 57.45 0.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.93 96.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -90.11 142.57 27.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.942 1.297 . . . . 0.0 109.864 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.68 125.09 10.93 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -134.91 141.56 46.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.473 0.709 . . . . 0.0 110.046 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.2 m -107.27 131.65 53.97 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.655 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 6.3 m -83.78 139.43 17.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.01 107.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 122.883 0.473 . . . . 0.0 110.196 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . 93.6 m-85 -74.96 103.33 5.12 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.08 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.0 p -111.72 147.96 34.49 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' HB1' HG23 ' A' ' 108' ' ' THR . . . -53.86 126.4 22.14 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.03 0.831 . . . . 0.0 110.356 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -74.63 165.01 25.93 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.268 0.355 . . . . 0.0 110.433 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.8 t -46.1 -35.9 5.35 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.776 1.23 . . . . 0.0 113.093 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.406 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 54.1 mt -61.27 -48.15 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.314 1.046 . . . . 0.0 111.044 -175.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 ' HB1' ' A' ' 104' ' ' ALA . 14.8 t -94.74 -14.91 24.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.192 -173.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.23 147.57 52.05 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.736 0.414 . . . . 0.0 111.963 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.92 128.39 36.25 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 166.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 58.79 88.62 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.171 0.919 . . . . 0.0 110.105 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 107' ' ' ILE . 60.5 mttp -70.14 -56.08 7.77 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.15 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.51 -77.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.261 1.424 . . . . 0.0 109.451 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.75 21.57 71.23 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.28 -41.88 89.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.147 0.979 . . . . 0.0 109.474 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -112.76 156.52 22.7 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.933 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -128.19 164.85 21.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.801 0.84 . . . . 0.0 108.775 170.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 63.71 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.405 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 130.21 42.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.361 0.665 . . . . 0.0 110.615 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -63.35 -57.49 10.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.472 0.709 . . . . 0.0 111.26 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -152.59 3.73 0.35 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.213 0.605 . . . . 0.0 111.125 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.839 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.0 140.2 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.577 0.751 . . . . 0.0 109.618 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.91 151.77 58.44 Favored Pre-proline 0 N--CA 1.476 0.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.92 121.4 3.61 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.512 1.475 . . . . 0.0 109.955 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 41' ' ' ARG . 17.4 pt -109.8 169.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.845 0.858 . . . . 0.0 109.483 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 141.35 11.24 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.198 0.523 . . . . 0.0 111.036 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -112.36 136.26 52.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 34' ' ' ILE . 87.3 m -114.01 107.81 16.17 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.695 0.798 . . . . 0.0 109.752 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -101.4 113.21 26.09 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.273 0.629 . . . . 0.0 109.445 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 21.7 m -96.6 146.36 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 94' ' ' GLN . 68.5 t -105.77 104.29 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -101.33 103.15 14.1 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 110.081 -171.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 12.8 mm100 -94.92 113.2 24.89 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.978 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.545 ' HB ' ' HG2' ' A' ' 97' ' ' GLU . 85.1 m -92.64 104.41 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 29' ' ' HIS . 2.0 mp -93.01 131.52 39.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.527 0.679 . . . . 0.0 110.25 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -133.83 118.62 18.2 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.126 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' HA ' HG13 ' A' ' 100' ' ' VAL . 56.2 m-85 -78.61 130.49 35.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.522 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 41.9 mtm180 -141.45 162.06 36.41 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 123.931 0.892 . . . . 0.0 109.314 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -89.54 175.08 7.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.73 -25.1 68.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.409 0.684 . . . . 0.0 112.097 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.52 -20.14 61.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.127 0.971 . . . . 0.0 111.104 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.03 3.29 60.54 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.373 0.421 . . . . 0.0 112.652 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.6 130.03 39.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.504 0.721 . . . . 0.0 109.532 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 34.9 t -82.55 103.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.274 0.488 . . . . 0.0 109.975 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -61.28 -39.59 91.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.337 0.655 . . . . 0.0 111.087 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -168.81 145.82 3.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.695 0.798 . . . . 0.0 109.005 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -137.52 109.99 7.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.408 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 174.55 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 124.689 1.243 . . . . 0.0 112.494 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 2.5 t-160 -75.99 78.64 2.86 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.88 0.738 . . . . 0.0 112.398 -155.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -92.44 128.36 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.96 166.03 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.4 p -156.85 141.62 16.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.551 0.74 . . . . 0.0 109.803 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 10.8 tp -121.86 123.48 41.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 122.585 0.354 . . . . 0.0 111.323 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -91.98 120.49 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.729 0.812 . . . . 0.0 109.663 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 89.9 m-85 -115.71 110.13 18.69 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.012 0.925 . . . . 0.0 109.209 173.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 m -103.24 102.04 12.0 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.683 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -85.97 99.33 11.36 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.5 t -89.64 133.4 34.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.422 0.629 . . . . 0.0 110.159 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.53 -156.35 9.29 Favored Glycine 0 C--O 1.242 0.617 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.832 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 144.67 37.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.969 0.508 . . . . 0.0 109.718 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.9 ttm-85 -115.17 129.94 56.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.866 0.466 . . . . 0.0 109.978 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 2.0 m-20 -75.4 113.83 13.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.6 -8.02 56.4 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.402 0.681 . . . . 0.0 111.411 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 t -78.68 -44.05 24.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.499 0.72 . . . . 0.0 110.925 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -101.57 -21.0 14.83 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.353 0.661 . . . . 0.0 112.055 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.75 25.74 71.21 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 21.3 ptmt -95.88 138.56 33.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.333 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -106.57 116.39 31.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.577 0.751 . . . . 0.0 110.266 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.6 mp -101.05 102.65 13.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -104.26 152.77 21.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.128 0.971 . . . . 0.0 108.936 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.55 120.98 40.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.378 0.671 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -74.98 -15.24 60.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.157 0.583 . . . . 0.0 112.172 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -85.38 -3.6 58.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.103 0.561 . . . . 0.0 111.103 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.48 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 88.3 t90 -60.77 128.03 34.56 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 p -155.31 114.51 3.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.6 tp -133.55 130.24 38.16 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 t -99.86 142.39 31.39 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.007 0.523 . . . . 0.0 109.7 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -123.22 145.02 49.0 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HG3' ' A' ' 61' ' ' GLU . 4.7 m -70.44 118.03 12.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.076 1.351 . . . . 0.0 110.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 115.92 29.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.0 OUTLIER -168.6 -155.78 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.33 1.052 . . . . 0.0 109.014 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 65.19 11.74 7.45 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.41 1.084 . . . . 0.0 111.819 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 100.28 8.99 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 87.2 Cg_endo -85.09 -173.35 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.547 2.165 . . . . 0.0 111.92 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.0 p -146.47 131.15 8.83 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.65 120.52 7.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.456 2.104 . . . . 0.0 111.039 172.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.65 105.95 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -106.72 114.46 45.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.2 mm -71.7 138.94 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 123.515 0.51 . . . . 0.0 109.785 -174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.17 8.66 85.15 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.961 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 96.8 m-85 -140.31 152.04 45.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.663 0.785 . . . . 0.0 110.074 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 m -134.28 115.67 14.39 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.39 150.94 45.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.927 0.891 . . . . 0.0 111.362 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.01 -39.37 75.88 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.698 0.761 . . . . 0.0 109.008 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -129.62 92.97 36.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.34 -1.3 . . . . 0.0 107.812 169.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.58 -4.92 14.03 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.636 2.224 . . . . 0.0 112.516 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 23.4 ttt -145.8 108.73 4.56 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 168.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 98' ' ' GLU . 76.7 t -70.5 115.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.199 0.312 . . . . 0.0 111.574 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 52.59 63.38 4.98 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.913 1.383 . . . . 0.0 114.862 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.57 77.7 3.35 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.316 2.011 . . . . 0.0 110.136 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -155.82 148.42 23.95 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.72 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -80.25 106.78 12.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.28 128.26 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 m -111.11 123.84 51.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.053 0.541 . . . . 0.0 110.544 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HA ' HD21 ' A' ' 89' ' ' ASN . 77.1 t -113.56 122.79 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.175 0.59 . . . . 0.0 109.521 172.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.47 162.12 13.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 29.7 m -58.3 -29.84 66.18 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.686 0.794 . . . . 0.0 112.335 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -65.83 -31.94 73.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.416 1.086 . . . . 0.0 111.563 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.528 HD21 ' HA ' ' A' ' 85' ' ' VAL . 2.9 p-10 -115.86 19.24 15.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.367 0.667 . . . . 0.0 111.191 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 84.1 t80 -74.59 -33.01 62.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.26 0.624 . . . . 0.0 112.591 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.74 -22.8 56.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.111 0.564 . . . . 0.0 109.598 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -81.67 136.49 35.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.701 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -100.3 159.08 15.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.672 ' HB2' HG13 ' A' ' 11' ' ' VAL . 55.4 mt-30 -109.4 34.12 3.95 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.82 101.14 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.898 0.879 . . . . 0.0 110.251 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 28.3 tpt180 -133.34 142.24 48.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.641 0.777 . . . . 0.0 110.404 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 14' ' ' THR . 40.2 mt-10 -90.56 119.1 30.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 169.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.594 ' HG2' HG13 ' A' ' 78' ' ' VAL . 10.5 tp10 -105.09 114.51 28.76 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.8 m -91.61 132.46 36.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.626 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -106.85 119.0 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.96 109.99 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 66.4 m-85 -80.49 101.32 9.02 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.543 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 m -91.64 152.36 20.28 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.599 ' HB1' HG23 ' A' ' 108' ' ' THR . . . -49.21 133.49 19.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.379 0.536 . . . . 0.0 110.023 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.36 155.23 21.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.854 0.862 . . . . 0.0 109.989 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -45.9 -34.11 3.66 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.004 1.321 . . . . 0.0 113.81 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.8 mm -72.47 -46.85 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.954 0.501 . . . . 0.0 110.549 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.599 HG23 ' HB1' ' A' ' 104' ' ' ALA . 14.9 t -91.81 3.3 55.45 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.424 0.69 . . . . 0.0 111.717 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -67.4 110.54 3.63 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -125.54 160.44 29.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.402 1.081 . . . . 0.0 108.788 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -90.32 101.38 14.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.415 0.686 . . . . 0.0 109.563 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -138.47 -55.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.335 1.054 . . . . 0.0 108.604 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.28 -169.59 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.997 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.97 18.09 18.71 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.1 -77.81 0.14 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -178.56 123.88 0.1 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 108.451 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -81.37 82.8 7.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.516 1.15 . . . . 0.0 108.667 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -66.88 91.0 0.19 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.465 -2.152 . . . . 0.0 111.795 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -89.02 -10.4 47.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.112 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -74.5 85.21 2.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.703 0.401 . . . . 0.0 110.371 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 50.75 85.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 112.488 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.7 p80 . . . . . 0 CA--C 1.556 1.191 0 C-N-CA 122.95 0.5 . . . . 0.0 110.093 -178.267 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.906 0.384 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.0 mm -106.61 138.82 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.494 1.118 . . . . 0.0 109.302 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -118.97 141.25 29.88 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 44.3 Cg_endo -68.12 128.11 17.05 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.27 1.98 . . . . 0.0 110.513 171.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 41' ' ' ARG . 13.4 pt -132.15 137.06 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -133.77 140.8 47.18 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.352 -0.217 . . . . 0.0 111.023 -170.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -101.92 151.51 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.234 1.014 . . . . 0.0 109.063 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.403 HG23 HG23 ' A' ' 34' ' ' ILE . 92.4 m -123.55 109.19 13.48 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.813 0.845 . . . . 0.0 110.436 -177.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -112.25 125.92 54.67 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 25.5 m -105.08 141.49 20.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.801 HG21 HG11 ' A' ' 83' ' ' VAL . 43.0 t -100.72 105.56 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -98.84 106.52 18.79 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.108 -170.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -93.19 95.87 9.66 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 90.1 m -85.02 136.14 33.71 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.3 134.94 47.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.411 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 42.0 m170 -103.58 119.28 38.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.839 172.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' OH ' HD12 ' A' ' 63' ' ' LEU . 93.8 m-85 -91.67 121.06 32.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 24' ' ' VAL . 3.5 tpt180 -144.04 158.7 43.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -90.37 172.48 8.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.56 0.744 . . . . 0.0 109.773 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 101' ' ' ILE . 15.0 pt-20 -62.98 -43.31 99.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.921 0.888 . . . . 0.0 111.911 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.03 -16.63 61.49 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.444 1.098 . . . . 0.0 111.451 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 16.69 23.37 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.518 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.48 147.27 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.231 0.515 . . . . 0.0 110.171 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 81.4 t -75.68 121.05 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.114 0.566 . . . . 0.0 110.524 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.42 -57.88 2.63 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 166.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -172.8 75.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.071 0.948 . . . . 0.0 108.499 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 8.6 p-10 -88.36 57.43 4.24 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -168.37 18.44 0.02 OUTLIER 'General case' 0 C--N 1.356 0.861 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -104.36 129.71 52.25 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.707 0.685 . . . . 0.0 110.461 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 14' ' ' THR . 43.3 t -129.65 135.36 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.39 1.076 . . . . 0.0 110.514 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.66 154.63 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 51.8 p -148.5 143.41 26.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.644 0.778 . . . . 0.0 110.683 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 58' ' ' GLN . 60.7 mt -106.23 125.41 50.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.652 0.781 . . . . 0.0 108.893 174.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.403 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -95.52 102.61 13.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HD2' ' HB3' ' A' ' 56' ' ' LEU . 96.9 m-85 -93.79 102.03 14.15 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.099 0.96 . . . . 0.0 109.338 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 103.64 14.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.341 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.33 101.89 11.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.577 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 63.5 p -73.33 148.91 43.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.221 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.01 -177.07 24.5 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.992 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 139.59 42.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.613 0.706 . . . . 0.0 110.564 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 5' ' ' ILE . 20.9 ttm-85 -116.28 122.62 45.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.954 0.502 . . . . 0.0 110.186 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.83 112.34 13.32 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.59 -10.74 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 t -72.86 -53.49 11.28 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.764 0.826 . . . . 0.0 110.399 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -96.29 -18.6 19.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.614 0.765 . . . . 0.0 111.267 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.93 62.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.506 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -94.46 128.51 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.829 0.851 . . . . 0.0 110.318 -176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.33 111.04 23.17 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.092 0.957 . . . . 0.0 109.963 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.29 107.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -101.35 117.27 34.61 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.19 121.27 17.24 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 123.402 0.439 . . . . 0.0 109.997 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -63.3 -36.12 82.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.798 1.239 . . . . 0.0 112.009 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -78.29 -7.66 57.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.719 0.408 . . . . 0.0 110.897 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.95 127.62 33.08 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.243 0.544 . . . . 0.0 109.918 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.8 p -137.49 157.16 47.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.589 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.504 HD12 HE21 ' A' ' 58' ' ' GLN . 0.4 OUTLIER -130.77 124.23 30.94 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 m -115.72 122.29 45.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.348 0.659 . . . . 0.0 109.704 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.598 ' HB2' HD13 ' A' ' 33' ' ' LEU . 76.4 mt-30 -122.35 145.3 48.39 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.376 0.67 . . . . 0.0 109.42 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.581 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 30.6 m -69.38 125.75 27.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.313 1.045 . . . . 0.0 110.708 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.42 109.13 15.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.8 -171.83 0.4 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.362 1.465 . . . . 0.0 109.23 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.22 86.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.545 1.138 . . . . 0.0 112.393 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -98.59 115.11 65.89 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.527 0.731 . . . . 0.0 109.29 -178.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.9 80.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.96 3.106 . . . . 0.0 113.262 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 p -95.13 137.47 22.18 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.819 0.848 . . . . 0.0 110.982 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -44.54 125.77 6.4 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.133 3.222 . . . . 0.0 114.223 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.9 t -85.97 108.94 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 172.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.58 132.45 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.288 0.635 . . . . 0.0 109.315 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.79 124.1 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.31 3.88 88.41 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.302 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -136.06 149.62 48.83 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.815 0.808 . . . . 0.0 109.747 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -137.87 131.05 30.45 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.7 57.05 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.552 0.533 . . . . 0.0 109.924 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.13 -31.79 71.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.69 98.65 7.04 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.559 1.144 . . . . 0.0 108.739 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.34 -6.02 18.13 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.357 2.038 . . . . 0.0 112.383 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.609 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 36.1 ttm -136.99 120.51 17.11 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.054 0.942 . . . . 0.0 108.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.39 143.09 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.673 0.789 . . . . 0.0 109.627 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.38 57.89 17.45 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.294 0.996 . . . . 0.0 112.453 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -85.48 56.91 4.38 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.753 2.302 . . . . 0.0 111.245 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -154.64 120.38 5.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.504 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 1.8 mp0 -48.2 123.42 6.37 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 125.371 1.669 . . . . 0.0 111.027 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.801 HG11 HG21 ' A' ' 11' ' ' VAL . 81.4 t -89.65 121.11 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 123.659 0.6 . . . . 0.0 110.728 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 m -104.81 112.41 25.51 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 89' ' ' ASN . 95.3 t -99.76 109.39 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 13.7 t70 -95.51 166.67 11.74 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.2 m -57.23 -33.77 67.89 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.332 0.653 . . . . 0.0 111.711 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 20.7 ptmt -67.4 -36.3 81.02 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.841 0.857 . . . . 0.0 111.745 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' A' ' 85' ' ' VAL . 4.6 p-10 -115.85 27.61 9.18 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.886 0.875 . . . . 0.0 110.035 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -64.61 -37.05 86.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.382 0.673 . . . . 0.0 111.399 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.92 -6.44 56.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.472 0.309 . . . . 0.0 110.666 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.89 135.42 34.15 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.229 0.538 . . . . 0.0 110.984 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.04 -25.66 17.84 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 0.0 111.751 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 51.91 12.29 0.18 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 127.577 2.351 . . . . 0.0 116.077 171.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -151.01 153.46 35.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.92 . . . . 0.0 109.428 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.52 -159.61 0.98 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.829 -167.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' THR . 1.8 tm-20 -90.9 112.74 24.73 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.301 0.64 . . . . 0.0 109.275 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -112.47 125.11 53.88 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.149 0.98 . . . . 0.0 109.665 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.9 m -91.13 133.41 35.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.51 0.724 . . . . 0.0 109.958 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.54 144.45 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 20' ' ' GLU . 40.8 mm -114.52 111.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.864 0.466 . . . . 0.0 111.582 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -82.82 105.49 13.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.564 1.146 . . . . 0.0 109.254 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 p -110.97 146.02 37.37 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.25 104.35 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.46 1.1 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -71.38 177.04 4.16 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.929 0.892 . . . . 0.0 111.732 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -62.05 -26.7 68.42 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.288 0.635 . . . . 0.0 111.983 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.05 -51.93 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.79 0.836 . . . . 0.0 111.251 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -73.17 -26.13 61.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.442 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.23 -17.24 64.73 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.11 0.564 . . . . 0.0 111.993 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.41 160.95 30.41 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.059 0.457 . . . . 0.0 110.269 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -76.66 84.88 3.31 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.54 -78.0 0.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.599 1.16 . . . . 0.0 108.072 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -94.62 -177.65 4.29 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.99 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.04 39.74 62.88 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.71 -52.13 61.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 0.0 109.541 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 49.0 53.21 12.97 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.047 1.739 . . . . 0.0 112.381 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -71.89 87.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -89.25 79.87 7.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.024 -164.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -90.38 -30.59 17.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.157 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -66.1 146.94 54.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.051 0.94 . . . . 0.0 108.747 172.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -69.64 -47.1 64.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.932 -171.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.649 0.78 . . . . 0.0 109.378 176.631 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.4 tpt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.7 mm -121.21 155.6 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 124.579 1.152 . . . . 0.0 109.3 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 8.8 pt-20 -128.38 149.94 72.91 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 167.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.34 128.16 11.01 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 122.063 1.842 . . . . 0.0 111.377 168.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.5 pt -126.24 168.44 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.73 143.22 19.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.462 0.705 . . . . 0.0 109.651 174.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.447 ' HG2' ' HE2' ' A' ' 90' ' ' PHE . 22.9 tpp180 -105.41 161.01 14.69 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 34' ' ' ILE . 21.6 m -130.2 108.47 10.06 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.45 0.7 . . . . 0.0 109.285 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.517 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp-100 -112.44 117.73 33.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 33.3 m -102.15 134.59 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 120.81 0.338 . . . . 0.0 110.202 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.6 t -93.43 108.93 21.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -94.55 98.89 11.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.521 0.728 . . . . 0.0 109.747 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -96.29 97.41 9.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.368 0.604 . . . . 0.0 109.807 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 HG22 ' A' ' 30' ' ' VAL . 29.8 m -92.17 138.91 31.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.489 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 118' ' ' HIS . 1.8 mp -122.56 139.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -106.62 146.74 30.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.899 1.28 . . . . 0.0 108.335 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -114.65 111.2 20.95 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -175.31 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 26.5 mmt85 -126.84 168.19 14.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.641 0.777 . . . . 0.0 109.445 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -105.8 172.22 6.92 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.977 0.911 . . . . 0.0 108.612 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.06 -22.49 63.06 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.519 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -69.52 -21.99 63.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.856 0.862 . . . . 0.0 111.503 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.78 -3.41 55.97 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.65 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.79 157.9 37.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.657 0.783 . . . . 0.0 110.871 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 12.3 t -102.18 123.9 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . . . -76.17 -47.28 24.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' H ' ' HB2' ' A' ' 17' ' ' TYR . 38.1 t-80 -169.96 159.65 7.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.793 0.837 . . . . 0.0 110.125 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -120.73 152.36 38.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.885 0.474 . . . . 0.0 111.815 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 53.53 76.28 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.648 1.579 . . . . 0.0 112.794 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.461 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 51.4 m170 -120.47 112.39 18.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 14' ' ' THR . 47.9 t -119.21 141.2 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.033 0.933 . . . . 0.0 111.461 -162.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.65 116.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 165.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 p -115.29 124.04 50.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.88 0.872 . . . . 0.0 109.642 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 83.6 mt -106.99 134.43 50.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.801 0.441 . . . . 0.0 111.054 -177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -87.6 121.93 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.427 1.091 . . . . 0.0 110.336 -174.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 72.2 m-85 -111.31 104.47 12.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.236 1.014 . . . . 0.0 108.637 173.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -93.05 103.82 16.08 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.114 0.565 . . . . 0.0 110.327 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -85.63 104.36 15.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.8 p -72.1 163.75 27.37 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.138 0.494 . . . . 0.0 111.074 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.23 -158.27 22.91 Favored Glycine 0 C--O 1.238 0.362 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 139.21 17.59 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.03 0.532 . . . . 0.0 110.042 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm-85 -102.34 129.35 48.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.47 ' HA ' HD13 ' A' ' 2' ' ' ILE . 32.5 t70 -77.02 118.38 19.53 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 1' ' ' MET . 83.9 mt -82.55 -9.1 59.55 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -169.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -94.92 -30.41 14.17 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.31 0.504 . . . . 0.0 111.458 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.01 -30.25 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.909 0.484 . . . . 0.0 110.254 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.18 2.58 77.18 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.222 -174.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.03 45.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.253 0.621 . . . . 0.0 109.693 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -105.37 118.49 36.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.787 0.835 . . . . 0.0 110.054 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.4 107.6 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -95.76 165.16 12.44 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.899 0.88 . . . . 0.0 109.831 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 29.6 m-20 -75.15 113.45 12.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.2 m -75.61 -23.84 56.46 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.851 0.46 . . . . 0.0 111.393 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -85.96 -3.99 59.06 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.798 0.839 . . . . 0.0 111.369 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 80.5 t90 -60.3 128.98 39.4 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.191 0.52 . . . . 0.0 109.684 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -154.84 113.57 3.58 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.67 140.48 48.19 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 82' ' ' GLU . 5.3 t -108.7 153.94 22.73 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -148.06 144.26 27.75 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.477 HG22 ' HG2' ' A' ' 61' ' ' GLU . 24.1 m -79.16 109.49 13.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.222 1.009 . . . . 0.0 112.927 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -102.61 102.02 12.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.288 0.635 . . . . 0.0 109.505 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' HG2' HG22 ' A' ' 59' ' ' THR . 13.0 pt-20 -173.87 -169.86 0.52 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.727 0.811 . . . . 0.0 109.416 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 70.95 20.68 5.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.754 ' HB3' ' HA ' ' A' ' 118' ' ' HIS . 2.3 mm? -92.54 110.33 44.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.107 0.563 . . . . 0.0 110.298 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HG2' ' HB3' ' A' ' 119' ' ' HIS . 90.2 Cg_endo -85.09 -146.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.74 2.96 . . . . 0.0 111.149 173.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.498 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 2.1 m -162.55 163.37 18.18 Favored Pre-proline 0 N--CA 1.495 1.782 0 C-N-CA 124.341 1.056 . . . . 0.0 110.192 174.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.69 125.41 15.42 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 121.882 1.721 . . . . 0.0 110.428 169.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.42 107.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.0 mt -100.84 122.07 52.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -72.8 128.64 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.049 0.94 . . . . 0.0 111.01 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.96 1.5 89.75 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.35 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -126.6 159.78 32.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 0.0 110.689 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.52 ' HB ' ' HG3' ' A' ' 109' ' ' GLN . 52.0 m -145.35 135.52 23.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.176 1.391 . . . . 0.0 107.493 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -71.11 139.32 50.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.074 0.55 . . . . 0.0 111.086 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HA ' HE22 ' A' ' 109' ' ' GLN . 11.9 t70 -69.36 -18.44 63.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.48 1.912 . . . . 0.0 110.551 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.786 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.92 82.64 7.09 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 29.9 Cg_endo -90.26 23.03 0.7 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.541 2.827 . . . . 0.0 114.12 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.66 144.63 27.29 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -131.34 136.61 57.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 164.293 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.32 71.0 0.2 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 78' ' ' VAL . 53.0 Cg_exo -58.26 -16.42 28.15 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.35 2.033 . . . . 0.0 110.773 162.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 59' ' ' THR . 29.7 t70 74.23 -71.53 0.13 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 126.682 1.993 . . . . 0.0 109.71 172.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 61.6 mt-10 -140.16 134.47 31.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.953 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.56 124.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.3 m -100.12 123.94 44.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.178 0.591 . . . . 0.0 109.853 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.21 121.39 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.26 161.96 16.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.294 1.038 . . . . 0.0 109.403 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 68.2 m -62.02 -29.08 70.03 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.004 0.431 . . . . 0.0 110.942 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.53 -46.61 89.53 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.037 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -100.07 2.79 43.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.095 0.558 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HE2' ' HG2' ' A' ' 7' ' ' ARG . 79.1 t80 -62.09 -33.84 75.19 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.119 0.968 . . . . 0.0 113.345 -168.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.59 -27.21 66.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.109 0.48 . . . . 0.0 110.157 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -93.73 156.88 16.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.189 0.995 . . . . 0.0 109.189 170.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.517 ' HE2' ' OE1' ' A' ' 9' ' ' GLN . 18.4 ptpt -119.39 139.0 52.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.78 40.29 1.14 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.577 0.703 . . . . 0.0 109.656 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -51.27 149.53 3.92 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.304 168.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -152.59 115.84 4.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.834 0.349 . . . . 0.0 111.281 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -104.51 110.68 23.05 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -121.67 171.39 8.88 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 110.283 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.8 m -130.9 134.49 46.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.374 0.669 . . . . 0.0 111.598 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.786 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 3.7 m -98.26 142.0 15.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 123.319 0.647 . . . . 0.0 110.227 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -114.08 114.82 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 0.0 110.318 -175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.96 103.29 15.9 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -97.96 174.43 6.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.27 156.25 15.95 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' OD1' HG22 ' A' ' 106' ' ' THR . 6.5 t-20 -51.13 166.9 0.09 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.392 1.077 . . . . 0.0 112.937 -167.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.436 HG22 ' OD1' ' A' ' 105' ' ' ASN . 12.5 t -44.64 -20.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.615 1.566 . . . . 0.0 114.637 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.1 mt -42.02 -62.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.162 1.385 . . . . 0.0 111.54 169.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 t -111.46 -4.04 14.98 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.817 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.52 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -64.11 140.19 58.84 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.919 0.887 . . . . 0.0 111.052 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -129.25 155.93 44.78 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.461 1.104 . . . . 0.0 109.073 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 69.07 151.81 0.09 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.847 1.259 . . . . 0.0 111.669 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -161.48 -54.67 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 43.73 -82.0 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.204 1.802 . . . . 0.0 113.748 170.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.76 63.89 0.37 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 mt -105.8 -46.55 4.1 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -136.46 154.52 50.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.355 0.662 . . . . 0.0 111.182 176.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.591 ' HA ' HG11 ' A' ' 100' ' ' VAL . 3.1 t-160 178.89 153.25 0.38 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.454 1.102 . . . . 0.0 108.663 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.754 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.6 t60 -163.52 145.5 9.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.522 ' HB3' ' HG2' ' A' ' 64' ' ' PRO . 43.9 t60 -165.98 130.4 2.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.727 1.211 . . . . 0.0 107.928 160.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -141.21 130.2 23.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.853 0.861 . . . . 0.0 109.195 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -87.68 130.41 34.81 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.176 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG2' HD12 ' A' ' 43' ' ' LEU . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.499 HD12 ' HD3' ' A' ' 40' ' ' LYS . 41.6 mm -107.87 142.98 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.939 0.896 . . . . 0.0 109.998 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.6 148.59 65.2 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.058 0.543 . . . . 0.0 109.94 166.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.2 125.53 10.36 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 0.0 110.506 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 41' ' ' ARG . 45.0 pt -125.68 154.95 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.177 0.513 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -159.68 145.86 16.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.832 173.144 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -111.15 156.68 21.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.335 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 34' ' ' ILE . 59.2 m -129.49 122.19 28.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.263 0.625 . . . . 0.0 110.284 -172.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp-100 -122.76 107.16 11.59 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 4.2 m -92.62 133.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 94' ' ' GLN . 69.3 t -102.02 124.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 173.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -123.05 115.34 21.69 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -164.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.667 HE21 ' HG3' ' A' ' 80' ' ' PRO . 8.4 mm-40 -89.47 104.71 17.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.413 1.085 . . . . 0.0 111.068 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -95.35 112.5 24.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.154 0.982 . . . . 0.0 109.176 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 98' ' ' GLU . 87.2 mt -111.58 131.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.508 0.671 . . . . 0.0 111.083 -170.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -112.06 116.28 30.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.403 ' HB3' ' HE2' ' A' ' 102' ' ' TYR . 34.2 m-85 -86.02 107.08 17.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -133.26 156.85 46.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.915 0.886 . . . . 0.0 109.476 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -89.15 176.4 6.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.4 0.68 . . . . 0.0 110.949 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.74 -24.9 67.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.135 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.84 -7.78 58.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.782 0.833 . . . . 0.0 111.225 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.27 82.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.95 150.68 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.092 0.557 . . . . 0.0 109.957 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.7 t -74.41 127.03 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.093 0.557 . . . . 0.0 110.563 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.44 -62.99 1.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -159.52 99.77 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.308 1.043 . . . . 0.0 109.566 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.97 171.44 15.2 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.624 -0.672 . . . . 0.0 110.875 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 57.54 80.33 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.496 1.118 . . . . 0.0 111.679 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -130.94 91.99 3.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.85 127.47 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.699 . . . . 0.0 110.918 -169.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.98 149.97 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.1 p -144.46 144.64 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.923 0.392 . . . . 0.0 110.884 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.68 124.08 51.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.181 0.992 . . . . 0.0 109.109 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 10' ' ' VAL . 1.8 mp -94.9 109.29 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.351 1.06 . . . . 0.0 108.894 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 57.9 m-85 -97.36 99.08 10.53 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -98.82 103.29 15.23 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.403 0.681 . . . . 0.0 109.749 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.46 108.88 14.46 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 t -92.5 159.16 15.65 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.376 0.67 . . . . 0.0 110.742 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.02 -161.93 26.07 Favored Glycine 0 C--O 1.238 0.375 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.716 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.499 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -144.15 142.02 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.216 0.606 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 5' ' ' ILE . 15.8 ttm180 -104.74 125.11 50.49 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.713 0.405 . . . . 0.0 110.122 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.86 106.59 8.62 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 1' ' ' MET . 96.2 mt -75.78 -2.76 31.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.986 0.914 . . . . 0.0 112.171 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -42.37 60.88 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.527 0.731 . . . . 0.0 109.932 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.04 -24.62 14.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.816 0.846 . . . . 0.0 111.234 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.46 16.09 72.11 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.994 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -87.99 143.51 27.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.432 0.693 . . . . 0.0 111.142 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.46 107.65 19.91 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.529 1.132 . . . . 0.0 110.508 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.62 97.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 59.8 m95 -90.31 171.89 9.15 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.065 0.946 . . . . 0.0 109.406 171.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 26.9 m-20 -76.82 115.73 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 164.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -62.17 -31.68 72.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.108 0.563 . . . . 0.0 110.324 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -92.04 15.45 13.31 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.688 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 90.5 t90 -70.4 127.86 34.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 81.0 p -154.86 115.53 3.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.768 1.227 . . . . 0.0 107.805 170.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 35' ' ' PHE . 62.5 tp -103.57 132.97 49.36 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 m -110.23 115.42 29.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.804 0.842 . . . . 0.0 109.516 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -129.34 132.52 47.12 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.543 0.737 . . . . 0.0 109.126 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.4 m -85.34 135.21 33.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.156 0.583 . . . . 0.0 111.266 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.06 104.92 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 160.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.7 -174.09 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.349 1.06 . . . . 0.0 108.589 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.97 21.78 12.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.755 0.822 . . . . 0.0 112.824 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.37 114.13 65.55 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.27 -165.92 0.31 Allowed 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 123.055 2.503 . . . . 0.0 113.31 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 76' ' ' PRO . 59.7 p -157.18 146.98 15.44 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 118.47 5.36 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.999 1.799 . . . . 0.0 110.286 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.52 104.63 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.03 119.01 41.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.48 132.27 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.839 0.712 . . . . 0.0 109.812 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.43 12.43 80.44 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.373 -0.681 . . . . 0.0 112.86 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 87.5 m-85 -137.25 148.97 46.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.752 0.821 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -110.31 126.95 54.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.795 1.638 . . . . 0.0 107.729 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.8 143.96 26.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.938 0.79 . . . . 0.0 109.987 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -37.33 78.37 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.261 0.625 . . . . 0.0 110.938 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -146.91 98.32 4.11 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 63.3 Cg_endo -68.28 -8.07 21.87 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.466 2.111 . . . . 0.0 112.511 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ttt -143.78 105.77 4.36 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.24 111.59 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.28 78.74 0.24 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.667 ' HG3' HE21 ' A' ' 13' ' ' GLN . 61.4 Cg_endo -71.23 -0.63 8.37 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.825 2.35 . . . . 0.0 113.446 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 76.1 -159.68 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.009 1.324 . . . . 0.0 112.456 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.97 128.73 31.53 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.87 109.83 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.134 1.374 . . . . 0.0 107.91 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.8 m -98.31 128.73 44.88 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.73 115.07 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.9 p30 -90.7 173.08 8.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.764 0.826 . . . . 0.0 110.196 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -60.2 -29.93 69.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.417 1.087 . . . . 0.0 113.206 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -82.68 -38.33 23.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.103 0.561 . . . . 0.0 110.668 -175.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.45 8.95 40.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.99 -24.57 67.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.717 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.71 -21.41 55.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 110.299 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.65 118.43 33.1 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.176 0.991 . . . . 0.0 110.924 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . 21.1 pttp -83.87 127.78 34.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 11' ' ' VAL . 36.8 mt-30 -86.78 42.4 1.01 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -64.03 121.36 13.96 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 110.535 -175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -113.93 145.41 41.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -116.02 110.05 18.38 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 15' ' ' ILE . 17.4 mm-40 -93.18 155.97 17.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.766 0.793 . . . . 0.0 110.725 175.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.2 m -142.28 107.53 4.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.888 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -79.33 137.82 21.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mm -108.87 122.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.403 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.0 m-85 -88.77 106.09 18.13 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.725 1.21 . . . . 0.0 109.413 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 p -112.47 130.39 56.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.17 129.14 23.71 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.028 0.931 . . . . 0.0 113.152 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -54.31 -179.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.517 1.527 . . . . 0.0 114.037 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -66.01 -12.74 57.29 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.609 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -56.76 -50.17 75.67 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 123.965 0.906 . . . . 0.0 110.34 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 t -73.54 -18.22 61.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.233 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -93.77 -164.67 1.2 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.554 1.141 . . . . 0.0 109.29 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.736 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 41.9 m-80 -95.32 -177.76 4.22 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 164.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -82.73 94.59 7.64 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 86.25 -39.53 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.634 2.374 . . . . 0.0 111.156 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.736 ' HB3' ' HB2' ' A' ' 110' ' ' ASN . 1.3 p-10 39.91 -94.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.458 1.903 . . . . 0.0 113.428 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.48 35.13 88.19 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.13 0.395 . . . . 0.0 113.476 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.27 -82.77 0.08 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.037 0.535 . . . . 0.0 110.256 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.48 -30.06 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.582 0.753 . . . . 0.0 111.449 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 35.5 m170 62.42 104.82 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.904 1.282 . . . . 0.0 110.289 -168.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -62.64 150.09 41.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -60.79 132.46 53.94 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.171 0.588 . . . . 0.0 110.01 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -82.08 57.32 3.49 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.192 0.996 . . . . 0.0 111.64 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -143.27 86.7 1.92 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.596 1.159 . . . . 0.0 107.956 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.933 0.893 . . . . 0.0 109.821 -173.137 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.9 mm -113.95 151.21 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.386 0.675 . . . . 0.0 109.315 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.77 151.3 77.84 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.225 0.61 . . . . 0.0 110.011 170.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.75 133.79 28.43 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.606 2.204 . . . . 0.0 111.986 171.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 41' ' ' ARG . 11.6 pt -142.57 137.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.8 mptm? -133.72 154.26 51.08 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.487 0.715 . . . . 0.0 109.114 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 23.7 mmm180 -121.82 149.65 43.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 108.307 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 34' ' ' ILE . 27.1 m -122.26 108.05 12.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 6.2 tp-100 -105.37 148.98 26.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 28.6 m -124.98 123.78 66.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 110.197 173.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.56 115.54 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -96.37 152.03 18.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.091 0.957 . . . . 0.0 111.275 -171.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.701 ' HG3' ' HB2' ' A' ' 96' ' ' ARG . 8.4 tt0 -125.77 107.89 10.96 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -82.61 106.54 14.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.313 0.645 . . . . 0.0 110.791 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -99.6 133.11 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 121.533 0.682 . . . . 0.0 109.844 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -111.88 125.68 54.29 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -97.41 123.66 41.33 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 70.8 mtp180 -141.52 -173.86 3.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.757 0.823 . . . . 0.0 110.648 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.14 164.69 14.77 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.4 -26.17 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.838 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -19.16 64.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.157 1.383 . . . . 0.0 110.849 175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.97 -14.45 63.9 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.96 153.27 29.82 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 111.364 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.9 t -92.52 133.86 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.196 0.598 . . . . 0.0 110.164 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.26 -54.09 3.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 0.0 110.184 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -157.24 96.21 1.54 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.652 1.181 . . . . 0.0 108.804 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.66 142.39 32.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 68.63 86.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.039 1.336 . . . . 0.0 111.417 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -141.16 92.79 2.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -111.2 133.68 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -166.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.0 p -108.48 137.13 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.4 m -113.32 137.72 51.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.93 0.492 . . . . 0.0 110.442 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.2 mt -98.92 123.36 43.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.424 HG23 HG23 ' A' ' 8' ' ' THR . 2.1 mp -99.85 105.4 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.019 0.927 . . . . 0.0 108.664 -173.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.28 107.61 20.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.893 0.877 . . . . 0.0 110.096 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 m -83.81 103.09 12.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.447 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 20.4 tt0 -85.53 107.79 17.63 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 17.0 p -91.65 139.64 30.49 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.64 -167.13 16.03 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 136.68 35.42 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.29 0.545 . . . . 0.0 110.75 -175.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HB2' HD13 ' A' ' 5' ' ' ILE . 25.7 ttm180 -103.58 122.21 44.51 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.821 0.449 . . . . 0.0 110.176 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 2' ' ' ILE . 8.0 t70 -74.67 113.28 11.75 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.598 1.159 . . . . 0.0 108.582 169.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.7 mt -84.66 -4.44 59.01 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 t -87.11 -36.32 18.17 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.644 0.656 . . . . 0.0 110.86 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.04 -31.09 11.61 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.57 63.65 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.916 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 133.53 45.88 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.018 0.927 . . . . 0.0 110.138 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.55 113.93 27.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.353 0.661 . . . . 0.0 110.081 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.98 104.29 15.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.495 ' CZ2' HD12 ' A' ' 5' ' ' ILE . 55.2 m95 -103.75 119.86 39.78 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.88 131.06 43.2 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.78 0.675 . . . . 0.0 110.711 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -64.5 -26.28 68.36 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.297 0.998 . . . . 0.0 110.215 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -64.29 -22.25 66.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.69 0.796 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.447 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 67.8 t-105 -74.32 127.17 32.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.458 0.474 . . . . 0.0 109.896 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 p -153.87 144.53 22.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.514 1.126 . . . . 0.0 109.528 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 tt -134.12 125.18 27.42 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.4 m -107.92 127.64 53.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -130.8 140.19 50.26 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 91.8 m -101.56 132.83 47.0 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 111.117 -175.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 m-85 -72.52 102.46 3.24 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.71 141.96 28.53 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.2 1.0 . . . . 0.0 108.307 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.79 108.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.401 1.08 . . . . 0.0 110.77 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 107.14 21.4 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.55 102.89 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.213 2.609 . . . . 0.0 112.92 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -98.64 134.06 22.02 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.131 0.972 . . . . 0.0 110.62 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 120.66 7.97 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.67 2.247 . . . . 0.0 110.583 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.07 107.25 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mt -102.33 114.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.0 mm -75.62 137.86 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.53 87.42 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.346 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 97.9 m-85 -141.75 162.33 35.74 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.393 0.677 . . . . 0.0 110.26 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -147.24 120.03 8.66 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.95 148.23 52.13 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 123.799 0.687 . . . . 0.0 109.456 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.5 -33.6 73.09 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.787 0.68 . . . . 0.0 109.277 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 97.71 7.07 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.612 168.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.72 -6.23 17.34 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.199 1.932 . . . . 0.0 111.568 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tpt -128.47 125.61 38.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.388 1.075 . . . . 0.0 108.384 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.12 130.26 36.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 109.403 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.75 161.16 49.34 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.365 1.041 . . . . 0.0 113.418 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.5 118.81 5.91 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 123.206 2.604 . . . . 0.0 113.672 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 22.4 m-20 -109.79 94.54 5.08 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.711 0.805 . . . . 0.0 109.715 173.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -72.47 91.67 1.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.17 0.588 . . . . 0.0 110.768 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 85' ' ' VAL . 74.8 t -85.52 103.03 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.873 0.869 . . . . 0.0 110.183 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.1 m -90.17 106.54 18.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.401 0.68 . . . . 0.0 109.548 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HA ' HD21 ' A' ' 89' ' ' ASN . 85.4 t -106.5 110.7 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 170.98 12.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.411 1.084 . . . . 0.0 108.23 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.3 m -65.7 -23.8 66.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.324 166.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -67.53 -45.28 76.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.978 1.311 . . . . 0.0 110.694 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 85' ' ' VAL . 3.4 p-10 -113.66 29.64 7.84 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.724 0.81 . . . . 0.0 109.892 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 9' ' ' GLN . 59.9 t80 -62.07 -46.53 88.68 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.616 0.767 . . . . 0.0 111.78 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.5 -1.09 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.48 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.01 149.69 25.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.888 0.875 . . . . 0.0 109.459 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -108.57 144.07 36.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.471 0.708 . . . . 0.0 109.699 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.4 40.11 3.75 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.37 103.67 1.69 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.583 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.701 ' HB2' ' HG3' ' A' ' 13' ' ' GLN . 28.2 mmm180 -76.42 156.41 33.16 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.458 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.87 132.15 18.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.453 0.301 . . . . 0.0 110.454 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 47.1 mt-10 -141.75 138.33 32.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.516 0.726 . . . . 0.0 110.643 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.5 m -109.03 115.28 29.76 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.41 141.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.08 113.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.747 0.419 . . . . 0.0 110.151 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 63.2 m-85 -84.05 110.45 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.995 0.918 . . . . 0.0 108.877 173.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -99.63 143.56 29.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.81 123.92 10.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.572 0.749 . . . . 0.0 109.295 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -45.75 158.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.592 1.957 . . . . 0.0 113.317 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.546 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 11.2 t -47.78 -20.48 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.886 1.274 . . . . 0.0 113.294 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.2 mm -50.58 -53.48 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -87.39 -30.74 20.53 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 75.6 mt-30 -64.53 -61.45 2.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.182 0.515 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 64.66 -85.99 0.02 OUTLIER 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.579 1.551 . . . . 0.0 109.861 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.2 mttm 56.78 -169.91 0.09 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.575 1.15 . . . . 0.0 111.785 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -104.23 -36.69 7.56 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.77 -166.18 0.21 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.952 1.301 . . . . 0.0 109.612 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.69 37.06 92.15 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 119.544 1.066 . . . . 0.0 111.296 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.25 -60.83 2.88 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 110.138 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -173.29 157.07 3.27 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -86.15 93.25 8.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 167.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -82.25 85.68 6.79 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.723 0.773 . . . . 0.0 110.986 -169.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.97 -70.14 0.74 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 168.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 52.37 -88.17 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.861 1.664 . . . . 0.0 112.687 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 38.8 m80 73.35 -60.37 0.54 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.893 1.677 . . . . 0.0 112.274 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 N--CA 1.485 1.314 0 C-N-CA 124.827 1.251 . . . . 0.0 110.112 -177.691 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' HD3' ' A' ' 40' ' ' LYS . 29.4 mm -118.72 119.86 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.409 1.084 . . . . 0.0 110.037 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 43' ' ' LEU . 10.5 pt-20 -97.88 137.42 20.93 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 167.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.98 122.95 8.53 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.909 1.739 . . . . 0.0 110.355 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 42.0 pt -119.34 161.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.401 0.68 . . . . 0.0 110.368 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 136.82 12.82 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -96.83 154.34 17.35 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 34' ' ' ILE . 76.6 m -128.54 105.45 8.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -99.48 102.14 13.6 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.6 m -91.13 117.5 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.7 t -89.75 107.1 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.3 m -92.49 102.22 14.67 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.488 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 9.5 tt0 -91.73 105.24 17.57 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.561 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.9 p -92.91 106.21 18.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 98' ' ' GLU . 19.9 mt -97.29 132.5 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.724 0.773 . . . . 0.0 111.681 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -116.75 118.09 31.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.98 -1.464 . . . . 0.0 107.056 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -87.33 115.41 24.73 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.0 ttt-85 -147.37 145.42 29.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.635 0.374 . . . . 0.0 110.518 -171.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -79.48 163.2 24.92 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.477 1.111 . . . . 0.0 111.031 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.99 -28.32 69.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.452 0.701 . . . . 0.0 110.324 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.54 -20.03 65.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.048 1.339 . . . . 0.0 112.042 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.74 -10.25 66.42 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.869 -176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.29 54.14 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.564 0.746 . . . . 0.0 109.494 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 27' ' ' ASP . 39.8 t -86.76 124.89 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.91 51.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.541 0.737 . . . . 0.0 110.857 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -166.25 119.22 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.309 1.043 . . . . 0.0 108.531 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB2' HG11 ' A' ' 24' ' ' VAL . 22.7 t70 -98.19 162.2 13.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.23 0.612 . . . . 0.0 110.037 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 61.97 73.76 0.46 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.822 1.249 . . . . 0.0 112.323 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -127.62 83.7 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 171.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -102.35 127.23 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.599 -171.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 p -117.48 134.91 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -130.01 127.71 40.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 50.3 mt -108.81 131.23 55.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.609 0.764 . . . . 0.0 110.655 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.617 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -82.05 113.07 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.148 0.979 . . . . 0.0 109.619 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -103.99 103.75 13.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.514 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 85.5 m -91.95 107.17 19.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.93 0.892 . . . . 0.0 111.23 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 8.0 tt0 -86.63 107.78 18.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.0 p -78.19 169.58 18.03 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.851 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.95 -158.93 22.94 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.449 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -149.35 144.85 26.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.706 0.802 . . . . 0.0 109.531 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm180 -119.25 119.9 35.44 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.953 0.501 . . . . 0.0 110.566 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.8 113.81 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.206 1.002 . . . . 0.0 108.803 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 3' ' ' GLU . 52.0 mt -82.86 -6.63 59.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -73.55 -48.32 33.94 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.071 0.548 . . . . 0.0 110.533 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -93.07 -26.44 17.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.967 0.507 . . . . 0.0 110.928 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.24 54.36 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.071 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HG3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -95.41 137.59 34.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.708 0.803 . . . . 0.0 110.918 -174.069 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -98.58 113.79 25.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.862 0.865 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.2 mp -100.15 110.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -100.35 139.15 36.43 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.7 t70 -68.01 108.53 3.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 p -77.12 -9.88 59.03 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.189 0.596 . . . . 0.0 112.29 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -97.74 -1.13 44.07 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.339 0.656 . . . . 0.0 111.262 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 62.3 t-105 -66.48 150.52 48.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.435 0.694 . . . . 0.0 110.826 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.4 p -151.73 135.84 16.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 36' ' ' THR . 1.4 tm? -111.51 124.1 51.58 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 m -99.94 127.82 46.09 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.762 0.825 . . . . 0.0 108.845 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 60.6 tp60 -139.62 132.33 28.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 17.1 m -75.02 105.07 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.33 0.652 . . . . 0.0 112.056 -171.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.44 100.13 3.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 161.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -109.32 157.45 18.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.331 1.052 . . . . 0.0 110.138 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -46.69 114.99 0.93 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.943 1.697 . . . . 0.0 114.376 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' A' ' 15' ' ' ILE . 3.7 mm? -82.36 124.3 78.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.51 100.52 0.23 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.735 2.29 . . . . 0.0 112.349 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 t -86.19 104.53 5.63 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.84 122.32 11.15 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.044 2.496 . . . . 0.0 112.475 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.23 107.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.53 135.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.648 0.779 . . . . 0.0 108.938 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.33 118.89 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.495 -172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.09 68.13 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.154 -173.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 81.5 m-85 -141.21 136.52 31.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.816 0.846 . . . . 0.0 111.014 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.1 m -118.78 124.76 48.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 108.597 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.54 138.48 53.32 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.347 0.659 . . . . 0.0 110.971 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.91 -27.4 65.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.424 1.09 . . . . 0.0 110.593 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 94.5 7.29 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.058 0.943 . . . . 0.0 108.661 169.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.55 -5.45 16.9 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.432 2.088 . . . . 0.0 112.19 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.9 tpt -131.62 110.42 10.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.283 1.033 . . . . 0.0 108.487 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.05 129.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 77.13 0.56 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -167.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -97.57 8.13 1.26 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.371 2.047 . . . . 0.0 114.618 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -162.38 172.77 15.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.251 1.024 . . . . 0.0 112.838 -169.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 33.9 mt-10 -85.46 129.77 34.74 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.341 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.51 140.14 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.027 0.931 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.6 m -112.12 120.98 43.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.799 0.84 . . . . 0.0 109.964 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -97.46 118.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.68 157.33 16.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.615 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 68.0 m -58.71 -33.64 70.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.74 0.816 . . . . 0.0 112.461 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.52 -30.29 69.07 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -117.64 24.24 11.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 34.5 t80 -62.65 -34.17 76.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.096 0.558 . . . . 0.0 111.998 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.63 -1.37 50.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.875 0.87 . . . . 0.0 111.704 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -101.16 163.07 12.46 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.93 0.892 . . . . 0.0 110.509 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -84.46 175.35 9.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.936 0.894 . . . . 0.0 111.103 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -121.9 -36.84 2.94 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 165.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -171.86 158.09 4.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.426 1.491 . . . . 0.0 107.87 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 76.7 mtm180 -138.92 -87.99 0.22 Allowed 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.09 109.99 22.65 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -166.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' HB2' HG12 ' A' ' 15' ' ' ILE . 71.0 mm-40 -118.04 114.23 22.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.564 1.145 . . . . 0.0 109.609 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 83.4 m -106.63 122.06 45.58 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.74 132.81 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 30.1 mm -104.18 122.15 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.886 0.475 . . . . 0.0 110.67 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 97.0 m-85 -91.71 108.91 20.25 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.077 0.951 . . . . 0.0 109.974 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 m -98.29 131.42 44.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.798 0.839 . . . . 0.0 109.786 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.76 7.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.059 0.944 . . . . 0.0 111.015 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 1.9 m-20 -58.72 152.77 18.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.835 1.254 . . . . 0.0 111.628 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -58.56 -24.55 61.05 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.584 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.61 -47.92 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.614 1.166 . . . . 0.0 110.591 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -80.25 -16.84 53.8 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.492 0.317 . . . . 0.0 111.125 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 105' ' ' ASN . 84.9 mm-40 -64.66 -48.47 74.64 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 173.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 56.9 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.922 1.389 . . . . 0.0 111.366 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.1 89.21 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -96.06 -44.14 7.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.288 0.635 . . . . 0.0 109.682 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.56 171.38 15.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.733 0.813 . . . . 0.0 109.653 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.28 55.24 19.43 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -169.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.39 -73.89 0.07 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.333 1.053 . . . . 0.0 111.211 -171.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 68.93 -43.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 127.204 2.202 . . . . 0.0 113.228 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -78.9 128.88 33.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.802 0.841 . . . . 0.0 110.574 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -168.94 73.34 0.09 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.961 0.886 . . . . 0.0 110.235 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -73.34 -44.5 58.69 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -163.57 171.78 15.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.801 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -91.91 149.02 21.78 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.291 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.876 0.369 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.9 mm -112.64 157.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.842 1.257 . . . . 0.0 109.094 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -124.38 146.96 53.66 Favored Pre-proline 0 N--CA 1.479 1.005 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.64 126.38 12.03 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.071 1.847 . . . . 0.0 111.581 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.8 pt -127.18 167.39 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.581 0.752 . . . . 0.0 109.802 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 138.78 12.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.554 0.692 . . . . 0.0 111.622 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.582 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -87.32 133.83 33.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.9 m -125.29 104.88 8.72 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.2 146.78 24.09 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.131 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 34' ' ' ILE . 35.1 m -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' SER . 94.3 t -91.62 102.37 13.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m -101.78 104.27 15.04 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.84 0.856 . . . . 0.0 109.159 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.784 HE21 ' HB2' ' A' ' 98' ' ' GLU . 52.1 tt0 -112.95 125.27 54.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 109.948 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 30' ' ' VAL . 85.5 m -99.25 108.09 20.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.479 0.712 . . . . 0.0 109.687 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 98' ' ' GLU . 1.8 mp -83.57 116.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -95.77 108.81 21.17 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.128 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' HA ' HG22 ' A' ' 100' ' ' VAL . 97.3 m-85 -79.99 117.98 21.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -137.44 165.57 25.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.979 0.512 . . . . 0.0 109.875 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -94.04 175.53 6.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.312 1.045 . . . . 0.0 109.265 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.26 -21.37 60.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.41 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.05 -19.21 65.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.219 1.007 . . . . 0.0 110.882 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.36 69.12 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.143 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.24 136.8 56.51 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.953 0.901 . . . . 0.0 110.747 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.49 112.9 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.75 72.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.121 0.568 . . . . 0.0 110.203 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -177.11 116.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.401 1.081 . . . . 0.0 109.789 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.46 -38.08 55.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.79 77.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.769 0.428 . . . . 0.0 111.104 -167.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HE1' ' HD2' ' A' ' 64' ' ' PRO . 9.4 t-160 -121.45 91.13 3.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 14' ' ' THR . 21.6 t -102.14 120.3 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.255 -162.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.761 ' HB ' HD23 ' A' ' 63' ' ' LEU . 9.0 p -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.879 0.872 . . . . 0.0 109.153 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 67.7 p -136.71 132.01 34.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.79 0.836 . . . . 0.0 109.716 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.542 HD11 ' HA ' ' A' ' 60' ' ' PHE . 74.9 mt -110.62 125.67 53.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG12 ' A' ' 10' ' ' VAL . 2.4 mp -88.14 112.26 23.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 56' ' ' LEU . 95.2 m-85 -104.26 124.53 49.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.208 1.003 . . . . 0.0 108.417 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -121.27 107.69 12.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.87 0.468 . . . . 0.0 110.385 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 32.6 tt0 -84.79 95.95 9.13 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 109.089 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -76.12 135.09 39.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.11 -168.12 12.3 Favored Glycine 0 C--O 1.251 1.16 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -140.02 143.39 36.4 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.6 ttm180 -112.77 122.38 47.48 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.586 0.355 . . . . 0.0 110.261 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.3 t70 -71.18 118.2 13.66 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.15 -18.33 55.72 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -75.86 -49.09 18.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.726 0.298 . . . . 0.0 110.24 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 49.7 t-20 -88.68 -31.82 18.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -0.57 58.75 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.854 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 21.2 ptmt -70.33 146.09 50.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.284 1.034 . . . . 0.0 111.591 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.74 112.46 24.16 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.534 0.733 . . . . 0.0 109.855 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.59 93.67 3.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -85.77 140.4 30.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.4 t70 -68.4 110.05 3.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -78.49 -5.46 52.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.736 0.814 . . . . 0.0 111.813 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 53' ' ' LYS . 7.9 mtmp? -101.65 -4.78 25.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.098 0.559 . . . . 0.0 110.236 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.1 t-105 -62.44 120.31 10.81 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.125 0.57 . . . . 0.0 110.179 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 11.0 p -139.13 111.58 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.168 0.987 . . . . 0.0 108.667 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 35' ' ' PHE . 64.1 tp -102.21 135.17 44.28 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 11.6 m -98.34 144.95 27.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -148.87 129.32 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 7.0 m -73.67 104.65 4.67 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.754 0.659 . . . . 0.0 110.006 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -65.62 103.53 0.88 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.03 -164.7 0.64 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.254 1.022 . . . . 0.0 108.243 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.1 18.41 10.99 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.525 1.13 . . . . 0.0 111.627 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.2 tm? -107.28 106.09 57.45 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 171.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD2' ' HE1' ' A' ' 29' ' ' HIS . 73.3 Cg_endo -70.66 -165.13 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.253 2.636 . . . . 0.0 113.728 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 t -164.65 106.52 0.84 Allowed Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 121.4 8.22 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.712 2.274 . . . . 0.0 112.316 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.09 108.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 40.7 mt -101.55 134.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.92 134.46 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.353 0.661 . . . . 0.0 109.891 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.67 20.07 71.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.071 0.857 . . . . 0.0 112.988 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 65.0 m-85 -139.17 150.75 45.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.651 0.739 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -136.86 118.93 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.15 150.53 48.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.092 0.557 . . . . 0.0 110.336 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.03 -40.6 78.53 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.04 99.44 16.45 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.126 170.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.16 -2.45 12.34 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.054 2.503 . . . . 0.0 112.117 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.3 ttt -144.31 115.76 8.08 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -80.72 110.16 15.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.496 0.718 . . . . 0.0 111.165 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . 59.39 61.43 7.29 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.848 1.342 . . . . 0.0 114.314 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.83 82.43 2.15 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.544 2.163 . . . . 0.0 110.743 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -161.42 137.41 8.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.141 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.0 mt-10 -76.02 89.48 2.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.055 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 t -82.25 126.84 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.553 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 20.0 m -98.46 117.78 33.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.373 0.669 . . . . 0.0 109.909 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.3 t -99.31 116.61 42.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 7.0 p-10 -104.76 172.03 7.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 t -58.53 -30.09 66.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 113.004 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -71.01 -38.19 72.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.127 0.571 . . . . 0.0 111.128 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -107.93 10.83 28.37 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.0 0.52 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.26 -47.19 77.61 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.241 0.616 . . . . 0.0 112.079 -170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.47 -23.67 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.749 0.655 . . . . 0.0 110.814 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.2 143.28 26.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.275 0.63 . . . . 0.0 110.547 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.571 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.53 162.96 22.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 160.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -125.3 -39.22 2.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.82 142.97 45.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -132.68 -52.83 0.93 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.345 1.058 . . . . 0.0 109.447 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.87 148.18 35.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.327 0.584 . . . . 0.0 111.679 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.784 ' HB2' HE21 ' A' ' 13' ' ' GLN . 12.5 tp10 -122.25 155.57 35.62 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.744 1.218 . . . . 0.0 108.627 169.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -139.74 99.78 3.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.7 m -82.22 141.7 14.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.68 110.54 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.967 0.413 . . . . 0.0 110.888 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.61 104.62 10.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 m -98.77 173.93 6.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.23 146.53 15.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 121.137 0.494 . . . . 0.0 111.051 -172.482 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.442 HD12 ' HD3' ' A' ' 40' ' ' LYS . 38.1 mm -112.6 130.45 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.913 0.885 . . . . 0.0 110.655 -172.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.48 143.37 26.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 166.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -77.6 123.44 6.45 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.325 1.35 . . . . 0.0 111.516 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.6 pt -110.42 172.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.642 0.777 . . . . 0.0 109.807 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.92 146.55 6.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 19.7 mtm180 -113.02 170.15 8.42 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.256 1.022 . . . . 0.0 109.075 168.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 34' ' ' ILE . 34.1 m -135.92 106.43 6.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.331 0.652 . . . . 0.0 110.199 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.1 108.27 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.592 0.757 . . . . 0.0 109.024 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.1 m -92.17 145.48 7.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' SER . 92.3 t -119.28 104.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 m -94.84 107.35 19.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.603 0.761 . . . . 0.0 111.654 -166.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.592 HE22 ' HB2' ' A' ' 96' ' ' ARG . 7.2 tp-100 -96.32 104.97 16.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.618 0.767 . . . . 0.0 108.963 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.491 HG22 HG22 ' A' ' 30' ' ' VAL . 34.5 p -91.75 110.29 21.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -89.5 127.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -107.69 122.56 46.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -92.54 108.06 19.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -117.36 151.17 37.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.94 178.0 8.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.259 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.87 -32.28 73.44 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.33 -18.47 62.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.746 0.818 . . . . 0.0 111.348 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.65 -3.32 56.12 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.932 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.85 142.69 57.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.288 0.635 . . . . 0.0 110.902 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.66 107.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.92 0.488 . . . . 0.0 110.069 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.63 -46.91 74.28 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.243 0.617 . . . . 0.0 109.482 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -161.31 153.87 20.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.646 1.579 . . . . 0.0 108.536 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.72 -153.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.39 0.676 . . . . 0.0 111.548 -173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.89 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.675 1.19 . . . . 0.0 113.356 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -80.98 91.9 6.11 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 165.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 14' ' ' THR . 47.1 t -91.29 123.33 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.232 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 63' ' ' LEU . 7.4 p -115.16 151.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.4 p -143.57 136.1 27.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 70.0 mt -98.32 122.29 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 8' ' ' THR . 2.3 mp -89.01 114.62 27.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.026 0.93 . . . . 0.0 108.901 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 56' ' ' LEU . 97.9 m-85 -109.93 99.43 8.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.841 0.856 . . . . 0.0 108.726 172.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.7 m -90.17 102.18 14.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 50' ' ' TRP . 38.0 tt0 -78.79 105.68 10.26 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 119.677 -0.201 . . . . 0.0 110.791 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.6 p -74.37 143.53 44.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 124.071 0.857 . . . . 0.0 110.259 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -160.35 10.1 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -155.79 137.62 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 117.913 0.856 . . . . 0.0 110.876 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.657 ' HB2' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -113.24 128.73 56.56 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.525 0.73 . . . . 0.0 109.156 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 29.0 t70 -79.77 130.15 35.09 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.374 0.67 . . . . 0.0 109.39 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.42 -16.47 45.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 t -94.53 -36.12 11.97 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.401 0.546 . . . . 0.0 110.982 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -89.85 -31.8 17.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.892 0.477 . . . . 0.0 109.962 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.88 27.42 60.59 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HE2' HD11 ' A' ' 49' ' ' ILE . 21.1 ptmt -96.38 140.69 30.66 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.694 0.798 . . . . 0.0 110.946 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.02 115.49 30.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 0.0 110.481 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.433 HD11 ' HE2' ' A' ' 47' ' ' LYS . 3.6 mp -109.77 104.01 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.525 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 74.5 m95 -90.36 145.48 24.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.233 1.013 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 28.1 t70 -67.57 113.85 5.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.16 0.584 . . . . 0.0 110.292 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -62.75 -39.32 93.75 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.913 0.885 . . . . 0.0 112.13 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -82.72 -6.92 59.64 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.671 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 60.0 t90 -54.36 124.63 16.54 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 19.9 p -154.34 108.45 2.98 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 35' ' ' PHE . 37.4 tp -101.06 127.0 47.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.9 m -98.83 112.9 24.85 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -119.95 124.77 46.78 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 15.7 m -80.88 135.24 35.88 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.211 0.605 . . . . 0.0 111.619 -174.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -82.61 117.62 22.71 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 158.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -172.45 179.93 2.38 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.001 1.438 . . . . 0.0 109.089 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.53 52.78 4.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.914 0.759 . . . . 0.0 112.273 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.55 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -97.33 98.22 4.68 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 168.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.69 92.35 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.782 2.321 . . . . 0.0 111.89 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.1 p -85.82 131.75 46.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.926 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.21 138.57 61.98 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.87 2.38 . . . . 0.0 113.072 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -88.57 111.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 mt -102.56 128.63 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.29 132.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.871 0.468 . . . . 0.0 109.828 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.45 79.87 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.517 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 88.6 m-85 -143.88 157.95 44.02 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.073 0.949 . . . . 0.0 109.107 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.4 m -145.61 116.97 7.96 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.653 0.781 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.32 135.41 57.0 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.673 0.608 . . . . 0.0 109.562 170.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.65 -14.57 61.62 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 0.0 110.773 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.08 84.75 7.23 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.49 1.116 . . . . 0.0 108.575 172.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.16 -5.67 17.01 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.361 2.041 . . . . 0.0 111.661 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 tpt -116.8 109.31 16.95 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.332 1.053 . . . . 0.0 108.312 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 40.6 t -100.96 133.12 45.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 92.53 0.21 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 123.945 0.778 . . . . 0.0 111.59 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -104.44 21.27 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.055 2.504 . . . . 0.0 112.981 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.76 148.02 29.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -165.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 37.1 mt-10 -87.63 129.64 35.05 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.257 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.75 108.84 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.047 0.939 . . . . 0.0 110.016 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 m -92.58 101.13 13.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.4 0.68 . . . . 0.0 110.623 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.25 116.59 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 9.9 t70 -93.46 163.94 13.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 49.0 m -57.2 -27.75 62.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.283 1.033 . . . . 0.0 111.93 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -69.69 -30.89 68.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.169 0.988 . . . . 0.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -115.53 8.9 15.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.944 0.498 . . . . 0.0 111.714 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 82.9 t80 -62.03 -33.89 75.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.876 0.87 . . . . 0.0 112.25 -173.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.74 -18.1 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.323 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -95.63 156.42 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 170.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -141.74 138.71 32.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.691 1.197 . . . . 0.0 108.13 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.36 45.48 0.96 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 0.0 109.694 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.03 121.58 15.02 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.466 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HB2' HE22 ' A' ' 13' ' ' GLN . 53.5 mmm-85 -127.15 177.44 6.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.516 0.726 . . . . 0.0 109.901 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -130.31 122.32 27.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.71 110.59 20.42 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 94.9 m -97.3 122.96 40.92 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.537 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -99.16 137.05 27.77 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.0 mm -100.41 118.76 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 122.782 0.433 . . . . 0.0 110.166 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 91.4 m-85 -88.67 95.63 10.33 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 p -86.65 139.15 31.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.41 114.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.245 1.018 . . . . 0.0 110.649 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 . . . . . 0 C--O 1.241 0.632 0 O-C-N 124.397 1.061 . . . . 0.0 109.758 -177.771 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 42' ' ' ASP . 31.5 mm -121.33 154.03 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.801 1.241 . . . . 0.0 109.204 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.07 146.45 53.74 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.59 122.49 5.53 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 121.326 1.351 . . . . 0.0 111.681 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 41' ' ' ARG . 24.5 pt -117.2 169.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 0.0 110.029 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.01 144.21 8.23 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.869 0.468 . . . . 0.0 111.414 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . 84.9 mtt180 -102.06 169.87 8.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.4 1.08 . . . . 0.0 108.946 165.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -144.09 116.85 8.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.099 0.559 . . . . 0.0 110.72 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -114.05 125.03 53.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -104.84 134.64 45.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.21 118.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -109.07 117.64 34.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.206 1.002 . . . . 0.0 110.304 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -90.39 108.64 19.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 p -85.63 104.58 15.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.5 mp -92.68 121.7 43.54 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -125.72 130.91 52.46 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.101 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -92.3 121.99 34.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.956 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -134.99 162.45 32.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.37 0.668 . . . . 0.0 109.32 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -93.33 171.94 8.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.977 0.911 . . . . 0.0 109.444 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.04 -25.13 66.91 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.542 0.737 . . . . 0.0 110.741 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.0 -20.33 66.15 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.89 1.276 . . . . 0.0 111.815 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.52 -19.26 54.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 120.075 -0.291 . . . . 0.0 112.481 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.25 137.51 52.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.024 0.93 . . . . 0.0 110.901 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.98 109.95 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.81 63.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.115 0.566 . . . . 0.0 109.973 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -153.67 166.85 31.52 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.83 1.252 . . . . 0.0 110.487 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.62 82.0 0.59 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -171.76 -3.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' HB3' HD21 ' A' ' 63' ' ' LEU . 22.1 m170 -99.46 82.22 2.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.67 1.123 . . . . 0.0 111.269 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.91 130.96 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.4 117.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 m -105.83 127.42 53.1 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.445 1.098 . . . . 0.0 108.954 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 58' ' ' GLN . 94.9 mt -108.67 130.86 55.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.461 0.705 . . . . 0.0 110.06 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.3 118.9 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 108.921 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -108.13 104.16 13.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.0 m -94.63 105.75 17.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.425 0.69 . . . . 0.0 109.484 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 35.4 tt0 -79.8 83.79 5.69 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -74.36 133.44 42.51 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.99 -162.08 9.04 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 142.06 32.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.595 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.5 ttm180 -112.2 124.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.295 0.638 . . . . 0.0 109.949 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' HA ' HD13 ' A' ' 2' ' ' ILE . 27.3 t70 -74.53 120.79 20.56 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.4 mt -83.8 -27.31 28.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -73.22 -41.16 64.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.898 0.317 . . . . 0.0 111.026 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -87.98 -29.73 20.55 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.98 36.34 32.32 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -104.37 142.47 34.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.659 0.784 . . . . 0.0 109.69 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 51.1 mt-10 -97.15 114.1 25.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.42 116.44 34.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -114.58 132.72 56.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.78 127.04 32.21 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 t -67.77 -31.05 70.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.975 0.91 . . . . 0.0 111.789 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -86.56 2.75 47.01 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.02 0.528 . . . . 0.0 111.449 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 56' ' ' LEU . 77.6 t90 -58.79 134.52 56.93 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.32 0.648 . . . . 0.0 110.564 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.1 p -156.04 122.14 5.04 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.909 0.883 . . . . 0.0 109.321 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 1.5 tm? -104.38 133.86 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -107.12 123.21 47.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.309 0.644 . . . . 0.0 110.31 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.6 mm-40 -129.2 134.01 47.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 0.0 108.902 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.8 m -97.41 118.68 34.42 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.408 0.683 . . . . 0.0 111.377 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -72.94 119.67 17.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -170.09 -163.47 0.36 Allowed 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.534 1.146 . . . . 0.0 108.56 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 64.32 19.69 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.254 1.021 . . . . 0.0 112.544 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 29' ' ' HIS . 35.9 tp -139.74 98.93 7.74 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.287 0.635 . . . . 0.0 109.372 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 77' ' ' MET . 53.6 Cg_endo -88.89 -166.47 0.25 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.366 2.711 . . . . 0.0 111.899 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -116.57 147.11 39.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.129 0.972 . . . . 0.0 110.501 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.68 125.11 16.9 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.546 2.164 . . . . 0.0 111.555 171.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.87 109.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.26 1.024 . . . . 0.0 109.908 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.02 123.45 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -73.6 135.29 27.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.525 1.53 . . . . 0.0 108.895 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.02 -1.41 86.69 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.599 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 94.5 m-85 -139.5 168.43 19.83 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 117.681 0.74 . . . . 0.0 112.157 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -150.45 121.5 7.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.465 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 147.16 52.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.428 0.691 . . . . 0.0 111.121 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -63.12 -32.42 73.8 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.941 0.896 . . . . 0.0 110.422 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -142.16 93.62 7.24 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.1 -1.7 9.95 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.958 2.439 . . . . 0.0 113.266 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 24.8 ttt -148.68 140.06 23.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.28 122.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.02 112.25 3.08 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 124.8 1.312 . . . . 0.0 113.173 -171.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.52 90.49 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.181 2.587 . . . . 0.0 110.677 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -140.17 137.37 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.72 106.22 9.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.592 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.39 112.53 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.508 1.123 . . . . 0.0 109.263 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -100.85 135.51 42.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.97 0.508 . . . . 0.0 110.593 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -103.79 124.67 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.34 164.29 13.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.046 0.939 . . . . 0.0 109.309 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.0 t -58.31 -37.75 75.71 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.764 1.226 . . . . 0.0 112.972 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.16 -41.32 22.6 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.826 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.3 -0.8 51.29 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 117.755 0.252 . . . . 0.0 111.577 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -57.91 -31.32 66.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 0.0 112.388 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.56 -21.79 61.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.32 0.648 . . . . 0.0 111.372 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.19 120.53 40.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.82 0.848 . . . . 0.0 109.45 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.15 105.32 3.93 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.731 0.777 . . . . 0.0 109.05 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -84.65 41.65 0.86 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 111.039 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.95 160.92 19.61 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.247 1.019 . . . . 0.0 111.449 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.63 169.22 19.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.008 0.523 . . . . 0.0 110.215 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.28 126.31 42.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.84 0.856 . . . . 0.0 109.64 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 15' ' ' ILE . 15.7 mm-40 -101.39 123.14 44.98 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.017 0.527 . . . . 0.0 109.744 169.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -109.15 109.8 20.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.1 m -85.77 141.49 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.209 0.603 . . . . 0.0 109.97 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.9 m-85 -76.66 107.8 9.21 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.6 p -109.15 142.03 40.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.07 124.8 10.81 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 124.369 1.043 . . . . 0.0 110.525 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.7 p30 . . . . . 0 CA--C 1.56 1.332 0 C-N-CA 123.956 0.902 . . . . 0.0 110.728 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' HD12 ' A' ' 43' ' ' LEU . 16.7 tpt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.111 0.481 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -102.65 143.46 15.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.908 0.883 . . . . 0.0 109.319 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.78 146.77 51.55 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.97 123.0 4.99 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.478 1.452 . . . . 0.0 111.315 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 38.9 pt -116.76 169.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.329 0.585 . . . . 0.0 110.874 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -161.31 152.41 18.54 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.007 174.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' NH2' HD21 ' A' ' 91' ' ' LEU . 27.3 ttp180 -124.2 147.7 47.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.525 HG23 HG23 ' A' ' 34' ' ' ILE . 51.4 m -116.91 106.8 13.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.335 0.654 . . . . 0.0 110.881 -169.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -107.05 102.94 12.25 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.66 127.01 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' SER . 59.7 t -91.4 103.25 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' ' 95' ' ' ASN . 29.7 m -96.18 100.56 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.293 -172.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -92.62 100.91 13.34 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 60.7 m -87.01 104.42 16.29 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 68.6 mt -89.89 123.77 42.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 111.545 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 22.9 m170 -101.18 120.56 40.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' VAL . 17.7 m-85 -90.89 116.51 28.77 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 43.8 mtm105 -134.14 177.08 8.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.267 0.627 . . . . 0.0 109.96 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -104.06 169.59 8.41 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.231 1.012 . . . . 0.0 109.648 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.39 -26.24 68.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.151 0.58 . . . . 0.0 111.28 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.41 -17.26 63.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.271 1.028 . . . . 0.0 110.618 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.57 32.85 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.06 44.65 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.088 0.955 . . . . 0.0 111.862 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 37.7 t -86.73 121.6 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.691 0.396 . . . . 0.0 109.977 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -77.68 -57.15 3.97 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -168.49 103.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 109.655 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 5.0 p-10 -86.48 -171.41 3.53 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.98 0.512 . . . . 0.0 111.44 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 66.06 16.19 10.36 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.438 1.095 . . . . 0.0 112.56 171.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -89.59 90.54 8.3 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -94.6 145.42 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 124.534 1.134 . . . . 0.0 112.092 -169.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 63' ' ' LEU . 5.4 p -125.65 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.4 m -129.01 132.49 47.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.885 0.374 . . . . 0.0 110.723 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.89 123.84 45.69 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 HG23 ' A' ' 8' ' ' THR . 2.6 mp -82.82 112.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 56' ' ' LEU . 97.3 m-85 -108.83 100.76 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -98.65 108.16 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.501 1.121 . . . . 0.0 110.264 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.52 114.26 20.81 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -87.15 146.81 25.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.355 0.597 . . . . 0.0 110.243 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.48 -157.72 9.74 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.919 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 140.27 25.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.344 0.572 . . . . 0.0 110.007 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.4 ttm180 -104.64 135.63 45.69 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.332 0.586 . . . . 0.0 109.666 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.08 109.59 16.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.831 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.4 mt -81.88 -2.95 52.94 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 t -92.51 -37.53 12.45 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.408 0.549 . . . . 0.0 111.042 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.6 -28.01 13.75 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.143 0.577 . . . . 0.0 109.734 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.88 37.06 9.59 Favored Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -113.65 140.98 47.76 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.568 0.747 . . . . 0.0 109.737 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.1 121.4 38.94 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.391 0.677 . . . . 0.0 110.203 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.36 97.68 5.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.401 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 79.1 m95 -91.95 141.47 28.59 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.7 t70 -69.03 116.39 9.43 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.8 p -66.58 -30.38 70.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.703 0.801 . . . . 0.0 111.627 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -80.97 -16.44 53.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.618 0.767 . . . . 0.0 111.151 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 60.4 t-105 -62.07 132.23 52.19 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.112 0.565 . . . . 0.0 111.883 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.1 p -155.03 144.66 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.896 1.278 . . . . 0.0 108.307 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.506 ' HB2' ' HD1' ' A' ' 35' ' ' PHE . 96.7 mt -120.13 130.1 54.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.232 0.613 . . . . 0.0 109.413 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 m -106.22 119.95 40.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.89 145.3 44.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.774 0.829 . . . . 0.0 108.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' HG2' ' A' ' 82' ' ' GLU . 16.6 m -99.18 123.61 43.6 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.089 0.556 . . . . 0.0 111.376 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -65.2 128.32 35.34 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 159.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -171.43 168.61 6.46 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.359 0.663 . . . . 0.0 110.837 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.51 14.62 9.65 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.219 1.408 . . . . 0.0 113.339 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 31' ' ' VAL . 4.6 mm? -62.63 113.21 8.3 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.785 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.54 166.23 28.04 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.157 1.905 . . . . 0.0 110.555 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -156.15 123.08 2.67 Favored Pre-proline 0 N--CA 1.472 0.629 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.44 125.0 15.26 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.307 2.005 . . . . 0.0 111.945 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.9 t -77.18 104.77 5.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mt -101.71 113.4 37.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.1 mm -75.58 134.87 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.303 0.641 . . . . 0.0 109.854 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.01 4.22 82.13 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.969 -169.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -134.43 167.57 20.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.963 0.905 . . . . 0.0 110.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.4 m -156.03 117.55 3.92 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -75.15 152.42 38.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.233 0.54 . . . . 0.0 111.702 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.46 -26.88 60.32 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.79 1.236 . . . . 0.0 109.668 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 92.97 4.12 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.767 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.61 3.53 7.63 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.564 2.176 . . . . 0.0 112.659 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 ttt -147.41 78.27 1.46 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.252 0.621 . . . . 0.0 110.151 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.8 t -84.67 152.79 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.74 -81.49 0.34 Allowed Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.112 -1.382 . . . . 0.0 111.724 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -31.75 78.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.762 1 C-N-CA 125.589 4.192 . . . . 0.0 117.073 -162.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -161.32 144.11 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 109.713 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 28.0 mt-10 -91.76 120.54 32.58 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.48 128.6 51.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.196 0.999 . . . . 0.0 109.055 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 29.2 m -110.25 109.67 20.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.436 HG22 ' NE2' ' A' ' 94' ' ' GLN . 86.9 t -95.76 110.59 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 163.63 19.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.463 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -67.84 -27.15 66.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.812 0.445 . . . . 0.0 111.364 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -76.27 -29.47 57.46 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.327 0.651 . . . . 0.0 112.735 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -116.07 23.82 11.9 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.563 0.345 . . . . 0.0 110.998 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -61.44 -48.51 80.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.785 0.834 . . . . 0.0 111.897 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.442 HD21 ' NH2' ' A' ' 7' ' ' ARG . 3.2 mm? -75.28 -10.48 59.5 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -83.76 120.24 25.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.163 0.585 . . . . 0.0 109.724 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.57 148.86 40.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.068 0.937 . . . . 0.0 111.428 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -137.1 14.64 3.05 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.82 168.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' A' ' 12' ' ' THR . 2.9 p-10 -79.79 140.96 36.68 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -172.28 169.76 5.28 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.9 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.57 135.22 36.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.184 0.994 . . . . 0.0 108.668 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 5.5 mm-40 -126.27 111.38 14.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.34 1.056 . . . . 0.0 110.401 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 m -96.2 130.77 43.19 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.573 -0.704 . . . . 0.0 110.578 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.0 m -96.0 143.07 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 164.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.0 mm -114.69 110.47 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.858 0.463 . . . . 0.0 110.543 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 85.1 m-85 -88.26 102.51 14.9 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.8 m -87.01 172.93 9.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.76 156.67 8.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -168.151 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 40' ' ' LYS . 32.8 mm -127.31 154.88 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.841 0.857 . . . . 0.0 109.93 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 10.6 pt-20 -121.75 146.06 44.78 Favored Pre-proline 0 N--CA 1.485 1.293 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 165.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.69 125.38 11.06 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.873 1.716 . . . . 0.0 111.265 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.6 pt -128.15 174.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.664 0.785 . . . . 0.0 109.825 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.55 150.19 7.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 110.951 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -108.99 151.95 25.63 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -134.91 107.93 7.62 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.174 0.59 . . . . 0.0 110.264 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -105.43 124.16 49.08 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.2 m -104.26 139.17 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' SER . 38.8 t -94.76 104.97 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -102.17 102.39 12.83 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.677 ' HG2' ' HB3' ' A' ' 96' ' ' ARG . 25.1 mt-30 -104.46 121.35 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.793 0.837 . . . . 0.0 109.803 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 30' ' ' VAL . 32.0 m -92.24 103.4 15.87 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -84.81 128.3 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.241 0.617 . . . . 0.0 109.435 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -106.13 137.69 43.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -108.96 121.25 44.73 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 3.7 tpp180 -145.85 130.15 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 161.58 25.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.289 0.635 . . . . 0.0 110.564 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.22 -25.0 68.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.745 0.818 . . . . 0.0 112.218 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.03 -9.2 58.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 111.62 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.28 68.66 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.94 55.0 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 123.686 0.794 . . . . 0.0 110.232 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 27' ' ' ASP . 47.9 t -90.15 110.08 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.596 0.758 . . . . 0.0 110.521 -172.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.26 -49.46 13.68 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.213 0.205 . . . . 0.0 110.676 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -176.99 90.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.751 1.22 . . . . 0.0 108.463 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.644 ' HB2' HG13 ' A' ' 24' ' ' VAL . 8.8 t70 -98.62 41.08 1.15 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.256 0.623 . . . . 0.0 111.757 -161.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -152.99 16.46 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.63 -0.669 . . . . 0.0 111.883 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.483 ' HE1' ' HG2' ' A' ' 64' ' ' PRO . 9.5 t60 -75.74 93.14 3.08 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 120.725 0.297 . . . . 0.0 110.97 -173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 14' ' ' THR . 39.2 t -95.3 146.03 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 122.784 0.434 . . . . 0.0 110.452 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.16 149.11 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.459 1.103 . . . . 0.0 108.472 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 62.1 p -143.4 127.42 17.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 26.3 mt -104.91 127.16 52.63 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 174.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.7 115.94 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.134 0.973 . . . . 0.0 108.986 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' HA ' HD23 ' A' ' 56' ' ' LEU . 69.3 m-85 -108.02 110.43 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 m -111.18 108.24 17.84 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -94.31 110.0 21.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -76.79 142.46 40.34 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.545 0.528 . . . . 0.0 109.8 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.16 -165.54 11.17 Favored Glycine 0 C--O 1.248 1.015 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -142.43 139.45 31.63 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 40.0 ttm180 -107.75 122.93 47.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.638 0.199 . . . . 0.0 110.949 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.1 114.04 6.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.613 1.165 . . . . 0.0 109.403 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.9 -20.21 35.86 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -78.68 -40.22 34.49 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.255 0.48 . . . . 0.0 110.757 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -91.66 -29.81 16.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.662 0.785 . . . . 0.0 110.229 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.6 44.72 7.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HE3' HD11 ' A' ' 49' ' ' ILE . 30.4 ttpt -116.0 142.43 46.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.618 1.567 . . . . 0.0 109.172 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -108.91 121.17 44.54 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.892 0.477 . . . . 0.0 110.451 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' HE3' ' A' ' 47' ' ' LYS . 3.7 mp -98.59 107.73 20.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.511 1.124 . . . . 0.0 108.275 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.06 119.32 39.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 37.2 t70 -62.69 115.78 4.61 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.369 0.668 . . . . 0.0 109.883 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 m -64.47 -26.28 68.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.421 1.088 . . . . 0.0 111.936 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -82.47 -13.25 57.04 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.951 0.901 . . . . 0.0 111.414 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.2 t-105 -68.75 137.49 54.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.527 0.731 . . . . 0.0 110.383 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.3 p -152.42 146.92 25.69 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.256 1.022 . . . . 0.0 108.738 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.9 tp -124.81 125.39 43.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.3 m -97.54 112.32 24.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.49 132.74 53.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 61' ' ' GLU . 4.8 m -68.43 108.79 3.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.86 0.725 . . . . 0.0 109.986 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -97.06 96.73 8.67 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.568 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.4 pt-20 -168.41 -159.95 0.29 Allowed 'General case' 0 C--O 1.245 0.846 0 C-N-CA 124.098 0.959 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.81 31.55 16.38 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 78' ' ' VAL . 2.2 tm? -84.55 107.94 12.99 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HG2' ' HE1' ' A' ' 29' ' ' HIS . 56.1 Cg_endo -71.29 89.94 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.149 2.566 . . . . 0.0 113.278 -170.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -85.64 125.98 67.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.967 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.7 118.59 5.47 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.443 2.096 . . . . 0.0 110.469 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.92 108.53 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mt -107.37 117.53 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.365 0.602 . . . . 0.0 109.991 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 69' ' ' ILE . 1.3 mp -74.64 138.95 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.675 1.59 . . . . 0.0 109.344 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.74 8.91 87.19 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.698 0.624 . . . . 0.0 112.253 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.4 m-85 -140.51 167.68 21.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.478 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.4 m -148.67 116.98 6.47 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.809 0.843 . . . . 0.0 109.629 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -64.38 154.25 36.08 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.986 0.914 . . . . 0.0 110.757 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.27 -39.65 91.18 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.078 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 92.53 5.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.139 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.22 -0.3 8.42 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.065 2.51 . . . . 0.0 113.04 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.0 ttt -140.9 89.98 2.3 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 21.4 t -76.68 145.01 10.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.72 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.28 127.92 2.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.18 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 8.7 Cg_exo -72.38 29.48 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 124.12 3.213 . . . . 0.0 115.094 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 69.9 -72.47 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.192 1.397 . . . . 0.0 111.609 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.5 130.12 41.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.779 0.831 . . . . 0.0 109.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.1 t -118.1 114.4 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -96.33 110.73 23.01 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.408 0.683 . . . . 0.0 109.422 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.34 114.34 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -92.23 162.02 14.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.5 0.72 . . . . 0.0 109.782 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -30.95 71.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.236 1.014 . . . . 0.0 111.939 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.03 -29.03 69.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.913 0.885 . . . . 0.0 111.741 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -115.11 4.83 14.72 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.084 0.554 . . . . 0.0 111.831 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.61 -23.82 63.57 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.63 161.7 23.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.991 0.917 . . . . 0.0 109.975 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 156.6 32.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.409 ' OE1' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -119.74 47.04 1.8 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -54.16 122.35 10.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.21 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.677 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 66.0 ttt180 -133.76 172.2 13.1 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.754 0.659 . . . . 0.0 109.641 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.32 119.72 10.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 43.3 mt-10 -123.44 110.37 15.02 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.018 0.527 . . . . 0.0 110.95 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -85.59 122.29 29.49 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.03 134.7 30.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.159 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 170.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 mm -103.17 119.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 86.5 m-85 -84.04 106.94 16.09 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.994 0.918 . . . . 0.0 108.669 170.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.5 p -107.67 134.93 49.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 108.89 0.24 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.511 1.132 . . . . 0.0 110.442 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 p30 . . . . . 0 N--CA 1.477 0.911 0 C-N-CA 123.652 0.781 . . . . 0.0 112.324 -171.365 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.6 tpt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 42' ' ' ASP . 33.1 mm -126.59 152.51 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.203 1.001 . . . . 0.0 109.001 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 13.9 pt-20 -128.38 155.14 78.99 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.29 127.08 5.77 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.616 1.544 . . . . 0.0 111.6 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -125.72 168.15 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.144 0.578 . . . . 0.0 110.447 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 150.53 23.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.285 0.634 . . . . 0.0 109.932 174.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.448 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 98.7 mtt180 -114.25 159.64 19.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.057 0.543 . . . . 0.0 109.895 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.618 HG23 HG23 ' A' ' 34' ' ' ILE . 28.6 m -113.54 113.38 25.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -110.75 98.05 7.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.4 m -88.38 133.01 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 105.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 27.6 m -103.39 99.48 9.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.132 0.491 . . . . 0.0 110.228 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.581 ' HG2' ' H ' ' A' ' 96' ' ' ARG . 18.6 mt-30 -94.39 131.8 39.68 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.608 0.763 . . . . 0.0 111.433 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.499 HG23 HG22 ' A' ' 30' ' ' VAL . 50.9 m -103.54 105.53 15.8 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.8 mp -91.03 130.55 40.03 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -129.45 138.71 51.59 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.649 0.738 . . . . 0.0 110.509 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 66.4 m-85 -94.61 119.65 33.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.92 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 53.8 ttt180 -144.86 134.31 23.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 0.0 111.194 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -71.08 163.02 28.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.446 1.099 . . . . 0.0 112.128 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.83 -38.64 79.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.339 . . . . 0.0 112.787 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.37 -17.72 60.14 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.233 1.013 . . . . 0.0 112.026 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.23 28.39 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.691 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 139.52 39.87 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.47 131.25 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 118.129 0.422 . . . . 0.0 110.498 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.87 -58.03 3.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.321 0.648 . . . . 0.0 109.762 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 97.0 m-70 -150.92 171.4 17.32 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.123 1.369 . . . . 0.0 109.128 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -153.75 29.44 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.413 0.625 . . . . 0.0 111.512 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.01 -3.13 17.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.903 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -88.22 75.85 8.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.655 0.741 . . . . 0.0 109.62 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 14' ' ' THR . 27.2 t -100.93 112.49 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.959 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.06 146.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.574 1.149 . . . . 0.0 109.307 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -136.29 141.1 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.569 0.748 . . . . 0.0 110.333 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt -112.61 126.79 55.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.441 171.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 8' ' ' THR . 2.0 mp -88.2 104.61 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.261 1.024 . . . . 0.0 108.936 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.604 ' HA ' HD23 ' A' ' 56' ' ' LEU . 67.1 m-85 -97.13 100.72 12.2 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -82.15 101.94 10.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.545 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -87.48 100.97 13.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -94.07 149.76 20.95 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.827 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.77 -151.31 6.17 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.076 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 142.83 27.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.452 0.701 . . . . 0.0 109.655 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.617 ' HB2' HD13 ' A' ' 5' ' ' ILE . 21.4 ttm-85 -101.15 126.92 47.9 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.247 0.546 . . . . 0.0 110.09 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.0 t70 -74.58 111.77 10.11 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.51 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.2 mt -83.75 -11.29 57.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -173.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.6 t -78.49 -39.75 37.38 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.766 0.712 . . . . 0.0 110.631 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -94.99 -31.64 13.53 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.36 61.13 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HE3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -79.08 139.82 38.01 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.704 0.802 . . . . 0.0 110.216 -173.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.9 124.38 35.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.262 0.625 . . . . 0.0 109.736 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HE3' ' A' ' 47' ' ' LYS . 48.8 mm -111.11 137.4 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 93.6 m95 -126.49 139.67 53.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -173.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 27.5 t0 -65.91 109.15 2.41 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.3 t -61.78 -30.57 70.88 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.009 0.818 . . . . 0.0 111.035 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.83 -3.28 50.6 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.88 0.872 . . . . 0.0 112.04 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.5 t-105 -78.51 116.84 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 0.0 109.641 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 p -142.0 130.18 22.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.4 tp -123.23 136.17 54.6 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 m -120.06 117.49 28.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.673 0.789 . . . . 0.0 108.964 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -129.93 149.61 51.58 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.6 m -106.6 122.58 46.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.438 0.695 . . . . 0.0 112.243 -170.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 66.9 m-85 -71.37 96.66 1.49 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 12.5 pt-20 -139.9 178.9 6.92 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.588 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.78 42.13 31.87 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.359 1.037 . . . . 0.0 110.516 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -105.13 97.28 12.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -174.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -91.11 -165.31 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.235 2.623 . . . . 0.0 112.407 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' A' ' 102' ' ' TYR . 70.6 p -154.21 146.49 17.33 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.484 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.34 120.44 7.76 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.169 1.913 . . . . 0.0 111.329 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.75 106.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.6 mt -94.85 126.48 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.91 131.2 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.975 0.91 . . . . 0.0 110.877 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.81 5.36 89.88 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.106 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.5 159.32 42.14 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.775 0.797 . . . . 0.0 111.601 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.3 m -147.52 129.02 14.97 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.07 156.17 30.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.519 0.327 . . . . 0.0 111.045 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 -42.15 69.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.37 86.42 58.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.369 169.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.59 -6.19 17.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.362 2.041 . . . . 0.0 111.786 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.4 tpt -143.95 114.2 7.43 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.901 1.68 . . . . 0.0 106.546 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 63' ' ' LEU . 83.0 t -68.81 123.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.5 116.21 8.21 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.319 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 91.3 Cg_exo -48.04 131.07 21.05 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.598 2.865 . . . . 0.0 113.956 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.85 132.89 31.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -82.72 118.63 23.5 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.217 1.007 . . . . 0.0 109.638 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.8 t -102.09 132.82 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.106 0.962 . . . . 0.0 108.831 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 m -113.46 113.35 25.03 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 0.0 110.07 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.429 HG22 ' NE2' ' A' ' 94' ' ' GLN . 94.0 t -97.7 112.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.78 157.09 16.97 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.589 1.156 . . . . 0.0 108.473 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.8 t -53.43 -33.04 52.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.654 1.181 . . . . 0.0 112.556 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -69.74 -54.92 11.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.429 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.36 19.95 3.04 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -56.82 -37.18 70.86 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.34 1.056 . . . . 0.0 111.718 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.16 -15.32 53.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.71 0.404 . . . . 0.0 111.06 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.02 118.33 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.841 0.856 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.18 152.44 25.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.938 0.495 . . . . 0.0 109.854 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.429 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -141.71 23.36 2.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.933 0.893 . . . . 0.0 109.705 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 12' ' ' THR . 21.7 p-10 -65.09 114.07 4.37 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.972 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' H ' ' HG2' ' A' ' 13' ' ' GLN . 54.9 mtm-85 -82.4 165.29 20.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.886 0.851 . . . . 0.0 110.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.95 123.94 33.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 170.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' A' ' 15' ' ' ILE . 36.6 mt-10 -129.12 125.49 37.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.996 0.518 . . . . 0.0 111.158 -172.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -99.93 125.36 45.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.662 0.785 . . . . 0.0 109.01 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -95.37 137.32 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 51.4 mm -105.99 111.4 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.052 0.141 . . . . 0.0 110.7 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' A' ' 65' ' ' SER . 79.8 m-85 -85.69 104.26 15.24 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.244 0.618 . . . . 0.0 109.63 175.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -89.77 175.33 7.28 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.02 155.78 1.75 Allowed 'General case' 0 C--O 1.246 0.919 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.483 1.22 0 C-N-CA 124.514 1.125 . . . . 0.0 113.554 -168.597 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 42' ' ' ASP . 30.5 mm -109.62 148.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.417 0.687 . . . . 0.0 109.275 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -123.74 137.18 28.29 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.25 126.62 12.51 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.006 1.804 . . . . 0.0 110.723 174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.4 pt -128.85 135.61 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -142.4 132.74 24.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -113.66 135.22 54.17 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 34' ' ' ILE . 27.5 m -98.5 104.53 16.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.633 0.773 . . . . 0.0 109.03 -166.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.9 tp-100 -97.62 92.14 5.76 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 34' ' ' ILE . 19.4 m -88.02 118.34 33.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 94' ' ' GLN . 86.3 t -88.62 107.66 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.6 m -94.52 108.2 20.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.364 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' HB3' HG13 ' A' ' 31' ' ' VAL . 9.0 tt0 -104.89 106.18 16.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 30' ' ' VAL . 94.6 m -93.54 107.05 18.96 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -84.77 127.27 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.159 0.504 . . . . 0.0 110.239 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -112.37 109.5 19.16 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.216 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 39.7 m-85 -78.47 115.27 18.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.91 160.09 40.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.998 0.519 . . . . 0.0 110.539 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -93.87 168.43 10.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.172 0.989 . . . . 0.0 109.861 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.77 -27.4 67.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.22 -17.16 62.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.358 1.063 . . . . 0.0 111.528 -176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.78 -12.65 42.04 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.33 58.51 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.679 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.54 124.61 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.74 -60.36 2.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.228 0.611 . . . . 0.0 110.577 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.602 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 91.2 m-70 -152.61 105.63 3.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.562 1.145 . . . . 0.0 108.622 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.89 -20.31 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.142 0.577 . . . . 0.0 111.853 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.49 96.53 6.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.116 0.966 . . . . 0.0 110.478 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -146.18 74.58 1.37 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 14' ' ' THR . 39.6 t -92.28 125.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.363 -167.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 13' ' ' GLN . 3.5 p -105.7 115.45 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 168.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 57.5 p -123.65 117.42 24.97 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.1 mt -97.46 129.66 44.64 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 HG12 ' A' ' 10' ' ' VAL . 2.8 mp -86.84 105.04 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.511 0.724 . . . . 0.0 109.341 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -98.53 107.79 20.33 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 m -75.58 103.14 5.56 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 87' ' ' SER . 6.2 tp60 -78.69 100.96 7.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.547 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 39.8 t -99.13 143.29 29.57 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.835 -173.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.51 -164.81 16.14 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.239 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.45 150.7 36.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.434 0.694 . . . . 0.0 109.218 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.588 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.8 ttm180 -119.74 125.11 47.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.676 0.391 . . . . 0.0 110.716 -171.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 26.4 t70 -75.79 115.68 15.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.952 0.901 . . . . 0.0 108.675 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.63 -15.2 58.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -74.85 -43.42 54.61 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.372 0.606 . . . . 0.0 109.993 -173.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -96.48 -29.09 14.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.925 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.48 27.13 33.62 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 19.6 ptmt -93.83 137.67 32.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.922 0.889 . . . . 0.0 109.933 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.48 116.66 29.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.41 87.86 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -80.57 128.63 33.82 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.9 t70 -62.2 126.33 26.97 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 123.52 0.512 . . . . 0.0 110.313 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -64.44 -29.2 70.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.554 1.142 . . . . 0.0 112.039 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.82 -0.34 42.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.286 0.634 . . . . 0.0 111.882 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 51.4 t-105 -66.18 131.09 45.36 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.026 0.441 . . . . 0.0 111.413 -173.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.0 p -150.24 141.01 22.72 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.107 170.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.87 132.11 55.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.7 m -120.04 128.0 53.11 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.023 0.529 . . . . 0.0 110.149 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.76 144.98 35.79 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m -91.87 124.75 36.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.394 1.077 . . . . 0.0 112.195 -169.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -83.36 111.78 19.32 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.64 -162.35 0.38 Allowed 'General case' 0 C--O 1.238 0.493 0 O-C-N 125.049 1.468 . . . . 0.0 108.547 170.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.5 1.34 1.66 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.285 1.434 . . . . 0.0 112.841 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.23 114.03 50.24 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.49 -163.5 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.889 2.392 . . . . 0.0 113.451 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -158.84 124.88 2.4 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' O ' HG13 ' A' ' 68' ' ' ILE . 18.2 Cg_endo -53.61 123.18 12.73 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.879 2.386 . . . . 0.0 111.168 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.12 109.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.61 0.764 . . . . 0.0 109.737 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 66' ' ' PRO . 52.3 mt -112.78 108.31 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.26 124.74 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 110.555 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.94 56.04 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.603 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -134.85 142.89 46.73 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.697 0.799 . . . . 0.0 111.023 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 105' ' ' ASN . 87.3 m -113.04 117.25 31.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 145.44 47.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 109.993 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.64 -31.31 72.48 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.031 0.933 . . . . 0.0 110.196 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.52 109.31 3.6 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 164.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.27 -5.78 17.08 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.674 2.249 . . . . 0.0 111.749 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.8 ttt -140.12 124.28 17.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG11 HG13 ' A' ' 15' ' ' ILE . 2.5 t -102.31 155.49 4.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.715 0.806 . . . . 0.0 108.992 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.43 85.98 0.84 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -104.83 24.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.036 2.491 . . . . 0.0 113.549 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -156.48 132.21 9.58 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -165.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.4 mt-10 -72.01 126.88 30.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.109 166.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.68 128.17 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.776 0.83 . . . . 0.0 110.748 174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.0 m -109.92 111.49 22.92 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.497 1.119 . . . . 0.0 108.401 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 ' HG2' ' A' ' 9' ' ' GLN . 58.5 t -95.68 108.26 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.92 170.35 11.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.023 0.929 . . . . 0.0 109.57 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 18.2 p -60.93 -30.08 70.0 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.992 0.917 . . . . 0.0 111.57 170.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -67.54 -63.62 1.02 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.032 0.933 . . . . 0.0 111.453 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -90.9 15.9 10.47 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.284 0.634 . . . . 0.0 111.544 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.45 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 36.3 t80 -55.84 -36.1 67.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.671 1.189 . . . . 0.0 112.303 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.38 -13.54 60.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.994 0.518 . . . . 0.0 111.354 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -101.15 145.05 29.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.868 0.867 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.81 145.54 31.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.488 ' HB2' HG11 ' A' ' 11' ' ' VAL . 64.2 mm-40 -104.06 0.06 29.31 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.973 -0.454 . . . . 0.0 111.994 -170.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -149.82 -172.99 4.29 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.805 0.842 . . . . 0.0 110.203 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -158.37 -160.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.661 0.784 . . . . 0.0 110.265 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 5.2 mp0 -85.91 106.43 17.1 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 30.7 mm-40 -95.48 111.69 23.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.4 m -104.86 117.02 33.0 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.872 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.2 m -82.56 141.34 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.2 116.43 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 122.66 0.384 . . . . 0.0 110.225 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -83.75 99.94 10.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 p -89.73 174.71 7.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.09 153.64 14.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.445 0.566 . . . . 0.0 109.967 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 5.0 t-20 . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 121.246 0.546 . . . . 0.0 111.333 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 mm -120.04 158.03 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.773 1.229 . . . . 0.0 109.594 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 9.0 pt-20 -128.75 151.65 77.53 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.93 124.42 7.39 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 121.652 1.568 . . . . 0.0 110.764 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -114.72 163.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.335 1.054 . . . . 0.0 108.546 171.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 142.33 13.52 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 53.6 mtp180 -107.7 156.26 19.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.993 1.317 . . . . 0.0 108.442 168.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 34' ' ' ILE . 37.7 m -129.37 108.55 10.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.095 0.558 . . . . 0.0 110.088 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -98.39 120.98 39.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.1 m -108.11 134.83 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.7 t -100.62 104.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 95' ' ' ASN . 31.4 m -106.05 120.61 42.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.052 0.541 . . . . 0.0 109.927 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.45 127.18 53.1 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.529 HG23 HG22 ' A' ' 30' ' ' VAL . 59.1 m -94.24 103.68 15.7 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.34 125.32 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.395 0.616 . . . . 0.0 110.389 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.408 ' HB2' HG23 ' A' ' 99' ' ' THR . 24.0 m-70 -113.28 109.03 18.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HA ' HG22 ' A' ' 100' ' ' VAL . 65.9 m-85 -81.0 115.01 20.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 16.0 mmt85 -131.3 159.68 37.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.995 0.918 . . . . 0.0 109.419 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -88.58 174.49 8.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.109 0.563 . . . . 0.0 109.56 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.39 -26.52 66.49 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.947 0.499 . . . . 0.0 110.545 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.14 -19.51 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.849 1.26 . . . . 0.0 111.12 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.47 66.0 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.302 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.42 152.58 42.98 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.411 0.685 . . . . 0.0 111.053 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 27' ' ' ASP . 57.4 t -73.21 114.94 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.47 -45.78 13.24 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -173.99 126.51 0.36 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.455 1.102 . . . . 0.0 108.192 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 24' ' ' VAL . 9.9 t70 -131.82 88.03 2.52 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.257 -0.902 . . . . 0.0 111.085 -166.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 p30 179.0 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 64' ' ' PRO . 18.8 m170 -83.37 85.32 7.25 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.911 1.232 . . . . 0.0 111.38 -169.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 14' ' ' THR . 40.5 t -94.97 119.8 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.941 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 63' ' ' LEU . 11.7 p -112.69 150.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 0.0 109.073 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 m -141.64 136.65 31.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 35.7 mt -103.88 124.17 48.46 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -88.57 110.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.645 ' HA ' HD23 ' A' ' 56' ' ' LEU . 98.5 m-85 -105.61 101.24 10.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.989 0.916 . . . . 0.0 109.291 173.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.2 m -97.28 103.25 15.16 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.641 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -85.32 100.79 12.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -80.09 135.65 36.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.09 -163.48 11.91 Favored Glycine 0 C--O 1.245 0.84 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.494 ' HE2' ' HB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.87 137.78 41.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 5' ' ' ILE . 33.5 ttm180 -111.95 124.84 53.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.86 115.07 8.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.244 1.018 . . . . 0.0 108.266 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.8 -24.84 55.97 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -80.51 -43.42 20.79 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.775 0.262 . . . . 0.0 111.238 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.43 -28.52 20.84 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.582 0.353 . . . . 0.0 110.597 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.02 23.55 48.57 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.88 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.7 ptmt -94.17 142.68 27.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.375 0.67 . . . . 0.0 110.544 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.5 111.73 24.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.946 0.898 . . . . 0.0 110.553 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' HB ' ' HE2' ' A' ' 40' ' ' LYS . 3.5 mp -108.03 103.4 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 73.1 m95 -87.96 152.06 22.34 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 110.103 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.31 105.72 7.52 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.3 p -72.57 -19.74 61.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.894 0.877 . . . . 0.0 110.854 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -85.54 -0.86 56.23 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.481 0.712 . . . . 0.0 110.94 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.55 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 89.4 t90 -65.88 132.17 48.02 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 110.368 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 28.5 p -154.56 105.43 2.63 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 35' ' ' PHE . 55.6 tp -97.18 126.71 42.54 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.6 m -97.3 110.37 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.05 134.38 55.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.1 m -69.1 118.83 12.49 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.14 0.976 . . . . 0.0 111.445 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -112.5 92.77 4.14 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.854 0.462 . . . . 0.0 109.985 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -159.83 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.264 1.426 . . . . 0.0 108.164 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.425 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . 70.39 15.74 7.26 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.377 1.071 . . . . 0.0 112.555 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -65.86 116.27 30.76 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.159 0.584 . . . . 0.0 110.346 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 29' ' ' HIS . 57.6 Cg_endo -71.33 86.71 0.79 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.049 2.499 . . . . 0.0 111.792 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -89.35 130.78 42.6 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.573 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.85 120.62 8.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.87 1.713 . . . . 0.0 110.737 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.49 102.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.0 111.72 33.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.33 129.22 30.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 123.652 0.595 . . . . 0.0 110.413 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.18 -3.32 86.29 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.013 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 22.0 m-85 -118.13 149.03 41.72 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.186 0.994 . . . . 0.0 108.422 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.1 m -140.66 121.91 14.86 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -67.2 152.22 46.14 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.363 0.665 . . . . 0.0 110.402 175.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.63 -30.96 70.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.287 0.565 . . . . 0.0 110.146 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.27 6.3 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.667 1.187 . . . . 0.0 108.178 173.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.12 -4.2 13.68 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.524 2.149 . . . . 0.0 111.403 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 62' ' ' ALA . 38.0 tpp -146.75 129.86 16.47 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.4 0.68 . . . . 0.0 109.216 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.423 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 94.9 t -96.83 124.35 49.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 O-C-N 124.309 1.006 . . . . 0.0 110.576 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.89 152.34 18.82 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.958 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -85.93 36.69 0.52 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.872 3.048 . . . . 0.0 113.475 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 75.88 -55.16 0.61 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.837 1.655 . . . . 0.0 111.751 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -126.14 150.36 48.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.99 0.916 . . . . 0.0 109.925 170.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.44 118.82 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.658 1.183 . . . . 0.0 108.555 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.0 m -101.15 103.58 14.64 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -95.39 118.9 42.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -88.25 171.83 9.9 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.357 1.063 . . . . 0.0 108.921 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.5 t -69.78 -22.36 63.34 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 123.951 0.782 . . . . 0.0 110.533 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.15 -53.4 25.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.709 0.804 . . . . 0.0 110.119 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -96.5 24.24 6.08 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.728 0.811 . . . . 0.0 111.244 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -72.26 -31.13 65.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.011 0.525 . . . . 0.0 111.249 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.34 -11.43 59.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.521 0.329 . . . . 0.0 110.167 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -94.64 136.19 35.23 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -104.16 146.85 28.16 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.67 21.45 16.15 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 6.7 t30 -64.03 118.57 8.68 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.205 1.002 . . . . 0.0 110.255 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -135.8 176.03 9.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.613 0.765 . . . . 0.0 109.345 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.17 117.72 34.94 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -96.32 132.09 42.16 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.043 0.537 . . . . 0.0 109.99 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.408 HG23 ' HB2' ' A' ' 16' ' ' HIS . 75.3 m -138.46 107.05 5.86 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.9 m -84.61 141.13 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 39.4 mm -116.83 113.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 95.0 m-85 -81.44 108.95 15.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 109.383 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.5 p -96.09 130.97 42.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.03 96.19 1.71 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.592 0.757 . . . . 0.0 109.767 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 . . . . . 0 N--CA 1.474 0.742 0 C-N-CA 124.286 1.034 . . . . 0.0 109.997 177.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.535 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.5 tpt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.867 0.365 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.92 157.11 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.076 1.35 . . . . 0.0 107.886 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 12.4 pt-20 -134.65 146.86 60.77 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.23 124.19 6.47 Favored 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 121.417 1.412 . . . . 0.0 111.517 171.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 41' ' ' ARG . 27.6 pt -119.28 170.77 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 0.0 110.391 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.64 142.11 4.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 110.543 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.478 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 81.3 mtp180 -104.63 169.51 8.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.743 0.817 . . . . 0.0 109.774 170.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.609 HG23 HG23 ' A' ' 34' ' ' ILE . 35.5 m -120.33 108.46 14.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.692 0.797 . . . . 0.0 108.958 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.2 tp60 -105.81 99.65 9.24 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 31.0 m -89.42 127.91 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.41 116.19 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -104.25 105.06 15.07 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 124.195 0.934 . . . . 0.0 111.464 -163.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 96' ' ' ARG . 9.5 mm100 -91.74 99.19 12.12 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.6 0.76 . . . . 0.0 109.578 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 p -79.31 103.92 9.57 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.86 132.88 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 41.0 m-70 -120.35 119.67 33.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.174 0.989 . . . . 0.0 108.522 -174.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -91.32 116.75 29.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.3 mtm105 -142.11 155.22 45.34 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 123.417 0.687 . . . . 0.0 109.414 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -81.27 170.88 15.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.19 -27.87 69.0 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.035 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.78 -18.99 65.57 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 111.784 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.98 -11.52 69.44 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 148.13 48.87 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.849 0.859 . . . . 0.0 110.617 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 55.4 t -91.4 129.8 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.668 0.387 . . . . 0.0 110.471 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.4 -60.45 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -163.77 90.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.346 1.459 . . . . 0.0 108.97 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.5 p-10 -91.48 28.14 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -131.02 21.97 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 111.93 -170.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.16 81.68 5.55 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.014 -1.054 . . . . 0.0 110.404 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.52 127.59 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.222 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HB ' HD23 ' A' ' 63' ' ' LEU . 14.8 p -120.44 150.0 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.467 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 55.4 m -138.73 141.15 38.89 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.743 0.817 . . . . 0.0 108.971 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 58' ' ' GLN . 77.4 mt -110.94 132.44 54.2 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.609 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -81.96 115.52 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.885 0.874 . . . . 0.0 108.768 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.42 100.47 10.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.1 m -75.58 105.77 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -81.83 95.37 7.28 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.695 0.798 . . . . 0.0 109.185 176.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.8 t -87.68 152.56 22.06 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.33 0.586 . . . . 0.0 111.999 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -166.44 -157.5 10.33 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.596 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.12 140.76 30.99 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.445 0.698 . . . . 0.0 110.229 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.7 ttm-85 -102.96 123.61 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -74.93 113.65 12.48 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.535 HD12 ' HG3' ' A' ' 1' ' ' MET . 57.5 mt -82.94 -15.52 50.98 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.1 t -87.28 -38.76 16.0 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.772 0.26 . . . . 0.0 110.385 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -86.88 -32.22 20.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.076 0.55 . . . . 0.0 110.245 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.38 38.23 11.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.489 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.3 ptmt -112.8 140.77 47.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.879 0.872 . . . . 0.0 109.993 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -98.65 107.77 20.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.975 0.91 . . . . 0.0 109.752 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.7 mp -95.92 117.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 77.0 m95 -103.62 124.74 49.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.26 110.01 1.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m -65.0 -20.86 66.71 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.928 0.891 . . . . 0.0 112.797 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.94 -21.76 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.271 0.629 . . . . 0.0 110.439 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -59.01 139.02 57.26 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.929 0.768 . . . . 0.0 111.634 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 70.1 p -149.89 132.98 16.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.913 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD11 HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -124.22 125.45 44.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -113.09 133.86 54.81 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HB3' HD13 ' A' ' 33' ' ' LEU . 76.5 mm-40 -134.41 145.06 48.56 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 m -92.44 116.65 29.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.534 0.734 . . . . 0.0 110.595 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.2 95.51 1.27 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.424 0.63 . . . . 0.0 110.343 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.7 -164.04 1.93 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.801 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.13 28.37 17.08 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.73 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.568 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.3 tm? -119.29 94.92 48.91 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -86.22 152.37 9.43 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.325 2.683 . . . . 0.0 111.883 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' OH ' ' A' ' 102' ' ' TYR . 45.9 m -105.1 149.05 37.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.961 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.45 127.7 25.65 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.064 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.76 107.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mt -107.55 133.75 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.67 132.07 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.694 0.797 . . . . 0.0 108.941 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.19 -6.31 81.94 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.934 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -133.82 165.44 24.96 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.382 0.673 . . . . 0.0 110.476 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -151.09 130.05 12.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 154.51 33.9 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.993 0.517 . . . . 0.0 110.939 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -64.68 -38.23 90.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.515 0.674 . . . . 0.0 109.183 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 88.85 28.93 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 114.501 -1.227 . . . . 0.0 107.997 171.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.94 -5.13 16.41 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.841 2.361 . . . . 0.0 112.798 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.3 tpt -147.56 114.91 6.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.33 118.82 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.09 135.51 51.75 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.375 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.69 97.32 0.32 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.287 1.991 . . . . 0.0 111.964 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -114.14 113.17 24.34 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.305 0.642 . . . . 0.0 110.853 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.38 118.14 17.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.336 0.654 . . . . 0.0 111.179 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.87 135.78 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.37 1.068 . . . . 0.0 108.58 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -105.14 110.25 22.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.27 0.628 . . . . 0.0 109.751 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.595 HG22 HE21 ' A' ' 94' ' ' GLN . 94.0 t -95.66 108.49 21.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.446 ' H ' ' ND2' ' A' ' 89' ' ' ASN . 1.1 p30 -110.86 176.54 4.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.738 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.66 -24.04 65.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.24 -51.16 10.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.198 0.599 . . . . 0.0 110.175 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.446 ' ND2' ' H ' ' A' ' 86' ' ' ASP . 6.4 p30 -92.23 6.68 45.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 52.7 t80 -54.75 -34.6 62.74 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.625 1.17 . . . . 0.0 112.251 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.1 -23.64 47.83 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.97 116.05 28.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.297 0.639 . . . . 0.0 109.987 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -79.83 106.15 11.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 122.092 0.949 . . . . 0.0 109.029 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.595 HE21 HG22 ' A' ' 85' ' ' VAL . 15.6 pt20 -91.77 38.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.418 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -70.3 154.44 41.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.44 1.096 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HB2' ' NE2' ' A' ' 13' ' ' GLN . 44.7 mmm-85 -129.5 141.4 51.01 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.244 0.545 . . . . 0.0 111.756 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -102.78 110.41 22.33 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 163.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -115.7 136.16 53.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.382 0.673 . . . . 0.0 110.286 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.4 m -113.47 119.14 36.56 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 167.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.03 140.71 15.37 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.69 120.12 53.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 C-N-CA 122.927 0.491 . . . . 0.0 110.683 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.401 ' OH ' ' HB3' ' A' ' 65' ' ' SER . 54.3 m-85 -85.54 104.83 15.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.603 0.761 . . . . 0.0 109.868 172.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.9 t -98.31 155.45 17.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 128.94 19.07 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.69 0.619 . . . . 0.0 109.39 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.4 p30 . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 122.282 0.233 . . . . 0.0 111.052 -175.476 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 42' ' ' ASP . 41.0 mm -117.35 136.17 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.97 146.16 35.55 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -77.16 124.08 7.05 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 121.507 1.471 . . . . 0.0 109.919 167.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -112.52 -176.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.8 0.84 . . . . 0.0 109.849 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -151.63 146.41 25.79 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.665 0.786 . . . . 0.0 109.008 173.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 36' ' ' THR . 24.8 tpt180 -103.69 138.08 40.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -121.32 105.71 10.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.04 107.35 14.84 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 109.708 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 14.5 m -90.45 119.02 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 93' ' ' LYS . 92.2 t -91.13 118.59 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.524 ' H ' ' HD3' ' A' ' 93' ' ' LYS . 70.7 m -106.96 103.3 12.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.329 0.651 . . . . 0.0 110.434 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 94.03 5.85 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.444 HG23 HG22 ' A' ' 12' ' ' THR . 82.2 p -86.47 114.47 23.25 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 52.7 mt -110.68 126.19 68.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-O 121.936 0.874 . . . . 0.0 111.234 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.32 110.25 22.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.324 -1.762 . . . . 0.0 106.865 -173.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HD1' HG22 ' A' ' 100' ' ' VAL . 23.0 m-85 -82.08 109.78 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.6 mtm180 -141.22 164.22 30.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.35 0.66 . . . . 0.0 109.791 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -92.2 175.95 6.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.401 0.68 . . . . 0.0 110.314 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.62 -25.66 68.06 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.387 171.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.14 -17.08 63.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.603 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.05 -13.5 66.81 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.04 57.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.372 1.069 . . . . 0.0 111.046 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 38.7 t -83.28 114.98 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 122.948 0.499 . . . . 0.0 109.974 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.29 -56.54 4.94 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -170.81 94.5 0.2 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 0.0 110.147 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.84 106.62 18.58 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.768 -0.582 . . . . 0.0 110.169 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -179.71 -6.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.507 0.723 . . . . 0.0 112.292 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -82.85 86.19 6.97 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.266 0.555 . . . . 0.0 111.487 -163.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.02 125.39 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 0.0 110.71 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -120.25 145.51 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -138.65 131.49 29.41 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.642 0.777 . . . . 0.0 109.703 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 87.7 mt -110.69 136.1 50.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 0.0 109.767 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.42 114.71 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -100.94 96.33 7.19 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 85.1 m -113.59 104.27 12.08 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.626 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -130.92 139.61 50.1 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 61.2 p -90.81 141.55 28.69 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -167.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.96 -142.37 5.46 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.62 139.44 18.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.632 0.716 . . . . 0.0 111.205 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB2' HD13 ' A' ' 5' ' ' ILE . 17.2 ttm180 -103.88 127.12 51.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.102 0.561 . . . . 0.0 110.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 32.4 t70 -73.62 111.25 8.58 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.065 0.946 . . . . 0.0 108.914 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.02 -11.37 56.86 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.5 t -83.24 -31.93 26.73 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.359 0.527 . . . . 0.0 110.401 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -101.39 -30.84 11.23 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.049 0.54 . . . . 0.0 110.207 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.05 49.16 4.35 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 20.0 ptmt -130.29 143.77 50.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.502 1.121 . . . . 0.0 109.521 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -95.27 127.67 41.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.075 0.55 . . . . 0.0 110.49 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.88 126.13 61.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.453 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 81.7 m95 -125.07 143.42 50.93 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.304 1.042 . . . . 0.0 108.268 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 23.2 t70 -62.93 143.13 57.98 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.95 0.5 . . . . 0.0 110.384 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.8 p -68.6 -38.21 80.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.232 0.213 . . . . 0.0 111.496 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.18 -0.94 57.49 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.841 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 37' ' ' GLN . 19.5 t90 -48.3 120.64 3.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.991 0.916 . . . . 0.0 111.394 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 p -154.91 130.01 9.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 37' ' ' GLN . 23.6 tp -115.08 139.56 49.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 m -110.87 150.37 29.27 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.487 0.715 . . . . 0.0 109.803 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 5.5 tp-100 -153.87 127.91 8.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 m -78.27 110.27 13.14 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.31 0.644 . . . . 0.0 111.286 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.434 ' HD2' HG21 ' A' ' 83' ' ' VAL . 15.0 m-85 -75.53 130.23 38.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.25 174.42 8.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.821 0.848 . . . . 0.0 109.961 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 69.91 56.81 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.586 1.154 . . . . 0.0 111.802 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 3.5 mm? -113.7 91.83 22.51 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.467 0.707 . . . . 0.0 109.976 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.47 99.9 0.77 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 123.655 2.904 . . . . 0.0 113.097 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 m -78.73 124.25 85.16 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.772 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.3 122.93 11.58 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 123.521 2.814 . . . . 0.0 112.895 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.0 108.8 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.0 mt -101.89 117.12 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.9 mm -72.88 135.75 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.202 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.49 84.01 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.709 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -130.22 172.17 12.09 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.279 1.032 . . . . 0.0 110.322 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -144.52 123.53 12.8 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.88 131.41 45.46 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.95 -38.58 76.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.854 0.862 . . . . 0.0 109.245 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.6 84.9 49.34 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.604 169.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.0 -4.39 11.38 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.107 2.538 . . . . 0.0 113.227 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 63' ' ' LEU . 17.1 tpt -143.97 136.62 27.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.281 1.032 . . . . 0.0 108.699 172.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -125.54 126.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 71.67 0.91 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 123.914 0.759 . . . . 0.0 112.551 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -96.67 22.52 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.328 2.685 . . . . 0.0 114.355 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -165.81 -169.19 1.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 118.366 0.53 . . . . 0.0 112.216 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 9.2 mp0 -68.04 133.18 48.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.134 1.374 . . . . 0.0 111.601 -171.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.434 HG21 ' HD2' ' A' ' 60' ' ' PHE . 60.0 t -122.21 110.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.06 0.944 . . . . 0.0 109.178 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.6 m -96.82 117.19 30.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.955 0.502 . . . . 0.0 109.774 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 90' ' ' PHE . 37.8 t -97.98 116.32 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.55 162.55 14.15 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.796 0.838 . . . . 0.0 110.899 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 39.9 p -57.78 -35.23 70.51 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.52 1.128 . . . . 0.0 110.802 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -49.59 -49.73 45.51 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.007 1.442 . . . . 0.0 111.202 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -118.35 16.12 13.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.818 -172.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' HA ' HG12 ' A' ' 85' ' ' VAL . 9.6 t80 -66.08 -27.07 67.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.543 0.61 . . . . 0.0 112.459 -166.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.5 -16.87 57.03 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -102.65 156.11 17.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.045 1.338 . . . . 0.0 110.201 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 12' ' ' THR . 9.2 ptpp? -111.71 126.68 55.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -77.91 -12.62 60.0 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -116.15 127.66 55.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.75 -93.05 0.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.904 0.882 . . . . 0.0 109.523 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -108.32 104.94 14.43 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 3.3 mp0 -110.68 135.63 51.0 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -121.5 122.09 38.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.423 0.689 . . . . 0.0 110.09 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' A' ' 17' ' ' TYR . 1.6 m -83.23 141.86 14.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.4 110.73 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.089 0.556 . . . . 0.0 110.848 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -85.94 96.23 9.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 p -99.6 140.05 34.36 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.33 142.09 10.73 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.557 0.536 . . . . 0.0 110.801 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.491 1.6 0 C-N-CA 125.089 1.356 . . . . 0.0 113.016 -162.264 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' HD12 ' A' ' 43' ' ' LEU . 28.0 ttt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 42' ' ' ASP . 49.6 mm -123.91 141.19 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.317 0.647 . . . . 0.0 109.828 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -112.63 128.65 25.28 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 166.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.15 126.63 18.28 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.45 2.1 . . . . 0.0 110.851 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 41' ' ' ARG . 34.0 pt -124.03 -179.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.409 0.684 . . . . 0.0 109.75 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 157.71 24.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.735 1.214 . . . . 0.0 108.291 170.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.509 ' HD3' ' HD2' ' A' ' 90' ' ' PHE . 57.3 ttt-85 -126.77 152.7 46.54 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 34' ' ' ILE . 86.6 m -121.07 108.77 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.454 1.101 . . . . 0.0 108.886 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -100.8 121.78 42.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 34.6 m -105.29 118.09 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 83' ' ' VAL . 97.9 t -97.55 110.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -118.12 131.55 56.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.749 . . . . 0.0 110.57 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 42.3 mt-30 -103.33 100.27 10.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -76.83 100.5 5.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.569 HD12 ' HB ' ' A' ' 78' ' ' VAL . 13.0 tt -101.55 135.52 37.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 122.261 1.029 . . . . 0.0 111.009 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -118.98 148.42 43.0 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.842 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.17 115.76 19.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 37.5 mtm180 -138.13 152.42 48.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HE2' HG21 ' A' ' 68' ' ' ILE . 63.5 m-85 -77.97 169.76 17.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.495 0.718 . . . . 0.0 110.627 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.31 -22.72 63.76 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.843 0.457 . . . . 0.0 111.483 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.96 -12.37 60.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.635 0.774 . . . . 0.0 111.312 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 2.45 68.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.77 147.71 48.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.976 0.51 . . . . 0.0 110.264 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 96.7 t -82.23 135.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.126 0.571 . . . . 0.0 109.94 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 -63.11 1.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -157.2 97.42 1.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.584 1.154 . . . . 0.0 108.788 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -80.38 -9.23 59.75 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.065 0.546 . . . . 0.0 112.422 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.1 71.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.28 1.032 . . . . 0.0 110.877 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -124.7 122.32 37.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 159.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.35 111.75 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.5 p -106.81 125.52 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.759 0.824 . . . . 0.0 108.87 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.3 p -123.92 133.9 53.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.328 0.651 . . . . 0.0 109.418 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 76.7 mt -99.4 123.09 43.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -93.22 116.5 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 8' ' ' THR . 13.7 m-85 -106.43 97.69 7.46 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.4 m -114.57 116.46 28.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.8 44.36 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -76.91 178.12 7.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.926 -165.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.34 -166.73 31.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.186 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 137.74 35.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.7 ttm180 -110.17 124.87 52.35 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.044 0.537 . . . . 0.0 109.887 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 26.5 t70 -74.55 113.83 12.25 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.832 1.253 . . . . 0.0 109.882 173.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 1' ' ' MET . 88.9 mt -85.08 -1.86 57.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.6 t -87.67 -28.61 21.71 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.863 0.756 . . . . 0.0 110.842 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -107.59 -30.84 8.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.569 0.348 . . . . 0.0 110.225 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.71 11.98 56.19 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.86 -173.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -84.89 145.95 27.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.041 0.937 . . . . 0.0 110.279 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.29 121.4 42.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.249 0.62 . . . . 0.0 110.273 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.98 116.02 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -108.97 158.86 17.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.59 1.156 . . . . 0.0 109.079 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 54' ' ' TRP . 17.7 t70 -82.9 125.34 31.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -73.0 -25.88 61.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.745 0.418 . . . . 0.0 111.978 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -81.23 -13.17 58.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.14 0.576 . . . . 0.0 110.789 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' ASP . 8.8 t90 -69.28 134.58 49.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.138 0.975 . . . . 0.0 111.583 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -152.11 121.41 6.77 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.458 1.503 . . . . 0.0 107.441 172.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.09 124.86 44.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -109.95 129.84 55.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -129.4 145.48 51.4 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 m -112.01 120.32 41.46 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.841 0.456 . . . . 0.0 111.446 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 13' ' ' GLN . 51.0 m-85 -65.24 136.49 56.68 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 164.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -170.59 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.68 0.792 . . . . 0.0 109.754 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.55 86.09 5.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.783 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 15' ' ' ILE . 3.3 tm? -144.13 112.79 5.24 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -93.17 178.71 1.19 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.552 2.834 . . . . 0.0 111.743 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -159.17 151.38 17.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.211 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.75 117.83 5.36 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 121.963 1.775 . . . . 0.0 110.62 172.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.9 107.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 19' ' ' TYR . 40.9 mt -102.31 116.33 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.82 139.97 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.7 3.58 89.44 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.401 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.83 171.44 14.51 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.188 0.995 . . . . 0.0 110.073 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -158.5 109.22 2.11 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.17 151.12 46.73 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.559 0.743 . . . . 0.0 111.265 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -73.33 -20.04 60.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.179 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.33 101.57 2.96 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 158.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.26 0.28 5.49 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.151 1.9 . . . . 0.0 113.157 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.6 ttt -150.55 136.67 18.53 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.722 0.809 . . . . 0.0 109.584 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.599 HG11 ' HG3' ' A' ' 98' ' ' GLU . 91.8 t -121.52 107.57 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 163.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.82 -95.74 0.11 Allowed Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.058 -1.412 . . . . 0.0 111.369 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -33.8 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.721 1 C-N-CA 125.463 4.109 . . . . 0.0 115.991 -169.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -168.16 126.73 1.19 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.491 1.116 . . . . 0.0 109.22 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.67 121.5 26.93 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 11' ' ' VAL . 84.2 t -103.23 123.12 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.728 0.811 . . . . 0.0 109.41 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.4 m -103.03 131.17 50.21 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.417 HG22 ' NE2' ' A' ' 94' ' ' GLN . 43.0 t -121.13 112.38 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 4.1 m-20 -79.99 164.69 23.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.836 0.854 . . . . 0.0 109.251 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.6 p -54.56 -36.52 64.43 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.986 0.804 . . . . 0.0 110.384 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -47.87 -49.34 29.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.351 1.46 . . . . 0.0 112.406 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -119.43 23.69 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.675 0.79 . . . . 0.0 111.604 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.509 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 12.4 t80 -75.13 -19.76 59.74 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 122.006 -0.434 . . . . 0.0 111.161 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.31 -16.46 27.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.688 0.795 . . . . 0.0 109.196 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -89.08 160.97 16.79 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.204 1.001 . . . . 0.0 109.687 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -111.85 159.55 18.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.58 0.752 . . . . 0.0 109.443 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.417 ' NE2' HG22 ' A' ' 85' ' ' VAL . 12.0 pt20 -143.39 33.39 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.174 0.59 . . . . 0.0 110.064 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.63 166.35 15.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 111.786 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.17 166.11 24.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.837 0.855 . . . . 0.0 111.445 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -129.92 108.29 10.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' HG3' HG11 ' A' ' 78' ' ' VAL . 25.0 mm-40 -94.29 145.55 24.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.847 0.459 . . . . 0.0 110.104 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.5 m -139.99 98.11 3.39 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.44 142.46 13.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.32 116.74 52.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.017 0.927 . . . . 0.0 110.584 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.87 98.73 9.33 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -83.88 159.96 21.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 144.42 6.97 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.583 0.628 . . . . 0.0 109.805 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.488 1.459 0 C-N-CA 124.655 1.182 . . . . 0.0 112.002 -164.125 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 42' ' ' ASP . 27.3 mm -116.19 134.07 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.61 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.0 134.99 19.42 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 165.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.51 130.4 24.99 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.687 2.258 . . . . 0.0 111.676 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 41' ' ' ARG . 18.8 pt -125.09 163.72 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.92 0.888 . . . . 0.0 109.995 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -156.3 146.58 21.48 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 12.6 mmm180 -117.72 140.33 49.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.988 1.315 . . . . 0.0 108.506 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.448 HG23 HG23 ' A' ' 34' ' ' ILE . 28.9 m -111.52 122.2 47.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.432 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 5.6 tp-100 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.2 m -119.64 132.82 68.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.051 0.453 . . . . 0.0 110.609 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.61 123.29 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -110.09 105.1 14.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 110.485 -162.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 46.2 tt0 -98.55 109.62 22.35 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.664 HG23 HG22 ' A' ' 30' ' ' VAL . 31.4 m -85.99 104.36 15.54 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.574 0.75 . . . . 0.0 110.378 -177.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -93.08 129.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 122.033 -0.417 . . . . 0.0 110.47 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.201 1.0 . . . . 0.0 108.452 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.433 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -97.73 118.28 33.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 23.7 mtm180 -143.48 159.65 42.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.477 0.711 . . . . 0.0 109.65 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 81.1 m-85 -86.5 170.92 11.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.213 1.005 . . . . 0.0 109.916 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -69.15 -22.93 63.91 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.566 0.698 . . . . 0.0 110.313 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.62 -20.94 66.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.327 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.64 -20.51 46.05 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.39 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.17 136.91 52.55 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 0.0 111.452 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 58.7 t -85.57 109.57 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.211 0.604 . . . . 0.0 110.629 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 -49.72 45.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.01 0.524 . . . . 0.0 110.139 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -173.33 90.24 0.08 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.19 -25.73 62.65 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.25 80.69 2.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.702 0.801 . . . . 0.0 110.386 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -134.18 79.51 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 14' ' ' THR . 12.9 t -93.81 118.52 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 113.826 -1.533 . . . . 0.0 108.77 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -102.4 157.71 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -143.27 141.75 31.14 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 109.414 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 88.8 mt -99.9 125.89 45.95 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 8' ' ' THR . 3.2 mp -86.06 114.53 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.08 120.2 40.05 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.361 1.464 . . . . 0.0 108.851 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.3 m -100.88 101.73 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.545 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 2.2 mp0 -89.55 79.52 6.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 37.2 p -85.45 137.08 33.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.48 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.43 -156.25 9.71 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -143.25 135.34 26.95 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.3 ttm180 -107.44 122.13 46.01 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 109.447 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.526 ' HA ' HD13 ' A' ' 2' ' ' ILE . 12.2 t70 -69.63 127.74 34.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -83.16 -23.01 33.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -71.53 -46.92 58.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.13 0.491 . . . . 0.0 110.006 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -88.71 -32.23 18.06 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.091 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.56 0.29 73.03 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 -169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -67.22 136.58 55.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.476 1.11 . . . . 0.0 110.846 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.58 107.86 18.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.48 0.712 . . . . 0.0 110.288 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 49' ' ' ILE . 2.9 mp -94.12 91.84 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CH2' ' HG2' ' A' ' 7' ' ' ARG . 36.7 m95 -84.02 124.06 30.66 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 31.6 t70 -52.88 124.43 14.08 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.842 0.714 . . . . 0.0 110.05 -176.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 m -57.85 -37.8 74.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.52 0.728 . . . . 0.0 111.621 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -96.93 16.46 19.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.917 0.887 . . . . 0.0 111.206 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.545 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 40.5 t-105 -64.87 142.17 58.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.556 0.342 . . . . 0.0 110.594 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 55.8 p -155.36 140.94 17.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.095 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -116.8 130.44 56.72 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -112.26 124.39 52.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.26 0.624 . . . . 0.0 109.541 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -135.69 141.33 44.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -103.58 126.79 50.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.299 0.64 . . . . 0.0 111.624 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 37.1 m-85 -69.13 112.69 5.9 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.81 -169.66 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.56 1.163 . . . . 0.0 109.072 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.96 5.63 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.342 1.057 . . . . 0.0 112.164 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.423 HD23 HG21 ' A' ' 78' ' ' VAL . 31.5 tp -116.63 100.28 53.33 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.804 0.842 . . . . 0.0 108.982 -172.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -92.6 -151.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.285 2.657 . . . . 0.0 111.64 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -149.59 145.16 18.65 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.204 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.82 127.58 24.91 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.131 2.554 . . . . 0.0 112.003 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -77.23 106.59 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.2 134.21 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.008 0.923 . . . . 0.0 108.933 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.34 120.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.576 1.55 . . . . 0.0 109.479 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.58 81.32 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.514 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 93.3 m-85 -139.18 160.76 39.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.53 0.732 . . . . 0.0 110.096 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -151.04 126.36 10.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.4 150.32 35.7 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.749 0.82 . . . . 0.0 111.001 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.8 -29.8 70.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.882 0.739 . . . . 0.0 109.446 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -133.48 96.7 16.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.755 168.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.48 -7.6 21.64 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.794 2.33 . . . . 0.0 111.928 175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 tpt -139.12 126.87 22.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 63' ' ' LEU . 88.3 t -65.65 120.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.31 116.46 5.75 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 124.818 1.324 . . . . 0.0 112.694 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 59.9 Cg_endo -70.42 128.96 16.14 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 112.623 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -142.24 135.04 28.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.978 0.418 . . . . 0.0 110.776 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.3 103.9 12.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.581 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -84.03 134.35 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 109.207 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.7 m -121.35 113.78 20.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.363 0.665 . . . . 0.0 109.618 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.17 114.33 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -82.51 174.52 10.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.364 0.602 . . . . 0.0 109.856 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.4 p -71.43 -22.12 61.88 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.934 172.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.21 4.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.126 0.97 . . . . 0.0 109.715 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.66 29.82 3.55 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.323 1.049 . . . . 0.0 110.251 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 9' ' ' GLN . 49.2 t80 -50.94 -48.77 60.77 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.496 1.118 . . . . 0.0 110.634 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.633 ' H ' HD12 ' A' ' 91' ' ' LEU . 1.8 mp -82.58 -23.77 34.28 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.653 -161.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.99 115.07 10.78 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -88.91 106.93 18.73 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.64 46.36 1.33 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.882 0.849 . . . . 0.0 110.229 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -62.55 157.76 19.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.748 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 78.0 ttt180 -157.15 147.3 20.93 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 -172.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.14 144.74 26.11 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 10.4 tp10 -136.34 108.44 7.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 172.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 84.3 m -100.65 122.6 43.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.241 0.617 . . . . 0.0 109.62 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.463 HG12 ' HG2' ' A' ' 75' ' ' LYS . 2.4 m -90.71 142.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.24 106.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.474 0.31 . . . . 0.0 110.432 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 87.2 m-85 -72.75 107.48 5.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.749 1.22 . . . . 0.0 109.682 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p -108.21 140.26 41.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 100.58 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.16 0.984 . . . . 0.0 110.77 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.0 p30 . . . . . 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.971 -171.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.7 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.82 0.343 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.481 HD12 ' HD3' ' A' ' 40' ' ' LYS . 35.4 mm -120.2 142.38 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.204 1.002 . . . . 0.0 109.121 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -120.99 149.92 52.09 Favored Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.26 127.78 13.06 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.395 2.064 . . . . 0.0 111.151 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.9 pt -135.1 137.21 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 2.2 mptm? -137.13 142.11 42.26 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -116.75 137.67 52.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 34' ' ' ILE . 85.1 m -120.71 104.91 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.361 0.664 . . . . 0.0 109.363 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -105.06 119.2 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.086 0.554 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 32' ' ' SER . 35.0 m -97.5 125.86 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 104.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -95.9 102.47 14.27 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.852 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.658 HE21 HD11 ' A' ' 15' ' ' ILE . 28.2 tt0 -108.28 113.03 25.8 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 30' ' ' VAL . 95.7 m -92.73 107.53 19.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.865 0.866 . . . . 0.0 109.772 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.658 HD11 HE21 ' A' ' 13' ' ' GLN . 1.6 mp -90.13 130.63 39.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.387 0.613 . . . . 0.0 109.932 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 11.5 m-70 -109.26 110.36 21.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.566 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 100' ' ' VAL . 85.0 m-85 -87.29 116.3 25.28 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.403 HH21 HD11 ' A' ' 101' ' ' ILE . 61.7 mtm180 -134.33 -171.32 2.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.52 0.728 . . . . 0.0 110.528 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -121.43 167.4 12.85 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.61 -17.98 63.57 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.803 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.45 -17.26 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.627 1.171 . . . . 0.0 111.192 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.55 54.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.44 137.98 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.57 1.148 . . . . 0.0 111.244 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.3 137.59 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.208 0.603 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.45 -60.49 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.15 115.29 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.309 1.043 . . . . 0.0 108.893 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.628 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.8 p-10 -102.3 26.29 7.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.654 0.781 . . . . 0.0 112.862 -173.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.23 10.79 39.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.677 0.791 . . . . 0.0 111.776 -173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -90.13 73.06 7.26 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.167 0.984 . . . . 0.0 111.038 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 14' ' ' THR . 24.3 t -93.63 119.01 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.898 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 63' ' ' LEU . 6.1 p -105.84 130.99 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 60.4 p -122.36 118.34 28.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.619 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 39.7 mt -98.97 122.9 42.83 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -82.83 124.66 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.097 0.959 . . . . 0.0 109.898 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HA ' HD23 ' A' ' 56' ' ' LEU . 85.5 m-85 -115.35 101.82 9.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.194 0.998 . . . . 0.0 109.099 172.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 m -95.82 107.7 19.97 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -94.33 123.81 37.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 57.5 p -88.14 138.73 31.19 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.746 0.654 . . . . 0.0 109.663 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.21 -171.57 18.01 Favored Glycine 0 C--O 1.241 0.566 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.126 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -136.55 143.84 43.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.7 ttm180 -114.95 118.62 33.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.632 0.373 . . . . 0.0 110.44 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.04 107.11 8.03 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.534 HD12 ' HG3' ' A' ' 1' ' ' MET . 84.4 mt -79.98 -1.31 39.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.927 0.891 . . . . 0.0 112.719 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -73.42 -43.25 60.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.419 0.688 . . . . 0.0 109.927 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.424 HD22 ' HB3' ' A' ' 47' ' ' LYS . 6.0 t30 -100.57 -24.12 14.53 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.925 0.89 . . . . 0.0 109.887 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.85 34.11 35.29 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.733 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' HD22 ' A' ' 45' ' ' ASN . 21.9 ptmt -104.13 141.98 35.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 110.777 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 42.0 mt-10 -97.92 122.86 41.54 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 123.276 0.63 . . . . 0.0 110.728 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 49' ' ' ILE . 2.6 mp -103.26 105.23 17.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -102.61 137.25 41.09 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -69.12 118.56 12.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 t -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.392 0.677 . . . . 0.0 111.171 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.27 -18.52 60.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.273 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -61.43 128.03 34.34 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 p -153.99 117.44 4.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.941 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 35' ' ' PHE . 57.0 tp -101.22 130.14 47.28 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -95.55 111.07 23.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 5.6 tp-100 -112.06 124.66 52.89 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.5 m -64.57 118.52 8.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.527 1.131 . . . . 0.0 110.642 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -106.97 115.03 29.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 59' ' ' THR . 12.3 pt-20 -179.32 -161.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.03 0.932 . . . . 0.0 109.897 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.92 -98.39 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.862 1.265 . . . . 0.0 110.276 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HG ' HG12 ' A' ' 15' ' ' ILE . 3.6 mm? 47.36 91.57 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.767 0.827 . . . . 0.0 111.179 -170.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.81 97.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.566 2.844 . . . . 0.0 112.588 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -81.99 113.54 43.98 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.487 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' ILE . 17.9 Cg_endo -56.2 121.2 9.57 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.47 2.113 . . . . 0.0 110.432 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.91 103.62 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 66' ' ' PRO . 48.5 mt -107.22 112.91 42.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -76.94 137.87 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.351 0.66 . . . . 0.0 109.786 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.94 4.5 84.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.199 -170.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.9 m-85 -142.63 162.76 34.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.575 0.75 . . . . 0.0 111.415 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -151.19 135.02 16.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.638 1.175 . . . . 0.0 107.85 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 159.18 29.87 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.791 0.836 . . . . 0.0 111.061 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.64 -34.55 74.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 105.12 6.64 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.167 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.82 -4.61 15.69 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.102 1.868 . . . . 0.0 111.688 163.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.5 tpp -135.19 107.38 7.2 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 98' ' ' GLU . 95.7 t -83.7 123.41 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.393 0.677 . . . . 0.0 111.701 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.81 53.58 13.42 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 125.022 1.451 . . . . 0.0 115.397 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 72.9 Cg_endo -74.14 80.68 2.12 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.251 1.967 . . . . 0.0 111.851 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -158.48 119.42 3.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.12 0.568 . . . . 0.0 109.703 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.01 100.85 0.45 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 123.967 0.792 . . . . 0.0 111.058 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.4 112.17 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.991 0.916 . . . . 0.0 110.548 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.4 m -94.97 101.23 12.99 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.324 0.65 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.91 124.64 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.94 170.38 16.56 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.994 0.809 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 16.7 t -70.46 -27.0 63.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.34 171.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.27 -49.82 62.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.718 1.207 . . . . 0.0 111.34 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -104.38 23.1 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.837 0.455 . . . . 0.0 111.21 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 52.7 t80 -58.94 -53.46 58.18 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.349 1.059 . . . . 0.0 112.696 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.95 -4.37 37.77 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.259 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.93 134.11 44.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.571 0.748 . . . . 0.0 110.019 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -90.19 172.57 8.7 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.181 0.593 . . . . 0.0 109.939 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 15.06 4.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.768 0.827 . . . . 0.0 110.784 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -162.62 -165.86 1.24 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 108.856 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.74 -53.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.381 0.672 . . . . 0.0 109.858 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -145.03 115.53 7.63 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.654 -170.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HG2' HG13 ' A' ' 78' ' ' VAL . 16.7 tp10 -107.25 148.29 29.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.825 1.25 . . . . 0.0 109.777 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -136.85 117.84 14.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.26 0.624 . . . . 0.0 109.975 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -86.7 141.75 13.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.403 HD11 HH21 ' A' ' 18' ' ' ARG . 30.9 mm -112.23 120.55 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 56.7 m-85 -80.21 117.79 21.32 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.77 0.828 . . . . 0.0 109.501 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.1 p -110.93 158.43 18.76 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 119.16 8.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.143 0.577 . . . . 0.0 110.638 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 123.911 0.884 . . . . 0.0 112.902 -167.151 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.0 mm -114.09 154.12 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.692 1.197 . . . . 0.0 109.841 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.23 150.73 49.81 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.86 0.864 . . . . 0.0 108.797 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.1 124.22 4.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.897 1.731 . . . . 0.0 111.674 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.626 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -121.55 171.67 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.373 0.669 . . . . 0.0 111.292 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.49 146.68 4.17 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.115 0.884 . . . . 0.0 110.738 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -106.97 165.33 11.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.796 0.838 . . . . 0.0 110.21 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' ILE . 93.1 m -131.88 106.29 7.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.145 0.978 . . . . 0.0 109.608 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -114.29 103.4 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 27.8 m -89.89 132.23 35.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 121.017 0.437 . . . . 0.0 109.85 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 94' ' ' GLN . 75.8 t -99.79 107.75 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -96.03 107.64 19.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.666 0.786 . . . . 0.0 110.89 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.453 HE21 HG11 ' A' ' 78' ' ' VAL . 3.2 tp60 -88.79 113.53 24.44 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 m -107.85 106.95 17.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 108.418 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 63' ' ' LEU . 19.0 tt -104.13 137.71 31.83 Favored 'Isoleucine or valine' 0 C--O 1.265 1.87 0 CA-C-O 122.229 1.014 . . . . 0.0 111.88 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -115.78 161.18 19.12 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.94 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.61 109.5 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.037 0.935 . . . . 0.0 108.872 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 32.1 mtm180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.245 0.618 . . . . 0.0 109.768 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 87.7 m-85 -88.52 176.05 7.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.454 0.702 . . . . 0.0 110.291 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.14 -22.28 60.55 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.468 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.46 -19.71 60.88 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.677 0.791 . . . . 0.0 110.607 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 -10.44 53.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.318 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.54 136.15 57.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.671 0.789 . . . . 0.0 111.076 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 56.0 t -80.35 111.9 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.645 0.378 . . . . 0.0 110.307 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.88 5.46 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -165.92 -175.35 3.36 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.704 1.602 . . . . 0.0 109.038 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.59 -161.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.039 0.936 . . . . 0.0 108.64 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 73.69 35.91 0.8 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.214 1.006 . . . . 0.0 109.799 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -111.37 121.32 44.93 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.18 144.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.031 0.532 . . . . 0.0 110.536 -173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -136.95 121.25 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -119.37 131.2 55.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.692 0.797 . . . . 0.0 109.245 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 96.5 mt -105.2 129.11 53.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.158 0.583 . . . . 0.0 110.005 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.57 HG23 HG23 ' A' ' 8' ' ' THR . 2.7 mp -87.53 111.9 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 123.972 0.795 . . . . 0.0 108.956 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HA ' HD23 ' A' ' 56' ' ' LEU . 41.3 m-85 -94.19 101.03 13.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.74 104.14 16.44 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -81.14 97.14 7.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 110.131 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 p -76.03 139.3 41.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.585 0.553 . . . . 0.0 110.453 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.48 -160.33 9.66 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.639 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 143.47 29.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HB2' HD13 ' A' ' 5' ' ' ILE . 36.0 ttm180 -112.39 128.8 56.41 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.329 0.652 . . . . 0.0 110.489 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 2' ' ' ILE . 16.3 t0 -72.59 121.99 20.64 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.94 -21.31 34.12 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -77.23 -49.76 14.39 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -171.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.36 -28.4 21.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.567 0.747 . . . . 0.0 109.676 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.91 30.51 20.42 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.354 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.74 136.36 42.7 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.323 1.049 . . . . 0.0 110.06 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -91.65 120.18 32.19 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.093 0.557 . . . . 0.0 110.358 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.31 116.65 36.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -114.28 136.9 52.46 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 6.8 m-20 -64.12 125.73 25.43 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 m -62.1 -41.9 98.68 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.758 0.661 . . . . 0.0 111.088 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.91 7.73 26.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.656 0.782 . . . . 0.0 111.984 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 81.0 t90 -61.46 132.62 54.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -155.33 123.02 5.66 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.049 0.939 . . . . 0.0 108.807 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 35' ' ' PHE . 22.9 tp -109.07 135.05 50.85 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -112.14 116.45 30.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.84 0.856 . . . . 0.0 108.871 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -119.93 144.66 47.32 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.815 0.446 . . . . 0.0 110.141 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.505 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.6 m -88.93 113.05 24.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.587 1.155 . . . . 0.0 112.24 -167.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.543 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 2.7 m-85 -99.98 102.38 13.73 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.935 0.894 . . . . 0.0 109.7 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.7 pt-20 -163.39 -165.68 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.285 0.634 . . . . 0.0 109.697 173.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.32 17.04 10.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.351 1.06 . . . . 0.0 111.807 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.449 HD11 HG21 ' A' ' 15' ' ' ILE . 43.0 tp -102.0 99.7 12.97 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.995 0.918 . . . . 0.0 109.078 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -92.68 -165.34 0.14 Allowed 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.529 2.819 . . . . 0.0 113.344 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -150.67 146.41 19.54 Favored Pre-proline 0 CA--C 1.557 1.218 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.755 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.66 139.4 48.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.536 2.824 . . . . 0.0 113.079 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.87 107.8 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.59 130.49 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.47 129.99 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.3 86.99 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.893 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 86.8 m-85 -140.37 146.31 38.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.34 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.0 m -144.03 134.08 24.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.655 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -66.58 156.61 34.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.639 0.775 . . . . 0.0 111.66 -175.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -65.63 -25.01 67.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.811 0.844 . . . . 0.0 110.214 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.35 85.19 6.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 -7.32 21.1 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.187 1.925 . . . . 0.0 112.982 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.4 ttt -146.61 95.37 2.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.709 1.204 . . . . 0.0 107.946 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 75' ' ' LYS . 53.9 t -71.81 111.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.679 0.792 . . . . 0.0 109.911 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.59 84.74 0.25 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.797 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 28.2 Cg_exo -65.44 0.04 3.18 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.593 2.862 . . . . 0.0 113.655 166.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 72.35 -88.39 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.881 1.672 . . . . 0.0 110.555 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -141.74 139.09 32.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.892 0.877 . . . . 0.0 110.517 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.3 t -116.03 120.33 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.16 0.984 . . . . 0.0 108.963 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.4 m -99.24 101.87 13.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.414 0.686 . . . . 0.0 109.596 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.33 125.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.16 168.0 16.21 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.139 0.976 . . . . 0.0 110.336 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.6 t -62.49 -27.47 69.15 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.267 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.74 -56.73 17.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.429 1.492 . . . . 0.0 110.773 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -105.19 15.38 27.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.648 0.779 . . . . 0.0 111.599 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -61.53 -24.5 66.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 0.0 111.185 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.28 -24.77 61.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.784 0.834 . . . . 0.0 111.156 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.0 136.11 33.42 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 109.264 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.66 138.89 33.55 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 11' ' ' VAL . 44.1 mt-30 -100.24 57.45 0.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.93 96.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -90.11 142.57 27.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.942 1.297 . . . . 0.0 109.864 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.68 125.09 10.93 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -134.91 141.56 46.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.473 0.709 . . . . 0.0 110.046 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.2 m -107.27 131.65 53.97 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.655 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 6.3 m -83.78 139.43 17.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.01 107.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 122.883 0.473 . . . . 0.0 110.196 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . 93.6 m-85 -74.96 103.33 5.12 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.08 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.0 p -111.72 147.96 34.49 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.86 126.4 22.14 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.03 0.831 . . . . 0.0 110.356 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 p30 . . . . . 0 N--CA 1.474 0.746 0 O-C-N 123.268 0.355 . . . . 0.0 110.433 179.509 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.0 140.2 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.577 0.751 . . . . 0.0 109.618 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.91 151.77 58.44 Favored Pre-proline 0 N--CA 1.476 0.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.92 121.4 3.61 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.512 1.475 . . . . 0.0 109.955 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 41' ' ' ARG . 17.4 pt -109.8 169.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.845 0.858 . . . . 0.0 109.483 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 141.35 11.24 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.198 0.523 . . . . 0.0 111.036 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -112.36 136.26 52.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 34' ' ' ILE . 87.3 m -114.01 107.81 16.17 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.695 0.798 . . . . 0.0 109.752 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -101.4 113.21 26.09 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.273 0.629 . . . . 0.0 109.445 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 21.7 m -96.6 146.36 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 94' ' ' GLN . 68.5 t -105.77 104.29 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.616 ' HB ' HD22 ' A' ' 95' ' ' ASN . 22.8 m -101.33 103.15 14.1 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 110.081 -171.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 12.8 mm100 -94.92 113.2 24.89 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.978 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.545 ' HB ' ' HG2' ' A' ' 97' ' ' GLU . 85.1 m -92.64 104.41 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 29' ' ' HIS . 2.0 mp -93.01 131.52 39.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.527 0.679 . . . . 0.0 110.25 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -133.83 118.62 18.2 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.126 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' HA ' HG13 ' A' ' 100' ' ' VAL . 56.2 m-85 -78.61 130.49 35.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.522 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 41.9 mtm180 -141.45 162.06 36.41 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 123.931 0.892 . . . . 0.0 109.314 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -89.54 175.08 7.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.73 -25.1 68.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.409 0.684 . . . . 0.0 112.097 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.52 -20.14 61.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.127 0.971 . . . . 0.0 111.104 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.03 3.29 60.54 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.373 0.421 . . . . 0.0 112.652 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.6 130.03 39.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.504 0.721 . . . . 0.0 109.532 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 34.9 t -82.55 103.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.274 0.488 . . . . 0.0 109.975 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -61.28 -39.59 91.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.337 0.655 . . . . 0.0 111.087 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -168.81 145.82 3.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.695 0.798 . . . . 0.0 109.005 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -137.52 109.99 7.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.408 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 174.55 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 124.689 1.243 . . . . 0.0 112.494 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 2.5 t-160 -75.99 78.64 2.86 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.88 0.738 . . . . 0.0 112.398 -155.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -92.44 128.36 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.96 166.03 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.4 p -156.85 141.62 16.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.551 0.74 . . . . 0.0 109.803 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 10.8 tp -121.86 123.48 41.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 122.585 0.354 . . . . 0.0 111.323 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -91.98 120.49 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.729 0.812 . . . . 0.0 109.663 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 89.9 m-85 -115.71 110.13 18.69 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.012 0.925 . . . . 0.0 109.209 173.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 m -103.24 102.04 12.0 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.683 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -85.97 99.33 11.36 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.5 t -89.64 133.4 34.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.422 0.629 . . . . 0.0 110.159 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.53 -156.35 9.29 Favored Glycine 0 C--O 1.242 0.617 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.832 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 144.67 37.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.969 0.508 . . . . 0.0 109.718 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.9 ttm-85 -115.17 129.94 56.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.866 0.466 . . . . 0.0 109.978 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 2.0 m-20 -75.4 113.83 13.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.6 -8.02 56.4 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.402 0.681 . . . . 0.0 111.411 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 t -78.68 -44.05 24.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.499 0.72 . . . . 0.0 110.925 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -101.57 -21.0 14.83 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.353 0.661 . . . . 0.0 112.055 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.75 25.74 71.21 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 21.3 ptmt -95.88 138.56 33.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.333 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -106.57 116.39 31.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.577 0.751 . . . . 0.0 110.266 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.6 mp -101.05 102.65 13.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -104.26 152.77 21.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.128 0.971 . . . . 0.0 108.936 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.55 120.98 40.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.378 0.671 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -74.98 -15.24 60.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.157 0.583 . . . . 0.0 112.172 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -85.38 -3.6 58.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.103 0.561 . . . . 0.0 111.103 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.48 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 88.3 t90 -60.77 128.03 34.56 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 p -155.31 114.51 3.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.6 tp -133.55 130.24 38.16 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 t -99.86 142.39 31.39 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.007 0.523 . . . . 0.0 109.7 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -123.22 145.02 49.0 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HG3' ' A' ' 61' ' ' GLU . 4.7 m -70.44 118.03 12.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.076 1.351 . . . . 0.0 110.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 115.92 29.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.0 OUTLIER -168.6 -155.78 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.33 1.052 . . . . 0.0 109.014 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 65.19 11.74 7.45 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.41 1.084 . . . . 0.0 111.819 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 100.28 8.99 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 87.2 Cg_endo -85.09 -173.35 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.547 2.165 . . . . 0.0 111.92 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.0 p -146.47 131.15 8.83 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.65 120.52 7.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.456 2.104 . . . . 0.0 111.039 172.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.65 105.95 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -106.72 114.46 45.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.2 mm -71.7 138.94 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 123.515 0.51 . . . . 0.0 109.785 -174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.17 8.66 85.15 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.961 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 96.8 m-85 -140.31 152.04 45.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.663 0.785 . . . . 0.0 110.074 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 m -134.28 115.67 14.39 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.39 150.94 45.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.927 0.891 . . . . 0.0 111.362 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.01 -39.37 75.88 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.698 0.761 . . . . 0.0 109.008 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -129.62 92.97 36.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.34 -1.3 . . . . 0.0 107.812 169.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.58 -4.92 14.03 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.636 2.224 . . . . 0.0 112.516 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 23.4 ttt -145.8 108.73 4.56 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 168.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 98' ' ' GLU . 76.7 t -70.5 115.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.199 0.312 . . . . 0.0 111.574 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 52.59 63.38 4.98 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.913 1.383 . . . . 0.0 114.862 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.57 77.7 3.35 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.316 2.011 . . . . 0.0 110.136 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -155.82 148.42 23.95 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.72 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -80.25 106.78 12.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.28 128.26 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 m -111.11 123.84 51.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.053 0.541 . . . . 0.0 110.544 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HA ' HD21 ' A' ' 89' ' ' ASN . 77.1 t -113.56 122.79 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.175 0.59 . . . . 0.0 109.521 172.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.47 162.12 13.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 29.7 m -58.3 -29.84 66.18 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.686 0.794 . . . . 0.0 112.335 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -65.83 -31.94 73.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.416 1.086 . . . . 0.0 111.563 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.528 HD21 ' HA ' ' A' ' 85' ' ' VAL . 2.9 p-10 -115.86 19.24 15.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.367 0.667 . . . . 0.0 111.191 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 84.1 t80 -74.59 -33.01 62.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.26 0.624 . . . . 0.0 112.591 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.74 -22.8 56.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.111 0.564 . . . . 0.0 109.598 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -81.67 136.49 35.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.701 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -100.3 159.08 15.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.672 ' HB2' HG13 ' A' ' 11' ' ' VAL . 55.4 mt-30 -109.4 34.12 3.95 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.616 HD22 ' HB ' ' A' ' 12' ' ' THR . 27.9 t-20 -58.82 101.14 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.898 0.879 . . . . 0.0 110.251 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 28.3 tpt180 -133.34 142.24 48.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.641 0.777 . . . . 0.0 110.404 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 14' ' ' THR . 40.2 mt-10 -90.56 119.1 30.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 169.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.594 ' HG2' HG13 ' A' ' 78' ' ' VAL . 10.5 tp10 -105.09 114.51 28.76 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.8 m -91.61 132.46 36.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.626 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -106.85 119.0 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.96 109.99 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 66.4 m-85 -80.49 101.32 9.02 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.543 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 m -91.64 152.36 20.28 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.21 133.49 19.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.379 0.536 . . . . 0.0 110.023 173.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 123.854 0.862 . . . . 0.0 109.989 -177.398 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.906 0.384 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.0 mm -106.61 138.82 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.494 1.118 . . . . 0.0 109.302 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -118.97 141.25 29.88 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 44.3 Cg_endo -68.12 128.11 17.05 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.27 1.98 . . . . 0.0 110.513 171.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 41' ' ' ARG . 13.4 pt -132.15 137.06 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -133.77 140.8 47.18 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.352 -0.217 . . . . 0.0 111.023 -170.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -101.92 151.51 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.234 1.014 . . . . 0.0 109.063 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.403 HG23 HG23 ' A' ' 34' ' ' ILE . 92.4 m -123.55 109.19 13.48 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.813 0.845 . . . . 0.0 110.436 -177.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -112.25 125.92 54.67 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 25.5 m -105.08 141.49 20.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.801 HG21 HG11 ' A' ' 83' ' ' VAL . 43.0 t -100.72 105.56 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -98.84 106.52 18.79 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.108 -170.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -93.19 95.87 9.66 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 90.1 m -85.02 136.14 33.71 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.3 134.94 47.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.411 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 42.0 m170 -103.58 119.28 38.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.839 172.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' OH ' HD12 ' A' ' 63' ' ' LEU . 93.8 m-85 -91.67 121.06 32.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 24' ' ' VAL . 3.5 tpt180 -144.04 158.7 43.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -90.37 172.48 8.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.56 0.744 . . . . 0.0 109.773 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 101' ' ' ILE . 15.0 pt-20 -62.98 -43.31 99.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.921 0.888 . . . . 0.0 111.911 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.03 -16.63 61.49 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.444 1.098 . . . . 0.0 111.451 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 16.69 23.37 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.518 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.48 147.27 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.231 0.515 . . . . 0.0 110.171 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 81.4 t -75.68 121.05 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.114 0.566 . . . . 0.0 110.524 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.42 -57.88 2.63 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 166.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 29' ' ' HIS . 22.1 t60 -172.8 75.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.071 0.948 . . . . 0.0 108.499 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 8.6 p-10 -88.36 57.43 4.24 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -168.37 18.44 0.02 OUTLIER 'General case' 0 C--N 1.356 0.861 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.503 ' HB2' ' HD2' ' A' ' 26' ' ' HIS . 5.4 t60 -104.36 129.71 52.25 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.707 0.685 . . . . 0.0 110.461 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 14' ' ' THR . 43.3 t -129.65 135.36 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.39 1.076 . . . . 0.0 110.514 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.66 154.63 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 51.8 p -148.5 143.41 26.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.644 0.778 . . . . 0.0 110.683 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 58' ' ' GLN . 60.7 mt -106.23 125.41 50.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.652 0.781 . . . . 0.0 108.893 174.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.403 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -95.52 102.61 13.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HD2' ' HB3' ' A' ' 56' ' ' LEU . 96.9 m-85 -93.79 102.03 14.15 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.099 0.96 . . . . 0.0 109.338 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 103.64 14.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.341 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.33 101.89 11.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.577 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 63.5 p -73.33 148.91 43.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.221 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.01 -177.07 24.5 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.992 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 139.59 42.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.613 0.706 . . . . 0.0 110.564 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 5' ' ' ILE . 20.9 ttm-85 -116.28 122.62 45.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.954 0.502 . . . . 0.0 110.186 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.83 112.34 13.32 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.59 -10.74 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 t -72.86 -53.49 11.28 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.764 0.826 . . . . 0.0 110.399 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.29 -18.6 19.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.614 0.765 . . . . 0.0 111.267 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.93 62.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.506 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -94.46 128.51 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.829 0.851 . . . . 0.0 110.318 -176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.33 111.04 23.17 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.092 0.957 . . . . 0.0 109.963 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.29 107.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -101.35 117.27 34.61 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.19 121.27 17.24 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 123.402 0.439 . . . . 0.0 109.997 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -63.3 -36.12 82.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.798 1.239 . . . . 0.0 112.009 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -78.29 -7.66 57.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.719 0.408 . . . . 0.0 110.897 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.95 127.62 33.08 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.243 0.544 . . . . 0.0 109.918 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.8 p -137.49 157.16 47.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.589 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.504 HD12 HE21 ' A' ' 58' ' ' GLN . 0.4 OUTLIER -130.77 124.23 30.94 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 m -115.72 122.29 45.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.348 0.659 . . . . 0.0 109.704 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.598 ' HB2' HD13 ' A' ' 33' ' ' LEU . 76.4 mt-30 -122.35 145.3 48.39 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.376 0.67 . . . . 0.0 109.42 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.581 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 30.6 m -69.38 125.75 27.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.313 1.045 . . . . 0.0 110.708 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.42 109.13 15.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.8 -171.83 0.4 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.362 1.465 . . . . 0.0 109.23 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.22 86.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.545 1.138 . . . . 0.0 112.393 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -98.59 115.11 65.89 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.527 0.731 . . . . 0.0 109.29 -178.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.9 80.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.96 3.106 . . . . 0.0 113.262 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 p -95.13 137.47 22.18 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.819 0.848 . . . . 0.0 110.982 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -44.54 125.77 6.4 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.133 3.222 . . . . 0.0 114.223 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.9 t -85.97 108.94 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 172.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.58 132.45 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.288 0.635 . . . . 0.0 109.315 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.79 124.1 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.31 3.88 88.41 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.302 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -136.06 149.62 48.83 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.815 0.808 . . . . 0.0 109.747 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -137.87 131.05 30.45 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.7 57.05 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.552 0.533 . . . . 0.0 109.924 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.13 -31.79 71.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.69 98.65 7.04 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.559 1.144 . . . . 0.0 108.739 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.34 -6.02 18.13 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.357 2.038 . . . . 0.0 112.383 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.609 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 36.1 ttm -136.99 120.51 17.11 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.054 0.942 . . . . 0.0 108.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.39 143.09 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.673 0.789 . . . . 0.0 109.627 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.38 57.89 17.45 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.294 0.996 . . . . 0.0 112.453 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -85.48 56.91 4.38 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.753 2.302 . . . . 0.0 111.245 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -154.64 120.38 5.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.504 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 1.8 mp0 -48.2 123.42 6.37 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 125.371 1.669 . . . . 0.0 111.027 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.801 HG11 HG21 ' A' ' 11' ' ' VAL . 81.4 t -89.65 121.11 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 123.659 0.6 . . . . 0.0 110.728 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 m -104.81 112.41 25.51 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 89' ' ' ASN . 95.3 t -99.76 109.39 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 13.7 t70 -95.51 166.67 11.74 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.2 m -57.23 -33.77 67.89 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.332 0.653 . . . . 0.0 111.711 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 20.7 ptmt -67.4 -36.3 81.02 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.841 0.857 . . . . 0.0 111.745 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' A' ' 85' ' ' VAL . 4.6 p-10 -115.85 27.61 9.18 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.886 0.875 . . . . 0.0 110.035 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -64.61 -37.05 86.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.382 0.673 . . . . 0.0 111.399 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.92 -6.44 56.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.472 0.309 . . . . 0.0 110.666 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.89 135.42 34.15 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.229 0.538 . . . . 0.0 110.984 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.04 -25.66 17.84 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 0.0 111.751 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.425 HE21 HG22 ' A' ' 85' ' ' VAL . 26.9 pt20 51.91 12.29 0.18 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 127.577 2.351 . . . . 0.0 116.077 171.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -151.01 153.46 35.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.92 . . . . 0.0 109.428 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.52 -159.61 0.98 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.829 -167.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' THR . 1.8 tm-20 -90.9 112.74 24.73 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.301 0.64 . . . . 0.0 109.275 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -112.47 125.11 53.88 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.149 0.98 . . . . 0.0 109.665 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.9 m -91.13 133.41 35.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.51 0.724 . . . . 0.0 109.958 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.54 144.45 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 20' ' ' GLU . 40.8 mm -114.52 111.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.864 0.466 . . . . 0.0 111.582 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -82.82 105.49 13.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.564 1.146 . . . . 0.0 109.254 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 p -110.97 146.02 37.37 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.25 104.35 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.46 1.1 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.5 p30 . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 123.929 0.892 . . . . 0.0 111.732 -175.712 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.4 tpt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.7 mm -121.21 155.6 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 124.579 1.152 . . . . 0.0 109.3 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 8.8 pt-20 -128.38 149.94 72.91 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 167.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.34 128.16 11.01 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 122.063 1.842 . . . . 0.0 111.377 168.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.5 pt -126.24 168.44 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.73 143.22 19.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.462 0.705 . . . . 0.0 109.651 174.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.447 ' HG2' ' HE2' ' A' ' 90' ' ' PHE . 22.9 tpp180 -105.41 161.01 14.69 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 34' ' ' ILE . 21.6 m -130.2 108.47 10.06 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.45 0.7 . . . . 0.0 109.285 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.517 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp-100 -112.44 117.73 33.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 33.3 m -102.15 134.59 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 120.81 0.338 . . . . 0.0 110.202 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.6 t -93.43 108.93 21.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -94.55 98.89 11.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.521 0.728 . . . . 0.0 109.747 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.29 97.41 9.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.368 0.604 . . . . 0.0 109.807 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 HG22 ' A' ' 30' ' ' VAL . 29.8 m -92.17 138.91 31.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.489 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.56 139.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -106.62 146.74 30.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.899 1.28 . . . . 0.0 108.335 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -114.65 111.2 20.95 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -175.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 26.5 mmt85 -126.84 168.19 14.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.641 0.777 . . . . 0.0 109.445 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -105.8 172.22 6.92 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.977 0.911 . . . . 0.0 108.612 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.06 -22.49 63.06 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.519 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -69.52 -21.99 63.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.856 0.862 . . . . 0.0 111.503 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.78 -3.41 55.97 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.65 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.79 157.9 37.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.657 0.783 . . . . 0.0 110.871 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 12.3 t -102.18 123.9 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . . . -76.17 -47.28 24.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.447 ' H ' ' HB2' ' A' ' 17' ' ' TYR . 38.1 t-80 -169.96 159.65 7.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.793 0.837 . . . . 0.0 110.125 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -120.73 152.36 38.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.885 0.474 . . . . 0.0 111.815 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 53.53 76.28 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.648 1.579 . . . . 0.0 112.794 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.461 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 51.4 m170 -120.47 112.39 18.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 14' ' ' THR . 47.9 t -119.21 141.2 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.033 0.933 . . . . 0.0 111.461 -162.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.65 116.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 165.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 p -115.29 124.04 50.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.88 0.872 . . . . 0.0 109.642 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 83.6 mt -106.99 134.43 50.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.801 0.441 . . . . 0.0 111.054 -177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -87.6 121.93 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.427 1.091 . . . . 0.0 110.336 -174.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 72.2 m-85 -111.31 104.47 12.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.236 1.014 . . . . 0.0 108.637 173.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -93.05 103.82 16.08 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.114 0.565 . . . . 0.0 110.327 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.63 104.36 15.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.8 p -72.1 163.75 27.37 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.138 0.494 . . . . 0.0 111.074 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.23 -158.27 22.91 Favored Glycine 0 C--O 1.238 0.362 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 139.21 17.59 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.03 0.532 . . . . 0.0 110.042 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm-85 -102.34 129.35 48.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.47 ' HA ' HD13 ' A' ' 2' ' ' ILE . 32.5 t70 -77.02 118.38 19.53 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 1' ' ' MET . 83.9 mt -82.55 -9.1 59.55 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -169.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -94.92 -30.41 14.17 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.31 0.504 . . . . 0.0 111.458 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.01 -30.25 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.909 0.484 . . . . 0.0 110.254 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.18 2.58 77.18 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.222 -174.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.03 45.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.253 0.621 . . . . 0.0 109.693 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -105.37 118.49 36.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.787 0.835 . . . . 0.0 110.054 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.4 107.6 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -95.76 165.16 12.44 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.899 0.88 . . . . 0.0 109.831 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 29.6 m-20 -75.15 113.45 12.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.2 m -75.61 -23.84 56.46 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.851 0.46 . . . . 0.0 111.393 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -85.96 -3.99 59.06 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.798 0.839 . . . . 0.0 111.369 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 80.5 t90 -60.3 128.98 39.4 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.191 0.52 . . . . 0.0 109.684 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -154.84 113.57 3.58 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.67 140.48 48.19 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 82' ' ' GLU . 5.3 t -108.7 153.94 22.73 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -148.06 144.26 27.75 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.477 HG22 ' HG2' ' A' ' 61' ' ' GLU . 24.1 m -79.16 109.49 13.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.222 1.009 . . . . 0.0 112.927 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -102.61 102.02 12.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.288 0.635 . . . . 0.0 109.505 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' HG2' HG22 ' A' ' 59' ' ' THR . 13.0 pt-20 -173.87 -169.86 0.52 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.727 0.811 . . . . 0.0 109.416 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 70.95 20.68 5.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HB2' HG12 ' A' ' 78' ' ' VAL . 2.3 mm? -92.54 110.33 44.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.107 0.563 . . . . 0.0 110.298 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.09 -146.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.74 2.96 . . . . 0.0 111.149 173.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -162.55 163.37 18.18 Favored Pre-proline 0 N--CA 1.495 1.782 0 C-N-CA 124.341 1.056 . . . . 0.0 110.192 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.69 125.41 15.42 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 121.882 1.721 . . . . 0.0 110.428 169.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.42 107.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.0 mt -100.84 122.07 52.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -72.8 128.64 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.049 0.94 . . . . 0.0 111.01 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.96 1.5 89.75 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.35 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -126.6 159.78 32.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 0.0 110.689 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -145.35 135.52 23.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.176 1.391 . . . . 0.0 107.493 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -71.11 139.32 50.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.074 0.55 . . . . 0.0 111.086 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -69.36 -18.44 63.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.48 1.912 . . . . 0.0 110.551 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.786 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.92 82.64 7.09 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 29.9 Cg_endo -90.26 23.03 0.7 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.541 2.827 . . . . 0.0 114.12 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.66 144.63 27.29 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -131.34 136.61 57.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 164.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.32 71.0 0.2 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 78' ' ' VAL . 53.0 Cg_exo -58.26 -16.42 28.15 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.35 2.033 . . . . 0.0 110.773 162.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 59' ' ' THR . 29.7 t70 74.23 -71.53 0.13 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 126.682 1.993 . . . . 0.0 109.71 172.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 61.6 mt-10 -140.16 134.47 31.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.953 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.56 124.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.3 m -100.12 123.94 44.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.178 0.591 . . . . 0.0 109.853 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.21 121.39 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.26 161.96 16.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.294 1.038 . . . . 0.0 109.403 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 68.2 m -62.02 -29.08 70.03 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.004 0.431 . . . . 0.0 110.942 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.53 -46.61 89.53 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.037 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -100.07 2.79 43.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.095 0.558 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HE2' ' HG2' ' A' ' 7' ' ' ARG . 79.1 t80 -62.09 -33.84 75.19 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.119 0.968 . . . . 0.0 113.345 -168.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.59 -27.21 66.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.109 0.48 . . . . 0.0 110.157 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -93.73 156.88 16.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.189 0.995 . . . . 0.0 109.189 170.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.517 ' HE2' ' OE1' ' A' ' 9' ' ' GLN . 18.4 ptpt -119.39 139.0 52.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.78 40.29 1.14 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.577 0.703 . . . . 0.0 109.656 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 95' ' ' ASN . 0.1 OUTLIER -51.27 149.53 3.92 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.304 168.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -152.59 115.84 4.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.834 0.349 . . . . 0.0 111.281 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -104.51 110.68 23.05 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -121.67 171.39 8.88 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 110.283 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.8 m -130.9 134.49 46.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.374 0.669 . . . . 0.0 111.598 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.786 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 3.7 m -98.26 142.0 15.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 123.319 0.647 . . . . 0.0 110.227 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -114.08 114.82 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 0.0 110.318 -175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.96 103.29 15.9 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -97.96 174.43 6.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.27 156.25 15.95 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.486 1.347 0 C-N-CA 124.392 1.077 . . . . 0.0 112.937 -167.574 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG2' HD12 ' A' ' 43' ' ' LEU . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.499 HD12 ' HD3' ' A' ' 40' ' ' LYS . 41.6 mm -107.87 142.98 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.939 0.896 . . . . 0.0 109.998 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.6 148.59 65.2 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.058 0.543 . . . . 0.0 109.94 166.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.2 125.53 10.36 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 0.0 110.506 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 41' ' ' ARG . 45.0 pt -125.68 154.95 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.177 0.513 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -159.68 145.86 16.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.832 173.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -111.15 156.68 21.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.335 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 34' ' ' ILE . 59.2 m -129.49 122.19 28.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.263 0.625 . . . . 0.0 110.284 -172.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp-100 -122.76 107.16 11.59 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 4.2 m -92.62 133.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 94' ' ' GLN . 69.3 t -102.02 124.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 173.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -123.05 115.34 21.69 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -164.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.667 HE21 ' HG3' ' A' ' 80' ' ' PRO . 8.4 mm-40 -89.47 104.71 17.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.413 1.085 . . . . 0.0 111.068 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -95.35 112.5 24.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.154 0.982 . . . . 0.0 109.176 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 98' ' ' GLU . 87.2 mt -111.58 131.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.508 0.671 . . . . 0.0 111.083 -170.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -112.06 116.28 30.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.403 ' HB3' ' HE2' ' A' ' 102' ' ' TYR . 34.2 m-85 -86.02 107.08 17.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -133.26 156.85 46.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.915 0.886 . . . . 0.0 109.476 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -89.15 176.4 6.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.4 0.68 . . . . 0.0 110.949 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.74 -24.9 67.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.135 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.84 -7.78 58.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.782 0.833 . . . . 0.0 111.225 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.27 82.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.95 150.68 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.092 0.557 . . . . 0.0 109.957 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.7 t -74.41 127.03 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.093 0.557 . . . . 0.0 110.563 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.44 -62.99 1.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -159.52 99.77 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.308 1.043 . . . . 0.0 109.566 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.97 171.44 15.2 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.624 -0.672 . . . . 0.0 110.875 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 57.54 80.33 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.496 1.118 . . . . 0.0 111.679 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -130.94 91.99 3.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.85 127.47 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.699 . . . . 0.0 110.918 -169.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.98 149.97 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.1 p -144.46 144.64 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.923 0.392 . . . . 0.0 110.884 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.68 124.08 51.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.181 0.992 . . . . 0.0 109.109 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 10' ' ' VAL . 1.8 mp -94.9 109.29 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.351 1.06 . . . . 0.0 108.894 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 57.9 m-85 -97.36 99.08 10.53 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -98.82 103.29 15.23 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.403 0.681 . . . . 0.0 109.749 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.46 108.88 14.46 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 t -92.5 159.16 15.65 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.376 0.67 . . . . 0.0 110.742 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.02 -161.93 26.07 Favored Glycine 0 C--O 1.238 0.375 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.716 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.499 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -144.15 142.02 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.216 0.606 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 5' ' ' ILE . 15.8 ttm180 -104.74 125.11 50.49 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.713 0.405 . . . . 0.0 110.122 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.86 106.59 8.62 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 1' ' ' MET . 96.2 mt -75.78 -2.76 31.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.986 0.914 . . . . 0.0 112.171 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -42.37 60.88 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.527 0.731 . . . . 0.0 109.932 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.04 -24.62 14.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.816 0.846 . . . . 0.0 111.234 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.46 16.09 72.11 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.994 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -87.99 143.51 27.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.432 0.693 . . . . 0.0 111.142 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.46 107.65 19.91 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.529 1.132 . . . . 0.0 110.508 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.62 97.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 59.8 m95 -90.31 171.89 9.15 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.065 0.946 . . . . 0.0 109.406 171.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 26.9 m-20 -76.82 115.73 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 164.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -62.17 -31.68 72.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.108 0.563 . . . . 0.0 110.324 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -92.04 15.45 13.31 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.688 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 90.5 t90 -70.4 127.86 34.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 81.0 p -154.86 115.53 3.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.768 1.227 . . . . 0.0 107.805 170.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 35' ' ' PHE . 62.5 tp -103.57 132.97 49.36 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 m -110.23 115.42 29.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.804 0.842 . . . . 0.0 109.516 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -129.34 132.52 47.12 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.543 0.737 . . . . 0.0 109.126 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.4 m -85.34 135.21 33.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.156 0.583 . . . . 0.0 111.266 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.06 104.92 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 160.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.7 -174.09 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.349 1.06 . . . . 0.0 108.589 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.97 21.78 12.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.755 0.822 . . . . 0.0 112.824 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.37 114.13 65.55 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.27 -165.92 0.31 Allowed 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 123.055 2.503 . . . . 0.0 113.31 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 76' ' ' PRO . 59.7 p -157.18 146.98 15.44 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 118.47 5.36 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.999 1.799 . . . . 0.0 110.286 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.52 104.63 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.03 119.01 41.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.48 132.27 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.839 0.712 . . . . 0.0 109.812 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.43 12.43 80.44 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.373 -0.681 . . . . 0.0 112.86 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 87.5 m-85 -137.25 148.97 46.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.752 0.821 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -110.31 126.95 54.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.795 1.638 . . . . 0.0 107.729 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.8 143.96 26.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.938 0.79 . . . . 0.0 109.987 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -37.33 78.37 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.261 0.625 . . . . 0.0 110.938 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -146.91 98.32 4.11 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 63.3 Cg_endo -68.28 -8.07 21.87 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.466 2.111 . . . . 0.0 112.511 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ttt -143.78 105.77 4.36 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.24 111.59 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.28 78.74 0.24 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.667 ' HG3' HE21 ' A' ' 13' ' ' GLN . 61.4 Cg_endo -71.23 -0.63 8.37 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.825 2.35 . . . . 0.0 113.446 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 76.1 -159.68 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.009 1.324 . . . . 0.0 112.456 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.97 128.73 31.53 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.87 109.83 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.134 1.374 . . . . 0.0 107.91 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.8 m -98.31 128.73 44.88 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.73 115.07 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.9 p30 -90.7 173.08 8.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.764 0.826 . . . . 0.0 110.196 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -60.2 -29.93 69.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.417 1.087 . . . . 0.0 113.206 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -82.68 -38.33 23.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.103 0.561 . . . . 0.0 110.668 -175.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.45 8.95 40.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.99 -24.57 67.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.717 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.71 -21.41 55.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 110.299 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.65 118.43 33.1 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.176 0.991 . . . . 0.0 110.924 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . 21.1 pttp -83.87 127.78 34.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 11' ' ' VAL . 36.8 mt-30 -86.78 42.4 1.01 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -64.03 121.36 13.96 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 110.535 -175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -113.93 145.41 41.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -116.02 110.05 18.38 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 15' ' ' ILE . 17.4 mm-40 -93.18 155.97 17.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.766 0.793 . . . . 0.0 110.725 175.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.2 m -142.28 107.53 4.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.888 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -79.33 137.82 21.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mm -108.87 122.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.403 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.0 m-85 -88.77 106.09 18.13 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.725 1.21 . . . . 0.0 109.413 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 p -112.47 130.39 56.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.17 129.14 23.71 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.028 0.931 . . . . 0.0 113.152 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 . . . . . 0 N--CA 1.493 1.717 0 C-N-CA 125.517 1.527 . . . . 0.0 114.037 -176.917 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.9 mm -113.95 151.21 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.386 0.675 . . . . 0.0 109.315 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.77 151.3 77.84 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.225 0.61 . . . . 0.0 110.011 170.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.75 133.79 28.43 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.606 2.204 . . . . 0.0 111.986 171.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 41' ' ' ARG . 11.6 pt -142.57 137.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.8 mptm? -133.72 154.26 51.08 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.487 0.715 . . . . 0.0 109.114 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 23.7 mmm180 -121.82 149.65 43.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 108.307 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 34' ' ' ILE . 27.1 m -122.26 108.05 12.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 6.2 tp-100 -105.37 148.98 26.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 28.6 m -124.98 123.78 66.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 110.197 173.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.56 115.54 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -96.37 152.03 18.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.091 0.957 . . . . 0.0 111.275 -171.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.701 ' HG3' ' HB2' ' A' ' 96' ' ' ARG . 52.9 tt0 -125.77 107.89 10.96 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -82.61 106.54 14.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.313 0.645 . . . . 0.0 110.791 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -99.6 133.11 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 121.533 0.682 . . . . 0.0 109.844 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -111.88 125.68 54.29 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -97.41 123.66 41.33 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 70.8 mtp180 -141.52 -173.86 3.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.757 0.823 . . . . 0.0 110.648 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.14 164.69 14.77 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.4 -26.17 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.838 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -19.16 64.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.157 1.383 . . . . 0.0 110.849 175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.97 -14.45 63.9 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.96 153.27 29.82 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 111.364 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.9 t -92.52 133.86 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.196 0.598 . . . . 0.0 110.164 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.26 -54.09 3.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 0.0 110.184 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -157.24 96.21 1.54 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.652 1.181 . . . . 0.0 108.804 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.66 142.39 32.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 68.63 86.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.039 1.336 . . . . 0.0 111.417 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -141.16 92.79 2.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -111.2 133.68 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -166.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.0 p -108.48 137.13 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.4 m -113.32 137.72 51.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.93 0.492 . . . . 0.0 110.442 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.2 mt -98.92 123.36 43.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.424 HG23 HG23 ' A' ' 8' ' ' THR . 2.1 mp -99.85 105.4 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.019 0.927 . . . . 0.0 108.664 -173.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.28 107.61 20.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.893 0.877 . . . . 0.0 110.096 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 m -83.81 103.09 12.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.447 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 32.6 tt0 -85.53 107.79 17.63 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 17.0 p -91.65 139.64 30.49 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.64 -167.13 16.03 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 136.68 35.42 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.29 0.545 . . . . 0.0 110.75 -175.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HB2' HD13 ' A' ' 5' ' ' ILE . 25.7 ttm180 -103.58 122.21 44.51 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.821 0.449 . . . . 0.0 110.176 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 2' ' ' ILE . 8.0 t70 -74.67 113.28 11.75 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.598 1.159 . . . . 0.0 108.582 169.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.7 mt -84.66 -4.44 59.01 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 t -87.11 -36.32 18.17 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.644 0.656 . . . . 0.0 110.86 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.04 -31.09 11.61 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.57 63.65 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.916 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 133.53 45.88 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.018 0.927 . . . . 0.0 110.138 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.55 113.93 27.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.353 0.661 . . . . 0.0 110.081 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.98 104.29 15.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.495 ' CZ2' HD12 ' A' ' 5' ' ' ILE . 55.2 m95 -103.75 119.86 39.78 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.88 131.06 43.2 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.78 0.675 . . . . 0.0 110.711 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -64.5 -26.28 68.36 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.297 0.998 . . . . 0.0 110.215 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -64.29 -22.25 66.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.69 0.796 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.447 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 67.8 t-105 -74.32 127.17 32.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.458 0.474 . . . . 0.0 109.896 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 p -153.87 144.53 22.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.514 1.126 . . . . 0.0 109.528 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 tt -134.12 125.18 27.42 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.4 m -107.92 127.64 53.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -130.8 140.19 50.26 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 91.8 m -101.56 132.83 47.0 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 111.117 -175.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 m-85 -72.52 102.46 3.24 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.71 141.96 28.53 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.2 1.0 . . . . 0.0 108.307 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.79 108.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.401 1.08 . . . . 0.0 110.77 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 107.14 21.4 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.55 102.89 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.213 2.609 . . . . 0.0 112.92 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -98.64 134.06 22.02 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.131 0.972 . . . . 0.0 110.62 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 120.66 7.97 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.67 2.247 . . . . 0.0 110.583 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.07 107.25 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mt -102.33 114.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.0 mm -75.62 137.86 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.53 87.42 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.346 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 97.9 m-85 -141.75 162.33 35.74 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.393 0.677 . . . . 0.0 110.26 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -147.24 120.03 8.66 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.95 148.23 52.13 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 123.799 0.687 . . . . 0.0 109.456 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.5 -33.6 73.09 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.787 0.68 . . . . 0.0 109.277 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 97.71 7.07 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.612 168.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.72 -6.23 17.34 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.199 1.932 . . . . 0.0 111.568 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tpt -128.47 125.61 38.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.388 1.075 . . . . 0.0 108.384 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.489 HG11 HE22 ' A' ' 13' ' ' GLN . 29.9 t -86.12 130.26 36.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 109.403 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.75 161.16 49.34 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.365 1.041 . . . . 0.0 113.418 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.5 118.81 5.91 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 123.206 2.604 . . . . 0.0 113.672 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 22.4 m-20 -109.79 94.54 5.08 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.711 0.805 . . . . 0.0 109.715 173.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -72.47 91.67 1.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.17 0.588 . . . . 0.0 110.768 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 85' ' ' VAL . 74.8 t -85.52 103.03 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.873 0.869 . . . . 0.0 110.183 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.1 m -90.17 106.54 18.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.401 0.68 . . . . 0.0 109.548 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HA ' HD21 ' A' ' 89' ' ' ASN . 85.4 t -106.5 110.7 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 170.98 12.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.411 1.084 . . . . 0.0 108.23 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.3 m -65.7 -23.8 66.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.324 166.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -67.53 -45.28 76.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.978 1.311 . . . . 0.0 110.694 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 85' ' ' VAL . 3.4 p-10 -113.66 29.64 7.84 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.724 0.81 . . . . 0.0 109.892 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 9' ' ' GLN . 59.9 t80 -62.07 -46.53 88.68 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.616 0.767 . . . . 0.0 111.78 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.5 -1.09 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.48 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.01 149.69 25.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.888 0.875 . . . . 0.0 109.459 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -108.57 144.07 36.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.471 0.708 . . . . 0.0 109.699 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.4 40.11 3.75 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.37 103.67 1.69 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.583 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.701 ' HB2' ' HG3' ' A' ' 13' ' ' GLN . 28.2 mmm180 -76.42 156.41 33.16 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.458 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.87 132.15 18.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.453 0.301 . . . . 0.0 110.454 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 47.1 mt-10 -141.75 138.33 32.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.516 0.726 . . . . 0.0 110.643 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.5 m -109.03 115.28 29.76 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.41 141.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.08 113.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.747 0.419 . . . . 0.0 110.151 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 63.2 m-85 -84.05 110.45 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.995 0.918 . . . . 0.0 108.877 173.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -99.63 143.56 29.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.81 123.92 10.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.572 0.749 . . . . 0.0 109.295 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 126.592 1.957 . . . . 0.0 113.317 -162.072 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' HD3' ' A' ' 40' ' ' LYS . 29.4 mm -118.72 119.86 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.409 1.084 . . . . 0.0 110.037 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 43' ' ' LEU . 10.5 pt-20 -97.88 137.42 20.93 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 167.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.98 122.95 8.53 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.909 1.739 . . . . 0.0 110.355 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 42.0 pt -119.34 161.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.401 0.68 . . . . 0.0 110.368 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 136.82 12.82 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -96.83 154.34 17.35 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 34' ' ' ILE . 76.6 m -128.54 105.45 8.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -99.48 102.14 13.6 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.6 m -91.13 117.5 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.7 t -89.75 107.1 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.3 m -92.49 102.22 14.67 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.488 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 9.5 tt0 -91.73 105.24 17.57 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.561 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.9 p -92.91 106.21 18.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 98' ' ' GLU . 19.9 mt -97.29 132.5 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.724 0.773 . . . . 0.0 111.681 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -116.75 118.09 31.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.98 -1.464 . . . . 0.0 107.056 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -87.33 115.41 24.73 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.0 ttt-85 -147.37 145.42 29.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.635 0.374 . . . . 0.0 110.518 -171.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -79.48 163.2 24.92 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.477 1.111 . . . . 0.0 111.031 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.99 -28.32 69.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.452 0.701 . . . . 0.0 110.324 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.54 -20.03 65.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.048 1.339 . . . . 0.0 112.042 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.74 -10.25 66.42 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.869 -176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.29 54.14 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.564 0.746 . . . . 0.0 109.494 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 27' ' ' ASP . 39.8 t -86.76 124.89 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.91 51.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.541 0.737 . . . . 0.0 110.857 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -166.25 119.22 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.309 1.043 . . . . 0.0 108.531 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB2' HG11 ' A' ' 24' ' ' VAL . 22.7 t70 -98.19 162.2 13.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.23 0.612 . . . . 0.0 110.037 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 61.97 73.76 0.46 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.822 1.249 . . . . 0.0 112.323 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -127.62 83.7 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 171.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -102.35 127.23 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.599 -171.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 p -117.48 134.91 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -130.01 127.71 40.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 50.3 mt -108.81 131.23 55.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.609 0.764 . . . . 0.0 110.655 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.617 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -82.05 113.07 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.148 0.979 . . . . 0.0 109.619 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -103.99 103.75 13.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.514 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 85.5 m -91.95 107.17 19.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.93 0.892 . . . . 0.0 111.23 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 8.0 tt0 -86.63 107.78 18.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.0 p -78.19 169.58 18.03 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.851 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.95 -158.93 22.94 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.449 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -149.35 144.85 26.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.706 0.802 . . . . 0.0 109.531 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm180 -119.25 119.9 35.44 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.953 0.501 . . . . 0.0 110.566 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.8 113.81 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.206 1.002 . . . . 0.0 108.803 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 3' ' ' GLU . 52.0 mt -82.86 -6.63 59.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -73.55 -48.32 33.94 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.071 0.548 . . . . 0.0 110.533 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 47' ' ' LYS . 5.5 t30 -93.07 -26.44 17.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.967 0.507 . . . . 0.0 110.928 176.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.24 54.36 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.071 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HG3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -95.41 137.59 34.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.708 0.803 . . . . 0.0 110.918 -174.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -98.58 113.79 25.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.862 0.865 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.2 mp -100.15 110.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -100.35 139.15 36.43 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.7 t70 -68.01 108.53 3.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 p -77.12 -9.88 59.03 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.189 0.596 . . . . 0.0 112.29 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -97.74 -1.13 44.07 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.339 0.656 . . . . 0.0 111.262 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 62.3 t-105 -66.48 150.52 48.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.435 0.694 . . . . 0.0 110.826 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.4 p -151.73 135.84 16.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 36' ' ' THR . 1.4 tm? -111.51 124.1 51.58 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 m -99.94 127.82 46.09 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.762 0.825 . . . . 0.0 108.845 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 8.5 tp-100 -139.62 132.33 28.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 17.1 m -75.02 105.07 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.33 0.652 . . . . 0.0 112.056 -171.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.44 100.13 3.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 161.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -109.32 157.45 18.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.331 1.052 . . . . 0.0 110.138 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -46.69 114.99 0.93 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.943 1.697 . . . . 0.0 114.376 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' A' ' 15' ' ' ILE . 3.7 mm? -82.36 124.3 78.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.51 100.52 0.23 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.735 2.29 . . . . 0.0 112.349 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 t -86.19 104.53 5.63 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.84 122.32 11.15 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.044 2.496 . . . . 0.0 112.475 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.23 107.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.53 135.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.648 0.779 . . . . 0.0 108.938 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.33 118.89 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.495 -172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.09 68.13 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.154 -173.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 81.5 m-85 -141.21 136.52 31.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.816 0.846 . . . . 0.0 111.014 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.1 m -118.78 124.76 48.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 108.597 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.54 138.48 53.32 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.347 0.659 . . . . 0.0 110.971 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.91 -27.4 65.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.424 1.09 . . . . 0.0 110.593 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 94.5 7.29 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.058 0.943 . . . . 0.0 108.661 169.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.55 -5.45 16.9 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.432 2.088 . . . . 0.0 112.19 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.9 tpt -131.62 110.42 10.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.283 1.033 . . . . 0.0 108.487 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.05 129.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 77.13 0.56 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -167.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -97.57 8.13 1.26 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.371 2.047 . . . . 0.0 114.618 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -162.38 172.77 15.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.251 1.024 . . . . 0.0 112.838 -169.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 33.9 mt-10 -85.46 129.77 34.74 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.341 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.51 140.14 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.027 0.931 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.6 m -112.12 120.98 43.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.799 0.84 . . . . 0.0 109.964 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -97.46 118.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.68 157.33 16.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.615 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 68.0 m -58.71 -33.64 70.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.74 0.816 . . . . 0.0 112.461 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.52 -30.29 69.07 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -117.64 24.24 11.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 34.5 t80 -62.65 -34.17 76.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.096 0.558 . . . . 0.0 111.998 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.63 -1.37 50.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.875 0.87 . . . . 0.0 111.704 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -101.16 163.07 12.46 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.93 0.892 . . . . 0.0 110.509 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -84.46 175.35 9.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.936 0.894 . . . . 0.0 111.103 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -121.9 -36.84 2.94 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 165.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -171.86 158.09 4.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.426 1.491 . . . . 0.0 107.87 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 76.7 mtm180 -138.92 -87.99 0.22 Allowed 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.09 109.99 22.65 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -166.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' HB2' HG12 ' A' ' 15' ' ' ILE . 71.0 mm-40 -118.04 114.23 22.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.564 1.145 . . . . 0.0 109.609 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 83.4 m -106.63 122.06 45.58 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.74 132.81 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 30.1 mm -104.18 122.15 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.886 0.475 . . . . 0.0 110.67 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 97.0 m-85 -91.71 108.91 20.25 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.077 0.951 . . . . 0.0 109.974 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 m -98.29 131.42 44.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.798 0.839 . . . . 0.0 109.786 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.76 7.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.059 0.944 . . . . 0.0 111.015 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.835 1.254 . . . . 0.0 111.628 -176.128 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.876 0.369 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.9 mm -112.64 157.16 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.842 1.257 . . . . 0.0 109.094 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -124.38 146.96 53.66 Favored Pre-proline 0 N--CA 1.479 1.005 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.64 126.38 12.03 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.071 1.847 . . . . 0.0 111.581 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.8 pt -127.18 167.39 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.581 0.752 . . . . 0.0 109.802 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 138.78 12.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.554 0.692 . . . . 0.0 111.622 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.582 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -87.32 133.83 33.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.9 m -125.29 104.88 8.72 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.2 146.78 24.09 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.131 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 34' ' ' ILE . 35.1 m -126.63 131.89 70.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' SER . 94.3 t -91.62 102.37 13.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m -101.78 104.27 15.04 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.84 0.856 . . . . 0.0 109.159 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.784 HE21 ' HB2' ' A' ' 98' ' ' GLU . 52.1 tt0 -112.95 125.27 54.21 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 109.948 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 30' ' ' VAL . 85.5 m -99.25 108.09 20.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.479 0.712 . . . . 0.0 109.687 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 98' ' ' GLU . 1.8 mp -83.57 116.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -95.77 108.81 21.17 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.128 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' HA ' HG22 ' A' ' 100' ' ' VAL . 97.3 m-85 -79.99 117.98 21.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -137.44 165.57 25.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.979 0.512 . . . . 0.0 109.875 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -94.04 175.53 6.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.312 1.045 . . . . 0.0 109.265 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -73.26 -21.37 60.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.41 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.05 -19.21 65.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.219 1.007 . . . . 0.0 110.882 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.27 -12.36 69.12 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.143 -173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.24 136.8 56.51 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.953 0.901 . . . . 0.0 110.747 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -90.49 112.9 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.75 72.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.121 0.568 . . . . 0.0 110.203 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -177.11 116.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.401 1.081 . . . . 0.0 109.789 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.46 -38.08 55.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -106.79 77.26 1.16 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.769 0.428 . . . . 0.0 111.104 -167.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HE1' ' HD2' ' A' ' 64' ' ' PRO . 9.4 t-160 -121.45 91.13 3.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 14' ' ' THR . 21.6 t -102.14 120.3 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.255 -162.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.761 ' HB ' HD23 ' A' ' 63' ' ' LEU . 9.0 p -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.879 0.872 . . . . 0.0 109.153 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 67.7 p -136.71 132.01 34.3 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.79 0.836 . . . . 0.0 109.716 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.542 HD11 ' HA ' ' A' ' 60' ' ' PHE . 74.9 mt -110.62 125.67 53.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG12 ' A' ' 10' ' ' VAL . 2.4 mp -88.14 112.26 23.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 56' ' ' LEU . 95.2 m-85 -104.26 124.53 49.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.208 1.003 . . . . 0.0 108.417 170.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -121.27 107.69 12.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.87 0.468 . . . . 0.0 110.385 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 32.6 tt0 -84.79 95.95 9.13 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 109.089 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -76.12 135.09 39.83 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.11 -168.12 12.3 Favored Glycine 0 C--O 1.251 1.16 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -140.02 143.39 36.4 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.6 ttm180 -112.77 122.38 47.48 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.586 0.355 . . . . 0.0 110.261 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.3 t70 -71.18 118.2 13.66 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 169.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.15 -18.33 55.72 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -75.86 -49.09 18.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.726 0.298 . . . . 0.0 110.24 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 49.7 t-20 -88.68 -31.82 18.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -0.57 58.75 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.854 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 21.2 ptmt -70.33 146.09 50.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.284 1.034 . . . . 0.0 111.591 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.74 112.46 24.16 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.534 0.733 . . . . 0.0 109.855 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.59 93.67 3.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 50.0 m95 -85.77 140.4 30.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.4 t70 -68.4 110.05 3.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.1 t -78.49 -5.46 52.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.736 0.814 . . . . 0.0 111.813 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 53' ' ' LYS . 7.9 mtmp? -101.65 -4.78 25.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.098 0.559 . . . . 0.0 110.236 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.1 t-105 -62.44 120.31 10.81 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.125 0.57 . . . . 0.0 110.179 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 11.0 p -139.13 111.58 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.168 0.987 . . . . 0.0 108.667 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 35' ' ' PHE . 64.1 tp -102.21 135.17 44.28 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 11.6 m -98.34 144.95 27.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -148.87 129.32 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 7.0 m -73.67 104.65 4.67 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.754 0.659 . . . . 0.0 110.006 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -65.62 103.53 0.88 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.03 -164.7 0.64 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.254 1.022 . . . . 0.0 108.243 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.1 18.41 10.99 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.525 1.13 . . . . 0.0 111.627 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.2 tm? -107.28 106.09 57.45 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 171.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD2' ' HE1' ' A' ' 29' ' ' HIS . 73.3 Cg_endo -70.66 -165.13 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.253 2.636 . . . . 0.0 113.728 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 t -164.65 106.52 0.84 Allowed Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 121.4 8.22 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.712 2.274 . . . . 0.0 112.316 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.09 108.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 71' ' ' TYR . 40.7 mt -101.55 134.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.8 mm -67.92 134.46 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.353 0.661 . . . . 0.0 109.891 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.67 20.07 71.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.071 0.857 . . . . 0.0 112.988 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 65.0 m-85 -139.17 150.75 45.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.651 0.739 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -136.86 118.93 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.15 150.53 48.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.092 0.557 . . . . 0.0 110.336 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -69.03 -40.6 78.53 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.04 99.44 16.45 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.126 170.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.16 -2.45 12.34 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.054 2.503 . . . . 0.0 112.117 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.3 ttt -144.31 115.76 8.08 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -80.72 110.16 15.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.496 0.718 . . . . 0.0 111.165 -171.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . 59.39 61.43 7.29 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.848 1.342 . . . . 0.0 114.314 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.83 82.43 2.15 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 122.544 2.163 . . . . 0.0 110.743 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -161.42 137.41 8.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.141 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.0 mt-10 -76.02 89.48 2.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.055 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 t -82.25 126.84 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.553 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' THR . 20.0 m -98.46 117.78 33.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.373 0.669 . . . . 0.0 109.909 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.3 t -99.31 116.61 42.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 7.0 p-10 -104.76 172.03 7.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.4 t -58.53 -30.09 66.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.016 0.926 . . . . 0.0 113.004 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -71.01 -38.19 72.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.127 0.571 . . . . 0.0 111.128 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -107.93 10.83 28.37 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.0 0.52 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -65.26 -47.19 77.61 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 123.241 0.616 . . . . 0.0 112.079 -170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.47 -23.67 61.08 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.749 0.655 . . . . 0.0 110.814 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.2 143.28 26.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.275 0.63 . . . . 0.0 110.547 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.571 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -67.53 162.96 22.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 160.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -125.3 -39.22 2.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -114.82 142.97 45.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -132.68 -52.83 0.93 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.345 1.058 . . . . 0.0 109.447 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.87 148.18 35.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.327 0.584 . . . . 0.0 111.679 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.784 ' HB2' HE21 ' A' ' 13' ' ' GLN . 12.5 tp10 -122.25 155.57 35.62 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.744 1.218 . . . . 0.0 108.627 169.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -139.74 99.78 3.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.7 m -82.22 141.7 14.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.68 110.54 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.967 0.413 . . . . 0.0 110.888 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.61 104.62 10.33 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 m -98.77 173.93 6.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.23 146.53 15.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.03 151.95 38.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.137 0.494 . . . . 0.0 111.051 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -58.37 -11.12 2.5 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 125.253 1.421 . . . . 0.0 112.632 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.57 -53.0 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.882 0.873 . . . . 0.0 110.279 167.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 -2.15 41.09 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.897 0.479 . . . . 0.0 111.466 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -115.87 141.24 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.173 0.589 . . . . 0.0 111.548 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.46 155.1 36.59 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.552 0.741 . . . . 0.0 109.398 168.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.69 90.92 0.18 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.489 0.662 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.05 -33.0 67.63 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.229 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -111.11 124.32 51.95 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.539 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.42 36.34 0.13 Allowed Glycine 0 C--N 1.322 -0.245 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.311 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -91.93 0.62 57.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.707 1.203 . . . . 0.0 110.893 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 66.64 101.71 0.05 OUTLIER 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.52 1.528 . . . . 0.0 109.56 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -53.47 107.03 0.21 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.43 1.092 . . . . 0.0 111.211 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -73.0 113.32 9.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.406 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -121.43 173.84 7.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.01 0.924 . . . . 0.0 110.039 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -77.3 125.04 28.69 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.799 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -82.64 -40.85 20.19 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.818 0.847 . . . . 0.0 109.466 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.252 1.186 0 O-C-N 125.022 1.451 . . . . 0.0 109.977 -171.109 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.442 HD12 ' HD3' ' A' ' 40' ' ' LYS . 38.1 mm -112.6 130.45 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.913 0.885 . . . . 0.0 110.655 -172.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -106.48 143.37 26.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 166.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -77.6 123.44 6.45 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.325 1.35 . . . . 0.0 111.516 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.6 pt -110.42 172.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.642 0.777 . . . . 0.0 109.807 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.92 146.55 6.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 19.7 mtm180 -113.02 170.15 8.42 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.256 1.022 . . . . 0.0 109.075 168.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 34' ' ' ILE . 34.1 m -135.92 106.43 6.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.331 0.652 . . . . 0.0 110.199 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.1 108.27 20.86 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.592 0.757 . . . . 0.0 109.024 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.1 m -92.17 145.48 7.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' SER . 92.3 t -119.28 104.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.0 m -94.84 107.35 19.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.603 0.761 . . . . 0.0 111.654 -166.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.592 HE22 ' HB2' ' A' ' 96' ' ' ARG . 7.2 tp-100 -96.32 104.97 16.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.618 0.767 . . . . 0.0 108.963 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.491 HG22 HG22 ' A' ' 30' ' ' VAL . 34.5 p -91.75 110.29 21.62 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -89.5 127.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -107.69 122.56 46.96 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -92.54 108.06 19.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -117.36 151.17 37.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.94 178.0 8.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.608 0.763 . . . . 0.0 109.259 169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.87 -32.28 73.44 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -71.33 -18.47 62.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.746 0.818 . . . . 0.0 111.348 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.65 -3.32 56.12 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.932 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.85 142.69 57.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.288 0.635 . . . . 0.0 110.902 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.66 107.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.92 0.488 . . . . 0.0 110.069 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.63 -46.91 74.28 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.243 0.617 . . . . 0.0 109.482 170.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -161.31 153.87 20.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.646 1.579 . . . . 0.0 108.536 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.72 -153.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.39 0.676 . . . . 0.0 111.548 -173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.89 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.675 1.19 . . . . 0.0 113.356 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -80.98 91.9 6.11 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 165.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 14' ' ' THR . 47.1 t -91.29 123.33 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.232 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 63' ' ' LEU . 7.4 p -115.16 151.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 164.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.4 p -143.57 136.1 27.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 70.0 mt -98.32 122.29 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 8' ' ' THR . 2.3 mp -89.01 114.62 27.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.026 0.93 . . . . 0.0 108.901 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 56' ' ' LEU . 97.9 m-85 -109.93 99.43 8.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.841 0.856 . . . . 0.0 108.726 172.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.7 m -90.17 102.18 14.9 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 50' ' ' TRP . 38.0 tt0 -78.79 105.68 10.26 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 119.677 -0.201 . . . . 0.0 110.791 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.6 p -74.37 143.53 44.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 124.071 0.857 . . . . 0.0 110.259 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.38 -160.35 10.1 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -155.79 137.62 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 117.913 0.856 . . . . 0.0 110.876 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.657 ' HB2' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -113.24 128.73 56.56 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.525 0.73 . . . . 0.0 109.156 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 29.0 t70 -79.77 130.15 35.09 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.374 0.67 . . . . 0.0 109.39 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.42 -16.47 45.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.9 t -94.53 -36.12 11.97 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.401 0.546 . . . . 0.0 110.982 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -89.85 -31.8 17.18 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.892 0.477 . . . . 0.0 109.962 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.88 27.42 60.59 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HE2' HD11 ' A' ' 49' ' ' ILE . 21.1 ptmt -96.38 140.69 30.66 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.694 0.798 . . . . 0.0 110.946 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.02 115.49 30.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 0.0 110.481 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.433 HD11 ' HE2' ' A' ' 47' ' ' LYS . 3.6 mp -109.77 104.01 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.525 ' HB3' ' NE2' ' A' ' 37' ' ' GLN . 74.5 m95 -90.36 145.48 24.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.233 1.013 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 28.1 t70 -67.57 113.85 5.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.16 0.584 . . . . 0.0 110.292 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -62.75 -39.32 93.75 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.913 0.885 . . . . 0.0 112.13 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -82.72 -6.92 59.64 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.671 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.548 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 60.0 t90 -54.36 124.63 16.54 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 19.9 p -154.34 108.45 2.98 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 35' ' ' PHE . 37.4 tp -101.06 127.0 47.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.9 m -98.83 112.9 24.85 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -119.95 124.77 46.78 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 15.7 m -80.88 135.24 35.88 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.211 0.605 . . . . 0.0 111.619 -174.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -82.61 117.62 22.71 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 158.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -172.45 179.93 2.38 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.001 1.438 . . . . 0.0 109.089 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.53 52.78 4.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.914 0.759 . . . . 0.0 112.273 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.55 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -97.33 98.22 4.68 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 168.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.69 92.35 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.782 2.321 . . . . 0.0 111.89 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.1 p -85.82 131.75 46.21 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.926 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.21 138.57 61.98 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.87 2.38 . . . . 0.0 113.072 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -88.57 111.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 mt -102.56 128.63 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.29 132.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.871 0.468 . . . . 0.0 109.828 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.45 79.87 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.517 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 88.6 m-85 -143.88 157.95 44.02 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.073 0.949 . . . . 0.0 109.107 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.4 m -145.61 116.97 7.96 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.653 0.781 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.32 135.41 57.0 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.673 0.608 . . . . 0.0 109.562 170.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.65 -14.57 61.62 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.532 0.733 . . . . 0.0 110.773 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -147.08 84.75 7.23 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.49 1.116 . . . . 0.0 108.575 172.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.16 -5.67 17.01 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.361 2.041 . . . . 0.0 111.661 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 tpt -116.8 109.31 16.95 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.332 1.053 . . . . 0.0 108.312 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 40.6 t -100.96 133.12 45.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 92.53 0.21 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 123.945 0.778 . . . . 0.0 111.59 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -104.44 21.27 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.055 2.504 . . . . 0.0 112.981 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.76 148.02 29.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -165.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 37.1 mt-10 -87.63 129.64 35.05 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.257 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.75 108.84 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.047 0.939 . . . . 0.0 110.016 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 m -92.58 101.13 13.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.4 0.68 . . . . 0.0 110.623 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.25 116.59 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 9.9 t70 -93.46 163.94 13.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 49.0 m -57.2 -27.75 62.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.283 1.033 . . . . 0.0 111.93 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -69.69 -30.89 68.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.169 0.988 . . . . 0.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -115.53 8.9 15.28 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.944 0.498 . . . . 0.0 111.714 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 82.9 t80 -62.03 -33.89 75.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.876 0.87 . . . . 0.0 112.25 -173.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.74 -18.1 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.323 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -95.63 156.42 16.33 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.211 0.604 . . . . 0.0 109.737 170.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -141.74 138.71 32.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.691 1.197 . . . . 0.0 108.13 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.36 45.48 0.96 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 0.0 109.694 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.03 121.58 15.02 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.466 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.592 ' HB2' HE22 ' A' ' 13' ' ' GLN . 53.5 mmm-85 -127.15 177.44 6.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.516 0.726 . . . . 0.0 109.901 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -130.31 122.32 27.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.71 110.59 20.42 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 94.9 m -97.3 122.96 40.92 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.537 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -99.16 137.05 27.77 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.0 mm -100.41 118.76 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 122.782 0.433 . . . . 0.0 110.166 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 91.4 m-85 -88.67 95.63 10.33 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 172.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 p -86.65 139.15 31.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.41 114.19 1.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.245 1.018 . . . . 0.0 110.649 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -62.6 149.85 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.397 1.061 . . . . 0.0 109.758 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.9 t -47.98 -32.96 7.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.644 1.178 . . . . 0.0 111.481 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.9 mm -54.34 -46.86 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.653 1.181 . . . . 0.0 111.511 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 t -89.15 -24.86 22.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.944 0.498 . . . . 0.0 111.036 -175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -71.7 -49.04 43.2 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.872 0.469 . . . . 0.0 111.154 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 173.12 12.91 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.116 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.82 135.51 16.27 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.756 0.822 . . . . 0.0 109.247 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -55.57 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.394 0.678 . . . . 0.0 110.304 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -178.23 171.42 1.67 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.317 1.447 . . . . 0.0 108.82 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.25 32.23 83.44 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.274 0.359 . . . . 0.0 112.495 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -92.12 -26.5 18.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.712 0.805 . . . . 0.0 110.589 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 65.72 -79.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.282 1.433 . . . . 0.0 110.625 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -169.04 -48.23 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.987 1.315 . . . . 0.0 108.158 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.5 m170 56.54 85.8 0.07 Allowed 'General case' 0 C--N 1.352 0.707 0 C-N-CA 125.754 1.622 . . . . 0.0 111.14 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -125.73 98.04 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -92.98 -179.95 5.26 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.537 0.735 . . . . 0.0 110.161 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -90.54 4.7 50.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.6 0.36 . . . . 0.0 111.101 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 125.199 1.399 . . . . 0.0 109.551 -169.682 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 42' ' ' ASP . 31.5 mm -121.33 154.03 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.801 1.241 . . . . 0.0 109.204 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.07 146.45 53.74 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.59 122.49 5.53 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 121.326 1.351 . . . . 0.0 111.681 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 41' ' ' ARG . 24.5 pt -117.2 169.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 0.0 110.029 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.01 144.21 8.23 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.869 0.468 . . . . 0.0 111.414 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . 84.9 mtt180 -102.06 169.87 8.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.4 1.08 . . . . 0.0 108.946 165.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -144.09 116.85 8.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.099 0.559 . . . . 0.0 110.72 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -114.05 125.03 53.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -104.84 134.64 45.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.21 118.43 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -109.07 117.64 34.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.206 1.002 . . . . 0.0 110.304 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -90.39 108.64 19.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 p -85.63 104.58 15.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.626 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.5 mp -92.68 121.7 43.54 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -125.72 130.91 52.46 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.101 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -92.3 121.99 34.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.956 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -134.99 162.45 32.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.37 0.668 . . . . 0.0 109.32 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -93.33 171.94 8.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.977 0.911 . . . . 0.0 109.444 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.04 -25.13 66.91 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.542 0.737 . . . . 0.0 110.741 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.0 -20.33 66.15 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.89 1.276 . . . . 0.0 111.815 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.52 -19.26 54.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 120.075 -0.291 . . . . 0.0 112.481 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.25 137.51 52.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.024 0.93 . . . . 0.0 110.901 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.98 109.95 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.71 -51.81 63.33 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.115 0.566 . . . . 0.0 109.973 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -153.67 166.85 31.52 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.83 1.252 . . . . 0.0 110.487 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.62 82.0 0.59 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -171.76 -3.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -171.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' HB3' HD21 ' A' ' 63' ' ' LEU . 22.1 m170 -99.46 82.22 2.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.67 1.123 . . . . 0.0 111.269 -174.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.91 130.96 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.4 117.64 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 m -105.83 127.42 53.1 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.445 1.098 . . . . 0.0 108.954 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 58' ' ' GLN . 94.9 mt -108.67 130.86 55.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.461 0.705 . . . . 0.0 110.06 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.3 118.9 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.847 0.859 . . . . 0.0 108.921 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -108.13 104.16 13.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.0 m -94.63 105.75 17.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.425 0.69 . . . . 0.0 109.484 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 35.4 tt0 -79.8 83.79 5.69 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -74.36 133.44 42.51 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.99 -162.08 9.04 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 142.06 32.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.595 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.5 ttm180 -112.2 124.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.295 0.638 . . . . 0.0 109.949 -175.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' HA ' HD13 ' A' ' 2' ' ' ILE . 27.3 t70 -74.53 120.79 20.56 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.4 mt -83.8 -27.31 28.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -73.22 -41.16 64.06 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.898 0.317 . . . . 0.0 111.026 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -87.98 -29.73 20.55 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.98 36.34 32.32 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -104.37 142.47 34.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.659 0.784 . . . . 0.0 109.69 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 51.1 mt-10 -97.15 114.1 25.75 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.42 116.44 34.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 44.8 m95 -114.58 132.72 56.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.78 127.04 32.21 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 t -67.77 -31.05 70.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.975 0.91 . . . . 0.0 111.789 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -86.56 2.75 47.01 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.02 0.528 . . . . 0.0 111.449 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 56' ' ' LEU . 77.6 t90 -58.79 134.52 56.93 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.32 0.648 . . . . 0.0 110.564 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.1 p -156.04 122.14 5.04 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.909 0.883 . . . . 0.0 109.321 171.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 54' ' ' TRP . 1.5 tm? -104.38 133.86 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -107.12 123.21 47.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.309 0.644 . . . . 0.0 110.31 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.461 ' HB3' HD13 ' A' ' 33' ' ' LEU . 29.6 mm-40 -129.2 134.01 47.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.088 0.955 . . . . 0.0 108.902 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.8 m -97.41 118.68 34.42 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.408 0.683 . . . . 0.0 111.377 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -72.94 119.67 17.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -170.09 -163.47 0.36 Allowed 'General case' 0 C--O 1.243 0.73 0 O-C-N 124.534 1.146 . . . . 0.0 108.56 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 64.32 19.69 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.254 1.021 . . . . 0.0 112.544 168.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 29' ' ' HIS . 35.9 tp -139.74 98.93 7.74 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.287 0.635 . . . . 0.0 109.372 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 77' ' ' MET . 53.6 Cg_endo -88.89 -166.47 0.25 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.366 2.711 . . . . 0.0 111.899 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -116.57 147.11 39.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.129 0.972 . . . . 0.0 110.501 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.68 125.11 16.9 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.546 2.164 . . . . 0.0 111.555 171.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.87 109.89 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.26 1.024 . . . . 0.0 109.908 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.02 123.45 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -73.6 135.29 27.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.525 1.53 . . . . 0.0 108.895 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.02 -1.41 86.69 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.599 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 94.5 m-85 -139.5 168.43 19.83 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 117.681 0.74 . . . . 0.0 112.157 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -150.45 121.5 7.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.465 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 147.16 52.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.428 0.691 . . . . 0.0 111.121 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -63.12 -32.42 73.8 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.941 0.896 . . . . 0.0 110.422 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -142.16 93.62 7.24 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.1 -1.7 9.95 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.958 2.439 . . . . 0.0 113.266 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' PRO . 24.8 ttt -148.68 140.06 23.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.28 122.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.02 112.25 3.08 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 124.8 1.312 . . . . 0.0 113.173 -171.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.52 90.49 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.181 2.587 . . . . 0.0 110.677 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -140.17 137.37 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.72 106.22 9.4 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.592 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.39 112.53 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.508 1.123 . . . . 0.0 109.263 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -100.85 135.51 42.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.97 0.508 . . . . 0.0 110.593 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -103.79 124.67 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -91.34 164.29 13.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.046 0.939 . . . . 0.0 109.309 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.0 t -58.31 -37.75 75.71 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.764 1.226 . . . . 0.0 112.972 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.16 -41.32 22.6 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.826 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.3 -0.8 51.29 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 117.755 0.252 . . . . 0.0 111.577 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -57.91 -31.32 66.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.438 1.095 . . . . 0.0 112.388 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.56 -21.79 61.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.32 0.648 . . . . 0.0 111.372 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.19 120.53 40.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.82 0.848 . . . . 0.0 109.45 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.15 105.32 3.93 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.731 0.777 . . . . 0.0 109.05 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -84.65 41.65 0.86 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 111.039 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.95 160.92 19.61 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.247 1.019 . . . . 0.0 111.449 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -146.63 169.22 19.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.008 0.523 . . . . 0.0 110.215 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.28 126.31 42.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.84 0.856 . . . . 0.0 109.64 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 15' ' ' ILE . 15.7 mm-40 -101.39 123.14 44.98 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.017 0.527 . . . . 0.0 109.744 169.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -109.15 109.8 20.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.1 m -85.77 141.49 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.3 mm -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.209 0.603 . . . . 0.0 109.97 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.9 m-85 -76.66 107.8 9.21 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.6 p -109.15 142.03 40.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.07 124.8 10.81 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 124.369 1.043 . . . . 0.0 110.525 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 51.7 p30 -69.45 -141.31 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.956 0.902 . . . . 0.0 110.728 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.2 t -54.93 -9.9 0.42 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 98.2 mt -45.52 -52.85 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 124.51 1.124 . . . . 0.0 110.725 166.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -101.91 -27.25 13.09 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.039 0.536 . . . . 0.0 111.189 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -93.91 -172.45 2.86 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.847 0.859 . . . . 0.0 111.656 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -96.79 -31.84 12.43 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.352 1.061 . . . . 0.0 109.596 167.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.5 143.86 30.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.837 0.855 . . . . 0.0 110.102 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 105' ' ' ASN . 43.4 mtpt -80.74 -84.83 0.1 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 166.59 -170.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.137 1.375 . . . . 0.0 109.258 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.2 45.26 40.72 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.052 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.6 mt -52.07 -38.91 58.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.469 1.108 . . . . 0.0 110.543 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -155.27 130.38 9.49 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.523 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -66.25 109.84 2.81 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.864 0.866 . . . . 0.0 110.592 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -75.78 104.2 6.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 109.209 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -60.96 100.65 0.12 Allowed 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.718 0.77 . . . . 0.0 111.027 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -137.11 129.46 29.77 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.551 0.74 . . . . 0.0 109.093 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -76.22 85.03 3.04 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.988 1.315 . . . . 0.0 109.329 -170.267 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' HD12 ' A' ' 43' ' ' LEU . 16.7 tpt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.111 0.481 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -102.65 143.46 15.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.908 0.883 . . . . 0.0 109.319 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.78 146.77 51.55 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.97 123.0 4.99 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.478 1.452 . . . . 0.0 111.315 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 38.9 pt -116.76 169.77 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.329 0.585 . . . . 0.0 110.874 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -161.31 152.41 18.54 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.007 174.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' NH2' HD21 ' A' ' 91' ' ' LEU . 27.3 ttp180 -124.2 147.7 47.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.525 HG23 HG23 ' A' ' 34' ' ' ILE . 51.4 m -116.91 106.8 13.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.335 0.654 . . . . 0.0 110.881 -169.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -107.05 102.94 12.25 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.66 127.01 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' SER . 59.7 t -91.4 103.25 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' ' 95' ' ' ASN . 29.7 m -96.18 100.56 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.293 -172.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -92.62 100.91 13.34 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 60.7 m -87.01 104.42 16.29 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 68.6 mt -89.89 123.77 42.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 121.339 0.59 . . . . 0.0 111.545 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 22.9 m170 -101.18 120.56 40.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' HA ' HG22 ' A' ' 100' ' ' VAL . 17.7 m-85 -90.89 116.51 28.77 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 43.8 mtm105 -134.14 177.08 8.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.267 0.627 . . . . 0.0 109.96 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -104.06 169.59 8.41 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.231 1.012 . . . . 0.0 109.648 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.39 -26.24 68.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.151 0.58 . . . . 0.0 111.28 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.41 -17.26 63.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.271 1.028 . . . . 0.0 110.618 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.57 32.85 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.06 44.65 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.088 0.955 . . . . 0.0 111.862 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 37.7 t -86.73 121.6 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.691 0.396 . . . . 0.0 109.977 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -77.68 -57.15 3.97 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -168.49 103.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.311 1.045 . . . . 0.0 109.655 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 5.0 p-10 -86.48 -171.41 3.53 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.98 0.512 . . . . 0.0 111.44 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 66.06 16.19 10.36 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.438 1.095 . . . . 0.0 112.56 171.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -89.59 90.54 8.3 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -94.6 145.42 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 124.534 1.134 . . . . 0.0 112.092 -169.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 63' ' ' LEU . 5.4 p -125.65 129.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 29.4 m -129.01 132.49 47.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.885 0.374 . . . . 0.0 110.723 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.89 123.84 45.69 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 HG23 ' A' ' 8' ' ' THR . 2.6 mp -82.82 112.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 56' ' ' LEU . 97.3 m-85 -108.83 100.76 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -98.65 108.16 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.501 1.121 . . . . 0.0 110.264 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.52 114.26 20.81 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -87.15 146.81 25.89 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.355 0.597 . . . . 0.0 110.243 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.48 -157.72 9.74 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.919 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 140.27 25.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.344 0.572 . . . . 0.0 110.007 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.4 ttm180 -104.64 135.63 45.69 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.332 0.586 . . . . 0.0 109.666 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.08 109.59 16.54 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.831 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.533 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.4 mt -81.88 -2.95 52.94 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.1 t -92.51 -37.53 12.45 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.408 0.549 . . . . 0.0 111.042 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -98.6 -28.01 13.75 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.143 0.577 . . . . 0.0 109.734 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.88 37.06 9.59 Favored Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -113.65 140.98 47.76 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.568 0.747 . . . . 0.0 109.737 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.1 121.4 38.94 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.391 0.677 . . . . 0.0 110.203 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.36 97.68 5.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.401 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 79.1 m95 -91.95 141.47 28.59 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.7 t70 -69.03 116.39 9.43 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 78.8 p -66.58 -30.38 70.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.703 0.801 . . . . 0.0 111.627 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -80.97 -16.44 53.47 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.618 0.767 . . . . 0.0 111.151 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 60.4 t-105 -62.07 132.23 52.19 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.112 0.565 . . . . 0.0 111.883 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.1 p -155.03 144.66 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.896 1.278 . . . . 0.0 108.307 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.506 ' HB2' ' HD1' ' A' ' 35' ' ' PHE . 96.7 mt -120.13 130.1 54.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.232 0.613 . . . . 0.0 109.413 175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 m -106.22 119.95 40.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.89 145.3 44.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.774 0.829 . . . . 0.0 108.946 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' HG2' ' A' ' 82' ' ' GLU . 16.6 m -99.18 123.61 43.6 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.089 0.556 . . . . 0.0 111.376 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -65.2 128.32 35.34 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 159.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -171.43 168.61 6.46 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.359 0.663 . . . . 0.0 110.837 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.51 14.62 9.65 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.219 1.408 . . . . 0.0 113.339 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 31' ' ' VAL . 4.6 mm? -62.63 113.21 8.3 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.785 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.54 166.23 28.04 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.157 1.905 . . . . 0.0 110.555 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -156.15 123.08 2.67 Favored Pre-proline 0 N--CA 1.472 0.629 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.44 125.0 15.26 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.307 2.005 . . . . 0.0 111.945 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.9 t -77.18 104.77 5.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mt -101.71 113.4 37.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.1 mm -75.58 134.87 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.303 0.641 . . . . 0.0 109.854 -174.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.01 4.22 82.13 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.969 -169.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -134.43 167.57 20.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.963 0.905 . . . . 0.0 110.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.4 m -156.03 117.55 3.92 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -75.15 152.42 38.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.233 0.54 . . . . 0.0 111.702 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.46 -26.88 60.32 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.79 1.236 . . . . 0.0 109.668 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 92.97 4.12 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.767 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.61 3.53 7.63 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.564 2.176 . . . . 0.0 112.659 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 ttt -147.41 78.27 1.46 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.252 0.621 . . . . 0.0 110.151 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.8 t -84.67 152.79 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.74 -81.49 0.34 Allowed Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.112 -1.382 . . . . 0.0 111.724 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -31.75 78.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.762 1 C-N-CA 125.589 4.192 . . . . 0.0 117.073 -162.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -161.32 144.11 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 109.713 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 28.0 mt-10 -91.76 120.54 32.58 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.48 128.6 51.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.196 0.999 . . . . 0.0 109.055 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 29.2 m -110.25 109.67 20.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.436 HG22 ' NE2' ' A' ' 94' ' ' GLN . 86.9 t -95.76 110.59 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 163.63 19.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.463 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -67.84 -27.15 66.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.812 0.445 . . . . 0.0 111.364 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -76.27 -29.47 57.46 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.327 0.651 . . . . 0.0 112.735 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -116.07 23.82 11.9 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.563 0.345 . . . . 0.0 110.998 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -61.44 -48.51 80.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.785 0.834 . . . . 0.0 111.897 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.442 HD21 ' NH2' ' A' ' 7' ' ' ARG . 3.2 mm? -75.28 -10.48 59.5 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -83.76 120.24 25.78 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.163 0.585 . . . . 0.0 109.724 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.57 148.86 40.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.068 0.937 . . . . 0.0 111.428 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -137.1 14.64 3.05 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.82 168.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' A' ' 12' ' ' THR . 2.9 p-10 -79.79 140.96 36.68 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -172.28 169.76 5.28 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.9 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -94.57 135.22 36.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.184 0.994 . . . . 0.0 108.668 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 5.5 mm-40 -126.27 111.38 14.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.34 1.056 . . . . 0.0 110.401 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 m -96.2 130.77 43.19 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.573 -0.704 . . . . 0.0 110.578 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 17' ' ' TYR . 2.0 m -96.0 143.07 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 164.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.0 mm -114.69 110.47 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.858 0.463 . . . . 0.0 110.543 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 85.1 m-85 -88.26 102.51 14.9 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.43 ' HB2' HE21 ' A' ' 109' ' ' GLN . 34.8 m -87.01 172.93 9.62 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 173.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.76 156.67 8.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -58.59 153.2 16.78 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.7 t -46.75 -26.03 0.86 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.594 1.558 . . . . 0.0 113.317 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.14 -53.16 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.654 0.782 . . . . 0.0 110.772 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -91.53 -4.83 55.02 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 103' ' ' SER . 90.8 mt-30 -64.12 87.27 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.264 0.554 . . . . 0.0 111.166 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -72.76 135.31 45.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.302 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -118.68 147.33 43.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.17 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -78.96 -60.99 2.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 t70 57.18 -167.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.809 1.244 . . . . 0.0 110.375 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.09 -54.72 0.46 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.3 mt 64.53 6.26 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.94 1.296 . . . . 0.0 112.375 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.23 -175.58 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.704 1.601 . . . . 0.0 111.461 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -87.17 7.63 27.34 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.583 0.753 . . . . 0.0 110.924 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -62.75 114.12 3.42 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.362 1.065 . . . . 0.0 111.801 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.6 t60 63.33 29.99 15.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.691 1.197 . . . . 0.0 111.846 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -84.78 -27.66 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -149.1 -52.49 0.16 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.781 1.632 . . . . 0.0 106.971 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.954 1.302 . . . . 0.0 107.835 170.095 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 40' ' ' LYS . 32.8 mm -127.31 154.88 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.841 0.857 . . . . 0.0 109.93 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 10.6 pt-20 -121.75 146.06 44.78 Favored Pre-proline 0 N--CA 1.485 1.293 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 165.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.69 125.38 11.06 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.873 1.716 . . . . 0.0 111.265 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.6 pt -128.15 174.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.664 0.785 . . . . 0.0 109.825 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.55 150.19 7.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 110.951 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -108.99 151.95 25.63 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -134.91 107.93 7.62 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.174 0.59 . . . . 0.0 110.264 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -105.43 124.16 49.08 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.2 m -104.26 139.17 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' SER . 38.8 t -94.76 104.97 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -102.17 102.39 12.83 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.677 ' HG2' ' HB3' ' A' ' 96' ' ' ARG . 25.1 mt-30 -104.46 121.35 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.793 0.837 . . . . 0.0 109.803 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 30' ' ' VAL . 32.0 m -92.24 103.4 15.87 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -84.81 128.3 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.241 0.617 . . . . 0.0 109.435 175.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -106.13 137.69 43.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -108.96 121.25 44.73 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 3.7 tpp180 -145.85 130.15 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 161.58 25.78 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.289 0.635 . . . . 0.0 110.564 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.22 -25.0 68.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.745 0.818 . . . . 0.0 112.218 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.03 -9.2 58.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 111.62 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.45 -3.28 68.66 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.94 55.0 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 123.686 0.794 . . . . 0.0 110.232 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 27' ' ' ASP . 47.9 t -90.15 110.08 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.596 0.758 . . . . 0.0 110.521 -172.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.26 -49.46 13.68 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.213 0.205 . . . . 0.0 110.676 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -176.99 90.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.751 1.22 . . . . 0.0 108.463 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.644 ' HB2' HG13 ' A' ' 24' ' ' VAL . 8.8 t70 -98.62 41.08 1.15 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 123.256 0.623 . . . . 0.0 111.757 -161.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -152.99 16.46 0.56 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.63 -0.669 . . . . 0.0 111.883 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.483 ' HE1' ' HG2' ' A' ' 64' ' ' PRO . 9.5 t60 -75.74 93.14 3.08 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 120.725 0.297 . . . . 0.0 110.97 -173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 14' ' ' THR . 39.2 t -95.3 146.03 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 122.784 0.434 . . . . 0.0 110.452 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.16 149.11 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.459 1.103 . . . . 0.0 108.472 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 62.1 p -143.4 127.42 17.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.31 0.644 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 26.3 mt -104.91 127.16 52.63 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 174.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.7 115.94 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.134 0.973 . . . . 0.0 108.986 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' HA ' HD23 ' A' ' 56' ' ' LEU . 69.3 m-85 -108.02 110.43 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 m -111.18 108.24 17.84 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -94.31 110.0 21.79 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -76.79 142.46 40.34 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.545 0.528 . . . . 0.0 109.8 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.16 -165.54 11.17 Favored Glycine 0 C--O 1.248 1.015 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.462 ' HB2' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -142.43 139.45 31.63 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 5' ' ' ILE . 40.0 ttm180 -107.75 122.93 47.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.638 0.199 . . . . 0.0 110.949 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.1 114.04 6.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.613 1.165 . . . . 0.0 109.403 171.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -82.9 -20.21 35.86 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -78.68 -40.22 34.49 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.255 0.48 . . . . 0.0 110.757 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -91.66 -29.81 16.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.662 0.785 . . . . 0.0 110.229 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.6 44.72 7.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HE3' HD11 ' A' ' 49' ' ' ILE . 30.4 ttpt -116.0 142.43 46.8 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.618 1.567 . . . . 0.0 109.172 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -108.91 121.17 44.54 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.892 0.477 . . . . 0.0 110.451 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.5 HD11 ' HE3' ' A' ' 47' ' ' LYS . 3.7 mp -98.59 107.73 20.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.511 1.124 . . . . 0.0 108.275 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.06 119.32 39.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 37.2 t70 -62.69 115.78 4.61 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.369 0.668 . . . . 0.0 109.883 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.2 m -64.47 -26.28 68.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.421 1.088 . . . . 0.0 111.936 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -82.47 -13.25 57.04 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.951 0.901 . . . . 0.0 111.414 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.2 t-105 -68.75 137.49 54.09 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.527 0.731 . . . . 0.0 110.383 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.3 p -152.42 146.92 25.69 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.256 1.022 . . . . 0.0 108.738 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.9 tp -124.81 125.39 43.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.3 m -97.54 112.32 24.22 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.49 132.74 53.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 61' ' ' GLU . 4.8 m -68.43 108.79 3.4 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.86 0.725 . . . . 0.0 109.986 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -97.06 96.73 8.67 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.568 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.4 pt-20 -168.41 -159.95 0.29 Allowed 'General case' 0 C--O 1.245 0.846 0 C-N-CA 124.098 0.959 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.81 31.55 16.38 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 78' ' ' VAL . 2.2 tm? -84.55 107.94 12.99 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HG2' ' HE1' ' A' ' 29' ' ' HIS . 56.1 Cg_endo -71.29 89.94 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.149 2.566 . . . . 0.0 113.278 -170.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -85.64 125.98 67.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.967 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.7 118.59 5.47 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.443 2.096 . . . . 0.0 110.469 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -73.92 108.53 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.1 mt -107.37 117.53 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.365 0.602 . . . . 0.0 109.991 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 69' ' ' ILE . 1.3 mp -74.64 138.95 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.675 1.59 . . . . 0.0 109.344 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.74 8.91 87.19 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.698 0.624 . . . . 0.0 112.253 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.4 m-85 -140.51 167.68 21.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.478 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.421 HG21 ' HG2' ' A' ' 116' ' ' GLU . 95.4 m -148.67 116.98 6.47 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.809 0.843 . . . . 0.0 109.629 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -64.38 154.25 36.08 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.986 0.914 . . . . 0.0 110.757 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.27 -39.65 91.18 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.078 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 92.53 5.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.139 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.22 -0.3 8.42 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.065 2.51 . . . . 0.0 113.04 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.0 ttt -140.9 89.98 2.3 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 21.4 t -76.68 145.01 10.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.72 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.28 127.92 2.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.18 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 8.7 Cg_exo -72.38 29.48 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 124.12 3.213 . . . . 0.0 115.094 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 69.9 -72.47 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.192 1.397 . . . . 0.0 111.609 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.5 130.12 41.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.779 0.831 . . . . 0.0 109.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 75.1 t -118.1 114.4 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -96.33 110.73 23.01 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.408 0.683 . . . . 0.0 109.422 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.34 114.34 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -92.23 162.02 14.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.5 0.72 . . . . 0.0 109.782 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -30.95 71.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.236 1.014 . . . . 0.0 111.939 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -66.03 -29.03 69.31 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.913 0.885 . . . . 0.0 111.741 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -115.11 4.83 14.72 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.084 0.554 . . . . 0.0 111.831 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.61 -23.82 63.57 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.63 161.7 23.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.991 0.917 . . . . 0.0 109.975 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 156.6 32.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' OE1' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -119.74 47.04 1.8 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -54.16 122.35 10.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.21 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.677 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 66.0 ttt180 -133.76 172.2 13.1 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.754 0.659 . . . . 0.0 109.641 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -143.32 119.72 10.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 43.3 mt-10 -123.44 110.37 15.02 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.018 0.527 . . . . 0.0 110.95 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -85.59 122.29 29.49 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.03 134.7 30.74 Favored 'Isoleucine or valine' 0 C--O 1.251 1.159 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 170.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 mm -103.17 119.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 86.5 m-85 -84.04 106.94 16.09 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.994 0.918 . . . . 0.0 108.669 170.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.5 p -107.67 134.93 49.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.09 108.89 0.24 Allowed 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.511 1.132 . . . . 0.0 110.442 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -71.42 166.68 21.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.652 0.781 . . . . 0.0 112.324 -171.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 7.0 t -63.29 -15.6 57.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.161 0.584 . . . . 0.0 112.354 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.91 -54.88 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.841 0.857 . . . . 0.0 109.518 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 t -78.25 -21.47 49.84 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 122.37 0.268 . . . . 0.0 110.495 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.607 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 16.5 mm100 -88.91 -168.75 2.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 109.591 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -107.04 -66.11 1.04 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.226 0.611 . . . . 0.0 109.536 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -138.57 148.25 43.96 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.281 0.632 . . . . 0.0 111.019 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.597 ' HE3' ' HG3' ' A' ' 109' ' ' GLN . 14.7 ptpt -172.03 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.157 1.383 . . . . 0.0 109.971 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 66.78 -174.34 0.19 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.021 1.329 . . . . 0.0 110.95 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.58 -35.18 2.85 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.4 mt 73.41 -9.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.598 1.559 . . . . 0.0 114.403 170.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 72' ' ' THR . 36.9 mt-10 68.57 -170.66 0.18 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.419 1.087 . . . . 0.0 109.135 -170.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.84 145.3 23.14 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.793 -0.567 . . . . 0.0 111.012 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -87.87 148.76 24.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.908 0.883 . . . . 0.0 111.233 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -143.28 84.83 1.83 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.523 0.729 . . . . 0.0 110.292 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -135.56 132.41 37.17 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -76.44 95.84 3.93 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.674 0.609 . . . . 0.0 110.495 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.172 0.989 . . . . 0.0 110.281 -178.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.6 tpt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 42' ' ' ASP . 33.1 mm -126.59 152.51 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.203 1.001 . . . . 0.0 109.001 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 13.9 pt-20 -128.38 155.14 78.99 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.29 127.08 5.77 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 121.616 1.544 . . . . 0.0 111.6 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -125.72 168.15 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.144 0.578 . . . . 0.0 110.447 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 150.53 23.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.285 0.634 . . . . 0.0 109.932 174.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.448 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 98.7 mtt180 -114.25 159.64 19.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.057 0.543 . . . . 0.0 109.895 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.618 HG23 HG23 ' A' ' 34' ' ' ILE . 28.6 m -113.54 113.38 25.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -110.75 98.05 7.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.4 m -88.38 133.01 31.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 105.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 27.6 m -103.39 99.48 9.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.132 0.491 . . . . 0.0 110.228 -171.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.581 ' HG2' ' H ' ' A' ' 96' ' ' ARG . 18.6 mt-30 -94.39 131.8 39.68 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.608 0.763 . . . . 0.0 111.433 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.499 HG23 HG22 ' A' ' 30' ' ' VAL . 50.9 m -103.54 105.53 15.8 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 98' ' ' GLU . 1.8 mp -91.03 130.55 40.03 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -129.45 138.71 51.59 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.649 0.738 . . . . 0.0 110.509 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 66.4 m-85 -94.61 119.65 33.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.92 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 53.8 ttt180 -144.86 134.31 23.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.994 0.426 . . . . 0.0 111.194 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -71.08 163.02 28.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.446 1.099 . . . . 0.0 112.128 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.83 -38.64 79.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.339 . . . . 0.0 112.787 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.37 -17.72 60.14 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.233 1.013 . . . . 0.0 112.026 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.23 28.39 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.691 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 139.52 39.87 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.47 131.25 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 118.129 0.422 . . . . 0.0 110.498 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.87 -58.03 3.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.321 0.648 . . . . 0.0 109.762 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 97.0 m-70 -150.92 171.4 17.32 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.123 1.369 . . . . 0.0 109.128 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -153.75 29.44 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.413 0.625 . . . . 0.0 111.512 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.01 -3.13 17.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.903 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -88.22 75.85 8.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.655 0.741 . . . . 0.0 109.62 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 14' ' ' THR . 27.2 t -100.93 112.49 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.959 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.06 146.74 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.574 1.149 . . . . 0.0 109.307 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -136.29 141.1 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.569 0.748 . . . . 0.0 110.333 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 77.0 mt -112.61 126.79 55.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.441 171.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 8' ' ' THR . 2.0 mp -88.2 104.61 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.261 1.024 . . . . 0.0 108.936 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.604 ' HA ' HD23 ' A' ' 56' ' ' LEU . 67.1 m-85 -97.13 100.72 12.2 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -82.15 101.94 10.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.545 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -87.48 100.97 13.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -94.07 149.76 20.95 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.827 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.77 -151.31 6.17 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.076 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 142.83 27.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.452 0.701 . . . . 0.0 109.655 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.617 ' HB2' HD13 ' A' ' 5' ' ' ILE . 21.4 ttm-85 -101.15 126.92 47.9 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.247 0.546 . . . . 0.0 110.09 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 17.0 t70 -74.58 111.77 10.11 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.51 170.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 1' ' ' MET . 88.2 mt -83.75 -11.29 57.32 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -173.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.6 t -78.49 -39.75 37.38 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.766 0.712 . . . . 0.0 110.631 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -94.99 -31.64 13.53 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.36 61.13 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HE3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -79.08 139.82 38.01 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.704 0.802 . . . . 0.0 110.216 -173.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.9 124.38 35.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.262 0.625 . . . . 0.0 109.736 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' HE3' ' A' ' 47' ' ' LYS . 48.8 mm -111.11 137.4 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 93.6 m95 -126.49 139.67 53.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -173.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 27.5 t0 -65.91 109.15 2.41 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.3 t -61.78 -30.57 70.88 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.009 0.818 . . . . 0.0 111.035 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.83 -3.28 50.6 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.88 0.872 . . . . 0.0 112.04 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 14.5 t-105 -78.51 116.84 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 0.0 109.641 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.2 p -142.0 130.18 22.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 35' ' ' PHE . 36.4 tp -123.23 136.17 54.6 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.1 m -120.06 117.49 28.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.673 0.789 . . . . 0.0 108.964 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -129.93 149.61 51.58 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.6 m -106.6 122.58 46.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.438 0.695 . . . . 0.0 112.243 -170.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 66.9 m-85 -71.37 96.66 1.49 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 12.5 pt-20 -139.9 178.9 6.92 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.588 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.78 42.13 31.87 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.359 1.037 . . . . 0.0 110.516 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -105.13 97.28 12.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -174.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -91.11 -165.31 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 123.235 2.623 . . . . 0.0 112.407 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' A' ' 102' ' ' TYR . 70.6 p -154.21 146.49 17.33 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.484 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.34 120.44 7.76 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.169 1.913 . . . . 0.0 111.329 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.75 106.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.6 mt -94.85 126.48 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.91 131.2 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 123.975 0.91 . . . . 0.0 110.877 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.81 5.36 89.88 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.106 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.5 159.32 42.14 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.775 0.797 . . . . 0.0 111.601 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.3 m -147.52 129.02 14.97 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.07 156.17 30.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.519 0.327 . . . . 0.0 111.045 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 -42.15 69.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.37 86.42 58.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.369 169.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.59 -6.19 17.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.362 2.041 . . . . 0.0 111.786 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.4 tpt -143.95 114.2 7.43 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.901 1.68 . . . . 0.0 106.546 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 63' ' ' LEU . 83.0 t -68.81 123.57 22.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.5 116.21 8.21 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-O 118.696 -1.058 . . . . 0.0 113.319 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 91.3 Cg_exo -48.04 131.07 21.05 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.598 2.865 . . . . 0.0 113.956 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.85 132.89 31.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -82.72 118.63 23.5 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.217 1.007 . . . . 0.0 109.638 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.8 t -102.09 132.82 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.106 0.962 . . . . 0.0 108.831 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 m -113.46 113.35 25.03 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 0.0 110.07 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.429 HG22 ' NE2' ' A' ' 94' ' ' GLN . 94.0 t -97.7 112.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.78 157.09 16.97 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.589 1.156 . . . . 0.0 108.473 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.8 t -53.43 -33.04 52.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.654 1.181 . . . . 0.0 112.556 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -69.74 -54.92 11.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.429 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.36 19.95 3.04 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 120.909 0.385 . . . . 0.0 111.593 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -56.82 -37.18 70.86 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.34 1.056 . . . . 0.0 111.718 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.16 -15.32 53.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.71 0.404 . . . . 0.0 111.06 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.02 118.33 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.841 0.856 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.18 152.44 25.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.938 0.495 . . . . 0.0 109.854 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.429 ' NE2' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -141.71 23.36 2.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.933 0.893 . . . . 0.0 109.705 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 12' ' ' THR . 21.7 p-10 -65.09 114.07 4.37 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.972 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' H ' ' HG2' ' A' ' 13' ' ' GLN . 54.9 mtm-85 -82.4 165.29 20.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.886 0.851 . . . . 0.0 110.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.95 123.94 33.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 170.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' A' ' 15' ' ' ILE . 36.6 mt-10 -129.12 125.49 37.24 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.996 0.518 . . . . 0.0 111.158 -172.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -99.93 125.36 45.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.662 0.785 . . . . 0.0 109.01 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -95.37 137.32 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 51.4 mm -105.99 111.4 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.052 0.141 . . . . 0.0 110.7 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' A' ' 65' ' ' SER . 79.8 m-85 -85.69 104.26 15.24 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.244 0.618 . . . . 0.0 109.63 175.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -89.77 175.33 7.28 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HB3' HG21 ' A' ' 108' ' ' THR . . . -52.02 155.78 1.75 Allowed 'General case' 0 C--O 1.246 0.919 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 167.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 108' ' ' THR . 10.0 t-20 -50.75 161.28 0.36 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.514 1.125 . . . . 0.0 113.554 -168.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.3 t -45.48 -24.04 0.28 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.134 1.373 . . . . 0.0 114.002 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.1 mm -56.7 -44.67 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.779 0.832 . . . . 0.0 111.653 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.524 HG21 ' HB3' ' A' ' 104' ' ' ALA . 11.4 t -74.7 -28.23 60.72 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.756 0.313 . . . . 0.0 111.286 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.17 129.04 36.85 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.405 0.682 . . . . 0.0 110.607 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -72.4 171.25 12.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.603 1.161 . . . . 0.0 111.561 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 111' ' ' LYS . 10.4 mptt -85.74 85.93 7.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.914 0.885 . . . . 0.0 109.315 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -106.11 -33.04 7.98 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.445 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.18 72.25 5.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.329 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.49 8.04 12.19 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.458 171.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.2 mt -79.0 -70.35 0.51 Allowed 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 54.74 107.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 112.679 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -57.55 156.06 8.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.487 0.715 . . . . 0.0 110.633 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -62.83 87.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.521 0.677 . . . . 0.0 110.429 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -83.35 70.69 10.22 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.823 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -70.91 -47.9 56.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.275 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -158.47 104.96 1.84 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 22.6 p-80 . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -165.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 42' ' ' ASP . 30.5 mm -109.62 148.01 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.417 0.687 . . . . 0.0 109.275 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -123.74 137.18 28.29 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.25 126.62 12.51 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.006 1.804 . . . . 0.0 110.723 174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 41' ' ' ARG . 32.4 pt -128.85 135.61 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -142.4 132.74 24.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -113.66 135.22 54.17 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 34' ' ' ILE . 27.5 m -98.5 104.53 16.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.633 0.773 . . . . 0.0 109.03 -166.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.9 tp-100 -97.62 92.14 5.76 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 34' ' ' ILE . 19.4 m -88.02 118.34 33.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 94' ' ' GLN . 86.3 t -88.62 107.66 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.6 m -94.52 108.2 20.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.364 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' HB3' HG13 ' A' ' 31' ' ' VAL . 9.0 tt0 -104.89 106.18 16.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 30' ' ' VAL . 94.6 m -93.54 107.05 18.96 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -84.77 127.27 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.159 0.504 . . . . 0.0 110.239 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -112.37 109.5 19.16 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.216 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' ' 26' ' ' HIS . 39.7 m-85 -78.47 115.27 18.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.91 160.09 40.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.998 0.519 . . . . 0.0 110.539 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -93.87 168.43 10.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.172 0.989 . . . . 0.0 109.861 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.77 -27.4 67.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.22 -17.16 62.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.358 1.063 . . . . 0.0 111.528 -176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.78 -12.65 42.04 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.33 58.51 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.679 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.54 124.61 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.74 -60.36 2.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.228 0.611 . . . . 0.0 110.577 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.602 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 91.2 m-70 -152.61 105.63 3.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.562 1.145 . . . . 0.0 108.622 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.89 -20.31 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.142 0.577 . . . . 0.0 111.853 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.49 96.53 6.16 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.116 0.966 . . . . 0.0 110.478 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -146.18 74.58 1.37 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 14' ' ' THR . 39.6 t -92.28 125.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.363 -167.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 13' ' ' GLN . 3.5 p -105.7 115.45 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 168.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 57.5 p -123.65 117.42 24.97 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.1 mt -97.46 129.66 44.64 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 HG12 ' A' ' 10' ' ' VAL . 2.8 mp -86.84 105.04 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.511 0.724 . . . . 0.0 109.341 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -98.53 107.79 20.33 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 m -75.58 103.14 5.56 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 87' ' ' SER . 6.2 tp60 -78.69 100.96 7.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.547 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 39.8 t -99.13 143.29 29.57 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.835 -173.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.51 -164.81 16.14 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.239 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.45 150.7 36.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.434 0.694 . . . . 0.0 109.218 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.588 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.8 ttm180 -119.74 125.11 47.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.676 0.391 . . . . 0.0 110.716 -171.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 26.4 t70 -75.79 115.68 15.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.952 0.901 . . . . 0.0 108.675 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.63 -15.2 58.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 p -74.85 -43.42 54.61 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.372 0.606 . . . . 0.0 109.993 -173.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -96.48 -29.09 14.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.925 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.48 27.13 33.62 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 19.6 ptmt -93.83 137.67 32.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.922 0.889 . . . . 0.0 109.933 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.48 116.66 29.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.41 87.86 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -80.57 128.63 33.82 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 17.9 t70 -62.2 126.33 26.97 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 123.52 0.512 . . . . 0.0 110.313 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -64.44 -29.2 70.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.554 1.142 . . . . 0.0 112.039 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -98.82 -0.34 42.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.286 0.634 . . . . 0.0 111.882 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 51.4 t-105 -66.18 131.09 45.36 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.026 0.441 . . . . 0.0 111.413 -173.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.0 p -150.24 141.01 22.72 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.107 170.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.87 132.11 55.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.7 m -120.04 128.0 53.11 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.023 0.529 . . . . 0.0 110.149 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.76 144.98 35.79 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m -91.87 124.75 36.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.394 1.077 . . . . 0.0 112.195 -169.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -83.36 111.78 19.32 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 165.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.64 -162.35 0.38 Allowed 'General case' 0 C--O 1.238 0.493 0 O-C-N 125.049 1.468 . . . . 0.0 108.547 170.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.5 1.34 1.66 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.285 1.434 . . . . 0.0 112.841 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.23 114.03 50.24 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.49 -163.5 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.889 2.392 . . . . 0.0 113.451 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -158.84 124.88 2.4 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' O ' HG13 ' A' ' 68' ' ' ILE . 18.2 Cg_endo -53.61 123.18 12.73 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.879 2.386 . . . . 0.0 111.168 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.12 109.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.61 0.764 . . . . 0.0 109.737 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 66' ' ' PRO . 52.3 mt -112.78 108.31 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.26 124.74 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.945 0.898 . . . . 0.0 110.555 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.87 7.94 56.04 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.603 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -134.85 142.89 46.73 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.697 0.799 . . . . 0.0 111.023 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 105' ' ' ASN . 87.3 m -113.04 117.25 31.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 145.44 47.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 109.993 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.64 -31.31 72.48 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.031 0.933 . . . . 0.0 110.196 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.52 109.31 3.6 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 164.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.27 -5.78 17.08 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.674 2.249 . . . . 0.0 111.749 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.8 ttt -140.12 124.28 17.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG11 HG13 ' A' ' 15' ' ' ILE . 2.5 t -102.31 155.49 4.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.715 0.806 . . . . 0.0 108.992 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.43 85.98 0.84 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -104.83 24.38 0.1 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.036 2.491 . . . . 0.0 113.549 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -156.48 132.21 9.58 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -165.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 44.4 mt-10 -72.01 126.88 30.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.109 166.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.68 128.17 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.776 0.83 . . . . 0.0 110.748 174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.0 m -109.92 111.49 22.92 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.497 1.119 . . . . 0.0 108.401 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 ' HG2' ' A' ' 9' ' ' GLN . 58.5 t -95.68 108.26 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.92 170.35 11.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.023 0.929 . . . . 0.0 109.57 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 18.2 p -60.93 -30.08 70.0 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.992 0.917 . . . . 0.0 111.57 170.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -67.54 -63.62 1.02 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.032 0.933 . . . . 0.0 111.453 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -90.9 15.9 10.47 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.284 0.634 . . . . 0.0 111.544 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.45 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 36.3 t80 -55.84 -36.1 67.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.671 1.189 . . . . 0.0 112.303 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.38 -13.54 60.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.994 0.518 . . . . 0.0 111.354 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -101.15 145.05 29.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.868 0.867 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.81 145.54 31.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 172.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.488 ' HB2' HG11 ' A' ' 11' ' ' VAL . 64.2 mm-40 -104.06 0.06 29.31 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.973 -0.454 . . . . 0.0 111.994 -170.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -149.82 -172.99 4.29 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.805 0.842 . . . . 0.0 110.203 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -158.37 -160.92 0.93 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.661 0.784 . . . . 0.0 110.265 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 5.2 mp0 -85.91 106.43 17.1 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 30.7 mm-40 -95.48 111.69 23.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.4 m -104.86 117.02 33.0 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.872 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.2 m -82.56 141.34 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.2 116.43 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 122.66 0.384 . . . . 0.0 110.225 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -83.75 99.94 10.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 p -89.73 174.71 7.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.09 153.64 14.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.445 0.566 . . . . 0.0 109.967 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 5.0 t-20 -64.99 156.79 30.15 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.246 0.546 . . . . 0.0 111.333 -173.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.636 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 9.0 t -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.546 1.138 . . . . 0.0 112.537 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.8 mt -57.07 -46.14 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 124.018 0.927 . . . . 0.0 110.529 172.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.2 t -88.84 -19.4 25.97 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.636 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 24.5 mt-30 -94.52 -165.52 1.32 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.244 0.618 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -89.11 164.08 15.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.155 0.582 . . . . 0.0 111.807 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -83.3 112.6 20.04 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.597 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -140.75 -48.08 0.42 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.456 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.52 -92.68 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.24 1.416 . . . . 0.0 109.527 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 55.6 24.01 38.02 Favored Glycine 0 C--N 1.358 1.799 0 O-C-N 123.518 0.511 . . . . 0.0 113.796 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.1 mt -86.66 -26.13 24.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.2 1.0 . . . . 0.0 109.569 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 56.08 89.57 0.04 OUTLIER 'General case' 0 C--N 1.352 0.683 0 C-N-CA 125.705 1.602 . . . . 0.0 110.984 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -63.09 134.49 56.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.037 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -164.68 133.14 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.84 1.256 . . . . 0.0 107.931 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -166.78 115.24 0.86 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -125.39 116.65 22.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.897 0.879 . . . . 0.0 109.077 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -78.2 82.76 4.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.923 0.868 . . . . 0.0 109.235 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 CA--C 1.548 0.892 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.759 178.349 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 mm -120.04 158.03 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.773 1.229 . . . . 0.0 109.594 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 9.0 pt-20 -128.75 151.65 77.53 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.93 124.42 7.39 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 121.652 1.568 . . . . 0.0 110.764 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -114.72 163.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.335 1.054 . . . . 0.0 108.546 171.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.84 142.33 13.52 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 53.6 mtp180 -107.7 156.26 19.28 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.993 1.317 . . . . 0.0 108.442 168.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 34' ' ' ILE . 37.7 m -129.37 108.55 10.38 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.095 0.558 . . . . 0.0 110.088 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -98.39 120.98 39.75 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 35.1 m -108.11 134.83 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.893 0.378 . . . . 0.0 110.925 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.7 t -100.62 104.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 95' ' ' ASN . 31.4 m -106.05 120.61 42.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.052 0.541 . . . . 0.0 109.927 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.45 127.18 53.1 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.529 HG23 HG22 ' A' ' 30' ' ' VAL . 59.1 m -94.24 103.68 15.7 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.34 125.32 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.395 0.616 . . . . 0.0 110.389 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.408 ' HB2' HG23 ' A' ' 99' ' ' THR . 24.0 m-70 -113.28 109.03 18.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HA ' HG22 ' A' ' 100' ' ' VAL . 65.9 m-85 -81.0 115.01 20.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 16.0 mmt85 -131.3 159.68 37.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.995 0.918 . . . . 0.0 109.419 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -88.58 174.49 8.04 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.109 0.563 . . . . 0.0 109.56 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.39 -26.52 66.49 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.947 0.499 . . . . 0.0 110.545 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.14 -19.51 64.02 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.849 1.26 . . . . 0.0 111.12 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.47 66.0 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.302 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.42 152.58 42.98 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.411 0.685 . . . . 0.0 111.053 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 27' ' ' ASP . 57.4 t -73.21 114.94 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.47 -45.78 13.24 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -173.99 126.51 0.36 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.455 1.102 . . . . 0.0 108.192 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 24' ' ' VAL . 9.9 t70 -131.82 88.03 2.52 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.257 -0.902 . . . . 0.0 111.085 -166.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 p30 179.0 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 64' ' ' PRO . 18.8 m170 -83.37 85.32 7.25 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.911 1.232 . . . . 0.0 111.38 -169.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 14' ' ' THR . 40.5 t -94.97 119.8 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.941 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 63' ' ' LEU . 11.7 p -112.69 150.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.892 0.877 . . . . 0.0 109.073 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 m -141.64 136.65 31.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.623 0.769 . . . . 0.0 109.731 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 35.7 mt -103.88 124.17 48.46 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -88.57 110.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.645 ' HA ' HD23 ' A' ' 56' ' ' LEU . 98.5 m-85 -105.61 101.24 10.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.989 0.916 . . . . 0.0 109.291 173.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.2 m -97.28 103.25 15.16 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.641 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -85.32 100.79 12.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -80.09 135.65 36.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.09 -163.48 11.91 Favored Glycine 0 C--O 1.245 0.84 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.494 ' HE2' ' HB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.87 137.78 41.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 5' ' ' ILE . 33.5 ttm180 -111.95 124.84 53.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.86 115.07 8.66 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.244 1.018 . . . . 0.0 108.266 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.8 -24.84 55.97 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 t -80.51 -43.42 20.79 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.775 0.262 . . . . 0.0 111.238 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.43 -28.52 20.84 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.582 0.353 . . . . 0.0 110.597 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.02 23.55 48.57 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.88 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.7 ptmt -94.17 142.68 27.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.375 0.67 . . . . 0.0 110.544 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -105.5 111.73 24.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.946 0.898 . . . . 0.0 110.553 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' HB ' ' HE2' ' A' ' 40' ' ' LYS . 3.5 mp -108.03 103.4 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 73.1 m95 -87.96 152.06 22.34 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 110.103 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.31 105.72 7.52 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.3 p -72.57 -19.74 61.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.894 0.877 . . . . 0.0 110.854 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -85.54 -0.86 56.23 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.481 0.712 . . . . 0.0 110.94 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.55 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 89.4 t90 -65.88 132.17 48.02 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 110.368 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 28.5 p -154.56 105.43 2.63 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 171.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 35' ' ' PHE . 55.6 tp -97.18 126.71 42.54 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.6 m -97.3 110.37 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.05 134.38 55.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.1 m -69.1 118.83 12.49 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.14 0.976 . . . . 0.0 111.445 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -112.5 92.77 4.14 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.854 0.462 . . . . 0.0 109.985 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.16 -159.83 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.264 1.426 . . . . 0.0 108.164 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.425 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . 70.39 15.74 7.26 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.377 1.071 . . . . 0.0 112.555 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.47 HD21 HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -65.86 116.27 30.76 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.159 0.584 . . . . 0.0 110.346 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 29' ' ' HIS . 57.6 Cg_endo -71.33 86.71 0.79 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.049 2.499 . . . . 0.0 111.792 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -89.35 130.78 42.6 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.573 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.85 120.62 8.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.87 1.713 . . . . 0.0 110.737 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.49 102.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.0 111.72 33.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.33 129.22 30.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 123.652 0.595 . . . . 0.0 110.413 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.81 ' HA3' ' HB ' ' A' ' 108' ' ' THR . . . 84.18 -3.32 86.29 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.013 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 22.0 m-85 -118.13 149.03 41.72 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.186 0.994 . . . . 0.0 108.422 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.1 m -140.66 121.91 14.86 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' ILE . . . -67.2 152.22 46.14 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.363 0.665 . . . . 0.0 110.402 175.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.63 -30.96 70.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.287 0.565 . . . . 0.0 110.146 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.27 6.3 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.667 1.187 . . . . 0.0 108.178 173.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.12 -4.2 13.68 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.524 2.149 . . . . 0.0 111.403 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 62' ' ' ALA . 38.0 tpp -146.75 129.86 16.47 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.4 0.68 . . . . 0.0 109.216 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.423 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 94.9 t -96.83 124.35 49.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 O-C-N 124.309 1.006 . . . . 0.0 110.576 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.89 152.34 18.82 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.958 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -85.93 36.69 0.52 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.872 3.048 . . . . 0.0 113.475 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 75.88 -55.16 0.61 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.837 1.655 . . . . 0.0 111.751 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -126.14 150.36 48.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.99 0.916 . . . . 0.0 109.925 170.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.44 118.82 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.658 1.183 . . . . 0.0 108.555 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.0 m -101.15 103.58 14.64 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -95.39 118.9 42.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -88.25 171.83 9.9 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.357 1.063 . . . . 0.0 108.921 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.5 t -69.78 -22.36 63.34 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 123.951 0.782 . . . . 0.0 110.533 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -68.15 -53.4 25.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.709 0.804 . . . . 0.0 110.119 176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -96.5 24.24 6.08 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.728 0.811 . . . . 0.0 111.244 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -72.26 -31.13 65.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.011 0.525 . . . . 0.0 111.249 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.34 -11.43 59.31 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.521 0.329 . . . . 0.0 110.167 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -94.64 136.19 35.23 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -104.16 146.85 28.16 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.67 21.45 16.15 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 6.7 t30 -64.03 118.57 8.68 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.205 1.002 . . . . 0.0 110.255 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -135.8 176.03 9.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.613 0.765 . . . . 0.0 109.345 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.17 117.72 34.94 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -96.32 132.09 42.16 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.043 0.537 . . . . 0.0 109.99 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.408 HG23 ' HB2' ' A' ' 16' ' ' HIS . 75.3 m -138.46 107.05 5.86 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.9 m -84.61 141.13 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 39.4 mm -116.83 113.15 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 95.0 m-85 -81.44 108.95 15.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 109.383 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.5 p -96.09 130.97 42.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.03 96.19 1.71 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.592 0.757 . . . . 0.0 109.767 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -68.59 167.97 13.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.286 1.034 . . . . 0.0 109.997 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.0 t -69.9 -9.65 55.68 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.215 0.606 . . . . 0.0 111.359 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HB ' ' HA2' ' A' ' 70' ' ' GLY . 56.2 mt -50.81 -58.52 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.335 1.454 . . . . 0.0 110.282 169.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.81 ' HB ' ' HA3' ' A' ' 70' ' ' GLY . 15.3 t -72.08 -23.38 61.34 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.373 0.42 . . . . 0.0 111.747 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.37 -35.76 66.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.535 0.683 . . . . 0.0 110.296 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.418 ' HB3' ' HD3' ' A' ' 111' ' ' LYS . 34.2 m-80 -115.87 -166.08 1.1 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.595 1.158 . . . . 0.0 109.93 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -53.77 131.53 39.68 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.705 0.802 . . . . 0.0 109.971 170.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 19.2 pttp -127.85 -58.19 1.24 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 65.05 -76.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.392 1.077 . . . . 0.0 110.39 -165.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.23 33.74 74.05 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.51 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -96.01 -76.75 0.49 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 43.08 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.302 1.841 . . . . 0.0 112.722 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -139.44 122.76 17.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.402 1.081 . . . . 0.0 108.365 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -135.17 104.65 5.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.685 0.794 . . . . 0.0 109.001 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -121.15 117.88 28.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.812 0.845 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -79.94 -16.84 54.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.484 0.714 . . . . 0.0 111.153 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -99.43 126.12 45.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.416 0.686 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 . . . . . 0 C--O 1.25 1.127 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.5 tpt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.867 0.365 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.92 157.11 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.076 1.35 . . . . 0.0 107.886 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 12.4 pt-20 -134.65 146.86 60.77 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.23 124.19 6.47 Favored 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 121.417 1.412 . . . . 0.0 111.517 171.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 41' ' ' ARG . 27.6 pt -119.28 170.77 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 0.0 110.391 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.64 142.11 4.43 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.377 0.671 . . . . 0.0 110.543 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.478 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 81.3 mtp180 -104.63 169.51 8.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.743 0.817 . . . . 0.0 109.774 170.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.609 HG23 HG23 ' A' ' 34' ' ' ILE . 35.5 m -120.33 108.46 14.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.692 0.797 . . . . 0.0 108.958 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . 6.2 tp60 -105.81 99.65 9.24 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 31.0 m -89.42 127.91 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.41 116.19 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -104.25 105.06 15.07 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 124.195 0.934 . . . . 0.0 111.464 -163.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 96' ' ' ARG . 9.5 mm100 -91.74 99.19 12.12 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.6 0.76 . . . . 0.0 109.578 176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 p -79.31 103.92 9.57 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.86 132.88 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 41.0 m-70 -120.35 119.67 33.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.174 0.989 . . . . 0.0 108.522 -174.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -91.32 116.75 29.09 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.3 mtm105 -142.11 155.22 45.34 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 123.417 0.687 . . . . 0.0 109.414 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -81.27 170.88 15.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.223 1.009 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.19 -27.87 69.0 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.035 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.78 -18.99 65.57 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 111.784 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.98 -11.52 69.44 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 148.13 48.87 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.849 0.859 . . . . 0.0 110.617 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 55.4 t -91.4 129.8 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.668 0.387 . . . . 0.0 110.471 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.4 -60.45 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -163.77 90.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.346 1.459 . . . . 0.0 108.97 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.5 p-10 -91.48 28.14 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -131.02 21.97 4.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 0.0 111.93 -170.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.16 81.68 5.55 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.014 -1.054 . . . . 0.0 110.404 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.52 127.59 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.222 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HB ' HD23 ' A' ' 63' ' ' LEU . 14.8 p -120.44 150.0 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.467 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 55.4 m -138.73 141.15 38.89 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.743 0.817 . . . . 0.0 108.971 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 58' ' ' GLN . 77.4 mt -110.94 132.44 54.2 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.609 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -81.96 115.52 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.885 0.874 . . . . 0.0 108.768 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -105.42 100.47 10.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.1 m -75.58 105.77 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -81.83 95.37 7.28 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.695 0.798 . . . . 0.0 109.185 176.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.8 t -87.68 152.56 22.06 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.33 0.586 . . . . 0.0 111.999 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -166.44 -157.5 10.33 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.596 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.12 140.76 30.99 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.445 0.698 . . . . 0.0 110.229 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.7 ttm-85 -102.96 123.61 46.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -74.93 113.65 12.48 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.535 HD12 ' HG3' ' A' ' 1' ' ' MET . 57.5 mt -82.94 -15.52 50.98 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -170.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.1 t -87.28 -38.76 16.0 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.772 0.26 . . . . 0.0 110.385 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -86.88 -32.22 20.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.076 0.55 . . . . 0.0 110.245 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.38 38.23 11.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.489 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG3' HD11 ' A' ' 49' ' ' ILE . 20.3 ptmt -112.8 140.77 47.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.879 0.872 . . . . 0.0 109.993 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -98.65 107.77 20.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.975 0.91 . . . . 0.0 109.752 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.407 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.7 mp -95.92 117.59 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.478 ' CH2' ' HG3' ' A' ' 7' ' ' ARG . 77.0 m95 -103.62 124.74 49.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.26 110.01 1.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m -65.0 -20.86 66.71 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.928 0.891 . . . . 0.0 112.797 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -81.94 -21.76 37.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.271 0.629 . . . . 0.0 110.439 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -59.01 139.02 57.26 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.929 0.768 . . . . 0.0 111.634 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 70.1 p -149.89 132.98 16.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.913 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD11 HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -124.22 125.45 44.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -113.09 133.86 54.81 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HB3' HD13 ' A' ' 33' ' ' LEU . 76.5 mm-40 -134.41 145.06 48.56 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.0 m -92.44 116.65 29.17 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.534 0.734 . . . . 0.0 110.595 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.2 95.51 1.27 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.424 0.63 . . . . 0.0 110.343 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.7 -164.04 1.93 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.801 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.13 28.37 17.08 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.738 0.815 . . . . 0.0 111.73 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.568 HD23 ' HB ' ' A' ' 31' ' ' VAL . 1.3 tm? -119.29 94.92 48.91 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -86.22 152.37 9.43 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.325 2.683 . . . . 0.0 111.883 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' OH ' ' A' ' 102' ' ' TYR . 45.9 m -105.1 149.05 37.19 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.961 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.45 127.7 25.65 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.064 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.76 107.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mt -107.55 133.75 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.67 132.07 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.694 0.797 . . . . 0.0 108.941 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.19 -6.31 81.94 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.815 -0.436 . . . . 0.0 112.934 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -133.82 165.44 24.96 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.382 0.673 . . . . 0.0 110.476 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -151.09 130.05 12.53 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 154.51 33.9 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.993 0.517 . . . . 0.0 110.939 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -64.68 -38.23 90.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.515 0.674 . . . . 0.0 109.183 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 88.85 28.93 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 114.501 -1.227 . . . . 0.0 107.997 171.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.94 -5.13 16.41 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.841 2.361 . . . . 0.0 112.798 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.3 tpt -147.56 114.91 6.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.33 118.82 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.09 135.51 51.75 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.375 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.69 97.32 0.32 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.287 1.991 . . . . 0.0 111.964 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -114.14 113.17 24.34 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.305 0.642 . . . . 0.0 110.853 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.38 118.14 17.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.336 0.654 . . . . 0.0 111.179 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.87 135.78 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.37 1.068 . . . . 0.0 108.58 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -105.14 110.25 22.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.27 0.628 . . . . 0.0 109.751 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.595 HG22 HE21 ' A' ' 94' ' ' GLN . 94.0 t -95.66 108.49 21.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.446 ' H ' ' ND2' ' A' ' 89' ' ' ASN . 1.1 p30 -110.86 176.54 4.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.738 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.66 -24.04 65.28 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.24 -51.16 10.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.198 0.599 . . . . 0.0 110.175 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.446 ' ND2' ' H ' ' A' ' 86' ' ' ASP . 6.4 p30 -92.23 6.68 45.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 9' ' ' GLN . 52.7 t80 -54.75 -34.6 62.74 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.625 1.17 . . . . 0.0 112.251 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.1 -23.64 47.83 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.97 116.05 28.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.297 0.639 . . . . 0.0 109.987 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -79.83 106.15 11.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 122.092 0.949 . . . . 0.0 109.029 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.595 HE21 HG22 ' A' ' 85' ' ' VAL . 15.6 pt20 -91.77 38.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.418 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -70.3 154.44 41.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.44 1.096 . . . . 0.0 111.146 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HB2' ' NE2' ' A' ' 13' ' ' GLN . 44.7 mmm-85 -129.5 141.4 51.01 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.244 0.545 . . . . 0.0 111.756 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -102.78 110.41 22.33 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 163.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -115.7 136.16 53.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.382 0.673 . . . . 0.0 110.286 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.4 m -113.47 119.14 36.56 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 167.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.03 140.71 15.37 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.0 mm -103.69 120.12 53.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.931 0 C-N-CA 122.927 0.491 . . . . 0.0 110.683 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.401 ' OH ' ' HB3' ' A' ' 65' ' ' SER . 54.3 m-85 -85.54 104.83 15.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.603 0.761 . . . . 0.0 109.868 172.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.9 t -98.31 155.45 17.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 128.94 19.07 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.69 0.619 . . . . 0.0 109.39 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.75 158.67 26.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.282 0.233 . . . . 0.0 111.052 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.6 t -58.71 -19.26 38.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.452 0.701 . . . . 0.0 112.377 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.08 -48.9 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.423 1.089 . . . . 0.0 110.675 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.5 t -89.72 -19.33 24.92 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.95 87.37 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -82.04 174.91 10.8 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.211 0.529 . . . . 0.0 110.361 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -79.69 94.91 5.8 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.16 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -154.62 -43.92 0.09 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.339 -173.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -137.91 177.22 8.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.299 0.64 . . . . 0.0 110.547 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.11 60.82 0.26 Allowed Glycine 0 CA--C 1.502 -0.741 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.41 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.03 -41.74 75.43 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.63 0.772 . . . . 0.0 109.84 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -166.56 137.48 3.38 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.2 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -74.17 141.44 45.51 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.552 0.741 . . . . 0.0 110.126 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -84.92 27.82 0.73 Allowed 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.549 1.14 . . . . 0.0 111.715 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -168.78 22.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.132 0.973 . . . . 0.0 110.255 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 m80 65.95 -171.22 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.608 1.163 . . . . 0.0 110.011 -165.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -47.17 136.21 9.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.317 1.047 . . . . 0.0 112.673 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 CA--C 1.552 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 109.875 178.078 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 42' ' ' ASP . 41.0 mm -117.35 136.17 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.97 146.16 35.55 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -77.16 124.08 7.05 Favored 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 121.507 1.471 . . . . 0.0 109.919 167.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.528 HD13 ' HB2' ' A' ' 41' ' ' ARG . 14.5 pt -112.52 -176.03 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.8 0.84 . . . . 0.0 109.849 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -151.63 146.41 25.79 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.665 0.786 . . . . 0.0 109.008 173.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 36' ' ' THR . 24.8 tpt180 -103.69 138.08 40.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -121.32 105.71 10.79 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.04 107.35 14.84 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 109.708 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 14.5 m -90.45 119.02 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 93' ' ' LYS . 92.2 t -91.13 118.59 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.524 ' H ' ' HD3' ' A' ' 93' ' ' LYS . 70.7 m -106.96 103.3 12.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.329 0.651 . . . . 0.0 110.434 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 94.03 5.85 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.444 HG23 HG22 ' A' ' 12' ' ' THR . 82.2 p -86.47 114.47 23.25 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 52.7 mt -110.68 126.19 68.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 CA-C-O 121.936 0.874 . . . . 0.0 111.234 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.32 110.25 22.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 113.324 -1.762 . . . . 0.0 106.865 -173.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HD1' HG22 ' A' ' 100' ' ' VAL . 23.0 m-85 -82.08 109.78 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 39.6 mtm180 -141.22 164.22 30.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.35 0.66 . . . . 0.0 109.791 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -92.2 175.95 6.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.401 0.68 . . . . 0.0 110.314 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.62 -25.66 68.06 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.387 171.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.14 -17.08 63.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.603 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.05 -13.5 66.81 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.04 57.97 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.372 1.069 . . . . 0.0 111.046 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 38.7 t -83.28 114.98 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 122.948 0.499 . . . . 0.0 109.974 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.29 -56.54 4.94 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -170.81 94.5 0.2 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 0.0 110.147 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.84 106.62 18.58 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.768 -0.582 . . . . 0.0 110.169 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -179.71 -6.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.507 0.723 . . . . 0.0 112.292 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -82.85 86.19 6.97 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.266 0.555 . . . . 0.0 111.487 -163.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.02 125.39 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 0.0 110.71 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -120.25 145.51 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -138.65 131.49 29.41 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.642 0.777 . . . . 0.0 109.703 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 87.7 mt -110.69 136.1 50.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 0.0 109.767 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.42 114.71 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -100.94 96.33 7.19 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 85.1 m -113.59 104.27 12.08 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.626 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -130.92 139.61 50.1 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 61.2 p -90.81 141.55 28.69 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -167.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.96 -142.37 5.46 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.62 139.44 18.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.632 0.716 . . . . 0.0 111.205 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB2' HD13 ' A' ' 5' ' ' ILE . 17.2 ttm180 -103.88 127.12 51.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.102 0.561 . . . . 0.0 110.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 32.4 t70 -73.62 111.25 8.58 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.065 0.946 . . . . 0.0 108.914 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.02 -11.37 56.86 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.5 t -83.24 -31.93 26.73 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.359 0.527 . . . . 0.0 110.401 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -101.39 -30.84 11.23 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.049 0.54 . . . . 0.0 110.207 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.05 49.16 4.35 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 42' ' ' ASP . 20.0 ptmt -130.29 143.77 50.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.502 1.121 . . . . 0.0 109.521 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -95.27 127.67 41.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.075 0.55 . . . . 0.0 110.49 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.88 126.13 61.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.453 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 81.7 m95 -125.07 143.42 50.93 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.304 1.042 . . . . 0.0 108.268 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 23.2 t70 -62.93 143.13 57.98 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.95 0.5 . . . . 0.0 110.384 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 76.8 p -68.6 -38.21 80.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.232 0.213 . . . . 0.0 111.496 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.18 -0.94 57.49 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.841 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 37' ' ' GLN . 19.5 t90 -48.3 120.64 3.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.991 0.916 . . . . 0.0 111.394 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 p -154.91 130.01 9.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 37' ' ' GLN . 23.6 tp -115.08 139.56 49.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 m -110.87 150.37 29.27 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.487 0.715 . . . . 0.0 109.803 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.402 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 5.5 tp-100 -153.87 127.91 8.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 173.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 m -78.27 110.27 13.14 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.31 0.644 . . . . 0.0 111.286 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.434 ' HD2' HG21 ' A' ' 83' ' ' VAL . 15.0 m-85 -75.53 130.23 38.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.25 174.42 8.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.821 0.848 . . . . 0.0 109.961 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 69.91 56.81 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.586 1.154 . . . . 0.0 111.802 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 3.5 mm? -113.7 91.83 22.51 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.467 0.707 . . . . 0.0 109.976 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.47 99.9 0.77 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 123.655 2.904 . . . . 0.0 113.097 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 m -78.73 124.25 85.16 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.942 -0.552 . . . . 0.0 109.772 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.3 122.93 11.58 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 123.521 2.814 . . . . 0.0 112.895 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.0 108.8 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.0 mt -101.89 117.12 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 45.9 mm -72.88 135.75 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.202 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.49 84.01 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.709 -171.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -130.22 172.17 12.09 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.279 1.032 . . . . 0.0 110.322 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -144.52 123.53 12.8 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.88 131.41 45.46 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.95 -38.58 76.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.854 0.862 . . . . 0.0 109.245 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -132.6 84.9 49.34 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.604 169.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.0 -4.39 11.38 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.107 2.538 . . . . 0.0 113.227 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 63' ' ' LEU . 17.1 tpt -143.97 136.62 27.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.281 1.032 . . . . 0.0 108.699 172.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -125.54 126.22 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.9 71.67 0.91 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 123.914 0.759 . . . . 0.0 112.551 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -96.67 22.52 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.328 2.685 . . . . 0.0 114.355 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -165.81 -169.19 1.46 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 118.366 0.53 . . . . 0.0 112.216 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 9.2 mp0 -68.04 133.18 48.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.134 1.374 . . . . 0.0 111.601 -171.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.434 HG21 ' HD2' ' A' ' 60' ' ' PHE . 60.0 t -122.21 110.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.06 0.944 . . . . 0.0 109.178 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.6 m -96.82 117.19 30.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.955 0.502 . . . . 0.0 109.774 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 90' ' ' PHE . 37.8 t -97.98 116.32 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.55 162.55 14.15 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.796 0.838 . . . . 0.0 110.899 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 54' ' ' TRP . 39.9 p -57.78 -35.23 70.51 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.52 1.128 . . . . 0.0 110.802 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -49.59 -49.73 45.51 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 125.007 1.442 . . . . 0.0 111.202 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -118.35 16.12 13.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.818 -172.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' HA ' HG12 ' A' ' 85' ' ' VAL . 9.6 t80 -66.08 -27.07 67.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.543 0.61 . . . . 0.0 112.459 -166.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.5 -16.87 57.03 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -102.65 156.11 17.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.045 1.338 . . . . 0.0 110.201 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 12' ' ' THR . 9.2 ptpp? -111.71 126.68 55.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -77.91 -12.62 60.0 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -116.15 127.66 55.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.75 -93.05 0.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.904 0.882 . . . . 0.0 109.523 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -108.32 104.94 14.43 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 3.3 mp0 -110.68 135.63 51.0 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -121.5 122.09 38.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.423 0.689 . . . . 0.0 110.09 -176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' A' ' 17' ' ' TYR . 1.6 m -83.23 141.86 14.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.4 110.73 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.089 0.556 . . . . 0.0 110.848 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -85.94 96.23 9.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 p -99.6 140.05 34.36 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.33 142.09 10.73 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.557 0.536 . . . . 0.0 110.801 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.81 -173.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.089 1.356 . . . . 0.0 113.016 -162.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.54 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 10.0 t -51.96 -11.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.95 1.3 . . . . 0.0 113.751 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.1 mt -48.1 -47.3 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.108 1.363 . . . . 0.0 111.336 167.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.8 t -108.3 -25.24 11.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 112.429 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.54 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 19.0 mt-30 -76.82 165.77 24.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.979 0.511 . . . . 0.0 110.23 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -67.1 122.3 17.49 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -66.81 135.28 53.69 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 124.176 0.923 . . . . 0.0 111.241 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -163.19 -53.97 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.468 1.107 . . . . 0.0 109.15 -172.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -165.94 138.21 3.98 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.94 0.896 . . . . 0.0 109.532 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.78 5.88 3.44 Favored Glycine 0 C--N 1.318 -0.425 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.18 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.4 mt -73.02 -21.61 60.79 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.111 0.964 . . . . 0.0 110.775 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.79 105.52 0.46 Allowed 'General case' 0 C--N 1.354 0.775 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -142.08 17.97 2.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.36 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -75.37 75.57 2.46 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.36 0.6 . . . . 0.0 110.094 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -92.41 162.75 14.12 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -74.1 -69.06 0.47 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -144.74 -52.13 0.29 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 167.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 CA--C 1.556 1.191 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.826 166.477 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' HD12 ' A' ' 43' ' ' LEU . 28.0 ttt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 42' ' ' ASP . 49.6 mm -123.91 141.19 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.317 0.647 . . . . 0.0 109.828 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -112.63 128.65 25.28 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 166.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.15 126.63 18.28 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.45 2.1 . . . . 0.0 110.851 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 41' ' ' ARG . 34.0 pt -124.03 -179.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.409 0.684 . . . . 0.0 109.75 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 157.71 24.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.735 1.214 . . . . 0.0 108.291 170.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.509 ' HD3' ' HD2' ' A' ' 90' ' ' PHE . 57.3 ttt-85 -126.77 152.7 46.54 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 34' ' ' ILE . 86.6 m -121.07 108.77 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.454 1.101 . . . . 0.0 108.886 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -100.8 121.78 42.28 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 34.6 m -105.29 118.09 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 83' ' ' VAL . 97.9 t -97.55 110.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -118.12 131.55 56.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.574 0.749 . . . . 0.0 110.57 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 42.3 mt-30 -103.33 100.27 10.15 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -76.83 100.5 5.52 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.569 HD12 ' HB ' ' A' ' 78' ' ' VAL . 13.0 tt -101.55 135.52 37.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 122.261 1.029 . . . . 0.0 111.009 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -118.98 148.42 43.0 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.842 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -127.17 115.76 19.59 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 37.5 mtm180 -138.13 152.42 48.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HE2' HG21 ' A' ' 68' ' ' ILE . 63.5 m-85 -77.97 169.76 17.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.495 0.718 . . . . 0.0 110.627 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.31 -22.72 63.76 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.843 0.457 . . . . 0.0 111.483 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.96 -12.37 60.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.635 0.774 . . . . 0.0 111.312 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 2.45 68.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.77 147.71 48.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.976 0.51 . . . . 0.0 110.264 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 96.7 t -82.23 135.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.126 0.571 . . . . 0.0 109.94 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 -63.11 1.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -157.2 97.42 1.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.584 1.154 . . . . 0.0 108.788 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -80.38 -9.23 59.75 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.065 0.546 . . . . 0.0 112.422 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.1 71.03 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.28 1.032 . . . . 0.0 110.877 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -124.7 122.32 37.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 159.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.35 111.75 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.5 p -106.81 125.52 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.759 0.824 . . . . 0.0 108.87 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.3 p -123.92 133.9 53.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.328 0.651 . . . . 0.0 109.418 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 76.7 mt -99.4 123.09 43.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 8' ' ' THR . 3.4 mp -93.22 116.5 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 8' ' ' THR . 13.7 m-85 -106.43 97.69 7.46 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.4 m -114.57 116.46 28.82 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.01 154.8 44.36 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 m -76.91 178.12 7.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.926 -165.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -172.34 -166.73 31.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.186 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 137.74 35.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.7 ttm180 -110.17 124.87 52.35 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.044 0.537 . . . . 0.0 109.887 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . 26.5 t70 -74.55 113.83 12.25 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.832 1.253 . . . . 0.0 109.882 173.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 1' ' ' MET . 88.9 mt -85.08 -1.86 57.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.6 t -87.67 -28.61 21.71 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.863 0.756 . . . . 0.0 110.842 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -107.59 -30.84 8.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.569 0.348 . . . . 0.0 110.225 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.71 11.98 56.19 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.86 -173.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -84.89 145.95 27.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.041 0.937 . . . . 0.0 110.279 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.29 121.4 42.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.249 0.62 . . . . 0.0 110.273 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.98 116.02 43.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -108.97 158.86 17.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.59 1.156 . . . . 0.0 109.079 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 54' ' ' TRP . 17.7 t70 -82.9 125.34 31.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -73.0 -25.88 61.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.745 0.418 . . . . 0.0 111.978 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -81.23 -13.17 58.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.14 0.576 . . . . 0.0 110.789 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' ASP . 8.8 t90 -69.28 134.58 49.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.138 0.975 . . . . 0.0 111.583 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 51.5 p -152.11 121.41 6.77 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.458 1.503 . . . . 0.0 107.441 172.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.09 124.86 44.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -109.95 129.84 55.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -129.4 145.48 51.4 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 m -112.01 120.32 41.46 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.841 0.456 . . . . 0.0 111.446 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 13' ' ' GLN . 51.0 m-85 -65.24 136.49 56.68 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 164.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -170.59 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.68 0.792 . . . . 0.0 109.754 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.55 86.09 5.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.783 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 15' ' ' ILE . 3.3 tm? -144.13 112.79 5.24 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -93.17 178.71 1.19 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.552 2.834 . . . . 0.0 111.743 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -159.17 151.38 17.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.211 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.75 117.83 5.36 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 121.963 1.775 . . . . 0.0 110.62 172.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.9 107.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 19' ' ' TYR . 40.9 mt -102.31 116.33 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.82 139.97 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.7 3.58 89.44 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.401 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.83 171.44 14.51 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.188 0.995 . . . . 0.0 110.073 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -158.5 109.22 2.11 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.17 151.12 46.73 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.559 0.743 . . . . 0.0 111.265 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -73.33 -20.04 60.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.179 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.33 101.57 2.96 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 158.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.26 0.28 5.49 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.151 1.9 . . . . 0.0 113.157 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.6 ttt -150.55 136.67 18.53 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.722 0.809 . . . . 0.0 109.584 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.599 HG11 ' HG3' ' A' ' 98' ' ' GLU . 91.8 t -121.52 107.57 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 163.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.82 -95.74 0.11 Allowed Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.058 -1.412 . . . . 0.0 111.369 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -33.8 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.721 1 C-N-CA 125.463 4.109 . . . . 0.0 115.991 -169.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -168.16 126.73 1.19 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.491 1.116 . . . . 0.0 109.22 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.67 121.5 26.93 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 11' ' ' VAL . 84.2 t -103.23 123.12 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.728 0.811 . . . . 0.0 109.41 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.4 m -103.03 131.17 50.21 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.417 HG22 ' NE2' ' A' ' 94' ' ' GLN . 43.0 t -121.13 112.38 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 4.1 m-20 -79.99 164.69 23.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.836 0.854 . . . . 0.0 109.251 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.6 p -54.56 -36.52 64.43 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.986 0.804 . . . . 0.0 110.384 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -47.87 -49.34 29.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.351 1.46 . . . . 0.0 112.406 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -119.43 23.69 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.675 0.79 . . . . 0.0 111.604 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.509 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 12.4 t80 -75.13 -19.76 59.74 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 122.006 -0.434 . . . . 0.0 111.161 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.31 -16.46 27.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.688 0.795 . . . . 0.0 109.196 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -89.08 160.97 16.79 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.204 1.001 . . . . 0.0 109.687 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -111.85 159.55 18.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.58 0.752 . . . . 0.0 109.443 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.417 ' NE2' HG22 ' A' ' 85' ' ' VAL . 12.0 pt20 -143.39 33.39 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.174 0.59 . . . . 0.0 110.064 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.63 166.35 15.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 111.786 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -137.17 166.11 24.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.837 0.855 . . . . 0.0 111.445 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -129.92 108.29 10.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' HG3' HG11 ' A' ' 78' ' ' VAL . 25.0 mm-40 -94.29 145.55 24.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.847 0.459 . . . . 0.0 110.104 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.5 m -139.99 98.11 3.39 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -85.44 142.46 13.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.32 116.74 52.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.017 0.927 . . . . 0.0 110.584 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.87 98.73 9.33 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -83.88 159.96 21.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.515 ' HB3' HG21 ' A' ' 108' ' ' THR . . . -50.09 144.42 6.97 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.583 0.628 . . . . 0.0 109.805 173.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -46.86 153.53 0.4 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.655 1.182 . . . . 0.0 112.002 -164.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.626 HG21 ' HE2' ' A' ' 112' ' ' LYS . 3.4 t -42.49 -21.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.702 1.601 . . . . 0.0 114.56 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.6 mm -48.75 -52.63 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 125.011 1.325 . . . . 0.0 111.89 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 104' ' ' ALA . 15.2 t -75.39 -24.22 57.18 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.717 0.407 . . . . 0.0 111.535 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -81.65 164.3 21.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.239 0.616 . . . . 0.0 109.597 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.446 ' N ' HD22 ' A' ' 110' ' ' ASN . 0.9 OUTLIER -83.26 85.46 7.21 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? 60.16 -165.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.653 1.181 . . . . 0.0 110.492 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.626 ' HE2' HG21 ' A' ' 106' ' ' THR . 85.2 mttt -100.76 -60.81 1.46 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.2 t70 68.72 155.92 0.13 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.981 1.712 . . . . 0.0 111.201 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.99 95.18 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.5 mt 68.75 -65.25 0.29 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.661 1.984 . . . . 0.0 110.973 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.72 119.38 20.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.968 0.907 . . . . 0.0 110.06 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -134.89 108.93 8.18 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 64.05 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.379 1.072 . . . . 0.0 108.905 -169.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -65.67 -36.95 85.14 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.592 0.757 . . . . 0.0 112.384 -170.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 61.56 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.603 1.161 . . . . 0.0 109.295 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -163.18 -57.35 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.356 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 124.225 1.01 . . . . 0.0 108.802 179.401 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 42' ' ' ASP . 27.3 mm -116.19 134.07 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.525 1.13 . . . . 0.0 109.61 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.0 134.99 19.42 Favored Pre-proline 0 N--CA 1.484 1.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 165.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.51 130.4 24.99 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.687 2.258 . . . . 0.0 111.676 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 41' ' ' ARG . 18.8 pt -125.09 163.72 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.92 0.888 . . . . 0.0 109.995 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -156.3 146.58 21.48 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 12.6 mmm180 -117.72 140.33 49.82 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.988 1.315 . . . . 0.0 108.506 170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.448 HG23 HG23 ' A' ' 34' ' ' ILE . 28.9 m -111.52 122.2 47.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.432 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 5.6 tp-100 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.2 m -119.64 132.82 68.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 CA-C-O 121.051 0.453 . . . . 0.0 110.609 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.61 123.29 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -110.09 105.1 14.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 110.485 -162.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 46.2 tt0 -98.55 109.62 22.35 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.664 HG23 HG22 ' A' ' 30' ' ' VAL . 31.4 m -85.99 104.36 15.54 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.574 0.75 . . . . 0.0 110.378 -177.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.7 mp -93.08 129.08 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 122.033 -0.417 . . . . 0.0 110.47 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.201 1.0 . . . . 0.0 108.452 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.433 ' HA ' HG22 ' A' ' 100' ' ' VAL . 71.4 m-85 -97.73 118.28 33.92 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 23.7 mtm180 -143.48 159.65 42.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.477 0.711 . . . . 0.0 109.65 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 81.1 m-85 -86.5 170.92 11.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.213 1.005 . . . . 0.0 109.916 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -69.15 -22.93 63.91 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.566 0.698 . . . . 0.0 110.313 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.62 -20.94 66.11 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.327 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.64 -20.51 46.05 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.39 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.17 136.91 52.55 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 0.0 111.452 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 58.7 t -85.57 109.57 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.211 0.604 . . . . 0.0 110.629 -175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 -49.72 45.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.01 0.524 . . . . 0.0 110.139 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -173.33 90.24 0.08 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.624 1.17 . . . . 0.0 108.624 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -71.19 -25.73 62.65 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -100.25 80.69 2.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.702 0.801 . . . . 0.0 110.386 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -134.18 79.51 1.81 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 165.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 14' ' ' THR . 12.9 t -93.81 118.52 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 113.826 -1.533 . . . . 0.0 108.77 -174.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -102.4 157.71 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 m -143.27 141.75 31.14 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 109.414 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 88.8 mt -99.9 125.89 45.95 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 8' ' ' THR . 3.2 mp -86.06 114.53 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.08 120.2 40.05 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.361 1.464 . . . . 0.0 108.851 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.3 m -100.88 101.73 12.62 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.545 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 2.2 mp0 -89.55 79.52 6.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 37.2 p -85.45 137.08 33.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.48 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.43 -156.25 9.71 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -143.25 135.34 26.95 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HB2' HD13 ' A' ' 5' ' ' ILE . 39.3 ttm180 -107.44 122.13 46.01 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 109.447 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.526 ' HA ' HD13 ' A' ' 2' ' ' ILE . 12.2 t70 -69.63 127.74 34.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.5 mt -83.16 -23.01 33.1 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -71.53 -46.92 58.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.13 0.491 . . . . 0.0 110.006 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -88.71 -32.23 18.06 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.091 172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.56 0.29 73.03 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 -169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -67.22 136.58 55.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.476 1.11 . . . . 0.0 110.846 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.58 107.86 18.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.48 0.712 . . . . 0.0 110.288 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 49' ' ' ILE . 2.9 mp -94.12 91.84 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CH2' ' HG2' ' A' ' 7' ' ' ARG . 36.7 m95 -84.02 124.06 30.66 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 31.6 t70 -52.88 124.43 14.08 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.842 0.714 . . . . 0.0 110.05 -176.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 m -57.85 -37.8 74.51 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.52 0.728 . . . . 0.0 111.621 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -96.93 16.46 19.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.917 0.887 . . . . 0.0 111.206 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.545 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 40.5 t-105 -64.87 142.17 58.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.556 0.342 . . . . 0.0 110.594 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 55.8 p -155.36 140.94 17.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.095 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -116.8 130.44 56.72 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -112.26 124.39 52.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.26 0.624 . . . . 0.0 109.541 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -135.69 141.33 44.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -103.58 126.79 50.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.299 0.64 . . . . 0.0 111.624 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 37.1 m-85 -69.13 112.69 5.9 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -167.81 -169.66 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.56 1.163 . . . . 0.0 109.072 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.96 5.63 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.342 1.057 . . . . 0.0 112.164 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.423 HD23 HG21 ' A' ' 78' ' ' VAL . 31.5 tp -116.63 100.28 53.33 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.804 0.842 . . . . 0.0 108.982 -172.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -92.6 -151.19 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.285 2.657 . . . . 0.0 111.64 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -149.59 145.16 18.65 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.328 0.651 . . . . 0.0 110.204 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.82 127.58 24.91 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.131 2.554 . . . . 0.0 112.003 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -77.23 106.59 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.4 mt -97.2 134.21 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.008 0.923 . . . . 0.0 108.933 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.34 120.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.576 1.55 . . . . 0.0 109.479 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.61 13.58 81.32 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.514 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 93.3 m-85 -139.18 160.76 39.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.53 0.732 . . . . 0.0 110.096 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -151.04 126.36 10.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.4 150.32 35.7 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.749 0.82 . . . . 0.0 111.001 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.8 -29.8 70.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.882 0.739 . . . . 0.0 109.446 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -133.48 96.7 16.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.755 168.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.48 -7.6 21.64 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.794 2.33 . . . . 0.0 111.928 175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 tpt -139.12 126.87 22.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 63' ' ' LEU . 88.3 t -65.65 120.98 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.31 116.46 5.75 Favored Glycine 0 C--N 1.356 1.647 0 O-C-N 124.818 1.324 . . . . 0.0 112.694 -174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 59.9 Cg_endo -70.42 128.96 16.14 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 112.623 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -142.24 135.04 28.46 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.978 0.418 . . . . 0.0 110.776 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.3 103.9 12.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.581 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.6 t -84.03 134.35 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 109.207 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.7 m -121.35 113.78 20.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.363 0.665 . . . . 0.0 109.618 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.17 114.33 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.7 m-20 -82.51 174.52 10.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.364 0.602 . . . . 0.0 109.856 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.4 p -71.43 -22.12 61.88 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.934 172.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.21 4.26 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.126 0.97 . . . . 0.0 109.715 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.66 29.82 3.55 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.323 1.049 . . . . 0.0 110.251 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 9' ' ' GLN . 49.2 t80 -50.94 -48.77 60.77 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.496 1.118 . . . . 0.0 110.634 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.633 ' H ' HD12 ' A' ' 91' ' ' LEU . 1.8 mp -82.58 -23.77 34.28 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.512 -1.676 . . . . 0.0 110.653 -161.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -71.99 115.07 10.78 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -88.91 106.93 18.73 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.64 46.36 1.33 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.882 0.849 . . . . 0.0 110.229 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -62.55 157.76 19.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.748 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 78.0 ttt180 -157.15 147.3 20.93 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 -172.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.14 144.74 26.11 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 10.4 tp10 -136.34 108.44 7.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 172.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 84.3 m -100.65 122.6 43.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.241 0.617 . . . . 0.0 109.62 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.463 HG12 ' HG2' ' A' ' 75' ' ' LYS . 2.4 m -90.71 142.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.24 106.01 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.474 0.31 . . . . 0.0 110.432 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 87.2 m-85 -72.75 107.48 5.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.749 1.22 . . . . 0.0 109.682 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 p -108.21 140.26 41.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 100.58 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.16 0.984 . . . . 0.0 110.77 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -76.99 -174.13 3.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.971 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.7 t -69.98 -19.33 63.35 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.916 0.486 . . . . 0.0 112.23 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -68.0 -47.64 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.253 0.621 . . . . 0.0 110.604 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -71.07 -10.57 59.98 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.171 0.51 . . . . 0.0 111.195 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -99.18 177.6 5.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.995 0.918 . . . . 0.0 109.792 173.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 67.1 4.42 3.61 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.758 1.223 . . . . 0.0 113.83 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 66.14 170.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.821 1.248 . . . . 0.0 111.999 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -98.38 -44.38 6.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.213 0.605 . . . . 0.0 110.278 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -79.49 97.97 6.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.683 0.793 . . . . 0.0 110.251 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.38 5.05 85.42 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 115.256 -0.884 . . . . 0.0 113.465 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.28 -31.03 71.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.0 0.92 . . . . 0.0 110.844 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.62 140.51 37.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.67 0.788 . . . . 0.0 109.56 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.79 160.9 27.32 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.146 0.578 . . . . 0.0 110.602 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.7 m80 66.24 91.17 0.09 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.468 1.107 . . . . 0.0 109.874 -175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -170.32 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.703 0.801 . . . . 0.0 110.719 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.3 m80 62.21 -171.89 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.335 1.054 . . . . 0.0 112.096 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -157.12 -57.08 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.175 0.59 . . . . 0.0 110.102 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 124.549 1.14 . . . . 0.0 110.356 -177.422 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG3' HD12 ' A' ' 43' ' ' LEU . 14.7 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.82 0.343 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.481 HD12 ' HD3' ' A' ' 40' ' ' LYS . 35.4 mm -120.2 142.38 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.204 1.002 . . . . 0.0 109.121 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -120.99 149.92 52.09 Favored Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.26 127.78 13.06 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.395 2.064 . . . . 0.0 111.151 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 41' ' ' ARG . 30.9 pt -135.1 137.21 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 2.2 mptm? -137.13 142.11 42.26 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -116.75 137.67 52.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 34' ' ' ILE . 85.1 m -120.71 104.91 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.361 0.664 . . . . 0.0 109.363 -172.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -105.06 119.2 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.086 0.554 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 32' ' ' SER . 35.0 m -97.5 125.86 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.1 t -90.86 104.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -95.9 102.47 14.27 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.852 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.658 HE21 HD11 ' A' ' 15' ' ' ILE . 28.2 tt0 -108.28 113.03 25.8 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 30' ' ' VAL . 95.7 m -92.73 107.53 19.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.865 0.866 . . . . 0.0 109.772 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.658 HD11 HE21 ' A' ' 13' ' ' GLN . 1.6 mp -90.13 130.63 39.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.387 0.613 . . . . 0.0 109.932 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 11.5 m-70 -109.26 110.36 21.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.566 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 100' ' ' VAL . 85.0 m-85 -87.29 116.3 25.28 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.403 HH21 HD11 ' A' ' 101' ' ' ILE . 61.7 mtm180 -134.33 -171.32 2.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.52 0.728 . . . . 0.0 110.528 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -121.43 167.4 12.85 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 177.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.61 -17.98 63.57 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.803 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.45 -17.26 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.627 1.171 . . . . 0.0 111.192 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.55 54.08 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.44 137.98 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.57 1.148 . . . . 0.0 111.244 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.3 137.59 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.208 0.603 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.45 -60.49 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.15 115.29 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.309 1.043 . . . . 0.0 108.893 173.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.628 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 6.8 p-10 -102.3 26.29 7.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.654 0.781 . . . . 0.0 112.862 -173.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.23 10.79 39.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.677 0.791 . . . . 0.0 111.776 -173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -90.13 73.06 7.26 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.167 0.984 . . . . 0.0 111.038 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 14' ' ' THR . 24.3 t -93.63 119.01 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.898 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 63' ' ' LEU . 6.1 p -105.84 130.99 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 60.4 p -122.36 118.34 28.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.619 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 39.7 mt -98.97 122.9 42.83 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -82.83 124.66 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.097 0.959 . . . . 0.0 109.898 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HA ' HD23 ' A' ' 56' ' ' LEU . 85.5 m-85 -115.35 101.82 9.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.194 0.998 . . . . 0.0 109.099 172.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.1 m -95.82 107.7 19.97 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -94.33 123.81 37.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 57.5 p -88.14 138.73 31.19 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.746 0.654 . . . . 0.0 109.663 173.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.21 -171.57 18.01 Favored Glycine 0 C--O 1.241 0.566 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.126 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -136.55 143.84 43.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 5' ' ' ILE . 38.7 ttm180 -114.95 118.62 33.95 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.632 0.373 . . . . 0.0 110.44 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.04 107.11 8.03 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.534 HD12 ' HG3' ' A' ' 1' ' ' MET . 84.4 mt -79.98 -1.31 39.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.927 0.891 . . . . 0.0 112.719 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -73.42 -43.25 60.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.419 0.688 . . . . 0.0 109.927 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.424 HD22 ' HB3' ' A' ' 47' ' ' LYS . 6.0 t30 -100.57 -24.12 14.53 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.925 0.89 . . . . 0.0 109.887 174.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.85 34.11 35.29 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.733 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' HD22 ' A' ' 45' ' ' ASN . 21.9 ptmt -104.13 141.98 35.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.859 0.864 . . . . 0.0 110.777 -172.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG2' ' HE ' ' A' ' 41' ' ' ARG . 42.0 mt-10 -97.92 122.86 41.54 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 123.276 0.63 . . . . 0.0 110.728 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 49' ' ' ILE . 2.6 mp -103.26 105.23 17.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -102.61 137.25 41.09 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -69.12 118.56 12.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 t -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.392 0.677 . . . . 0.0 111.171 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.27 -18.52 60.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.273 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -61.43 128.03 34.34 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 p -153.99 117.44 4.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.941 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 35' ' ' PHE . 57.0 tp -101.22 130.14 47.28 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -95.55 111.07 23.06 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 5.6 tp-100 -112.06 124.66 52.89 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.5 m -64.57 118.52 8.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.527 1.131 . . . . 0.0 110.642 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -106.97 115.03 29.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 59' ' ' THR . 12.3 pt-20 -179.32 -161.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.03 0.932 . . . . 0.0 109.897 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.92 -98.39 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.862 1.265 . . . . 0.0 110.276 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HG ' HG12 ' A' ' 15' ' ' ILE . 3.6 mm? 47.36 91.57 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.767 0.827 . . . . 0.0 111.179 -170.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.81 97.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.566 2.844 . . . . 0.0 112.588 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.0 m -81.99 113.54 43.98 Favored Pre-proline 0 C--O 1.239 0.503 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.487 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' ILE . 17.9 Cg_endo -56.2 121.2 9.57 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.47 2.113 . . . . 0.0 110.432 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.91 103.62 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 66' ' ' PRO . 48.5 mt -107.22 112.91 42.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -76.94 137.87 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.351 0.66 . . . . 0.0 109.786 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.94 4.5 84.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.199 -170.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 95.9 m-85 -142.63 162.76 34.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.575 0.75 . . . . 0.0 111.415 -176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -151.19 135.02 16.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.638 1.175 . . . . 0.0 107.85 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 159.18 29.87 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.791 0.836 . . . . 0.0 111.061 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -60.64 -34.55 74.44 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.551 0.691 . . . . 0.0 109.578 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 105.12 6.64 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.167 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.82 -4.61 15.69 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.102 1.868 . . . . 0.0 111.688 163.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.5 tpp -135.19 107.38 7.2 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 98' ' ' GLU . 95.7 t -83.7 123.41 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.393 0.677 . . . . 0.0 111.701 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.81 53.58 13.42 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 125.022 1.451 . . . . 0.0 115.397 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 72.9 Cg_endo -74.14 80.68 2.12 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.251 1.967 . . . . 0.0 111.851 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -158.48 119.42 3.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.12 0.568 . . . . 0.0 109.703 -176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.01 100.85 0.45 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 123.967 0.792 . . . . 0.0 111.058 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.4 112.17 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.991 0.916 . . . . 0.0 110.548 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.4 m -94.97 101.23 12.99 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.324 0.65 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.91 124.64 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.94 170.38 16.56 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.994 0.809 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 16.7 t -70.46 -27.0 63.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.34 171.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.27 -49.82 62.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.718 1.207 . . . . 0.0 111.34 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -104.38 23.1 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.837 0.455 . . . . 0.0 111.21 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 52.7 t80 -58.94 -53.46 58.18 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.349 1.059 . . . . 0.0 112.696 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.95 -4.37 37.77 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.259 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.93 134.11 44.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.571 0.748 . . . . 0.0 110.019 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -90.19 172.57 8.7 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.181 0.593 . . . . 0.0 109.939 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.93 15.06 4.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.768 0.827 . . . . 0.0 110.784 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -162.62 -165.86 1.24 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 108.856 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -177.74 -53.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.381 0.672 . . . . 0.0 109.858 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -145.03 115.53 7.63 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.654 -170.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HG2' HG13 ' A' ' 78' ' ' VAL . 16.7 tp10 -107.25 148.29 29.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.825 1.25 . . . . 0.0 109.777 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -136.85 117.84 14.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.26 0.624 . . . . 0.0 109.975 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -86.7 141.75 13.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.403 HD11 HH21 ' A' ' 18' ' ' ARG . 30.9 mm -112.23 120.55 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 56.7 m-85 -80.21 117.79 21.32 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.77 0.828 . . . . 0.0 109.501 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 90.1 p -110.93 158.43 18.76 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 119.16 8.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.143 0.577 . . . . 0.0 110.638 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -75.53 -169.02 0.93 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.911 0.884 . . . . 0.0 112.902 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 14.6 t -50.96 -21.75 1.91 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.558 1.543 . . . . 0.0 114.587 -177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.65 -44.53 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.98 0.512 . . . . 0.0 111.566 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -85.78 -26.27 25.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.878 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 12.1 mm100 -80.01 167.33 20.59 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.604 0.762 . . . . 0.0 110.656 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -97.16 110.38 22.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 68.48 176.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.832 1.253 . . . . 0.0 112.006 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' HE3' HG21 ' A' ' 106' ' ' THR . 9.5 ptpp? -127.67 -47.03 1.42 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.067 0.547 . . . . 0.0 111.376 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -80.2 108.14 13.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.41 0.684 . . . . 0.0 110.682 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.88 14.94 3.57 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 123.161 0.288 . . . . 0.0 112.422 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.3 mt -87.17 -57.31 3.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.551 0.741 . . . . 0.0 109.611 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 60.02 -75.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.867 1.667 . . . . 0.0 112.454 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -88.15 128.09 35.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.919 1.287 . . . . 0.0 109.954 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 41.0 m80 67.96 139.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.874 1.269 . . . . 0.0 112.764 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.77 152.5 17.75 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.355 0.662 . . . . 0.0 110.406 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -68.55 -18.41 64.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.203 1.001 . . . . 0.0 111.964 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 29.7 m80 76.84 107.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.95 1.7 . . . . 0.0 110.102 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 . . . . . 0 C--O 1.25 1.108 0 C-N-CA 124.203 1.001 . . . . 0.0 111.197 -176.755 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.0 mm -114.09 154.12 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.692 1.197 . . . . 0.0 109.841 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.23 150.73 49.81 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.86 0.864 . . . . 0.0 108.797 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.1 124.22 4.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 121.897 1.731 . . . . 0.0 111.674 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.626 HD13 ' HB2' ' A' ' 41' ' ' ARG . 35.4 pt -121.55 171.67 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.373 0.669 . . . . 0.0 111.292 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.49 146.68 4.17 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.115 0.884 . . . . 0.0 110.738 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -106.97 165.33 11.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.796 0.838 . . . . 0.0 110.21 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' ILE . 93.1 m -131.88 106.29 7.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.145 0.978 . . . . 0.0 109.608 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -114.29 103.4 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 27.8 m -89.89 132.23 35.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 121.017 0.437 . . . . 0.0 109.85 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 94' ' ' GLN . 75.8 t -99.79 107.75 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -96.03 107.64 19.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.666 0.786 . . . . 0.0 110.89 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.453 HE21 HG11 ' A' ' 78' ' ' VAL . 3.2 tp60 -88.79 113.53 24.44 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 m -107.85 106.95 17.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 108.418 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 63' ' ' LEU . 19.0 tt -104.13 137.71 31.83 Favored 'Isoleucine or valine' 0 C--O 1.265 1.87 0 CA-C-O 122.229 1.014 . . . . 0.0 111.88 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -115.78 161.18 19.12 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.94 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.61 109.5 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.037 0.935 . . . . 0.0 108.872 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 32.1 mtm180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.245 0.618 . . . . 0.0 109.768 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 87.7 m-85 -88.52 176.05 7.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.454 0.702 . . . . 0.0 110.291 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.14 -22.28 60.55 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.468 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.46 -19.71 60.88 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.677 0.791 . . . . 0.0 110.607 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 -10.44 53.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.318 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.54 136.15 57.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.671 0.789 . . . . 0.0 111.076 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 56.0 t -80.35 111.9 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.645 0.378 . . . . 0.0 110.307 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.62 -56.88 5.46 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -165.92 -175.35 3.36 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.704 1.602 . . . . 0.0 109.038 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.59 -161.22 0.28 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.039 0.936 . . . . 0.0 108.64 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 73.69 35.91 0.8 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.214 1.006 . . . . 0.0 109.799 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -111.37 121.32 44.93 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -131.18 144.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.031 0.532 . . . . 0.0 110.536 -173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -136.95 121.25 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -119.37 131.2 55.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.692 0.797 . . . . 0.0 109.245 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 96.5 mt -105.2 129.11 53.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.158 0.583 . . . . 0.0 110.005 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.57 HG23 HG23 ' A' ' 8' ' ' THR . 2.7 mp -87.53 111.9 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 123.972 0.795 . . . . 0.0 108.956 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HA ' HD23 ' A' ' 56' ' ' LEU . 41.3 m-85 -94.19 101.03 13.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 m -92.74 104.14 16.44 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -81.14 97.14 7.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 110.131 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.2 p -76.03 139.3 41.38 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.585 0.553 . . . . 0.0 110.453 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.48 -160.33 9.66 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.639 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 143.47 29.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HB2' HD13 ' A' ' 5' ' ' ILE . 36.0 ttm180 -112.39 128.8 56.41 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.329 0.652 . . . . 0.0 110.489 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 2' ' ' ILE . 16.3 t0 -72.59 121.99 20.64 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.94 -21.31 34.12 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.79 0.836 . . . . 0.0 112.289 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -77.23 -49.76 14.39 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -171.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.36 -28.4 21.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.567 0.747 . . . . 0.0 109.676 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.91 30.51 20.42 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.354 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.74 136.36 42.7 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.323 1.049 . . . . 0.0 110.06 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -91.65 120.18 32.19 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.093 0.557 . . . . 0.0 110.358 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.31 116.65 36.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -114.28 136.9 52.46 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 6.8 m-20 -64.12 125.73 25.43 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 m -62.1 -41.9 98.68 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.758 0.661 . . . . 0.0 111.088 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.91 7.73 26.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.656 0.782 . . . . 0.0 111.984 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 81.0 t90 -61.46 132.62 54.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -155.33 123.02 5.66 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.049 0.939 . . . . 0.0 108.807 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 35' ' ' PHE . 22.9 tp -109.07 135.05 50.85 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -112.14 116.45 30.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.84 0.856 . . . . 0.0 108.871 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -119.93 144.66 47.32 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.815 0.446 . . . . 0.0 110.141 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.505 HG22 ' HG2' ' A' ' 61' ' ' GLU . 31.6 m -88.93 113.05 24.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.587 1.155 . . . . 0.0 112.24 -167.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.543 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 2.7 m-85 -99.98 102.38 13.73 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.935 0.894 . . . . 0.0 109.7 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' THR . 11.7 pt-20 -163.39 -165.68 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.285 0.634 . . . . 0.0 109.697 173.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.32 17.04 10.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.351 1.06 . . . . 0.0 111.807 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.449 HD11 HG21 ' A' ' 15' ' ' ILE . 43.0 tp -102.0 99.7 12.97 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.995 0.918 . . . . 0.0 109.078 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -92.68 -165.34 0.14 Allowed 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.529 2.819 . . . . 0.0 113.344 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -150.67 146.41 19.54 Favored Pre-proline 0 CA--C 1.557 1.218 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.755 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.66 139.4 48.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.536 2.824 . . . . 0.0 113.079 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.87 107.8 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.59 130.49 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.47 129.99 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.3 86.99 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.893 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 86.8 m-85 -140.37 146.31 38.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.34 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.0 m -144.03 134.08 24.15 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.655 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -66.58 156.61 34.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.639 0.775 . . . . 0.0 111.66 -175.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -65.63 -25.01 67.18 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.811 0.844 . . . . 0.0 110.214 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.35 85.19 6.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 171.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 -7.32 21.1 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.187 1.925 . . . . 0.0 112.982 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.4 ttt -146.61 95.37 2.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.709 1.204 . . . . 0.0 107.946 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 75' ' ' LYS . 53.9 t -71.81 111.14 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.679 0.792 . . . . 0.0 109.911 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.59 84.74 0.25 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.797 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 60' ' ' PHE . 28.2 Cg_exo -65.44 0.04 3.18 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.593 2.862 . . . . 0.0 113.655 166.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 72.35 -88.39 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.881 1.672 . . . . 0.0 110.555 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -141.74 139.09 32.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.892 0.877 . . . . 0.0 110.517 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.3 t -116.03 120.33 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.16 0.984 . . . . 0.0 108.963 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.4 m -99.24 101.87 13.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.414 0.686 . . . . 0.0 109.596 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.33 125.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.16 168.0 16.21 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.139 0.976 . . . . 0.0 110.336 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 54' ' ' TRP . 22.6 t -62.49 -27.47 69.15 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.267 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.74 -56.73 17.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.429 1.492 . . . . 0.0 110.773 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -105.19 15.38 27.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.648 0.779 . . . . 0.0 111.599 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -61.53 -24.5 66.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 0.0 111.185 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.28 -24.77 61.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.784 0.834 . . . . 0.0 111.156 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.0 136.11 33.42 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 109.264 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.66 138.89 33.55 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 11' ' ' VAL . 44.1 mt-30 -100.24 57.45 0.95 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.93 96.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -90.11 142.57 27.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.942 1.297 . . . . 0.0 109.864 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.68 125.09 10.93 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -134.91 141.56 46.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.473 0.709 . . . . 0.0 110.046 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.2 m -107.27 131.65 53.97 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.655 ' HB ' ' HB1' ' A' ' 73' ' ' ALA . 6.3 m -83.78 139.43 17.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 170.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.01 107.56 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 122.883 0.473 . . . . 0.0 110.196 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . 93.6 m-85 -74.96 103.33 5.12 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.08 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.0 p -111.72 147.96 34.49 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' HB1' HG23 ' A' ' 108' ' ' THR . . . -53.86 126.4 22.14 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.03 0.831 . . . . 0.0 110.356 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -74.63 165.01 25.93 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.268 0.355 . . . . 0.0 110.433 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.416 HG21 ' HD2' ' A' ' 117' ' ' HIS . 3.8 t -46.1 -35.9 5.35 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.776 1.23 . . . . 0.0 113.093 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.406 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 54.1 mt -61.27 -48.15 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.314 1.046 . . . . 0.0 111.044 -175.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.523 HG23 ' HB1' ' A' ' 104' ' ' ALA . 14.8 t -94.74 -14.91 24.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.192 -173.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.23 147.57 52.05 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.736 0.414 . . . . 0.0 111.963 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.92 128.39 36.25 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 166.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 58.79 88.62 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.171 0.919 . . . . 0.0 110.105 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 107' ' ' ILE . 60.5 mttp -70.14 -56.08 7.77 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.15 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.51 -77.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.261 1.424 . . . . 0.0 109.451 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.75 21.57 71.23 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.28 -41.88 89.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.147 0.979 . . . . 0.0 109.474 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -112.76 156.52 22.7 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.933 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.416 ' HD2' HG21 ' A' ' 106' ' ' THR . 36.7 m80 -128.19 164.85 21.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.801 0.84 . . . . 0.0 108.775 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 63.71 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.888 0.875 . . . . 0.0 110.405 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.98 130.21 42.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.361 0.665 . . . . 0.0 110.615 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -63.35 -57.49 10.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.472 0.709 . . . . 0.0 111.26 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -152.59 3.73 0.35 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.213 0.605 . . . . 0.0 111.125 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 71.6 t60 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.0 140.2 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.577 0.751 . . . . 0.0 109.618 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -121.91 151.77 58.44 Favored Pre-proline 0 N--CA 1.476 0.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.92 121.4 3.61 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.512 1.475 . . . . 0.0 109.955 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 41' ' ' ARG . 17.4 pt -109.8 169.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.845 0.858 . . . . 0.0 109.483 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.94 141.35 11.24 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.198 0.523 . . . . 0.0 111.036 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -112.36 136.26 52.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 34' ' ' ILE . 87.3 m -114.01 107.81 16.17 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.695 0.798 . . . . 0.0 109.752 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -101.4 113.21 26.09 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.273 0.629 . . . . 0.0 109.445 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 21.7 m -96.6 146.36 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 94' ' ' GLN . 68.5 t -105.77 104.29 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.616 ' HB ' HD22 ' A' ' 95' ' ' ASN . 22.8 m -101.33 103.15 14.1 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 110.081 -171.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 12.8 mm100 -94.92 113.2 24.89 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.978 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.545 ' HB ' ' HG2' ' A' ' 97' ' ' GLU . 85.1 m -92.64 104.41 16.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 29' ' ' HIS . 2.0 mp -93.01 131.52 39.81 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 CA-C-O 121.527 0.679 . . . . 0.0 110.25 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -133.83 118.62 18.2 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.126 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' HA ' HG13 ' A' ' 100' ' ' VAL . 56.2 m-85 -78.61 130.49 35.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.522 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 41.9 mtm180 -141.45 162.06 36.41 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 123.931 0.892 . . . . 0.0 109.314 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -89.54 175.08 7.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.73 -25.1 68.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.409 0.684 . . . . 0.0 112.097 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.52 -20.14 61.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.127 0.971 . . . . 0.0 111.104 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.03 3.29 60.54 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.373 0.421 . . . . 0.0 112.652 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.6 130.03 39.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.504 0.721 . . . . 0.0 109.532 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 34.9 t -82.55 103.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.274 0.488 . . . . 0.0 109.975 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 18' ' ' ARG . . . -61.28 -39.59 91.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.337 0.655 . . . . 0.0 111.087 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -168.81 145.82 3.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.695 0.798 . . . . 0.0 109.005 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -137.52 109.99 7.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.408 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 174.55 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 124.689 1.243 . . . . 0.0 112.494 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.423 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 2.5 t-160 -75.99 78.64 2.86 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.88 0.738 . . . . 0.0 112.398 -155.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 14' ' ' THR . 48.2 t -92.44 128.36 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.96 166.03 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.4 p -156.85 141.62 16.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.551 0.74 . . . . 0.0 109.803 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 10.8 tp -121.86 123.48 41.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 122.585 0.354 . . . . 0.0 111.323 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 8' ' ' THR . 2.4 mp -91.98 120.49 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.729 0.812 . . . . 0.0 109.663 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 89.9 m-85 -115.71 110.13 18.69 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.012 0.925 . . . . 0.0 109.209 173.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 m -103.24 102.04 12.0 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.683 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -85.97 99.33 11.36 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.5 t -89.64 133.4 34.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.422 0.629 . . . . 0.0 110.159 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.53 -156.35 9.29 Favored Glycine 0 C--O 1.242 0.617 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.832 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 144.67 37.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.969 0.508 . . . . 0.0 109.718 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.458 ' HB2' HD13 ' A' ' 5' ' ' ILE . 14.9 ttm-85 -115.17 129.94 56.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.866 0.466 . . . . 0.0 109.978 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 2.0 m-20 -75.4 113.83 13.24 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.6 -8.02 56.4 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.402 0.681 . . . . 0.0 111.411 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 t -78.68 -44.05 24.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.499 0.72 . . . . 0.0 110.925 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -101.57 -21.0 14.83 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.353 0.661 . . . . 0.0 112.055 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.75 25.74 71.21 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 42' ' ' ASP . 21.3 ptmt -95.88 138.56 33.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.333 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -106.57 116.39 31.85 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.577 0.751 . . . . 0.0 110.266 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.6 mp -101.05 102.65 13.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -104.26 152.77 21.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.128 0.971 . . . . 0.0 108.936 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.55 120.98 40.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.378 0.671 . . . . 0.0 110.089 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -74.98 -15.24 60.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.157 0.583 . . . . 0.0 112.172 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -85.38 -3.6 58.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.103 0.561 . . . . 0.0 111.103 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.48 ' HH2' ' HB3' ' A' ' 35' ' ' PHE . 88.3 t90 -60.77 128.03 34.56 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 p -155.31 114.51 3.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.6 tp -133.55 130.24 38.16 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 t -99.86 142.39 31.39 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.007 0.523 . . . . 0.0 109.7 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -123.22 145.02 49.0 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HG3' ' A' ' 61' ' ' GLU . 4.7 m -70.44 118.03 12.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.076 1.351 . . . . 0.0 110.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 115.92 29.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' A' ' 59' ' ' THR . 0.0 OUTLIER -168.6 -155.78 0.16 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.33 1.052 . . . . 0.0 109.014 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 65.19 11.74 7.45 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.41 1.084 . . . . 0.0 111.819 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.48 100.28 8.99 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 87.2 Cg_endo -85.09 -173.35 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.547 2.165 . . . . 0.0 111.92 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.0 p -146.47 131.15 8.83 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.65 120.52 7.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.456 2.104 . . . . 0.0 111.039 172.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.65 105.95 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -106.72 114.46 45.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.2 mm -71.7 138.94 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 123.515 0.51 . . . . 0.0 109.785 -174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.17 8.66 85.15 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.961 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 96.8 m-85 -140.31 152.04 45.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.663 0.785 . . . . 0.0 110.074 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 m -134.28 115.67 14.39 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.39 150.94 45.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.927 0.891 . . . . 0.0 111.362 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.01 -39.37 75.88 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.698 0.761 . . . . 0.0 109.008 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -129.62 92.97 36.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.34 -1.3 . . . . 0.0 107.812 169.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.58 -4.92 14.03 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.636 2.224 . . . . 0.0 112.516 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 23.4 ttt -145.8 108.73 4.56 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 168.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.594 HG13 ' HG2' ' A' ' 98' ' ' GLU . 76.7 t -70.5 115.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.199 0.312 . . . . 0.0 111.574 -173.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 52.59 63.38 4.98 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.913 1.383 . . . . 0.0 114.862 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.57 77.7 3.35 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.316 2.011 . . . . 0.0 110.136 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -155.82 148.42 23.95 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.72 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -80.25 106.78 12.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -80.28 128.26 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 m -111.11 123.84 51.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.053 0.541 . . . . 0.0 110.544 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HA ' HD21 ' A' ' 89' ' ' ASN . 77.1 t -113.56 122.79 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.175 0.59 . . . . 0.0 109.521 172.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.47 162.12 13.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 29.7 m -58.3 -29.84 66.18 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.686 0.794 . . . . 0.0 112.335 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -65.83 -31.94 73.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.416 1.086 . . . . 0.0 111.563 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.528 HD21 ' HA ' ' A' ' 85' ' ' VAL . 2.9 p-10 -115.86 19.24 15.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.367 0.667 . . . . 0.0 111.191 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 84.1 t80 -74.59 -33.01 62.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.26 0.624 . . . . 0.0 112.591 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.74 -22.8 56.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.111 0.564 . . . . 0.0 109.598 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -81.67 136.49 35.5 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.701 170.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -100.3 159.08 15.41 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.672 ' HB2' HG13 ' A' ' 11' ' ' VAL . 55.4 mt-30 -109.4 34.12 3.95 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.616 HD22 ' HB ' ' A' ' 12' ' ' THR . 27.9 t-20 -58.82 101.14 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.898 0.879 . . . . 0.0 110.251 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 28.3 tpt180 -133.34 142.24 48.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.641 0.777 . . . . 0.0 110.404 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 14' ' ' THR . 40.2 mt-10 -90.56 119.1 30.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 169.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.594 ' HG2' HG13 ' A' ' 78' ' ' VAL . 10.5 tp10 -105.09 114.51 28.76 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.8 m -91.61 132.46 36.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.626 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -106.85 119.0 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.96 109.99 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 66.4 m-85 -80.49 101.32 9.02 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.543 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 m -91.64 152.36 20.28 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.599 ' HB1' HG23 ' A' ' 108' ' ' THR . . . -49.21 133.49 19.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.379 0.536 . . . . 0.0 110.023 173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.36 155.23 21.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.854 0.862 . . . . 0.0 109.989 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -45.9 -34.11 3.66 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.004 1.321 . . . . 0.0 113.81 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.8 mm -72.47 -46.85 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.954 0.501 . . . . 0.0 110.549 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.599 HG23 ' HB1' ' A' ' 104' ' ' ALA . 14.9 t -91.81 3.3 55.45 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.424 0.69 . . . . 0.0 111.717 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -67.4 110.54 3.63 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -125.54 160.44 29.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.402 1.081 . . . . 0.0 108.788 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -90.32 101.38 14.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.415 0.686 . . . . 0.0 109.563 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -138.47 -55.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.335 1.054 . . . . 0.0 108.604 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.28 -169.59 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.997 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.97 18.09 18.71 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.1 -77.81 0.14 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -178.56 123.88 0.1 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 108.451 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -81.37 82.8 7.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 122.516 1.15 . . . . 0.0 108.667 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -66.88 91.0 0.19 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.465 -2.152 . . . . 0.0 111.795 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -89.02 -10.4 47.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.112 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -74.5 85.21 2.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.703 0.401 . . . . 0.0 110.371 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 50.75 85.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 112.488 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.7 p80 . . . . . 0 CA--C 1.556 1.191 0 C-N-CA 122.95 0.5 . . . . 0.0 110.093 -178.267 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.906 0.384 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.0 mm -106.61 138.82 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.494 1.118 . . . . 0.0 109.302 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -118.97 141.25 29.88 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 44.3 Cg_endo -68.12 128.11 17.05 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.27 1.98 . . . . 0.0 110.513 171.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 41' ' ' ARG . 13.4 pt -132.15 137.06 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -133.77 140.8 47.18 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.352 -0.217 . . . . 0.0 111.023 -170.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -101.92 151.51 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.234 1.014 . . . . 0.0 109.063 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.403 HG23 HG23 ' A' ' 34' ' ' ILE . 92.4 m -123.55 109.19 13.48 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.813 0.845 . . . . 0.0 110.436 -177.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -112.25 125.92 54.67 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 25.5 m -105.08 141.49 20.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.801 HG21 HG11 ' A' ' 83' ' ' VAL . 43.0 t -100.72 105.56 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -98.84 106.52 18.79 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.108 -170.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -93.19 95.87 9.66 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' GLU . 90.1 m -85.02 136.14 33.71 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.3 mt -137.3 134.94 47.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.411 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 42.0 m170 -103.58 119.28 38.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.839 172.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' OH ' HD12 ' A' ' 63' ' ' LEU . 93.8 m-85 -91.67 121.06 32.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 24' ' ' VAL . 3.5 tpt180 -144.04 158.7 43.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -90.37 172.48 8.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.56 0.744 . . . . 0.0 109.773 172.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 101' ' ' ILE . 15.0 pt-20 -62.98 -43.31 99.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.921 0.888 . . . . 0.0 111.911 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.03 -16.63 61.49 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.444 1.098 . . . . 0.0 111.451 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 16.69 23.37 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.518 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.48 147.27 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.231 0.515 . . . . 0.0 110.171 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 81.4 t -75.68 121.05 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.114 0.566 . . . . 0.0 110.524 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.42 -57.88 2.63 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 166.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 29' ' ' HIS . 22.1 t60 -172.8 75.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.071 0.948 . . . . 0.0 108.499 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' HIS . 8.6 p-10 -88.36 57.43 4.24 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.469 0.652 . . . . 0.0 111.545 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -168.37 18.44 0.02 OUTLIER 'General case' 0 C--N 1.356 0.861 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.503 ' HB2' ' HD2' ' A' ' 26' ' ' HIS . 5.4 t60 -104.36 129.71 52.25 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.707 0.685 . . . . 0.0 110.461 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 14' ' ' THR . 43.3 t -129.65 135.36 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.39 1.076 . . . . 0.0 110.514 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.66 154.63 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 51.8 p -148.5 143.41 26.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.644 0.778 . . . . 0.0 110.683 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 58' ' ' GLN . 60.7 mt -106.23 125.41 50.96 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.652 0.781 . . . . 0.0 108.893 174.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.403 HG23 HG23 ' A' ' 8' ' ' THR . 2.5 mp -95.52 102.61 13.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HD2' ' HB3' ' A' ' 56' ' ' LEU . 96.9 m-85 -93.79 102.03 14.15 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.099 0.96 . . . . 0.0 109.338 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 103.64 14.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.341 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.33 101.89 11.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.577 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 63.5 p -73.33 148.91 43.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.221 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.01 -177.07 24.5 Favored Glycine 0 N--CA 1.465 0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.992 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 139.59 42.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.613 0.706 . . . . 0.0 110.564 -177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 5' ' ' ILE . 20.9 ttm-85 -116.28 122.62 45.48 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.954 0.502 . . . . 0.0 110.186 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.83 112.34 13.32 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.59 -10.74 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 t -72.86 -53.49 11.28 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.764 0.826 . . . . 0.0 110.399 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.29 -18.6 19.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.614 0.765 . . . . 0.0 111.267 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.19 26.93 62.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.506 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -94.46 128.51 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.829 0.851 . . . . 0.0 110.318 -176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.33 111.04 23.17 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.092 0.957 . . . . 0.0 109.963 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.29 107.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -101.35 117.27 34.61 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -70.19 121.27 17.24 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 123.402 0.439 . . . . 0.0 109.997 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 t -63.3 -36.12 82.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.798 1.239 . . . . 0.0 112.009 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -78.29 -7.66 57.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.719 0.408 . . . . 0.0 110.897 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.95 127.62 33.08 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.243 0.544 . . . . 0.0 109.918 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.8 p -137.49 157.16 47.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.589 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.504 HD12 HE21 ' A' ' 58' ' ' GLN . 0.4 OUTLIER -130.77 124.23 30.94 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 m -115.72 122.29 45.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.348 0.659 . . . . 0.0 109.704 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.598 ' HB2' HD13 ' A' ' 33' ' ' LEU . 76.4 mt-30 -122.35 145.3 48.39 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.376 0.67 . . . . 0.0 109.42 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.581 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 30.6 m -69.38 125.75 27.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.313 1.045 . . . . 0.0 110.708 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.42 109.13 15.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.8 -171.83 0.4 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.362 1.465 . . . . 0.0 109.23 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.22 86.62 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.545 1.138 . . . . 0.0 112.393 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -98.59 115.11 65.89 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.527 0.731 . . . . 0.0 109.29 -178.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.9 80.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.96 3.106 . . . . 0.0 113.262 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 p -95.13 137.47 22.18 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.819 0.848 . . . . 0.0 110.982 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -44.54 125.77 6.4 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.133 3.222 . . . . 0.0 114.223 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.9 t -85.97 108.94 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 172.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.58 132.45 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.288 0.635 . . . . 0.0 109.315 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.79 124.1 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.31 3.88 88.41 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.302 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -136.06 149.62 48.83 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.815 0.808 . . . . 0.0 109.747 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -137.87 131.05 30.45 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.7 57.05 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.552 0.533 . . . . 0.0 109.924 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -68.13 -31.79 71.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.69 98.65 7.04 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.559 1.144 . . . . 0.0 108.739 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.34 -6.02 18.13 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.357 2.038 . . . . 0.0 112.383 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.609 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 36.1 ttm -136.99 120.51 17.11 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.054 0.942 . . . . 0.0 108.646 177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.39 143.09 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.673 0.789 . . . . 0.0 109.627 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.38 57.89 17.45 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.294 0.996 . . . . 0.0 112.453 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -85.48 56.91 4.38 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.753 2.302 . . . . 0.0 111.245 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -154.64 120.38 5.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.504 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 59' ' ' THR . 1.8 mp0 -48.2 123.42 6.37 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 125.371 1.669 . . . . 0.0 111.027 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.801 HG11 HG21 ' A' ' 11' ' ' VAL . 81.4 t -89.65 121.11 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 123.659 0.6 . . . . 0.0 110.728 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 m -104.81 112.41 25.51 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 89' ' ' ASN . 95.3 t -99.76 109.39 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 13.7 t70 -95.51 166.67 11.74 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.2 m -57.23 -33.77 67.89 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.332 0.653 . . . . 0.0 111.711 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 20.7 ptmt -67.4 -36.3 81.02 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.841 0.857 . . . . 0.0 111.745 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' A' ' 85' ' ' VAL . 4.6 p-10 -115.85 27.61 9.18 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.886 0.875 . . . . 0.0 110.035 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -64.61 -37.05 86.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.382 0.673 . . . . 0.0 111.399 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.92 -6.44 56.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.472 0.309 . . . . 0.0 110.666 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.89 135.42 34.15 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.229 0.538 . . . . 0.0 110.984 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.04 -25.66 17.84 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 0.0 111.751 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.425 HE21 HG22 ' A' ' 85' ' ' VAL . 26.9 pt20 51.91 12.29 0.18 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 127.577 2.351 . . . . 0.0 116.077 171.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -151.01 153.46 35.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.92 . . . . 0.0 109.428 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.52 -159.61 0.98 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.829 -167.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 14' ' ' THR . 1.8 tm-20 -90.9 112.74 24.73 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.301 0.64 . . . . 0.0 109.275 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -112.47 125.11 53.88 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.149 0.98 . . . . 0.0 109.665 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.9 m -91.13 133.41 35.37 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.51 0.724 . . . . 0.0 109.958 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.54 144.45 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 20' ' ' GLU . 40.8 mm -114.52 111.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 122.864 0.466 . . . . 0.0 111.582 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -82.82 105.49 13.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.564 1.146 . . . . 0.0 109.254 172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 p -110.97 146.02 37.37 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.25 104.35 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.46 1.1 . . . . 0.0 110.121 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -71.38 177.04 4.16 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.929 0.892 . . . . 0.0 111.732 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.4 t -62.05 -26.7 68.42 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.288 0.635 . . . . 0.0 111.983 -175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.5 mm -61.05 -51.93 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.79 0.836 . . . . 0.0 111.251 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -73.17 -26.13 61.07 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.442 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -67.23 -17.24 64.73 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.11 0.564 . . . . 0.0 111.993 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -69.41 160.95 30.41 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.059 0.457 . . . . 0.0 110.269 174.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -76.66 84.88 3.31 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.54 -78.0 0.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.599 1.16 . . . . 0.0 108.072 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -94.62 -177.65 4.29 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.99 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.04 39.74 62.88 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -171.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.71 -52.13 61.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 0.0 109.541 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 49.0 53.21 12.97 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.047 1.739 . . . . 0.0 112.381 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -71.89 87.47 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -89.25 79.87 7.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.024 -164.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -90.38 -30.59 17.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.157 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -66.1 146.94 54.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.051 0.94 . . . . 0.0 108.747 172.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -69.64 -47.1 64.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 120.891 0.377 . . . . 0.0 110.932 -171.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.649 0.78 . . . . 0.0 109.378 176.631 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 43' ' ' LEU . 13.4 tpt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 42' ' ' ASP . 40.7 mm -121.21 155.6 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 124.579 1.152 . . . . 0.0 109.3 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 41' ' ' ARG . 8.8 pt-20 -128.38 149.94 72.91 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 167.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.34 128.16 11.01 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 122.063 1.842 . . . . 0.0 111.377 168.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 41' ' ' ARG . 26.5 pt -126.24 168.44 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.12 0.568 . . . . 0.0 110.445 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.73 143.22 19.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.462 0.705 . . . . 0.0 109.651 174.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.447 ' HG2' ' HE2' ' A' ' 90' ' ' PHE . 22.9 tpp180 -105.41 161.01 14.69 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 34' ' ' ILE . 21.6 m -130.2 108.47 10.06 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.45 0.7 . . . . 0.0 109.285 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.517 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp-100 -112.44 117.73 33.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 33.3 m -102.15 134.59 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 120.81 0.338 . . . . 0.0 110.202 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.6 t -93.43 108.93 21.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -94.55 98.89 11.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.521 0.728 . . . . 0.0 109.747 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -96.29 97.41 9.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.368 0.604 . . . . 0.0 109.807 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 HG22 ' A' ' 30' ' ' VAL . 29.8 m -92.17 138.91 31.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.489 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 118' ' ' HIS . 1.8 mp -122.56 139.75 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -106.62 146.74 30.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.899 1.28 . . . . 0.0 108.335 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -114.65 111.2 20.95 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -175.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' VAL . 26.5 mmt85 -126.84 168.19 14.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.641 0.777 . . . . 0.0 109.445 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -105.8 172.22 6.92 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.977 0.911 . . . . 0.0 108.612 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.06 -22.49 63.06 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.519 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -69.52 -21.99 63.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.856 0.862 . . . . 0.0 111.503 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.78 -3.41 55.97 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.65 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.79 157.9 37.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.657 0.783 . . . . 0.0 110.871 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 12.3 t -102.18 123.9 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . . . -76.17 -47.28 24.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' H ' ' HB2' ' A' ' 17' ' ' TYR . 38.1 t-80 -169.96 159.65 7.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.793 0.837 . . . . 0.0 110.125 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -120.73 152.36 38.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.885 0.474 . . . . 0.0 111.815 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 53.53 76.28 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.648 1.579 . . . . 0.0 112.794 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.461 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 51.4 m170 -120.47 112.39 18.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 14' ' ' THR . 47.9 t -119.21 141.2 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.033 0.933 . . . . 0.0 111.461 -162.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.65 116.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 165.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 p -115.29 124.04 50.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.88 0.872 . . . . 0.0 109.642 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 83.6 mt -106.99 134.43 50.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.801 0.441 . . . . 0.0 111.054 -177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -87.6 121.93 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.427 1.091 . . . . 0.0 110.336 -174.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 72.2 m-85 -111.31 104.47 12.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.236 1.014 . . . . 0.0 108.637 173.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -93.05 103.82 16.08 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.114 0.565 . . . . 0.0 110.327 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.63 104.36 15.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.8 p -72.1 163.75 27.37 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.138 0.494 . . . . 0.0 111.074 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.23 -158.27 22.91 Favored Glycine 0 C--O 1.238 0.362 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 139.21 17.59 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.03 0.532 . . . . 0.0 110.042 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm-85 -102.34 129.35 48.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.47 ' HA ' HD13 ' A' ' 2' ' ' ILE . 32.5 t70 -77.02 118.38 19.53 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 1' ' ' MET . 83.9 mt -82.55 -9.1 59.55 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -169.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -94.92 -30.41 14.17 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.31 0.504 . . . . 0.0 111.458 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.01 -30.25 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.909 0.484 . . . . 0.0 110.254 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.18 2.58 77.18 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.222 -174.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.03 45.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.253 0.621 . . . . 0.0 109.693 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -105.37 118.49 36.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.787 0.835 . . . . 0.0 110.054 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.4 107.6 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -95.76 165.16 12.44 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.899 0.88 . . . . 0.0 109.831 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 29.6 m-20 -75.15 113.45 12.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.2 m -75.61 -23.84 56.46 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.851 0.46 . . . . 0.0 111.393 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -85.96 -3.99 59.06 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.798 0.839 . . . . 0.0 111.369 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 80.5 t90 -60.3 128.98 39.4 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.191 0.52 . . . . 0.0 109.684 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -154.84 113.57 3.58 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.67 140.48 48.19 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 82' ' ' GLU . 5.3 t -108.7 153.94 22.73 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -148.06 144.26 27.75 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.477 HG22 ' HG2' ' A' ' 61' ' ' GLU . 24.1 m -79.16 109.49 13.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.222 1.009 . . . . 0.0 112.927 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -102.61 102.02 12.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.288 0.635 . . . . 0.0 109.505 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' HG2' HG22 ' A' ' 59' ' ' THR . 13.0 pt-20 -173.87 -169.86 0.52 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.727 0.811 . . . . 0.0 109.416 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 70.95 20.68 5.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.754 ' HB3' ' HA ' ' A' ' 118' ' ' HIS . 2.3 mm? -92.54 110.33 44.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.107 0.563 . . . . 0.0 110.298 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HG2' ' HB3' ' A' ' 119' ' ' HIS . 90.2 Cg_endo -85.09 -146.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.74 2.96 . . . . 0.0 111.149 173.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.498 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 2.1 m -162.55 163.37 18.18 Favored Pre-proline 0 N--CA 1.495 1.782 0 C-N-CA 124.341 1.056 . . . . 0.0 110.192 174.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.69 125.41 15.42 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 121.882 1.721 . . . . 0.0 110.428 169.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.42 107.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.0 mt -100.84 122.07 52.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -72.8 128.64 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.049 0.94 . . . . 0.0 111.01 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.96 1.5 89.75 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.35 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -126.6 159.78 32.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 0.0 110.689 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.52 ' HB ' ' HG3' ' A' ' 109' ' ' GLN . 52.0 m -145.35 135.52 23.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.176 1.391 . . . . 0.0 107.493 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -71.11 139.32 50.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.074 0.55 . . . . 0.0 111.086 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HA ' HE22 ' A' ' 109' ' ' GLN . 11.9 t70 -69.36 -18.44 63.79 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.48 1.912 . . . . 0.0 110.551 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.786 ' HD3' ' HA ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -148.92 82.64 7.09 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 29.9 Cg_endo -90.26 23.03 0.7 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.541 2.827 . . . . 0.0 114.12 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.66 144.63 27.29 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 170.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.542 HG22 ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -131.34 136.61 57.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 164.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.32 71.0 0.2 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 78' ' ' VAL . 53.0 Cg_exo -58.26 -16.42 28.15 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.35 2.033 . . . . 0.0 110.773 162.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 59' ' ' THR . 29.7 t70 74.23 -71.53 0.13 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 126.682 1.993 . . . . 0.0 109.71 172.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 61.6 mt-10 -140.16 134.47 31.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.953 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.56 124.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.3 m -100.12 123.94 44.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.178 0.591 . . . . 0.0 109.853 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.21 121.39 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.26 161.96 16.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.294 1.038 . . . . 0.0 109.403 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 54' ' ' TRP . 68.2 m -62.02 -29.08 70.03 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.004 0.431 . . . . 0.0 110.942 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.53 -46.61 89.53 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.037 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -100.07 2.79 43.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.095 0.558 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' HE2' ' HG2' ' A' ' 7' ' ' ARG . 79.1 t80 -62.09 -33.84 75.19 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.119 0.968 . . . . 0.0 113.345 -168.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.59 -27.21 66.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.109 0.48 . . . . 0.0 110.157 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -93.73 156.88 16.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.189 0.995 . . . . 0.0 109.189 170.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.517 ' HE2' ' OE1' ' A' ' 9' ' ' GLN . 18.4 ptpt -119.39 139.0 52.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.78 40.29 1.14 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.577 0.703 . . . . 0.0 109.656 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 95' ' ' ASN . 0.1 OUTLIER -51.27 149.53 3.92 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.304 168.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -152.59 115.84 4.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.834 0.349 . . . . 0.0 111.281 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -104.51 110.68 23.05 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -121.67 171.39 8.88 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 110.283 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.8 m -130.9 134.49 46.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.374 0.669 . . . . 0.0 111.598 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.786 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 3.7 m -98.26 142.0 15.29 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 123.319 0.647 . . . . 0.0 110.227 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -114.08 114.82 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 0.0 110.318 -175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -88.96 103.29 15.9 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -97.96 174.43 6.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.27 156.25 15.95 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' OD1' HG22 ' A' ' 106' ' ' THR . 6.5 t-20 -51.13 166.9 0.09 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.392 1.077 . . . . 0.0 112.937 -167.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.436 HG22 ' OD1' ' A' ' 105' ' ' ASN . 12.5 t -44.64 -20.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.615 1.566 . . . . 0.0 114.637 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.1 mt -42.02 -62.44 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.162 1.385 . . . . 0.0 111.54 169.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 t -111.46 -4.04 14.98 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.817 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.52 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -64.11 140.19 58.84 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.919 0.887 . . . . 0.0 111.052 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -129.25 155.93 44.78 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.461 1.104 . . . . 0.0 109.073 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 69.07 151.81 0.09 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.847 1.259 . . . . 0.0 111.669 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -161.48 -54.67 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 43.73 -82.0 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.204 1.802 . . . . 0.0 113.748 170.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.76 63.89 0.37 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 mt -105.8 -46.55 4.1 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -136.46 154.52 50.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.355 0.662 . . . . 0.0 111.182 176.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.591 ' HA ' HG11 ' A' ' 100' ' ' VAL . 3.1 t-160 178.89 153.25 0.38 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.454 1.102 . . . . 0.0 108.663 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.754 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 2.6 t60 -163.52 145.5 9.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.522 ' HB3' ' HG2' ' A' ' 64' ' ' PRO . 43.9 t60 -165.98 130.4 2.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.727 1.211 . . . . 0.0 107.928 160.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -141.21 130.2 23.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.853 0.861 . . . . 0.0 109.195 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -87.68 130.41 34.81 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.176 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG2' HD12 ' A' ' 43' ' ' LEU . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.499 HD12 ' HD3' ' A' ' 40' ' ' LYS . 41.6 mm -107.87 142.98 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.939 0.896 . . . . 0.0 109.998 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.6 148.59 65.2 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.058 0.543 . . . . 0.0 109.94 166.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.2 125.53 10.36 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 0.0 110.506 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 41' ' ' ARG . 45.0 pt -125.68 154.95 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.177 0.513 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' HZ3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -159.68 145.86 16.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.832 173.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -111.15 156.68 21.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.335 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.486 HG23 HG23 ' A' ' 34' ' ' ILE . 59.2 m -129.49 122.19 28.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.263 0.625 . . . . 0.0 110.284 -172.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' OE1' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp-100 -122.76 107.16 11.59 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 34' ' ' ILE . 4.2 m -92.62 133.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 94' ' ' GLN . 69.3 t -102.02 124.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 173.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -123.05 115.34 21.69 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -164.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.667 HE21 ' HG3' ' A' ' 80' ' ' PRO . 8.4 mm-40 -89.47 104.71 17.24 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.413 1.085 . . . . 0.0 111.068 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -95.35 112.5 24.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.154 0.982 . . . . 0.0 109.176 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 98' ' ' GLU . 87.2 mt -111.58 131.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.508 0.671 . . . . 0.0 111.083 -170.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -112.06 116.28 30.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.403 ' HB3' ' HE2' ' A' ' 102' ' ' TYR . 34.2 m-85 -86.02 107.08 17.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -133.26 156.85 46.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.915 0.886 . . . . 0.0 109.476 -174.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -89.15 176.4 6.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.4 0.68 . . . . 0.0 110.949 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -65.74 -24.9 67.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.135 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.84 -7.78 58.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.782 0.833 . . . . 0.0 111.225 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.27 82.57 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.95 150.68 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.092 0.557 . . . . 0.0 109.957 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.7 t -74.41 127.03 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.093 0.557 . . . . 0.0 110.563 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.44 -62.99 1.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -159.52 99.77 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.308 1.043 . . . . 0.0 109.566 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.97 171.44 15.2 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.624 -0.672 . . . . 0.0 110.875 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 t70 57.54 80.33 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.496 1.118 . . . . 0.0 111.679 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -130.94 91.99 3.14 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.85 127.47 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.699 . . . . 0.0 110.918 -169.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.98 149.97 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.1 p -144.46 144.64 31.47 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.923 0.392 . . . . 0.0 110.884 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.68 124.08 51.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.181 0.992 . . . . 0.0 109.109 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 10' ' ' VAL . 1.8 mp -94.9 109.29 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.351 1.06 . . . . 0.0 108.894 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HB3' ' HH2' ' A' ' 54' ' ' TRP . 57.9 m-85 -97.36 99.08 10.53 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -98.82 103.29 15.23 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.403 0.681 . . . . 0.0 109.749 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.46 108.88 14.46 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 t -92.5 159.16 15.65 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.376 0.67 . . . . 0.0 110.742 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.02 -161.93 26.07 Favored Glycine 0 C--O 1.238 0.375 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.716 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.499 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -144.15 142.02 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.216 0.606 . . . . 0.0 109.392 177.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 5' ' ' ILE . 15.8 ttm180 -104.74 125.11 50.49 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.713 0.405 . . . . 0.0 110.122 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.86 106.59 8.62 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 1' ' ' MET . 96.2 mt -75.78 -2.76 31.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.986 0.914 . . . . 0.0 112.171 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -42.37 60.88 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.527 0.731 . . . . 0.0 109.932 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.04 -24.62 14.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.816 0.846 . . . . 0.0 111.234 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.46 16.09 72.11 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.994 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -87.99 143.51 27.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.432 0.693 . . . . 0.0 111.142 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.46 107.65 19.91 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.529 1.132 . . . . 0.0 110.508 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.62 97.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 6' ' ' LYS . 59.8 m95 -90.31 171.89 9.15 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.065 0.946 . . . . 0.0 109.406 171.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 54' ' ' TRP . 26.9 m-20 -76.82 115.73 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 164.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -62.17 -31.68 72.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.108 0.563 . . . . 0.0 110.324 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -92.04 15.45 13.31 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.688 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 90.5 t90 -70.4 127.86 34.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 81.0 p -154.86 115.53 3.92 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.768 1.227 . . . . 0.0 107.805 170.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 35' ' ' PHE . 62.5 tp -103.57 132.97 49.36 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 m -110.23 115.42 29.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.804 0.842 . . . . 0.0 109.516 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -129.34 132.52 47.12 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.543 0.737 . . . . 0.0 109.126 175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.4 m -85.34 135.21 33.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.156 0.583 . . . . 0.0 111.266 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.06 104.92 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 160.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.7 -174.09 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.349 1.06 . . . . 0.0 108.589 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 60.97 21.78 12.05 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.755 0.822 . . . . 0.0 112.824 170.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.37 114.13 65.55 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.27 -165.92 0.31 Allowed 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 123.055 2.503 . . . . 0.0 113.31 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 76' ' ' PRO . 59.7 p -157.18 146.98 15.44 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 118.47 5.36 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 121.999 1.799 . . . . 0.0 110.286 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.52 104.63 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.03 119.01 41.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.48 132.27 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 123.839 0.712 . . . . 0.0 109.812 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.43 12.43 80.44 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 119.373 -0.681 . . . . 0.0 112.86 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 87.5 m-85 -137.25 148.97 46.81 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.752 0.821 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -110.31 126.95 54.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.795 1.638 . . . . 0.0 107.729 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.8 143.96 26.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.938 0.79 . . . . 0.0 109.987 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -37.33 78.37 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.261 0.625 . . . . 0.0 110.938 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -146.91 98.32 4.11 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 170.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 63.3 Cg_endo -68.28 -8.07 21.87 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.466 2.111 . . . . 0.0 112.511 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ttt -143.78 105.77 4.36 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.24 111.59 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.28 78.74 0.24 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.667 ' HG3' HE21 ' A' ' 13' ' ' GLN . 61.4 Cg_endo -71.23 -0.63 8.37 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.825 2.35 . . . . 0.0 113.446 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 76.1 -159.68 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.009 1.324 . . . . 0.0 112.456 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.97 128.73 31.53 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.87 109.83 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.134 1.374 . . . . 0.0 107.91 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.8 m -98.31 128.73 44.88 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.73 115.07 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.9 p30 -90.7 173.08 8.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.764 0.826 . . . . 0.0 110.196 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -60.2 -29.93 69.03 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.417 1.087 . . . . 0.0 113.206 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -82.68 -38.33 23.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.103 0.561 . . . . 0.0 110.668 -175.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.45 8.95 40.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -62.99 -24.57 67.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.717 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.71 -21.41 55.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 110.299 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.65 118.43 33.1 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.176 0.991 . . . . 0.0 110.924 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HB3' ' OE1' ' A' ' 9' ' ' GLN . 21.1 pttp -83.87 127.78 34.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 164.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 11' ' ' VAL . 36.8 mt-30 -86.78 42.4 1.01 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -64.03 121.36 13.96 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.574 0.702 . . . . 0.0 110.535 -175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -113.93 145.41 41.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -116.02 110.05 18.38 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.612 ' HB2' HG12 ' A' ' 15' ' ' ILE . 17.4 mm-40 -93.18 155.97 17.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.766 0.793 . . . . 0.0 110.725 175.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.2 m -142.28 107.53 4.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.888 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -79.33 137.82 21.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mm -108.87 122.62 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.403 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 94.0 m-85 -88.77 106.09 18.13 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.725 1.21 . . . . 0.0 109.413 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 p -112.47 130.39 56.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.17 129.14 23.71 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.028 0.931 . . . . 0.0 113.152 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -54.31 -179.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.517 1.527 . . . . 0.0 114.037 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -66.01 -12.74 57.29 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.609 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.0 mm -56.76 -50.17 75.67 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 123.965 0.906 . . . . 0.0 110.34 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 t -73.54 -18.22 61.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.233 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -93.77 -164.67 1.2 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.554 1.141 . . . . 0.0 109.29 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.736 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 41.9 m-80 -95.32 -177.76 4.22 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 164.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -82.73 94.59 7.64 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 86.25 -39.53 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 127.634 2.374 . . . . 0.0 111.156 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.736 ' HB3' ' HB2' ' A' ' 110' ' ' ASN . 1.3 p-10 39.91 -94.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.458 1.903 . . . . 0.0 113.428 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.48 35.13 88.19 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.13 0.395 . . . . 0.0 113.476 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.27 -82.77 0.08 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.037 0.535 . . . . 0.0 110.256 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.48 -30.06 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.582 0.753 . . . . 0.0 111.449 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 35.5 m170 62.42 104.82 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.904 1.282 . . . . 0.0 110.289 -168.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -62.64 150.09 41.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -60.79 132.46 53.94 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.171 0.588 . . . . 0.0 110.01 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -82.08 57.32 3.49 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.192 0.996 . . . . 0.0 111.64 -175.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -143.27 86.7 1.92 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.596 1.159 . . . . 0.0 107.956 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.933 0.893 . . . . 0.0 109.821 -173.137 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 42' ' ' ASP . 37.9 mm -113.95 151.21 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.386 0.675 . . . . 0.0 109.315 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.77 151.3 77.84 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.225 0.61 . . . . 0.0 110.011 170.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.75 133.79 28.43 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.606 2.204 . . . . 0.0 111.986 171.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 41' ' ' ARG . 11.6 pt -142.57 137.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 38' ' ' SER . 1.8 mptm? -133.72 154.26 51.08 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.487 0.715 . . . . 0.0 109.114 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG2' ' CH2' ' A' ' 50' ' ' TRP . 23.7 mmm180 -121.82 149.65 43.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 108.307 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 34' ' ' ILE . 27.1 m -122.26 108.05 12.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 6.2 tp-100 -105.37 148.98 26.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 28.6 m -124.98 123.78 66.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 110.197 173.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.56 115.54 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -96.37 152.03 18.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.091 0.957 . . . . 0.0 111.275 -171.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.701 ' HG3' ' HB2' ' A' ' 96' ' ' ARG . 52.9 tt0 -125.77 107.89 10.96 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -82.61 106.54 14.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.313 0.645 . . . . 0.0 110.791 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 1.8 mp -99.6 133.11 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 121.533 0.682 . . . . 0.0 109.844 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -111.88 125.68 54.29 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -97.41 123.66 41.33 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 24' ' ' VAL . 70.8 mtp180 -141.52 -173.86 3.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.757 0.823 . . . . 0.0 110.648 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.14 164.69 14.77 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.634 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.4 -26.17 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.838 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.96 -19.16 64.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.157 1.383 . . . . 0.0 110.849 175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.97 -14.45 63.9 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.96 153.27 29.82 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 111.364 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 25.9 t -92.52 133.86 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.196 0.598 . . . . 0.0 110.164 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.26 -54.09 3.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 0.0 110.184 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -157.24 96.21 1.54 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.652 1.181 . . . . 0.0 108.804 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.66 142.39 32.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 68.63 86.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.039 1.336 . . . . 0.0 111.417 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -141.16 92.79 2.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -111.2 133.68 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -166.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.0 p -108.48 137.13 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.4 m -113.32 137.72 51.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.93 0.492 . . . . 0.0 110.442 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 97.2 mt -98.92 123.36 43.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.424 HG23 HG23 ' A' ' 8' ' ' THR . 2.1 mp -99.85 105.4 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.019 0.927 . . . . 0.0 108.664 -173.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -97.28 107.61 20.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.893 0.877 . . . . 0.0 110.096 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 m -83.81 103.09 12.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.447 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 32.6 tt0 -85.53 107.79 17.63 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 17.0 p -91.65 139.64 30.49 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.64 -167.13 16.03 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 136.68 35.42 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.29 0.545 . . . . 0.0 110.75 -175.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HB2' HD13 ' A' ' 5' ' ' ILE . 25.7 ttm180 -103.58 122.21 44.51 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.821 0.449 . . . . 0.0 110.176 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.438 ' HA ' HD13 ' A' ' 2' ' ' ILE . 8.0 t70 -74.67 113.28 11.75 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 124.598 1.159 . . . . 0.0 108.582 169.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.7 mt -84.66 -4.44 59.01 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 t -87.11 -36.32 18.17 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.644 0.656 . . . . 0.0 110.86 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.04 -31.09 11.61 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.57 63.65 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.916 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 133.53 45.88 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.018 0.927 . . . . 0.0 110.138 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.55 113.93 27.72 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.353 0.661 . . . . 0.0 110.081 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.98 104.29 15.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.495 ' CZ2' HD12 ' A' ' 5' ' ' ILE . 55.2 m95 -103.75 119.86 39.78 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.88 131.06 43.2 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.78 0.675 . . . . 0.0 110.711 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -64.5 -26.28 68.36 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.297 0.998 . . . . 0.0 110.215 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -64.29 -22.25 66.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.69 0.796 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.447 ' NE1' ' HA ' ' A' ' 37' ' ' GLN . 67.8 t-105 -74.32 127.17 32.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.458 0.474 . . . . 0.0 109.896 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.1 p -153.87 144.53 22.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.514 1.126 . . . . 0.0 109.528 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 tt -134.12 125.18 27.42 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.4 m -107.92 127.64 53.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -130.8 140.19 50.26 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 91.8 m -101.56 132.83 47.0 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 111.117 -175.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.2 m-85 -72.52 102.46 3.24 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.71 141.96 28.53 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.2 1.0 . . . . 0.0 108.307 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.79 108.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.401 1.08 . . . . 0.0 110.77 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.32 107.14 21.4 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.55 102.89 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.213 2.609 . . . . 0.0 112.92 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.4 m -98.64 134.06 22.02 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.131 0.972 . . . . 0.0 110.62 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 120.66 7.97 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.67 2.247 . . . . 0.0 110.583 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.07 107.25 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mt -102.33 114.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.0 mm -75.62 137.86 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.53 87.42 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.346 -172.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 97.9 m-85 -141.75 162.33 35.74 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.393 0.677 . . . . 0.0 110.26 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -147.24 120.03 8.66 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.95 148.23 52.13 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 123.799 0.687 . . . . 0.0 109.456 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.5 -33.6 73.09 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.787 0.68 . . . . 0.0 109.277 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.9 97.71 7.07 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.612 168.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.72 -6.23 17.34 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.199 1.932 . . . . 0.0 111.568 162.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tpt -128.47 125.61 38.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.388 1.075 . . . . 0.0 108.384 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.489 HG11 HE22 ' A' ' 13' ' ' GLN . 29.9 t -86.12 130.26 36.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 109.403 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.75 161.16 49.34 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 124.365 1.041 . . . . 0.0 113.418 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.5 118.81 5.91 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 123.206 2.604 . . . . 0.0 113.672 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 22.4 m-20 -109.79 94.54 5.08 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.711 0.805 . . . . 0.0 109.715 173.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -72.47 91.67 1.4 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.17 0.588 . . . . 0.0 110.768 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 85' ' ' VAL . 74.8 t -85.52 103.03 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.873 0.869 . . . . 0.0 110.183 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.1 m -90.17 106.54 18.55 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.401 0.68 . . . . 0.0 109.548 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HA ' HD21 ' A' ' 89' ' ' ASN . 85.4 t -106.5 110.7 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 170.98 12.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.411 1.084 . . . . 0.0 108.23 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.3 m -65.7 -23.8 66.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.324 166.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -67.53 -45.28 76.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.978 1.311 . . . . 0.0 110.694 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 85' ' ' VAL . 3.4 p-10 -113.66 29.64 7.84 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.724 0.81 . . . . 0.0 109.892 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 9' ' ' GLN . 59.9 t80 -62.07 -46.53 88.68 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.616 0.767 . . . . 0.0 111.78 -174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.5 -1.09 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.48 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.01 149.69 25.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.888 0.875 . . . . 0.0 109.459 170.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -108.57 144.07 36.75 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.471 0.708 . . . . 0.0 109.699 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.4 40.11 3.75 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.37 103.67 1.69 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.583 -168.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.701 ' HB2' ' HG3' ' A' ' 13' ' ' GLN . 28.2 mmm180 -76.42 156.41 33.16 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.458 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.87 132.15 18.48 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.453 0.301 . . . . 0.0 110.454 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 47.1 mt-10 -141.75 138.33 32.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.516 0.726 . . . . 0.0 110.643 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.5 m -109.03 115.28 29.76 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.41 141.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.08 113.55 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.747 0.419 . . . . 0.0 110.151 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 63.2 m-85 -84.05 110.45 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.995 0.918 . . . . 0.0 108.877 173.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -99.63 143.56 29.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.81 123.92 10.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.572 0.749 . . . . 0.0 109.295 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -45.75 158.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.592 1.957 . . . . 0.0 113.317 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.546 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 11.2 t -47.78 -20.48 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.886 1.274 . . . . 0.0 113.294 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.2 mm -50.58 -53.48 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.3 1.04 . . . . 0.0 111.428 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -87.39 -30.74 20.53 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 106' ' ' THR . 75.6 mt-30 -64.53 -61.45 2.21 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.182 0.515 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 64.66 -85.99 0.02 OUTLIER 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.579 1.551 . . . . 0.0 109.861 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.2 mttm 56.78 -169.91 0.09 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.575 1.15 . . . . 0.0 111.785 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -104.23 -36.69 7.56 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 164.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.77 -166.18 0.21 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.952 1.301 . . . . 0.0 109.612 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.69 37.06 92.15 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 119.544 1.066 . . . . 0.0 111.296 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.25 -60.83 2.88 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 110.138 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -173.29 157.07 3.27 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -86.15 93.25 8.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 167.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -82.25 85.68 6.79 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.723 0.773 . . . . 0.0 110.986 -169.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.97 -70.14 0.74 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 168.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 52.37 -88.17 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.861 1.664 . . . . 0.0 112.687 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 38.8 m80 73.35 -60.37 0.54 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.893 1.677 . . . . 0.0 112.274 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 N--CA 1.485 1.314 0 C-N-CA 124.827 1.251 . . . . 0.0 110.112 -177.691 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' HD3' ' A' ' 40' ' ' LYS . 29.4 mm -118.72 119.86 62.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.409 1.084 . . . . 0.0 110.037 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 43' ' ' LEU . 10.5 pt-20 -97.88 137.42 20.93 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 167.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.98 122.95 8.53 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.909 1.739 . . . . 0.0 110.355 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 41' ' ' ARG . 42.0 pt -119.34 161.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.401 0.68 . . . . 0.0 110.368 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 136.82 12.82 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -96.83 154.34 17.35 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.617 HG23 HG23 ' A' ' 34' ' ' ILE . 76.6 m -128.54 105.45 8.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -99.48 102.14 13.6 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 23.6 m -91.13 117.5 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.7 t -89.75 107.1 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.3 m -92.49 102.22 14.67 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.488 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 9.5 tt0 -91.73 105.24 17.57 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.561 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.9 p -92.91 106.21 18.2 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 98' ' ' GLU . 19.9 mt -97.29 132.5 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.724 0.773 . . . . 0.0 111.681 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -116.75 118.09 31.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.98 -1.464 . . . . 0.0 107.056 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -87.33 115.41 24.73 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 43.0 ttt-85 -147.37 145.42 29.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.635 0.374 . . . . 0.0 110.518 -171.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -79.48 163.2 24.92 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.477 1.111 . . . . 0.0 111.031 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.99 -28.32 69.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.452 0.701 . . . . 0.0 110.324 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.54 -20.03 65.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.048 1.339 . . . . 0.0 112.042 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.74 -10.25 66.42 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.869 -176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.29 54.14 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.564 0.746 . . . . 0.0 109.494 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 27' ' ' ASP . 39.8 t -86.76 124.89 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.88 -43.91 51.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.541 0.737 . . . . 0.0 110.857 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -166.25 119.22 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.309 1.043 . . . . 0.0 108.531 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB2' HG11 ' A' ' 24' ' ' VAL . 22.7 t70 -98.19 162.2 13.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.23 0.612 . . . . 0.0 110.037 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 61.97 73.76 0.46 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.822 1.249 . . . . 0.0 112.323 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -127.62 83.7 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 171.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -102.35 127.23 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.599 -171.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 p -117.48 134.91 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -130.01 127.71 40.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 50.3 mt -108.81 131.23 55.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.609 0.764 . . . . 0.0 110.655 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.617 HG23 HG23 ' A' ' 8' ' ' THR . 3.0 mp -82.05 113.07 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.148 0.979 . . . . 0.0 109.619 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -103.99 103.75 13.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.514 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 85.5 m -91.95 107.17 19.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.93 0.892 . . . . 0.0 111.23 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HA ' ' NE1' ' A' ' 54' ' ' TRP . 8.0 tt0 -86.63 107.78 18.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.0 p -78.19 169.58 18.03 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.851 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.95 -158.93 22.94 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.449 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HD3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -149.35 144.85 26.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.706 0.802 . . . . 0.0 109.531 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' HD13 ' A' ' 5' ' ' ILE . 37.4 ttm180 -119.25 119.9 35.44 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.953 0.501 . . . . 0.0 110.566 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.8 113.81 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.206 1.002 . . . . 0.0 108.803 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 3' ' ' GLU . 52.0 mt -82.86 -6.63 59.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -73.55 -48.32 33.94 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.071 0.548 . . . . 0.0 110.533 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 47' ' ' LYS . 5.5 t30 -93.07 -26.44 17.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.967 0.507 . . . . 0.0 110.928 176.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.24 54.36 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.071 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HG3' HD11 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -95.41 137.59 34.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.708 0.803 . . . . 0.0 110.918 -174.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -98.58 113.79 25.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.862 0.865 . . . . 0.0 110.148 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 47' ' ' LYS . 3.2 mp -100.15 110.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -100.35 139.15 36.43 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 12.7 t70 -68.01 108.53 3.1 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.8 p -77.12 -9.88 59.03 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.189 0.596 . . . . 0.0 112.29 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -97.74 -1.13 44.07 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.339 0.656 . . . . 0.0 111.262 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 62.3 t-105 -66.48 150.52 48.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.435 0.694 . . . . 0.0 110.826 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.4 p -151.73 135.84 16.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' A' ' 36' ' ' THR . 1.4 tm? -111.51 124.1 51.58 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 m -99.94 127.82 46.09 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.762 0.825 . . . . 0.0 108.845 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LEU . 8.5 tp-100 -139.62 132.33 28.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 17.1 m -75.02 105.07 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.33 0.652 . . . . 0.0 112.056 -171.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.44 100.13 3.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 161.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -109.32 157.45 18.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.331 1.052 . . . . 0.0 110.138 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -46.69 114.99 0.93 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.943 1.697 . . . . 0.0 114.376 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' A' ' 15' ' ' ILE . 3.7 mm? -82.36 124.3 78.27 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.51 100.52 0.23 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.735 2.29 . . . . 0.0 112.349 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 t -86.19 104.53 5.63 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.84 122.32 11.15 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.044 2.496 . . . . 0.0 112.475 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.23 107.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.53 135.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.648 0.779 . . . . 0.0 108.938 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.33 118.89 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.495 -172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.66 8.09 68.13 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.154 -173.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 102' ' ' TYR . 81.5 m-85 -141.21 136.52 31.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.816 0.846 . . . . 0.0 111.014 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.1 m -118.78 124.76 48.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 108.597 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.54 138.48 53.32 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.347 0.659 . . . . 0.0 110.971 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.91 -27.4 65.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.424 1.09 . . . . 0.0 110.593 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 94.5 7.29 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.058 0.943 . . . . 0.0 108.661 169.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.55 -5.45 16.9 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.432 2.088 . . . . 0.0 112.19 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.9 tpt -131.62 110.42 10.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.283 1.033 . . . . 0.0 108.487 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.05 129.08 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 77.13 0.56 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -167.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -97.57 8.13 1.26 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.371 2.047 . . . . 0.0 114.618 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -162.38 172.77 15.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.251 1.024 . . . . 0.0 112.838 -169.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 59' ' ' THR . 33.9 mt-10 -85.46 129.77 34.74 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.341 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.8 t -111.51 140.14 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.027 0.931 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.6 m -112.12 120.98 43.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.799 0.84 . . . . 0.0 109.964 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -97.46 118.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.68 157.33 16.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.615 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 68.0 m -58.71 -33.64 70.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.74 0.816 . . . . 0.0 112.461 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.52 -30.29 69.07 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -117.64 24.24 11.21 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.192 0.997 . . . . 0.0 110.065 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 34.5 t80 -62.65 -34.17 76.53 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.096 0.558 . . . . 0.0 111.998 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.63 -1.37 50.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.875 0.87 . . . . 0.0 111.704 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -101.16 163.07 12.46 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.93 0.892 . . . . 0.0 110.509 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -84.46 175.35 9.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.936 0.894 . . . . 0.0 111.103 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -121.9 -36.84 2.94 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 165.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -171.86 158.09 4.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.426 1.491 . . . . 0.0 107.87 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 76.7 mtm180 -138.92 -87.99 0.22 Allowed 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.09 109.99 22.65 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -166.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' HB2' HG12 ' A' ' 15' ' ' ILE . 71.0 mm-40 -118.04 114.23 22.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.564 1.145 . . . . 0.0 109.609 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 83.4 m -106.63 122.06 45.58 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.74 132.81 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 30.1 mm -104.18 122.15 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.886 0.475 . . . . 0.0 110.67 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . 97.0 m-85 -91.71 108.91 20.25 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.077 0.951 . . . . 0.0 109.974 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 m -98.29 131.42 44.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.798 0.839 . . . . 0.0 109.786 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.76 7.9 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.059 0.944 . . . . 0.0 111.015 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 1.9 m-20 -58.72 152.77 18.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.835 1.254 . . . . 0.0 111.628 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 t -58.56 -24.55 61.05 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.584 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -65.61 -47.92 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.614 1.166 . . . . 0.0 110.591 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -80.25 -16.84 53.8 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.492 0.317 . . . . 0.0 111.125 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 105' ' ' ASN . 84.9 mm-40 -64.66 -48.47 74.64 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 173.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 56.9 -81.05 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.922 1.389 . . . . 0.0 111.366 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.1 89.21 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -96.06 -44.14 7.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.288 0.635 . . . . 0.0 109.682 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.56 171.38 15.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.733 0.813 . . . . 0.0 109.653 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.28 55.24 19.43 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -169.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.39 -73.89 0.07 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.333 1.053 . . . . 0.0 111.211 -171.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 68.93 -43.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 127.204 2.202 . . . . 0.0 113.228 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -78.9 128.88 33.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.802 0.841 . . . . 0.0 110.574 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -168.94 73.34 0.09 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.961 0.886 . . . . 0.0 110.235 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -73.34 -44.5 58.69 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -163.57 171.78 15.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.801 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -91.91 149.02 21.78 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.291 . . . . . . . . 0 0 . 1 stop_ save_